PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, HS; Nishanian, TG; Mood, K; Bong, YS; Daar, IO				Lee, Hyun-Shik; Nishanian, Tagvor G.; Mood, Kathleen; Bong, Yong-Sik; Daar, Ira O.			EphrinB1 controls cell-cell junctions through the Par polarity complex	NATURE CELL BIOLOGY			English	Article							COLORECTAL-CANCER PROGRESSION; RECEPTOR TYROSINE KINASE; EPH RECEPTOR; EPITHELIAL TIGHT; XENOPUS EMBRYOS; PROTEIN PAR6; EYE FIELD; REVERSE; ADHESION; PHOSPHORYLATION	A body of evidence is emerging that shows a requirement for ephrin ligands in the proper migration of cells, and the formation of cell and tissue boundaries. These processes are dependent on the cell-cell adhesion system, which plays a crucial role in normal morphogenetic processes during development, as well as in invasion and metastasis(1-9). Although ephrinB ligands are bi-directional signalling molecules, the precise mechanism by which ephrinB1 signals through its intracellular domain to regulate cell-cell adhesion in epithelial cells remains unclear. Here, we present evidence that ephrinB1 associates with the Par polarity complex protein Par-6 (a scaffold protein required for establishing tight junctions) and can compete with the small GTPase Cdc42 for association with Par-6. This competition causes inactivation of the Par complex, resulting in the loss of tight junctions. Moreover, the interaction between ephrinB1 and Par-6 is disrupted by tyrosine phosphorylation of the intracellular domain of ephrinB1. Thus, we have identified a mechanism by which ephrinB1 signalling regulates cell-cell junctions in epithelial cells, and this may influence how we devise therapeutic interventions regarding these molecules in metastatic disease.	[Lee, Hyun-Shik; Nishanian, Tagvor G.; Mood, Kathleen; Bong, Yong-Sik; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Daar, IO (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov	Lee, Hyun-Shik/G-3555-2011	Daar, Ira/0000-0003-2657-526X	Intramural NIH HHS [Z01 BC010006-12, Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010006, ZIABC010958] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Moody SA, 2000, METH MOL B, V135, P331; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang J, 2006, J PATHOL, V208, P453, DOI 10.1002/path.1937	35	67	67	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					979	986		10.1038/ncb1758	http://dx.doi.org/10.1038/ncb1758			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604196	Green Accepted			2022-12-25	WOS:000258147100016
J	Xu, B; Roos, JL; Levy, S; Van Rensburg, EJ; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Levy, Shawn; Van Rensburg, E. J.; Gogos, Joseph A.; Karayiorgou, Maria			Strong association of de novo copy number mutations with sporadic schizophrenia	NATURE GENETICS			English	Article							CARDIO-FACIAL SYNDROME; BIPOLAR DISORDER; GENES; CITRON; SUSCEPTIBILITY; REARRANGEMENTS; METAANALYSIS; BIOGENESIS; PATHWAYS; DELETION	Schizophrenia is an etiologically heterogeneous psychiatric disease, which exists in familial and nonfamilial (sporadic) forms(1). Here, we examine the possibility that rare de novo copy number (CN) mutations with relatively high penetrance contribute to the genetic component of schizophrenia. We carried out a whole-genome scan and implemented a number of steps for finding and confirming CN mutations. Confirmed de novo mutations were significantly associated with schizophrenia (P = 0.00078) and were collectively similar to 8 times more frequent in sporadic (but not familial) cases with schizophrenia than in unaffected controls. In comparison, rare inherited CN mutations were only modestly enriched in sporadic cases. Our results suggest that rare de novo germline mutations contribute to schizophrenia vulnerability in sporadic cases and that rare genetic lesions at many different loci can account, at least in part, for the genetic heterogeneity of this disease.	[Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Roos, J. Louw] Weskoppies Hosp, ZA-0001 Pretoria, South Africa; [Levy, Shawn] Vanderbilt Univ, Nashville, TN 37232 USA; [Van Rensburg, E. J.] Univ Pretoria, Dept Genet, ZA-0001 Pretoria, South Africa; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Vanderbilt University; University of Pretoria; Columbia University	Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu; mk2758@columbia.edu	van Rensburg, Elizabeth J./B-9104-2011	van Rensburg, Elizabeth/0000-0003-2077-230X; Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, R01MH077235] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA68485] Funding Source: Medline; NEI NIH HHS [P30 EY08126] Funding Source: Medline; NIMH NIH HHS [MH077235, MH061399] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Bennett RL, 1997, AM J HUM GENET, V61, P1450, DOI 10.1086/301634; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Karayiorgou M, 2006, EUR J HUM GENET, V14, P512, DOI 10.1038/sj.ejhg.5201587; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lyons-Warren A, 2005, MOL PSYCHIATR, V10, P807, DOI 10.1038/sj.mp.4001703; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wiehahn GJ, 2004, AM J MED GENET B, V129B, P20, DOI 10.1002/ajmg.b.20168; Yue Y, 1999, J NEUROSCI, V19, P2090	30	617	642	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					880	885		10.1038/ng.162	http://dx.doi.org/10.1038/ng.162			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511947				2022-12-25	WOS:000257166500023
J	Michnick, SW; Sidhu, SS				Michnick, Stephen W.; Sidhu, Sachdev S.			Submitting antibodies to binding arbitration	NATURE CHEMICAL BIOLOGY			English	Editorial Material							PHAGE DISPLAY; SYNTHETIC ANTIBODIES; HUMAN GENOME; LIBRARIES; RECOGNITION; GENERATION; SCAFFOLDS; 1-PERCENT; PEPTIDES; RNA	For the last 30 years, the production of affinity reagents and particularly antibodies for research and therapeutic applications has been dominated by hybridoma and polyclonal technologies, while more modern, reliable and inexpensive approaches have lagged. Here we discuss why this is the case and how a cultural shift in the biomedical research community could bring the new technologies for creating antibodies and other tailor-designed binding proteins into the mainstream, with the potential for myriad new applications in research and medicine.	[Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Michnick, Stephen W.] Univ Montreal, Robert Cedergren Ctr, Montreal, PQ H3C 3J7, Canada; [Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Universite de Montreal; Universite de Montreal; University of Toronto; University of Toronto	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca; sachdev.sidhu@utoronto.ca						Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bradbury A, 2003, TRENDS BIOTECHNOL, V21, P312, DOI 10.1016/S0167-7799(03)00117-3; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; KOHLER G, 1975, NATURE, V256, P497; Lal SP, 2002, DRUG DISCOV TODAY, V7, pS143, DOI 10.1016/S1359-6446(02)02413-3; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Mathonet P, 2004, CURR OPIN STRUC BIOL, V14, P505, DOI 10.1016/j.sbi.2004.06.007; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Uchiyama F, 2005, J BIOSCI BIOENG, V99, P448, DOI 10.1263/jbb.99.448; Wittrup KD, 2001, CURR OPIN BIOTECH, V12, P395, DOI 10.1016/S0958-1669(00)00233-0; Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105	19	26	27	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					326	329		10.1038/nchembio0608-326	http://dx.doi.org/10.1038/nchembio0608-326			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18488004				2022-12-25	WOS:000256068600003
J	Obermeier, B; Mentele, R; Malotka, J; Kellermann, J; Kumpfel, T; Wekerle, H; Lottspeich, F; Hohlfeld, R; Dornmair, K				Obermeier, Birgit; Mentele, Reinhard; Malotka, Joachim; Kellermann, Josef; Kuempfel, Tania; Wekerle, Hartmut; Lottspeich, Friedrich; Hohlfeld, Reinhard; Dornmair, Klaus			Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CLONAL EXPANSION; SOMATIC HYPERMUTATION; B-CELLS; IDENTIFICATION; SEGMENTS; GENES; BRAIN; ANTIBODIES; COMPONENTS	We describe a method for correlating the immunoglobulin (Ig) proteomes with the B cell transcriptomes in human fluid and tissue samples, using multiple sclerosis as a paradigm. Oligoclonal Ig bands and elevated numbers of clonally expanded B cells in the cerebrospinal fluid (CSF) are diagnostic hallmarks of multiple sclerosis. Here we compared the Ig transcriptomes of B cells with the corresponding Ig proteomes in CSF samples from four subjects with multiple sclerosis. We created individual Ig transcriptome databases that contained the subject-specific mutations introduced by V(D) J recombination and somatic hypermutation and then searched the CSF for corresponding characteristic peptides by mass spectrometry. In each sample, the Ig transcriptomes and proteomes strongly overlapped, showing that CSF B cells indeed produce the oligoclonal Ig bands. This approach can be applied to other organ-specific diagnostic fluid or tissue samples to compare the Ig transcripts of local B cells with the corresponding antibody proteomes of individual subjects.	[Obermeier, Birgit; Mentele, Reinhard; Kuempfel, Tania; Hohlfeld, Reinhard; Dornmair, Klaus] Univ Munich, Univ Hosp Grosshadern, Inst Clin Neuroimmunol, D-81377 Munich, Germany; [Obermeier, Birgit; Malotka, Joachim; Wekerle, Hartmut; Hohlfeld, Reinhard; Dornmair, Klaus] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Mentele, Reinhard; Kellermann, Josef; Lottspeich, Friedrich] Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany	University of Munich; Max Planck Society; Max Planck Society	Dornmair, K (corresponding author), Univ Munich, Univ Hosp Grosshadern, Inst Clin Neuroimmunol, Marchioninistr 15, D-81377 Munich, Germany.	dornmair@neuro.mpg.de	Kümpfel, Tania/ABH-1780-2021					Baranzini SE, 1999, J IMMUNOL, V163, P5133; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kabat EA, 1942, J CLIN INVEST, V21, P571, DOI 10.1172/JCI101335; KASCHKA WP, 1979, INFECT IMMUN, V26, P933, DOI 10.1128/IAI.26.3.933-941.1979; LINK H, 1970, CLIN EXP IMMUNOL, V6, P435; LOSY J, 1990, ACTA NEUROL SCAND, V82, P4; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Monson NL, 2005, J NEUROIMMUNOL, V158, P170, DOI 10.1016/j.jneuroim.2004.04.022; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; OBERMEIER B, 2008, NAT PROTOC      0518; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Owens GP, 2007, J IMMUNOL, V179, P6343, DOI 10.4049/jimmunol.179.9.6343; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; VANDVIK B, 1976, SCAND J IMMUNOL, V5, P427, DOI 10.1111/j.1365-3083.1976.tb00297.x; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WARREN KG, 1995, P NATL ACAD SCI USA, V92, P11061, DOI 10.1073/pnas.92.24.11061; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199	25	192	204	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					688	693		10.1038/nm1714	http://dx.doi.org/10.1038/nm1714			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18488038				2022-12-25	WOS:000256468700036
J	Xue, WY; Xing, YZ; Weng, XY; Zhao, Y; Tang, WJ; Wang, L; Zhou, HJ; Yu, SB; Xu, CG; Li, XH; Zhang, QF				Xue, Weiya; Xing, Yongzhong; Weng, Xiaoyu; Zhao, Yu; Tang, Weijiang; Wang, Lei; Zhou, Hongju; Yu, Sibin; Xu, Caiguo; Li, Xianghua; Zhang, Qifa			Natural variation in Ghd7 is an important regulator of heading date and yield potential in rice	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; TIME GENE CONSTANS; RESPONSE REGULATOR; FLOWERING-TIME; PHOTOPERIOD SENSITIVITY; FLORAL INDUCTION; ALPHA-SUBUNIT; PLANT HEIGHT; ORYZA-SATIVA; GRAIN WIDTH	Yield potential, plant height and heading date are three classes of traits that determine the productivity of many crop plants. Here we show that the quantitative trait locus (QTL) Ghd7, isolated from an elite rice hybrid and encoding a CCT domain protein, has major effects on an array of traits in rice, including number of grains per panicle, plant height and heading date. Enhanced expression of Ghd7 under long-day conditions delays heading and increases plant height and panicle size. Natural mutants with reduced function enable rice to be cultivated in temperate and cooler regions. Thus, Ghd7 has played crucial roles for increasing productivity and adaptability of rice globally.	[Xue, Weiya; Xing, Yongzhong; Weng, Xiaoyu; Zhao, Yu; Tang, Weijiang; Wang, Lei; Zhou, Hongju; Yu, Sibin; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	xue, weiya/L-5834-2015; Weng, Xiaoyu/J-4899-2019	weng, xiaoyu/0000-0002-3831-7551; , sibin/0000-0003-0458-7526; Xing, Yongzhong/0000-0003-1376-1514				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Oka H. I., 1988, Origin of cultivated rice.; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng KM, 1998, ACTA BOT SIN, V40, P1108; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Salome PA, 2006, PLANT CELL, V18, P55, DOI 10.1105/tpc.105.037994; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xing YZ, 2001, ACTA BOT SIN, V43, P721; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu SB, 2002, THEOR APPL GENET, V104, P619, DOI 10.1007/s00122-001-0772-5; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	44	1023	1267	24	418	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					761	767		10.1038/ng.143	http://dx.doi.org/10.1038/ng.143			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454147				2022-12-25	WOS:000256212000018
J	Kinchen, JM; Doukoumetzidis, K; Almendinger, J; Stergiou, L; Tosello-Trampont, A; Sifri, CD; Hengartner, MO; Ravichandran, KS				Kinchen, Jason M.; Doukoumetzidis, Kimon; Almendinger, Johann; Stergiou, Lilli; Tosello-Trampont, Annie; Sifri, Costi D.; Hengartner, Michael O.; Ravichandran, Kodi S.			A pathway for phagosome maturation during engulfment of apoptotic cells	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN COMPLEX; DYNAMIN; DOMAIN; REMOVAL; PHAGOCYTOSIS; DEGRADATION; CLEARANCE; TRANSPORT; DEATH	removal of apoptotic cells is critical for the physiological well-being of the organism(1) and defects in corpse removal have been linked to disease states(2,3).Genes regulating corpse recognition and internalization have been identified(4), but few molecules involved in the processing of internalized corpses are known. through a combination of targeted and unbiased reverse genetic screens in Caenorhabditis elegans, and studies in mammalian cells, we have identified genes required for maturation of apoptotic-cell-containing phagosomes. We have further ordered these candidates, which include the GtPases RAB-5 and RAB-7 and the HOPs complex, into a coherent linear pathway for the maturation of apoptotic cells within phagosomes. In-depth analysis of two additional candidate genes, the phosphatidylinositol 3 kinase ( PI( 3) K) vps -34 and dyn- 1/dynamin, showed an accumulation of internalized, but undegraded, corpses within abnormal rab5-negative phagosomes. We ordered these candidates in our pathway, with DYN-1 functioning upstream of VPs-34 in the recruitment and/or retention of RAB-5 in the phagosome. Finally, we have also identified a previously undescribed biochemical complex containing Vps34, dynamin and Rab5(GDP), thus providing a mechanism for Rab5 recruitment to the nascent phagosome.	[Doukoumetzidis, Kimon; Almendinger, Johann; Stergiou, Lilli; Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Kinchen, Jason M.; Tosello-Trampont, Annie; Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Sifri, Costi D.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA	University of Zurich; University of Virginia; University of Virginia	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.	Michael.Hengartner@molbio.unizh.ch; ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Hengartner, Michael O/E-6235-2011	Sifri, Costi/0000-0001-6033-2515; Hengartner, Michael/0000-0002-7584-596X; Ravichandran, Kodi/0000-0001-9049-1410; Kinchen, Jason/0000-0001-8430-2265	NIGMS NIH HHS [R01 GM064709, R01 GM064709-07, R01 GM069998, R01 GM069998-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, R01GM069998] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Franz Sandra, 2006, Curr Rheumatol Rep, V8, P245, DOI 10.1007/s11926-006-0001-y; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	37	193	288	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					556	566		10.1038/ncb1718	http://dx.doi.org/10.1038/ncb1718			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425118	Green Accepted			2022-12-25	WOS:000255502400012
J	Qiu, W; Hu, M; Sridhar, A; Opeskin, K; Fox, S; Shipitsin, M; Trivett, M; Thompson, ER; Ramakrishna, M; Gorringe, KL; Polyak, K; Haviv, I; Campbell, IG				Qiu, Wen; Hu, Min; Sridhar, Anita; Opeskin, Ken; Fox, Stephen; Shipitsin, Michail; Trivett, Melanie; Thompson, Ella R.; Ramakrishna, Manasa; Gorringe, Kylie L.; Polyak, Kornelia; Haviv, Izhak; Campbell, Ian G.			No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas	NATURE GENETICS			English	Article							STROMAL CELLS; TUMOR STROMA; MUTATIONS; HETEROZYGOSITY; INSTABILITY; PCR	There is increasing evidence showing that the stromal cells surrounding cancer epithelial cells, rather than being passive bystanders, might have a role in modifying tumor outgrowth. The molecular basis of this aspect of carcinoma etiology is controversial. Some studies have reported a high frequency of genetic aberrations in carcinoma-associated fibroblasts (CAFs), whereas other studies have reported very low or zero mutation rates. Resolution of this contentious area is of critical importance in terms of understanding both the basic biology of cancer as well as the potential clinical implications of CAF somatic alterations. We undertook genome-wide copy number and loss of heterozygosity (LOH) analysis of CAFs derived from breast and ovarian carcinomas using a 500K SNP array platform. Our data show conclusively that LOH and copy number alterations are extremely rare in CAFs and cannot be the basis of the carcinoma-promoting phenotypes of breast and ovarian CAFs.	[Qiu, Wen; Sridhar, Anita; Thompson, Ella R.; Ramakrishna, Manasa; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic 3002, Australia; [Qiu, Wen; Haviv, Izhak] Univ Melbourne, Dept Biochem, Melbourne, Vic 3010, Australia; [Hu, Min; Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hu, Min; Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Opeskin, Ken] St Vincents Hosp, Dept Pathol, Fitzroy, Vic 3065, Australia; [Opeskin, Ken; Thompson, Ella R.; Ramakrishna, Manasa; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Fox, Stephen; Trivett, Melanie] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic 3002, Australia; [Haviv, Izhak] Peter MacCallum Canc Ctr, Canc Cell Biol Lab, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Campbell, IG (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic 3002, Australia.	ian.campbell@petermac.org	Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011; Haviv, Izhak/E-3782-2015; Fox, Stephen/G-9719-2016	Gorringe, Kylie L/0000-0001-5681-2022; Haviv, Izhak/0000-0002-0837-5005; Fox, Stephen/0000-0002-7648-8896; Campbell, Ian/0000-0002-7773-4155; Thompson, Ella/0000-0001-5206-5111	NATIONAL CANCER INSTITUTE [R01CA116235, P50CA089393, R01CA094074] Funding Source: NIH RePORTER; NCI NIH HHS [CA116235, R01 CA116235-01A1, R01 CA094074, R01 CA094074-05, P50 CA089393, R01 CA116235-03, R01 CA116235-02, R01 CA116235, P50 CA089393-080014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Huang Jing, 2004, Human Genomics, V1, P287; Jiang XX, 1996, CANCER RES, V56, P3534; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Macintosh CA, 1998, CANCER RES, V58, P23; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Matsumoto N, 2003, CANCER RES, V63, P6158; Moinfar F, 2000, CANCER RES, V60, P2562; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sieben NLG, 2000, HUM PATHOL, V31, P1414, DOI 10.1053/hupa.2000.20381; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Tuhkanen H, 2006, INT J CANCER, V119, P1345, DOI 10.1002/ijc.21785; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Winter JM, 2006, CANCER BIOL THER, V5, P360, DOI 10.4161/cbt.5.4.2552; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	30	224	228	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					650	655		10.1038/ng.117	http://dx.doi.org/10.1038/ng.117			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408720	Green Accepted			2022-12-25	WOS:000255366700035
J	Austin, MB; O'Maille, PE; Noel, JP				Austin, Michael B.; O'Maille, Paul E.; Noel, Joseph P.			Evolving biosynthetic tangos negotiate mechanistic landscapes	NATURE CHEMICAL BIOLOGY			English	Editorial Material							III POLYKETIDE SYNTHASE; CHALCONE SYNTHASE; CYCLIZATION; PATHWAYS	The dependence of polyketide synthase and terpene cyclase mechanistic adaptation on the chemistry of their oligomeric substrates illuminates a convergent evolutionary strategy for shaping cyclization in these otherwise disparate reactions. Evolution of these enzyme families relies on rhythmic tangos, in which the enzymes and substrates together determine product outcome by negotiating decision networks governing intrinsic and induced chemical reactivities.	[Austin, Michael B.; O'Maille, Paul E.; Noel, Joseph P.] Jack H Skirball Ctr Chem Biol & Prot, Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Noel, JP (corresponding author), Jack H Skirball Ctr Chem Biol & Prot, Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noel@salk.edu	Noel, Joseph P/A-9459-2009		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Austin MB, 2007, ACS SYM SER, V955, P185; Bomati EK, 2005, J BIOL CHEM, V280, P30496, DOI 10.1074/jbc.M502239200; CANE DE, 1985, ACCOUNTS CHEM RES, V18, P220, DOI 10.1021/ar00115a005; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Deguerry F, 2006, ARCH BIOCHEM BIOPHYS, V454, P123, DOI 10.1016/j.abb.2006.08.006; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Gunawardena K, 2002, PHYTOCHEMISTRY, V59, P197, DOI 10.1016/S0031-9422(01)00438-1; GUTSCHE CD, 1968, TETRAHEDRON, V24, P859, DOI 10.1016/0040-4020(68)88035-4; Gutta P, 2006, J AM CHEM SOC, V128, P6172, DOI 10.1021/ja058031n; HEATHCOCK CH, 1985, SCIENCE, V229, P862, DOI 10.1126/science.3927485; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Mercke P, 1999, ARCH BIOCHEM BIOPHYS, V369, P213, DOI 10.1006/abbi.1999.1358; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101	24	45	46	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					217	222		10.1038/nchembio0408-217	http://dx.doi.org/10.1038/nchembio0408-217			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18347585	Green Accepted			2022-12-25	WOS:000254268300002
J	Jones, CA; London, NR; Chen, H; Park, KW; Sauvaget, D; Stockton, RA; Wythe, JD; Suh, W; Larrieu-Lahargue, F; Mukouyama, YS; Lindblom, P; Seth, P; Frias, A; Nishiya, N; Ginsberg, MH; Gerhardt, H; Zhang, K; Li, DY				Jones, Christopher A.; London, Nyall R.; Chen, Haoyu; Park, Kye Won; Sauvaget, Dominique; Stockton, Rebecca A.; Wythe, Joshua D.; Suh, Wonhee; Larrieu-Lahargue, Frederic; Mukouyama, Yoh-Suke; Lindblom, Per; Seth, Pankaj; Frias, Antonio; Nishiya, Naoyuki; Ginsberg, Mark H.; Gerhardt, Holger; Zhang, Kang; Li, Dean Y.			Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability	NATURE MEDICINE			English	Article							OXYGEN-INDUCED RETINOPATHY; MACULAR DEGENERATION; AXON GUIDANCE; SLIT; MOUSE; RECEPTOR; MIDLINE; GROWTH; NEOVASCULARIZATION; MORPHOGENESIS	The angiogenic sprout has been compared to the growing axon, and indeed, many proteins direct pathfinding by both structures(1). The Roundabout ( Robo) proteins are guidance receptors with well- established functions in the nervous system(2,3); however, their role in the mammalian vasculature remains ill defined(4-8). Here we show that an endothelial-specific Robo, Robo4, maintains vascular integrity. Activation of Robo4 by Slit2 inhibits vascular endothelial growth factor ( VEGF)- 165 - induced migration, tube formation and permeability in vitro and VEGF- 165 - stimulated vascular leak in vivo by blocking Src family kinase activation. In mouse models of retinal and choroidal vascular disease, Slit2 inhibited angiogenesis and vascular leak, whereas deletion of Robo4 enhanced these pathologic processes. Our results define a previously unknown function for Robo receptors in stabilizing the vasculature and suggest that activating Robo4 may have broad therapeutic application in diseases characterized by excessive angiogenesis and/ or vascular leak.	Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Jones, Christopher A.; London, Nyall R.; Park, Kye Won; Wythe, Joshua D.; Suh, Wonhee; Larrieu-Lahargue, Frederic; Frias, Antonio; Zhang, Kang; Li, Dean Y.] Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; [Chen, Haoyu; Stockton, Rebecca A.; Zhang, Kang] Univ Utah, Dept Ophthalmol, Salt Lake City, UT 84112 USA; [Sauvaget, Dominique; Lindblom, Per; Gerhardt, Holger] London Res Inst Canc Res, Vasc Biol Lab, London WC2A 3PX, England; [Nishiya, Naoyuki; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mukouyama, Yoh-Suke] NHLBI, Stem Cell & Neuro Vasc Dev & Patterning Sect, Dev Biol Lab, Genet & Dev Biol Ctr,NIH, Bethesda, MD 20892 USA; [Seth, Pankaj] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Renal Div, Boston, MA 02215 USA; [Seth, Pankaj] Harvard Univ, Sch Med, Ctr Study Tumor Microenvironm, Boston, MA 02215 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of London; Institute of Cancer Research - UK; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Li, DY (corresponding author), Univ Utah, Dept Oncol Sci, 15 North 2030 East, Salt Lake City, UT 84112 USA.	Kang.Zhang@hmbg.utah.edu; Dean.Li@hmbg.utah.edu	Gerhardt, Holger/G-4610-2011; Xiao, Yang/B-5668-2012; Chen, Haoyu/A-7432-2013; Chu, Kai On/E-2325-2016; Zhang, Kang/Y-2740-2019; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Chen, Haoyu/0000-0003-0676-4610; Zhang, Kang/0000-0002-4549-1697; Mukouyama, Yoh-suke/0000-0002-9084-4922; Wythe, Joshua/0000-0002-3225-2937; Park, Kye Won/0000-0003-2771-249X; Gerhardt, Holger/0000-0001-9228-7472; Nishiya, Naoyuki/0000-0003-1575-9944	Cancer Research UK Funding Source: Medline; Intramural NIH HHS [Z01 HL005702-02] Funding Source: Medline; NHLBI NIH HHS [R01 HL068873, R01 HL077671, R01 HL068873-05, R01 HL077671-03, R01 HL084516-02, R01 HL065648, R01 HL077671-04, R01 HL084516-01A1, R01 HL084516, R01 HL068873-06] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084516, Z01HL005702, R01HL065648, R01HL077671, R01HL068873] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Patel K, 2001, DEVELOPMENT, V128, P5031; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Silva RLE, 2005, INVEST OPHTH VIS SCI, V46, P3323, DOI 10.1167/iovs.04-1210; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Werdich XQ, 2004, EXP EYE RES, V79, P623, DOI 10.1016/j.exer.2004.07.006; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	29	293	330	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					448	453		10.1038/nm1742	http://dx.doi.org/10.1038/nm1742			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18345009	Green Accepted			2022-12-25	WOS:000254674100033
J	Jones, KS; Petrow-Sadowski, C; Huang, YK; Bertolette, DC; Ruscetti, FW				Jones, Kathryn S.; Petrow-Sadowski, Cari; Huang, Ying K.; Bertolette, Daniel C.; Ruscetti, Francis W.			Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells	NATURE MEDICINE			English	Article							LYMPHOTROPIC VIRUS TYPE-1; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; HEPARAN-SULFATE PROTEOGLYCANS; BLOOD MONONUCLEAR-CELLS; I TAX; ASYMPTOMATIC CARRIERS; IMMUNE SUPPRESSION; VIRAL REPLICATION; MESSENGER-RNA; LEUKEMIA	Cell- free human T- lymphotropic virus type 1 ( HTLV- 1) virions are poorly infectious in vitro for their primary target cells, CD4(+) T cells. Here, we show that HTLV- 1 can efficiently infect myeloid and plasmacytoid dendritic cells ( DCs). Moreover, DCs exposed to HTLV- 1, both before and after being productively infected, can rapidly, efficiently and reproducibly transfer virus to autologous primary CD4(+) T cells. This DC- mediated transfer of HTLV-1 involves heparan sulfate proteoglycans and neuropilin-1 and results in long- term productive infection and interleukin-2- independent transformation of the CD4(+) T cells. These studies, along with observations of HTLV-1- infected DCs in the peripheral blood of infected individuals, indicate that DCs have a central role in HTLV-1 transmission, dissemination and persistence in vivo. In addition to altering the current paradigm concerning how HTLV-1 transmission occurs, these studies suggest that impairment of DC function after HTLV- 1 infection plays a part in pathogenesis.	[Jones, Kathryn S.; Petrow-Sadowski, Cari] Sci Applicat Int Corp, Basic Res Program, Frederick, MD USA; [Huang, Ying K.; Bertolette, Daniel C.; Ruscetti, Francis W.] NCI, Ctr Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jones, KS (corresponding author), Sci Applicat Int Corp, Basic Res Program, Frederick, MD USA.	joneska@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010252] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Dahoodi ZM, 2003, J CLIN EXP HEMATOPAT, V43, P43; Arnulf B, 2004, LEUKEMIA, V18, P126, DOI 10.1038/sj.leu.2403176; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Ceccaldi PE, 2006, J VIROL, V80, P4771, DOI 10.1128/JVI.80.10.4771-4780.2006; Courreges MC, 2007, J VIROL, V81, P3769, DOI 10.1128/JVI.02728-06; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; DONEGAN E, 1994, TRANSFUSION, V34, P478, DOI 10.1046/j.1537-2995.1994.34694295061.x; EHRLICH GD, 1989, BLOOD, V74, P1066; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Furukawa Y, 2001, BLOOD, V97, P987, DOI 10.1182/blood.V97.4.987; Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05; GREEN PL, 1995, J VIROL, V69, P387, DOI 10.1128/JVI.69.1.387-394.1995; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Hague BF, 2003, VIRUS RES, V93, P31, DOI 10.1016/S0168-1702(03)00048-0; Hishizawa M, 2004, BRIT J HAEMATOL, V125, P568, DOI 10.1111/j.1365-2141.2004.04956.x; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jones KS, 2006, J VIROL, V80, P8291, DOI 10.1128/JVI.00389-06; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Jones KS, 2005, J IMMUNOL, V174, P4262, DOI 10.4049/jimmunol.174.7.4262; Kampani K, 2007, J VIROL METHODS, V141, P125, DOI 10.1016/j.jviromet.2006.11.043; KATSUKI T, 1987, JPN J CANCER RES, V78, P639; Kubota R, 2003, BLOOD, V101, P3074, DOI 10.1182/blood-2002-08-2477; Li M, 2007, J VIROL METHODS, V142, P159, DOI 10.1016/j.jviromet.2007.01.023; Liu BY, 2005, P NATL ACAD SCI USA, V102, P63, DOI 10.1073/pnas.0406424101; MACATONIA SE, 1992, AIDS RES HUM RETROV, V8, P1699, DOI 10.1089/aid.1992.8.1699; Makino M, 2001, SCAND J IMMUNOL, V54, P574, DOI 10.1046/j.1365-3083.2001.01003.x; Makino M, 1999, J VIROL, V73, P4575, DOI 10.1128/JVI.73.6.4575-4581.1999; Makino M, 2000, VIROLOGY, V274, P140, DOI 10.1006/viro.2000.0445; Manel N, 2003, BLOOD, V101, P1913, DOI 10.1182/blood-2002-09-2681; Mascarenhas RE, 2006, CLIN VACCINE IMMUNOL, V13, P547, DOI 10.1128/CVI.13.5.547-552.2006; Nath MD, 2003, BLOOD, V101, P3085, DOI 10.1182/blood-2002-07-2277; Overbaugh J, 2004, NAT MED, V10, P20, DOI 10.1038/nm0104-20; PERSAUD D, 1995, J VIROL, V69, P6297, DOI 10.1128/JVI.69.10.6297-6303.1995; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Pohl C, 2007, CELL MICROBIOL, V9, P279, DOI 10.1111/j.1462-5822.2006.00863.x; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; SHINZATO O, 1991, BLOOD, V78, P2082; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; TAGUCHI H, 1989, ACTA MED OKAYAMA, V43, P317; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Ureta-Vidal A, 2001, J INFECT DIS, V183, P857, DOI 10.1086/319264; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88; Zhang L, 2006, J VIROL, V80, P7459, DOI 10.1128/JVI.00130-06; ZUCKERMAN AJ, 1995, HAEMOPHILIA, V1, P2, DOI 10.1111/j.1365-2516.1995.tb00122.x	50	198	203	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					429	436		10.1038/nm1745	http://dx.doi.org/10.1038/nm1745			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376405				2022-12-25	WOS:000254674100030
J	Loer, B; Bauer, R; Bornheim, R; Grell, J; Kremmer, E; Kolanus, W; Hoch, M				Loeer, Birgit; Bauer, Reinhard; Bornheim, Roland; Grell, Jessica; Kremmer, Elisabeth; Kolanus, Waldemar; Hoch, Michael			The NHL-domain protein Wech is crucial for the integrin-cytoskeleton link	NATURE CELL BIOLOGY			English	Article							PS INTEGRINS; RING FINGER; DROSOPHILA; ADHESION; KINASE; MORPHOGENESIS; TALIN; ACTIVATION; MUSCLE; MATRIX	Integrin transmembrane receptors mediate cell adhesion through intracellular linker proteins that connect to the cytoskeleton(1,2). Of the numerous linker proteins identified, only a few, including Talin and Integrin-linked-kinase ( ILK), are essential and evolutionarily conserved. The wech gene encodes a newly discovered and highly conserved regulator of integrin-mediated adhesion in Drosophila melanogaster. Embryos deficient in wech have very similar phenotypes to integrin-null or Talin-null embryos, including muscle detachment from the body wall. The Wech protein contains a B-box zinc-finger and a coiled-coil domain, which is also found in RBCC/ TRIM family(3) members, and an NHL domain(4). In beta-integrin or Talin mutants, Wech is mislocalized, whereas ILK localization depends on Wech. We provide evidence that Wech interacts with the head domain of Talin and the kinase domain of ILK, and propose that Wech is required to connect both core proteins of the linker complex during embryonic muscle attachment. Both the NHL and the B-box/ coiled-coil domains of Wech are required for proper interaction with Talin and ILK. The single murine Wech orthologue is also colocalized with Talin and ILK in muscle tissue. We propose that Wech proteins are crucial and evolutionarily conserved regulators of the integrin-cytoskeleton link.	[Loeer, Birgit; Bauer, Reinhard; Hoch, Michael] Univ Bonn, Lab Mol Dev Biol, Program Unit Dev & Genet, Life & Med Sci Inst, D-53115 Bonn, Germany; [Bornheim, Roland; Grell, Jessica; Kolanus, Waldemar] Univ Bonn, Lab Mol Immunol, LIMES Inst, Program Unit Mol Cell & Immune Biol, D-53115 Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hoch, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, Program Unit Dev & Genet, Life & Med Sci Inst, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de						Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Liu SC, 2000, J CELL SCI, V113, P3563; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Paululat A, 1999, CELL TISSUE RES, V296, P151, DOI 10.1007/s004410051276; ROOTE CE, 1995, DEV BIOL, V169, P322, DOI 10.1006/dbio.1995.1147; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	31	48	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					422	U103		10.1038/ncb1704	http://dx.doi.org/10.1038/ncb1704			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18327251				2022-12-25	WOS:000254561700012
J	Thomas, G; Jacobs, KB; Yeager, M; Kraft, P; Wacholder, S; Orr, N; Yu, K; Chatterjee, N; Welch, R; Hutchinson, A; Crenshaw, A; Cancel-Tassin, G; Staats, BJ; Wang, Z; Gonzalez-Bosquet, J; Fang, J; Deng, X; Berndt, SI; Calle, EE; Feigelson, HS; Thun, MJ; Rodriguez, C; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Giovannucci, E; Willett, WC; Cussenot, O; Valeri, A; Andriole, GL; Crawford, ED; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, R; Hayes, RB; Hunter, DJ; Chanock, SJ				Thomas, Gilles; Jacobs, Kevin B.; Yeager, Meredith; Kraft, Peter; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Cancel-Tassin, Geraldine; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Giovannucci, Edward; Willett, Walter C.; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Crawford, E. David; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.			Multiple loci identified in a genome-wide association study of prostate cancer	NATURE GENETICS			English	Article							94 AMINO-ACIDS; SECRETORY PROTEIN; BINDING-PROTEIN; GENE; SUSCEPTIBILITY; VARIANTS; RISK	We followed our initial genome-wide association study (GWAS) of 527,869 SNPs on 1,172 individuals with prostate cancer and 1,157 controls of European origin-nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial prospective study-by testing 26,958 SNPs in four independent studies (total of 3,941 cases and 3,964 controls). In the combined joint analysis, we confirmed three previously reported loci (two independent SNPs at 8q24 and one in HNF1B (formerly known as TCF2 on 17q); P < 10(-10)). In addition, loci on chromosomes 7, 10 (two loci) and 11 were highly significant (between P < 7.31 x 10(-13) and P < 2.14 x 10(-6)). Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer. Of the nine loci that showed highly suggestive associations (P < 2.5 x 10(-5)), four best fit a recessive model and included candidate susceptibility genes: CPNE3, IL16 and CDH13. Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals.	[Thomas, Gilles; Yeager, Meredith; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Albanes, Demetrius; Weinstein, Stephanie; Tucker, Margaret; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Yeager, Meredith; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Deng, Xiang] NCI Frederick, SAIC Frederick Inc, Adv Technol Program, Core Genotyping Facil, Frederick, MD 21702 USA; [Kraft, Peter; Schumacher, Fredrick R.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-0030 Helsinki, Finland; [Thomas, Gilles; Giovannucci, Edward; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA; [Crawford, E. David] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80014 USA; [Gerhard, Daniela S.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Off Canc Genom, Bethesda, MD 20892 USA; [Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Pediat Oncol Branch, Bethesda, MD 20892 USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine] CeRePP Hop Tenon, AP HP, F-75970 Paris, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Chanock, SJ (corresponding author), NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Berndt, Sonja I/J-8423-2016; Yeager, Meredith/AAA-5322-2020; Schumacher, Fredrick/R-6043-2019; Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017; Tucker, Margaret A/B-4297-2015; Wang, Zhaoming/R-5527-2018	Schumacher, Fredrick/0000-0002-3073-7463; Weinstein, Stephanie J/0000-0002-3834-1535; Wang, Zhaoming/0000-0001-7556-3869; Hayes, Richard/0000-0002-0918-661X; cussenot, olivier/0000-0002-9912-0533; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Staats, Brian/0000-0002-3818-3792; Gonzalez Bosquet, Jesus/0000-0002-2079-4528	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA098233, Z01CP010178, T32CA009001, U01CA098710] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820821] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0821096, 1021718] Funding Source: National Science Foundation; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA 09001, U01 CA098710, CA55075, N01-CN-45165, U01CA098233, N01-CO-12400] Funding Source: Medline; CCR NIH HHS [N01-RC-37004, N01-RC-45035] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gimm O, 2001, J CLIN ENDOCR METAB, V86, P1801, DOI 10.1210/jc.86.4.1801; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Janssen JWG, 2000, BLOOD, V95, P2691; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Paliwal S, 2007, CANCER RES, V67, P9322, DOI 10.1158/0008-5472.CAN-07-1743; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Valeri A, 2003, ANN HUM GENET, V67, P125, DOI 10.1046/j.1469-1809.2003.00022.x; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	30	736	775	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					310	315		10.1038/ng.91	http://dx.doi.org/10.1038/ng.91			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264096	Green Published			2022-12-25	WOS:000253548400021
J	Huang, QH; Gumireddy, K; Schrier, M; Le Sage, C; Nagel, R; Nair, S; Egan, DA; Li, AP; Huang, GH; Klein-Szanto, AJ; Gimotty, PA; Katsaros, D; Coukos, G; Zhang, L; Pure, E; Agami, R				Huang, Qihong; Gumireddy, Kiranmai; Schrier, Mariette; Le Sage, Carlos; Nagel, Remco; Nair, Suresh; Egan, David A.; Li, Anping; Huang, Guanghua; Klein-Szanto, Andres J.; Gimotty, Phyllis A.; Katsaros, Dionyssios; Coukos, George; Zhang, Lin; Pure, Ellen; Agami, Reuven			The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis	NATURE CELL BIOLOGY			English	Article							ADHESION MOLECULES; MESSENGER-RNA; EXPRESSION; CD44; CARCINOMA; CADHERIN; GROWTH; GENES; CELLS	MicroRNAs ( miRNAs) are single-stranded, noncoding RNAs that are important in many biological processes(1,2). Although the oncogenic and tumour-suppressive functions of several miRNAs have been characterized, the role of miRNAs in mediating tumour metastasis was addressed only recently(3) and still remains largely unexplored(4,5). To identify potential metastasis-promoting miRNAs, we set up a genetic screen using a nonmetastatic, human breast tumour cell line that was transduced with a miRNA-expression library and subjected to a trans-well migration assay. We found that human miR-373 and miR-520c stimulated cancer cell migration and invasion in vitro and in vivo, and that certain cancer cell lines depend on endogenous miR-373 activity to migrate efficiently. Mechanistically, the migration phenotype of miR-373 and miR-520c can be explained by suppression of CD44. We found significant upregulation of miR-373 in clinical breast cancer metastasis samples that correlated inversely with CD44 expression. Taken together, our findings indicate that miRNAs are involved in tumour migration and invasion, and implicate miR-373 and miR-520c as metastasis-promoting miRNAs.	[Huang, Qihong; Gumireddy, Kiranmai; Li, Anping; Huang, Guanghua; Pure, Ellen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Schrier, Mariette; Le Sage, Carlos; Nagel, Remco; Nair, Suresh; Agami, Reuven] Netherlands Canc Inst, Div Tumor Biol, Amsterdam, Netherlands; [Egan, David A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Ctr, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	The Wistar Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Fox Chase Cancer Center; University of Pennsylvania; University of Turin; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Huang, QH (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	qhuang@wistar.org; r.agami@nki.nl	agami, reuven/GOG-8289-2022; Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012; Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Huang, Guanghua/0000-0002-4761-7548; Coukos, George/0000-0001-8813-7367; Agami, Reuven/0000-0002-2848-2473				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berner HS, 2003, HISTOPATHOLOGY, V42, P546, DOI 10.1046/j.1365-2559.2003.01622.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Cichy J, 2000, J BIOL CHEM, V275, P18061, DOI 10.1074/jbc.M907962199; Cichy J, 2002, J BIOL CHEM, V277, P44440, DOI 10.1074/jbc.M207437200; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jaeger EB, 2001, CANCER METAST REV, V20, P279, DOI 10.1023/A:1015587411668; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Pereira PA, 2001, ANTICANCER RES, V21, P2713; PLASTERK RHA, 2007, CELL, V449, P682; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ren JL, 2005, WORLD J GASTROENTERO, V11, P2674, DOI 10.3748/wjg.v11.i17.2674; Sasaki M, 2003, LAB INVEST, V83, P1403, DOI 10.1097/01.LAB.0000092230.59485.9E; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037	36	799	871	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					202	U83		10.1038/ncb1681	http://dx.doi.org/10.1038/ncb1681			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193036				2022-12-25	WOS:000252897800016
J	Coury, F; Annels, N; Rivollier, A; Olsson, S; Santoro, A; Speziani, C; Azocar, O; Flacher, M; Djebali, S; Tebib, J; Brytting, M; Egeler, RM; Rabourdin-Combe, C; Henter, JI; Arico, M; Delprat, C				Coury, Fabienne; Annels, Nicola; Rivollier, Aymeric; Olsson, Selma; Santoro, Alessandra; Speziani, Carole; Azocar, Olga; Flacher, Monique; Djebali, Sophia; Tebib, Jacques; Brytting, Maria; Egeler, R. Maarten; Rabourdin-Combe, Chantal; Henter, Jan-Inge; Arico, Maurizio; Delprat, Christine			Langerhans cell histiocytosis reveals a new IL-17A dependent pathway of dendritic cell fusion	NATURE MEDICINE			English	Article							CD4 T-CELLS; RHEUMATOID-ARTHRITIS; EXPRESSION; RECEPTOR; DISEASE; INTERLEUKIN-17; INFECTION; CYTOKINE; IL-23; DIFFERENTIATION	IL-17A is a T cell-specific cytokine(1) that is involved in chronic inflammations, such as Mycobacterium infection(2), Crohn's disease(3), rheumatoid arthritis(4) and multiple sclerosis(5). Mouse models have explained the molecular basis of IL-17A production(6,7) and have shown that IL-17A has a positive effect not only on granuloma formation(8) and neurodegeneration(9) through unknown mechanisms, but also on bone resorption through Receptor activator of NF-kappa B ligand (RANKL) induction in osteoblasts(4,10). Langerhans cell histiocytosis (LCH) is a rare disease of unknown etiology, lacking an animal model, that cumulates symptoms that are found separately in various IL-17A-related diseases, such as aggressive chronic granuloma formation, bone resorption and soft tissue lesions with occasional neurodegeneration(11,12). We examined IL-17A in the context of LCH and found that there were high serum levels of IL-17A during active LCH and unexpected IL-17A synthesis by dendritic cells (DCs), the major cell type in LCH lesions. We also found an IL-17A-dependent pathway for DC fusion, which was highly potentiated by IFN-gamma and led to giant cells expressing three major tissue-destructive enzymes: tartrate resistant acidic phosphatase and matrix metalloproteinases 9 and 12. IFN-gamma expression has been previously documented in LCH13 and observed in IL-17A-related diseases(14-17). Notably, serum IL-17A-dependent fusion activity correlates with LCH activity. Thus, IL-17A and IL-17A-stimulated DCs represent targets that may have clinical value in the treatment of LCH and other IL-17A-related inflammatory disorders.	[Coury, Fabienne; Rivollier, Aymeric; Speziani, Carole; Azocar, Olga; Flacher, Monique; Djebali, Sophia; Rabourdin-Combe, Chantal; Delprat, Christine] INSERM, U851, F-69007 Lyon, France; [Tebib, Jacques] Univ Lyon, F-69007 Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France; [Rivollier, Aymeric; Speziani, Carole; Azocar, Olga; Flacher, Monique; Djebali, Sophia; Rabourdin-Combe, Chantal; Delprat, Christine] IFR128, F-69007 Lyon, France; [Coury, Fabienne; Tebib, Jacques] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France; [Annels, Nicola; Egeler, R. Maarten] Leiden Univ, Med Ctr, Dept Pediat Immunol, NL-2300 RC Leiden, Netherlands; [Annels, Nicola; Egeler, R. Maarten] Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands; [Annels, Nicola; Egeler, R. Maarten] Leiden Univ, Med Ctr, Dept Oncol, NL-2300 RC Leiden, Netherlands; [Coury, Fabienne; Egeler, R. Maarten] Leiden Univ, Med Ctr, Dept Bone Marrow Transplantat & Autoimmune Dis, NL-2300 RC Leiden, Netherlands; [Olsson, Selma; Henter, Jan-Inge] Karolinska Univ Hosp, Karolinska Inst, Dept Woman & Child Hlth, Child Canc Res Unit, S-17176 Stockholm, Sweden; [Santoro, Alessandra; Arico, Maurizio] Ospedale Bambini G Di Cristina, I-90134 Palermo, Italy; [Santoro, Alessandra] AO Cervello, I-90134 Palermo, Italy; [Brytting, Maria] Swedish Inst Infect Dis Control, Dept Virol, S-17182 Solna, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	Delprat, C (corresponding author), INSERM, U851, 21 Ave Tony Garnier, F-69007 Lyon, France.	cdelprat@free.fr	Arico, Maurizio/S-3039-2019; DJEBALI, SOPHIA/A-1798-2017	Arico, Maurizio/0000-0002-1908-6671; DJEBALI, SOPHIA/0000-0002-0567-5387; Rivollier, Aymeric Marie Christian/0000-0001-8734-2916; coury, fabienne/0000-0002-9175-8620; Henter, Jan-Inge/0000-0002-0629-2126				Aarvak T, 1999, J IMMUNOL, V162, P1246; Annels NE, 2003, J EXP MED, V197, P1385, DOI 10.1084/jem.20030137; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; Edgar JDM, 2001, J PEDIATR-US, V139, P600, DOI 10.1067/mpd.2001.117068; Egeler RM, 1999, BLOOD, V94, P4195; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Laman JD, 2003, TRENDS IMMUNOL, V24, P190, DOI 10.1016/S1471-4906(03)00063-2; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Rust R, 2006, J PATHOL, V209, P474, DOI 10.1002/path.2003; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; SATO NE, 2003, J EXP MED, V197, P1385; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	30	144	156	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					81	87		10.1038/nm1694	http://dx.doi.org/10.1038/nm1694			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157139				2022-12-25	WOS:000252222400026
J	Karaman, MW; Herrgard, S; Treiber, DK; Gallant, P; Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Hunt, JP; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Wodicka, LM; Zarrinkar, PP				Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.			A quantitative analysis of kinase inhibitor selectivity	NATURE BIOTECHNOLOGY			English	Article							TYROSINE KINASE; ANTITUMOR-ACTIVITY; C-KIT; DISCOVERY; TARGETS; DRUG; ABL; MAP; MECHANISMS; CANCER	Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets(1,2). The biological consequences of multi-kinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome(2-4). We present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome. The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns. To enable a global analysis of the results, we introduce the concept of a selectivity score as a general tool to quantify and differentiate the observed interaction patterns. We further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.	[Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.] Ambit Biosci, San Diego, CA 92121 USA		Zarrinkar, PP (corresponding author), Ambit Biosci, 4215 Sorrento Valley Blvd, San Diego, CA 92121 USA.	pzarrinkar@ambitbio.com	Gilley, Stephanie/AAY-2344-2021					Allen LF, 2002, SEMIN ONCOL, V29, P11, DOI 10.1053/sonc.2002.34049; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chen JP, 2007, BIOINFORMATICS, V23, P563, DOI 10.1093/bioinformatics/btl666; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Flaherty KT, 2007, CLIN CANCER RES, V13, p747S, DOI 10.1158/1078-0432.CCR-06-2063; Garber K, 2006, NAT BIOTECHNOL, V24, P127, DOI 10.1038/nbt0206-127; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Jirousek MR, 1996, J MED CHEM, V39, P2664, DOI 10.1021/jm950588y; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lowinger TB, 2002, CURR PHARM DESIGN, V8, P2269, DOI 10.2174/1381612023393125; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Morin MJ, 2000, ONCOGENE, V19, P6574, DOI 10.1038/sj.onc.1204102; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; SAKO T, 1988, CANCER RES, V48, P4646; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sheinerman FB, 2005, J MOL BIOL, V352, P1134, DOI 10.1016/j.jmb.2005.07.074; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Vieth M, 2004, BBA-PROTEINS PROTEOM, V1697, P243, DOI 10.1016/j.bbapap.2003.11.028; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168	33	1851	1988	9	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					127	132		10.1038/nbt1358	http://dx.doi.org/10.1038/nbt1358			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183025				2022-12-25	WOS:000252222500033
J	Qiao, J; Kottke, T; Willmon, C; Galivo, F; Wongthida, P; Diaz, RM; Thompson, J; Ryno, P; Barber, GN; Chester, J; Selby, P; Harrington, K; Melcher, A; Vile, RG				Qiao, Jian; Kottke, Timothy; Willmon, Candice; Galivo, Feorillo; Wongthida, Phonphimon; Diaz, Rosa Maria; Thompson, Jill; Ryno, Pamela; Barber, Glen N.; Chester, John; Selby, Peter; Harrington, Kevin; Melcher, Alan; Vile, Richard G.			Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy	NATURE MEDICINE			English	Article							VESICULAR STOMATITIS-VIRUS; BREAST-CANCER; MALIGNANT-MELANOMA; GENE-THERAPY; DELIVERY; VECTORS; INDUCTION; RESPONSES; EFFICACY; IMMUNITY	In many common cancers, dissemination of secondary tumors via the lymph nodes poses the most significant threat to the affected individual. Metastatic cells often reach the lymph nodes by mimicking the molecular mechanisms used by hematopoietic cells to traffic to peripheral lymphoid organs. Therefore, we exploited naive T cell trafficking in order to chaperone an oncolytic virus to lymphoid organs harboring metastatic cells. Metastatic burden was initially reduced by viral oncolysis and was then eradicated, as tumor cell killing in the lymph node and spleen generated protective antitumor immunity. Lymph node purging of tumor cells was possible even in virus-immune mice. Adoptive transfer of normal T cells loaded with oncolytic virus into individuals with cancer would be technically easy to implement both to reduce the distribution of metastases and to vaccinate the affected individual in situ against micrometastatic disease. As such, this adoptive transfer could have a great therapeutic impact, in the adjuvant setting, on many different cancer types.	[Qiao, Jian; Kottke, Timothy; Willmon, Candice; Galivo, Feorillo; Wongthida, Phonphimon; Diaz, Rosa Maria; Thompson, Jill; Ryno, Pamela; Vile, Richard G.] Mayo Clin, Program Mol Med, Rochester, MN 55905 USA; [Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard G.] Univ Leeds, Leeds Teaching Hosp UK Natl Hlth Serv Trust, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard G.] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Vile, Richard G.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Harrington, Kevin] Inst Canc Res, London SW7 3RP, England	Mayo Clinic; University of Miami; Cancer Research UK; University of Leeds; University of Leeds; Mayo Clinic; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Vile, RG (corresponding author), Mayo Clin, Program Mol Med, Rochester, MN 55905 USA.	vile.richard@mayo.edu		Willmon, Candice/0000-0002-9103-7364; Melcher, Alan/0000-0002-2042-3380; Harrington, Kevin/0000-0002-6014-348X; Galivo, Feorillo/0000-0002-0553-922X	NCI NIH HHS [CA RO1107082-02] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altman DG, 1991, PRACTICAL STAT MED R, P365; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Balachandran S, 2000, IUBMB LIFE, V50, P135, DOI 10.1080/15216540050212169; Benson JR, 2007, LANCET ONCOL, V8, P331, DOI 10.1016/S1470-2045(07)70103-1; Beri A, 2006, NAT CLIN PRACT UROL, V3, P602, DOI 10.1038/ncpuro0625; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chester J, 2002, NAT BIOTECHNOL, V20, P256, DOI 10.1038/nbt0302-256; Cole C, 2005, NAT MED, V11, P1073, DOI 10.1038/nm1297; Crittenden M, 2003, CANCER RES, V63, P3173; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Ebert O, 2005, CANCER GENE THER, V12, P350, DOI 10.1038/sj.cgt.7700794; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Harrington K, 2002, HUM GENE THER, V13, P1263, DOI 10.1089/104303402760128504; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kelly PF, 2007, MOL THER, V15, P211, DOI 10.1038/sj.mt.6300033; Kottke T, 2006, GENE THER, V13, P1166, DOI 10.1038/sj.gt.3302722; Lichty BD, 2004, HUM GENE THER, V15, P821, DOI 10.1089/1043034041839208; Linardakis E, 2002, CANCER RES, V62, P5495; Lun X, 2006, JNCI-J NATL CANCER I, V98, P1546, DOI 10.1093/jnci/djj413; Markovic SN, 2007, MAYO CLIN PROC, V82, P490, DOI 10.4065/82.4.490; Matsuura K, 2006, CANCER-AM CANCER SOC, V106, P1227, DOI 10.1002/cncr.21729; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murta EFC, 2000, TUMORI J, V86, P403, DOI 10.1177/030089160008600507; Ong HT, 2007, GENE THER, V14, P324, DOI 10.1038/sj.gt.3302880; Peters AM, 1998, BRIT J RADIOL, V71, P252, DOI 10.1259/bjr.71.843.9616233; Power AT, 2007, MOL THER, V15, P123, DOI 10.1038/sj.mt.6300039; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Shinozaki K, 2005, HEPATOLOGY, V41, P196, DOI 10.1002/hep.20536; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; Thanarajasingam U, 2007, CANCER RES, V67, P300, DOI 10.1158/0008-5472.CAN-06-1017; Thirukkumaran CM, 2007, BONE MARROW TRANSPL, V40, P1, DOI 10.1038/sj.bmt.1705668; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Thorne SH, 2005, CURR GENE THER, V5, P429, DOI 10.2174/1566523054546215; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yotnda P, 2004, BLOOD, V104, P2272, DOI 10.1182/blood-2003-11-3803	43	118	130	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					37	44		10.1038/nm1681	http://dx.doi.org/10.1038/nm1681			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18066076				2022-12-25	WOS:000252222400020
J	Dent, EW; Kwiatkowski, AV; Mebane, LM; Philippar, U; Barzik, M; Rubinson, DA; Gupton, S; Van Veen, JE; Furman, C; Zhang, JY; Alberts, AS; Mori, S; Gertler, FB				Dent, Erik W.; Kwiatkowski, Adam V.; Mebane, Leslie M.; Philippar, Ulrike; Barzik, Melanie; Rubinson, Douglas A.; Gupton, Stephanie; Van Veen, J. Edward; Furman, Craig; Zhang, Jiangyang; Alberts, Arthur S.; Mori, Susumu; Gertler, Frank B.			Filopodia are required for cortical neurite initiation	NATURE CELL BIOLOGY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ENA/VASP PROTEINS; AXON GUIDANCE; FIBROBLAST MOTILITY; NEURONAL POLARITY; GROWTH CONES; BARBED END; ACTIN; MICROTUBULES; OUTGROWTH	Extension of neurites from a cell body is essential to form a functional nervous system; however, the mechanisms underlying neuritogenesis are poorly understood. Ena/VASP proteins regulate actin dynamics and modulate elaboration of cellular protrusions. We recently reported that cortical axon-tract formation is lost in Ena/VASP-null mice and Ena/VASP-null cortical neurons lack filopodia and fail to elaborate neurites. Here, we report that neuritogenesis in Ena/VASP-null neurons can be rescued by restoring filopodia formation through ectopic expression of the actin nucleating protein mDia2. Conversely, wildtype neurons in which filopodia formation is blocked fail to elaborate neurites. We also report that laminin, which promotes the formation of filopodia-like actin-rich protrusions, rescues neuritogenesis in Ena/VASP-deficient neurons. Therefore, filopodia formation is a key prerequisite for neuritogenesis in cortical neurons. Neurite initiation also requires microtubule extension into filopodia, suggesting that interactions between actin-filament bundles and dynamic microtubules within filopodia are crucial for neuritogenesis.	MIT, Dept Biol, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Div Nucl Magnet Resonance Res, Baltimore, MD 21205 USA; Van Andel Res Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI 49503 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Johns Hopkins University; Van Andel Institute; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Gertler, FB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fgertler@mit.edu	Rubinson, Douglas/G-3502-2019; Barzik, Melanie/AAJ-9269-2021; Dent, Erik/L-6208-2019	Rubinson, Douglas/0000-0002-5337-5231; Dent, Erik/0000-0001-8525-7136; Zhang, Jiangyang/0000-0003-0740-2662; van Veen, J. Edward/0000-0003-1798-3210; Zhang, Jiangyang/0000-0003-4146-8163; Barzik, Melanie/0000-0003-3003-1281	NIGMS NIH HHS [GM68678, F32-GM071156] Funding Source: Medline; NINDS NIH HHS [F32-NS45366] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071156, R01GM068678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS045366] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EDSON K, 1993, DEVELOPMENT, V117, P689; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	50	223	227	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1347	U28		10.1038/ncb1654	http://dx.doi.org/10.1038/ncb1654			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026093				2022-12-25	WOS:000251317300008
J	Lawrence, S				Lawrence, Stacy			Pipelines turn to biotech	NATURE BIOTECHNOLOGY			English	News Item																			0	18	18	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1342	1342		10.1038/nbt1207-1342	http://dx.doi.org/10.1038/nbt1207-1342			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18066015	Bronze			2022-12-25	WOS:000251457800008
J	Lemke, EA; Summerer, D; Geierstanger, BH; Brittain, SM; Schultz, PG				Lemke, Edward A.; Summerer, Daniel; Geierstanger, Bernhard H.; Brittain, Scott M.; Schultz, Peter G.			Control of protein phosphorylation with a genetically encoded photocaged amino acid	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTION FACTOR PHO4; ION CHANNELS; RECEPTOR; PHO80-PHO85; DESIGN	We genetically encoded the photocaged amino acid 4,5-dimethoxy-2-nitrobenzylserine (DMNB-Ser, 1) in Saccharomyces cerevisiae in response to the amber nonsense codon TAG. This amino acid was converted to serine in living cells by irradiation with relatively low-energy blue light and was used to noninvasively photoactivate phosphorylation of the transcription factor Pho4, which controls the cellular response to inorganic phosphate1. When substituted at phosphoserine sites that control nuclear export of Pho4, 1 blocks phosphorylation and subsequent export by the receptor Msn5 (ref. 2). We triggered phosphorylation of individual serine residues with a visible laser pulse and monitored nuclear export of Pho4-GFP fusion constructs in real time. We observed distinct export kinetics for differentially phosphorylated Pho4 mutants, which demonstrates dynamic regulation of Pho4 function. This methodology should also facilitate the analysis of other cellular processes involving free serine residues, including catalysis, biomolecular recognition and ion transport.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd SR202, La Jolla, CA 92037 USA.	schultz@scripps.edu	Summerer, Daniel/E-2609-2013; Lemke, Edward A/J-3337-2015	Lemke, Edward A/0000-0002-0634-0503				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Deiters A, 2006, ANGEW CHEM INT EDIT, V45, P2728, DOI 10.1002/anie.200600264; Endo M, 2004, ANGEW CHEM INT EDIT, V43, P5643, DOI 10.1002/anie.200460889; England PM, 1997, P NATL ACAD SCI USA, V94, P11025, DOI 10.1073/pnas.94.20.11025; Ghosh M, 2002, J AM CHEM SOC, V124, P2440, DOI 10.1021/ja017592l; Hahn ME, 2004, ANGEW CHEM INT EDIT, V43, P5800, DOI 10.1002/anie.200461141; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lawrence DS, 2005, CURR OPIN CHEM BIOL, V9, P570, DOI 10.1016/j.cbpa.2005.09.002; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Pelliccioli AP, 2002, PHOTOCH PHOTOBIO SCI, V1, P441, DOI 10.1039/b200777k; Rothman DM, 2005, TRENDS CELL BIOL, V15, P502, DOI 10.1016/j.tcb.2005.07.003; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Summerer D, 2006, P NATL ACAD SCI USA, V103, P9785, DOI 10.1073/pnas.0603965103; Thomson D. J, 1991, ADV SPECTRUM ANAL AR, VI, P58; Veldhuyzen WF, 2003, J AM CHEM SOC, V125, P13358, DOI 10.1021/ja037801x; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; WALKER JW, 1993, BIOCHEMISTRY-US, V32, P1338, DOI 10.1021/bi00056a020; Wu N, 2004, J AM CHEM SOC, V126, P14306, DOI 10.1021/ja040175z; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Zou KY, 2002, J AM CHEM SOC, V124, P8220, DOI 10.1021/ja020405e	29	160	166	3	83	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					769	772		10.1038/nchembio.2007.44	http://dx.doi.org/10.1038/nchembio.2007.44			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17965709	Green Submitted			2022-12-25	WOS:000251028600010
J	Franklin, KA; Whitelam, GC				Franklin, Keara A.; Whitelam, Garry C.			Light-quality regulation of freezing tolerance in Arabidopsis thaliana	NATURE GENETICS			English	Article							LOW-TEMPERATURE INDUCTION; CIRCADIAN CLOCK; GENE-EXPRESSION; FLOWERING TIME; ABSCISIC-ACID; TRANSCRIPTIONAL ACTIVATORS; PHYTOCHROME-A; RESPONSES; CBF2; MUTANTS	To acquire freezing tolerance, higher plants require a period of low temperature ( usually < 4 degrees C) termed cold acclimation. Upon transfer of plants to low temperature, increased expression of the (C) under bar RT/ DRE (b) under bar inding (f) under bar actor (CBF) family of transcriptional activators leads to the upregulation of genes containing a C-repeat/drought-responsive (CRT/DRE) promoter element and metabolic changes that enhance tolerance to subzero temperatures(1). Here, we show that a low red to farred ratio (R/FR) light signal increases CBF gene expression in Arabidopsis thaliana in a manner dependent on the circadian clock. This light quality-dependent increase in CBF expression is sufficient to confer freezing tolerance at temperatures higher than those required for cold acclimation. Furthermore, the use of light-quality signals to stimulate CBF expression has revealed ambient temperature-dependent coupling of CBF transcription factors to downstream COLD REGULATED ( COR) genes, providing evidence for a second temperature-regulated step in this pathway.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Franklin, KA (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	kaf5@le.ac.uk						Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Amasino R, 2004, NAT GENET, V36, P111, DOI 10.1038/ng0204-111; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; CARABELLI M, 1993, PLANT J, V4, P469, DOI 10.1046/j.1365-313X.1993.04030469.x; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Halliday KJ, 2003, PLANT PHYSIOL, V131, P1913, DOI 10.1104/pp.102.018135; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169	28	200	221	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1410	1413		10.1038/ng.2007.3	http://dx.doi.org/10.1038/ng.2007.3			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17965713				2022-12-25	WOS:000250575900027
J	Varelas, X; Sakuma, R; Samavarchi-Tehrani, P; Peerani, R; Rao, BM; Dembowy, J; Yaffe, MB; Zandstra, PW; Wrana, JL				Varelas, Xaralabos; Sakuma, Rui; Samavarchi-Tehrani, Payman; Peerani, Raheem; Rao, Balaji M.; Dembowy, Joanna; Yaffe, Michael B.; Zandstra, Peter W.; Wrana, Jeffrey L.			TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; NUCLEAR IMPORT; SIGNAL-TRANSDUCTION; DIFFERENTIATION; TRANSCRIPTION; PHOSPHORYLATION; RECEPTOR; PROTEIN; PLURIPOTENCY	Transforming growth factor-beta (TGF beta) family members regulate many developmental and pathological events through Smad transcriptional modulators. How nuclear accumulation of Smad is coupled to the transcriptional machinery is poorly understood. Here we demonstrate that in response to TGF beta stimulation the transcriptional regulator TAZ binds heteromeric Smad2/3-4 complexes and is recruited to TGF beta response elements. In human embryonic stem cells TAZ is required to maintain self-renewal markers and loss of TAZ leads to inhibition of TGF beta signalling and differentiation into a neuroectoderm lineage. In the absence of TAZ, Smad2/3-4 complexes fail to accumulate in the nucleus and activate transcription. Furthermore, TAZ, which itself engages in shuttling, dominantly controls Smad nucleocytoplasmic localization and can be retained in the nucleus by transcriptional co-factors such as ARC105, a component of the Mediator complex. TAZ thus defines a hierarchical system regulating Smad nuclear accumulation and coupling to the transcriptional machinery.	[Varelas, Xaralabos; Sakuma, Rui; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Dembowy, Joanna; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet & Microbiol, Toronto, ON M5S 1A8, Canada; [Peerani, Raheem; Rao, Balaji M.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Yaffe, Michael B.] Harvard Univ, MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Yaffe, Michael B.] Harvard Univ, MIT, Ctr Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Rao, Balaji/0000-0001-5695-8953	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; IZZI L, 2007, EMBO J; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	47	474	494	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					837	848		10.1038/ncb1748	http://dx.doi.org/10.1038/ncb1748			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18568018				2022-12-25	WOS:000257268400013
J	Liang, J; Wan, M; Zhang, Y; Gu, PL; Xin, HW; Jung, SY; Qin, J; Wong, JM; Cooney, AJ; Liu, D; Zhou, SY				Liang, Jiancong; Wan, Ma; Zhang, Yi; Gu, Peili; Xin, Huawei; Jung, Sung Yun; Qin, Jun; Wong, Jiemin; Cooney, Austin J.; Liu, Dan; Zhou Songyang			Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells	NATURE CELL BIOLOGY			English	Article							PLURIPOTENCY; NURD; EXPRESSION; INTERACTS; FIBROBLASTS; MAINTENANCE; HOMOLOG; NETWORK; CLONING; GENES	Nanog and Oct4 are essential transcription factors that regulate self-renewal and pluripotency of ES cells. However, the mechanisms by which Nanog and Oct4 modulate ES cell fate remain unknown. Through characterization of endogenous Nanog and Oct4 protein complexes in mouse ES cells, we found that these transcription factors interact with each other and associate with proteins from multiple repression complexes, including the NuRD, Sin3A and PmI complexes. In addition, Nanog, Oct4 and repressor proteins co-occupy Nanog-target genes in mouse ES cells, suggesting that Nanog and Oct4 together may communicate with distinct repression complexes to control gene transcription. To our surprise, of the various core components in the NuRD complex with which Nanog and Oct4 interact, Mta1 was preferred, whereas Mbd3 and Rbbp7 were either absent or present at sub-stoichiometric levels. We named this unique Hdac1/2-and Mta1/2-containing complex NODE (for Nanog and Oct4 associated deacetylase). Interestingly, NODE contained histone deacetylase (HDAC) activity that seemed to be comparable to NuRD, and retained its association with Nanog and Oct4 in Mbd3(-/-)ES cells. In contrast to Mbd3 loss-of-function, knockdown of NODE subunits led to increased expression of developmentally regulated genes and ES-cell differentiation. Our data collectively suggest that Nanog and Oct4 associate with unique repressor complexes on their target genes to control ES cell fate.	[Gu, Peili; Qin, Jun; Wong, Jiemin; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liang, Jiancong; Wan, Ma; Zhang, Yi; Xin, Huawei; Jung, Sung Yun; Qin, Jun; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Cooney, Austin J.; Zhou Songyang] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.edu	Liang, Jiancong/AAC-1321-2022	Liang, Jiancong/0000-0002-7215-4346; Wong, Jiemin/0000-0002-5311-842X; Jung, Sung Yun/0000-0003-1521-7977	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069572, P01GM081627] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK73524] Funding Source: Medline; NIGMS NIH HHS [GM81627, GM69572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	35	336	347	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					731	739		10.1038/ncb1736	http://dx.doi.org/10.1038/ncb1736			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454139				2022-12-25	WOS:000256350100020
J	Degterev, A; Hitomi, J; Germscheid, M; Ch'en, IL; Korkina, O; Teng, X; Abbott, D; Cuny, GD; Yuan, C; Wagner, G; Hedrick, SM; Gerber, SA; Lugovskoy, A; Yuan, J				Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying			Identification of RIP1 kinase as a specific cellular target of necrostatins	NATURE CHEMICAL BIOLOGY			English	Article							NF-KAPPA-B; DEATH DOMAIN; SACCHAROMYCES-CEREVISIAE; NECROPTOSIS INHIBITORS; SIGNAL-TRANSDUCTION; ACTIVATION; APOPTOSIS; PROTEIN; ALPHA; UBIQUITINATION	Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their respective ligands under conditions where apoptotic execution is prevented. Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphological features as unregulated necrotic death. Here we report that necrostatin-1, a previously identified small-molecule inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-associated adaptor kinase RIP1 in vitro. We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1. In addition, we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1. Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.	[Degterev, Alexei; Germscheid, Megan; Korkina, Olga] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Degterev, Alexei; Hitomi, Junichi; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Harvard NeuroDiscovery Ctr, Lab Drug Discovery Neurodegenerat, Cambridge, MA 02139 USA; [Abbott, Derek] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Abbott, Derek] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Yuan, Chengye] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China; [Wagner, Gerhard; Lugovskoy, Alexey] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Gerber, Scott A.] Norris Cotton Canc Ctr, Dept Genet, Hanover, NH 03755 USA; [Gerber, Scott A.] Dartmouth Med Sch, Hanover, NH 03755 USA	Tufts University; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Harvard Medical School; Norris Cotton Cancer Center; Dartmouth College	Degterev, A (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harison Ave, Boston, MA 02111 USA.	alexei.degterev@tufts.edu; jyuan@hms.harvard.edu	Hedrick, Stephen M/E-9171-2010	Abbott, Derek/0000-0003-4387-8094; Gerber, Scott/0000-0002-2964-5051; Hedrick, Stephen/0000-0002-6345-8751; Cuny, Gregory/0000-0002-3188-4748	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS050560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012859, R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG012859, R01 AG012859] Funding Source: Medline; NIGMS NIH HHS [R01 GM064703, R01 GM64703] Funding Source: Medline; NIH HHS [DP1 OD000580] Funding Source: Medline; NINDS NIH HHS [UO1 NS050560, U01 NS050560] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck V, 1995, EMBO J, V14, P6173, DOI 10.1002/j.1460-2075.1995.tb00308.x; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hong QY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-50; Jagtap PG, 2007, J MED CHEM, V50, P1886, DOI 10.1021/jm061016o; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindsten T, 2006, CELL DEATH DIFFER, V13, P1272, DOI 10.1038/sj.cdd.4401953; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moshinsky DJ, 2003, BIOCHEM BIOPH RES CO, V310, P1026, DOI 10.1016/j.bbrc.2003.09.114; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; NAGAR B, 2002, CANCER RES, V62, P4243; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takahashi R, 2007, BBA-GEN SUBJECTS, V1770, P518, DOI 10.1016/j.bbagen.2006.11.011; Teng X, 2005, BIOORG MED CHEM LETT, V15, P5039, DOI 10.1016/j.bmcl.2005.07.077; Thakar J, 2006, PROTEINS, V63, P413, DOI 10.1002/prot.20895; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang K, 2007, BIOORG MED CHEM LETT, V17, P1455, DOI 10.1016/j.bmcl.2006.11.056; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	45	1388	1475	14	213	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2008	4	5					313	321		10.1038/nchembio.83	http://dx.doi.org/10.1038/nchembio.83			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291CM	18408713	Green Accepted			2022-12-25	WOS:000255170400012
J	Kanno, T; Bucher, E; Daxinger, L; Huettel, B; Bohmdorfer, G; Gregor, W; Kreil, DP; Matzke, M; Matzke, AJM				Kanno, Tatsuo; Bucher, Etienne; Daxinger, Lucia; Huettel, Bruno; Boehmdorfer, Gudrun; Gregor, Wolfgang; Kreil, David P.; Matzke, Marjori; Matzke, Antonius J. M.			A structural-maintenance-of-chromosomes hinge domain-containing protein is required for RNA-directed DNA methylation	NATURE GENETICS			English	Article							SEQUENCES; GENOME; IV; TRANSCRIPTION; DIMERIZATION; PATHWAY; GENE; DRD1	RNA-directed DNA methylation (RdDM) is a process in which dicer-generated small RNAs guide de novo cytosine methylation at the homologous DNA region(1,2). To identify components of the RdDM machinery important for Arabidopsis thaliana development, we targeted an enhancer active in meristems for methylation, which resulted in silencing of a downstream GFP reporter gene. This silencing system also features secondary siRNAs, which trigger methylation that spreads beyond the targeted enhancer region. A screen for mutants defective in meristem silencing and enhancer methylation retrieved six dms complementation groups, which included the known factors DRD1 (ref. 3; a SNF2-like chromatin-remodeling protein) and Pol IVb subunits(4,5). Additionally, we identified a previously unknown gene DMS3 (At3g49250), encoding a protein similar to the hinge-domain region of structural maintenance of chromosomes (SMC) proteins. This finding implicates a putative chromosome architectural protein that can potentially link nucleic acids(6) in facilitating an RNAi-mediated epigenetic modification involving secondary siRNAs and spreading of DNA methylation.	[Kanno, Tatsuo; Bucher, Etienne; Daxinger, Lucia; Huettel, Bruno; Boehmdorfer, Gudrun; Matzke, Marjori; Matzke, Antonius J. M.] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Gregor, Wolfgang] Univ Vet Med, Res Grp Mol Pharmacol & Toxicol, Dept Sci, A-1210 Vienna, Austria; [Kreil, David P.] Boku Univ, Dept Bioinformat, A-1190 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna	Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Bucher, Etienne/E-7681-2013; Daxinger, Lucia/A-6840-2013; Kreil, D/O-1783-2013; Matzke, Marjori/H-8689-2015; Matzke, Antonius/H-8698-2015	Bucher, Etienne/0000-0002-3114-3763; Kreil, D/0000-0001-7538-2056; Daxinger, Lucia/0000-0001-6557-6201; KANNO, Tatsuo/0000-0001-5958-4686				Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Cobbe N, 2006, GENETICS, V172, P991, DOI 10.1534/genetics.105.050567; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Gregor W, 2004, PLANT PHYSIOL, V134, P1191, DOI 10.1104/pp.103.031112; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	29	154	164	1	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					670	675		10.1038/ng.119	http://dx.doi.org/10.1038/ng.119			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425128				2022-12-25	WOS:000255366700038
J	Hunt, KA; Zhernakova, A; Turner, G; Heap, GAR; Franke, L; Bruinenberg, M; Romanos, J; Dinesen, LC; Ryan, AW; Panesar, D; Gwilliam, R; Takeuchi, F; McLaren, WM; Holmes, GKT; Howdle, PD; Walters, JRF; Sanders, DS; Playford, RJ; Trynka, G; Mulder, CJJ; Mearin, ML; Verbeek, WHM; Trimble, V; Stevens, FM; O'Morain, C; Kennedy, NP; Kelleher, D; Pennington, DJ; Strachan, DP; McArdle, WL; Mein, CA; Wapenaar, MC; Deloukas, P; McGinnis, R; McManus, R; Wijmenga, C; van Heel, DA				Hunt, Karen A.; Zhernakova, Alexandra; Turner, Graham; Heap, Graham A. R.; Franke, Lude; Bruinenberg, Marcel; Romanos, Jihane; Dinesen, Lotte C.; Ryan, Anthony W.; Panesar, Davinder; Gwilliam, Rhian; Takeuchi, Fumihiko; McLaren, William M.; Holmes, Geoffrey K. T.; Howdle, Peter D.; Walters, Julian R. F.; Sanders, David S.; Playford, Raymond J.; Trynka, Gosia; Mulder, Chris J. J.; Mearin, M. Luisa; Verbeek, Wieke H. M.; Trimble, Valerie; Stevens, Fiona M.; O'Morain, Colm; Kennedy, Nicholas P.; Kelleher, Dermot; Pennington, Daniel J.; Strachan, David P.; McArdle, Wendy L.; Mein, Charles A.; Wapenaar, Martin C.; Deloukas, Panos; McGinnis, Ralph; McManus, Ross; Wijmenga, Cisca; van Heel, David A.			Newly identified genetic risk variants for celiac disease related to the immune response	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; B-LYMPHOCYTES; REPLICATION; PROTEIN; POPULATION; ACTIVATION; EXPRESSION; REGION; MOUSE	Our genome-wide association study of celiac disease previously identified risk variants in the IL2-IL21 region. To identify additional risk variants, we genotyped 1,020 of the most strongly associated non-HLA markers in an additional 1,643 cases and 3,406 controls. Through joint analysis including the genome-wide association study data (767 cases, 1,422 controls), we identified seven previously unknown risk regions (P < 5 x 10(-7)). Six regions harbor genes controlling immune responses, including CCR3, IL12A, IL18RAP, RGS1, SH2B3 (nsSNP rs3184504) and TAGAP. Whole-blood IL18RAP mRNA expression correlated with IL18RAP genotype. Type 1 diabetes and celiac disease share HLA-DQ, IL2-IL21, CCR3 and SH2B3 risk regions. Thus, this extensive genome-wide association follow-up study has identified additional celiac disease risk variants in relevant biological pathways.	[Hunt, Karen A.; Heap, Graham A. R.; Panesar, Davinder; Playford, Raymond J.; Pennington, Daniel J.; van Heel, David A.] Inst Cell & Mol Sci, Barts E1 2AT, England; [Zhernakova, Alexandra; Franke, Lude; Wijmenga, Cisca] Univ Utrecht, Med Ctr, Dept Biomed Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; [Hunt, Karen A.; Heap, Graham A. R.; Panesar, Davinder; Playford, Raymond J.; Pennington, Daniel J.; van Heel, David A.] London Sch Med & Dent, London E1 2AT, England; [Turner, Graham; Ryan, Anthony W.; Trimble, Valerie; O'Morain, Colm; Kennedy, Nicholas P.; Kelleher, Dermot; McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Bruinenberg, Marcel; Romanos, Jihane; Trynka, Gosia; Wapenaar, Martin C.; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Bruinenberg, Marcel; Romanos, Jihane; Trynka, Gosia; Wapenaar, Martin C.; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Dinesen, Lotte C.] Univ Oxford, Gastroenterol Unit, Oxford OX3 7BN, England; [Gwilliam, Rhian; Takeuchi, Fumihiko; McLaren, William M.; Deloukas, Panos; McGinnis, Ralph] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Holmes, Geoffrey K. T.] Derbyshire Royal Infirm, Dept Gastroenterol, Derby DE1 2QY, England; [Howdle, Peter D.] St James Univ Hosp, Acad Med Unit, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Walters, Julian R. F.] Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Gastroenterol Sect, London W12 0HS, England; [Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; [Sanders, David S.] Royal Hallamshire Hosp, Liver Unit, Sheffield S10 2JF, S Yorkshire, England; [Mulder, Chris J. J.; Verbeek, Wieke H. M.] VU Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands; [Mearin, M. Luisa] VU Med Ctr, Dept Pediat Gastroenterol, NL-1007 MB Amsterdam, Netherlands; [Mearin, M. Luisa] Leiden Univ, Med Ctr, Dept Paediat Gastroenterol, NL-2300 RC Leiden, Netherlands; [Stevens, Fiona M.] Natl Univ Ireland, Dept Med, Galway, Ireland; [Strachan, David P.] Univ London St Georges Hosp, Div Commun Hlth Sci, London SW17 0RE, England; [McArdle, Wendy L.] Univ Bristol, ALSPAC, Bristol BS8 1TQ, Avon, England; [Mein, Charles A.] London Sch Med & Dent, London EC1M 6BQ, England; [Mein, Charles A.] Genome Ctr, Barts EC1M 6BQ, England	University of London; Queen Mary University London; Utrecht University; University of London; Queen Mary University London; Trinity College Dublin; University of Groningen; University of Groningen; University of Oxford; Wellcome Trust Sanger Institute; Saint James's University Hospital; University of Leeds; Imperial College London; University of Sheffield; University of Sheffield; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ollscoil na Gaillimhe-University of Galway; St Georges University London; University of Bristol; University of London; Queen Mary University London	van Heel, DA (corresponding author), Inst Cell & Mol Sci, 4 Newark St, Barts E1 2AT, England.	d.vanheel@qmul.ac.uk	Franke, Lude/P-7036-2016; McManus, Ross/AAE-9236-2020; Wijmenga, Cisca/D-2173-2009; Heap, Graham/A-9344-2011; Deloukas, Panos/B-2922-2013; Walters, Julian/D-5189-2009; Romanos, Jihane/F-7372-2012; Ryan, Anthony W/A-1336-2010; Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020; Kennedy, Nicholas/A-8055-2008	Franke, Lude/0000-0002-5159-8802; Deloukas, Panos/0000-0001-9251-070X; Walters, Julian/0000-0001-9720-5835; Wijmenga, Cisca/0000-0002-5635-1614; Trynka, Gosia/0000-0002-6955-9529; van Heel, David/0000-0002-0637-2265; McManus, Ross/0000-0002-0529-9617; Heap, Graham/0000-0003-4131-6792; McGinnis, Ralph/0000-0003-4540-9857; Pennington, Daniel/0000-0001-7889-9923; Playford, Raymond/0000-0003-1235-8504; McLaren, William/0000-0001-6218-1116; Ryan, Anthony/0000-0001-5005-3344; Mein, Charles/0000-0003-0811-9658; Zhernakova, Alexandra/0000-0002-4574-0841	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [084743, GR068094MA, 068094, 068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; ROSENTHAL R, 1991, META ANAL PROCEDURE; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	29	479	496	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					395	402		10.1038/ng.102	http://dx.doi.org/10.1038/ng.102			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311140	Green Submitted, Green Accepted			2022-12-25	WOS:000254388100009
J	Feng, BY; Toyama, BH; Wille, H; Colby, DW; Collins, SR; May, BCH; Prusiner, SB; Weissman, J; Shoichet, BK				Feng, Brian Y.; Toyama, Brandon H.; Wille, Holger; Colby, David W.; Collins, Sean R.; May, Barnaby C. H.; Prusiner, Stanley B.; Weissman, Jonathan; Shoichet, Brian K.			Small-molecule aggregates inhibit amyloid polymerization	NATURE CHEMICAL BIOLOGY			English	Article							PROMISCUOUS INHIBITORS; FIBRIL FORMATION; MECHANISM; DISEASE; NEUROTOXICITY; YEAST	Many amyloid inhibitors resemble molecules that form chemical aggregates, which are known to inhibit many proteins. Eight known chemical aggregators inhibited amyloid formation of the yeast and mouse prion proteins Sup35 and recMoPrP in a manner characteristic of colloidal inhibition. Similarly, three known anti-amyloid molecules inhibited P-lactamase in a detergent-dependent manner, which suggests that they too form colloidal aggregates. The colloids localized to preformed fibers and prevented new fiber formation in electron micrographs. They also blocked infection of yeast cells with Sup35 prions, which suggests that colloidal inhibition may be relevant in more biological milieus.	[Feng, Brian Y.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, Grad Grp Chem & Chem Biol, San Francisco, CA 94158 USA; [Toyama, Brandon H.; Collins, Sean R.; Weissman, Jonathan] Univ Calif San Francisco, Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Wille, Holger; Colby, David W.; May, Barnaby C. H.; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Wille, Holger] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Prusiner, Stanley B.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Grad Grp Chem & Chem Biol, San Francisco, CA 94158 USA.	shoichet@cgl.ucsf.edu	Wille, Holger/C-2280-2008; colby, david/E-5821-2011	Wille, Holger/0000-0001-5102-8706; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X; Colby, David/0000-0002-4856-6295; Toyama, Brandon/0000-0002-8355-9138; May, Barnaby/0000-0001-9855-018X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG021601, P01AG002132] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG021601, AG02132, AG021601, P01 AG002132, AG10770, P01 AG010770] Funding Source: Medline; NIGMS NIH HHS [R01 GM071630, GM71630, R01 GM071630-04A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abid K, 2006, CELL MOL LIFE SCI, V63, P2342, DOI 10.1007/s00018-006-6140-5; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Coan KED, 2007, MOL BIOSYST, V3, P208, DOI 10.1039/b616314a; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	14	217	224	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					197	199		10.1038/nchembio.65	http://dx.doi.org/10.1038/nchembio.65			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18223646	Green Accepted			2022-12-25	WOS:000253417400015
J	Thiele, DJ; Gitlin, AD				Thiele, Dennis J.; Gitlin, Andjonathan D.			Assembling the pieces	NATURE CHEMICAL BIOLOGY			English	Editorial Material							RAY-FLUORESCENCE MICROSCOPY; COPPER; IRON; METABOLISM; HOMEOSTASIS; TOPOGRAPHY; EVOLUTION; VIRULENCE; NUTRIENT; ELEMENTS	Transition metals function as cofactors in specific proteins, catalyzing electron exchange reactions, binding substrates and stabilizing protein structure. Studies of human diseases and of model organisms have defined many of the molecular details of metal uptake, trafficking, and excretion. The current challenge is to integrate these details into a systematic view of metal content, speciation, localization and use within organisms and ecosystems.	[Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Gitlin, Andjonathan D.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Duke University; Washington University (WUSTL)	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Res Dr,LSRC C351, Durham, NC 27710 USA.	dennis.thiele@duke.edu; gitliti@wustl.edu			NICHD NIH HHS [HD39522] Funding Source: Medline; NIDDK NIH HHS [R01 DK044464, DK61763, R37 DK044464, DK44464, R01 DK044464-13, R01 DK061763-09, DK074192, R01 DK074192, R01 DK061763] Funding Source: Medline; NIEHS NIH HHS [P42 ES010356, 5P42ES010356] Funding Source: Medline; NIGMS NIH HHS [GM41840, R01 GM041840] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044464, R01DK044464, R01DK061763, R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreini C, 2008, J PROTEOME RES, V7, P209, DOI 10.1021/pr070480u; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Falkowski PG, 2006, SCIENCE, V311, P1724, DOI 10.1126/science.1125937; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gitlin JD, 2006, SCIENCE, V314, P1252, DOI 10.1126/science.1136251; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Knapp CW, 2007, P NATL ACAD SCI USA, V104, P12040, DOI 10.1073/pnas.0702879104; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Mendelsohn BA, 2006, CELL METAB, V4, P155, DOI 10.1016/j.cmet.2006.05.001; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Williams RJP, 2001, COORDIN CHEM REV, V216, P583, DOI 10.1016/S0010-8545(00)00398-2; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	33	59	60	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					145	147		10.1038/nchembio0308-145	http://dx.doi.org/10.1038/nchembio0308-145			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18277968	Green Accepted			2022-12-25	WOS:000253417400002
J	Krutzik, PO; Crane, JM; Clutter, MR; Nolan, GP				Krutzik, Peter O.; Crane, Janelle M.; Clutter, Matthew R.; Nolan, Garry P.			High-content single-cell drug screening with phosphospecific flow cytometry	NATURE CHEMICAL BIOLOGY			English	Article							HIGH-THROUGHPUT; SIGNAL-TRANSDUCTION; CANCER-CELLS; T-CELLS; INHIBITORS; NETWORKS; INNOVATION; DISCOVERY; LEUKEMIA; EVENTS	Drug screening is often limited to cell-free assays involving purified enzymes, but it is arguably best applied against systems that represent disease states or complex physiological cellular networks. Here, we describe a high-content, cell-based drug discovery platform based on phosphospecific flow cytometry, or phosphoflow, that enabled screening for inhibitors against multiple endogenous kinase signaling pathways in heterogeneous primary cell populations at the single-cell level. From a library of small-molecule natural products, we identified pathway-selective inhibitors of Jak-Stat and MAP kinase signaling. Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds. Lead compound selectivity was confirmed in vivo in mice. Phosphoflow therefore provides a unique platform that can be applied throughout the drug discovery process, from early compound screening to in vivo testing and clinical monitoring of drug efficacy.	[Krutzik, Peter O.; Crane, Janelle M.; Clutter, Matthew R.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, 269 Campus Dr, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NHLBI NIH HHS [N01-HV-28183] Funding Source: Medline; NIAID NIH HHS [AI35304, T32 AI007290] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035304, T32AI007290] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURRES NS, 1989, J NAT PROD, V52, P522, DOI 10.1021/np50063a010; Chen R, 2006, CANCER RES, V66, P10959, DOI 10.1158/0008-5472.CAN-06-1216; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Clutter Matthew R, 2005, Drug Discov Today Technol, V2, P295, DOI 10.1016/j.ddtec.2005.08.010; Darzynkiewicz Z, 2004, CYTOM PART A, V58A, P21, DOI 10.1002/cyto.a.20003; DESSUREAULT J, 1975, CAN J BIOCHEM CELL B, V53, P149, DOI 10.1139/o75-023; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ilangumaran S, 2003, J IMMUNOL METHODS, V278, P221, DOI 10.1016/S0022-1759(03)00177-7; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Jacobberger JW, 2006, NAT METHODS, V3, P343, DOI 10.1038/nmeth0506-343; Jacobberger JW, 2003, CYTOM PART A, V54A, P75, DOI 10.1002/cyto.a.10063; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; MARUMO H, 1980, J ANTIBIOT, V33, P885, DOI 10.7164/antibiotics.33.885; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Narla RK, 1998, CLIN CANCER RES, V4, P1405; Nicholson RL, 2007, ACS CHEM BIOL, V2, P24, DOI 10.1021/cb600321j; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Quintas-Cardama A, 2007, CANCER-AM CANCER SOC, V109, P248, DOI 10.1002/cncr.22398; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHULZ KR, 2007, CURR PROTOC IMMUNOL, V78; Suzuki H, 1996, BIOSCI BIOTECH BIOCH, V60, P789, DOI 10.1271/bbb.60.789; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Valet G, 2006, DRUG DISCOV TODAY, V11, P785, DOI 10.1016/j.drudis.2006.07.003; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Young SM, 2005, J BIOMOL SCREEN, V10, P374, DOI 10.1177/1087057105274532; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	42	162	185	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					132	142		10.1038/nchembio.2007.59	http://dx.doi.org/10.1038/nchembio.2007.59			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18157122				2022-12-25	WOS:000252585400013
J	Bewley, CA				Bewley, Carole A.			Illuminating the switch in influenza viruses	NATURE BIOTECHNOLOGY			English	Editorial Material							RECEPTOR-BINDING; A VIRUSES; HEMAGGLUTININS; SPECIFICITY	Integrating data from glycan microarrays and X-ray structures sheds light on human adaptation of influenza viruses.	[Bewley, Carole A.] NIDDK, Natl Inst Hlth, Bioorgan Chem Lab, Bethesda, MD 20817 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bewley, CA (corresponding author), NIDDK, Natl Inst Hlth, Bioorgan Chem Lab, Bethesda, MD 20817 USA.	caroleb@mail.nih.gov		Bewley, Carole/0000-0003-2203-0852	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103, Z01DK032103] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CARROLL SM, 1981, J BIOL CHEM, V256, P8357; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; *WHO, 2007, CUM NUMB CONF HUM CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	12	15	16	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					60	62		10.1038/nbt0108-60	http://dx.doi.org/10.1038/nbt0108-60			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183018	Bronze			2022-12-25	WOS:000252222500021
J	Chen, JC; Tan, K; Zhou, HR; Lo, HF; Roux, DTL; Liddington, RC; Diacovo, TG				Chen, Jianchun; Tan, Kui; Zhou, Hairu; Lo, Hsuan-Fu; Roux, Diana Tronik-Le; Liddington, Robert C.; Diacovo, Thomas G.			Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies	NATURE BIOTECHNOLOGY			English	Article							VON-WILLEBRAND-FACTOR; IB-ALPHA; ADHESION; BINDING; DISEASE; MODEL; ACTIVATION; COLLAGEN; DEFECTS; COMPLEX	The A1 domain of von Willebrand factor (VWF-A1) plays a crucial role in hemostasis and thrombosis by initiating platelet adhesion at sites of arterial injury through interactions with the platelet receptor glycoprotein Ib alpha (GPIb alpha)(1-5). Here we report that murine VWF-A1 supports limited binding of human platelets. However, atomic models of GPIb alpha-VWF-A1 complexes identified an electrostatic 'hot-spot' that, when mutated in murine VWF-A1, switches its binding specificity from mouse to human GPIba. Furthermore, mice expressing this mutant VWF-A1 display a bleeding phenotype that can be corrected by infusion of human platelets. Mechanistically, human platelets correct the phenotype by forming occlusive thrombi, an event that can be abrogated by blockade of GPIba or by the preadministration of inhibitors of platelet activation or adhesion (clopidogrel (Plavix) and abciximab (ReoPro), respectively). Thus, by modifying a protein interface, we have generated a potential biological platform for preclinical screening of antithrombotics that specifically target human platelets.	[Chen, Jianchun; Tan, Kui; Zhou, Hairu; Lo, Hsuan-Fu; Diacovo, Thomas G.] Columbia Univ, Med Ctr, Dept Pediat, Irving Canc Res Inst, New York, NY 10032 USA; [Roux, Diana Tronik-Le] CEA, Dept Radiobiol & Radiopathol, DRR LRGH, F-91057 Evry, France; [Liddington, Robert C.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Diacovo, Thomas G.] Columbia Univ, Med Ctr, Dept Pathol, Irving Canc Res Inst, New York, NY 10032 USA	Columbia University; CEA; Sanford Burnham Prebys Medical Discovery Institute; Columbia University	Diacovo, TG (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, Irving Canc Res Inst, 1130 St Nicholas Ave, New York, NY 10032 USA.	td2142@columbia.edu			NCI NIH HHS [CA119342] Funding Source: Medline; NHLBI NIH HHS [HL063244, HL073646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bennett JS, 2001, ANNU REV MED, V52, P161, DOI 10.1146/annurev.med.52.1.161; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Hankey GJ, 2003, MED J AUSTRALIA, V178, P568, DOI 10.5694/j.1326-5377.2003.tb05361.x; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; PIETU G, 1989, BIOCHEM BIOPH RES CO, V164, P1339; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; SUGIMOTO M, 1991, BIOCHEMISTRY-US, V30, P5202, DOI 10.1021/bi00235a013; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	30	23	24	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					114	119		10.1038/nbt1373	http://dx.doi.org/10.1038/nbt1373			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18084279				2022-12-25	WOS:000252222500031
J	Eustaquio, AS; Pojer, F; Noel, JP; Moore, BS				Eustaquio, Alessandra S.; Pojer, Florence; Noel, Joseph P.; Moore, Bradley S.			Discovery and characterization of a marine bacterial SAM-dependent chlorinase	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-CATTLEYA; PROTEASOME INHIBITOR; SALINOSPORAMIDE-A; BIOSYNTHESIS; TRANSFERASE; FLUORINATION; MECHANISM; COENZYME	Halogen atom incorporation into a scaffold of bioactive compounds often amplifies biological activity, as is the case for the anticancer agent salinosporamide A (1), a chlorinated natural product from the marine bacterium Salinispora tropica. Significant effort in understanding enzymatic chlorination shows that oxidative routes predominate to form reactive electrophilic or radical chlorine species. Here we report the genetic, biochemical and structural characterization of the chlorinase SaIL, which halogenates S-adenosyl-L-methionine (2) with chloride to generate 5'-chloro-5'-deoxyadenosine (3) and L-methionine (4) in a rarely observed nucleophilic substitution strategy analogous to that of Streptomyces cattleya fluorinase. Further metabolic tailoring produces a halogenated polyketide synthase substrate specific for salinosporamide A biosynthesis. SaIL also accepts bromide and iodide as substrates, but not fluoride. High-resolution crystal structures of SAL and active site mutants complexed with substrates and products support the S(N)2 nucleophilic substitution mechanism and further illuminate halide specificity in this newly discovered halogenase family.	[Eustaquio, Alessandra S.; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Pojer, Florence; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Preteom, La Jolla, CA 92037 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Salk Institute; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, 9500 Gilman Dr, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu	Noel, Joseph P/A-9459-2009	Eustaquio, Alessandra/0000-0002-7852-7844; Moore, Bradley/0000-0002-4652-1253	NATIONAL CANCER INSTITUTE [R01CA127622] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA127622, CA127622] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akopiants K, 2006, J IND MICROBIOL BIOT, V33, P141, DOI 10.1007/s10295-005-0029-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beer LL, 2007, ORG LETT, V9, P845, DOI 10.1021/ol063102o; Cadicamo CD, 2004, CHEMBIOCHEM, V5, P685, DOI 10.1002/cbic.200300839; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Dam J, 2004, METHOD ENZYMOL, V384, P185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng H, 2006, ANGEW CHEM INT EDIT, V45, P759, DOI 10.1002/anie.200503582; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HARPER DB, 1994, NAT PROD REP, V11, P123, DOI 10.1039/np9941100123; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 2001, INT TABLES CRYSTALLO; Lam KS, 2007, J ANTIBIOT, V60, P13, DOI 10.1038/ja.2007.2; Laskowski Roman A, 2003, Methods Biochem Anal, V44, P273; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; Ni XH, 1998, P NATL ACAD SCI USA, V95, P12866, DOI 10.1073/pnas.95.22.12866; Ni XH, 1999, P NATL ACAD SCI USA, V96, P3611, DOI 10.1073/pnas.96.7.3611; Schaffrath C, 2003, FEBS LETT, V547, P111, DOI 10.1016/S0014-5793(03)00688-4; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563	29	160	167	2	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					69	74		10.1038/nchembio.2007.56	http://dx.doi.org/10.1038/nchembio.2007.56			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18059261	Green Accepted			2022-12-25	WOS:000251990000015
J	Hollox, EJ; Huffmeier, U; Zeeuwen, PLJM; Palla, R; Lascorz, J; Rodijk-Olthuis, D; van de Kerkhof, PCM; Traupe, H; de Jongh, G; den Heijer, M; Reis, A; Armour, JAL; Schalkwijk, J				Hollox, Edward J.; Huffmeier, Ulrike; Zeeuwen, Patrick L. J. M.; Palla, Raquel; Lascorz, Jesus; Rodijk-Olthuis, Diana; van de Kerkhof, Peter C. M.; Traupe, Heiko; de Jongh, Gys; den Heijer, Martin; Reis, Andre; Armour, John A. L.; Schalkwijk, Joost			Psoriasis is associated with increased beta-defensin genomic copy number	NATURE GENETICS			English	Article							GENE-CLUSTER; SUSCEPTIBILITY; KERATINOCYTES; DUPLICATIONS; POLYMORPHISM; EXPRESSION; SKIN	Psoriasis is a common inflammatory skin disease with a strong genetic component. We analyzed the genomic copy number polymorphism of the beta-defensin region on human chromosome 8 in 179 Dutch individuals with psoriasis and 272 controls and in 319 German individuals with psoriasis and 305 controls. Comparisons in both cohorts showed a significant association between higher genomic copy number for beta-defensin genes and risk of psoriasis.	[Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Huffmeier, Ulrike; Lascorz, Jesus; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Zeeuwen, Patrick L. J. M.; Rodijk-Olthuis, Diana; van de Kerkhof, Peter C. M.; de Jongh, Gys; Schalkwijk, Joost] Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Palla, Raquel] Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; [Traupe, Heiko] Univ Nottingham, Dept Dermatol, Nottingham NG7 2UH, England; [den Heijer, Martin] Radboud Univ Nijmegen Med Ctr, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands	University of Leicester; University of Erlangen Nuremberg; Radboud University Nijmegen; University of Nottingham; University of Nottingham; Radboud University Nijmegen; Radboud University Nijmegen	Armour, JAL (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	john.armour@nottingham.ac.uk	Schalkwijk, Joost/R-7509-2019; Zeeuwen, Patrick/N-1779-2013; Reis, André/D-2309-2009; van de Kerkhof, P.C.M./H-8059-2014; Huffmeier, Ulrike/D-2806-2013; den Heijer, Martin/J-8036-2015	Schalkwijk, Joost/0000-0002-1308-1319; Zeeuwen, Patrick/0000-0002-6878-2438; Reis, André/0000-0002-6301-6363; Huffmeier, Ulrike/0000-0001-6448-4671; Hollox, Edward/0000-0002-0115-2298; Armour, John/0000-0002-8558-8506; den Heijer, Martin/0000-0003-3620-5617	Wellcome Trust [071024] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	15	504	523	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					23	25		10.1038/ng.2007.48	http://dx.doi.org/10.1038/ng.2007.48			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059266	Green Accepted			2022-12-25	WOS:000252118600012
J	Jurica, MS				Jurica, Melissa S.			Searching for a wrench to throw into the splicing machine	NATURE CHEMICAL BIOLOGY			English	Editorial Material							PRE-MESSENGER-RNA; MACROLIDE ANTIBIOTICS; STRUCTURAL BASIS; RIBOSOMAL-RNA; TARGET; TRANSLOCATION; TRANSCRIPTION; MICROTUBULE; RESOLUTION; PROTEINS	Many macromolecular complexes function as nanoscale machines performing important cellular jobs. However, their complex and dynamic natures pose challenges for detailed structure-function analysis. Small-molecule inhibitors, which can be identified by high-throughput screening, provide important leverage into the study of macromolecular assemblies by allowing researchers to capture transient intermediate states and probe important functional components.	[Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Cell Dev & Mol Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Jurica, MS (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, 1156 High St, Santa Cruz, CA 95064 USA.	jurica@biology.ucsc.edu						Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J., 1996, 3 DIMENSIONAL ELECT, P1; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; NIERHAUS KH, 1980, NATURWISSENSCHAFTEN, V67, P234, DOI 10.1007/BF01054532; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; WIELAND T, 1991, EXPERIENTIA, V47, P1186, DOI 10.1007/BF01918382	28	11	11	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					3	6		10.1038/nchembio0108-3	http://dx.doi.org/10.1038/nchembio0108-3			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18084270				2022-12-25	WOS:000251990000002
J	Ninomiya, H; Winklbauer, R				Ninomiya, Hiromasa; Winklbauer, Rudolf			Epithelial coating controls mesenchymal shape change through tissue-positioning effects and reduction of surface-minimizing tension	NATURE CELL BIOLOGY			English	Article							XENOPUS-LAEVIS; PARAXIAL PROTOCADHERIN; VERTEBRATE DEVELOPMENT; CONVERGENT EXTENSION; SELECTIVE ADHESION; CELL MOVEMENTS; EXPRESSION; MESODERM; GASTRULATION; MORPHOGENESIS	signalling between mesenchymal and epithelial cells has a profound influence on organ morphogenesis. However, less is known about the mechanical function of epithelial mesenchymal interactions. Here, we describe two principal effects by which epithelia can regulate shape changes in mesenchymal cell aggregates. We propose that during formation of the embryonic body axis, the epithelial layer relieves surface minimizing tensions that would force cell aggregates into a spherical shape, and controls the serial arrangement of cell populations along the axis. the combined effects permit the tissue to deviate from a spherical form and to elongate.	[Ninomiya, Hiromasa; Winklbauer, Rudolf] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto	Winklbauer, R (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	winklbauer@zoo.utoronto.ca						Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; ANGRES B, 1991, DEVELOPMENT, V111, P829; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; del Rio OI, 1997, J COLLOID INTERF SCI, V196, P136; Foty RA, 1996, DEVELOPMENT, V122, P1611; GRANER F, 1993, J THEOR BIOL, V164, P455, DOI 10.1006/jtbi.1993.1167; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER RE, 1978, J MORPHOL, V157, P223, DOI 10.1002/jmor.1051570209; Kim SH, 1998, DEVELOPMENT, V125, P4681; Koibuchi N, 1998, DEV GROWTH DIFFER, V40, P355; Kuroda H, 1999, DEV GROWTH DIFFER, V41, P283; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; MOORE SW, 1995, DEVELOPMENT, V121, P3131; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schnabel R, 2006, DEV BIOL, V294, P418, DOI 10.1016/j.ydbio.2006.03.004; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; SHIH J, 1992, DEVELOPMENT, V116, P901; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Steinberg M. S., 1978, SPECIFICITY EMBRYOLO, V4, P99; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1978, RECEPTORS RECOGNIT B, V4; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435	39	59	60	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					61	U46		10.1038/ncb1669	http://dx.doi.org/10.1038/ncb1669			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084283				2022-12-25	WOS:000252116100013
J	Pera, MF; Hasegawa, K				Pera, Martin F.; Hasegawa, Kouichi			Simpler and safer cell reprogramming	NATURE BIOTECHNOLOGY			English	Editorial Material							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; GENERATION; INDUCTION; MOUSE	Induced pluripotent stem cells have been generated from mouse and human adult fibroblasts without the tumor-causing gene c-Myc.	[Pera, Martin F.; Hasegawa, Kouichi] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Pera, MF (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	pera@usc.edu	Hasegawa, Kouichi/Y-9349-2019; PERA, MARTIN/A-9812-2012	Hasegawa, Kouichi/0000-0001-5947-5471; PERA, MARTIN/0000-0001-6239-0428				Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1998, SCI AM, V279, P58, DOI 10.1038/scientificamerican1298-58; YU J, 2007, SCIENCE         1120	9	17	24	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					59	60		10.1038/nbt0108-59	http://dx.doi.org/10.1038/nbt0108-59			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183017				2022-12-25	WOS:000252222500020
J	Stephan, MT; Ponomarev, V; Brentjens, RJ; Chang, AH; Dobrenkov, KV; Heller, G; Sadelain, M				Stephan, Matthias T.; Ponomarev, Vladimir; Brentjens, Renier J.; Chang, Alex H.; Dobrenkov, Konstantin V.; Heller, Glenn; Sadelain, Michel			T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection	NATURE MEDICINE			English	Article							ANTIGEN-PRESENTING CELLS; EX-VIVO EXPANSION; IMMUNOLOGICAL SYNAPSE; IN-VIVO; ESTABLISHED TUMORS; PROSTATE-CANCER; CROSS-LINKING; GENE-TRANSFER; LYMPHOCYTES; CD28	To reject tumors, T cells must overcome poor tumor immunogenicity and an adverse tumor microenvironment. Providing agonistic costimulatory signals to tumor-infiltrating T cells to augment T cell function remains a challenge for the implementation of safe and effective immunotherapy. We hypothesized that T cells overexpressing selected costimulatory ligands could serve as cellular vehicles mediating powerful, yet constrained, anatomically targeted costimulation. Here, we show that primary human T cells expressing CD80 and 4-1BB ligand (4-1BBL) vigorously respond to tumor cells lacking costimulatory ligands and provoke potent rejection of large, systemic tumors in immunodeficient mice. In addition to showing costimulation of bystander T cells (transcostimulation), we show the effect of CD80 and 4-1BBL binding to their respective receptors in the immunological synapse of isolated single cells (autocostimulation). This new strategy of endowing T cells with constitutively expressed costimulatory ligands could be extended to other ligand-receptor pairs and used to enhance any targeted adoptive transfer therapy.	Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Immunol Grad Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	m-sadelain@ski.mskcc.org	CHANG, ALEX/A-8284-2011	Ponomarev, Vladimir/0000-0002-9119-9128; Stephan, Matthias/0000-0001-8310-0100	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA059350, R24CA083084] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P30CA08748, CA59350, R24 CA83084] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andarini S, 2004, CANCER RES, V64, P3281, DOI 10.1158/0008-5472.CAN-03-3911; Arlen PM, 2006, CLIN CANCER RES, V12, P1260, DOI 10.1158/1078-0432.CCR-05-2059; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Copier J, 2006, INT REV IMMUNOL, V25, P297, DOI 10.1080/08830180600992472; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; DING L, 1994, EUR J IMMUNOL, V24, P859, DOI 10.1002/eji.1830240413; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dustin Michael L., 2006, V43, P175, DOI 10.1007/019; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gallardo HF, 1997, GENE THER, V4, P1115, DOI 10.1038/sj.gt.3300506; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Guinn B, 1999, J IMMUNOL, V162, P5003; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Keller AM, 2007, P NATL ACAD SCI USA, V104, P5989, DOI 10.1073/pnas.0700946104; Kershaw MH, 2005, NAT REV IMMUNOL, V5, P928, DOI 10.1038/nri1729; Lamers CHJ, 2007, CANCER IMMUNOL IMMUN, V56, P1875, DOI 10.1007/s00262-007-0330-3; Latouche JB, 2000, NAT BIOTECHNOL, V18, P405, DOI 10.1038/74455; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Melero I, 1998, EUR J IMMUNOL, V28, P1116, DOI 10.1002/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A; Micklethwaite K, 2007, BIOL BLOOD MARROW TR, V13, P707, DOI 10.1016/j.bbmt.2007.02.004; Milowsky MI, 2007, J CLIN ONCOL, V25, P540, DOI 10.1200/JCO.2006.07.8097; Nam KO, 2005, J IMMUNOL, V174, P1898, DOI 10.4049/jimmunol.174.4.1898; Papanicolaou GA, 2003, BLOOD, V102, P2498, DOI 10.1182/blood-2003-02-0345; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sanchez-Lockhart M, 2006, J IMMUNOL, V176, P4778, DOI 10.4049/jimmunol.176.8.4778; Smythe JA, 1999, J IMMUNOL, V163, P3239; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	50	220	255	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1440	1449		10.1038/nm1676	http://dx.doi.org/10.1038/nm1676			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18026115				2022-12-25	WOS:000251445400018
J	Faghihi, MA; Modarresi, F; Khalil, AM; Wood, DE; Sahagan, BG; Morgan, TE; Finch, CE; Laurent, GS; Kenny, PJ; Wahlestedt, C				Faghihi, Mohammad Ali; Modarresi, Farzaneh; Khalil, Ahmad M.; Wood, Douglas E.; Sahagan, Barbara G.; Morgan, Todd E.; Finch, Caleb E.; Laurent, Georges St., III; Kenny, Paul J.; Wahlestedt, Claes			Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase	NATURE MEDICINE			English	Article							AMYLOID PRECURSOR PROTEIN; BACE1 GENE-EXPRESSION; A-BETA; OXIDATIVE STRESS; TRANSGENIC MICE; MITOCHONDRIAL DYSFUNCTION; NEUROLOGICAL DISORDERS; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM	Recent efforts have revealed that numerous protein-coding messenger RNAs have natural antisense transcript partners, most of which seem to be noncoding RNAs. Here we identify a conserved noncoding antisense transcript for beta-secretase-1 (BACE1), a crucial enzyme in Alzheimer's disease pathophysiology. The BACE1-antisense transcript (BACE1-AS) regulates BACE1 mRNA and subsequently BACE1 protein expression in vitro and in vivo. Upon exposure to various cell stressors including amyloid-beta 1-42 (A beta 1-42), expression of BACE1-AS becomes elevated, increasing BACE1 mRNA stability and generating additional A beta 1-42 through a post-transcriptional feed-forward mechanism. BACE1-AS concentrations were elevated in subjects with Alzheimer's disease and in amyloid precursor protein transgenic mice. These data show that BACE1 mRNA expression is under the control of a regulatory noncoding RNA that may drive Alzheimer's disease-associated pathophysiology. In summary, we report that a long noncoding RNA is directly implicated in the increased abundance of A beta 1-42 in Alzheimer's disease.	[Faghihi, Mohammad Ali; Modarresi, Farzaneh; Khalil, Ahmad M.; Wahlestedt, Claes] Scripps Res Inst, Mol & Integrat Neurosci Dept, Jupiter, FL 33458 USA; [Faghihi, Mohammad Ali] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Wood, Douglas E.; Sahagan, Barbara G.] Pfizer Inc, Global Res & Dev, Cent Nervous Syst Discovery, Groton, CT 06340 USA; [Morgan, Todd E.; Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Laurent, Georges St., III] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Laurent, Georges St., III] Univ Antiquia, Immunovirol Biogenesis Grp, Medellin 1226, Colombia; [Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Scripps Research Institute; Karolinska Institutet; Pfizer; University of Southern California; George Washington University; Universidad de Antioquia; Scripps Research Institute	Wahlestedt, C (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, 5353 Parkside Dr, Jupiter, FL 33458 USA.	clawah@scripps.edu	Finch, Caleb/AAA-7250-2022; Wahlestedt, Claes/A-7039-2009; Faghihi, Mohammad Ali/AAH-3139-2019; Faghihi, Mohammad Ali/AAD-7159-2020	Faghihi, Mohammad Ali/0000-0002-8330-9067	NIA NIH HHS [R21 AG029290-02, R21 AG029290, AG 029290] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG029290] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Borghi R, 2007, NEUROBIOL AGING, V28, P1009, DOI 10.1016/j.neurobiolaging.2006.05.004; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Esposito G, 2006, NEUROSCI LETT, V404, P342, DOI 10.1016/j.neulet.2006.06.012; Faghihi MA, 2004, EXPERT REV MOL DIAGN, V4, P317, DOI 10.1586/14737159.4.3.317; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Harkany T, 2000, REV NEUROSCIENCE, V11, P329; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Laurent GS, 2007, TRENDS NEUROSCI, V30, P612, DOI 10.1016/j.tins.2007.10.002; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Ma HF, 2007, P NATL ACAD SCI USA, V104, P8167, DOI 10.1073/pnas.0609521104; Matsuyama S, 2007, NEUROREPORT, V18, P1083, DOI 10.1097/WNR.0b013e3281e72b18; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Monaco S, 2006, CURR MED CHEM, V13, P1903, DOI 10.2174/092986706777585022; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Su Y, 2003, FEBS LETT, V546, P407, DOI 10.1016/S0014-5793(03)00645-8; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thakker DR, 2006, PHARMACOL THERAPEUT, V109, P413, DOI 10.1016/j.pharmthera.2005.08.006; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yatin SM, 1998, J MOL NEUROSCI, V11, P183, DOI 10.1385/JMN:11:3:183; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718; Zhu DH, 2006, J NEUROSCI, V26, P11111, DOI 10.1523/JNEUROSCI.3505-06.2006	50	1027	1107	3	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2008	14	7					723	730		10.1038/nm1784	http://dx.doi.org/10.1038/nm1784			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18587408	Green Accepted			2022-12-25	WOS:000257452700019
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Jakobsdottir, M; Steinberg, S; Gudjonsson, SA; Palsson, A; Thorleifsson, G; Palsson, S; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Vermeulen, SH; Goldstein, AM; Tucker, MA; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Vermeulen, Sita H.; Goldstein, Alisa M.; Tucker, Margaret A.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Two newly identified genetic determinants of pigmentation in Europeans	NATURE GENETICS			English	Article							TYRP1 GENE; POLYMORPHISM; AGOUTI; SKIN; POPULATION; SEQUENCE; ALBINISM; MELANOMA; HUMANS	We present results from a genome-wide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. Two coding variants in TPCN2 are associated with hair color, and a variant at the ASIP locus shows strong association with skin sensitivity to sun, freckling and red hair, phenotypic characteristics similar to those affected by well-known mutations in MC1R.	[Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Thorisdottir, Kristin; Ragnarsson, Rafn] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), deCODE genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Palsson, Snaebjorn/J-9113-2012; Sigurgeirsson, Bardur/AAP-7755-2020; Aben, Katja KH/G-9686-2016; Vermeulen, Sita H./L-4716-2015; Sigurgeirsson, Bárður/B-6130-2011; Palsson, Arnar/M-2742-2015; Tucker, Margaret A/B-4297-2015; Kiemeney, Lambertus A./D-3357-2009; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Aben, Katja KH/0000-0002-0214-2147; Vermeulen, Sita H./0000-0003-4913-8601; Palsson, Arnar/0000-0002-6525-8112; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Palsson, Snaebjorn/0000-0002-4297-3500	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP005803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Box NF, 1998, MAMM GENOME, V9, P50, DOI 10.1007/s003359900678; Frudakis T, 2003, GENETICS, V165, P2071; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Schmutz SM, 2007, J HERED, V98, P351, DOI 10.1093/jhered/esm036; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x	14	262	269	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					835	837		10.1038/ng.160	http://dx.doi.org/10.1038/ng.160			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488028				2022-12-25	WOS:000257166500016
J	Cuomo, ME; Knebel, A; Morrice, N; Paterson, H; Cohen, P; Mittnacht, S				Cuomo, Maria Emanuela; Knebel, Axel; Morrice, Nick; Paterson, Hugh; Cohen, Philip; Mittnacht, Sibylle			p53-driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation	NATURE CELL BIOLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CYCLIN; DUPLICATION; PROTEIN; P53; CANCER; KINASE; HUMAN-HERPESVIRUS-8; NUCLEOPHOSMIN; INHIBITION	Chromosome loss or gain is associated with a large number of solid cancers, providing genomic plasticity and thus adaptability to cancer cells(1,2). Numerical centrosome abnormalities arising from centrosome over-duplication or failed cytokinesis are a recognized cause of aneuploidy(3,4). In higher eukaryotic cells, the centrosome duplicates only once per cell cycle to ensure the formation of a bipolar mitotic spindle that orchestrates the balanced distribution of the sister chromatids to the respective daughter cells(5). Here we delineate the events that allow abnormal centrosome duplication, resulting in mitotic errors and incorrect chromosome segregation in cells with sustained cyclin-dependent kinase (CDK) activity. We have identified NPM1 as a substrate for CDK6 activated by the Kaposi's sarcoma herpesvirus (KSHV) D-type cyclin and shown that p53-driven apoptosis occurs downstream of NPM1 phosphorylation as a checkpoint mechanism that prevents accumulation of cells with supernumerary centrosomes. Our findings provide evidence that abnormal chromosome segregation in KSHV-infected cells is a direct consequence of NPM1 phosphorylation and predict that genomic instability is an inevitable consequence of latent KSHV infection.	[Cuomo, Maria Emanuela; Paterson, Hugh; Mittnacht, Sibylle] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, London SW3 6JB, England; [Knebel, Axel] Kinasource, Unit S Dudhope Mill 9, Dundee DD1 5AN, Scotland; [Knebel, Axel; Morrice, Nick; Cohen, Philip] Univ Dundee, James Black Ctr, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Dundee	Cuomo, ME (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England.	emanuela@icr.ac.uk		Knebel, Axel/0000-0002-9197-6054	Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U127084348] Funding Source: Medline; MRC [MC_U127084348] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Cuomo ME, 2005, J BIOL CHEM, V280, P35844, DOI 10.1074/jbc.M503877200; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Ojala PM, 1999, CANCER RES, V59, P4984; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002	28	38	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					723	730		10.1038/ncb1735	http://dx.doi.org/10.1038/ncb1735			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454140				2022-12-25	WOS:000256350100019
J	Kohler, A; Schneider, M; Cabal, GG; Nehrbass, U; Hurt, E				Koehler, Alwin; Schneider, Maren; Cabal, Ghislain G.; Nehrbass, Ulf; Hurt, Ed			Yeast Ataxin-7 links histone deubiquitination with gene gating and mRNA export	NATURE CELL BIOLOGY			English	Article							CEREVISIAE SAGA COMPLEX; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; H2B UBIQUITYLATION; POLYMERASE-II; ACETYLTRANSFERASE ACTIVITY; NUCLEAR-ENVELOPE; ASSOCIATION; UBP8; RECRUITMENT	Targeting of a gene to the nuclear pore complexes (NPCs), known as gene gating, can affect its transcriptional state1-9. However, the mechanism underlying gene gating is poorly understood. Here, we have identified SAGA-associated Sgf73 (ref. 10), the yeast orthologue of human Ataxin-7 (ref. 11), as a regulator of histone H2B ubiquitin levels, a modification linked to both transcription initiation and elongation(12,13). Sgf73 is a key component of a minimal histone-deubiquitinating complex. Activation of the H2B deubiquitinating protease, Ubp8, is cooperative and requires complex formation with the amino-terminal zinc-finger-containing domain of Sgf73 and Sgf11-Sus1. Through a separate domain, Sgf73 mediates recruitment of the TREX-2 mRNA export factors Sac3 and Thp1 to SAGA and their stable interaction with Sus1-Cdc31. This latter step is crucial to target TREX-2 to the NPC. Loss of Sgf73 from SAGA abrogates gene gating of GAL1 and causes a GAL1 mRNA export defect. Thus, Sgf73 provides a molecular scaffold to integrate the regulation of H2B ubiquitin levels, tethering of a gene to the NPC and export of mRNA.	[Koehler, Alwin; Schneider, Maren; Hurt, Ed] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; [Koehler, Alwin] Univ Kinderklin Heidelberg, D-69120 Heidelberg, Germany; [Cabal, Ghislain G.; Nehrbass, Ulf] Inst Pasteur, Unite Biol Cellulaire Noyau, F-75724 Paris 15, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Nehrbass, Ulf/0000-0002-7028-8076; Cabal, Ghislain/0000-0002-9728-506X				Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; KOHLER A, 2006, CELL, V17, P4428; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2006, NUCLEIC ACIDS RES, V34, P6225, DOI 10.1093/nar/gkl844; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	35	155	163	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					707	715		10.1038/ncb1733	http://dx.doi.org/10.1038/ncb1733			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488019				2022-12-25	WOS:000256350100017
J	Montagnoli, A; Valsasina, B; Croci, V; Menichincheri, M; Rainoldi, S; Marchesi, V; Tibolla, M; Tenca, P; Brotherton, D; Albanese, C; Patton, V; Alzani, R; Ciavolella, A; Sola, F; Molinari, A; Volpi, D; Avanzi, N; Fiorentini, F; Cattoni, M; Healy, S; Ballinari, D; Pesenti, E; Isacchi, A; Moll, J; Bensimon, A; Vanotti, E; Santocanale, C				Montagnoli, Alessia; Valsasina, Barbara; Croci, Valter; Menichincheri, Maria; Rainoldi, Sonia; Marchesi, Vanessa; Tibolla, Marcello; Tenca, Pierluigi; Brotherton, Deborah; Albanese, Clara; Patton, Veronica; Alzani, Rachele; Ciavolella, Antonella; Sola, Francesco; Molinari, Antonio; Volpi, Daniele; Avanzi, Nilla; Fiorentini, Francesco; Cattoni, Marina; Healy, Sandra; Ballinari, Dario; Pesenti, Enrico; Isacchi, Antonella; Moll, Jurgen; Bensimon, Aaron; Vanotti, Ermes; Santocanale, Corrado			A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; HUMAN HOMOLOG; CELL-CYCLE; PROTEIN; APOPTOSIS; MCM; IDENTIFICATION; MECHANISMS; DEPLETION	Cdc7 is an essential kinase that promotes DNA replication by activating origins of replication. Here, we characterized the potent Cdc7 inhibitor PHA-767491 (1) in biochemical and cell-based assays, and we tested its antitumor activity in rodents. We found that the compound blocks DNA synthesis and affects the phosphorylation of the replicative DNA helicase at Cdc7-dependent phosphorylation sites. Unlike current DNA synthesis inhibitors, PHA-767491 prevents the activation of replication origins but does not impede replication fork progression, and it does not trigger a sustained DNA damage response. Treatment with PHA-767491 results in apoptotic cell death in multiple cancer cell types and tumor growth inhibition in preclinical cancer models. To our knowledge, PHA-767491 is the first molecule that directly affects the mechanisms controlling initiation as opposed to elongation in DNA replication, and its activities suggest that Cdc7 kinase inhibition could be a new strategy for the development of anticancer therapeutics.	[Montagnoli, Alessia; Valsasina, Barbara; Croci, Valter; Menichincheri, Maria; Rainoldi, Sonia; Marchesi, Vanessa; Tibolla, Marcello; Albanese, Clara; Patton, Veronica; Alzani, Rachele; Ciavolella, Antonella; Sola, Francesco; Molinari, Antonio; Volpi, Daniele; Avanzi, Nilla; Fiorentini, Francesco; Cattoni, Marina; Healy, Sandra; Ballinari, Dario; Pesenti, Enrico; Isacchi, Antonella; Moll, Jurgen; Vanotti, Ermes; Santocanale, Corrado] Nerviano Med Sci Oncol, I-20014 Nerviano, Italy; [Bensimon, Aaron] Pasteur Biotop, Genom Vis, F-75724 Paris 15, France; [Santocanale, Corrado] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn & Sci, Galway, Ireland	Nerviano Medical Sciences S.r.l; Ollscoil na Gaillimhe-University of Galway	Santocanale, C (corresponding author), Nerviano Med Sci Oncol, Via Pasteur 10, I-20014 Nerviano, Italy.	corrado.santocanale@nuigalway.ie	Healy, Sandra J/D-5256-2013	Santocanale, Corrado/0000-0003-1337-5656				Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benakanakere I, 2006, CLIN CANCER RES, V12, P4062, DOI 10.1158/1078-0432.CCR-06-0427; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Cai DP, 2006, CANCER RES, V66, P435, DOI 10.1158/0008-5472.CAN-05-1769; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Feng DR, 2003, CANCER RES, V63, P7356; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilman, 2001, GOODMAN GILMANS PHAR, P1389; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; Hess GF, 1998, GENE, V211, P133, DOI 10.1016/S0378-1119(98)00094-8; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; Kerns EH, 2004, J PHARM SCI-US, V93, P1440, DOI 10.1002/jps.20075; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; KIM JM, 2007, ONCOGENE        1217, DOI DOI 10.1038/SJ.0NC.1210994; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pevarello P, 2004, J MED CHEM, V47, P3367, DOI 10.1021/jm031145u; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Senderowicz AM, 2003, CANCER BIOL THER, V2, pS84; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Vanotti E, 2008, J MED CHEM, V51, P487, DOI 10.1021/jm700956r; Wexler EJ, 2000, CLIN CANCER RES, V6, P3361	50	148	157	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					357	365		10.1038/nchembio.90	http://dx.doi.org/10.1038/nchembio.90			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18469809				2022-12-25	WOS:000256068600012
J	Town, T; Laouar, Y; Pittenger, C; Mori, T; Szekely, CA; Tan, J; Duman, RS; Flavell, RA				Town, Terrence; Laouar, Yasmina; Pittenger, Christopher; Mori, Takashi; Szekely, Christine A.; Tan, Jun; Duman, Ronald S.; Flavell, Richard A.			Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology	NATURE MEDICINE			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MOUSE MODEL; A-BETA; DISEASE; MICE; BRAIN; MICROGLIA; BURDEN; PROGRESSION; DEFICIENCY	Alzheimer's disease is the most common dementia and is pathologically characterized by deposition of amyloid-beta peptide (A beta) into beta-amyloid plaques, neuronal injury and low-level, chronic activation of brain immunity(1). Transforming growth factor-beta s (TGF-beta s) are pleiotropic cytokines that have key roles in immune cell activation, inflammation and repair after injury(2). We genetically interrupted TGF-beta and downstream Smad2/3 signaling (TGF-beta-Smad2/3) in innate immune cells by inducing expression of CD11c promoter-driven dominant-negative TGF-beta receptor type II in C57BL/6 mice (CD11c-DNR)(3), crossed these mice with mice overexpressing mutant human amyloid precursor protein, the Tg2576 Alzheimer's disease mouse model(4), and evaluated Alzheimer's disease-like pathology. Aged double-transgenic mice showed complete mitigation of Tg2576-associated hyperactivity and partial mitigation of defective spatial working memory. Brain parenchymal and cerebrovascular beta-amyloid deposits and A beta abundance were markedly (up to 90%) attenuated in Tg2576-CD11c-DNR mice. This was associated with increased infiltration of A beta-containing peripheral macrophages around cerebral vessels and beta-amyloid plaques. In vitro, cultures of peripheral macrophages, but not microglia, from CD11c-DNR mice showed blockade of classical TGF-beta activated Smad2/3 but also showed hyperactivation of alternative bone morphogenic protein-activated Smad1/5/8 signaling and increased A beta phagocytosis. Similar effects were noted after pharmacological inhibition of activin-like kinase-5, a type I TGF-beta receptor. Taken together, our results suggest that blockade of TGF-beta-Smad2/3 signaling in peripheral macrophages represents a new therapeutic target for Alzheimer's disease.	[Town, Terrence; Laouar, Yasmina; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Town, Terrence] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Biomed Sci & Neurosurg, Los Angeles, CA 90048 USA; [Pittenger, Christopher; Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Mori, Takashi] Saitama Med Univ, Saitama Med Ctr, Inst Med Sci, Kawagoe, Saitama 3508550, Japan; [Szekely, Christine A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Szekely, Christine A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL 33612 USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06508 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Cedars Sinai Medical Center; Yale University; Saitama Medical University; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of South Florida; Yale University; Howard Hughes Medical Institute; Yale University	Town, T (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	terrence.town@cshs.org; richard.flavell@yale.edu	Pittenger, Christopher/G-8402-2012; Tan, Jun/I-5339-2012	Pittenger, Christopher/0000-0003-2117-9321	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029726, R00AG029726] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [K99 AG029726-01, R00 AG029726, 4R00AG029726, R00 AG029726-02, K99 AG029726, 1K99AG029726] Funding Source: Medline; NINDS NIH HHS [R01 NS048335] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lemere CA, 2000, ANN NY ACAD SCI, V920, P328; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321	30	353	363	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					681	687		10.1038/nm1781	http://dx.doi.org/10.1038/nm1781			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18516051	Green Accepted			2022-12-25	WOS:000256468700035
J	Tenesa, A; Farrington, SM; Prendergast, JGD; Porteous, ME; Walker, M; Haq, N; Barnetson, RA; Theodoratou, E; Cetnarskyj, R; Cartwright, N; Semple, C; Clark, AJ; Reid, FJL; Smith, LA; Kavoussanakis, K; Koessler, T; Pharoah, PDP; Buch, S; Schafmayer, C; Tepel, J; Schreiber, S; Volzke, H; Schmidt, CO; Hampe, J; Chang-Claude, J; Hoffmeister, M; Brenner, H; Wilkening, S; Canzian, F; Capella, G; Moreno, V; Deary, IJ; Starr, JM; Tomlinson, IPM; Kemp, Z; Howarth, K; Carvajal-Carmona, L; Webb, E; Broderick, P; Vijayakrishnan, J; Houlston, RS; Rennert, G; Ballinger, D; Rozek, L; Gruber, SB; Matsuda, K; Kidokoro, T; Nakamura, Y; Zanke, BW; Greenwood, CMT; Rangrej, J; Kustra, R; Montpetit, A; Hudson, TJ; Gallinger, S; Campbell, H; Dunlop, MG				Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Porteous, Mary E.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cetnarskyj, Roseanne; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Reid, Fiona J. L.; Smith, Lorna A.; Kavoussanakis, Kostas; Koessler, Thibaud; Pharoah, Paul D. P.; Buch, Stephan; Schafmayer, Clemens; Tepel, Juergen; Schreiber, Stefan; Voelzke, Henry; Schmidt, Carsten O.; Hampe, Jochen; Chang-Claude, Jenny; Hoffmeister, Michael; Brenner, Hermann; Wilkening, Stefan; Canzian, Federico; Capella, Gabriel; Moreno, Victor; Deary, Ian J.; Starr, John M.; Tomlinson, Ian P. M.; Kemp, Zoe; Howarth, Kimberley; Carvajal-Carmona, Luis; Webb, Emily; Broderick, Peter; Vijayakrishnan, Jayaram; Houlston, Richard S.; Rennert, Gad; Ballinger, Dennis; Rozek, Laura; Gruber, Stephen B.; Matsuda, Koichi; Kidokoro, Tomohide; Nakamura, Yusuke; Zanke, Brent W.; Greenwood, Celia M. T.; Rangrej, Jagadish; Kustra, Rafal; Montpetit, Alexandre; Hudson, Thomas J.; Gallinger, Steven; Campbell, Harry; Dunlop, Malcolm G.			Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21	NATURE GENETICS			English	Article							GENETIC RISK; SNPS	In a genome-wide association study to identify loci associated with colorectal cancer (CRC) risk, we genotyped 555,510 SNPs in 1,012 early- onset Scottish CRC cases and 1,012 controls (phase 1). In phase 2, we genotyped the 15,008 highest-ranked SNPs in 2,057 Scottish cases and 2,111 controls. We then genotyped the five highest-ranked SNPs from the joint phase 1 and 2 analysis in 14,500 cases and 13,294 controls from seven populations, and identified a previously unreported association, rs3802842 on 11q23 (OR 1.1; P=5.8 x 10(-10)),showing population differences in risk. We also replicated and fine-mapped associations at 8q24 (rs7014346; OR 1.19; P=8.6x10(-26)) and 18q21 (rs4939827; OR 1.2; P=7.8 x 10(-28)). Risk was greater for rectal than for colon cancer for rs3802842 (P < 0.008) and rs4939827 (P < 0.009). Carrying all six possible risk alleles yielded OR 2.6 (95% CI 1.75-3.89) for CRC. These findings extend our understanding of the role of common genetic variation in CRC etiology.	[Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Campbell, Harry; Dunlop, Malcolm G.] Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Campbell, Harry; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Porteous, Mary E.; Cetnarskyj, Roseanne] Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; [Theodoratou, Evropi] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Reid, Fiona J. L.; Smith, Lorna A.; Kavoussanakis, Kostas] Univ Edinburgh, Edinburgh Parallel Comp Ctr, Edinburgh EH9 3JZ, Midlothian, Scotland; [Koessler, Thibaud; Pharoah, Paul D. P.] Univ Cambridge, Canc Res UK Labs, Dept Oncol, Cambridge CB1 8RN, England; [Buch, Stephan; Tepel, Juergen; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Buch, Stephan; Schafmayer, Clemens; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Schafmayer, Clemens; Tepel, Juergen] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Voelzke, Henry; Schmidt, Carsten O.] Univ Hosp Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Hoffmeister, Michael; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Wilkening, Stefan; Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, D-69120 Heidelberg, Germany; [Capella, Gabriel] IDIBELL Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; [Moreno, Victor] IDIBELL Catalan Inst Oncol, Bioinformat Unit, Barcelona 08907, Spain; [Moreno, Victor] Univ Barcelona, Barcelona 08907, Spain; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Edinburgh EH4 2DN, Midlothian, Scotland; [Tomlinson, Ian P. M.; Kemp, Zoe; Howarth, Kimberley; Carvajal-Carmona, Luis; Rangrej, Jagadish] Canc Res UK London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Vijayakrishnan, Jayaram; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Rennert, Gad] Technion x2013 Israel Inst Technol, CHS Natl Canc Control Ctr, Haifa, Israel; [Ballinger, Dennis] Technion x2013 Israel Inst Technol, Dept Community Med & Epidemiol, Carmel Med Ctr, Haifa, Israel; [Ballinger, Dennis] Technion x2013 Israel Inst Technol, B Rappaport Fac Med, Haifa, Israel; [Ballinger, Dennis] Perlegen Sci, Mountain View, CA 94043 USA; [Rozek, Laura; Gruber, Stephen B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Rozek, Laura; Gruber, Stephen B.] Univ Michigan, Sch Med, Dept Epidemiol & Human Genet, Ann Arbor, MI 48109 USA; [Matsuda, Koichi; Kidokoro, Tomohide; Nakamura, Yusuke] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci, Tokyo 1088639, Japan; [Zanke, Brent W.; Greenwood, Celia M. T.; Kustra, Rafal; Hudson, Thomas J.; Gallinger, Steven] Canc Care Ontario, Toronto, ON M5G 1L7, Canada; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Zanke, Brent W.] Univ Ottawa, Fac Med, Div Hematol, Ottawa, ON K1H 8L6, Canada; [Greenwood, Celia M. T.; Rangrej, Jagadish] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Greenwood, Celia M. T.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M57 3M7, Canada; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3G 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3G 1A4, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Univ Toronto, Toronto, ON M5G 1X5, Canada	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cancer Research UK; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Edinburgh; University of Edinburgh; Cancer Research UK; University of London; Institute of Cancer Research - UK; Clalit Health Services; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tokyo; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dunlop, MG (corresponding author), Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	Malcolm.Dunlop@hgu.mrc.ac.uk	Hoffmeister, Michael/AAB-2321-2022; Semple, Colin A M/A-5613-2009; Capella, Gabriel/I-1879-2015; Hampe, Jochen/A-2555-2010; Farrington, Susan M/Q-2710-2019; Theodoratou, Evropi/C-3430-2014; Hoffmeister, Michael/T-7187-2019; Dunlop, Malcolm G/F-1973-2011; Brenner, Hermann/B-4627-2017; Deary, Ian J/C-6297-2009; Brenner, Hermann/ABE-6383-2020; Pharoah, Paul/V-6658-2019; Schmidt, Carsten Oliver/AAH-2778-2019; Campbell, Harry/E-2959-2010; Farrington, Susan M/C-7319-2013; Buch, Stephan/AAV-5028-2021; Moreno, Victor/A-1697-2010; Canzian, Federico/I-2804-2014; Gallinger, Steven/E-4575-2013; Hoffmeister, Michael/B-5745-2012; Carvajal-Carmona, Luis G/B-3882-2010; Kössler, Thibaud/AAZ-9734-2020; Matsuda, Koichi/D-4597-2011	Hoffmeister, Michael/0000-0002-8307-3197; Semple, Colin A M/0000-0003-1765-4118; Capella, Gabriel/0000-0002-4669-7320; Hampe, Jochen/0000-0002-2421-6127; Farrington, Susan M/0000-0001-5955-7389; Theodoratou, Evropi/0000-0001-5887-9132; Hoffmeister, Michael/0000-0002-8307-3197; Dunlop, Malcolm G/0000-0002-3033-5851; Brenner, Hermann/0000-0002-6129-1572; Deary, Ian J/0000-0002-1733-263X; Brenner, Hermann/0000-0002-6129-1572; Pharoah, Paul/0000-0001-8494-732X; Schmidt, Carsten Oliver/0000-0001-5266-9396; Campbell, Harry/0000-0002-6169-6262; Moreno, Victor/0000-0002-2818-5487; Hoffmeister, Michael/0000-0002-8307-3197; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Houlston, Richard/0000-0002-5268-0242; Tenesa, Albert/0000-0003-4884-4475; Matsuda, Koichi/0000-0001-7292-2686; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Greenwood, Celia/0000-0002-2427-5696; Prendergast, James/0000-0001-8916-018X; Kossler, Thibaud/0000-0001-9196-9076; Canzian, Federico/0000-0002-4261-4583; Webb, Emily/0000-0002-4019-7456; Broderick, Peter/0000-0002-8348-5829; Kavoussanakis, Kostas/0000-0001-9167-7145	NATIONAL CANCER INSTITUTE [R01CA081488, U24CA074783, U01CA074783, K22CA095011, P30CA046592] Funding Source: NIH RePORTER; MRC [MC_U127527198] Funding Source: UKRI; Cancer Research UK [C48/A6361, A8896, C348/A3758] Funding Source: Medline; Medical Research Council [MC_U127527198, G0000657-53203] Funding Source: Medline; NCI NIH HHS [U01 CA074783-06, U24 CA074783, P30 CA46592, U01 CA074783-05, R01 CA81488, U01 CA076783, P30 CA046592, U01 CA074783, CA-95-011, U01 CA074783-07, R01 CA081488] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office		Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; CHURCHILL GA, 1994, GENETICS, V138, P963; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sokal R. R., 2012, BIOMETRY; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tenesa A, 2006, BRIT J CANCER, V95, P239, DOI 10.1038/sj.bjc.6603239; Tenesa A, 2006, EUR J HUM GENET, V14, P357, DOI 10.1038/sj.ejhg.5201554; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	16	479	492	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					631	637		10.1038/ng.133	http://dx.doi.org/10.1038/ng.133			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372901	Green Accepted			2022-12-25	WOS:000255366700032
J	Polozov, IV; Bezrukov, L; Gawrisch, K; Zimmerberg, J				Polozov, Ivan V.; Bezrukov, Ludmila; Gawrisch, Klaus; Zimmerberg, Joshua			Progressive ordering with decreasing temperature of the phospholipids of influenza virus	NATURE CHEMICAL BIOLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; ELECTRON-SPIN RESONANCE; PLASMA-MEMBRANE; LATERAL DIFFUSION; BIOLOGICAL-MEMBRANES; LIPID-MEMBRANES; CELL-MEMBRANES; RAFT FORMATION; LINE TENSION; MAS NMR	Using linewidth and spinning sideband intensities of lipid hydrocarbon chain resonances in proton magic angle spinning NMR spectra, we detected the temperature-dependent phase state of naturally occurring lipids of intact influenza virus without exogenous probes. Increasingly, below 41 degrees C ordered and disordered lipid domains coexisted for the viral envelope and extracts thereof. At 22 degrees C much lipid was in a gel phase, the fraction of which reversibly increased with cholesterol depletion. Diffusion measurements and fluorescence microscopy independently confirmed the existence of gel-phase domains. Thus the existence of ordered regions of lipids in biological membranes is now demonstrated. Above the physiological temperatures of influenza infection, the physical properties of viral envelope lipids, regardless of protein content, were indistinguishable from those of the disordered fraction. Viral fusion appears to be uncorrelated to ordered lipid content. Lipid ordering may contribute to viral stability at lower temperatures, which has recently been found to be critical for airborne transmission.	[Polozov, Ivan V.; Bezrukov, Ludmila; Zimmerberg, Joshua] NICHHD, Lab Cellular & Mol Biophys, Bethesda, MD 20892 USA; [Gawrisch, Klaus] NIAAA, NIH, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zimmerberg, J (corresponding author), NICHHD, Lab Cellular & Mol Biophys, 10D14,10 Ctr Dr MSC 1855, Bethesda, MD 20892 USA.	joshz@helix.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415, ZIAHD001409] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409, Z01HD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003, Z01AA000003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Blom TS, 2001, BIOCHEMISTRY-US, V40, P14635, DOI 10.1021/bi0156714; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; BUKRINSKAYA AG, 1987, BIOCHIM BIOPHYS ACTA, V897, P285, DOI 10.1016/0005-2736(87)90424-X; Campbell S, 2004, J VIROL, V78, P10556, DOI 10.1128/JVI.78.19.10556-10565.2004; Clarke JA, 2006, BIOPHYS J, V90, P2383, DOI 10.1529/biophysj.104.056499; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Filippov A, 2006, BIOPHYS J, V90, P2086, DOI 10.1529/biophysj.105.075150; Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaede HC, 2003, BIOPHYS J, V85, P1734, DOI 10.1016/S0006-3495(03)74603-7; Hac AE, 2005, BIOPHYS J, V88, P317, DOI 10.1529/biophysj.104.040444; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Heberle FA, 2005, BBA-MOL CELL RES, V1746, P186, DOI 10.1016/j.bbamcr.2005.05.008; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; LANDSBER.FR, 1971, P NATL ACAD SCI USA, V68, P2579, DOI 10.1073/pnas.68.10.2579; LANDSBERGER FR, 1976, BIOCHEMISTRY-US, V15, P2356, DOI 10.1021/bi00656a017; LENARD J, 1978, ANNU REV BIOPHYS BIO, V7, P139, DOI 10.1146/annurev.bb.07.060178.001035; LENARD J, 1974, BIOCHIM BIOPHYS ACTA, V344, P51, DOI 10.1016/0304-4157(74)90008-2; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MCMULLEN TPW, 1995, BBA-BIOMEMBRANES, V1234, P90, DOI 10.1016/0005-2736(94)00266-R; METSIKKO K, 1986, EMBO J, V5, P3429, DOI 10.1002/j.1460-2075.1986.tb04665.x; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; OLDFIELD E, 1987, BIOCHEMISTRY-US, V26, P6919, DOI 10.1021/bi00396a009; Paterson RG, 1993, MOL VIROLOGY PRACTIC, P35; PESSIN JE, 1980, J BIOL CHEM, V255, P9044; Polozov IV, 2006, BIOPHYS J, V90, P2051, DOI 10.1529/biophysj.105.070441; Polozov IV, 2004, BIOPHYS J, V87, P1741, DOI 10.1529/biophysj.104.040725; POLOZOV IV, 1994, CHEM PHYS LIPIDS, V69, P209, DOI 10.1016/0009-3084(94)90002-7; ROTHMAN JE, 1976, BIOCHEMISTRY-US, V15, P2361, DOI 10.1021/bi00656a018; Scheidt HA, 2005, BIOPHYS J, V89, P2504, DOI 10.1529/biophysj.105.062018; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SEFTON BM, 1974, J MOL BIOL, V90, P343, DOI 10.1016/0022-2836(74)90378-7; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEGMANN T, 1987, EMBO J, V6, P2651, DOI 10.1002/j.1460-2075.1987.tb02556.x; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2	50	150	155	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					248	255		10.1038/nchembio.77	http://dx.doi.org/10.1038/nchembio.77			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18311130	Green Published			2022-12-25	WOS:000254268300012
J	Flores, MVC; Lam, EYN; Crosier, KE; Crosier, PS				Flores, Maria Vega C.; Lam, Enid Yi Ni; Crosier, Kathryn E.; Crosier, Philip S.			Osteogenic transcription factor Runx2 is a maternal determinant of dorsoventral patterning in zebrafish	NATURE CELL BIOLOGY			English	Article							HOMEOBOX GENES; ORGANIZER FORMATION; AXIS FORMATION; EMBRYO; EXPRESSION; INDUCTION; VENT; WNT8; VOX	The maternal genome greatly influences vertebrate embryogenesis before activation of zygotic transcription. Dorsoventral patterning is initiated by maternal factors(1-3), but the molecular pathways involved are incompletely understood. In frogs and fish, localized zygotic domains are induced whereby cells either express dorsal or ventral genes(1,2). Wnt/beta-catenin signalling promotes expression of the earliest dorsal zygotic genes(4). Among key zygotic ventralizing factors are the bone morphogenetic proteins (Bmps)(5,6) and the Vent homeodomain family(2,7-10); the latter act as repressors of dorsal organizer gene transcription. Here we show that Runx2, a transcription factor essential for bone formation, is an important maternal determinant of ventral zygotic genes in zebrafish. Depletion of maternal Runx2b type2 strongly dorsalizes embryos, due to loss of the earliest zygotic expression of vox, vent and ved, resulting in expansion of dorsal gene expression. To date, Runx2b is the only known regulator of vox, vent and ved at the onset of zygotic transcription; we show that this regulation is direct. Runx2 transcripts are processed in mature mouse oocytes(11) and we show that murine Runx2 type2 can substitute for the zebrafish orthologue in its ventralizing function, suggesting that Runx2 may have an evolutionarily conserved role in axis formation.	[Flores, Maria Vega C.; Lam, Enid Yi Ni; Crosier, Kathryn E.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Auckland 1142, New Zealand	University of Auckland	Crosier, PS (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Private Bag 92019, Auckland 1142, New Zealand.	ps.crosier@auckland.ac.nz		Lam, Enid Yi Ni/0000-0001-5843-7836				Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2005, J Endocrinol Invest, V28, P3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Imai Y, 2001, DEVELOPMENT, V128, P2407; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kelly C, 2000, DEVELOPMENT, V127, P3899; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pei W, 2007, DEV BIOL, V308, P368, DOI 10.1016/j.ydbio.2007.05.026; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Sidi S, 2003, P NATL ACAD SCI USA, V100, P3315, DOI 10.1073/pnas.0530115100; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808	31	32	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					346	U80		10.1038/ncb1697	http://dx.doi.org/10.1038/ncb1697			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18246063				2022-12-25	WOS:000253778300017
J	Young, AP; Schlisio, S; Minamishima, YA; Zhang, Q; Li, LJ; Grisanzio, C; Signoretti, S; Kaelin, WG				Young, Arthur P.; Schlisio, Susanne; Minamishima, Yoji Andrew; Zhang, Qing; Li, Lianjie; Grisanzio, Chiara; Signoretti, Sabina; Kaelin, William G., Jr.			VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; E1A; INACTIVATION; P53; SUPPRESSION; ACTIVATION; INDUCTION; PROTEINS; COMPLEX; LESIONS	Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans(1). Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions(1). Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.	[Young, Arthur P.; Schlisio, Susanne; Minamishima, Yoji Andrew; Zhang, Qing; Li, Lianjie; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Grisanzio, Chiara; Signoretti, Sabina] Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; [Grisanzio, Chiara; Signoretti, Sabina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Li, Lianjie; Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Minamishima, Yoji Andrew/E-5380-2010; ZHANG, QING/AGY-7972-2022	Minamishima, Yoji Andrew/0000-0001-7995-9318; ZHANG, QING/0000-0002-6595-8995; Schlisio, Susanne/0000-0002-2605-3771				Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; KAELIN WG, ANN REV PATHOL, V2, P145; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; LI L, MOL CELL BIOL, V27, P5381; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; WALTHER MM, 1995, J UROLOGY, V154, P2010, DOI 10.1016/S0022-5347(01)66674-6; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0	32	185	190	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					361	U115		10.1038/ncb1699	http://dx.doi.org/10.1038/ncb1699			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297059				2022-12-25	WOS:000253778300019
J	Zheng, P; Allen, WB; Roesler, K; Williams, ME; Zhang, S; Li, J; Glassman, K; Ranch, J; Nubel, D; Solawetz, W; Bhattramakki, D; Llaca, V; Deschamps, S; Zhong, GY; Tarczynski, MC; Shen, B				Zheng, Peizhong; Allen, William B.; Roesler, Keith; Williams, Mark E.; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Llaca, Victor; Deschamps, Stephane; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo			A phenylalanine in DGAT is a key determinant of oil content and composition in maize	NATURE GENETICS			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; EXPRESSION; SELECTION; PLANT	Plant oil is an important renewable resource for biodiesel production and for dietary consumption by humans and livestock. Through genetic mapping of the oil trait in plants, studies have reported multiple quantitative trait loci (QTLs) with small effects, but the molecular basis of oil QTLs remains largely unknown(1-5). Here we show that a high-oil QTL (qHO6) affecting maize seed oil and oleic-acid contents encodes an acyl-CoA: diacylglycerol acyltransferase (DGAT1-2), which catalyzes the final step of oil synthesis. We further show that a phenylalanine insertion in DGAT1-2 at position 469 (F469) is responsible for the increased oil and oleic-acid contents. The DGAT1-2 allele with F469 is ancestral, whereas the allele without F469 is a more recent mutant selected by domestication or breeding. Ectopic expression of the high-oil DGAT1-2 allele increases oil and oleic-acid contents by up to 41% and 107%, respectively. This work provides insights into the molecular basis of natural variation of oil and oleic-acid contents in plants and highlights DGAT as a promising target for increasing oil and oleic-acid contents in other crops.	[Zheng, Peizhong; Allen, William B.; Roesler, Keith; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo] Pioneer HiBred Int Inc, Dupont Co, Johnston, IA 50131 USA; [Williams, Mark E.; Llaca, Victor; Deschamps, Stephane] Dupont Corp Genet Res, Expt Stn, Wilmington, DE 19880 USA	DuPont; DuPont	Shen, B (corresponding author), Pioneer HiBred Int Inc, Dupont Co, 7300 NW 62nd Ave,POB 1004, Johnston, IA 50131 USA.	Bo.Shen@pioneer.com	Deschamps, Stephane/R-3806-2019	Li, Jiming/0000-0003-4344-1896				ALREFAI R, 1995, GENOME, V38, P894, DOI 10.1139/g95-118; AN GH, 1989, PLANT CELL, V1, P115, DOI 10.1105/tpc.1.1.115; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Clark D, 2006, CROP SCI, V46, P807, DOI 10.2135/cropsci2005.06-0153; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kinney AJ, 2002, BIOCHEM SOC T, V30, P1099, DOI 10.1042/BST0301099; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert R. J., 2004, Plant Breeding Reviews, V24, P153; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; PONELEIT CG, 1965, SCIENCE, V147, P1585, DOI 10.1126/science.147.3665.1585; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Song XF, 2004, MAYDICA, V49, P41; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; White P. J., 2003, Corn: chemistry and technology, P355; Zhao Zuo-yu, 2006, Methods Mol Biol, V318, P315	25	285	352	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					367	372		10.1038/ng.85	http://dx.doi.org/10.1038/ng.85			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278045				2022-12-25	WOS:000253548400031
J	Lasaro, MO; Tatsis, N; Hensley, SE; Whitbeck, JC; Lin, SW; Rux, JJ; Wherry, EJ; Cohen, GH; Eisenberg, RJ; Ertl, HC				Lasaro, Marcio O.; Tatsis, Nia; Hensley, Scott E.; Whitbeck, J. Charles; Lin, Shih-Wen; Rux, John J.; Wherry, E. John; Cohen, Gary H.; Eisenberg, Roselyn J.; Ertl, Hildegund C.			Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses	NATURE MEDICINE			English	Article							VIRUS GLYCOPROTEIN-D; T-CELL-ACTIVATION; SIMPLEX VIRUS-1; B-LYMPHOCYTE; CRYSTAL-STRUCTURE; RECEPTOR; EXPRESSION; HVEM; GD; SUPERFAMILY	Interactions between the herpesvirus entry mediator (HVEM) and the B- and T-lymphocyte attenuator (BTLA) inhibit B and T cell activation. HVEM-BTLA interactions are blocked by herpes simplex virus (HSV) glycoprotein D (gD) through binding of its N-terminal domain to the BTLA binding site of HVEM. In this study, we inserted viral antigens into the C-terminal domain of gD and expressed these antigens with plasmid or E1-deleted (replication-defective) adenovirus vectors. Viral antigens fused to gD induced T and B cell responses to the antigen that were far more potent than those elicited by the same antigen expressed without gD. The immunopotentiating effect required binding of the gD chimeric protein to HVEM. Overall, the studies demonstrate that targeting of antigen to the BTLA binding site of HVEM augments the immunogenicity of vaccines.	[Lasaro, Marcio O.; Tatsis, Nia; Hensley, Scott E.; Lin, Shih-Wen; Rux, John J.; Wherry, E. John; Ertl, Hildegund C.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Lin, Shih-Wen] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Whitbeck, J. Charles; Eisenberg, Roselyn J.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Whitbeck, J. Charles; Cohen, Gary H.; Eisenberg, Roselyn J.] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Ertl, HC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	ertl@wistar.org	Wherry, John/ABI-1280-2020		NCI NIH HHS [R01 CA077523, CA10815, P30 CA010815] Funding Source: Medline; NIAID NIH HHS [R37 AI018289, P01 AI052271, AI-18289, R01 AI018289, AI-052271] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA077523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018289, R37AI018289, P01AI052271] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Connolly SA, 2003, J VIROL, V77, P8127, DOI 10.1128/JVI.77.14.8127-8140.2003; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Granger SW, 2003, CYTOKINE GROWTH F R, V14, P289, DOI 10.1016/S1359-6101(03)00031-5; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; He Z, 2000, VIROLOGY, V270, P146, DOI 10.1006/viro.2000.0271; Hensley SE, 2005, J IMMUNOL, V175, P6032, DOI 10.4049/jimmunol.175.9.6032; HIGHLANDER SL, 1987, J VIROL, V61, P3356, DOI 10.1128/JVI.61.11.3356-3364.1987; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; ISOLA VJ, 1989, J VIROL, V63, P2325, DOI 10.1128/JVI.63.5.2325-2334.1989; Kresge Kristen Jill, 2005, IAVI Rep, V9, P18; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lin KY, 1996, CANCER RES, V56, P21; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; RAO ZH, 1995, NATURE, V378, P743, DOI 10.1038/378743a0; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997	30	50	55	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					205	212		10.1038/nm1704	http://dx.doi.org/10.1038/nm1704			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18193057	Green Accepted			2022-12-25	WOS:000252946700031
J	Sowinski, S; Jolly, C; Berninghausen, O; Purbhoo, MA; Chauveau, A; Kohler, K; Oddos, S; Eissmann, P; Brodsky, FM; Hopkins, C; Onfelt, B; Sattentau, Q; Davis, DM				Sowinski, Stefanie; Jolly, Clare; Berninghausen, Otto; Purbhoo, Marco A.; Chauveau, Anne; Koehler, Karsten; Oddos, Stephane; Eissmann, Philipp; Brodsky, Frances M.; Hopkins, Colin; Oenfelt, Bjoern; Sattentau, Quentin; Davis, Daniel M.			Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission	NATURE CELL BIOLOGY			English	Article							DENDRITIC CELLS; IMMUNE CELLS; PROTEINS; SYNAPSE; REPLICATION; RETRACTION; FILOPODIA; INFECTION; FISSION; KINASE	Transmission of HIV-1 via intercellular connections has been estimated as 100-1000 times more efficient than a cell-free process, perhaps in part explaining persistent viral spread in the presence of neutralizing antibodies(1,2). Such effective intercellular transfer of HIV-1 could occur through virological synapses(3-5) or target-cell filopodia connected to infected cells(6). Here we report that membrane nanotubes, formed when T cells make contact and subsequently part, provide a new route for HIV-1 transmission. Membrane nanotubes are known to connect various cell types, including neuronal and immune cells(7-13), and allow calcium-mediated signals to spread between connected myeloid cells(9). However, T-cell nanotubes are distinct from open-ended membranous tethers between other cell types(7,12), as a dynamic junction persists within T-cell nanotubes or at their contact with cell bodies. We also report that an extracellular matrix scaffold allows T-cell nanotubes to adopt variably shaped contours. HIV-1 transfers to uninfected T cells through nanotubes in a receptor-dependent manner. These data lead us to propose that HIV-1 can spread using nanotubular connections formed by short-term intercellular unions in which T cells specialize.	[Sowinski, Stefanie; Berninghausen, Otto; Purbhoo, Marco A.; Chauveau, Anne; Koehler, Karsten; Oddos, Stephane; Eissmann, Philipp; Hopkins, Colin; Davis, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Jolly, Clare; Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Brodsky, Frances M.] Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; [Oenfelt, Bjoern] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Imperial College London; University of Oxford; University of California System; University of California San Francisco; Karolinska Institutet	Davis, DM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	d.davis@imperial.ac.uk	Jolly, Clare/A-4501-2013	Davis, Daniel/0000-0002-9182-291X; Brodsky, Frances/0000-0002-1334-9258; Jolly, Clare/0000-0002-4603-2281	Biotechnology and Biological Sciences Research Council [BB/D011663/1] Funding Source: Medline; Medical Research Council [G0500563, G0400453] Funding Source: Medline; NIAID NIH HHS [P01-AI064520] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI064520] Funding Source: NIH RePORTER; BBSRC [BB/D011663/1] Funding Source: UKRI; MRC [G0500563, G0400453] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; Daniels DR, 2007, LANGMUIR, V23, P6667, DOI 10.1021/la0635000; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; La Boissiere S, 2004, J VIROL, V78, P8002, DOI 10.1128/JVI.78.15.8002-8014.2004; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	31	551	564	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					211	219		10.1038/ncb1682	http://dx.doi.org/10.1038/ncb1682			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193035				2022-12-25	WOS:000252897800017
J	Peterfy, M; Ben-Zeev, O; Mao, HZ; Weissglas-Volkov, D; Aouizerat, BE; Pullinger, CR; Frost, PH; Kane, JP; Malloy, MJ; Reue, K; Pajukanta, P; Doolittle, MH				Peterfy, Miklos; Ben-Zeev, Osnat; Mao, Hui Z.; Weissglas-Volkov, Daphna; Aouizerat, Bradley E.; Pullinger, Clive R.; Frost, Philip H.; Kane, John P.; Malloy, Mary J.; Reue, Karen; Pajukanta, Paeivi; Doolittle, Mark H.			Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia	NATURE GENETICS			English	Article							LIPOPROTEIN-LIPASE; HEPATIC LIPASE; ENDOPLASMIC-RETICULUM; MATURATION; CLD/CLD; MICE; CLD; TRANSPORT; MOUSE	Hypertriglyceridemia is a hallmark of many disorders, including metabolic syndrome, diabetes, atherosclerosis and obesity(1-3). A well-known cause is the deficiency of lipoprotein lipase ( LPL), a key enzyme in plasma triglyceride hydrolysis(4-6). Mice carrying the combined lipase deficiency ( cld) mutation show severe hypertriglyceridemia owing to a decrease in the activity of LPL and a related enzyme, hepatic lipase ( HL)(7-9), caused by impaired maturation of nascent LPL and hepatic lipase polypeptides in the endoplasmic reticulum ( ER)(10). Here we identify the gene containing the cld mutation as Tmem112 and rename it Lmf1 ( Lipase maturation factor 1). Lmf1 encodes a transmembrane protein with an evolutionarily conserved domain of unknown function that localizes to the ER. A human subject homozygous for a deleterious mutation in LMF1 also shows combined lipase deficiency with concomitant hypertriglyceridemia and associated disorders. Thus, through its profound effect on lipase activity, LMF1 emerges as an important candidate gene in hypertriglyceridemia(4,11,12).	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterfy, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	mpeterfy@ucla.edu; markdool@ucla.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL082762] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NCRR NIH HHS [KL2-RR024130] Funding Source: Medline; NHGRI NIH HHS [T32 HG002536, T32 HG02536] Funding Source: Medline; NHLBI NIH HHS [HL28481, HL082762] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Ben-Zeev O, 2004, J BIOL CHEM, V279, P6171, DOI 10.1074/jbc.M310051200; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; BLANCHETTEMACKIE EJ, 1986, LAB INVEST, V55, P347; BOBERG J, 1964, CLIN CHIM ACTA, V10, P420, DOI 10.1016/0009-8981(64)90171-8; Boedeker JC, 2001, J LIPID RES, V42, P1858; Boonyaratanakornkit J, 2004, MAMM GENOME, V15, P914, DOI 10.1007/s00335-004-2409-x; Briquet-Laugier V, 1999, J LIPID RES, V40, P2044; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; ELBEIN SC, 1994, J CLIN ENDOCR METAB, V79, P1450, DOI 10.1210/jc.79.5.1450; Ginsberg HN, 2003, J CARDIOVASC RISK, V10, P121, DOI 10.1097/00043798-200304000-00007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HELIO T, 1994, HUM GENET, V94, P271; Henderson HE, 1999, J LIPID RES, V40, P735; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Okamoto Y, 1995, J Atheroscler Thromb, V2, P66; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; Pejic RN, 2006, J AM BOARD FAM MED, V19, P310, DOI 10.3122/jabfm.19.3.310; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2006, MAMM GENOME, V17, P1013, DOI 10.1007/s00335-006-0045-3; Ranganathan S, 2002, J ENDOCRINOL, V172, P155, DOI 10.1677/joe.0.1720155; Reue K, 1996, J LIPID RES, V37, P1387; Scow RO, 1998, CHEM PHYS LIPIDS, V93, P149, DOI 10.1016/S0009-3084(98)00039-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L	26	154	161	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1483	1487		10.1038/ng.2007.24	http://dx.doi.org/10.1038/ng.2007.24			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994020				2022-12-25	WOS:000251267400016
J	Aikawa, Y; Morimoto, K; Yamamoto, T; Chaki, H; Hashiramoto, A; Narita, H; Hirono, S; Shiozawa, S				Aikawa, Yukihiko; Morimoto, Kimiko; Yamamoto, Tetsuya; Chaki, Hisaaki; Hashiramoto, Akira; Narita, Hirokazu; Hirono, Shuichi; Shiozawa, Shunichi			Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1	NATURE BIOTECHNOLOGY			English	Article							STIMULATES OSTEOCLAST DIFFERENTIATION; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; JOINT INFLAMMATION; PREVENTS CARTILAGE; BONE DESTRUCTION; TRANSGENIC MICE; BINDING-SITES; WEE1 KINASE; AP-1	To inhibit arthritis upstream of inflammatory cytokine release and matrix metalloproteinase (MMP) action, we designed de novo a small-molecule inhibitor of c-Fos/activator protein-1 (AP-1) using three-dimensional (3D) pharmacophore modeling. This model was based on the 3D structure of the basic region-leucine zipper domain of AP-1-DNA complex. Administration of this inhibitor prevented type II collagen-induced arthritis from day 21, before the onset of arthritis, or from day 27, resolved arthritis after its onset. Suppression of disease was accomplished by reducing the amounts of inflammatory cytokines and MMPs in vivo in sera and joints and in vitro in synovial cell and chondrocyte cultures. The primary action of this molecule was the inhibition of matrix-degrading MMPs and inflammatory cytokines including interleukin 1 beta; this molecule also synergized with anti-tumor necrosis factor a to inhibit arthritis. Thus, selective inhibition of c-Fos/AP-1 resolves arthritis in a preclinical model of the disease.	[Hashiramoto, Akira; Shiozawa, Shunichi] Kobe Univ, Grad Sch Med & Hlth Sci, Div Rheumatol, Suma Ku, Kobe, Hyogo 6540142, Japan; [Hashiramoto, Akira; Shiozawa, Shunichi] Kobe Univ Hosp, Ctr Rheumat Dis, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Aikawa, Yukihiko; Morimoto, Kimiko; Yamamoto, Tetsuya; Chaki, Hisaaki; Narita, Hirokazu] Toyama Chem Co Ltd, Res Labs, Toyama 9308508, Japan; [Hirono, Shuichi] Kitasato Univ, Sch Pharm, Dept Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan	Kobe University; Kobe University; Kitasato University	Shiozawa, S (corresponding author), Kobe Univ, Grad Sch Med & Hlth Sci, Div Rheumatol, Suma Ku, Kobe, Hyogo 6540142, Japan.	shioz@kobe-u.ac.jp	Shiozawa, Shunichi/W-2992-2019					ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; CONWAY JG, 1995, J EXP MED, V182, P449, DOI 10.1084/jem.182.2.449; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hochberg MC, 2005, SEMIN ARTHRITIS RHEU, V34, P819, DOI 10.1016/j.semarthrit.2004.11.006; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kawabata D, 2004, ARTHRITIS RHEUM-US, V50, P660, DOI 10.1002/art.20023; Kawasaki H, 2003, ONCOGENE, V22, P6839, DOI 10.1038/sj.onc.1206903; Kawasaki H, 2001, EMBO J, V20, P4618, DOI 10.1093/emboj/20.16.4618; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; KOOPMAN WJ, 1994, SEMIN ARTHRITIS RHEU, V23, P50, DOI 10.1016/0049-0172(94)90085-X; KUROKI Y, 1992, BIOCHEM BIOPH RES CO, V182, P1389, DOI 10.1016/0006-291X(92)91887-V; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lewis EJ, 1997, BRIT J PHARMACOL, V121, P540, DOI 10.1038/sj.bjp.0701150; Mancarella L, 2007, J RHEUMATOL, V34, P1670; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; MIYAUCHI A, 1994, BIOCHEM BIOPH RES CO, V205, P1547, DOI 10.1006/bbrc.1994.2843; Mudgett JS, 1998, ARTHRITIS RHEUM-US, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; PROBERT L, 1995, EUR J IMMUNOL, V25, P1794, DOI 10.1002/eji.1830250647; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Rossi AG, 2006, NAT MED, V12, P1434, DOI 10.1038/nm1206-1434; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; SHIOZAWA S, 1983, ARTHRITIS RHEUM-US, V26, P472, DOI 10.1002/art.1780260404; SHIOZAWA S, 1992, J IMMUNOL, V148, P3100; Shiozawa S, 1997, J CLIN INVEST, V99, P1210, DOI 10.1172/JCI119277; SIRUMCONNOLLY K, 1991, NUCLEIC ACIDS RES, V19, P335, DOI 10.1093/nar/19.2.335; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Tsuchida K, 2006, J MED CHEM, V49, P80, DOI 10.1021/jm050550d; Tsuchida K, 2004, J MED CHEM, V47, P4239, DOI 10.1021/jm049890+; Van den Berg Wim B, 2002, Curr Rheumatol Rep, V4, P232; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106	43	136	145	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					817	823		10.1038/nbt1412	http://dx.doi.org/10.1038/nbt1412			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18587386				2022-12-25	WOS:000257491600027
J	Biddinger, SB; Haas, JT; Yu, BB; Bezy, O; Jing, EX; Zhang, WW; Unterman, TG; Carey, MC; Kahn, CR				Biddinger, Sudha B.; Haas, Joel T.; Yu, Bian B.; Bezy, Olivier; Jing, Enxuan; Zhang, Wenwei; Unterman, Terry G.; Carey, Martin C.; Kahn, C. Ronald			Hepatic insulin resistance directly promotes formation of cholesterol gallstones	NATURE MEDICINE			English	Article							ABCG8; LIVER; DISEASE; MICE; EXPRESSION; GENES; ALPHA; FOXO1	Despite the well-documented association between gallstones and the metabolic syndrome(1,2), the mechanistic links between these two disorders remain unknown. Here we show that mice solely with hepatic insulin resistance, created by liver-specific disruption of the insulin receptor (LIRKO mice)(3) are markedly predisposed toward cholesterol gallstone formation due to at least two distinct mechanisms. Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion. Hepatic insulin resistance also decreases expression of the bile acid synthetic enzymes, particularly Cyp7b1, and produces partial resistance to the farnesoid X receptor, leading to a lithogenic bile salt profile. As a result, after twelve weeks on a lithogenic diet, all of the LIRKO mice develop gallstones. Thus, hepatic insulin resistance provides a crucial link between the metabolic syndrome and increased cholesterol gallstone susceptibility.	[Biddinger, Sudha B.; Haas, Joel T.; Bezy, Olivier; Jing, Enxuan; Kahn, C. Ronald] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Biddinger, Sudha B.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Yu, Bian B.; Carey, Martin C.; Kahn, C. Ronald] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Zhang, Wenwei; Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA; [Zhang, Wenwei; Unterman, Terry G.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Zhang, Wenwei; Unterman, Terry G.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; [Carey, Martin C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Harvard University; Harvard Medical School	Biddinger, SB (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	sudha.biddinger@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Haas, Joel/R-6379-2018	Kahn, Ronald/0000-0002-7583-9228; Haas, Joel/0000-0002-0028-5988; Bezy, Olivier/0000-0003-4367-5043	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031036, R01DK073687, R01DK045935, K08DK073358, R37DK036588, P30DK036836, R01DK031036, K12DK063696, R01DK036588] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK073687, R01 DK045935, R01 DK073687, DK063695-05, K08 DK073358, K12 DK063696, R37 DK036588, DK45935, R01 DK036588, R37 DK036588-22, DK036588, DK036836-20, R01 DK073687-01, DK031036, P30 DK036836, R37 DK031036, R01 DK031036, K08 DK073358-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIYOSHI T, 1986, J LIPID RES, V27, P915; Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401; BENNION LJ, 1975, J CLIN INVEST, V56, P996, DOI 10.1172/JCI108180; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; CAREY MC, 1961, FUTURE PERSP IN PRES, V161, P77; Chen Q, 1999, GASTROENTEROLOGY, V116, P678, DOI 10.1016/S0016-5085(99)70190-3; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNDY SM, 1984, J CLIN INVEST, V73, P1156, DOI 10.1172/JCI111301; HEUMAN DM, 1989, J LIPID RES, V30, P719; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; OSLER W, 1992, PRINCIPLES PRACTICE, V432; Remaley AT, 2002, BIOCHEM BIOPH RES CO, V295, P276, DOI 10.1016/S0006-291X(02)00652-6; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SHAFFER EA, 1977, J CLIN INVEST, V59, P828, DOI 10.1172/JCI108705; Uppal H, 2008, HEPATOLOGY, V47, P1331, DOI 10.1002/hep.22175; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J BIOL CHEM, V280, P8742, DOI 10.1074/jbc.M411080200; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	30	200	218	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2008	14	7					778	782		10.1038/nm1785	http://dx.doi.org/10.1038/nm1785			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18587407	Green Accepted			2022-12-25	WOS:000257452700027
J	She, XW; Cheng, Z; Zollner, S; Church, DM; Eichler, EE				She, Xinwei; Cheng, Ze; Zoellner, Sebastian; Church, Deanna M.; Eichler, Evan E.			Mouse segmental duplication and copy number variation	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; ARRAY CGH; EVOLUTION; CHROMOSOME; EXPANSION; SELECTION; HOTSPOTS; STRAINS; SYNTENY	Detailed analyses of the clone-based genome assembly reveal that the recent duplication content of mouse (4.94%) is now comparable to that of human (5.5%), in contrast to previous estimates from the whole-genome shotgun sequence assembly. However, the architecture of mouse and human genomes differs markedly: most mouse duplications are organized into discrete clusters of tandem duplications that show depletion of genes and transcripts and enrichment of long interspersed nuclear element (LINE) and long terminal repeat (LTR) retroposons. We assessed copy number variation of the C57BL/6J duplicated regions within 15 mouse strains previously used for genetic association studies, sequencing and the Mouse Phenome Project. We determined that over 60% of these base pairs are polymorphic among the strains (on average, there was 20 Mb of copy-number-variable DNA between different mouse strains). Our data suggest that different mouse strains show comparable, if not greater, copy number polymorphism when compared to human; however, such variation is more locally restricted. We show large and complex patterns of interstrain copy number variation restricted to large gene families associated with spermatogenesis, pregnancy, viviparity, pheromone signaling and immune response.	[She, Xinwei; Cheng, Ze; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Church, Deanna M.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu			Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG002385-07, R01 HG002385, HG002385] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Armengol L, 2005, GENOMICS, V86, P692, DOI 10.1016/j.ygeno.2005.08.008; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BAILEY JA, 2003, P 68 COLD SPRING HAR; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sainz J, 2006, EUR J HUM GENET, V14, P216, DOI 10.1038/sj.ejhg.5201534; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808	30	172	176	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					909	914		10.1038/ng.172	http://dx.doi.org/10.1038/ng.172			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18500340	Green Accepted			2022-12-25	WOS:000257166500028
J	DeLuna, A; Vetsigian, K; Shoresh, N; Hegreness, M; Colon-Gonzalez, M; Chao, S; Kishony, R				DeLuna, Alexander; Vetsigian, Kalin; Shoresh, Noam; Hegreness, Matthew; Colon-Gonzalez, Maritrini; Chao, Sharon; Kishony, Roy			Exposing the fitness contribution of duplicated genes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; YEAST; ROBUSTNESS; NETWORK; BACKUP; NEOFUNCTIONALIZATION; REDUNDANCY; MUTATIONS; EVOLUTION	Duplicate genes from the whole-genome duplication (WGD) in yeast are often dispensable-removing one copy has little or no phenotypic consequence(1,2). It is unknown, however, whether such dispensability reflects insignificance of the ancestral function or compensation from paralogs(3-7). Here, using precise competition-based measurements of the fitness cost of single and double deletions, we estimate the exposed fitness contribution of WGD duplicate genes in metabolism and bound the importance of their ancestral pre-duplication function. We find that the functional overlap between paralogs sufficiently explains the apparent dispensability of individual WGD genes. Furthermore, the lower bound on the fitness value of the ancestral function, which is estimated by the degree of synergistic epistasis, is at least as large as the average fitness cost of deleting single non-WGD genes. These results suggest that most metabolic functions encoded by WGD genes are important today and were also important at the time of duplication.	[DeLuna, Alexander; Vetsigian, Kalin; Shoresh, Noam; Hegreness, Matthew; Colon-Gonzalez, Maritrini; Chao, Sharon; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	DeLuna, Alexander/H-9986-2016	DeLuna, Alexander/0000-0002-9236-2804; Colon-Gonzalez, Maritrini/0000-0001-6821-1726				Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2006, MOL BIOL EVOL, V23, P144, DOI 10.1093/molbev/msj015; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lynch M, 2000, GENETICS, V154, P459; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	30	118	122	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					676	681		10.1038/ng.123	http://dx.doi.org/10.1038/ng.123			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408719				2022-12-25	WOS:000255366700039
J	Kabashi, E; Valdmanis, PN; Dion, P; Spiegelman, D; McConkey, BJ; Velde, CV; Bouchard, JP; Lacomblez, L; Pochigaeva, K; Salachas, F; Pradat, PF; Camu, W; Meininger, V; Dupre, N; Rouleau, GA				Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; McConkey, Brendan J.; Velde, Christine Vande; Bouchard, Jean-Pierre; Lacomblez, Lucette; Pochigaeva, Ksenia; Salachas, Francois; Pradat, Pierre-Francois; Camu, William; Meininger, Vincent; Dupre, Nicolas; Rouleau, Guy A.			TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43; PROTEIN; DISEASE; BODIES	Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the degeneration of motor neurons. Here we report eight missense mutations in nine individuals-six from individuals with sporadic ALS ( SALS) and three from those with familial ALS ( FALS)-and a concurring increase of a smaller TDP-43 product. These findings further corroborate that TDP-43 is involved in ALS pathogenesis.	[Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; Velde, Christine Vande; Dupre, Nicolas; Rouleau, Guy A.] Ctr Hosp Univ Montreal, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada; [Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; Velde, Christine Vande; Dupre, Nicolas; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada; [McConkey, Brendan J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Bouchard, Jean-Pierre; Dupre, Nicolas] Univ Laval, Fac Med, Ctr Hosp Affilie Univ Quebec, Hop Enfants Jesus, Quebec City, PQ G1J 1Z4, Canada; [Lacomblez, Lucette; Pochigaeva, Ksenia; Salachas, Francois; Pradat, Pierre-Francois; Meininger, Vincent] Hop La Pitie Salpetriere, Div Paul Castaigne, Federat Malad Syst Nerveux, F-75651 Paris, France; [Camu, William] Inst Biol, Unite Neurol Comportementale & Degenerat, F-34967 Montpellier, France	Universite de Montreal; Universite de Montreal; University of Waterloo; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rouleau, GA (corresponding author), Ctr Hosp Univ Montreal, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019; Kabashi, Edor/C-5408-2014; Velde, Christine Vande/AAB-8828-2020; camu, william/AAB-4727-2020; Vande Velde, Christine/F-2721-2016; Pochigaeva, Ksenia/Y-8280-2018	Kabashi, Edor/0000-0003-4118-251X; Vande Velde, Christine/0000-0001-5926-1529; Valdmanis, Paul/0000-0001-8840-6969; spiegelman, dan/0000-0003-4971-8868; Pochigaeva, Ksenia/0000-0002-9803-6807				Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; GIJSELINCK I, IN PRESS NEUROBIOL A; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099	15	1166	1202	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					572	574		10.1038/ng.132	http://dx.doi.org/10.1038/ng.132			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372902				2022-12-25	WOS:000255366700024
J	Shi, S; Larson, K; Guo, DD; Lim, SJ; Dutta, P; Yan, SJ; Li, WX				Shi, Song; Larson, Kimberly; Guo, Dongdong; Lim, Su Jun; Dutta, Pranabananda; Yan, Shian-Jang; Li, Willis X.			Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability	NATURE CELL BIOLOGY			English	Article							DNA-BINDING; CELL-CYCLE; JAK-STAT; MELANOGASTER; ACTIVATION; PROTEINS; PATTERNS; DEFECTS	STAT ( Signal transducer and activator of transcription) is a potent transcription factor and its aberrant activation by phosphorylation is associated with human cancers(1-4). We have shown previously that overactivation of JAK, which phosphorylates STAT(5,6), disrupts heterochromatin formation globally in Drosophila melanogaster(7). However, it remains unclear how this effect is mediated and whether STAT is involved. Here, we demonstrate that Drosophila STAT ( STAT92E) is involved in controlling heterochromatin protein 1 ( HP1) distribution and heterochromatin stability. We found, unexpectedly, that loss of STAT92E, had the same effects as overactivation of JAK in disrupting heterochromatin formation and heterochromatic gene silencing, whereas overexpression of STAT92E had the opposite effects. We have further shown that the unphosphorylated or 'transcriptionally inactive' form of STAT92E is localized on heterochromatin in association with HP1, and is required for stabilizing HP1 localization and histone H3 Lys 9 methylation ( H3mK9). However, activation by phosphorylation reduces heterochromatin-associated STAT92E, causing HP1 displacement and heterochromatin destabilization. Thus, reducing levels of unphosphorylated STAT92E, either by loss of STAT92E or increased phosphorylation, causes heterochromatin instability. These results suggest that activation of STAT by phosphorylation controls both access to chromatin and activity of the transcription machinery.	[Shi, Song; Larson, Kimberly; Guo, Dongdong; Lim, Su Jun; Dutta, Pranabananda; Yan, Shian-Jang; Li, Willis X.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis X/AAL-7212-2020; Li, Willis/ABC-5695-2020	Li, Willis X/0000-0001-9041-7341; Li, Willis/0000-0001-9041-7341	NATIONAL CANCER INSTITUTE [R01CA131326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077046, R01GM065774] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131326-01A2, R01 CA131326] Funding Source: Medline; NIGMS NIH HHS [R01 GM077046, R01GM65774, R01 GM065774, R01 GM077046-04, R01GM077046] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Betz A, 2006, NAT GENET, V38, P977, DOI 10.1038/ng0906-977; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KAMINKER JS, 2002, GENOME BIOL, V0003; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; KELLUM R, 1995, J CELL SCI, V108, P1407; Li JH, 2003, MECH DEVELOP, V120, P1455, DOI 10.1016/j.mod.2003.09.004; Li WX, 2002, DEVELOPMENT, V129, P4241; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Ronsseray S, 2001, GENETICS, V159, P1631; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; SWEITZER SM, 1995, J BIOL CHEM, V270, P16510, DOI 10.1074/jbc.270.28.16510; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	27	85	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					491	U279		10.1038/ncb1713	http://dx.doi.org/10.1038/ncb1713			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344984	Green Accepted			2022-12-25	WOS:000254561700021
J	Han, Z; Fu, A; Wang, H; Diaz, R; Geng, L; Onishko, H; Hallahan, DE				Han, Zhaozhong; Fu, Allie; Wang, Hailun; Diaz, Roberto; Geng, Ling; Onishko, Halina; Hallahan, Dennis E.			Noninvasive assessment of cancer response to therapy	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; RENAL-CELL CARCINOMA; FACTOR-RECEPTOR; PHAGE DISPLAY; ANNEXIN-V; COLORECTAL-CANCER; TUMOR-GROWTH; SU11248; PTK787/ZK-222584	Rapid assessment of cancer response to a therapeutic regimen can determine efficacy early in the course of treatment. Although biopsies of cancer can be used to rapidly assess pharmacodynamic response, certain disease sites are less accessible to repeated biopsies. Here, we simultaneously assess response in all sites of disease within days of starting therapy by use of peptide ligands selected for their ability to discern responding from nonresponding cancers. When conjugated to near-infrared imaging agents, the HVGGSSV peptide differentiates between these two types of cancer. Rapid, noninvasive assessment of the pharmacodynamic response within cancer promises to accelerate drug development and minimize the duration	[Han, Zhaozhong; Fu, Allie; Wang, Hailun; Diaz, Roberto; Geng, Ling; Onishko, Halina; Hallahan, Dennis E.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37232 USA; [Wang, Hailun; Hallahan, Dennis E.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Hallahan, Dennis E.] Vanderbilt Univ, Sch Med, Dept Biomed Engn, Nashville, TN 37232 USA; [Hallahan, Dennis E.] Vanderbilt Ingram Can Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hallahan, DE (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, 1301 22nd Ave S,B902 TVC, Nashville, TN 37232 USA.	dennis.hallahan@vanderbilt.edu	Wang, Hailun/T-5696-2019	Wang, Hailun/0000-0001-8651-2856	NATIONAL CANCER INSTITUTE [R01CA112385, R01CA125757, R01CA089674] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA112385, R01-CA125757, R01-CA89674] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Drevs J, 2002, CANCER RES, V62, P4015; Hallahan D, 2003, CANCER CELL, V3, P63, DOI 10.1016/S1535-6108(02)00238-6; HALLAHAN DE, NAT PROTOC; Han ZZ, 2002, BIOCHEM BIOPH RES CO, V292, P1036, DOI 10.1006/bbrc.2002.6741; Hess-Stumpp H, 2005, CHEMBIOCHEM, V6, P550, DOI 10.1002/cbic.200400305; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Ladner RC, 1999, Q J NUCL MED, V43, P119; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Narula J, 2001, NAT MED, V7, P1347, DOI 10.1038/nm1201-1347; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Prenen H, 2006, CLIN CANCER RES, V12, P2622, DOI 10.1158/1078-0432.CCR-05-2275; Ruoslahti E, 2004, BIOCHEM SOC T, V32, P397, DOI 10.1042/BST0320397; Rusckowski M, 2000, J NUCL MED, V41, P363; Schueneman AJ, 2003, CANCER RES, V63, P4009; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Vand de Wiele C, 2003, J CLIN ONCOL, V21, P3483, DOI 10.1200/JCO.2003.12.096; Wood JM, 2000, CANCER RES, V60, P2178; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Yazici S, 2005, PROSTATE, V65, P203, DOI 10.1002/pros.20283	26	59	66	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					343	349		10.1038/nm1691	http://dx.doi.org/10.1038/nm1691			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18297085				2022-12-25	WOS:000253815700042
J	Nguyen, T; Ishida, K; Jenke-Kodama, H; Dittmann, E; Gurgui, C; Hochmuth, T; Taudien, S; Platzer, M; Hertweck, C; Piel, J				Nguyen, Tuanh; Ishida, Keishi; Jenke-Kodama, Holger; Dittmann, Elke; Gurgui, Cristian; Hochmuth, Thomas; Taudien, Stefan; Platzer, Matthias; Hertweck, Christian; Piel, Joern			Exploiting the mosaic structure of trans-acyltransferase polyketide synthases for natural product discovery and pathway dissection	NATURE BIOTECHNOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; LINEAR PLASMID PSLA2-L; PEPTIDE SYNTHETASE; BACTERIAL SYMBIONT; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; IDENTIFICATION; COMPLEX; MODEL; STRATEGIES	Modular polyketide synthases (PKSs) are giant bacterial enzymes that synthesize many polyketides of therapeutic value. In contrast to PKSs that provide acyltransferase ( AT) activities in cis, trans-AT PKSs lack integrated AT domains and exhibit unusual enzymatic features with poorly understood functions in polyketide assembly. This has retarded insight into the assembly of products such as mupirocin, leinamycin and bryostatin 1. We show that trans-AT PKSs evolved in a fundamentally different fashion from cis-AT systems, through horizontal recruitment and assembly of substrate-specific ketosynthase (KS) domains. The insights obtained from analysis of these KS mosaics will facilitate both the discovery of novel polyketides by genome mining, as we demonstrate for the thailandamides of Burkholderia thailandensis, and the extraction of chemical information from short trans-AT PCR products, as we show using metagenomic DNA of marine sponges. Our data also suggest new strategies for dissecting polyketide biosynthetic pathways and engineering polyketide assembly.	[Nguyen, Tuanh; Gurgui, Cristian; Hochmuth, Thomas; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Ishida, Keishi; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol HKI, D-07745 Jena, Germany; [Jenke-Kodama, Holger; Dittmann, Elke] Humboldt Univ, Inst Biol, Dept Mol Ecol, D-10115 Berlin, Germany; [Taudien, Stefan; Platzer, Matthias] Age Res Fritz Lipmann Inst, Leibniz Inst, D-07745 Jena, Germany	University of Bonn; Hans Knoll Institute (HKI); Humboldt University of Berlin; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Piel, J (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	joern.piel@uni-bonn.de	Dittmann, Elke/B-4742-2018; Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Dittmann, Elke/0000-0002-7549-7918; Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALBERTINI AM, 1995, MICROBIOL-SGM, V141, P299, DOI 10.1099/13500872-141-2-299; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fieseler L, 2007, APPL ENVIRON MICROB, V73, P2144, DOI 10.1128/AEM.02260-06; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Ginolhac A, 2005, J MOL EVOL, V60, P716, DOI 10.1007/s00239-004-0161-1; Gross H, 2007, APPL MICROBIOL BIOT, V75, P267, DOI 10.1007/s00253-007-0900-5; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Lopez JV, 2004, MOL GENET GENOMICS, V270, P420, DOI 10.1007/s00438-003-0937-9; McAlpine JB, 2005, J NAT PROD, V68, P493, DOI 10.1021/np0401664; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; Moffitt MC, 2003, J MOL EVOL, V56, P446, DOI 10.1007/s00239-002-2415-0; Moldenhauer J, 2007, ANGEW CHEM INT EDIT, V46, P8195, DOI 10.1002/anie.200703386; Paitan Y, 1999, J MOL BIOL, V286, P465, DOI 10.1006/jmbi.1998.2478; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; PATEL PS, 1995, J ANTIBIOT, V48, P997, DOI 10.7164/antibiotics.48.997; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; STEWART GJ, 1986, ANNU REV MICROBIOL, V40, P211, DOI 10.1146/annurev.micro.40.1.211; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Suwa M, 2000, GENE, V246, P123, DOI 10.1016/S0378-1119(00)00060-3; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784	49	275	282	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					225	233		10.1038/nbt1379	http://dx.doi.org/10.1038/nbt1379			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18223641				2022-12-25	WOS:000253193000026
J	Vilardaga, JP; Nikolaev, VO; Lorenz, K; Ferrandon, S; Zhuang, ZJ; Lohse, MJ				Vilardaga, Jean-Pierre; Nikolaev, Viacheslav O.; Lorenz, Kristina; Ferrandon, Sebastien; Zhuang, Zhenjie; Lohse, Martin J.			Conformational cross-talk between alpha(2A)-adrenergic and mu-opioid receptors controls cell signaling	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED-RECEPTOR; RESONANCE ENERGY-TRANSFER; LIVING CELLS; MEMBRANE MICRODOMAINS; MOLECULAR-BASIS; LIVE CELLS; ACTIVATION; DIMER; HETERODIMERIZATION; HOMODIMERIZATION	Morphine, a powerful analgesic, and norepinephrine, the principal neurotransmitter of sympathetic nerves, exert major inhibitory effects on both peripheral and brain neurons by activating distinct cell-surface G protein-coupled receptors-the mu-opioid receptor (MOR) and alpha(2A)-adrenergic receptor (alpha(2A)-AR), respectively. These receptors, either singly or as a heterodimer, activate common signal transduction pathways mediated through the inhibitory G proteins (G(i) and G(o)). Using fluorescence resonance energy transfer microscopy, we show that in the heterodimer, the MOR and alpha(2A)-AR communicate with each other through a cross-conformational switch that permits direct inhibition of one receptor by the other with subsecond kinetics. We discovered that morphine binding to the MOR triggers a conformational change in the norepinephrine-occupied alpha(2A)-AR that inhibits its signaling to Gi and the downstream MAP kinase cascade. These data highlight a new mechanism in signal transduction whereby a G protein-coupled receptor heterodimer mediates conformational changes that propagate from one receptor to the other and cause the second receptor's rapid inactivation.	[Vilardaga, Jean-Pierre; Ferrandon, Sebastien; Zhuang, Zhenjie] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre; Ferrandon, Sebastien; Zhuang, Zhenjie] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre; Ferrandon, Sebastien; Zhuang, Zhenjie] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-98078 Wurzburg, Germany; [Nikolaev, Viacheslav O.; Lorenz, Kristina; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-98078 Wurzburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	Vilardaga, JP (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, CPZN 8-218,185 Cambridge St, Boston, MA 02114 USA.	vilardaga.jeanpierre@mgh.harvard.edu	Nikolaev, Vyacheslav/AAT-7746-2020; soler, martha maricel m gomez/L-6025-2014; Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	soler, martha maricel m gomez/0000-0002-4412-8108; Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207; Nikolaev, Viacheslav/0000-0002-7529-5179; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Zhuang, Zhenjie/0000-0002-3688-1669				Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Franco R, 2005, TRENDS BIOCHEM SCI, V30, P360, DOI 10.1016/j.tibs.2005.05.010; Fuxe K, 2007, J NEURAL TRANSM, V114, P49, DOI 10.1007/s00702-006-0589-0; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; MILLIGAN GG, 2007, BIOCHIM BIOPHYS ACTA, V1758, P825; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; SPAULDING TC, 1979, EUR J PHARMACOL, V58, P19, DOI 10.1016/0014-2999(79)90335-2; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; VILARDAGA JP, 1995, BIOTECHNIQUES, V18, P604; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILCOX GL, 1987, BRAIN RES, V405, P84, DOI 10.1016/0006-8993(87)90992-9; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	39	217	222	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					126	131		10.1038/nchembio.64	http://dx.doi.org/10.1038/nchembio.64			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18193048				2022-12-25	WOS:000252585400012
J	Morishige, M; Hashimoto, S; Ogawa, E; Toda, Y; Kotani, H; Hirose, M; Wei, S; Hashimoto, A; Yamada, A; Yano, H; Mazaki, Y; Kodama, H; Nio, Y; Manabe, T; Wada, H; Kobayashi, H; Sabe, H				Morishige, Masaki; Hashimoto, Shigeru; Ogawa, Eiji; Toda, Yoshinobu; Kotani, Hirokazu; Hirose, Mayumi; Wei, Shumei; Hashimoto, Ari; Yamada, Atsuko; Yano, Hajime; Mazaki, Yuichi; Kodama, Hiroshi; Nio, Yoshinori; Manabe, Toshiaki; Wada, Hiromi; Kobayashi, Hidenori; Sabe, Hisataka			GeP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion	NATURE CELL BIOLOGY			English	Article							CELL-ADHESION; MIGRATION; METASTASIS; EXPRESSION; TUMOR; PROTEINS; IDENTIFICATION; INVASIVENESS; REQUIREMENT; INVADOPODIA	Epidermal growth factor (EGF) receptor ( EGFR) signalling is implicated in tumour invasion and metastasis(1,2). However, whether there are EGFR signalling pathways specifically used for tumour invasion still remains elusive. Overexpression of Arf6 and its effector, AMAP1, correlates with and is crucial for the invasive phenotypes of different breast cancer cells(3-6). Here we identify the mechanism by which Arf6 is activated to induce tumour invasion. We found that GEP100/BRAG2, a guanine nucleotide exchanging factor (GEF) for Arf6, is responsible for the invasive activity of MDA-MB-231 breast cancer cells, whereas the other ArfGEFs are not. GEP100, through its pleckstrin homology domain, bound directly to Tyr1068/1086-phosphorylated EGFR to activate Arf6. Overexpression of GEP100, together with Arf6, caused non-invasive MCF7 cells(7) to become invasive, which was dependent on EGF stimulation. Moreover, GEP100 knockdown blocked tumour metastasis. GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases. Our results indicate that GEP100 links EGFR signalling to Arf6 activation to induce invasive activities of some breast cancer cells, and hence may contribute to their metastasis and malignancy.	[Morishige, Masaki; Hashimoto, Shigeru; Wei, Shumei; Hashimoto, Ari; Yamada, Atsuko; Yano, Hajime; Mazaki, Yuichi; Sabe, Hisataka] Osaka Biosci Inst, Dept Mol Biol, Osaka 5650874, Japan; [Morishige, Masaki; Kobayashi, Hidenori] Oita Univ, Sch Med, Dept Neurosurg, Oita 8795593, Japan; [Ogawa, Eiji; Wada, Hiromi] Kyoto Univ, Dept Thorac Surg, Fac Med, Kyoto 6068507, Japan; [Ogawa, Eiji; Kotani, Hirokazu; Manabe, Toshiaki] Kyoto Univ Hosp, Lab Diagnost Pathol, Kyoto 6068501, Japan; [Toda, Yoshinobu; Kotani, Hirokazu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto 6068507, Japan; [Hirose, Mayumi] Osaka Univ, Lab Supramol Crystallog, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kodama, Hiroshi; Nio, Yoshinori] Kodama Breast Clin, Kyoto 6038325, Japan; [Sabe, Hisataka] Kyoto Univ, Grad Sch Biosci, Kyoto 6068607, Japan	Oita University; Kyoto University; Kyoto University; Kyoto University; Osaka University; Kyoto University	Sabe, H (corresponding author), Osaka Biosci Inst, Dept Mol Biol, Osaka 5650874, Japan.	sabe@obi.or.jp	Sabe, Hisataka/A-4066-2012; まゆみ, 廣瀬/AAK-5735-2020; Sabe, Hisataka/GPF-4385-2022; Hashimoto, Shigeru/D-7138-2012; Hashimoto, Ari/D-7125-2012	Mazaki, Yuichi/0000-0003-4192-0834				Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derrien V, 2002, J CELL SCI, V115, P2867; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FITZPATRICK SL, 1984, CANCER RES, V44, P3442; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Price JT, 1999, CANCER RES, V59, P5475; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; ZAJCHOWSKI D, 1988, CANCER RES, V48, P7041; Zajchowski DA, 2001, CANCER RES, V61, P5168	31	152	159	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					85	U70		10.1038/ncb1672	http://dx.doi.org/10.1038/ncb1672			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084281				2022-12-25	WOS:000252116100016
J	Irion, S; Luche, H; Gadue, P; Fehling, HJ; Kennedy, M; Keller, G				Irion, Stefan; Luche, Herve; Gadue, Paul; Fehling, Hans Joerg; Kennedy, Marion; Keller, Gordon			Identification and targeting of the ROSA26 locus in human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							RED FLUORESCENT PROTEIN; HUMAN BLASTOCYSTS; EXPRESSION; MOUSE; DIFFERENTIATION; RECOMBINATION; STRAIN; ACTIVATION; IDENTIFY; LEVEL	The derivation of human embryonic stem (hES) cells has opened new avenues for studies on human development and provided a potential source of cells for replacement therapy. To reveal the full potential of hES cells, it would be advantageous to be able to genetically alter them as is routinely done with mouse ES cells through homologous recombination. The mouse Rosa26 locus is particularly useful for genetic modification as it can be targeted with high efficiency and is expressed in most cell types tested. Here we report the identification of the human homolog of the mouse Rosa26 locus. We demonstrate targeting of a red-fluorescent protein (tdRFP) cDNA to this locus through homologous recombination and expression of this targeted reporter in multiple hES cell-derived lineages. Through recombinase-mediated cassette exchange, we show replacement of the tdRFP cDNA with other cDNAs, providing a cell line in which transgenes can be readily introduced into a broadly expressed locus.	Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; Univ Clin Ulm, Inst Immunol, Lab Mol Immunol, D-89081 Ulm, Germany; Mt Sinai Sch Med, Dept Gene & Cell Med, Black Family Stem Cell Inst, New York, NY 10029 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ulm University; Icahn School of Medicine at Mount Sinai	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, 101 Coll St, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca		Keller, Gordon/0000-0001-9309-9297; LUCHE, Herve/0000-0003-4309-8338	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075019] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL8062] Funding Source: Medline; NIGMS NIH HHS [P20GM075019] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kennedy M, 2003, METHOD ENZYMOL, V365, P39; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Siegel RW, 2001, FEBS LETT, V499, P147, DOI 10.1016/S0014-5793(01)02541-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	26	194	230	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1477	1482		10.1038/nbt1362	http://dx.doi.org/10.1038/nbt1362			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18037879				2022-12-25	WOS:000251457800038
J	Baum, JA; Bogaert, T; Clinton, W; Heck, GR; Feldmann, P; Ilagan, O; Johnson, S; Plaetinck, G; Munyikwa, T; Pleau, M; Vaughn, T; Roberts, J				Baum, James A.; Bogaert, Thierry; Clinton, William; Heck, Gregory R.; Feldmann, Pascale; Ilagan, Oliver; Johnson, Scott; Plaetinck, Geert; Munyikwa, Tichafa; Pleau, Michael; Vaughn, Ty; Roberts, James			Control of coleopteran insect pests through RNA interference	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRANDED-RNA; CORN-ROOTWORM; TRIBOLIUM COLEOPTERA; ARTIFICIAL DIET; GENE; CHRYSOMELIDAE; DUPLICATION; SEQUENCES; ELEGANS; DSRNA	Commercial biotechnology solutions for controlling lepidopteran and coleopteran insect pests on crops depend on the expression of Bacillus thuringiensis insecticidal proteins(1,2), most of which permeabilize the membranes of gut epithelial cells of susceptible insects(3). However, insect control strategies involving a different mode of action would be valuable for managing the emergence of insect resistance. Toward this end, we demonstrate that ingestion of doublestranded (ds)RNAs supplied in an artificial diet triggers RNA interference in several coleopteran species, most notably the western corn rootworm (WCR) Diabrotica virgifera virgifera LeConte. This may result in larval stunting and mortality. Transgenic corn plants engineered to express WCR dsRNAs show a significant reduction in WCR feeding damage in a growth chamber assay, suggesting that the RNAi pathway can be exploited to control insect pests via in planta expression of a dsRNA.	Monsanto Co, Chesterfield, MO 63017 USA; Devgen NV, B-9052 Ghent, Belgium	Monsanto	Roberts, J (corresponding author), Monsanto Co, 700 Chesterfield Pkway W, Chesterfield, MO 63017 USA.	james.k.roberts@monsanto.com	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012	Johnson, Scott/0000-0002-8388-8345				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; ANDERSON S, 2007, Patent No. 0050860; ARMSTRONG CL, 2003, Patent No. 6603061; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; DREES BM, 1999, HDB CORN INSECTS; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; James C, 2003, CURR SCI INDIA, V84, P303; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; MARRONE PG, 1985, J ECON ENTOMOL, V78, P290, DOI 10.1093/jee/78.1.290; MCELWAIN EF, 1989, NUCLEIC ACIDS RES, V17, P1764, DOI 10.1093/nar/17.4.1764; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Sambrook J., 2001, MOL CLONING; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836	25	1087	1290	28	504	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1322	1326		10.1038/nbt1359	http://dx.doi.org/10.1038/nbt1359			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17982443				2022-12-25	WOS:000251086500034
J	Audet, M; Bouvier, M				Audet, Martin; Bouvier, Michel			Insights into signaling from the beta(2)-adrenergic receptor structure	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; BETA-ARRESTIN; INVERSE AGONISTS; DRUG EFFICACY; BINDING-SITE; ACTIVATION; DISTINCT; TRAFFICKING; REVEALS	With more than 800 members, the G protein - coupled receptor family constitutes the largest group of membrane proteins involved in signal transduction. Until the end of last year, high-resolution three-dimensional structures were available for only one of them - the light receptor rhodopsin. Recently the structure of the beta 2-adrenergic receptor has been obtained, and it revealed interesting differences with the structure of rhodopsin. Analyses of these differences raise important questions about the binding modes of diffusible ligands in the receptor and allow formulation of testable hypotheses about the structural determinants linking drug binding to specific signaling responses. The three-dimensional structure derived from the beta 2-adrenergic receptor crystal has been used to virtually dock ligands with distinct activities. The different binding modes of these ligands, which correlated with their reported efficacy profiles, suggest that it could be possible to predict the structural determinants of drug signaling efficacies.	Univ Montreal, Dept Biochim, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Audet, M (corresponding author), Univ Montreal, Dept Biochim, Inst Res Immunol & Canc, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100				Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; BENOVIC JL, 1984, BIOCHEMISTRY-US, V23, P4510, DOI 10.1021/bi00315a002; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; COSTA T, 1992, MOL PHARMACOL, V41, P549; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Karoor V, 1996, J BIOL CHEM, V271, P29347, DOI 10.1074/jbc.271.46.29347; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Raimondi F, 2008, J AM CHEM SOC, V130, P4310, DOI 10.1021/ja077268b; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; VALIQUETTE M, 1995, EMBO J, V14, P5542, DOI 10.1002/j.1460-2075.1995.tb00241.x; Watson C, 2000, MOL PHARMACOL, V58, P1230, DOI 10.1124/mol.58.6.1230; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	34	77	80	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					397	403		10.1038/nchembio.97	http://dx.doi.org/10.1038/nchembio.97			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18560432				2022-12-25	WOS:000256929900008
J	Winter, M; Sombroek, D; Dauth, I; Moehlenbrink, J; Scheuermann, K; Crone, J; Hofmann, TG				Winter, Melanie; Sombroek, Dirk; Dauth, Ilka; Moehlenbrink, Jutta; Scheuermann, Karin; Crone, Johanna; Hofmann, Thomas G.			Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR	NATURE CELL BIOLOGY			English	Article							HOMEODOMAIN-INTERACTING PROTEIN-KINASE-2; CELL-CYCLE CHECKPOINTS; PROTEIN KINASE-2; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; P53 PHOSPHORYLATION; IONIZING-RADIATION; NUCLEAR-BODIES; TRANSCRIPTION; DEGRADATION	The tumour suppressor HIPK2 is an important regulator of cell death induced by DNA damage, but how its activity is regulated remains largely unclear. Here we demonstrate that HIPK2 is an unstable protein that colocalizes and interacts with the E3 ubiquitin ligase Siah-1 in unstressed cells. Siah-1 knockdown increases HIPK2 stability and steady-state levels, whereas Siah-1 expression facilitates HIPK2 polyubiquitination, degradation and thereby inactivation. During recovery from sublethal DNA damage, HIPK2, which is stabilized on DNA damage, is degraded through a Siah-1-dependent, p53-controlled pathway. Downregulation of Siah-1 inhibits HIPK2 degradation and recovery from damage, driving the cells into apoptosis. We have also demonstrated that DNA damage triggers disruption of the HIPK2-Siah-1 complex, resulting in HIPK2 stabilization and activation. Disruption of the HIPK2-Siah-1 complex is mediated by the ATM/ATR pathway and involves ATM/ATR-dependent phosphorylation of Siah-1 at Ser 19. Our results provide a molecular framework for HIPK2 regulation in unstressed and damaged cells.	[Winter, Melanie; Sombroek, Dirk; Dauth, Ilka; Moehlenbrink, Jutta; Scheuermann, Karin; Crone, Johanna; Hofmann, Thomas G.] German Canc Res Ctr, Cellular Senescence Grp, DKFZ, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hofmann, TG (corresponding author), German Canc Res Ctr, Cellular Senescence Grp, DKFZ, Im Neuenheimer Feld 242, D-69120 Heidelberg, Germany.	t.hofmann@dkfz.de						Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hofmann TG, 2005, J BIOL CHEM, V280, P29224, DOI 10.1074/jbc.M503921200; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hofmann TG, 2000, ONCOGENE, V19, P1153, DOI 10.1038/sj.onc.1203406; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; LUNA RMD, 1995, NATURE, V378, P203; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Moller A, 2003, CANCER RES, V63, P4310; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	50	156	159	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					812	824		10.1038/ncb1743	http://dx.doi.org/10.1038/ncb1743			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18536714				2022-12-25	WOS:000257268400011
J	Yang, Z; Loncarek, J; Khodjakov, A; Rieder, CL				Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.			Extra centrosomes and/or chromosomes prolong mitosis in human cells	NATURE CELL BIOLOGY			English	Article							CYCLE PROGRESSION; ANAPHASE ONSET; SOMATIC-CELLS; CHECKPOINT; SPINDLE; TUMORS	Using laser microsurgery and cell fusion we have explored how additional centrosomes and/or chromosomes influence the duration of mitosis in human cells. We found that doubling the chromosome number added approximately 10 min to a 20 min division, whereas doubling the number of centrosomes added approximately 30 min more. extra centrosomes and/or chromosomes prolong mitosis by delaying satisfaction of the spindle assembly checkpoint. thus mitosis can be prolonged by non-genetic means and extra chromosomes and centrosomes probably contribute to the elevated mitotic index seen in many tumours.	[Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.] New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Albany, NY 12201 USA; [Khodjakov, Alexey; Rieder, Conly L.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Khodjakov, Alexey; Rieder, Conly L.] Marine Biol Lab, Woods Hole, MA 02543 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Marine Biological Laboratory - Woods Hole	Rieder, CL (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Empire State Plaza, Albany, NY 12201 USA.	rieder@wadsworth.org	Yang, Zhenye/G-9641-2018; yang, zhenye/D-3519-2009	Loncarek, Jadranka/0000-0003-1879-5473; Yang, Zhenye/0000-0001-7797-5891	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040198, R37GM040198, R01GM059363] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59363, R01 GM059363, R01 GM059363-10, R37 GM040198, R37 GM040198-24, GM40198] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; SISKEN JE, 1985, CELL TISSUE KINET, V18, P137, DOI 10.1111/j.1365-2184.1985.tb00642.x; SISKEN JE, 1982, J CELL PHYSIOL, V113, P219, DOI 10.1002/jcp.1041130206; Sluder G, 1997, J CELL SCI, V110, P421; Therman Eeva, 1989, Critical Reviews in Oncogenesis, V1, P293; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716	15	101	103	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					748	751		10.1038/ncb1738	http://dx.doi.org/10.1038/ncb1738			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469805	Green Accepted, Green Submitted			2022-12-25	WOS:000256350100022
J	Amos, CI; Wu, XF; Broderick, P; Gorlov, IP; Gu, J; Eisen, T; Dong, Q; Zhang, Q; Gu, XJ; Vijayakrishnan, J; Sullivan, K; Matakidou, A; Wang, YF; Mills, G; Doheny, K; Tsai, YY; Chen, WV; Shete, S; Spitz, MR; Houlston, RS				Amos, Christopher I.; Wu, Xifeng; Broderick, Peter; Gorlov, Ivan P.; Gu, Jian; Eisen, Timothy; Dong, Qiong; Zhang, Qing; Gu, Xiangjun; Vijayakrishnan, Jayaram; Sullivan, Kate; Matakidou, Athena; Wang, Yufei; Mills, Gordon; Doheny, Kimberly; Tsai, Ya-Yu; Chen, Wei Vivien; Shete, Sanjay; Spitz, Margaret R.; Houlston, Richard S.			Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1	NATURE GENETICS			English	Article							POPULATION; EXPRESSION; CELLS; RISK; RETINOBLASTOMA; RELATIVES; MAPS	To identify risk variants for lung cancer, we conducted a multistage genome-wide association study. In the discovery phase, we analyzed 315,450 tagging SNPs in 1,154 current and former (ever) smoking cases of European ancestry and 1,137 frequency-matched, ever-smoking controls from Houston, Texas. For replication, we evaluated the ten SNPs most significantly associated with lung cancer in an additional 711 cases and 632 controls from Texas and 2,013 cases and 3,062 controls from the UK. Two SNPs, rs1051730 and rs8034191, mapping to a region of strong linkage disequilibrium within 15q25.1 containing PSMA4 and the nicotinic acetylcholine receptor subunit genes CHRNA3 and CHRNA5, were significantly associated with risk in both replication sets. Combined analysis yielded odds ratios of 1.32 (P < 1 x 10(-17)) for both SNPs. Haplotype analysis was consistent with there being a single risk variant in this region. We conclude that variation in a region of 15q25.1 containing nicotinic acetylcholine receptors genes contributes to lung cancer risk.	[Amos, Christopher I.; Wu, Xifeng; Gorlov, Ivan P.; Gu, Jian; Dong, Qiong; Zhang, Qing; Gu, Xiangjun; Chen, Wei Vivien; Shete, Sanjay; Spitz, Margaret R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Broderick, Peter; Vijayakrishnan, Jayaram; Matakidou, Athena; Wang, Yufei; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge CB2 2RE, England; [Mills, Gordon] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Doheny, Kimberly; Tsai, Ya-Yu] Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Johns Hopkins University	Amos, CI (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	camos@mdanderson.org	Gu, Jian/Q-4780-2018; Peng, Bo/A-6920-2009	Gu, Jian/0000-0003-3499-0973; Peng, Bo/0000-0001-8225-2284; Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Broderick, Peter/0000-0002-8348-5829	Cancer Research UK Funding Source: Medline; NCI NIH HHS [R01CA133996, R01 CA127219-02, R01CA55769, P50 CA070907, P30 CA016672, R01 CA133996, R01 CA121197-02, P50 CA70907, R01 CA121197, R01 CA127219, R01CA121197, R01 CA055769] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA133996, R01CA127219, R01CA055769, P30CA016672, R01CA121197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amos CI, 1999, RECENT RESULTS CANC, V151, P3; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Ho YS, 2005, TOXICOL APPL PHARM, V205, P133, DOI 10.1016/j.taap.2004.09.019; Hwang SJ, 2003, HUM GENET, V113, P238, DOI 10.1007/s00439-003-0968-7; Jonsson S, 2004, JAMA-J AM MED ASSOC, V292, P2977, DOI 10.1001/jama.292.24.2977; Kleinerman RA, 2000, JNCI-J NATL CANCER I, V92, P2037, DOI 10.1093/jnci/92.24.2037; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SACCONE SF, 1976, HUM MOL GENET, V16, P36; SANDERS BM, 1989, BRIT J CANCER, V60, P358, DOI 10.1038/bjc.1989.285; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; TAKEMIYA M, 1987, CLIN GENET, V31, P35; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Webb EL, 2006, HUM MOL GENET, V15, P3263, DOI 10.1093/hmg/ddl401; Yamanaka A, 1997, JPN J CLIN ONCOL, V27, P415, DOI 10.1093/jjco/27.6.415; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898	23	961	1007	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					616	622		10.1038/ng.109	http://dx.doi.org/10.1038/ng.109			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18385676	Green Accepted			2022-12-25	WOS:000255366700030
J	Fukuhara, S; Sako, K; Minami, T; Noda, K; Kim, HZ; Kodama, T; Shibuya, M; Takakura, N; Koh, GY; Mochizuki, N				Fukuhara, Shigetomo; Sako, Keisuke; Minami, Takashi; Noda, Kazuomi; Kim, Hak Zoo; Kodama, Tatsuhiko; Shibuya, Masabumi; Takakura, Nobuyuki; Koh, Gou Young; Mochizuki, Naoki			Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1	NATURE CELL BIOLOGY			English	Article							VASCULAR ENDOTHELIAL CADHERIN; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; ADULT VASCULATURE; PLASMA LEAKAGE; GROWTH-FACTORS; IN-VIVO; ANGIOGENESIS; ACTIVATION; PROTEIN	Tie2 belongs to the receptor tyrosine kinase family and functions as a receptor for Angiopoietin-1 (Ang1). Gene-targeting analyses of either Ang1 or Tie2 in mice reveal a critical role of Ang1-Tie2 signalling in developmental vascular formation. It remains elusive how the Tie2 signalling pathway plays distinct roles in both vascular quiescence and angiogenesis. We demonstrate here that Ang1 bridges Tie2 at cell-cell contacts, resulting in trans-association of Tie2 in the presence of cell-cell contacts. In clear contrast, in isolated cells, extracellular matrix-bound Ang1 locates Tie2 at cell-substratum contacts. Furthermore, Tie2 activated at cell-cell or cell-substratum contacts leads to preferential activation of Akt and Erk, respectively. Microarray analyses and real-time PCR validation clearly show the differential gene expression profile in vascular endothelial cells upon Ang1 stimulation in the presence or absence of cell-cell contacts, implying downstream signalling is dependent upon the spatial localization of Tie2.	[Fukuhara, Shigetomo; Sako, Keisuke; Noda, Kazuomi; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Minami, Takashi; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kim, Hak Zoo; Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Kim, Hak Zoo; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Res Inst Microbial Dis, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; University of Tokyo; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of Tokyo; Osaka University	Fukuhara, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Koh, Gou Young/C-1615-2011	sako, keisuke/0000-0002-6453-8075				Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Aplin AE, 1999, J BIOL CHEM, V274, P31223, DOI 10.1074/jbc.274.44.31223; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoon M, 2003, BIOCHEM BIOPH RES CO, V308, P101, DOI 10.1016/S0006-291X(03)01341-X; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zanetti A, 2002, ARTERIOSCL THROM VAS, V22, P617, DOI 10.1161/01.ATV.0000012268.84961.AD	47	275	290	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					513	526		10.1038/ncb1714	http://dx.doi.org/10.1038/ncb1714			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425120				2022-12-25	WOS:000255502400008
J	Mendez, I; Vinuela, A; Astradsson, A; Mukhida, K; Hallett, P; Robertson, H; Tierney, T; Holness, R; Dagher, A; Trojanowski, JQ; Isacson, O				Mendez, Ivar; Vinuela, Angel; Astradsson, Arnar; Mukhida, Karim; Hallett, Penelope; Robertson, Harold; Tierney, Travis; Holness, Renn; Dagher, Alain; Trojanowski, John Q.; Isacson, Ole			Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years	NATURE MEDICINE			English	Article							ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; LEWY BODIES; STEM-CELLS; TRANSPLANTATION	Postmortem analysis of five subjects with Parkinson's disease 9-14 years after transplantation of fetal midbrain cell suspensions revealed surviving grafts that included dopamine and serotonin neurons without pathology. These findings are important for the understanding of the etiopathogenesis of midbrain dopamine neuron degeneration and future use of cell replacement therapies.	[Vinuela, Angel; Astradsson, Arnar; Hallett, Penelope; Tierney, Travis; Isacson, Ole] Harvard Univ, Belmont, MA 02478 USA; [Vinuela, Angel; Astradsson, Arnar; Hallett, Penelope; Tierney, Travis; Isacson, Ole] McLean Hosp, US Natl Inst Neurol Disorders & Stroke, Udall Parkinsons Dis Res Ctr Excellence, Belmont, MA 02478 USA; [Mendez, Ivar; Mukhida, Karim; Robertson, Harold; Holness, Renn] Dalhousie Univ, Halifax, NS B3H 3A7, Canada; [Mendez, Ivar; Mukhida, Karim; Robertson, Harold; Holness, Renn] Queen Elizabeth 2 Hlth Sci Ctr, Div Neurosurg, Halifax, NS B3H 3A7, Canada; [Mendez, Ivar; Mukhida, Karim; Robertson, Harold; Holness, Renn] Queen Elizabeth 2 Hlth Sci Ctr, Dept Anat & Neurobiol, Halifax, NS B3H 3A7, Canada; [Mendez, Ivar; Mukhida, Karim; Robertson, Harold; Holness, Renn] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pharmacol, Halifax, NS B3H 3A7, Canada; [Tierney, Travis] Massachusetts Gen Hosp, Neurosci Serv, Boston, MA 02114 USA; [Dagher, Alain] McGill Univ, Montreal, PQ H3A 2B4, Canada; [Dagher, Alain] Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada; [Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Inst Aging,NINDS Udall Parkinsons Dis Res Ctr Exc, Philadelphia, PA 19104 USA	Harvard University; Harvard University; McLean Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); NIH National Library of Medicine (NLM); Dalhousie University; Queen Elizabeth II Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Harvard University; Massachusetts General Hospital; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania; Pennsylvania Medicine	Isacson, O (corresponding author), Harvard Univ, 115 Mill St, Belmont, MA 02478 USA.	isacson@hms.harvard.edu		Hallett, Penelope/0000-0002-8858-9096; Isacson, Ole/0000-0001-8091-8302	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793, P50NS053488] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS039793, P50 NS039793-08, P50 NS053488, NS 053488, P50 NS 39793] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba M, 1998, AM J PATHOL, V152, P879; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Galvin JE, 2001, EXP NEUROL, V168, P347, DOI 10.1006/exnr.2000.7615; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Lewy F., 1914, DEUT Z NERVENHEILKD, V50, P50; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Takahashi H, 2001, NEUROPATHOLOGY, V21, P315, DOI 10.1046/j.1440-1789.2001.00403.x	15	319	334	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2008	14	5					507	509		10.1038/nm1752	http://dx.doi.org/10.1038/nm1752			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	298IQ	18391961	Green Accepted			2022-12-25	WOS:000255681800030
J	Nygren, JM; Liuba, K; Breitbach, M; Stott, S; Thoren, L; Roell, W; Geisen, C; Sasse, P; Kirik, D; Bjorklund, A; Nerlov, C; Fleischmann, BK; Jovinge, S; Jacobsen, SEW				Nygren, Jens M.; Liuba, Karina; Breitbach, Martin; Stott, Simon; Thoren, Lina; Roell, Wilhelm; Geisen, Caroline; Sasse, Philipp; Kirik, Deniz; Bjorklund, Anders; Nerlov, Claus; Fleischmann, Bernd K.; Jovinge, Stefan; Jacobsen, Sten Eirik W.			Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SKELETAL-MUSCLE; PURKINJE NEURONS; MYELOMONOCYTIC CELLS; VASCULAR ENDOTHELIUM; IN-VIVO; MICE; CARDIOMYOCYTES; HEPATOCYTES	Recent studies have suggested that regeneration of non-haematopoietic cell lineages can occur through heterotypic cell fusion(1-3) with haematopoietic cells of the myeloid lineage(2 - 6). Here we show that lymphocytes also form heterotypic-fusion hybrids with cardiomyocytes, skeletal muscle, hepatocytes and Purkinje neurons. However, through lineage fate-mapping we demonstrate that such in vivo fusion of lymphoid and myeloid blood cells does not occur to an appreciable extent in steady-state adult tissues or during normal development. Rather, fusion of blood cells with different non-haematopoietic cell types is induced by organ-specific injuries or whole-body irradiation(1-10), which has been used in previous studies to condition recipients of bone marrow transplants. Our findings demonstrate that blood cells of the lymphoid and myeloid lineages contribute to various non-haematopoietic tissues by forming rare fusion hybrids, but almost exclusively in response to injuries or inflammation.	[Nygren, Jens M.; Liuba, Karina; Thoren, Lina; Jovinge, Stefan; Jacobsen, Sten Eirik W.] Lund Univ, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden; [Nygren, Jens M.; Liuba, Karina; Stott, Simon; Thoren, Lina; Kirik, Deniz; Bjorklund, Anders; Nerlov, Claus; Jovinge, Stefan; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden; [Nygren, Jens M.] Lund Univ, Div Immunol, Dept Expt Med Sci, S-22184 Lund, Sweden; [Breitbach, Martin; Geisen, Caroline; Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; [Stott, Simon; Kirik, Deniz; Bjorklund, Anders] Lund Univ, Wallenberg Neurosci Ctr, Div Neurobiol, S-22362 Lund, Sweden; [Roell, Wilhelm] Univ Bonn, Dept Cardiac Surg, D-53105 Bonn, Germany; [Nerlov, Claus] EMBL Monterotondo, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Jovinge, Stefan] Lund Univ, Univ Lund Hosp, Dept Cardiol, Coronary Program,Heart & Lung Div, S-22185 Lund, Sweden; [Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Headington OX3 9DS, England	Lund University; Lund University; Lund University; University of Bonn; Lund University; University of Bonn; European Molecular Biology Laboratory (EMBL); Lund University; Skane University Hospital; University of Oxford	Jacobsen, SEW (corresponding author), Lund Univ, Hematopoiet Stem Cell Lab, BMC B10, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Kirik, Deniz/E-5156-2011; Sasse, Philipp/G-9866-2013; Björklund, Anders/ABA-1326-2020; Jacobsen, Sten Eirik W/D-3974-2018	Sasse, Philipp/0000-0002-8502-9472; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Roell, Wilhelm/0000-0002-2213-5024; Stott, Simon/0000-0002-5741-4664; Nygren, Jens M/0000-0002-3576-2393	Medical Research Council [G0700711B] Funding Source: researchfish; MRC [G0501838] Funding Source: UKRI; Medical Research Council [G0501838] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Hallahan D, 1996, CANCER RES, V56, P5150; Irintchev A, 2002, CELL TISSUE RES, V308, P143, DOI 10.1007/s00441-002-0519-x; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; OGLE BM, 2005, NATURE REV MOL CELL; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; STADTFELD M, 2007, DEV BIOL; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	30	120	127	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					584	592		10.1038/ncb1721	http://dx.doi.org/10.1038/ncb1721			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425115				2022-12-25	WOS:000255502400015
J	Neumann, H; Peak-Chew, SY; Chin, JW				Neumann, Heinz; Peak-Chew, Sew Y.; Chin, Jason W.			Genetically encoding N-epsilon-acetyllysine in recombinant proteins	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; ACETYLATION CONTROLS; PYRROLYSINE; CODE; UAG; ENZYME	N-epsilon-acetylation of lysine (1) is a reversible post-translational modification with a regulatory role that rivals that of phosphorylation in eukaryotes. No general methods exist to synthesize proteins containing N-epsilon-acetyllysine (2) at defined sites. Here we demonstrate the site-specific incorporation of N-epsilon-acetyllysine in recombinant proteins produced in Escherichia coli via the evolution of an orthogonal N-epsilon-acetyllysyl-tRNA synthetase/tRNACUA pair. This strategy should find wide applications in defining the cellular role of this modification.	[Neumann, Heinz; Peak-Chew, Sew Y.; Chin, Jason W.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	chin@mrc-lmb.cam.ac.uk	Neumann, Heinz/F-7875-2014; Neumann, Heinz/ABC-7323-2021	Neumann, Heinz/0000-0001-9657-1913; 	MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; WANG K, 2007, J W NAT BIOTECHNOL, V25, P770; YANG XJ, 2007, S EMBO REP, V8, P556	15	435	463	2	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					232	234		10.1038/nchembio.73	http://dx.doi.org/10.1038/nchembio.73			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18278036				2022-12-25	WOS:000254268300008
J	Omori, Y; Zhao, CT; Saras, A; Mukhopadhyay, S; Kim, W; Furukawa, T; Sengupta, P; Veraksa, A; Malicki, J				Omori, Yoshihiro; Zhao, Chengtian; Saras, Arunesh; Mukhopadhyay, Saikat; Kim, Woong; Furukawa, Takahisa; Sengupta, Piali; Veraksa, Alexey; Malicki, Jarema			elipsa is an early determinant of ciliogenesis that links the IFT particle to membrane-associated small GTPase Rab8	NATURE CELL BIOLOGY			English	Article							MUTATIONS AFFECTING DEVELOPMENT; INTRAFLAGELLAR TRANSPORT; CAENORHABDITIS-ELEGANS; SENSORY CILIA; ZEBRAFISH RETINA; PROTEIN; NEURONS; GENES; COMPLEX; FUSION	The formation and function of cilia involves the movement of intraflagellar transport ( IFT) particles underneath the ciliary membrane, along axonemal microtubules(1,2). Although this process has been studied extensively, its molecular basis remains incompletely understood. For example, it is unknown how the IFT particle interacts with transmembrane proteins. To study the IFT particle further, we examined elipsa, a locus characterized by mutations that cause particularly early ciliogenesis defects in zebrafish. We show here that elipsa encodes a coiled-coil polypeptide that localizes to cilia. Elipsa protein binds to ift20, a component of IFT particles, and Elipsa homologue in Caenorhabditis elegans, DYF-11, translocates in sensory cilia, similarly to the IFT particle. This indicates that Elipsa is an IFT particle polypeptide. In the context of zebrafish embryogenesis, Elipsa interacts genetically with Rabaptin5, a well-studied regulator of endocytosis, which in turn interacts with Rab8, a small GTPase, known to localize to cilia. We show that Rabaptin5 binds to both Elipsa and Rab8, suggesting that these proteins provide a bridging mechanism between the IFT particle and protein complexes that assemble at the ciliary membrane.	[Omori, Yoshihiro; Zhao, Chengtian; Saras, Arunesh; Malicki, Jarema] Harvard Univ, Sch Med, Dept Ophthalmol, MEEI, Boston, MA 02114 USA; [Mukhopadhyay, Saikat; Kim, Woong; Sengupta, Piali] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Mukhopadhyay, Saikat; Kim, Woong; Sengupta, Piali] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Veraksa, Alexey] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Brandeis University; Brandeis University; University of Massachusetts System; University of Massachusetts Boston	Malicki, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, MEEI, R513,243 Charles St, Boston, MA 02114 USA.	jarema_malicki@meei.harvard.ed	malicki, jarema/G-8611-2014	malicki, jarema/0000-0002-5947-8805; Mukhopadhyay, Saikat/0000-0003-4790-3090; Veraksa, Alexey/0000-0003-2920-080X	NEI NIH HHS [P30EY14104, R01 EY11882, R01 EY016859] Funding Source: Medline; NIDCD NIH HHS [R01 DC005103] Funding Source: Medline; NINDS NIH HHS [P30 NS44232] Funding Source: Medline; PHS HHS [R01 56223] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011882, R01EY016859, P30EY014104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005103] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Brand M, 1996, DEVELOPMENT, V123, P129; Colbert HA, 1997, J NEUROSCI, V17, P8259; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kunitomo H, 2008, GENES CELLS, V13, P13, DOI 10.1111/j.1365-2443.2007.01147.x; Ling L, 2000, J BIOL CHEM, V275, P23852, DOI 10.1074/jbc.M001095200; Malicki J, 1996, DEVELOPMENT, V123, P263; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941	34	168	175	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					437	U140		10.1038/ncb1706	http://dx.doi.org/10.1038/ncb1706			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364699				2022-12-25	WOS:000254561700014
J	Raffatellu, M; Santos, RL; Verhoeven, DE; George, MD; Wilson, RP; Winter, SE; Godinez, I; Sankaran, S; Paixao, TA; Gordon, MA; Kolls, JK; Dandekar, S; Baumler, AJ				Raffatellu, Manuela; Santos, Renato L.; Verhoeven, David E.; George, Michael D.; Wilson, R. Paul; Winter, Sebastian E.; Godinez, Ivan; Sankaran, Sumathi; Paixao, Tatiane A.; Gordon, Melita A.; Kolls, Jay K.; Dandekar, Satya; Baumler, Andreas J.			Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut	NATURE MEDICINE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HUMAN AIRWAY EPITHELIUM; HIV-INFECTED PATIENTS; T-CELL DEPLETION; NEUTROPHIL RECRUITMENT; GASTROINTESTINAL-TRACT; KLEBSIELLA-PNEUMONIAE; IMMUNE-RESPONSE; GENE-EXPRESSION; SIV INFECTION	Salmonella typhimurium causes a localized enteric infection in immunocompetent individuals, whereas HIV- infected individuals develop a life- threatening bacteremia. Here we show that simian immunodeficiency virus (SIV) infection results in depletion of T helper type 17 (T(H)17) cells in the ileal mucosa of rhesus macaques, thereby impairing mucosal barrier functions to S. typhimurium dissemination. In SIV- negative macaques, the gene expression profile induced by S. typhimurium in ligated ileal loops was dominated by T(H)17 responses, including the expression of interleukin- 17 (IL- 17) and IL- 22. T(H)17 cells were markedly depleted in SIV- infected rhesus macaques, resulting in blunted T(H)17 responses to S. typhimurium infection and increased bacterial dissemination. IL- 17 receptor - deficient mice showed increased systemic dissemination of S. typhimurium from the gut, suggesting that IL- 17 deficiency causes defects in mucosal barrier function. We conclude that SIV infection impairs the IL- 17 axis, an arm of the mucosal immune response preventing systemic microbial dissemination from the gastrointestinal tract.	[Raffatellu, Manuela; Santos, Renato L.; Verhoeven, David E.; George, Michael D.; Wilson, R. Paul; Winter, Sebastian E.; Godinez, Ivan; Sankaran, Sumathi; Paixao, Tatiane A.; Dandekar, Satya; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Gordon, Melita A.] Univ Liverpool, Fac Med, Div Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Kolls, Jay K.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	University of California System; University of California Davis; University of Liverpool; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Kolls, Jay/AAH-1829-2019; de Lima Santos, Renato/A-1134-2008; brasileira, Inct Pecuaria/J-9542-2013; Baumler, Andreas J/H-2301-2011; Gordon, Melita/F-5563-2012; Paixão, Tatiane/A-2871-2013; Winter, Sebastian E/A-4118-2009	Kolls, Jay/0000-0001-5151-6304; de Lima Santos, Renato/0000-0002-4830-0470; Baumler, Andreas J/0000-0001-9152-7809; Gordon, Melita/0000-0002-0629-0884; Paixão, Tatiane/0000-0001-8284-9902; Winter, Sebastian E/0000-0003-1532-9178; Verhoeven, David/0000-0002-0766-4606; Raffatellu, Manuela/0000-0001-6487-4215	NHLBI NIH HHS [R01 HL061271-08, R01 HL079142, R01 HL061271, R01 HL079142-04, R37 HL079142] Funding Source: Medline; NIAID NIH HHS [R01 AI044170, AI06055, R29 AI040124, AI43274, R01 AI043274, AI044170, R01 AI040124, AI065534, R21 AI065534, AI040124] Funding Source: Medline; NIDDK NIH HHS [DK43183, DK61297, R01 DK043183, R01 DK061297] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079142, R01HL061271, R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065534, R01AI043274, R01AI044170, R29AI040124, R01AI040124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061297, R01DK043183] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAUSA KO, 1977, SCAND J INFECT DIS, V9, P181, DOI 10.3109/inf.1977.9.issue-3.05; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BERNSTEIN LJ, 1985, PEDIATR INFECT DIS J, V4, P472, DOI 10.1097/00006454-198509000-00005; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Coffey MJ, 1998, J CLIN INVEST, V102, P663, DOI 10.1172/JCI2117; Daniel M D, 1987, Cancer Detect Prev Suppl, V1, P501; ENG RHK, 1986, AM J CLIN PATHOL, V86, P105, DOI 10.1093/ajcp/86.1.105; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; George S, 1998, J INFECT DIS, V178, P1530, DOI 10.1086/314460; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HEISE C, 1994, J INFECT DIS, V169, P1116, DOI 10.1093/infdis/169.5.1116; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Kankwatira AM, 2004, TROP DOCT, V34, P198, DOI 10.1177/004947550403400404; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Karim M, 1991, J Pak Med Assoc, V41, P35; KENT TH, 1966, ARCH PATHOL, V82, P272; Laan M, 1999, J IMMUNOL, V162, P2347; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Nau GJ, 2003, J IMMUNOL, V170, P5203, DOI 10.4049/jimmunol.170.10.5203; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pitrak DL, 1999, AIDS, V13, pS25; Pitrak DL, 1999, AM J HEALTH-SYST PH, V56, pS9, DOI 10.1093/ajhp/56.suppl_5.S9; Raffatellu M, 2007, INFECT IMMUN, V75, P4342, DOI 10.1128/IAI.01571-06; Reis BP, 2003, VET MICROBIOL, V97, P269, DOI 10.1016/j.vetmic.2003.09.019; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Schwartz S, 2005, BIOCHEM BIOPH RES CO, V337, P505, DOI 10.1016/j.bbrc.2005.09.075; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Thamlikitkul V, 1996, TROP MED INT HEALTH, V1, P443, DOI 10.1046/j.1365-3156.1996.d01-92.x; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	49	440	449	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					421	428		10.1038/nm1743	http://dx.doi.org/10.1038/nm1743			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376406	Green Accepted			2022-12-25	WOS:000254674100029
J	Smalley, MJ; Reis-Filho, JS; Ashworth, A				Smalley, Matthew J.; Reis-Filho, Jorge S.; Ashworth, Alan			BRCa1 and stem cells: tumour typecasting	NATURE CELL BIOLOGY			English	Editorial Material							BREAST-CANCER	Phenotypic variation between tumour types is likely to reflect the nature of the cell of origin and the genes involved in pathogenesis. Compared with most sporadic breast cancers, those arising in carriers of BRCA1 mutations usually have distinctive pathological characteristics. a new study suggests that a role for BRCA1 in the determination of stem-cell fate may explain this phenomenon.	[Smalley, Matthew J.; Reis-Filho, Jorge S.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Smalley, MJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	Matthew.Smalley@icr.ac.uk; Jorge.Reis-Filho@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Smalley, Matthew J/M-7000-2015	Smalley, Matthew J/0000-0001-9540-1146				Ashworth A, 2005, CANCER CELL, V8, P95, DOI 10.1016/j.ccr.2005.07.011; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; Novelli M, 2003, P NATL ACAD SCI USA, V100, P3311, DOI 10.1073/pnas.0437825100; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876	16	15	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					377	379		10.1038/ncb0408-377	http://dx.doi.org/10.1038/ncb0408-377			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379596				2022-12-25	WOS:000254561700004
J	Christianson, JC; Shaler, TA; Tyler, RE; Kopito, RR				Christianson, John C.; Shaler, Thomas A.; Tyler, Ryan E.; Kopito, Ron R.			OS-9 and GRP94 deliver mutant alpha 1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD	NATURE CELL BIOLOGY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; PROTEIN DISLOCATION; IDENTIFIES YOS9P; GENE; EXPRESSION; CHAPERONE; RECEPTOR	Terminally misfolded or unassembled proteins in the early secretory pathway are degraded by a ubiquitin- and proteasome-dependent process known as ER-associated degradation (ERAD). How substrates of this pathway are recognized within the ER and delivered to the cytoplasmic ubiquitin- conjugating machinery is unknown. We report here that OS-9 and XTP3-B/Erlectin are ER-resident glycoproteins that bind to ERAD substrates and, through the SEL1L adaptor, to the ER-membrane-embedded ubiquitin ligase Hrd1. Both proteins contain conserved mannose 6-phosphate receptor homology (MRH) domains, which are required for interaction with SEL1L, but not with substrate. OS-9 associates with the ER chaperone GRP94 which, together with Hrd1 and SEL1L, is required for the degradation of an ERAD substrate, mutant alpha(1)-antitrypsin. These data suggest that XTP3-B and OS-9 are components of distinct, partially redundant, quality control surveillance pathways that coordinate protein folding with membrane dislocation and ubiquitin conjugation in mammalian cells.	[Christianson, John C.; Tyler, Ryan E.; Kopito, Ron R.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Christianson, John C.; Tyler, Ryan E.; Kopito, Ron R.] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Shaler, Thomas A.] PPD, Menlo Pk, CA 94025 USA	Stanford University; Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Lorry Lokey Bldg,337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu	Christianson, John C/Y-4567-2019	Christianson, John/0000-0002-0474-1207	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074874-04, R01 GM074874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Cruciat CM, 2006, J BIOL CHEM, V281, P12986, DOI 10.1074/jbc.M511872200; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Grant B, 1996, GENETICS, V143, P237; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; WARD CL, 1994, J BIOL CHEM, V269, P25710; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	50	380	389	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					272	U13		10.1038/ncb1689	http://dx.doi.org/10.1038/ncb1689			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264092	Green Accepted			2022-12-25	WOS:000253778300009
J	Xu, D; Moon, AF; Song, D; Pedersen, LC; Liu, J				Xu, Ding; Moon, Andrea F.; Song, Danyin; Pedersen, Lars C.; Liu, Jian			Engineering sulfotransferases to modify heparan sulfate	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; BIOSYNTHESIS	The biosynthesis of heparan sulfate (HS) involves an array of specialized sulfotransferases. Here, we present a study aimed at engineering the substrate specificity of different HS 3-O-sulfotransferase isoforms. Based on the crystal structures, we identified a pair of amino acid residues responsible for selecting the substrates. Mutations of these residues altered the substrate specificities. Our results demonstrate the feasibility of tailoring the specificity of sulfotransferases to modify HS with desired functions.	[Xu, Ding; Song, Danyin; Liu, Jian] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA; [Moon, Andrea F.; Pedersen, Lars C.] Natl Inst Environm Hlth Sci, NIH, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, J (corresponding author), Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA.	jian-liu@unc.edu	Xu, Ding/B-2493-2009; Pedersen, Lars/C-6173-2019	Xu, Ding/0000-0001-9380-2712; Pedersen, Lars/0000-0002-4488-4077	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999] Funding Source: Medline; NIAID NIH HHS [AI50050, R01 AI050050, R01 AI050050-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikhailov D, 1996, BIOCHEM J, V315, P447, DOI 10.1042/bj3150447; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521	12	60	63	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					200	202		10.1038/nchembio.66	http://dx.doi.org/10.1038/nchembio.66			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18223645	Green Accepted, Green Submitted			2022-12-25	WOS:000253417400016
J	Yang, L; Yang, H; Rideout, K; Cho, T; Il Joo, K; Ziegler, L; Elliot, A; Walls, A; Yu, D; Baltimore, D; Wang, P				Yang, Lili; Yang, Haiguang; Rideout, Kendra; Cho, Taehoon; Il Joo, Kye; Ziegler, Leslie; Elliot, Abigail; Walls, Anthony; Yu, Dongzi; Baltimore, David; Wang, Pin			Engineered lentivector targeting of dendritic cells for in vivo immunization	NATURE BIOTECHNOLOGY			English	Article							THERAPEUTIC ANTITUMOR IMMUNITY; C-TYPE LECTINS; MOUSE DC-SIGN; LENTIVIRAL VECTORS; CANCER-IMMUNOTHERAPY; EFFICIENT TRANSDUCTION; ANTIGEN PRESENTATION; TUMOR-ANTIGEN; INDUCTION; VACCINES	We report a method of inducing antigen production in dendritic cells by in vivo targeting with lentiviral vectors that specifically bind to the dendritic cell-surface protein DC-SIGN. To target dendritic cells, we enveloped the lentivector with a viral glycoprotein from Sindbis virus engineered to be DC-SIGN-specific. In vitro, this lentivector specifically transduced dendritic cells and induced dendritic cell maturation. A high frequency ( up to 12%) of ovalbumin ( OVA)- specific CD8(+) T cells and a significant antibody response were observed 2 weeks after injection of a targeted lentiviral vector encoding an OVA transgene into naive mice. This approach also protected against the growth of OVA-expressing E.G7 tumors and induced regression of established tumors. Thus, lentiviral vectors targeting dendritic cells provide a simple method of producing effective immunity and may provide an alternative route for immunization with protein antigens.	[Yang, Lili; Elliot, Abigail; Walls, Anthony; Yu, Dongzi; Baltimore, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Yang, Haiguang; Rideout, Kendra; Cho, Taehoon; Il Joo, Kye; Ziegler, Leslie; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA	California Institute of Technology; University of Southern California	Baltimore, D (corresponding author), CALTECH, Dept Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	baltimo@caltech.edu; pinwang@usc.edu		Joo, Kye Il/0000-0001-8834-5561	NIAID NIH HHS [R01 AI068978, R01 AI068978-02, R01AI068978, R01 AI068978-03, R01 AI068978-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Belousova N, 2003, J VIROL, V77, P11367, DOI 10.1128/JVI.77.21.11367-11377.2003; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Breckpot K, 2007, GENE THER, V14, P847, DOI 10.1038/sj.gt.3302947; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Dakappagari N, 2006, J IMMUNOL, V176, P426, DOI 10.4049/jimmunol.176.1.426; de Gruijl TD, 2002, J IMMUNOL, V169, P5322, DOI 10.4049/jimmunol.169.9.5322; Dullaers M, 2006, GENE THER, V13, P630, DOI 10.1038/sj.gt.3302697; Esslinger C, 2002, HUM GENE THER, V13, P1091, DOI 10.1089/104303402753812494; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gong J, 1997, GENE THER, V4, P1023, DOI 10.1038/sj.gt.3300496; Kaplan JM, 1999, J IMMUNOL, V163, P699; Kim JH, 2005, HUM GENE THER, V16, P1255, DOI 10.1089/hum.2005.16.1255; Kirk CJ, 2000, HUM GENE THER, V11, P797, DOI 10.1089/10430340050015419; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Ribas Antoni, 2002, Current Gene Therapy, V2, P57, DOI 10.2174/1566523023348129; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schroers Roland, 2004, Methods Mol Biol, V246, P451; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Song W, 2000, GENE THER, V7, P2080, DOI 10.1038/sj.gt.3301336; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STRAUSS JH, 1994, ARCH VIROL, P473; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Temme A, 2002, GENE THER, V9, P1551, DOI 10.1038/sj.gt.3301821; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279; zum Buschenfelde CM, 2000, J IMMUNOL, V165, P4133, DOI 10.4049/jimmunol.165.7.4133	48	164	185	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2008	26	3					326	334		10.1038/nbt1390	http://dx.doi.org/10.1038/nbt1390			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	276EF	18297056	Green Accepted			2022-12-25	WOS:000254123400026
J	Yang, MH; Wu, MZ; Chiou, SH; Chen, PM; Chang, SY; Liu, CJ; Teng, SC; Wu, KJ				Yang, Muh-Hwa; Wu, Min-Zu; Chiou, Shih-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Liu, Chung-Ji; Teng, Shu-Chun; Wu, Kou-Juey			Direct regulation of TWIST by HIF-1 alpha promotes metastasis	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; HYPOXIA-INDUCIBLE FACTOR-1; TRANSCRIPTION FACTOR SNAIL; CADHERIN GENE-EXPRESSION; RENAL-CELL CARCINOMA; TUMOR PROGRESSION; NECK-CANCER; FACTOR 1-ALPHA; C-MYC; HEAD	Stabilization of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) transcription complex, caused by intratumoural hypoxia, promotes tumour progression and metastasis, leading to treatment failure and mortality in different types of human cancers. The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis. Notably, HIF-1 alpha- and TWIST-null mice show similarities in their phenotypes. Here, we have shown that hypoxia or overexpression of HIF-1 alpha promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes. We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter. However, siRNA-mediated repression of TWIST in HIF-1 alpha-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes. Co-expression of HIF-1 alpha, TWIST and Snail in primary tumours of patients with head and neck cancers correlated with metastasis and the worst prognosis. These results provide evidence of a key signalling pathway involving HIF-1 alpha and TWIST that promotes metastasis in response to intratumoural hypoxia.	[Yang, Muh-Hwa; Wu, Min-Zu; Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chiou, Shih-Hwa; Wu, Kou-Juey] Natl Yang Ming Univ, Dept Clin Med, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chen, Po-Min] Taipei Vet Gen Hosp, Div Hematol Oncol, Dept Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Chang, Shyue-Yih] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Wu, Kou-Juey] Taipei Vet Gen Hosp, Genom Res Ctr, Taipei 112, Taiwan; [Liu, Chung-Ji] Taipei Mackay Mem Hosp, Dept Dent, Taipei 104, Taiwan; [Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Mackay Memorial Hospital; National Taiwan University	Wu, KJ (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sec 2,Li Niong St, Taipei 112, Taiwan.	kjwu2@ym.edu.tw	Wu, Kou-Juey/P-4654-2015; Yang, Muh-Hwa/AAE-4691-2020	TENG, SHU-CHUN/0000-0002-6492-2560				Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Corsi AK, 2000, DEVELOPMENT, V127, P2041; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Pugh CW, 2001, BREAST CANCER RES, V3, P313, DOI 10.1186/bcr313; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sawair FA, 2003, J ORAL PATHOL MED, V32, P1, DOI 10.1034/j.1600-0714.2003.00060.x; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tickoo SK, 2007, J UROLOGY, V177, P1258, DOI 10.1016/j.juro.2006.11.100; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929	39	984	1022	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					295	305		10.1038/ncb1691	http://dx.doi.org/10.1038/ncb1691			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297062				2022-12-25	WOS:000253778300011
J	Kaplun, A; Binshtein, E; Vyazmensky, M; Steinmetz, A; Barak, Z; Chipman, DM; Tittmann, K; Shaanan, B				Kaplun, Alexander; Binshtein, Elad; Vyazmensky, Maria; Steinmetz, Andrea; Barak, Ze'ev; Chipman, David M.; Tittmann, Kai; Shaanan, Boaz			Glyoxylate carboligase lacks the canonical active site glutamate of thiamine-dependent enzymes	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE OXIDASE; MACROMOLECULAR STRUCTURES; ANOMALOUS DIFFRACTION; ESCHERICHIA-COLI; DIPHOSPHATE; MECHANISM; BINDING; TRANSKETOLASE; CATALYSIS; ACCELERATION	Thiamine diphosphate (ThDP), a derivative of vitamin B1, is an enzymatic cofactor whose special chemical properties allow it to play critical mechanistic roles in a number of essential metabolic enzymes. It has been assumed that all ThDP-dependent enzymes exploit a polar interaction between a strictly conserved glutamate and the N1' of the ThDP moiety. The crystal structure of glyoxylate carboligase challenges this paradigm by revealing that valine replaces the conserved glutamate. Through kinetic, spectroscopic and site-directed mutagenesis studies, we show that although this extreme change lowers the rate of the initial step of the enzymatic reaction, it ensures efficient progress through subsequent steps. Glyoxylate carboligase thus provides a unique illustration of the fine tuning between catalytic stages imposed during evolution on enzymes catalyzing multistep processes.	[Steinmetz, Andrea; Tittmann, Kai] Univ Halle Wittenberg, Inst Biochem, D-06099 Halle, Germany; [Kaplun, Alexander; Binshtein, Elad; Vyazmensky, Maria; Barak, Ze'ev; Chipman, David M.; Shaanan, Boaz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Martin Luther University Halle Wittenberg; Ben Gurion University	Shaanan, B (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, 1 Beer Sheva, IL-84105 Beer Sheva, Israel.	bshaanan@bgu.ac.il	Kaplun, Alexander/AAH-5033-2020; Shaanan, Boaz/F-1202-2012	Shaanan, Boaz/0000-0001-8925-4362; Binshtein, Elad/0000-0003-2745-104X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Ilan A, 2001, BIOCHEMISTRY-US, V40, P11946, DOI 10.1021/bi0104524; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHANG YY, 1993, J BIOL CHEM, V268, P3911; CHUNG ST, 1971, BIOCHEMISTRY-US, V10, P1205; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; GOLBIK R, 1991, BIOORG CHEM, V19, P10, DOI 10.1016/0045-2068(91)90039-R; GOTTO AM, 1961, BIOCHEM J, V81, P273, DOI 10.1042/bj0810273; GUPTA NK, 1966, ARCH BIOCHEM BIOPHYS, V113, P255, DOI 10.1016/0003-9861(66)90185-8; GUTOWSKI JA, 1976, J BIOL CHEM, V251, P2863; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan F, 1999, BIOCHEMISTRY-US, V38, P6369, DOI 10.1021/bi990373g; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEMP DS, 1970, J AM CHEM SOC, V92, P2554, DOI 10.1021/ja00711a062; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; KRAKOW G, 1961, J BACTERIOL, V81, P509, DOI 10.1128/JB.81.4.509-518.1961; KRAKOW G, 1956, BIOCHIM BIOPHYS ACTA, V21, P593, DOI 10.1016/0006-3002(56)90208-6; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LINDQVIST Y, 1993, CURR OPIN STRUC BIOL, V3, P896, DOI 10.1016/0959-440X(93)90153-C; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mosbacher TG, 2005, FEBS J, V272, P6067, DOI 10.1111/j.1742-4658.2005.04998.x; MULLER YA, 1993, STRUCTURE, V1, P95, DOI 10.1016/0969-2126(93)90025-C; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richardson JS, 2003, METHOD ENZYMOL, V374, P385, DOI 10.1016/S0076-6879(03)74018-X; SCHELLENBERGER A, 1967, ANGEW CHEM INT EDIT, V6, P1024, DOI 10.1002/anie.196710241; SCHELLENBERGER A, 1990, CHEM BER, V123, P1489, DOI 10.1002/cber.19901230709; SCHLOSS JV, 1988, NATURE, V331, P360, DOI 10.1038/331360a0; Tittmann K, 2005, P NATL ACAD SCI USA, V102, P553, DOI 10.1073/pnas.0408210101; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; VANDERDRIFT C, 1983, A VAN LEEUW J MICROB, V49, P167, DOI 10.1007/BF00393675; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vinogradov M, 2005, ANAL BIOCHEM, V342, P126, DOI 10.1016/j.ab.2005.03.049; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; Zhang S, 2005, BIOCHEMISTRY-US, V44, P2237, DOI 10.1021/bi047696j; Zhang S, 2004, J BIOL CHEM, V279, P54312, DOI 10.1074/jbc.M409278200	44	45	46	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					113	118		10.1038/nchembio.62	http://dx.doi.org/10.1038/nchembio.62			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18176558				2022-12-25	WOS:000252585400010
J	Balasubramanian, N; Scott, DW; Castle, JD; Casanova, JE; Schwartz, MA				Balasubramanian, Nagaraj; Scott, David W.; Castle, J. David; Casanova, James E.; Schwartz, Martin Alexander			Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CELL-MIGRATION; DOWNSTREAM ACTIVATION; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; ENDOGENOUS ARF6; RHO-GTPASES; RAC; INTERNALIZATION; MACROPHAGES	Integrin-mediated adhesion regulates membrane binding sites for Rac1 within lipid rafts. Detachment of cells from the substratum triggers the clearance of rafts from the plasma membrane through caveolin-dependent internalization. The small GTPase Arf6 and microtubules also regulate Rac-dependent cell spreading and migration, but the mechanisms are poorly understood. Here we show that endocytosis of rafts after detachment requires F-actin, followed by microtubule-dependent trafficking to recycling endosomes. When cells are replated on fibronectin, rafts exit from recycling endosomes in an Arf6-dependent manner and return to the plasma membrane along microtubules. Both of these steps are required for the plasma membrane targeting of Rac1 and for its activation. These data therefore define a new membrane raft trafficking pathway that is crucial for anchorage-dependent signalling.	Univ Virginia, Mellon Prostate Canc Res Inst, Robert M Beirne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Mellon Prostate Canc Res Inst, Robert M Beirne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu		Balasubramanian, Nagaraj/0000-0002-8219-8844; schwartz, martin/0000-0002-2071-1243	NIGMS NIH HHS [R01 GM047214, R01 GM047214-17, R01 GM47214] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; CHEUNG HT, 1980, CELL BIOL INT REP, V4, P1125, DOI 10.1016/0309-1651(80)90050-8; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DDOUZASCHOREY C, 2006, NATURE REV MOL CELL, V7, P347; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Golub T, 2005, BIOCHEM SOC SYMP, V72, P119, DOI 10.1042/bss0720119; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rosania GR, 1996, CELL MOTIL CYTOSKEL, V34, P230, DOI 10.1002/(SICI)1097-0169(1996)34:3<230::AID-CM6>3.0.CO;2-D; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song J, 1998, J CELL SCI, V111, P2257; Torgersen ML, 2001, J CELL SCI, V114, P3737; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	49	156	158	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1381	U73		10.1038/ncb1657	http://dx.doi.org/10.1038/ncb1657			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026091	Green Accepted			2022-12-25	WOS:000251317300011
J	Lee, G; Kim, H; Elkabetz, Y; Al Shamy, G; Panagiotakos, G; Barberi, T; Tabar, V; Studer, L				Lee, Gabsang; Kim, Hyesoo; Elkabetz, Yechiel; Al Shamy, George; Panagiotakos, Georgia; Barberi, Tiziano; Tabar, Viviane; Studer, Lorenz			Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							IN-VITRO; HIRSCHSPRUNG-DISEASE; GENE-EXPRESSION; SELF-RENEWAL; MOUSE; PRECURSORS; GENERATION; NEURONS; DERIVATION; TRANSPLANTATION	Vertebrate neural crest development depends on pluripotent, migratory precursor cells. Although avian and murine neural crest stem (NCS) cells have been identified, the isolation of human NCS cells has remained elusive. Here we report the derivation of NCS cells from human embryonic stem cells at the neural rosette stage. We show that NCS cells plated at clonal density give rise to multiple neural crest lineages. The human NCS cells can be propagated in vitro and directed toward peripheral nervous system lineages (peripheral neurons, Schwann cells) and mesenchymal lineages (smooth muscle, adipogenic, osteogenic and chondrogenic cells). Transplantation of human NCS cells into the developing chick embryo and adult mouse hosts demonstrates survival, migration and differentiation compatible with neural crest identity. The availability of unlimited numbers of human NCS cells offers new opportunities for studies of neural crest development and for efforts to model and treat neural crest-related disorders.	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Dept Neurosurg, New York, NY 10021 USA; Beckman Res Inst City Hope, Div Neurosci, Duarte, CA 91010 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City of Hope; Beckman Research Institute of City of Hope	Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480; Lee, Gabsang/0000-0002-5052-5927				Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; BAROFFIO A, 1991, DEVELOPMENT, V112, P301; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Bhattacherjee V, 2007, DIFFERENTIATION, V75, P463, DOI 10.1111/j.1432-0436.2006.00145.x; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Fuchs S, 2007, NEURODEGENER DIS, V4, P6, DOI 10.1159/000100354; Gitler AD, 2002, COLD SPRING HARB SYM, V67, P57, DOI 10.1101/sqb.2002.67.57; Goldstein RS, 2006, METH MOL B, V331, P137; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kang P, 2005, J DENT RES, V84, P678, DOI 10.1177/154405910508400801; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Marzi F, 2007, CANCER RES, V67, P2402, DOI 10.1158/0008-5472.CAN-06-3208; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Trainor PA, 2002, SCIENCE, V295, P1288, DOI 10.1126/science.1064540; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	48	391	429	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1468	1475		10.1038/nbt1365	http://dx.doi.org/10.1038/nbt1365			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18037878				2022-12-25	WOS:000251457800037
J	Saenz, HL; Engel, P; Stoeckli, MC; Lanz, C; Raddatz, G; Vayssier-Taussat, M; Birtles, R; Schuster, SC; Dehio, C				Saenz, Henri L.; Engel, Philipp; Stoeckli, Michele C.; Lanz, Christa; Raddatz, Gunter; Vayssier-Taussat, Muriel; Birtles, Richard; Schuster, Stephan C.; Dehio, Christoph			Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors	NATURE GENETICS			English	Article							PATHOGEN BARTONELLA; NEGATIVE SELECTION; SEQUENCE ALIGNMENT; GENUS BARTONELLA; BACILLIFORMIS; ERYTHROCYTES; TRANSPOSASE; STRATEGY; HENSELAE; HISTORY	The bacterial genus Bartonella comprises 21 pathogens causing characteristic intraerythrocytic infections. Bartonella bacilliformis is a severe pathogen representing an ancestral lineage, whereas the other species are benign pathogens that evolved by radial speciation. Here, we have used comparative and functional genomics to infer pathogenicity genes specific to the radiating lineage, and we suggest that these genes may have facilitated adaptation to the host environment. We determined the complete genome sequence of Bartonella tribocorum by shotgun sequencing and functionally identified 97 pathogenicity genes by signature-tagged mutagenesis. Eighty-one pathogenicity genes belong to the core genome ( 1,097 genes) of the radiating lineage inferred from genome comparison of B. tribocorum, Bartonella henselae and Bartonella quintana. Sixty-six pathogenicity genes are present in B. bacilliformis, and one has been lost by deletion. The 14 pathogenicity genes specific for the radiating lineage encode two laterally acquired type IV secretion systems, suggesting that these systems have a role in host adaptability.	Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Ecol Natl Vet Alfort, INRA, Unite Biol Mol Immunol Parasitaire Fongique, F-94700 Maisons Alfort, France; Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Liverpool L69 7LB, Merseyside, England; Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	University of Basel; Max Planck Society; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Liverpool; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schuster, SC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	scs@bx.psu.edu; christoph.dehio@unibas.ch	Dehio, Christoph/AAD-5572-2019; Engel, Philipp/N-1788-2015; Dehio, Christoph/R-8277-2016	Dehio, Christoph/0000-0001-7288-1052; Engel, Philipp/0000-0002-4678-6200; Dehio, Christoph/0000-0001-7288-1052; Saenz, Henri/0000-0001-7536-7817; Birtles, Richard/0000-0002-4216-5044				Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891; Birtles RJ, 2002, J CLIN MICROBIOL, V40, P3606, DOI 10.1128/JCM.40.10.3606-3612.2002; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Houpikian P, 2001, FEMS MICROBIOL LETT, V200, P1, DOI 10.1111/j.1574-6968.2001.tb10684.x; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Seubert A, 2002, INT J MED MICROBIOL, V291, P555; Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	44	109	373	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1469	1476		10.1038/ng.2007.38	http://dx.doi.org/10.1038/ng.2007.38			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18037886				2022-12-25	WOS:000251267400014
J	Tammela, T; Saaristo, A; Holopainen, T; Lyytikkae, J; Kotronen, A; Pitkonen, M; Abo-Ramadan, U; Ylae-Herttuala, S; Petrova, TV; Alitalo, K				Tammela, Tuomas; Saaristo, Anne; Holopainen, Tanja; Lyytikkae, Johannes; Kotronen, Anna; Pitkonen, Miia; Abo-Ramadan, Usama; Ylae-Herttuala, Seppo; Petrova, Tatiana V.; Alitalo, Kari			Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation	NATURE MEDICINE			English	Article							GROWTH-FACTOR-C; EDEMA FOLLOWING TREATMENT; GENE-THERAPY; VEGF-C; HEREDITARY LYMPHEDEMA; ENDOTHELIAL-CELLS; BREAST-CANCER; TRANSGENIC MICE; LYMPHANGIOGENESIS; METASTASIS	Surgery or radiation therapy of metastatic cancer often damages lymph nodes, leading to secondary lymphedema. Here we show, using a newly established mouse model, that collecting lymphatic vessels can be regenerated and fused to lymph node transplants after lymph node removal. Treatment of lymph node-excised mice with adenovirally delivered vascular endothelial growth factor-C (VEGF-C) or VEGF-D induced robust growth of the lymphatic capillaries, which gradually underwent intrinsic remodeling, differentiation and maturation into functional collecting lymphatic vessels, including the formation of uniform endothelial cell-cell junctions and intraluminal valves. The vessels also reacquired pericyte contacts, which downregulated lymphatic capillary markers during vessel maturation. Growth factor therapy improved the outcome of lymph node transplantation, including functional reconstitution of the immunological barrier against tumor metastasis. These results show that growth factor-induced maturation of lymphatic vessels is possible in adult mice and provide a basis for future therapy of lymphedema.	Univ Helsinki, Ludwig Inst Canc Res, Haartman Inst, Biomedicum,Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Turku Univ, Cent Hosp, Dept Neurol, Expt MRI Lab, FIN-20521 Turku, Finland; Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; Univ Helsinki, Biomedicum, Dev & Differentiat Lab, FIN-00014 Helsinki, Finland	Ludwig Institute for Cancer Research; University of Helsinki; University of Turku; University of Eastern Finland; University of Helsinki	Alitalo, K (corresponding author), Univ Helsinki, Ludwig Inst Canc Res, Haartman Inst, Biomedicum,Mol Canc Biol Lab, PO Box 63 Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	kari.alitalo@helsinki.fi	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Yla-Herttuala, Seppo/0000-0001-7593-2708; /0000-0003-3675-6961	NHLBI NIH HHS [5 R01 HL075183-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; BAUMEISTER RG, 1981, LANCET, V1, P147; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Clark B, 2005, QJM-INT J MED, V98, P343, DOI 10.1093/qjmed/hci053; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Enholm B, 2001, CIRC RES, V88, P623, DOI 10.1161/01.RES.88.6.623; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Ikomi F, 2006, MICROCIRCULATION, V13, P365, DOI 10.1080/10739680600745810; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Ito WD, 1997, CIRC RES, V80, P829; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Kozaki K, 2000, CANCER RES, V60, P2535; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Mortimer PS, 1996, QJM-MON J ASSOC PHYS, V89, P377; Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; RABSON JA, 1982, ANN SURG, V196, P92, DOI 10.1097/00000658-198207000-00019; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Saaristo A, 2004, FASEB J, V18, P1707, DOI 10.1096/fj.04-1592fje; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830	50	269	283	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1458	1466		10.1038/nm1689	http://dx.doi.org/10.1038/nm1689			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18059280				2022-12-25	WOS:000251445400020
J	Ishikawa, F; Yoshida, S; Saito, Y; Hijikata, A; Kitamura, H; Tanaka, S; Nakamura, R; Tanaka, T; Tomiyama, H; Saito, N; Fukata, M; Miyamoto, T; Lyons, B; Ohshima, K; Uchida, N; Taniguchi, S; Ohara, O; Akashi, K; Harada, M; Shultz, LD				Ishikawa, Fumihiko; Yoshida, Shuro; Saito, Yoriko; Hijikata, Atsushi; Kitamura, Hiroshi; Tanaka, Satoshi; Nakamura, Ryu; Tanaka, Toru; Tomiyama, Hiroko; Saito, Noriyuki; Fukata, Mitsuhiro; Miyamoto, Toshihiro; Lyons, Bonnie; Ohshima, Koichi; Uchida, Naoyuki; Taniguchi, Shuichi; Ohara, Osamu; Akashi, Koichi; Harada, Mine; Shultz, Leonard D.			Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region	NATURE BIOTECHNOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; SCID MICE; PROGENITOR CELLS; GENE-EXPRESSION; NOD/SCID MICE; R-PACKAGE; NICHE; CD44; HEMATOPOIESIS; HIERARCHY	Acute myelogenous leukemia (AML) is the most common adult leukemia, characterized by the clonal expansion of immature myeloblasts initiating from rare leukemic stem (LS) cells(1-3). To understand the functional properties of human LS cells, we developed a primary human AML xenotransplantation model using newborn nonobese diabetic/severe combined immunodeficient/interleukin (NOD/SCID/IL)2r gamma(null) mice carrying a complete null mutation of the cytokine gamma c upon the SCID background(4). Using this model, we demonstrated that LS cells exclusively recapitulate AML and retain self-renewal capacity in vivo. They home to and engraft within the osteoblast-rich area of the bone marrow, where AML cells are protected from chemotherapy-induced apoptosis. Quiescence of human LS cells may be a mechanism underlying resistance to cell cycle-dependent cytotoxic therapy. Global transcriptional profiling identified LS cell-specific transcripts that are stable through serial transplantation. These results indicate the potential utility of this AML xenograft model in the development of novel therapeutic strategies targeted at LS cells.	RIKEN, Res Ctr All & Immunol, Res Unit Human Dis Models, Yokohama, Kanagawa 2300045, Japan; RIKEN, Res Ctr All & Immunol, Lab Immunogennom, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Kyushu Univ, Grad Sch, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; Kyushu Univ Hosp, Ctr Cellular & Mol, Higashi Ku, Fukuoka 8128582, Japan; Harvard Univ, Massachusetts Gen Hosp, Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; Nippon Becton Dickinson Co, Minato Ku, Tokyo 1070052, Japan; Carl Zeisss, Shinjuku Ku, Tokyo, Japan; Jackson Lab, Bar Harbor, ME 04609 USA; Kurume Univ, Sch Med, Dept Pathol 1, Kurume, Fukuoka 8300003, Japan; Toranomon Gen Hosp, Dept Hematol, Minato Ku, Tokyo 14058470, Japan; Kazusa DNA Res Inst, Dept Human Genome Technol, Kisarazu 2900818, Japan; Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Immunol,AIDS, Boston, MA 02115 USA	RIKEN; RIKEN; Kyushu University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Becton Dickinson; Carl Zeiss AG; Jackson Laboratory; Kurume University; Toranomon Hospital; Kazusa DNA Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ishikawa, F (corresponding author), RIKEN, Res Ctr All & Immunol, Res Unit Human Dis Models, Yokohama, Kanagawa 2300045, Japan.	f_ishika@rcai.riken.jp	石川, 文彦/L-4488-2014; Ohara, Osamu/A-9119-2012; Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571; Hijikata, Atsushi/0000-0003-4297-8368				Ailles LE, 1997, BLOOD, V90, P2555, DOI 10.1182/blood.V90.7.2555.2555_2555_2564; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Charrad RS, 1999, NAT MED, V5, P669, DOI 10.1038/9518; Christianson SW, 1997, J IMMUNOL, V158, P3578; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lumkul R, 2002, LEUKEMIA, V16, P1818, DOI 10.1038/sj.leu.2402632; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	691	744	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1315	1321		10.1038/nbt1350	http://dx.doi.org/10.1038/nbt1350			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17952057				2022-12-25	WOS:000251086500033
J	Petersen, J; Nurse, P				Petersen, Janni; Nurse, Paul			TOR signalling regulates mitotic commitment through the stress MAP kinase pathway and the Polo and Cdc2 kinases	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE CONTROL; FISSION YEAST; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; ACTIVATED KINASE; RAPAMYCIN TOR; EIF2 KINASES; GROWTH; GENE; DIVISION	The coupling of growth to cell cycle progression allows eukaryotic cells to divide at particular sizes depending on nutrient availability. In fission yeast, this coupling involves the Spc1/Sty1 mitogen-activated protein kinase ( MAPK) pathway working through Polo kinase recruitment to the spindle pole bodies ( SPBs). Here we report that changes in nutrients influence TOR signalling, which modulates Spc1/Sty1 activity. Rapamycin-induced inhibition of TOR signalling advanced mitotic onset, mimicking the reduction in cell size at division seen after shifts to poor nitrogen sources. Gcn2, an effector of TOR signalling and modulator of translation, regulates the Pyp2 phosphatase that in turn modulates Spc1/Sty1 activity. Rapamycin-or nutrient-induced stimulation of Spc1/Sty1 activity promotes Polo kinase SPB recruitment and Cdc2 activation to advance mitotic onset. This advanced mitotic onset is abolished in cells depleted of Gcn2, Pyp2, or Spc1/Sty1 or on blockage of Spc1/Sty1-dependent Polo SPB recruitment. Therefore, TOR signalling modulates mitotic onset through the stress MAPK pathway via the Pyp2 phosphatase.	Rockefeller Univ, New York, NY 10021 USA; Univ Manchester, Manchester M13 9PT, Lancs, England	Rockefeller University; University of Manchester	Petersen, J (corresponding author), Rockefeller Univ, Box 5,1230 York Ave, New York, NY 10021 USA.	Janni.Petersen@manchester.ac.uk		Petersen, Janni/0000-0003-0729-9335				Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BOOHER R, 1987, EMBO J, V6, P3441, DOI 10.1002/j.1460-2075.1987.tb02667.x; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; DAVEY J, 1994, CURR GENET, V26, P105, DOI 10.1007/BF00313796; Degols G, 1996, MOL CELL BIOL, V16, P2870; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kawai M, 2001, CURR GENET, V39, P166; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pardo M, 2005, J CELL SCI, V118, P1705, DOI 10.1242/jcs.02305; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petersen J, 2001, J CELL SCI, V114, P4371; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Toone WM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P57; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443	52	142	142	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1263	U97		10.1038/ncb1646	http://dx.doi.org/10.1038/ncb1646			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952063				2022-12-25	WOS:000250659600012
J	Saburi, S; Hester, I; Fischer, E; Pontoglio, M; Eremina, V; Gessler, M; Quaggin, SE; Harrison, R; Mount, R; McNeill, H				Saburi, Sakura; Hester, Ian; Fischer, Evelyne; Pontoglio, Marco; Eremina, Vera; Gessler, Manfred; Quaggin, Sue E.; Harrison, Robert; Mount, Richard; McNeill, Helen			Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease	NATURE GENETICS			English	Article							PLANAR POLARITY; DROSOPHILA EYE; MICE LACKING; HAIR-CELLS; CILIA; ORIENTATION; EXPRESSION; CADHERINS; DEFECTS; GENES	Tissue organization in Drosophila is regulated by the core planar cell polarity (PCP) proteins Frizzled, Dishevelled, Prickle, Van Gogh and Flamingo. Core PCP proteins are conserved in mammals and function in mammalian tissue organization. Recent studies have identified another group of Drosophila PCP proteins, consisting of the protocadherins Fat and Dachsous (Ds) and the transmembrane protein Four-jointed (Fj). In Drosophila, Fat represses fj transcription, and Ds represses Fat activity in PCP. Here we show that Fat4 is an essential gene that has a key role in vertebrate PCP. Loss of Fat4 disrupts oriented cell divisions and tubule elongation during kidney development, leading to cystic kidney disease. Fat4 genetically interacts with the PCP genes Vangl2 and Fjx1 in cyst formation. In addition, Fat4 represses Fjx1 expression, indicating that Fat signaling is conserved. Together, these data suggest that Fat4 regulates vertebrate PCP and that loss of PCP signaling may underlie some cystic diseases in humans.	[Saburi, Sakura; Hester, Ian; Eremina, Vera; Quaggin, Sue E.; McNeill, Helen] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fischer, Evelyne; Pontoglio, Marco] Ctr Natl Rech Sci URA 2578, Dept Dev Biol, Gene Express Dev & Dis Lab, Inst Pasteur, Paris, France; [Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Quaggin, Sue E.] St Michaels Hosp, Toronto, ON M5G 1X5, Canada; [Harrison, Robert; Mount, Richard] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [McNeill, Helen] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McNeill, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mcneill@mshri.on.ca	fischer, evelyne/GLT-9457-2022; McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154; Gessler, Manfred/0000-0002-7915-6045; fischer, evelyne/0000-0001-5054-1444	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kume T, 2000, DEVELOPMENT, V127, P1387; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; Rock R, 2005, DEV DYNAM, V234, P747, DOI 10.1002/dvdy.20515; Saburi S, 2005, CURR OPIN CELL BIOL, V17, P482, DOI 10.1016/j.ceb.2005.08.011; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	30	384	394	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1010	1015		10.1038/ng.179	http://dx.doi.org/10.1038/ng.179			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604206				2022-12-25	WOS:000258026900019
J	Oishi, Y; Manabe, I; Tobe, K; Ohsugi, M; Kubota, T; Fujiu, K; Maemura, K; Kubota, N; Kadowaki, T; Nagai, R				Oishi, Yumiko; Manabe, Ichiro; Tobe, Kazuyuki; Ohsugi, Mitsuru; Kubota, Tetsuya; Fujiu, Katsuhito; Maemura, Koji; Kubota, Naoto; Kadowaki, Takashi; Nagai, Ryozo			SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-DELTA; CARNITINE PALMITOYLTRANSFERASE-I; SKELETAL-MUSCLE; UNCOUPLING PROTEIN-2; INSULIN-RESISTANCE; FAT OXIDATION; GENE; SUMO; EXPRESSION; BINDING	Obesity and metabolic syndrome are increasingly recognized as major risk factors for cardiovascular disease. Herein we show that Kruppel-like transcription factor 5 (KLF5) is a crucial regulator of energy metabolism. Klf5(+/-) mice were resistant to high fat-induced obesity, hypercholesterolemia and glucose intolerance, despite consuming more food than wild-type mice. This may in part reflect their enhanced energy expenditure. Expression of the genes involved in lipid oxidation and energy uncoupling, including those encoding carnitine-palmitoyl transferase-1b (Cpt1b) and uncoupling proteins 2 and 3 (Ucp2 and Ucp3), was upregulated in the soleus muscles of Klf5(+/-) m ice. Under basal conditions, KLF5 modified with small ubiquitin-related modifier (SUMO) proteins was associated with transcriptionally repressive regulatory complexes containing unliganded peroxisome proliferator-activated receptor-delta (PPAR-delta) and co-repressors and thus inhibited Cpt1b, Ucp2 and Ucp3 expression. Upon agonist stimulation of PPAR-delta, KLF5 was deSUMOylated, and became associated with transcriptional activation complexes containing both the liganded PPAR-delta and CREB binding protein (CBP). This activation complex increased the expression of Cpt1b, Ucp2 and Ucp3. Thus, SUMOylation seems to be a molecular switch affecting function of KLF5 and the transcriptional regulatory programs governing lipid metabolism.	[Oishi, Yumiko; Manabe, Ichiro; Fujiu, Katsuhito; Maemura, Koji; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Oishi, Yumiko; Kubota, Tetsuya; Kubota, Naoto; Kadowaki, Takashi] Natl Inst Hlth & Nutr, Clin Nutr Program, Shinjuku Ku, Tokyo 1628636, Japan; [Manabe, Ichiro] Univ Tokyo, Nano Bioengn Educ Program, Bunkyo Ku, Tokyo 1138655, Japan; [Tobe, Kazuyuki; Ohsugi, Mitsuru; Kubota, Tetsuya; Kubota, Naoto; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 9300194, Japan	University of Tokyo; National Institute of Health & Nutrition - Japan; University of Tokyo; University of Tokyo; University of Toyama	Manabe, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	manabe-tky@umin.ac.jp; nagai-tky@umin.ac.jp	Manabe, Ichiro/AAE-5105-2021; Kubota, Naoto/N-7892-2015; Manabe, Ichiro/E-1529-2014					Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Chou CC, 2007, J BIOL CHEM, V282, P27239, DOI 10.1074/jbc.M700351200; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; van der Leij FR, 2002, J BIOL CHEM, V277, P26994, DOI 10.1074/jbc.M203189200; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047	48	118	128	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					656	666		10.1038/nm1756	http://dx.doi.org/10.1038/nm1756			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18500350				2022-12-25	WOS:000256468700032
J	Rowlinson, SW; Yoshizato, H; Barclay, JL; Brooks, AJ; Behncken, SN; Kerr, LM; Millard, K; Palethorpe, K; Nielsen, K; Clyde-Smith, J; Hancock, JF; Waters, MJ				Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.			An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway	NATURE CELL BIOLOGY			English	Article							KINASE-ACTIVITY; FACTOR-I; DIMERIZATION; ACTIVATION; COMPLEX; ANTAGONIST; DOMAIN; IDENTIFICATION; PREADIPOCYTES; TRANSDUCTION	The growth and metabolic actions of growth hormone (GH) are believed to be mediated through the GH receptor (GHR) by JAK2 activation. The GHR exists as a constitutive homdimer, with signal transduction by ligand- induced realignment of receptor subunits(1). Based on the crystal structures(2,3), we identify a conformational change in the F'G' loop of the lower cytokine module, which results from binding of hGH but not G120R hGH antagonist. Mutations disabling this conformational change cause impairment of ERK but not JAK2 and STAT5 activation by the GHR in FDC-P1 cells. This results from the use of two associated tyrosine kinases by the GHR, with JAK2 activating STAT5, and Lyn activating ERK1/2. We provide evidence that Lyn signals through phospholipase C gamma, leading to activation of Ras. Accordingly, mice with mutations in the JAK2 association motif respond to GH with activation of hepatic Src and ERK1/2, but not JAK2/STAT5. We suggest that F'G' loop movement alters the signalling choice between JAK2 and a Src family kinase by regulating TMD realignment. Our findings could explain debilitated ERK but not STAT5 signalling in some GH- resistant dwarfs and suggest pathway- specific cytokine agonists.	[Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Waters, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.waters@imb.uq.edu.au	Brooks, Andrew/A-9969-2011; Barclay, Johanna/G-6293-2012; waters, michael j/C-9582-2014; Clyde-Smith, Jodi/R-8910-2016	Brooks, Andrew/0000-0002-2691-1668; Barclay, Johanna/0000-0001-5737-1775; Clyde-Smith, Jodi/0000-0001-9798-9924; Hancock, John/0000-0003-0542-4710				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Behncken SN, 1997, J BIOL CHEM, V272, P27077, DOI 10.1074/jbc.272.43.27077; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; CLARKSON RWE, 1995, MOL ENDOCRINOL, V9, P108, DOI 10.1210/me.9.1.108; Clayton PE, 1999, ACTA PAEDIATR, V88, P174, DOI 10.1111/j.1651-2227.1999.tb14382.x; COLOSI P, 1993, J BIOL CHEM, V268, P12617; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Daniel N, 1996, MOL CELL ENDOCRINOL, V118, P25, DOI 10.1016/0303-7207(95)03763-2; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Gent J, 2003, MOL ENDOCRINOL, V17, P967, DOI 10.1210/me.2002-0261; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Lewis MD, 2004, J CLIN ENDOCR METAB, V89, P1068, DOI 10.1210/jc.2003-030652; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Rowlinson SW, 1998, J BIOL CHEM, V273, P5307, DOI 10.1074/jbc.273.9.5307; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SMIT LS, 1999, HDB PHYSL, P445; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Walker JL, 1998, J CLIN ENDOCR METAB, V83, P2554, DOI 10.1210/jc.83.7.2554; Wan Y, 2003, MOL ENDOCRINOL, V17, P2240, DOI 10.1210/me.2003-0162; Zhu T, 2002, J BIOL CHEM, V277, P45592, DOI 10.1074/jbc.M201385200	32	75	78	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					740	747		10.1038/ncb1737	http://dx.doi.org/10.1038/ncb1737			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488018				2022-12-25	WOS:000256350100021
J	Monzen, K; Ito, Y; Naito, AT; Kasai, H; Hiroi, Y; Hayashi, D; Shiojima, I; Yamazaki, T; Miyazono, K; Asashima, M; Nagai, R; Komuro, I				Monzen, Koshiro; Ito, Yuzuru; Naito, Atsuhiko T.; Kasai, Hiroki; Hiroi, Yukio; Hayashi, Doubun; Shiojima, Ichiro; Yamazaki, Tsutomu; Miyazono, Kohei; Asashima, Makoto; Nagai, Ryozo; Komuro, Issei			A crucial role of a high mobility group protein HMGA2 in cardiogenesis	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEINS; CONGENITAL HEART-DISEASE; CARDIOMYOCYTE DIFFERENTIATION; XENOPUS EMBRYOS; GENE; INDUCTION; NKX2-5; TRANSCRIPTION; PROMOTES; ELEMENTS	The high mobility group ( HMG) of nuclear proteins regulates expression of many genes through architectural remodelling of the chromatin structure, and formation of multiprotein complexes on promoter/enhancer regions. This leads to the active transcription of their target genes(1-3). Here we show that HMGA2, a member of the HMGA sub-family of HMG proteins, has a critical function in cardiogenesis. Overexpression of HMGA2 enhanced, whereas siRNA-mediated knockdown of HMGA2 blocked, cardiomyocyte differentiation of the embryonal carcinoma cell line P19CL6. Moreover, overexpression of a dominant-negative HMGA2 or morpholino-mediated knockdown of HMGA2 expression blocked normal heart formation in Xenopus laevis embryos, suggesting that HMGA2 has an important role in cardiogenesis both in vitro and in vivo. Mechanistically, HMGA2 associated with Smad1/4 and showed synergistic trans-activation of the gene for a cardiac transcription factor Nkx2.5; a conserved HMGA2 binding site was required for the promoter activity of Nkx2.5 gene, both in P19CL6 cells and in transgenic Xenopus embryos. Thus, HMGA2 is a positive regulator of Nkx2.5 gene expression and is essential for normal cardiac development.	[Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan; [Monzen, Koshiro; Kasai, Hiroki; Hiroi, Yukio; Hayashi, Doubun; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Yuzuru; Asashima, Makoto] Japan Sci & Technol Agcy, ICORP Organ Regenerat Project, Meguro Ku, Tokyo, Japan; [Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; [Naito, Atsuhiko T.; Shiojima, Ichiro; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Chiba University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Asashima, Makoto/O-8389-2018	Asashima, Makoto/0000-0002-0012-026X				Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; Battista S, 1999, CANCER RES, V59, P4793; Breckenridge RA, 2001, DEV BIOL, V232, P191, DOI 10.1006/dbio.2001.0164; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Foley A, 2004, TRENDS CARDIOVAS MED, V14, P121, DOI 10.1016/j.tcm.2004.01.003; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hosoda T, 2001, J BIOL CHEM, V276, P35978, DOI 10.1074/jbc.M100485200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sparrow DB, 2000, DEV BIOL, V227, P65, DOI 10.1006/dbio.2000.9891; Srivastava D, 2001, ANNU REV PHYSIOL, V63, P451, DOI 10.1146/annurev.physiol.63.1.451; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	31	62	65	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					567	574		10.1038/ncb1719	http://dx.doi.org/10.1038/ncb1719			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425117				2022-12-25	WOS:000255502400013
J	Marangos, P; Carroll, J				Marangos, Petros; Carroll, John			Securin regulates entry into M-phase by modulating the stability of cyclin B	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MOUSE OOCYTES; CHROMATID SEPARATION; AURORA-B; DESTRUCTION; DEGRADATION; PROTEOLYSIS; INHIBITOR; FERTILIZATION; COMPETITION	Timely progression into mitosis is necessary for normal cell division. This transition is sensitive to the levels of cyclin B, the regulatory subunit of the master mitotic kinase, Cdk1. Cyclin B accumulates during G2 and prophase when its rate of destruction by the anaphase promoting complex ( APC) is low(1). Securin is also an APC substrate and is known for its role in inactivating the cohesin-cleaving enzyme, separase, until the metaphase to anaphase transition. Here we show that securin has an additional role in cell-cycle regulation, that of modulating the timing of entry into M-phase. In mouse oocytes, excess securin caused stabilization of cyclin B and precocious entry into M-phase. Depletion of securin increased cyclin B degradation, resulting in delayed progression into M-phase. This effect required APC activity and was reversed by expression of wild-type securin. These data reveal a role for securin at the G2-M transition and suggest a more general mechanism whereby physiological levels of co-competing APC substrates function in modulating the timing of cell-cycle transitions.	[Marangos, Petros; Carroll, John] UCL, Dept Cell & Dev Biol, Div Biosci, London WC1E 6BT, England	University of London; University College London	Marangos, P (corresponding author), UCL, Dept Cell & Dev Biol, Div Biosci, Gower St, London WC1E 6BT, England.	p.marangos@ucl.ac.uk; j.carroll@ucl.ac.uk	Holt, Janet E/B-2415-2013	Marangos, Petros/0000-0001-5121-8235; Carroll, John/0000-0001-9644-5861	Medical Research Council [G0400530] Funding Source: Medline; MRC [G0400530] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; DI FB, 2007, J CELL BIOL, V177, P425; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Marangos P, 2004, DEV BIOL, V272, P26, DOI 10.1016/j.ydbio.2004.04.012; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Salazar C, 2006, ANN NY ACAD SCI, V1091, P517, DOI 10.1196/annals.1378.093; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	31	66	70	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					445	U151		10.1038/ncb1707	http://dx.doi.org/10.1038/ncb1707			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364698				2022-12-25	WOS:000254561700015
J	van Grevenynghe, J; Procopio, FA; He, Z; Chomont, N; Riou, C; Zhang, YW; Gimmig, S; Boucher, G; Wilkinson, P; Shi, Y; Yassine-Diab, B; Said, EA; Trautmann, L; El Far, M; Balderas, RS; Boulassel, MR; Routy, JP; Haddad, EK; Sekaly, RP				van Grevenynghe, Julien; Procopio, Francesco A.; He, Zhong; Chomont, Nicolas; Riou, Catherine; Zhang, Yuwei; Gimmig, Sylvain; Boucher, Genevieve; Wilkinson, Peter; Shi, Yu; Yassine-Diab, Bader; Said, Elias A.; Trautmann, Lydie; El Far, Mohamed; Balderas, Robert S.; Boulassel, Mohamed-Rachid; Routy, Jean-Pierre; Haddad, Elias K.; Sekaly, Rafick-Pierre			Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection	NATURE MEDICINE			English	Article							KAPPA-B; SURVIVAL; GENE; EFFECTOR; DISEASE; POLYMORPHISMS; LYMPHOCYTES; SPECIFICITY; PROGRESSION; ACTIVATION	The persistence of central memory CD4(+) T cells (T-CM cells) is a major correlate of immunological protection in HIV/AIDS, as the rate of T-CM cell decline predicts HIV disease progression. In this study, we show that T-CM cells and effector memory CD4(+) T cells (T-EM cells) from HIV+ elite controller (EC) subjects are less susceptible to Fas-mediated apoptosis and persist longer after multiple rounds of T cell receptor triggering when compared to T-CM and T-EM cells from aviremic successfully treated (ST) subjects or from HIV- donors. We show that persistence of T-CM cells from EC subjects is a direct consequence of inactivation of the FOXO3a pathway. Silencing the transcriptionally active form of FOXO3a by small interfering RNA or by introducing a FOXO3a dominant-negative form (FOXO3a Nt) extended the long-term survival of T-CM cells from ST subjects to a length of time similar to that of T-CM cells from EC subjects. The crucial role of FOXO3a in the survival of memory cells will help shed light on the underlying immunological mechanisms that control viral replication in EC subjects.	[van Grevenynghe, Julien; Procopio, Francesco A.; He, Zhong; Chomont, Nicolas; Riou, Catherine; Zhang, Yuwei; Gimmig, Sylvain; Boucher, Genevieve; Wilkinson, Peter; Shi, Yu; Yassine-Diab, Bader; Said, Elias A.; Trautmann, Lydie; El Far, Mohamed; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Immunol Lab, Ctr Rech, Hop St Luc, Montreal, PQ H2X 1P1, Canada; [van Grevenynghe, Julien; Procopio, Francesco A.; He, Zhong; Chomont, Nicolas; Zhang, Yuwei; Shi, Yu; Yassine-Diab, Bader; Said, Elias A.; Trautmann, Lydie; El Far, Mohamed; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Immunol Lab, Dept Microbiol & Immunol, Montreal, PQ H3T 1J4, Canada; [van Grevenynghe, Julien; Procopio, Francesco A.; He, Zhong; Chomont, Nicolas; Zhang, Yuwei; Shi, Yu; Yassine-Diab, Bader; Said, Elias A.; Trautmann, Lydie; El Far, Mohamed; Routy, Jean-Pierre; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Ctr Hosp, Inst Natl Sante Rech Med U743, Ctr Rech, Montreal, PQ H2X 1P1, Canada; [Balderas, Robert S.] BD Biosci, San Diego, CA 92121 USA; [Boulassel, Mohamed-Rachid; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Immunodeficiency Serv, Montreal, PQ H3A 1A1, Canada; [Boulassel, Mohamed-Rachid; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Haematol, Montreal, PQ H3A 1A1, Canada; [Haddad, Elias K.; Sekaly, Rafick-Pierre] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University	Haddad, EK (corresponding author), Univ Montreal, Immunol Lab, Ctr Rech, Hop St Luc, 264 Rene Levesque Blvd E, Montreal, PQ H2X 1P1, Canada.	elias.haddad@umontreal.ca; rafick-pierre.sekaly@umontreal.ca	Wilkinson, Peter/AAK-6426-2020; Chomont, Nicolas/ABG-2545-2020; Procopio, Francesco/ABD-8065-2021; Zhang, Yuwei/H-3287-2018; Said, Elias/AAY-5557-2020	Wilkinson, Peter/0000-0002-1365-0470; Chomont, Nicolas/0000-0001-9747-5018; Boucher, Genevieve/0000-0001-6389-9007; Said, Elias/0000-0003-4224-6351; Trautmann, Lydie/0000-0002-3012-0009				Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bostik P, 2006, AIDS, V20, P181, DOI 10.1097/01.aids.0000198092.77948.8a; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Charvet C, 2003, ONCOGENE, V22, P4557, DOI 10.1038/sj.onc.1206778; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Harari A, 2002, BLOOD, V100, P1381, DOI 10.1182/blood-2001-11-0080; Harrer T, 1996, J IMMUNOL, V156, P2616; Hendel H, 1999, J IMMUNOL, V162, P6942; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim JR, 2006, OBESITY, V14, P188, DOI 10.1038/oby.2006.24; KNIGHT S C, 1990, International Reviews of Immunology, V6, P163, DOI 10.3109/08830189009056627; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lavoie PM, 2005, INT IMMUNOL, V17, P931, DOI 10.1093/intimm/dxh273; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Philp AJ, 2001, CANCER RES, V61, P7426; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shamim Z, 2006, BONE MARROW TRANSPL, V37, P485, DOI 10.1038/sj.bmt.1705277; Sun Y, 2005, J IMMUNOL, V174, P4753, DOI 10.4049/jimmunol.174.8.4753; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Wilson JDK, 2000, J INFECT DIS, V182, P792, DOI 10.1086/315764; Wu HC, 2006, J CLIN LAB ANAL, V20, P245, DOI 10.1002/jcla.20149; Zanetti M, 2006, TRENDS IMMUNOL, V27, P511, DOI 10.1016/j.it.2006.09.004	32	125	126	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					266	274		10.1038/nm1728	http://dx.doi.org/10.1038/nm1728			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18311149				2022-12-25	WOS:000253815700032
J	Aulehla, A; Wiegraebe, W; Baubet, V; Wahl, MB; Deng, CX; Taketo, M; Lewandoski, M; Pourquie, O				Aulehla, Alexander; Wiegraebe, Winfried; Baubet, Valerie; Wahl, Matthias B.; Deng, Chuxia; Taketo, Makoto; Lewandoski, Mark; Pourquie, Olivier			A beta-catenin gradient links the clock and wavefront systems in mouse embryo segmentation	NATURE CELL BIOLOGY			English	Article							ANTEROPOSTERIOR AXIS ELONGATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; GENE-EXPRESSION; LUNATIC-FRINGE; TRANSCRIPTION FACTORS; FLUORESCENT PROTEIN; IN-VIVO; NOTCH; WNT	Rhythmic production of vertebral precursors, the somites, causes bilateral columns of embryonic segments to form. This process involves a molecular oscillator - the segmentation clock - whose signal is translated into a spatial, periodic pattern by a complex signalling gradient system within the presomitic mesoderm (PSM). In mouse embryos, Wnt signalling has been implicated in both the clock and gradient mechanisms, but how the Wnt pathway can perform these two functions simultaneously remains unclear. Here, we use a yellow fluorescent protein (YFP)-based, real-time imaging system in mouse embryos to demonstrate that clock oscillations are independent of beta-catenin protein levels. In contrast, we show that the Wnt-signalling gradient is established through a nuclear beta-catenin protein gradient in the posterior PSM. This gradient of nuclear beta-catenin defines the size of the oscillatory field and controls key aspects of PSM maturation and segment formation, emphasizing the central role of Wnt signalling in this process.	[Aulehla, Alexander; Wiegraebe, Winfried; Wahl, Matthias B.; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Baubet, Valerie] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Deng, Chuxia] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Taketo, Makoto] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Lewandoski, Mark] NCI, Lab Canc & Dev Biol, NIH, Frederick, MD 21702 USA; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Pourquie, O (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; deng, chuxia/N-6713-2016	Pourquié, Olivier/0000-0001-5189-1227; Lewandoski, Mark/0000-0002-1066-3735; Aulehla, Alexander/0000-0003-3487-9239	Intramural NIH HHS [Z01 BC010338] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010338, Z01BC010338] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brault V, 2001, DEVELOPMENT, V128, P1253; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DEANGELIS H, 1997, NATURE, V386, P717; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; GONZELEZ RC, 2007, DIGITAL IMAGE PROCES; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones EAV, 2002, GENESIS, V34, P228, DOI 10.1002/gene.10162; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maruhashi M, 2005, DEV DYNAM, V234, P332, DOI 10.1002/dvdy.20546; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakajima Y, 2006, DEVELOPMENT, V133, P2517, DOI 10.1242/dev.02422; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Sawada A, 2001, DEVELOPMENT, V128, P4873; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717	50	224	226	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					186	U56		10.1038/ncb1679	http://dx.doi.org/10.1038/ncb1679			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18157121	Green Accepted			2022-12-25	WOS:000252897800014
J	Hosooka, T; Noguchi, T; Kotani, K; Nakamura, T; Sakaue, H; Inoue, H; Ogawa, W; Tobimatsu, K; Takazawa, K; Sakai, M; Matsuki, Y; Hiramatsu, R; Yasuda, T; Lazar, MA; Yamanashi, Y; Kasuga, M				Hosooka, Tetsuya; Noguchi, Tetsuya; Kotani, Ko; Nakamura, Takehiro; Sakaue, Hiroshi; Inoue, Hiroshi; Ogawa, Wataru; Tobimatsu, Kazutoshi; Takazawa, Kazuo; Sakai, Mashito; Matsuki, Yasushi; Hiramatsu, Ryuji; Yasuda, Tomoharu; Lazar, Mitchell A.; Yamanashi, Yuji; Kasuga, Masato			Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; GLUCOSE-INTOLERANCE; P62(DOK); MICE; SENSITIVITY; ADIPOGENESIS; INHIBITION	Insulin receptor substrate (IRS)-1 and IRS-2 have dominant roles in the action of insulin(1), but other substrates of the insulin receptor kinase, such as Gab1, c-Cbl, SH2-B and APS, are also of physiological relevance(2-5). Although the protein downstream of tyrosine kinases-1 (Dok1) is known to function as a multisite adapter molecule in insulin signaling(6-8), its role in energy homeostasis has remained unclear. Here we show that Dok1 regulates adiposity. Expression of Dok1 in white adipose tissue was markedly increased in mice fed a high-fat diet, whereas adipocytes lacking this adapter were smaller and showed a reduced hypertrophic response to this dietary manipulation. Dok1-deficient mice were leaner and showed improved glucose tolerance and insulin sensitivity compared with wild-type mice. Embryonic fibroblasts from Dok1-deficient mice were impaired in adipogenic differentiation, and this defect was accompanied by an increased activity of the protein kinase ERK and a consequent increase in the phosphorylation of peroxisome proliferator-activated receptor (PPAR)-gamma on Ser112. Mutation of this negative regulatory site for the transactivation activity of PPAR-gamma blocked development of the lean phenotype caused by Dok1 ablation. These results indicate that Dok1 promotes adipocyte hypertrophy by counteracting the inhibitory effect of ERK on PPAR-gamma and may thus confer predisposition to diet-induced obesity.	[Hosooka, Tetsuya; Noguchi, Tetsuya; Kotani, Ko; Nakamura, Takehiro; Sakaue, Hiroshi; Inoue, Hiroshi; Ogawa, Wataru; Tobimatsu, Kazutoshi; Takazawa, Kazuo; Sakai, Mashito; Kasuga, Masato] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Matsuki, Yasushi; Hiramatsu, Ryuji] Dainippon Sumitomo Pharma, Genom Sci Labs, Takarazuka, Hyogo 6658555, Japan; [Inoue, Hiroshi; Yasuda, Tomoharu; Yamanashi, Yuji] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Dept Cell Regulat, Tokyo 1138510, Japan; [Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Dept Med Genet & Pharmacol, Philadelphia, PA 19104 USA; [Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Kobe University; Tokyo Medical & Dental University (TMDU); University of Pennsylvania; University of Pennsylvania	Kasuga, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kasuga@med.kobe-u.ac.jp	Sakaue, Hiroshi/ABE-2337-2021; OGAWA, Wataru/AAQ-9586-2020; Yasuda, Tomoharu/J-5102-2019; Lazar, Mitchell A/AAF-3738-2019	Sakaue, Hiroshi/0000-0002-2468-2363; Yasuda, Tomoharu/0000-0001-9997-6852; Sakai, Mashito/0000-0002-4908-2727; Inoue, Hiroshi/0000-0002-7724-6637				Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Camp HS, 1997, J BIOL CHEM, V272, P10811; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HOSOMI Y, 1994, J BIOL CHEM, V269, P11498; Hosooka T, 2001, MOL CELL BIOL, V21, P5437, DOI 10.1128/MCB.21.16.5437-5446.2001; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Leitner JW, 1997, ENDOCRINOLOGY, V138, P2211, DOI 10.1210/en.138.5.2211; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Minami A, 2003, DIABETES, V52, P2657, DOI 10.2337/diabetes.52.11.2657; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Wick MJ, 2001, J BIOL CHEM, V276, P42843, DOI 10.1074/jbc.M102116200; Yamanashi Y, 2000, GENE DEV, V14, P11; YAMANASHI Y, 1997, DOK CELL, V88, P205	30	82	89	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					188	193		10.1038/nm1706	http://dx.doi.org/10.1038/nm1706			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18204460				2022-12-25	WOS:000252946700028
J	Nousiainen, HO; Kestila, M; Pakkasjarvi, N; Honkala, H; Kuure, S; Tallila, J; Vuopala, K; Ignatius, J; Herva, R; Peltonen, L				Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Kuure, Satu; Tallila, Jonna; Vuopala, Katri; Ignatius, Jaakko; Herva, Riitta; Peltonen, Leena			Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease	NATURE GENETICS			English	Article							BOX PROTEIN DBP5; PATHWAY	The most severe forms of motoneuron disease manifest in utero are characterized by marked atrophy of spinal cord motoneurons and fetal immobility. Here, we report that the defective gene underlying lethal motoneuron syndrome LCCS1 is the mRNA export mediator GLE1. Our finding of mutated GLE1 exposes a common pathway connecting the genes implicated in LCCS1, LCCS2 and LCCS3 and elucidates mRNA processing as a critical molecular mechanism in motoneuron development and maturation.	[Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Tallila, Jonna; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Kuure, Satu] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Vuopala, Katri] Lapland Cent Hosp, Dept Pathol, Rovaniemi 96100, Finland; [Ignatius, Jaakko] Oulu Univ Hosp, Dept Clin Genet, Oulu 90014, Finland; [Ignatius, Jaakko] Univ Oulu, Oulu 90014, Finland; [Herva, Riitta] Oulu Univ Hosp, Dept Pathol, Oulu 90029, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Kestila, M (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.	marjo.kestila@ktl.fi	, shkuure/AAE-2751-2019	, shkuure/0000-0002-9076-0622	NIEHS NIH HHS [P01 ES11253-03, P01 ES011253] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; HERVA R, 1988, AM J MED GENET, V29, P67, DOI 10.1002/ajmg.1320290109; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Makela-Bengs P, 1998, AM J HUM GENET, V63, P506, DOI 10.1086/301968; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Pakkasjarvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; VUOPALA K, 1995, HUM PATHOL, V26, P12, DOI 10.1016/0046-8177(95)90109-4; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	15	133	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					155	157		10.1038/ng.2007.65	http://dx.doi.org/10.1038/ng.2007.65			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204449	Green Accepted			2022-12-25	WOS:000252732900012
J	Romeis, J; Bartsch, D; Bigler, F; Candolfi, MP; Gielkens, MMC; Hartley, SE; Hellmich, RL; Huesing, JE; Jepson, PC; Layton, R; Quemada, H; Raybould, A; Rose, RI; Schiemann, J; Sears, MK; Shelton, AM; Sweet, J; Vaituzis, Z; Wolt, JD				Romeis, Joerg; Bartsch, Detlef; Bigler, Franz; Candolfi, Marco P.; Gielkens, Marco M. C.; Hartley, Susan E.; Hellmich, Richard L.; Huesing, Joseph E.; Jepson, Paul C.; Layton, Raymond; Quemada, Hector; Raybould, Alan; Rose, Robyn I.; Schiemann, Joachim; Sears, Mark K.; Shelton, Anthony M.; Sweet, Jeremy; Vaituzis, Zigfridas; Wolt, Jeffrey D.			Assessment of risk of insect-resistant transgenic crops to nontarget arthropods	NATURE BIOTECHNOLOGY			English	Article							GENETICALLY-MODIFIED CROPS; BT CORN POLLEN; GM CROPS; MAIZE; ENVIRONMENT; LEPIDOPTERA; MANAGEMENT; RELEASE	An international initiative is developing a scientifically rigorous approach to evaluate the potential risks to nontarget arthropods (NTAs) posed by insect-resistant, genetically modified (IRGM) crops. It adapts the tiered approach to risk assessment that is used internationally within regulatory toxicology and environmental sciences. The approach focuses on the formulation and testing of clearly stated risk hypotheses, making maximum use of available data and using formal decision guidelines to progress between testing stages (or tiers). It is intended to provide guidance to regulatory agencies that are currently developing their own NTA risk assessment guidelines for IRGM crops and to help harmonize regulatory requirements between different countries and different regions of the world.	[Romeis, Joerg; Bigler, Franz] Agroscope Reckenholz Tanikon Res Stn ART, CH-8046 Zurich, Switzerland; [Bartsch, Detlef] Fed Off Consumer Protect & Food Safety BVL, D-10117 Berlin, Germany; [Candolfi, Marco P.] RCC Labs India Private Ltd, Hyderabad 500078, Andhra Pradesh, India; [Gielkens, Marco M. C.] Natl Inst Publ Hlth & Environm, Expertise Ctr Substances, NL-3720 BA Bilthoven, Netherlands; [Hartley, Susan E.] Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England; [Hellmich, Richard L.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Hellmich, Richard L.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA 50011 USA; [Huesing, Joseph E.] Monsanto Co, St Louis, MO 63167 USA; [Jepson, Paul C.] Oregon State Univ, Integrated Plant Protect Ctr, Corvallis, OR 97331 USA; [Jepson, Paul C.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Layton, Raymond] DuPont Crop Genet, Johnston, IA 50131 USA; [Quemada, Hector] Calvin Coll, Dept Biol, Program Biosafety Syst, Grand Rapids, MI 49546 USA; [Raybould, Alan] Syngenta Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England; [Rose, Robyn I.] USDA, APHIS Biotechnol Regulatory Serv, Riverdale, MD 20737 USA; [Schiemann, Joachim] Julius Kuehn Inst, Fed Res Ctr Cultivated Plants, Inst Biosafety Genetically Modified Palnts, D-38104 Braunschweig, Germany; [Sears, Mark K.] Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; [Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Sweet, Jeremy] Green Willingham, Cambridge CB4 5JA, England; [Vaituzis, Zigfridas] US EPA, Biopesticides & Pollut Prevent Div, Washington, DC 20460 USA; [Wolt, Jeffrey D.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Wolt, Jeffrey D.] Iowa State Univ, Biosafety Inst Genetically Modified Agr Prod, Ames, IA 50011 USA	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Netherlands National Institute for Public Health & the Environment; University of Sussex; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Monsanto; Oregon State University; Oregon State University; DuPont; Calvin University; Syngenta; United States Department of Agriculture (USDA); Julius Kuhn-Institut; University of Guelph; Cornell University; United States Environmental Protection Agency; Iowa State University; Iowa State University	Romeis, J (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Reckenholzstr 191, CH-8046 Zurich, Switzerland.	joerg.romeis@art.admin.ch	Romeis, Joerg/J-5360-2013; Quemada, Hector/M-2848-2013; Jepson, Paul/E-8669-2011	Romeis, Joerg/0000-0003-3652-8360; Jepson, Paul/0000-0003-3419-4715; Bartsch, Detlef/0000-0003-2961-915X; Wolt, Jeff/0000-0003-0837-1976; Hartley, Sue/0000-0002-5117-687X				*ASTM, 2004, 1850 ASTM; Barrett K.L., 1994, ESCORT WORKSH EUR ST; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Blumel S., 2000, GUIDELINES EVALUATE; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Candolfi M, 2000, ANZ SCHADL-J PEST SC, V73, P141; CANDOLFI MP, GUIDANCE DOCUMENT RE; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Dively GP, 2004, ENVIRON ENTOMOL, V33, P1116, DOI 10.1603/0046-225X-33.4.1116; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.99; Glare T.R., 2000, BACILLUS THURINGIENS; Hellmich RL, 2001, P NATL ACAD SCI USA, V98, P11925, DOI 10.1073/pnas.211297698; Hill Ryan A., 2003, Environmental Biosafety Research, V2, P81, DOI 10.1051/ebr:2003004; HOKANSON K, 1999, P EC EFF PEST RES GE, P15; Jaffe G, 2006, NAT BIOTECHNOL, V24, P748, DOI 10.1038/nbt0706-748; JAMES C, 2006, 35 ISAAA; Johnson KL, 2007, TRENDS PLANT SCI, V12, P1, DOI 10.1016/j.tplants.2006.11.004; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; LEVIN SA, 1989, ECOTOXICOLOGY PROBLE, P3; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Nap JP, 2003, PLANT J, V33, P1, DOI 10.1046/j.0960-7412.2003.01602.x; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; *NRC, 1989, FIELD TEST GEN MOD O; OECD (Organisation for Economic Co-operation and Development), 1993, SAF CONS BIOT SCAL U; PETERS RH, 1991, CRITIQUE ECOLOGY; Prasifka JR, 2005, ENVIRON ENTOMOL, V34, P1181, DOI 10.1603/0046-225X(2005)034[1181:ATEOPM]2.0.CO;2; Raybould A, 2007, J APPL ENTOMOL, V131, P391, DOI 10.1111/j.1439-0418.2007.01200.x; Raybould Alan, 2006, Environmental Biosafety Research, V5, P119, DOI 10.1051/ebr:2007004; Romeis J., 2006, Bulletin OILB/SROP, V29, P197; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Rose R., 2007, WHITE PAPER TIER BAS; SCHOLTE EJ, 2005, 200506 CGM; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Secretariat of the Convention on Biological Diversity, 2000, CART PROT BIOS CONV; TIEDJE JM, 1989, ECOLOGY, V70, P298, DOI 10.2307/1937535; Touart LW, 1997, ECOL APPL, V7, P1086, DOI 10.1890/1051-0761(1997)007[1086:INFPRI]2.0.CO;2; US Environmental Protection Agency (USEPA), 1995, EPA PUBL; USEPA, 2001, BIOP REG ACT DOC BAC; *USEPA, 1998, 630R95002F EPA; *USEPA, 1996, HARM GUID SER MICR P, V885; Wolt J. D., 2000, AGBIOFORUM, V3, P39; Wolt JD, 2003, ENVIRON ENTOMOL, V32, P237, DOI 10.1603/0046-225X-32.2.237	46	344	393	1	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					203	208		10.1038/nbt1381	http://dx.doi.org/10.1038/nbt1381			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18259178	Green Published			2022-12-25	WOS:000253193000022
J	Bauer, TR; Allen, JM; Hai, M; Tuschong, LM; Khan, IF; Olson, EM; Adler, RL; Burkholder, TH; Gu, YC; Russell, DW; Hickstein, DD				Bauer, Thomas R., Jr.; Allen, James M.; Hai, Mehreen; Tuschong, Laura M.; Khan, Iram F.; Olson, Erik M.; Adler, Rima L.; Burkholder, Tanya H.; Gu, Yu-chen; Russell, David W.; Hickstein, Dennis D.			Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors	NATURE MEDICINE			English	Article							DISEASE PHENOTYPE; GENE-THERAPY; COMBINED IMMUNODEFICIENCY; REPOPULATING CELLS; HUMAN GENOME; TRANSDUCTION; TRANSCRIPTION; REPLICATION; REVERSE; ANTIGEN	Recent successes in treating genetic immunodeficiencies have demonstrated the therapeutic potential of stem cell gene therapy(1-4). However, the use of gammaretroviral vectors in these trials led to insertional activation of nearby oncogenes and leukemias in some study subjects, prompting studies of modified or alternative vector systems(5). Here we describe the use of foamy virus vectors to treat canine leukocyte adhesion deficiency ( CLAD). Four of five dogs with CLAD that received nonmyeloablative conditioning and infusion of autologous, CD34(+) hematopoietic stem cells transduced by a foamy virus vector expressing canine CD18 had complete reversal of the CLAD phenotype, which was sustained more than 2 years after infusion. In vitro assays showed correction of the lymphocyte proliferation and neutrophil adhesion defects that characterize CLAD. There were no genotoxic complications, and integration site analysis showed polyclonality of transduced cells and a decreased risk of integration near oncogenes as compared to gammaretroviral vectors. These results represent the first successful use of a foamy virus vector to treat a genetic disease, to our knowledge, and suggest that foamy virus vectors will be effective in treating human hematopoietic diseases.	[Allen, James M.; Khan, Iram F.; Olson, Erik M.; Russell, David W.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Bauer, Thomas R., Jr.; Hai, Mehreen; Tuschong, Laura M.; Adler, Rima L.; Gu, Yu-chen; Hickstein, Dennis D.] NCI, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA; [Burkholder, Tanya H.] NIH, Off Res Serv, Div Vet Resources, Bethesda, MD 20892 USA; [Russell, David W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Div Hematol, 1959 NE Pacific St,Box 357720, Seattle, WA 98195 USA.	drussell@u.washington.edu; hicksted@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [P01 HL053750, R01 HL085107, HL53750] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085107, P01HL053750] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Anderson D.C., 2001, METABOLIC MOL BASES, P4829; Bauer TR, 2006, BLOOD, V108, P3313, DOI 10.1182/blood-2006-03-006908; Bauer TR, 2005, EXP HEMATOL, V33, P706, DOI 10.1016/j.exphem.2005.03.010; Bauer TR, 2004, BLOOD, V103, P3582, DOI 10.1182/blood-2003-11-4008; BEATTY PG, 1983, J IMMUNOL, V131, P2913; Creevy KE, 2003, VET IMMUNOL IMMUNOP, V94, P11, DOI 10.1016/S0165-2427(03)00057-6; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Falcone V, 2003, CURR TOP MICROBIOL, V277, P161; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Gu YC, 2006, BONE MARROW TRANSPL, V37, P607, DOI 10.1038/sj.bmt.1705291; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; HAWLEY RG, 1994, GENE THER, V1, P136; Horn PA, 2004, BLOOD, V103, P3710, DOI 10.1182/blood-2003-07-2414; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Josephson NC, 2002, P NATL ACAD SCI USA, V99, P8295, DOI 10.1073/pnas.122131099; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Moebes A, 1997, J VIROL, V71, P7305, DOI 10.1128/JVI.71.10.7305-7311.1997; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Russell DW, 1996, J VIROL, V70, P217, DOI 10.1128/JVI.70.1.217-222.1996; Storb R, 1999, BLOOD, V94, P2523, DOI 10.1182/blood.V94.7.2523.419k18_2523_2529; Tone Y, 2007, BLOOD, V109, P1182, DOI 10.1182/blood-2006-08-039057; Trobridge G, 2004, J VIROL, V78, P2327, DOI 10.1128/JVI.78.5.2327-2335.2004; Trobridge G, 2002, MOL THER, V6, P321, DOI 10.1006/mthe.2002.0672; Trobridge GD, 1998, HUM GENE THER, V9, P2517, DOI 10.1089/10430349850019355; Trowald-Wigh G, 2000, J SMALL ANIM PRACT, V41, P211, DOI 10.1111/j.1748-5827.2000.tb03198.x; Vassilopoulos G, 2001, BLOOD, V98, P604, DOI 10.1182/blood.V98.3.604; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yu SF, 1999, J VIROL, V73, P1565, DOI 10.1128/JVI.73.2.1565-1572.1999	30	113	115	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					93	97		10.1038/nm1695	http://dx.doi.org/10.1038/nm1695			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157138	Green Accepted			2022-12-25	WOS:000252222400028
J	Brown, BD; Gentner, B; Cantore, A; Colleoni, S; Amendola, M; Zingale, A; Baccarini, A; Lazzari, G; Galli, C; Naldini, L				Brown, Brian D.; Gentner, Bernhard; Cantore, Alessio; Colleoni, Silvia; Amendola, Mario; Zingale, Anna; Baccarini, Alessia; Lazzari, Giovanna; Galli, Cesare; Naldini, Luigi			Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state	NATURE BIOTECHNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; HEMATOPOIETIC STEM-CELLS; RNAI ENZYME COMPLEX; GENE-THERAPY; IMMUNE-RESPONSE; TRANSCRIPTION FACTOR; DENDRITIC CELLS; VECTORS; MICE; IDENTIFICATION	We have shown previously that transgene expression can be suppressed in hematopoietic cells using vectors that are responsive to microRNA ( miRNA) regulation. Here we investigate the potential of this approach for more sophisticated control of transgene expression. Analysis of the relationship between miRNA expression levels and target mRNA suppression suggested that suppression depends on a threshold miRNA concentration. Using this information, we generated vectors that rapidly adjust transgene expression in response to changes in miRNA expression. These vectors sharply segregated transgene expression between closely related states of therapeutically relevant cells, including dendritic cells, hematopoietic and embryonic stem cells, and their progeny, allowing positive/negative selection according to the cells' differentiation state. Moreover, two miRNA target sites were combined to restrict transgene expression to a specific cell type in the liver. Notably, the vectors did not detectably perturb endogenous miRNA expression or regulation of natural targets. The properties of miRNA-regulated vectors should allow for safer and more effective therapeutic applications.	Univ Vita Salute San Raffaele, I-20132 Milan, Italy; Ist Sperimentale Italiano Lazzaro Spallanzani, Reproduct Technol Lab, CIZ, I-26100 Cremona, Italy; Univ Bologna, Dipartimento Clin Vet, I-40064 Ozzano Dell Emilia, Italy; Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Lazzaro Spallanzani; University of Bologna; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Naldini, L (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, 1425 Madison Ave, New York, NY 10029 USA.	naldini.luigi@hsr.it	amendola, mario/I-1728-2017; Cantore, Alessio/AAI-2090-2019; Naldini, Luigi/E-9083-2012	amendola, mario/0000-0002-1188-8856; Cantore, Alessio/0000-0002-9741-997X; NALDINI, Luigi/0000-0002-7835-527X; Gentner, Bernhard/0000-0001-6024-4718	Telethon [TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown BD, 2002, BLOOD, V100, P1133, DOI 10.1182/blood-2001-11-0067; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen M, 2003, ADV ENVIRON RES, V8, P93, DOI 10.1016/S1093-0191(02)00145-4; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimaldi E, 2005, CLIN LAB HAEMATOL, V27, P91, DOI 10.1111/j.1365-2257.2005.00676.x; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haviernik P, 2004, CURR GENE THER, V4, P263; Hawley TS, 1998, BLOOD, V92, P2003, DOI 10.1182/blood.V92.6.2003.418k11_2003_2011; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Sadeghi H, 2005, CURR GENE THER, V5, P411, DOI 10.2174/1566523054546189; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829	59	442	506	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1457	1467		10.1038/nbt1372	http://dx.doi.org/10.1038/nbt1372			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18026085				2022-12-25	WOS:000251457800036
J	Recher, M; Lang, KS; Navarini, A; Hunziker, L; Lang, PA; Fink, K; Freigang, S; Georgiev, P; Hangartner, L; Zellweger, R; Bergthaler, A; Hegazy, AN; Eschli, B; Theocharides, A; Jeker, LT; Merkler, D; Odermatt, B; Hersberger, M; Hengartner, H; Zinkernagel, RM				Recher, Mike; Lang, Karl S.; Navarini, Alexander; Hunziker, Lukas; Lang, Philipp A.; Fink, Katja; Freigang, Stefan; Georgiev, Panco; Hangartner, Lars; Zellweger, Raphael; Bergthaler, Andreas; Hegazy, Ahmed N.; Eschli, Bruno; Theocharides, Alexandre; Jeker, Lukas T.; Merkler, Doron; Odermatt, Bernhard; Hersberger, Martin; Hengartner, Hans; Zinkernagel, Rolf M.			Extralymphatic virus sanctuaries as a consequence of potent T-cell activation	NATURE MEDICINE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ANTIVIRAL IMMUNE-RESPONSES; CHRONIC VIRAL-INFECTION; HIV-1 INFECTION; INFLUENZA-VIRUS; MICE; DISEASE; PERSISTENT; IMMUNOPATHOLOGY; REPLICATION	T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as the kidneys and other extralymphatic organs. The mechanisms underlying this persistence are not well understood. Here we show that mice with potent virus-specific T-cell responses have reduced levels and delayed formation of neutralizing antibodies, and these mice fail to clear LCMV from extralymphatic epithelia. Transfer of virus-specific B cells but not virus-specific T cells augmented virus clearance from persistent sites. Virus elimination from the kidneys was associated with the formation of IgG deposits in the interstitial space, presumably from kidney-infiltrating B cells. CD8(+) T cells in the kidneys of mice that did not clear virus from this site were activated but showed evidence of exhaustion. Thus, we conclude that in this model of infection, site-specific virus persistence develops as a consequence of potent immune activation coupled with reductions in virus-specific neutralizing antibodies. Our results suggest that sanctuary-site formation depends both on organ anatomy and on the induction of different adaptive immune effector mechanisms. Boosting T-cell responses alone may not reduce virus persistence.	Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; Univ Zurich Hosp, Dept Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland; German Rheumatol Res Ctr, D-10117 Berlin, Germany; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel, Ctr Biomed, CH-4058 Basel, Switzerland; Univ Childrens Hosp Basel, CH-4058 Basel, Switzerland; Univ Gottingen, Dept Neuropathol, Gottingen, Germany; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	University of Zurich; University of Basel; University of Zurich; University Zurich Hospital; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Basel; University of Basel; University of Basel; University of Gottingen; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Recher, M (corresponding author), Univ Zurich, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	rechermike@bluewin.ch	Bergthaler, Andreas/ABG-5047-2020; Navarini, Alexander/C-5504-2014; Hangartner, Lars/H-3503-2011; Fink, Katja/AAI-1881-2021; Hangartner, Lars/AAS-1320-2021; Freigang, Stefan/A-8682-2013; Lang, Karl S/R-2505-2016; Merkler, Doron/N-9157-2016	Bergthaler, Andreas/0000-0003-0597-1976; Navarini, Alexander/0000-0001-7059-632X; Fink, Katja/0000-0002-3571-0390; Hangartner, Lars/0000-0002-3165-2058; Freigang, Stefan/0000-0003-4438-7828; Merkler, Doron/0000-0002-0247-2007; Lang, Karl/0000-0001-9783-7605; Hersberger, Martin/0000-0002-4472-329X; Hegazy, Ahmed N./0000-0002-2946-8251; Hunziker, Lukas/0000-0003-0081-8518; Jeker, Lukas/0000-0002-3359-8796; Recher, Mike/0000-0002-9121-6936; Theocharides, Alexandre/0000-0002-1535-8692				AHMED R, 1987, J VIROL, V61, P3920, DOI 10.1128/JVI.61.12.3920-3929.1987; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Andreansky S, 2004, P NATL ACAD SCI USA, V101, P2017, DOI 10.1073/pnas.0307320101; Arrieta JJ, 2001, AM J PATHOL, V158, P259, DOI 10.1016/S0002-9440(10)63964-8; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Becker JL, 1999, J CLIN INVEST, V104, P1673, DOI 10.1172/JCI7286; Bronke C, 2005, IMMUNOL LETT, V97, P215, DOI 10.1016/j.imlet.2004.11.004; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Hilleman MR, 2004, P NATL ACAD SCI USA, V101, P14560, DOI 10.1073/pnas.0404758101; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lauterbach H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-53; Legrand E, 1997, AIDS RES HUM RETROV, V13, P1383, DOI 10.1089/aid.1997.13.1383; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lo AWI, 2006, J PATHOL, V208, P142, DOI 10.1002/path.1897; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Ramos-Casals M, 2004, J RHEUMATOL, V31, P495; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wolf DG, 2003, BLOOD, V101, P463, DOI 10.1182/blood-2002-07-1982; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	43	47	47	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1316	1323		10.1038/nm1670	http://dx.doi.org/10.1038/nm1670			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17982463	Bronze, Green Published			2022-12-25	WOS:000250736900024
J	Xu, N; Donohoe, ME; Silva, SS; Lee, JT				Xu, Na; Donohoe, Mary E.; Silva, Susana S.; Lee, Jeannie T.			Evidence that homologous X-chromosome pairing requires transcription and Ctcf protein	NATURE GENETICS			English	Article							XIST GENE; CHROMATIN CONFORMATION; INACTIVATION CHOICE; TSIX TRANSCRIPTION; METHYLATION; RNA; COLOCALIZATION; IDENTIFICATION; NUCLEUS; BINDING	X-chromosome inactivation (XCI) ensures the equality of X-chromosome dosages in male and female mammals by silencing one X in the female(1). To achieve the mutually exclusive designation of active X (Xa) and inactive X ( Xi), the process necessitates that two Xs communicate in trans through homologous pairing(2,3). Pairing depends on a 15-kb region within the genes Tsix and Xite(2). Here, we dissect molecular requirements and find that pairing can be recapitulated by 1- to 2-kb subfragments of Tsix or Xite with little sequence similarity. However, a common denominator among them is the presence of the protein Ctcf, a chromatin insulator(4-7) that we find to be essential for pairing. By contrast, the Ctcf-interacting partner, Yy1 (ref. 8), is not required. Pairing also depends on transcription. Transcriptional inhibition prevents new pair formation but does not perturb existing pairs. The kinetics suggest a pairing half-life of < 1 h. We propose that pairing requires Ctcf binding and co-transcriptional activity of Tsix and Xite.	Harvard Univ, Sch Med,Dept Genet, Massachusetts Gen Hosp, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA; Programme Biomed, P-2780156 Oeiras, Portugal	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Sch Med,Dept Genet, Massachusetts Gen Hosp, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	30	160	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1390	1396		10.1038/ng.2007.5	http://dx.doi.org/10.1038/ng.2007.5			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17952071				2022-12-25	WOS:000250575900024
J	Varela, I; Pereira, S; Ugalde, AP; Navarro, CL; Suarez, MF; Cau, P; Cadinanos, J; Osorio, FG; Foray, N; Cobo, J; de Carlos, F; Levy, N; Freije, JMP; Lopez-Otin, C				Varela, Ignacio; Pereira, Sandrine; Ugalde, Alejandro P.; Navarro, Claire L.; Suarez, Maria F.; Cau, Pierre; Cadinanos, Juan; Osorio, Fernando G.; Foray, Nicolas; Cobo, Juan; de Carlos, Felix; Levy, Nicolas; Freije, Jose M. P.; Lopez-Otin, Carlos			Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging	NATURE MEDICINE			English	Article							GILFORD-PROGERIA-SYNDROME; PRELAMIN-A; INHIBITING FARNESYLATION; TRANSFERASE INHIBITORS; PROTEIN-PRENYLATION; LAMIN-A; MICE; DISEASE; DEFICIENT; DEFECTS	Several human progerias, including Hutchinson-Gilford progeria syndrome (HGPS), are caused by the accumulation at the nuclear envelope of farnesylated forms of truncated prelamin A, a protein that is also altered during normal aging(1,2). Previous studies in cells from individuals with HGPS have shown that farnesyltransferase inhibitors (FTIs) improve nuclear abnormalities associated with prelamin A accumulation, suggesting that these compounds could represent a therapeutic approach for this devastating progeroid syndrome(3). We show herein that both prelamin A and its truncated form progerin/LA Delta 50 undergo alternative prenylation by geranylgeranyltransferase in the setting of farnesyltransferase inhibition, which could explain the low efficiency of FTIs in ameliorating the phenotypes of progeroid mouse models. We also show that a combination of statins and aminobisphosphonates efficiently inhibits both farnesylation and geranylgeranylation of progerin and prelamin A and markedly improves the aging-like phenotypes of mice deficient in the metalloproteinase Zmpste24, including growth retardation, loss of weight, lipodystrophy, hair loss and bone defects. Likewise, the longevity of these mice is substantially extended. These findings open a new therapeutic approach for human progeroid syndromes associated with nuclear-envelope abnormalities.	[Varela, Ignacio; Ugalde, Alejandro P.; Suarez, Maria F.; Cadinanos, Juan; Osorio, Fernando G.; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Pereira, Sandrine; Navarro, Claire L.; Cau, Pierre; Levy, Nicolas] Univ Aix Marseille 2, Fac Med, INSERM, UMR S Genet Med & Geom Fonctionnelle 910, F-13385 Marseille 05, France; [Foray, Nicolas] INSERM, ID17, European Synchrotron Res Facil, U647, F-38043 Grenoble, France; [Cobo, Juan; de Carlos, Felix] Univ Oviedo, Inst Asturiano Odontol, E-33006 Oviedo, Spain; [Cobo, Juan; de Carlos, Felix] Univ Oviedo, Dept Cirugia & Especialidades Med Quirurg, E-33006 Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oviedo; University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Calle Fernando Bongera S-N, E-33006 Oviedo, Spain.	clo@uniovi.es	LEVY, Nicolas/J-1632-2014; Navarro, Claire/V-8774-2017; Foray, Nicolas/Q-2363-2019; Cau, Pierre/M-3541-2016; Varela, Ignacio/G-1699-2016; Freije, José M.P./A-6535-2008; Pineiro-Ugalde, Alejandro/AAB-5229-2020; Varela, Ignacio/AAA-7680-2021; López-Otín, Carlos/AAB-2106-2020; Suárez, María Fernanda Valencia/F-8200-2019; Foray, Nicolas/I-4755-2018	LEVY, Nicolas/0000-0001-5171-6365; Navarro, Claire/0000-0001-9490-2643; Foray, Nicolas/0000-0002-1282-1303; Varela, Ignacio/0000-0002-0969-506X; Freije, José M.P./0000-0002-4688-8266; Pineiro-Ugalde, Alejandro/0000-0003-2522-0627; Varela, Ignacio/0000-0002-0969-506X; López-Otín, Carlos/0000-0001-6964-1904; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Foray, Nicolas/0000-0002-1282-1303; Cadinanos, Juan/0000-0001-7561-7759				BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Cadinanos J, 2005, CELL CYCLE, V4, P1732, DOI 10.4161/cc.4.12.2202; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Issat T, 2007, INT J ONCOL, V30, P1413; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Konstantinopoulos PA, 2007, TRENDS PHARMACOL SCI, V28, P6, DOI 10.1016/j.tips.2006.11.005; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schmidmaier R, 2006, ANTI-CANCER DRUG, V17, P621, DOI 10.1097/01.cad.0000215058.85813.02; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yamagata T, 2007, RHEUMATOL INT, V27, P631, DOI 10.1007/s00296-006-0270-9; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200	30	290	309	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2008	14	7					767	772		10.1038/nm1786	http://dx.doi.org/10.1038/nm1786			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18587406				2022-12-25	WOS:000257452700025
J	Chang, DC; Liu, WJ; Anraku, I; Clark, DC; Pollitt, CC; Suhrbier, A; Hall, RA; Khromykh, AA				Chang, David C.; Liu, Wen J.; Anraku, Itaru; Clark, David C.; Pollitt, Christopher C.; Suhrbier, Andreas; Hall, Roy A.; Khromykh, Alexander A.			Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus	NATURE BIOTECHNOLOGY			English	Article							NONSTRUCTURAL PROTEIN NS1; T-LYMPHOCYTE RESPONSES; ENCEPHALITIS-VIRUS; KUNJIN VIRUS; PROTECTIVE IMMUNITY; FLAVIVIRUS VACCINES; RNA REPLICATION; IMMUNIZATION; MICE; RECOMBINATION	DNA vaccines encoding replication-defective viruses are safer than inactivated or live attenuated viruses but may fail to stimulate an immune response sufficient for effective vaccination. We augment the protective capacity of a capsid-deleted flavivirus DNA vaccine by co-expressing the capsid protein from a separate promoter. In transfected cells, the capsid-deleted RNA transcript is replicated and translated to produce secreted virus-like particles lacking the nucleocapsid. This RNA is also packaged with the help of co-expressed capsid protein to form secreted single-round infectious particles (SRIPs) that deliver the RNA into neighboring cells. In SRIP-infected cells, the RNA is replicated again and produces additional virus-like particles, but in the absence of capsid RNA no SRIPs are formed and no further spread occurs. Compared with an otherwise identical construct that does not encode capsid, our vaccine offers better protection to mice after lethal West Nile virus infection. It also elicits virus-neutralizing antibodies in horses. This approach may enable vaccination against pathogenic flaviviruses other than West Nile virus.	[Chang, David C.; Liu, Wen J.; Clark, David C.; Hall, Roy A.; Khromykh, Alexander A.] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia; [Anraku, Itaru; Suhrbier, Andreas] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pollitt, Christopher C.] Univ Queensland, Sch Vet Sci, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Khromykh, AA (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia.	a.khromykh@uq.edu.au	Khromykh, Alexander/X-7200-2018	Khromykh, Alexander/0000-0001-6206-6935; Suhrbier, Andreas/0000-0001-8986-9025				Aberle JH, 1999, J IMMUNOL, V163, P6756; Anraku I, 2002, J VIROL, V76, P3791, DOI 10.1128/JVI.76.8.3791-3799.2002; Castillo-Olivares J, 2004, VET RES, V35, P467, DOI 10.1051/vetres:2004022; Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Hall RA, 1999, VIROLOGY, V264, P66, DOI 10.1006/viro.1999.9956; Hall RA, 2004, EXPERT OPIN BIOL TH, V4, P1295, DOI 10.1517/14712598.4.8.1295; Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100; Hall RA, 2002, CURR TOP MICROBIOL, V267, P253; Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000; Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6; Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101; Konishi E, 1998, J VIROL, V72, P4925, DOI 10.1128/JVI.72.6.4925-4930.1998; Le TTT, 2001, VACCINE, V19, P4669, DOI 10.1016/S0264-410X(01)00243-2; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003; Monath TP, 2005, VACCINE, V23, P2956, DOI 10.1016/j.vaccine.2004.11.069; Ng T., 2003, VVolume 114, P221; PERTMER TM, 1995, VACCINE, V13, P1427, DOI 10.1016/0264-410X(95)00069-D; Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332; Pugachev KV, 2003, INT J PARASITOL, V33, P567, DOI 10.1016/S0020-7519(03)00063-8; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; SCHLESINGER JJ, 1990, J GEN VIROL, V71, P593, DOI 10.1099/0022-1317-71-3-593; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0	30	55	57	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2008	26	5					571	577		10.1038/nbt1400	http://dx.doi.org/10.1038/nbt1400			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	299LJ	18425125				2022-12-25	WOS:000255756800030
J	Gregory, PA; Bert, AG; Paterson, EL; Barry, SC; Tsykin, A; Farshid, G; Vadas, MA; Khew-Goodall, Y; Goodall, GJ				Gregory, Philip A.; Bert, Andrew G.; Paterson, Emily L.; Barry, Simon C.; Tsykin, Anna; Farshid, Gelareh; Vadas, Mathew A.; Khew-Goodall, Yeesim; Goodall, Gregory J.			The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1	NATURE CELL BIOLOGY			English	Article							CANCER CELL-LINES; BREAST-CANCER; E-CADHERIN; MICRORNA EXPRESSION; TRANSCRIPTIONAL REPRESSOR; GENES; METASTASIS; MORPHOGENESIS; PROGRESSION; DELTA-EF1	Epithelial to mesenchymal transition (EMT) facilitates tissue remodelling during embryonic development and is viewed as an essential early step in tumour metastasis. We found that all five members of the microRNA-200 family (miR- 200a, miR- 200b, miR- 200c, miR- 141 and miR- 429) and miR- 205 were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-beta or to ectopic expression of the protein tyrosine phosphatase Pez. Enforced expression of the miR- 200 family alone was sufficient to prevent TGF-beta-induced EMT. Together, these microRNAs cooperatively regulate expression of the E-cadherin transcriptional repressors ZEB1 ( also known as delta EF1) and SIP1 ( also known as ZEB2), factors previously implicated in EMT and tumour metastasis. Inhibition of the microRNAs was sufficient to induce EMT in a process requiring upregulation of ZEB1 and/or SIP1. Conversely, ectopic expression of these microRNAs in mesenchymal cells initiated mesenchymal to epithelial transition ( MET). Consistent with their role in regulating EMT, expression of these microRNAs was found to be lost in invasive breast cancer cell lines with mesenchymal phenotype. Expression of the miR- 200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. These data suggest that downregulation of the microRNAs may be an important step in tumour progression.	[Gregory, Philip A.; Bert, Andrew G.; Paterson, Emily L.; Tsykin, Anna; Vadas, Mathew A.; Khew-Goodall, Yeesim; Goodall, Gregory J.] Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA 5000, Australia; [Barry, Simon C.] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Barry, Simon C.] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Farshid, Gelareh] Inst Med & Vet Sci, Div Tissue Pathol, Adelaide, SA 5000, Australia; [Khew-Goodall, Yeesim] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Gregory, Philip A.; Vadas, Mathew A.; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; Womens & Childrens Hospital Australia; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA 5000, Australia.	greg.goodall@imvs.sa.gov.au	Gregory, Philip/F-4089-2013; Vadas, Mathew/R-1378-2019	Gregory, Philip/0000-0002-0999-0632; Barry, Simon/0000-0002-0597-7609; Goodall, Gregory/0000-0003-1294-0692; Bert, Andrew/0000-0003-3876-1537; Tsykin, Anna/0000-0001-5965-6803				Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; PARK SM, 2008, GENES DEV; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	35	2968	3132	2	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					593	601		10.1038/ncb1722	http://dx.doi.org/10.1038/ncb1722			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18376396				2022-12-25	WOS:000255502400016
J	Acar, M; Mettetal, JT; van Oudenaarden, A				Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander			Stochastic switching as a survival strategy in fluctuating environments	NATURE GENETICS			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; TOGGLE SWITCH; NOISE; HETEROGENEITY; CONSEQUENCES; PHENOTYPES; DIVERSITY; BACTERIA; NETWORKS	A classic problem in population and evolutionary biology is to understand how a population optimizes its fitness in fluctuating environments(1-4). A population might enhance its fitness by allowing individual cells to stochastically transition among multiple phenotypes, thus ensuring that some cells are always prepared for an unforeseen environmental fluctuation. Here we experimentally explore how switching affects population growth by using the galactose utilization network of Saccharomyces cerevisiae. We engineered a strain that randomly transitions between two phenotypes as a result of stochastic gene expression(5-9). Each phenotype was designed to confer a growth advantage over the other phenotype in a certain environment. When we compared the growth of two populations with different switching rates, we found that fast-switching populations outgrow slow switchers when the environment fluctuates rapidly, whereas slow-switching phenotypes outgrow fast switchers when the environment changes rarely. These results suggest that cells may tune inter-phenotype switching rates to the frequency of environmental changes.	[Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Acar, Murat/AIB-8244-2022; van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM077183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRYSON V, 1952, SCIENCE, V115, P45; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; LEVINS RICHARD, 1968; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	30	629	637	3	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					471	475		10.1038/ng.110	http://dx.doi.org/10.1038/ng.110			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362885				2022-12-25	WOS:000254388100020
J	Vermulst, M; Wanagat, J; Kujoth, GC; Bielas, JH; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Wanagat, Jonathan; Kujoth, Gregory C.; Bielas, Jason H.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; LIFE-SPAN; DIRECT REPEATS; RECOMBINATION	Mitochondrial DNA (mtDNA) mutations are thought to have a causal role in many age-related pathologies. Here we identify mtDNA deletions as a driving force behind the premature aging phenotype of mitochondrial mutator mice, and provide evidence for a homology-directed DNA repair mechanism in mitochondria that is directly linked to the formation of mtDNA deletions. In addition, our results demonstrate that the rate at which mtDNA mutations reach phenotypic expression differs markedly among tissues, which may be an important factor in determining the tolerance of a tissue to random mitochondrial mutagenesis.	[Vermulst, Marc; Bielas, Jason H.; Rabinovitch, Peter S.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Wanagat, Jonathan] Univ Washington, Dept Gerontol & Geriat Med, Seattle, WA 98195 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu	Wanagat, Jonathan/B-2856-2009	Wanagat, Jonathan/0000-0002-8460-8616; Kujoth, Gregory/0000-0002-6636-2800	NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P01AG001751] Funding Source: NIH RePORTER; NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG01751, AG021905] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988	15	292	298	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					392	394		10.1038/ng.95	http://dx.doi.org/10.1038/ng.95			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311139				2022-12-25	WOS:000254388100008
J	Yajima, A; Qin, Y; Zhou, X; Kawanishi, N; Xiao, X; Wang, J; Zhang, D; Wu, Y; Nukada, T; Yabuta, G; Qi, JH; Asano, T; Sakagami, Y				Yajima, Arata; Qin, Yong; Zhou, Xuan; Kawanishi, Naoki; Xiao, Xue; Wang, Jue; Zhang, Dan; Wu, Yi; Nukada, Tomoo; Yabuta, Goro; Qi, Jianhua; Asano, Tomoyo; Sakagami, Youji			Synthesis and absolute configuration of hormone alpha 1	NATURE CHEMICAL BIOLOGY			English	Article							COPULATION RELEASE PHEROMONE; MATING HORMONE; CALLOSOBRUCHUS-MACULATUS; COWPEA WEEVIL; PHYTOPHTHORA; STEREOISOMERS; ALPHA-1; ACID	An important biological event in phytopathogens of the genus Phytophthora is sexual reproduction, which is conducted by two mating types, A1 and A2. A factor known as hormone alpha 1 is secreted by the A1 mating type and induces the formation of sexual spores (oospores) in the A2 mating type. Here we describe the asymmetric synthesis and assignment of the absolute configuration of hormone alpha 1 by oospore-inducing assays of the synthesized isomers.	[Yajima, Arata; Kawanishi, Naoki; Nukada, Tomoo; Yabuta, Goro] Tokyo Univ Agr, Setagaya Ku, Fac Appl Biol Sci, Dept Fermentat Sci, Tokyo 1568502, Japan; [Qin, Yong; Zhou, Xuan; Xiao, Xue; Wang, Jue; Zhang, Dan; Wu, Yi] Sichuan Univ, W China Sch Pharm, Dept Chem Med Nat Prod, Chengdu 610041, Peoples R China; [Qin, Yong; Zhou, Xuan; Xiao, Xue; Wang, Jue; Zhang, Dan; Wu, Yi] Sichuan Univ, W China Sch Pharm, Key Lab Drug Targeting, Chengdu 610041, Peoples R China; [Qin, Yong; Zhou, Xuan; Xiao, Xue; Wang, Jue; Zhang, Dan; Wu, Yi] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Qi, Jianhua; Asano, Tomoyo; Sakagami, Youji] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Qi, Jianhua] Fudan Univ, Sch Pharm, Shanghai 200032, Peoples R China	Tokyo University of Agriculture; Sichuan University; Sichuan University; Sichuan University; Nagoya University; Fudan University	Yajima, A (corresponding author), Tokyo Univ Agr, Setagaya Ku, Fac Appl Biol Sci, Dept Fermentat Sci, Sakuragaoka 1-1-1, Tokyo 1568502, Japan.	ayaji@nodai.ac.jp; yongqin@scu.edu.cn; jhqi@fudan.edu.cn	Yajima, Arata/G-7677-2011; XIAO, XUE/J-4381-2014; zhou, xuan/GZA-8157-2022	Yajima, Arata/0000-0003-1167-6041				ASHBY S. F., 1929, Trains. Brit. Mycol. Soc., V14, P18; Bajpai R, 2007, TETRAHEDRON LETT, V48, P7965, DOI 10.1016/j.tetlet.2007.09.054; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Nakai T, 2005, BIOSCI BIOTECH BIOCH, V69, P2401, DOI 10.1271/bbb.69.2401; Ojika M, 2007, TETRAHEDRON-ASYMMETR, V18, P1763, DOI 10.1016/j.tetasy.2007.07.024; Qi JH, 2005, SCIENCE, V309, P1828, DOI 10.1126/science.1114756; SVAGE EJ, 1968, PHYTOPATHOLOGY, V58, P1004; Yajima A, 2006, TETRAHEDRON, V62, P4590, DOI 10.1016/j.tet.2006.02.059; Yajima A, 2007, TETRAHEDRON LETT, V48, P4601, DOI 10.1016/j.tetlet.2007.04.109; Yajima A, 2007, J CHEM ECOL, V33, P1328, DOI 10.1007/s10886-007-9311-4	11	28	30	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					235	237		10.1038/nchembio.74	http://dx.doi.org/10.1038/nchembio.74			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18297064				2022-12-25	WOS:000254268300009
J	Loenarz, C; Schofield, CJ				Loenarz, Christoph; Schofield, Christopher J.			Expanding chemical biology of 2-oxoglutarate oxygenases	NATURE CHEMICAL BIOLOGY			English	Editorial Material							HYPOXIA-INDUCIBLE FACTOR; BETA-HYDROXYLATION; STRUCTURAL BASIS; FTO GENE; DEMETHYLASE; PROTEINS; SUBSTRATE; ENZYMES; OBESITY; REPAIR	Beyond established roles in collagen biosynthesis, hypoxic signaling and fatty acid metabolism, recent reports have now revealed roles for human 2-oxoglutarate-dependent oxygenases in histone and nucleic acid demethylation and in signaling protein hydroxylation. The emerging role of these oxygenases in enabling a multiplicity of histone modifications has some analogy with their role in enabling structural diversity in secondary metabolism.	[Loenarz, Christoph; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England	University of Oxford	Loenarz, C (corresponding author), Univ Oxford, Chem Res Lab, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk		Loenarz, Christoph/0000-0002-8843-2531; Schofield, Christopher/0000-0002-0290-6565	BBSRC [BB/D011523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen HW, 2001, BIOCHEMISTRY-US, V40, P11651, DOI 10.1021/bi0115434; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, ESSAYS BIOCHEM, V43, P1; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Flashman E, 2007, NAT CHEM BIOL, V3, P86, DOI 10.1038/nchembio0207-86; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; HUTTON JJ, 1967, BIOCH BIOPHYS, V121, P384; Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schofield CJ, 2007, BIOCHEM SOC T, V35, P870, DOI 10.1042/BST0350870; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417	30	386	392	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					152	156		10.1038/nchembio0308-152	http://dx.doi.org/10.1038/nchembio0308-152			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18277970				2022-12-25	WOS:000253417400004
J	Niranjan, T; Bielesz, B; Gruenwald, A; Ponda, MP; Kopp, JB; Thomas, DB; Susztak, K				Niranjan, Thiruvur; Bielesz, Bernhard; Gruenwald, Antje; Ponda, Manish P.; Kopp, Jeffrey B.; Thomas, David B.; Susztak, Katalin			The Notch pathway in podocytes plays a role in the development of glomerular disease	NATURE MEDICINE			English	Article							DIABETIC-NEPHROPATHY; TGF-BETA; GROWTH ARREST; TRANSGENIC MICE; RENAL-DISEASE; RBP-J; EXPRESSION; APOPTOSIS; INHIBITION; PROTEIN	Albuminuria associated with sclerosis of the glomerulus leads to a progressive decline in renal function affecting millions of people. Here we report that activation of the Notch pathway, which is critical in glomerular patterning, contributes to the development of glomerular disease. Expression of the intracellular domain of Notch1 (ICN1) was increased in glomerular epithelial cells in diabetic nephropathy and in focal segmental glomerulosclerosis. Conditional re-expression of ICN1 in vivo exclusively in podocytes caused proteinuria and glomerulosclerosis. In vitro and in vivo studies showed that ICN1 induced apoptosis of podocytes through the activation of p53. Genetic deletion of a Notch transcriptional partner (Rbpj) specifically in podocytes or pharmacological inhibition of the Notch pathway (with a gamma-secretase inhibitor) protected rats with proteinuric kidney diseases. Collectively, our observations suggest that Notch activation in mature podocytes is a new mechanism in the pathogenesis of glomerular disease and thus could represent a new therapeutic target.	[Niranjan, Thiruvur; Bielesz, Bernhard; Gruenwald, Antje; Ponda, Manish P.; Susztak, Katalin] Albert Einstein Coll Med, Dept Med, Div Nephrol, Bronx, NY 10461 USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Thomas, David B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yeshiva University; Albert Einstein College of Medicine	Susztak, K (corresponding author), Albert Einstein Coll Med, Dept Med, Div Nephrol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ksusztak@aecom.yu.edu	Kopp, Jeffrey B/O-2681-2015; Susztak, Katalin/ABE-7474-2021; Bielesz, Bernhard/AAQ-2683-2021	Kopp, Jeffrey B/0000-0001-9052-186X; Susztak, Katalin/0000-0002-1005-3726; Bielesz, Bernhard/0000-0002-4491-0562	NIDDK NIH HHS [R01 DK076077, R01 DK076077-01A1, R01 DK076077-02, 1R01DK076077] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076077, ZIADK043308] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2003, Am J Kidney Dis, V42, P1; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Chen LH, 2005, AM J PHYSIOL-RENAL, V288, pF939, DOI 10.1152/ajprenal.00369.2004; Cheng HT, 2005, KIDNEY INT, V68, P1951, DOI 10.1111/j.1523-1755.2005.00627.x; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Hostetter TH, 2001, NEW ENGL J MED, V345, P910, DOI 10.1056/NEJM200109203451209; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kato H, 1997, DEVELOPMENT, V124, P4133; Kim SB, 2007, CELL DEATH DIFFER, V14, P982, DOI 10.1038/sj.cdd.4402083; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 2001, Adv Nephrol Necker Hosp, V31, P235; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; OKA C, 1995, DEVELOPMENT, V121, P3291; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Susztak K, 2003, J AM SOC NEPHROL, V14, pS271, DOI 10.1097/01.ASN.0000078035.81397.8A; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; Walsh DW, 2008, BBA-MOL BASIS DIS, V1782, P10, DOI 10.1016/j.bbadis.2007.09.005; Wang P, 2003, DEVELOPMENT, V130, P5019, DOI 10.1242/dev.00682; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	46	302	347	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2008	14	3					290	298		10.1038/nm1731	http://dx.doi.org/10.1038/nm1731			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18311147				2022-12-25	WOS:000253815700035
J	Rocca, DL; Martin, S; Jenkins, EL; Hanley, JG				Rocca, Daniel L.; Martin, Stephane; Jenkins, Emma L.; Hanley, Jonathan G.			Inhibition of Arp2/3-mediated actin polymerization by PICK1 regulates neuronal morphology and AMPA receptor endocytosis	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; LONG-TERM DEPRESSION; DENDRITIC SPINES; ARP2/3 COMPLEX; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; PROTEIN PICK1; IMAGING ACTIN; N-WASP	The dynamic regulation of actin polymerization plays crucial roles in cell morphology and endocytosis. The mechanistic details of these processes and the proteins involved are not fully understood, especially in neurons. PICK1 is a PDZ-BAR-domain protein involved in regulated AMPA receptor (AMPAR) endocytosis in neurons. Here, we demonstrate that PICK1 binds filamentous (F)-actin and the actin-nucleating Arp2/3 complex, and potently inhibits Arp2/3-mediated actin polymerization. RNA interference (RNAi) knockdown of PICK1 in neurons induces a reorganization of the actin cytoskeleton resulting in aberrant cell morphology. Wild-type PICK1 rescues this phenotype, but a mutant PICK1, PICK1(W413A), that does not bind or inhibit Arp2/3 has no effect. Furthermore, this mutant also blocks NMDA-induced AMPAR internalization. This study identifies PICK1 as a negative regulator of Arp2/3-mediated actin polymerization that is critical for a specific form of vesicle trafficking, and also for the development of neuronal architecture.	[Rocca, Daniel L.; Martin, Stephane; Jenkins, Emma L.; Hanley, Jonathan G.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Univ Walk, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk	Martin, Stéphane/G-5954-2012	Martin, Stéphane/0000-0001-6771-7645; Hanley, Jonathan/0000-0003-1704-4707	Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [G0601841B] Funding Source: researchfish; Medical Research Council [G0501455, G0501455(76848)] Funding Source: Medline; Wellcome Trust [072005] Funding Source: Medline; MRC [G0501455] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	41	161	168	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					259	U7		10.1038/ncb1688	http://dx.doi.org/10.1038/ncb1688			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297063	Green Accepted			2022-12-25	WOS:000253778300008
J	Stromnes, IM; Cerretti, LM; Liggitt, D; Harris, RA; Goverman, JM				Stromnes, Ingunn M.; Cerretti, Lauren M.; Liggitt, Denny; Harris, Robert A.; Goverman, Joan M.			Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells	NATURE MEDICINE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CD4 T-CELLS; MULTIPLE-SCLEROSIS; IFN-GAMMA; INTERFERON-GAMMA; MOUSE STRAINS; FAS LIGAND; INDUCTION; EXPRESSION	Multiple sclerosis is an inflammatory, demyelinating disease of the central nervous system (CNS) characterized by a wide range of clinical signs(1). The location of lesions in the CNS is variable and is a crucial determinant of clinical outcome. Multiple sclerosis is believed to be mediated by myelin-specific T cells, but the mechanisms that determine where T cells initiate inflammation are unknown. Differences in lesion distribution have been linked to the HLA complex, suggesting that T cell specificity influences sites of inflammation(2). We demonstrate that T cells that are specific for different myelin epitopes generate populations characterized by different T helper type 17 (T(H)17) to T helper type 1 (T(H)1) ratios depending on the functional avidity of interactions between TCR and peptide-MHC complexes. Notably, the T(H)17: T(H)1 ratio of infiltrating T cells determines where inflammation occurs in the CNS. Myelin-specific T cells infiltrate the meninges throughout the CNS, regardless of the T(H)17: T(H)1 ratio. However, T cell infiltration and inflammation in the brain parenchyma occurs only when T(H)17 cells outnumber T(H)1 cells and trigger a disproportionate increase in interleukin-17 expression in the brain. In contrast, T cells showing a wide range of T(H)17: T(H)1 ratios induce spinal cord parenchymal inflammation. These findings reveal critical differences in the regulation of inflammation in the brain and spinal cord.	[Stromnes, Ingunn M.; Cerretti, Lauren M.; Goverman, Joan M.] Dept Immunol, Seattle, WA 98195 USA; [Liggitt, Denny] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Harris, Robert A.] Karolinska Inst, Dept Clin Neurosci, Appl Immunol Grp, S-17176 Stockholm, Sweden	University of Washington; University of Washington Seattle; Karolinska Institutet	Goverman, JM (corresponding author), Dept Immunol, Box 357650,HSC H474B,1959 NE Pacific St, Seattle, WA 98195 USA.	goverman@u.washington.edu	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Goverman, Joan/0000-0002-7361-9424	NCI NIH HHS [T32-CA009537, T32 CA009537] Funding Source: Medline; NIAID NIH HHS [R01 AI072737-11, AI072737, R01 AI072737] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Abromson-Leeman S, 2004, AM J PATHOL, V165, P1519, DOI 10.1016/S0002-9440(10)63410-4; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Badie B, 2000, EXP NEUROL, V162, P290, DOI 10.1006/exnr.1999.7345; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Brabb T, 2000, J EXP MED, V192, P871, DOI 10.1084/jem.192.6.871; Cheng XD, 2007, J NEUROIMMUNOL, V185, P75, DOI 10.1016/j.jneuroim.2007.01.012; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fukazawa T, 2000, TISSUE ANTIGENS, V55, P199, DOI 10.1034/j.1399-0039.2000.550302.x; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kjellen P, 2001, J NEUROIMMUNOL, V120, P25, DOI 10.1016/S0165-5728(01)00407-6; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Muller DM, 2000, ACTA NEUROPATHOL, V100, P174, DOI 10.1007/s004019900163; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Raine C.S., 1997, MULTIPLE SCLEROSIS C, P243; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Tsunoda I, 2000, BRAIN PATHOL, V10, P402; van der Veen RC, 2001, INT IMMUNOPHARMACOL, V1, P1491, DOI 10.1016/S1567-5769(01)00093-5; Weissert R, 2001, J IMMUNOL, V166, P7588, DOI 10.4049/jimmunol.166.12.7588; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	30	458	466	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					337	342		10.1038/nm1715	http://dx.doi.org/10.1038/nm1715			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18278054	Green Accepted			2022-12-25	WOS:000253815700041
J	Choi, JK; Kim, YJ				Choi, Jung Kyoon; Kim, Young-Joon			Epigenetic regulation and the variability of gene expression	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; EUKARYOTIC GENOME; YEAST; IDENTIFICATION; REPRESSION; MACHINERY; LANDSCAPE; COMPLEXES	We characterized the genetic variability of gene expression in terms of trans and cis variability for each yeast transcript. Genes that are highly regulated by nucleosomes showed a high degree of trans variability. From the expression profiles of mutants for various chromatin modifiers, we found that transvariable genes are distinctly regulated at the chromatin level. The effect of chromatin regulators was highly significant, even when compared with that of transcription factors. The DNA-binding activities of transcription factors had a low influence on trans variability. In the case of the basal transcription factor TBP and TBP- associated factor TAF1, expression variability was coupled with the histone acetyltransferase activities of TAF1 and other factors, rather than with the binding of TBP to DNA. Additionally, we found that the correlation of TATA-box presence and expression variability could be explained in terms of chromatin regulation. The lack of activating histone modifications may subject TATA- containing promoters to chromatin regulation processes. Our results propose that epigenetic regulation has a central role in the variation and evolution of gene expression.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Genome Regulat Ctr, Seoul 120749, South Korea; [Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Yonsei University; Yonsei University	Kim, YJ (corresponding author), Yonsei Univ, Genome Regulat Ctr, 134 Sinchon Dong, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011					Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Durant M, 2006, MOL CELL BIOL, V26, P2791, DOI 10.1128/MCB.26.7.2791-2802.2006; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	31	83	84	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					141	147		10.1038/ng.2007.58	http://dx.doi.org/10.1038/ng.2007.58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18227874				2022-12-25	WOS:000252732900009
J	Harley, JB; Alarcon-Riquelme, ME; Criswell, LA; Jacob, CO; Kimberly, RP; Moser, KL; Tsao, BP; Vyse, TJ; Langefeld, CD				Harley, John B.; Alarcon-Riquelme, Marta E.; Criswell, Lindsey A.; Jacob, Chaim O.; Kimberly, Robert P.; Moser, Kathy L.; Tsao, Betty P.; Vyse, Timothy J.; Langefeld, Carl D.		Int Consortium Systemic Lupus Ery	Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; HUMAN SLE; DISEASE; LINKAGE; POLYMORPHISM; RISK; METAANALYSIS; EXPRESSION	Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease with complex etiology but strong clustering in families (lambda(S) = similar to 30). We performed a genomewide association scan using 317,501 SNPs in 720 women of European ancestry with SLE and in 2,337 controls, and we genotyped consistently associated SNPs in two additional independent sample sets totaling 1,846 affected women and 1,825 controls. Aside from the expected strong association between SLE and the HLA region on chromosome 6p21 and the previously confirmed non-HLA locus IRF5 on chromosome 7q32, we found evidence of association with replication (1.1 x 10(-7) < P-overall < 1.6 x 10(-23); odds ratio 0.82-1.62) in four regions: 16p11.2 (ITGAM), 11p15.5 (KIAA1542), 3p14.3 (PXK) and 1q25.1 (rs10798269). We also found evidence for association (P < 1 x 10(-5)) at FCGR2A, PTPN22 and STAT4, regions previously associated with SLE and other autoimmune diseases, as well as at >= 9 other loci (P < 2 x 10(-7)). Our results show that numerous genes, some with known immune-related functions, predispose to SLE.	[Harley, John B.; Moser, Kathy L.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta E.] Uppsala Univ, SE-75105 Uppsala, Sweden; [Criswell, Lindsey A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jacob, Chaim O.] Univ So Calif, Los Angeles, CA 90033 USA; [Kimberly, Robert P.] Univ Alabama, Birmingham, AL 35294 USA; [Moser, Kathy L.] Univ Minnesota, Minneapolis, MN 55455 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England; [Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Winston Salem, NC 27157 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Uppsala University; University of California System; University of California San Francisco; University of Southern California; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; Imperial College London; Wake Forest University; Wake Forest University School of Medicine	Harley, JB (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.		Alarcón-Riquelme, Marta E./ABF-8163-2020; Fernando, Michelle/F-5554-2012; Gillespie, Emily/N-1265-2013; Frank, Summer G/E-6861-2016; Rioux, John D/A-9599-2015	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Gillespie, Emily/0000-0001-5261-3931; Frank, Summer G/0000-0003-0779-4926; Rioux, John D/0000-0001-7560-8326; Gaffney, Patrick/0000-0002-1580-869X; Kelly, Jennifer/0000-0002-3203-2467; Tsao, Betty/0000-0001-7938-5975; Guthridge, Joel/0000-0002-9308-237X; Kimberly, Robert/0000-0002-5330-3086	NCRR NIH HHS [P20 RR020143, RR020143, U54 RR020278, RR020278] Funding Source: Medline; NIAID NIH HHS [AI24717, R01 AI024717, R37 AI024717] Funding Source: Medline; NIAMS NIH HHS [AR33062, AR22804, P30 AR053483, AR43814, AR43815, AR02175, K24 AR002175, R01 AR033062, AR43247, R01 AR052300, P01 AR049084, AR052300, AR49084, N01AR62277, P60 AR053308, AR24260, R01 AR043814-10A2, R01 AR043814] Funding Source: Medline; Wellcome Trust [051276] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033062, R01AR043815, R01AR052300, K24AR002175, N01AR62277, R01AR043814, R55AR043814, P01AR049084, P60AR053308, P30AR053483] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; NARAYANASWAMY CR, 1991, APPL STAT-J ROY ST C, V40, P309; NATH SK, 2008, NAT GENET       0120; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RISCH N, 1990, AM J HUM GENET, V46, P229; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Zou XQ, 2005, INT J MOL MED, V16, P701	29	1003	1031	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					204	210		10.1038/ng.81	http://dx.doi.org/10.1038/ng.81			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204446	Green Accepted			2022-12-25	WOS:000252732900019
J	Buckanovich, RJ; Facciabene, A; Kim, S; Benencia, F; Sasaroli, D; Balint, K; Katsaros, D; O'Brien-Jenkins, A; Gimotty, PA; Coukos, G				Buckanovich, Ronald J.; Facciabene, Andrea; Kim, Sarah; Benencia, Fabian; Sasaroli, Dimitra; Balint, Klara; Katsaros, Dionysios; O'Brien-Jenkins, Anne; Gimotty, Phyllis A.; Coukos, George			Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL OVARIAN-CANCER; NF-KAPPA-B; LYMPHOCYTE ACCUMULATION; LEUKOCYTE ADHESION; VASCULAR FUNCTION; EMERGING ROLE; EXPRESSION; ANTAGONISTS; IMMUNOTHERAPY	In spite of their having sufficient immunogenicity, tumor vaccines remain largely ineffective. The mechanisms underlying this lack of efficacy are still unclear. Here we report a previously undescribed mechanism by which the tumor endothelium prevents T cell homing and hinders tumor immunotherapy. Transcriptional profiling of microdissected tumor endothelial cells from human ovarian cancers revealed genes associated with the absence or presence of tumor-infiltrating lymphocytes (TILs). Overexpression of the endothelin B receptor (ETBR) was associated with the absence of TILs and short patient survival time. The ETBR inhibitor BQ-788 increased T cell adhesion to human endothelium in vitro, an effect countered by intercellular adhesion molecule-1 (ICAM-1) blockade or treatment with NO donors. In mice, ETBR neutralization by BQ-788 increased T cell homing to tumors; this homing required ICAM-1 and enabled tumor response to otherwise ineffective immunotherapy in vivo without changes in systemic antitumor immune response. These findings highlight a molecular mechanism with the potential to be pharmacologically manipulated to enhance the efficacy of tumor immunotherapy in humans.	[Buckanovich, Ronald J.; Facciabene, Andrea; Kim, Sarah; Benencia, Fabian; Sasaroli, Dimitra; Balint, Klara; O'Brien-Jenkins, Anne; Gimotty, Phyllis A.; Coukos, George] Univ Penn, Ctr Res Ovarian Canc Early Detect & Cure, Philadelphia, PA 19104 USA; [Buckanovich, Ronald J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Benencia, Fabian; Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Sasaroli, Dimitra] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis 68100, Greece; [Katsaros, Dionysios] Univ Turin, Dept Obstet & Gynecol, I-10126 Turin, Italy	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Democritus University of Thrace; University of Turin	Coukos, G (corresponding author), Univ Penn, Ctr Res Ovarian Canc Early Detect & Cure, Philadelphia, PA 19104 USA.	gcks@mail.med.upenn.edu	Benencia, Fabian/AAH-1613-2020; Coukos, George/ABG-7389-2020; Balint, Klara/ABB-8816-2021; Gimotty, Phyllis/GWZ-4136-2022	Benencia, Fabian/0000-0003-3049-6150; Gimotty, Phyllis/0000-0002-3850-9799; Coukos, George/0000-0001-8813-7367	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043459] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000671] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA098951, R01CA112162, P50CA083638] Funding Source: NIH RePORTER; FIC NIH HHS [D43-TW00671] Funding Source: Medline; NCI NIH HHS [R01-CA112162, R01-CA098951, P50-CA083638] Funding Source: Medline; NICHD NIH HHS [K12-HD43459] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baatz H, 2001, INFLAMM RES, V50, P534, DOI 10.1007/PL00000231; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Bagnato A, 2005, ENDOCR-RELAT CANCER, V12, P761, DOI 10.1677/erc.1.01077; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Buckanovich RJ, 2006, CANCER BIOL THER, V5, P635, DOI 10.4161/cbt.5.6.2676; Cardillo C, 1999, HYPERTENSION, V33, P753, DOI 10.1161/01.HYP.33.2.753; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; Courreges MC, 2006, CANCER GENE THER, V13, P182, DOI 10.1038/sj.cgt.7700888; Cowburn PJ, 2005, EUR J HEART FAIL, V7, P37, DOI 10.1016/j.ejheart.2004.08.001; D'Orleans-Juste P, 2002, PHARMACOL THERAPEUT, V95, P221, DOI 10.1016/S0163-7258(02)00235-8; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Feuerer M, 2006, J IMMUNOL, V176, P2857, DOI 10.4049/jimmunol.176.5.2857; Fukami T, 1996, J MED CHEM, V39, P2313, DOI 10.1021/jm9600914; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GAUTHIER TW, 1994, AM J PHYSIOL-GASTR L, V267, pG562, DOI 10.1152/ajpgi.1994.267.4.G562; Grimshaw MJ, 2004, CANCER RES, V64, P2461, DOI 10.1158/0008-5472.CAN-03-1069; Halcox JPJ, 2007, HYPERTENSION, V49, P1134, DOI 10.1161/HYPERTENSIONAHA.106.083303; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hickey MJ, 2001, CLIN SCI, V100, P1, DOI 10.1042/CS20000135; Hodi FS, 2006, ADV IMMUNOL, V90, P341, DOI 10.1016/S0065-2776(06)90009-1; Huddleston HG, 2005, GYNECOL ONCOL, V96, P77, DOI 10.1016/j.ygyno.2004.08.047; Iqbal J, 2005, MINI-REV MED CHEM, V5, P381, DOI 10.2174/1389557053544010; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Kubes P, 2000, GUT, V47, P6, DOI 10.1136/gut.47.1.6; Kuhlmann A, 2005, CORNEA, V24, P837, DOI 10.1097/01.ico.0000157400.81408.2b; Lelamali K, 2001, J CELL PHYSIOL, V188, P337, DOI 10.1002/jcp.1128; Levin ER, 1996, AM J NEPHROL, V16, P246, DOI 10.1159/000169004; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968; Morris CD, 2005, BRIT J CANCER, V92, P2148, DOI 10.1038/sj.bjc.6602676; Motte S, 2006, PHARMACOL THERAPEUT, V110, P386, DOI 10.1016/j.pharmthera.2005.08.012; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Peng XH, 2007, CANCER IMMUNOL IMMUN, V56, P797, DOI 10.1007/s00262-006-0240-9; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Sampaio ALF, 2004, J LEUKOCYTE BIOL, V76, P210, DOI 10.1189/jlb.1003504; Sampaio ALF, 2000, J LEUKOCYTE BIOL, V67, P189, DOI 10.1002/jlb.67.2.189; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schlom J, 2007, CLIN CANCER RES, V13, P3776, DOI 10.1158/1078-0432.CCR-07-0588; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Waldow T, 2006, NITRIC OXIDE-BIOL CH, V15, P103, DOI 10.1016/j.niox.2005.12.005; Wanecek M, 2000, EUR J PHARMACOL, V407, P1, DOI 10.1016/S0014-2999(00)00675-0; Wedgwood S, 2005, AM J PHYSIOL-LUNG C, V288, pL480, DOI 10.1152/ajplung.00283.2004; Wulfing P, 2003, CLIN CANCER RES, V9, P4125; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1	50	381	403	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					28	36		10.1038/nm1699	http://dx.doi.org/10.1038/nm1699			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157142				2022-12-25	WOS:000252222400019
J	Khetani, SR; Bhatia, SN				Khetani, Salman R.; Bhatia, Sangeeta N.			Microscale culture of human liver cells for drug development	NATURE BIOTECHNOLOGY			English	Article							HUMAN HEPATOCYTES; NONPARENCHYMAL CELLS; GENE-EXPRESSION; CYTOCHROME-P450 EXPRESSION; ENZYME-INDUCTION; RAT HEPATOCYTES; METABOLISM; HEPATOTOXICITY; COCULTURE; BIOLOGY	Tissue function depends on hierarchical structures extending from single cells (similar to 10 mu m) to functional subunits (100 mu m - 1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved(1) and have the advantages of miniaturization(2). Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity(3). We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.	[Khetani, Salman R.; Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital	Bhatia, SN (corresponding author), MIT, Dept Elect Engn & Comp Sci, Div Hlth Sci & Technol, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.	sbhatia@mit.edu						Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Eschbach E, 2005, J CELL BIOCHEM, V95, P243, DOI 10.1002/jcb.20360; Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Isley William L, 2003, Expert Opin Drug Saf, V2, P581, DOI 10.1517/14740338.2.6.581; Kaihara S, 2000, J PEDIATR SURG, V35, P1287, DOI 10.1053/jpsu.2000.9298; KAMALI F, 1993, EUR J CLIN PHARMACOL, V45, P551, DOI 10.1007/BF00315313; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; NAUGHTON BA, 1995, APPL BIOCHEM BIOTECH, V54, P65, DOI 10.1007/BF02787912; PIROTTE JH, 1984, ANN INTERN MED, V101, P403, DOI 10.7326/0003-4819-101-3-403_1; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd1131; Richert L, 2006, DRUG METAB DISPOS, V34, P870, DOI 10.1124/dmd.105.007708; Rodriguez-Antona C, 2001, ARCH BIOCHEM BIOPHYS, V393, P308, DOI 10.1006/abbi.2001.2499; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; Waring JF, 2003, TOXICOL IN VITRO, V17, P693, DOI 10.1016/S0887-2333(03)00102-4; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Zeilinger K, 2002, ATLA-ALTERN LAB ANIM, V30, P525, DOI 10.1177/026119290203000506	30	892	941	8	374	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					120	126		10.1038/nbt1361	http://dx.doi.org/10.1038/nbt1361			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18026090				2022-12-25	WOS:000252222500032
J	Blois, SM; Ilarregui, JM; Tometten, M; Garcia, M; Orsal, AS; Cordo-Russo, R; Toscano, MA; Bianco, GA; Kobelt, P; Handjiski, B; Tirado, I; Markert, UR; Klapp, BF; Poirier, F; Szekeres-Bartho, J; Rabinovich, GA; Arck, PC				Blois, Sandra M.; Ilarregui, Juan M.; Tometten, Mareike; Garcia, Mariana; Orsal, Arif S.; Cordo-Russo, Rosalia; Toscano, Marta A.; Bianco, German A.; Kobelt, Peter; Handjiski, Bori; Tirado, Irene; Markert, Udo R.; Klapp, Burghard F.; Poirier, Francoise; Szekeres-Bartho, Julia; Rabinovich, Gabriel A.; Arck, Petra C.			A pivotal role for galectin-1 in fetomaternal tolerance	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; MATERNAL-FETAL INTERFACE; EARLY HUMAN-PREGNANCY; DENDRITIC CELLS; RECOMBINANT GALECTIN-1; EXTRACELLULAR-MATRIX; MURINE PREGNANCIES; TROPHOBLAST CELLS; MOUSE PLACENTA; CROSS-TALK	A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1-deficient (Lgals1(-/-)) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)-secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.	Univ Med Berlin, Charite, Biomed Res Bldg, D-13353 Berlin, Germany; Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Immunopathol Lab, RA-1428 Buenos Aires, DF, Argentina; Univ Med Berlin, Charite, Dept Med, Div Hepatol Gastroenterol & Endocrinol, D-13353 Berlin, Germany; Univ Granada, Fac Med, Dept Bioquim & Biol Mol, Unidad Immunol, E-18012 Granada, Spain; Univ Jena, Dept Obstet, Placenta Labor, D-07740 Jena, Germany; Univ Paris 06, Inst Jacques Monod, Ctr Natl Rech, Dept Biol & Dev,UMR 7592, F-75251 Paris, France; Univ Paris 07, F-75221 Paris 05, France; Univ Pecs, Sch Med, Hungarian Acad Sci, Dept Med Microbiol & Immunol,Reprod & Tumor Immun, H-7643 Pecs, Hungary; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Granada; Friedrich Schiller University of Jena; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Pecs; University of Buenos Aires	Arck, PC (corresponding author), Univ Med Berlin, Charite, Biomed Res Bldg, Campus Virchow,Augusttenburger Platz 1, D-13353 Berlin, Germany.	sandra.blois@charite.de; gabyrabi@ciudad.com.ar; petra.arck@charite.de	Toscano, Marta/HGU-4103-2022; Russo, Rosalia Cordo/O-9149-2017; Arck, Petra C/D-7094-2013; MARKERT, UDO Rudolf/AAP-1663-2021	Russo, Rosalia Cordo/0000-0002-5984-9717; MARKERT, UDO Rudolf/0000-0001-5299-595X; Arck, Petra/0000-0002-2932-926X; Toscano, Marta/0000-0003-0502-8929; Ilarregui, Juan Martin/0000-0002-6871-6764; Blois, Sandra M/0000-0002-0434-2660				Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arck P, 2007, AM J REPROD IMMUNOL, V58, P268, DOI 10.1111/j.1600-0897.2007.00512.x; Ayatollahi M, 2005, TRANSPL P, V37, P4603, DOI 10.1016/j.transproceed.2005.11.023; Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G; Blois S, 2005, J IMMUNOL, V174, P1820, DOI 10.4049/jimmunol.174.4.1820; Blois SM, 2004, J IMMUNOL, V172, P5893, DOI 10.4049/jimmunol.172.10.5893; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Bozic M, 2004, PLACENTA, V25, P797, DOI 10.1016/j.placenta.2004.03.006; Chaouat G, 2005, CHEM IMMUNOL ALLERGY, V88, P34, DOI 10.1159/000087820; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Choe YS, 1997, MOL REPROD DEV, V48, P261, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;261::AID-MRD14&gt;3.0.CO;2-0; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; CLARK DA, 1993, AM J REPROD IMMUNOL, V29, P141, DOI 10.1111/j.1600-0897.1993.tb00579.x; Erlebacher A, 2004, J CLIN INVEST, V114, P39, DOI 10.1172/JC1200420645; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Garcia MG, 2007, PLACENTA, V28, P650, DOI 10.1016/j.placenta.2006.09.010; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; IROWSDALE J, 2006, NAT IMMUNOL, V7, P241; Jeschke U, 2004, HISTOCHEM CELL BIOL, V121, P501, DOI 10.1007/s00418-004-0660-6; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; LIN H, 1993, J IMMUNOL, V151, P4562; Liu AX, 2006, BIOL REPROD, V75, P414, DOI 10.1095/biolreprod.105.049379; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Miyazaki S, 2003, J LEUKOCYTE BIOL, V74, P514, DOI 10.1189/jlb.1102566; Perone MJ, 2006, J IMMUNOL, V177, P5278, DOI 10.4049/jimmunol.177.8.5278; Phillips B, 1996, BIOL REPROD, V55, P548, DOI 10.1095/biolreprod55.3.548; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Poehlmann TG, 2005, CHEM IMMUNOL ALLERGY, V89, P26, DOI 10.1159/000087907; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 1999, IMMUNOLOGY, V97, P100; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Walzel H, 2004, GLYCOBIOLOGY, V14, P871, DOI 10.1093/glycob/cwh101; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu XY, 2005, BIOL REPROD, V72, P338, DOI 10.1095/biolreprod.104.034108	49	370	388	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1450	1457		10.1038/nm1680	http://dx.doi.org/10.1038/nm1680			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18026113				2022-12-25	WOS:000251445400019
J	Nojima, H; Adachi, M; Matsui, T; Okawa, K; Tsukita, S; Tsukita, S				Nojima, Hisashi; Adachi, Makoto; Matsui, Takeshi; Okawa, Katsuya; Tsukita, Shoichiro; Tsukita, Sachiko			IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade	NATURE CELL BIOLOGY			English	Article							CYCLE PROGRESSION; MAP KINASE; PROTEIN; CDC42; EFFECTOR; RAC1; RAS; CALMODULIN; GROWTH; IDENTIFICATION	Proliferation of epithelial cells must be spatiotemporally regulated to maintain the organization of epithelial sheets. Here we show that the IQGAP family, comprising IQGAP1, 2 and 3, underlies lateral cell-cell contacts of epithelial cells. Of the three proteins, IQGAP3 is unique in that its expression is specifically confined to proliferating cells. Knockdown of IQGAP3 in cultured epithelial cells caused inhibition of proliferation and ERK activity. When exogenously expressed in quiescent cells, IQGAP3 was capable of inducing cell-cycle re-entry, which was completely inhibited by the MEK inhibitor U0126. Thus, IQGAP3 is necessary and sufficient for driving cell proliferation and ERK acts downstream of IQGAP3. Furthermore, IQGAP3 specifically interacted with the active, GTP-bound form of Ras, and in IQGAP3 knockdown cells, the activity of Ras, but not of other small GTPases, was inhibited. Thus, IQGAP3 regulates the promotion of cell proliferation through Ras-dependent ERK activation.	[Nojima, Hisashi; Matsui, Takeshi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Grad Sch Frontier Biosci, Biol Sci Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Adachi, Makoto; Tsukita, Shoichiro] Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Fac Med, Frontier Technol Ctr, Sakyo Ku, Kyoto 6068501, Japan	Osaka University; Kyoto University; Kyoto University	Tsukita, S (corresponding author), Osaka Univ, Grad Sch Med, Grad Sch Frontier Biosci, Biol Sci Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	atsukita@biosci.med.osaka-u.ac.jp	Matsui, Takeshi/C-4730-2017					Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GERDES J, 1984, J IMMUNOL, V133, P1710; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; TSUKITA S, 1993, J CELL BIOL, V123, P1049, DOI 10.1083/jcb.123.5.1049; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517	35	70	75	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					971	978		10.1038/ncb1757	http://dx.doi.org/10.1038/ncb1757			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604197				2022-12-25	WOS:000258147100015
J	Saurin, AT; Durgan, J; Cameron, AJ; Faisal, A; Marber, MS; Parker, PJ				Saurin, Adrian T.; Durgan, Joanne; Cameron, Angus J.; Faisal, Amir; Marber, Michael S.; Parker, Peter J.			The regulated assembly of a PKC epsilon complex controls the completion of cytokinesis	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CONTRACTILE RING; STRUCTURAL BASIS; CLEAVAGE FURROW; PHOSPHORYLATION; CELLS; IDENTIFICATION; SPECIFICITY; BINDING; TUMORIGENESIS	The cell cycle is exquisitely controlled by multiple sequential regulatory inputs to ensure fidelity. Here we demonstrate that the final step in division, the physical separation of daughter cells, is controlled by a member of the PKC gene superfamily. Specifically, we have identified three phosphorylation sites within PKC epsilon that control its association with 14-3-3. These phosphorylations are executed by p38 MAP kinase (Ser 350), GSK3 (Ser 346) and PKC itself (Ser 368). Integration of these signals is essential during mitosis because mutations that prevent phosphorylation of PKC epsilon and/or PKC epsilon binding to 14-3-3 also cause defects in the completion of cytokinesis. Using chemical genetic and dominant-negative approaches it is shown that selective inhibition of PKCe halts cells at the final stages of separation. This arrest is associated with persistent RhoA activation at the midbody and a delay in actomyosin ring dissociation. This study therefore identifies a new regulatory mechanism that controls exit from cytokinesis, which has implications for carcinogenesis.	[Saurin, Adrian T.; Durgan, Joanne; Cameron, Angus J.; Faisal, Amir; Parker, Peter J.] Imperial Canc Res Fund, Prot Phosphorylat Lab, London Res Inst, Canc Res UK, London WC2A 3PX, England; [Marber, Michael S.] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, New Hunts House, London SE1 1UL, England	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Parker, PJ (corresponding author), Imperial Canc Res Fund, Prot Phosphorylat Lab, London Res Inst, Canc Res UK, London WC2A 3PX, England.	peter.parker@cancer.org.uk	Faisal, Amir/AAE-8992-2020; Parker, Peter j/D-5192-2013; marber, michael/AAW-7916-2021	Cameron, Angus/0000-0003-3906-2789; Marber, Michael/0000-0002-3463-7128; Saurin, Adrian/0000-0001-9317-2255; parker, peter/0000-0002-6218-2933; Faisal, Amir/0000-0002-7376-8286	British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)		Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Dai JG, 2003, J NEUROCHEM, V84, P23, DOI 10.1046/j.1471-4159.2003.01254.x; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; FAISAL A, J BIOL CHEM; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Han DC, 2001, ONCOGENE, V20, P346, DOI 10.1038/sj.onc.1204068; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Nguyen TA, 2004, J BIOL CHEM, V279, P52714, DOI 10.1074/jbc.M403040200; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Saurin AT, 2002, CARDIOVASC RES, V55, P672, DOI 10.1016/S0008-6363(02)00325-5; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	37	94	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					891	901		10.1038/ncb1749	http://dx.doi.org/10.1038/ncb1749			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604201				2022-12-25	WOS:000258147100007
J	Eliscovich, C; Peset, I; Vernos, I; Mendez, R				Eliscovich, Carolina; Peset, Isabel; Vernos, Isabelle; Mendez, Raul			Spindle-localized CPE-mediated translation controls meiotic chromosome segregation	NATURE CELL BIOLOGY			English	Article							MOS MESSENGER-RNA; MITOTIC APPARATUS; XENOPUS-OOCYTES; MEIOSIS-I; MASKIN; PHOSPHORYLATION; CHROMOKINESIN; TRANSITION; TPX2; XKID	Meiotic progression requires the translational activation of stored maternal mRNAs, such as those encoding cyclin B1 or mos. The translation of these mRNAs is regulated by the cytoplasmic polyadenylation element (CPE) present in their 3'UTRs, which recruits the CPE-binding protein CPEB1. This RNA-binding protein not only dictates the timing and extent of translational activation by cytoplasmic polyadenylation(2,3) but also participates, together with the translational repressor Maskin, in the transport and localization, in a quiescent state, of its targets to subcellular locations where their translation will take place(4). During the early development of Xenopus laevis, CPEB localizes at the animal pole of oocytes and later on at embryonic spindles and centrosomes(5). Disruption of embryonic CPEB-mediated translational regulation results in abnormalities in the mitotic apparatus and inhibits embryonic mitosis(5). Here we show that spindle-localized translational activation of CPE-regulated mRNAs, encoding for proteins with a known function in spindle assembly and chromosome segregation, is essential for completion of the first meiotic division and for chromosome segregation in Xenopus oocytes.	[Eliscovich, Carolina; Peset, Isabel; Vernos, Isabelle; Mendez, Raul] CRG, Barcelona 08003, Spain; [Vernos, Isabelle] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), CRG, C Dr Aiguader 88, Barcelona 08003, Spain.	raul.mendez@crg.es	Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214; Mendez, Raul/0000-0002-1952-6905	ICREA Funding Source: Custom	ICREA(ICREA)		Alliegro MC, 2006, P NATL ACAD SCI USA, V103, P9034, DOI 10.1073/pnas.0602859103; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Becker Bret E., 2006, V322, P69; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Perez LH, 2002, NAT CELL BIOL, V4, P737, DOI 10.1038/ncb850; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; WORMINGTON M, 1991, METHOD CELL BIOL, V36, P167; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	26	68	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					858	865		10.1038/ncb1746	http://dx.doi.org/10.1038/ncb1746			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18536713				2022-12-25	WOS:000257268400015
J	Lu, CW; Yabuuchi, A; Chen, LY; Viswanathan, S; Kim, K; Daley, GQ				Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.			Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos	NATURE GENETICS			English	Article							PREIMPLANTATION DEVELOPMENT; DIFFERENTIATION; LINEAGE; KINASE; SPECIFICATION; REQUIREMENT; BLASTOCYSTS; BLASTOMERES; EXPRESSION; ENDODERM	In blastocyst chimeras, embryonic stem (ES) cells contribute to embryonic tissues but not extraembryonic trophectoderm. Conditional activation of HRas1(Q61L) in ES cells in vitro induces the trophectoderm marker Cdx2 and enables derivation of trophoblast stem (TS) cell lines that, when injected into blastocysts, chimerize placental tissues. Erk2, the downstream effector of Ras-mitogen-activated protein kinase (MAPK) signaling, is asymmetrically expressed in the apical membranes of the 8-cell-stage embryo just before morula compaction. Inhibition of MAPK signaling in cultured mouse embryos compromises Cdx2 expression, delays blastocyst development and reduces trophectoderm outgrowth from embryo explants. These data show that ectopic Ras activation can divert ES cells toward extraembryonic trophoblastic fates and implicate Ras-MAPK signaling in promoting trophectoderm formation from mouse embryos.	[Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.] Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA; [Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Kim, Kitai] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Viswanathan, Srinivas] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Chen, Lingyi/G-6309-2013; Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R01 DK059279-06, R01 DK070055, R01 DK070055-01, R01 DK059279] Funding Source: Medline; NIH HHS [DP1 OD000256-01, DP1 OD000256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Auman HJ, 2002, DEVELOPMENT, V129, P2733; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; KATSUKI M, 1989, MOL BIOL MED, V6, P567; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; Maekawa M, 2007, DEVELOPMENT, V134, P2751, DOI 10.1242/dev.003756; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUTHERLAND AE, 1990, DEV BIOL, V137, P13, DOI 10.1016/0012-1606(90)90003-2; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	30	117	117	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					921	926		10.1038/ng.173	http://dx.doi.org/10.1038/ng.173			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536715	Green Accepted			2022-12-25	WOS:000257166500030
J	Schneider, JW; Gao, Z; Li, S; Farooqi, M; Tang, TS; Bezprozvanny, I; Frantz, DE; Hsieh, J				Schneider, Jay W.; Gao, Zhengliang; Li, Shijie; Farooqi, Midhat; Tang, Tie-Shan; Bezprozvanny, Ilya; Frantz, Doug E.; Hsieh, Jenny			Small-molecule activation of neuronal cell fate	NATURE CHEMICAL BIOLOGY			English	Article							ENHANCER FACTOR 2C; PROGENITOR CELLS; NUCLEAR EXPORT; STEM-CELLS; DIFFERENTIATION; MEF2; NEUROGENESIS; EXPRESSION; SURVIVAL	We probed an epigenetic regulatory path from small molecule to neuronal gene activation. Isoxazole small molecules triggered robust neuronal differentiation in adult neural stem cells, rapidly signaling to the neuronal genome via Ca(2+) influx. Ca(2+)-activated CaMK phosphorylated and mediated nuclear export of the MEF2 regulator HDAC5, thereby de-repressing neuronal genes. These results provide new tools to explore the epigenetic signaling circuitry specifying neuronal cell fate and new leads for neuro-regenerative drugs.	[Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gao, Zhengliang; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gao, Zhengliang; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Li, Shijie; Farooqi, Midhat] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Tang, Tie-Shan; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Frantz, Doug E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu			NHLBI NIH HHS [U01 HL100401, R03 HL096261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA093271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401, R03HL096261] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004	15	118	124	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					408	410		10.1038/nchembio.95	http://dx.doi.org/10.1038/nchembio.95			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18552832				2022-12-25	WOS:000256929900010
J	Tomlinson, IPM; Webb, E; Carvajal-Carmona, L; Broderick, P; Howarth, K; Pittman, AM; Spain, S; Lubbe, S; Walther, A; Sullivan, K; Jaeger, E; Fielding, S; Rowan, A; Vijayakrishnan, J; Domingo, E; Chandler, I; Kemp, Z; Qureshi, M; Farrington, SM; Tenesa, A; Prendergast, JGD; Barnetson, RA; Penegar, S; Barclay, E; Wood, W; Martin, L; Gorman, M; Thomas, H; Peto, J; Bishop, DT; Gray, R; Maher, ER; Lucassen, A; Kerr, D; Evans, DGR; Schafmayer, C; Buch, S; Volzke, H; Hampe, J; Schreiber, S; John, U; Koessler, T; Pharoah, P; van Wezel, T; Morreau, H; Wijnen, JT; Hopper, JL; Southey, MC; Giles, GG; Severi, G; Castellvi-Bel, S; Ruiz-Ponte, C; Carracedo, A; Castells, A; Forsti, A; Hemminki, K; Vodicka, P; Naccarati, A; Lipton, L; Ho, JWC; Cheng, KK; Sham, PC; Luk, J; Agundez, JAG; Ladero, JM; de la Hoya, M; Caldes, T; Niittymaeki, I; Tuupanen, S; Karhu, A; Aaltonen, L; Cazier, JB; Campbell, H; Dunlop, MG; Houlston, RS				Tomlinson, Ian P. M.; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Howarth, Kimberley; Pittman, Alan M.; Spain, Sarah; Lubbe, Steven; Walther, Axel; Sullivan, Kate; Jaeger, Emma; Fielding, Sarah; Rowan, Andrew; Vijayakrishnan, Jayaram; Domingo, Enric; Chandler, Ian; Kemp, Zoe; Qureshi, Mobshra; Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Penegar, Steven; Barclay, Ella; Wood, Wendy; Martin, Lynn; Gorman, Maggie; Thomas, Huw; Peto, Julian; Bishop, D. Timothy; Gray, Richard; Maher, Eamonn R.; Lucassen, Anneke; Kerr, David; Evans, D. Gareth R.; Schafmayer, Clemens; Buch, Stephan; Voelzke, Henry; Hampe, Jochen; Schreiber, Stefan; John, Ulrich; Koessler, Thibaud; Pharoah, Paul; van Wezel, Tom; Morreau, Hans; Wijnen, Juul T.; Hopper, John L.; Southey, Melissa C.; Giles, Graham G.; Severi, Gianluca; Castellvi-Bel, Sergi; Ruiz-Ponte, Clara; Carracedo, Angel; Castells, Antoni; Foersti, Asta; Hemminki, Kari; Vodicka, Pavel; Naccarati, Alessio; Lipton, Lara; Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.; Agundez, Jose A. G.; Ladero, Jose M.; de la Hoya, Miguel; Caldes, Trinidad; Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri; Cazier, Jean-Baptiste; Campbell, Harry; Dunlop, Malcolm G.; Houlston, Richard S.		CORGI Consortium; EPICOLON Consortium	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3	NATURE GENETICS			English	Article							PROSTATE-CANCER; BREAST-CANCER; RISK; METAANALYSIS; VARIANT; EIF3S3; TUMORS; GENES; SCAN	To identify colorectal cancer (CRC) susceptibility alleles, we conducted a genome-wide association study. In phase 1, we genotyped 550,163 tagSNPs in 940 familial colorectal tumor cases (627 CRC, 313 high-risk adenoma) and 965 controls. In phase 2, we genotyped 42,708 selected SNPs in 2,873 CRC cases and 2,871 controls. In phase 3, we evaluated 11 SNPs showing association at P < 10(-4) in a joint analysis of phases 1 and 2 in 4,287 CRC cases and 3,743 controls. Two SNPs were taken forward to phase 4 genotyping ( 10,731 CRC cases and 10,961 controls from eight centers). In addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P=2.5 x 10(-13) overall; P=6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P=3.3 x 10(-18) overall; P=9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H. These data provide further evidence for the 'common-disease common-variant' model of CRC predisposition.	[Tomlinson, Ian P. M.; Carvajal-Carmona, Luis; Howarth, Kimberley; Spain, Sarah; Walther, Axel; Jaeger, Emma; Rowan, Andrew; Domingo, Enric; Kemp, Zoe; Barclay, Ella; Martin, Lynn; Gorman, Maggie] London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan M.; Lubbe, Steven; Sullivan, Kate; Fielding, Sarah; Vijayakrishnan, Jayaram; Chandler, Ian; Qureshi, Mobshra; Penegar, Steven; Wood, Wendy; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Dunlop, Malcolm G.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Martin, Lynn; Evans, D. Gareth R.; Dunlop, Malcolm G.] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn; Maher, Eamonn R.] Univ Birmingham, Sch Med, Dept Med & Mol Genet, Birmingham B15 2TG, W Midlands, England; [Martin, Lynn; Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin, Harrow HA1 3UJ, Middx, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Canc Res UK Epidemiol & Genet Unit, Sutton SM2 5NG, Surrey, England; [Bishop, D. Timothy] Univ Leeds, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TA, W Midlands, England; [Lucassen, Anneke] Univ Southampton, Southampton SO16 5YA, Hants, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Clib Genet Serv, Southampton SO16 5YA, Hants, England; [Kerr, David] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schafmayer, Clemens; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, SHIP Biobank, D-17487 Greifswald, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, Dept Community Med, D-17487 Greifswald, Germany; [Buch, Stephan; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Buch, Stephan; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wijnen, Juul T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Parkville, Vic 3052, Australia; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Castellvi-Bel, Sergi; Castells, Antoni] IDIBAPS, Dept Gastroenterol, Inst Malalties Digest & Metab, Hosp Clin,CIBER EHD, Barcelona, Catalonia, Spain; [Ruiz-Ponte, Clara; Carracedo, Angel] CeGen USC, CIBERER, Genom Med Grp, FPGMX,Spanish Natl Genotyping Ctr,Hosp Clin, Santiago De Compostela, Galicia, Spain; [Foersti, Asta; Hemminki, Kari] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Foersti, Asta; Hemminki, Kari] Karolinska Inst, Ctr Family & Community Med, S-14183 Huddinge, Sweden; [Vodicka, Pavel; Naccarati, Alessio] Acad Sci Czech Republic, Inst Expt Med, Prague 14200, Czech Republic; [Lipton, Lara] Western Hosp, Dept Med Oncol & Clin Haematol, Footscray, Vic 3011, Australia; [Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Sch Med, Badajoz, Spain; [Ladero, Jose M.] San Carlos Univ Hosp, Serv Gastroenterol, Madrid, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Hosp San Carlos, Mol Oncol Lab, Madrid 28040, Spain; [Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Cazier, Jean-Baptiste] London Res Inst, London WC2A 3PX, England; [Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Koessler, Thibaud; Pharoah, Paul] Univ Cambridge, Can Res United Kingdom Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; [van Wezel, Tom; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands	University of London; Institute of Cancer Research - UK; University of Edinburgh; University of Edinburgh; University of Manchester; University of Birmingham; Birmingham Women's Hospital; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; University of Leeds; University of Birmingham; University of Southampton; Radcliffe Infirmary; University of Oxford; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; University of Melbourne; Cancer Council Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Western Hospital; University of Hong Kong; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; University of Helsinki; University of Edinburgh; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Tomlinson, IPM (corresponding author), London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk; richard.houlston@icr.ac.uk	Agúndez, José A. G./A-5503-2008; Pittman, Alan/AAP-2534-2020; Cazier, Jean-Baptiste/F-2369-2010; Severi, Gianluca/H-3774-2018; van Wezel, Tom/A-9599-2008; Sham, Pak Chung/C-4388-2009; Castells, Antoni/ABC-1002-2021; MAHER, EAMONN R/A-9507-2008; de la Hoya, MIguel/Z-2911-2019; Evans, D Gareth/AAB-4308-2022; Hampe, Jochen/A-2555-2010; Pittman, Alan M/D-6231-2012; Vodicka, Pavel/H-3370-2014; van Wezel, Tom/Z-3092-2019; Farrington, Susan M/C-7319-2013; Carracedo, Angel/D-4257-2012; Ruiz-Ponte, Clara/I-3849-2015; Severi, Gianluca/Q-1824-2019; Campbell, Harry/E-2959-2010; Lubbe, Steven/L-8261-2013; Cheng, King Yip/C-4551-2009; Luk, John/A-4085-2008; Domingo, Enric/A-9099-2018; Pharoah, Paul/V-6658-2019; van Wezel, Tom/AAL-5626-2021; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/Q-2710-2019; Kössler, Thibaud/AAZ-9734-2020; Carvajal-Carmona, Luis G/B-3882-2010; Buch, Stephan/AAV-5028-2021; Cazier, Jean-Baptiste/GLR-2949-2022; Aaltonen, Lauri/A-5375-2010; Lucassen, Anneke/D-7764-2017; Spain, Sarah/G-1968-2010	Agúndez, José A. G./0000-0001-6895-9160; Pittman, Alan/0000-0002-8112-2987; Cazier, Jean-Baptiste/0000-0001-7581-9051; Severi, Gianluca/0000-0001-7157-419X; van Wezel, Tom/0000-0001-5773-7730; Castells, Antoni/0000-0001-8431-2033; MAHER, EAMONN R/0000-0002-6226-6918; Evans, D Gareth/0000-0002-8482-5784; Hampe, Jochen/0000-0002-2421-6127; Pittman, Alan M/0000-0002-8112-2987; van Wezel, Tom/0000-0001-5773-7730; Carracedo, Angel/0000-0003-1085-8986; Ruiz-Ponte, Clara/0000-0002-2200-0162; Severi, Gianluca/0000-0001-7157-419X; Campbell, Harry/0000-0002-6169-6262; Lubbe, Steven/0000-0002-7103-6671; Luk, John/0000-0002-6323-7940; Domingo, Enric/0000-0003-4390-8767; Pharoah, Paul/0000-0001-8494-732X; Dunlop, Malcolm G/0000-0002-3033-5851; Farrington, Susan M/0000-0001-5955-7389; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Cazier, Jean-Baptiste/0000-0001-7581-9051; Aaltonen, Lauri/0000-0001-6839-4286; Castellvi-Bel, Sergi/0000-0003-1217-5097; Webb, Emily/0000-0002-4019-7456; Kossler, Thibaud/0000-0001-9196-9076; Penegar, Steven/0000-0002-3768-0236; Karhu, Auli/0000-0002-7927-0796; de la Hoya, Miguel/0000-0002-8113-1410; Prendergast, James/0000-0001-8916-018X; Giles, Graham/0000-0003-4946-9099; Lucassen, Anneke/0000-0003-3324-4338; Bishop, Tim/0000-0002-8752-8785; John, Ulrich/0000-0003-0587-5298; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Spain, Sarah/0000-0002-7591-8364; Wood, Wendy/0000-0001-9062-4455; Broderick, Peter/0000-0002-8348-5829; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Tenesa, Albert/0000-0003-4884-4475; Houlston, Richard/0000-0002-5268-0242; Southey, Melissa/0000-0002-6313-9005; Gray, Richard/0000-0003-4440-574X	MRC [G0301096, MC_U127527198] Funding Source: UKRI; Cancer Research UK [A8896, C348/A3758, C48/A6361] Funding Source: Medline; Medical Research Council [G0301096, G0000657-53203, MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2003, HUM GENET, V112, P434, DOI 10.1007/s00439-002-0902-4; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; PETITTI D, 1994, META ANAL DECISION A; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Shima H, 2005, PATHOBIOLOGY, V72, P220, DOI 10.1159/000086792; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; World Heath Organization, 1977, INT CLASS DIS 1975 R; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	22	463	473	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					623	630		10.1038/ng.111	http://dx.doi.org/10.1038/ng.111			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372905				2022-12-25	WOS:000255366700031
J	Narayan, M; Welker, E; Zhai, HL; Han, XM; Xu, GQ; McLafferty, FW; Scheraga, HA				Narayan, Mahesh; Welker, Ervin; Zhai, Huili; Han, Xuemei; Xu, Guoqiang; McLafferty, Fred W.; Scheraga, Harold A.			Detecting native folds in mixtures of proteins that contain disulfide bonds	NATURE BIOTECHNOLOGY			English	Article							PANCREATIC RIBONUCLEASE-A; MASS-SPECTROMETRY; CYSTEINES; PATHWAYS; STATE	High-throughput in vitro refolding of proteins that contain disulfide bonds, for which soluble expression is particularly difficult, is severely impeded by the absence of effective methods for detecting their native forms. We demonstrate such a method, which combines mass spectrometry with mild reductions, requires no prior experimentation or knowledge of proteins' physicochemical characteristics, function or activity, and is amenable to automation. These are necessary criteria for structural genomics and proteomics applications.	[Narayan, Mahesh; Welker, Ervin; Zhai, Huili; Han, Xuemei; Xu, Guoqiang; McLafferty, Fred W.; Scheraga, Harold A.] Cornell Univ, Baker Lab Chem & Chem Biol, Ithaca, NY 14353 USA; [Narayan, Mahesh] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Welker, Ervin] Hungarian Acad, Biol Res Ctr, Inst Enzymol, H-1114 Budapest, Hungary	Cornell University; University of Texas System; University of Texas El Paso; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Narayan, M (corresponding author), Cornell Univ, Baker Lab Chem & Chem Biol, Ithaca, NY 14353 USA.	mnarayan@utep.edu; welker@brc.hu.edu; has5@cornell.edu	Welker, Ervin/AAC-6493-2022	Xu, Guoqiang/0000-0002-4753-4769	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM024893-37, R37 GM016609, GM-24893, R01 GM016609, R01 GM024893, GM-16609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024893, R01GM016609, R37GM016609] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Fiser A, 2002, METHOD ENZYMOL, V353, P10; Ge Y, 2002, J AM CHEM SOC, V124, P672, DOI 10.1021/ja011335z; Han XM, 2006, SCIENCE, V314, P109, DOI 10.1126/science.1128868; Narayan M, 2000, ACCOUNTS CHEM RES, V33, P805, DOI 10.1021/ar000063m; Rothwarf DM, 1998, BIOCHEMISTRY-US, V37, P3760, DOI 10.1021/bi972822n; Ruoppolo M, 2000, BIOCHEMISTRY-US, V39, P12033, DOI 10.1021/bi001044n; Song JN, 2004, BIOCHEM BIOPH RES CO, V318, P142, DOI 10.1016/j.bbrc.2004.03.189; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P1483, DOI 10.1021/bi011893q; Welker E, 2004, J AM CHEM SOC, V126, P3720, DOI 10.1021/ja031658q; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798	15	9	9	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					427	429		10.1038/nbt1380	http://dx.doi.org/10.1038/nbt1380			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18278035	Green Accepted			2022-12-25	WOS:000254782500025
J	Rosenfeld, N; Aharonov, R; Meiri, E; Rosenwald, S; Spector, Y; Zepeniuk, M; Benjamin, H; Shabes, N; Tabak, S; Levy, A; Lebanony, D; Goren, Y; Silberschein, E; Targan, N; Ben-Ari, A; Gilad, S; Sion-Vardy, N; Tobar, A; Feinmesser, M; Kharenko, O; Nativ, O; Nass, D; Perelman, M; Yosepovich, A; Shalmon, B; Polak-Charcon, S; Fridman, E; Avniel, A; Bentwich, I; Bentwich, Z; Cohen, D; Chajut, A; Barshack, I				Rosenfeld, Nitzan; Aharonov, Ranit; Meiri, Eti; Rosenwald, Shai; Spector, Yael; Zepeniuk, Merav; Benjamin, Hila; Shabes, Norberto; Tabak, Sarit; Levy, Asaf; Lebanony, Danit; Goren, Yaron; Silberschein, Erez; Targan, Nurit; Ben-Ari, Alex; Gilad, Shlomit; Sion-Vardy, Netta; Tobar, Ana; Feinmesser, Meora; Kharenko, Oleg; Nativ, Ofer; Nass, Dvora; Perelman, Marina; Yosepovich, Ady; Shalmon, Bruria; Polak-Charcon, Sylvie; Fridman, Eddie; Avniel, Amir; Bentwich, Isaac; Bentwich, Zvi; Cohen, Dalia; Chajut, Ayelet; Barshack, Iris			MicroRNAs accurately identify cancer tissue origin	NATURE BIOTECHNOLOGY			English	Article							CHAIN-REACTION ASSAY; GENE-EXPRESSION; UNKNOWN PRIMARY; BREAST-CANCER; MOLECULAR CLASSIFICATION; MAMMALIAN MICRORNAS; DIFFERENTIATION; SIGNATURE; TARGETS; CARCINOMA	MicroRNAs ( miRNAs) belong to a class of noncoding, regulatory RNAs that is involved in oncogenesis and shows remarkable tissue specificity. Their potential for tumor classification suggests they may be used in identifying the tissue in which cancers of unknown primary origin arose, a major clinical problem. We measured miRNA expression levels in 400 paraffin-embedded and fresh-frozen samples from 22 different tumor tissues and metastases. We used miRNA microarray data of 253 samples to construct a transparent classifier based on 48 miRNAs. Two-thirds of samples were classified with high confidence, with accuracy 490%. In an independent blinded test-set of 83 samples, overall high- confidence accuracy reached 89%. Classification accuracy reached 100% for most tissue classes, including 131 metastatic samples. We further validated the utility of the miRNA biomarkers by quantitative RT-PCR using 65 additional blinded test samples. Our findings demonstrate the effectiveness of miRNAs as biomarkers for tracing the tissue of origin of cancers of unknown primary origin.	[Rosenfeld, Nitzan; Aharonov, Ranit; Meiri, Eti; Rosenwald, Shai; Spector, Yael; Zepeniuk, Merav; Benjamin, Hila; Shabes, Norberto; Tabak, Sarit; Levy, Asaf; Lebanony, Danit; Goren, Yaron; Silberschein, Erez; Targan, Nurit; Ben-Ari, Alex; Gilad, Shlomit; Avniel, Amir; Bentwich, Isaac; Bentwich, Zvi; Cohen, Dalia; Chajut, Ayelet] Rosetta Genom Ltd, IL-76706 Rehovot, Israel; [Sion-Vardy, Netta] Soroka Univ Med Ctr, IL-84101 Beer Sheva, Israel; [Tobar, Ana; Feinmesser, Meora] Beilinson Med Ctr, Rabin Med Ctr, Dept Pathol, IL-49100 Petah Tiqwa, Israel; [Kharenko, Oleg] Tel Aviv Sourasky Med Ctr, Inst Pathol, IL-64239 Tel Aviv, Israel; [Nativ, Ofer] Bnai Zion Med Ctr, IL-31048 Haifa, Israel; [Nass, Dvora; Perelman, Marina; Yosepovich, Ady; Shalmon, Bruria; Polak-Charcon, Sylvie; Fridman, Eddie; Barshack, Iris] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel; [Nass, Dvora; Perelman, Marina; Yosepovich, Ady; Shalmon, Bruria; Polak-Charcon, Sylvie; Fridman, Eddie; Barshack, Iris] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Ben Gurion University; Soroka Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Bnai Zion Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Barshack, I (corresponding author), Rosetta Genom Ltd, IL-76706 Rehovot, Israel.	ranit_ah@rosettagenomics.com; barshack@sheba.health.gov.il	Levy, Asaf/ABA-2623-2020	Fridman, Eddie/0000-0002-0317-7085				Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Blaszyk H, 2003, APMIS, V111, P1089, DOI 10.1111/j.1600-0463.2003.apm1111203.x; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HAINSWORTH JD, 1993, NEW ENGL J MED, V329, P257; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hino Kimihiro, 2007, Nucleic Acids Symp Ser (Oxf), P415, DOI 10.1093/nass/nrm208; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Parker DC, 2003, AM J SURG PATHOL, V27, P1, DOI 10.1097/00000478-200301000-00001; Pimiento JM, 2007, AM J SURG, V194, P833, DOI 10.1016/j.amjsurg.2007.08.039; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shaw PHS, 2007, CLIN ONCOL-UK, V19, P87, DOI 10.1016/j.clon.2006.09.009; Shedden KA, 2003, AM J PATHOL, V163, P1985, DOI 10.1016/S0002-9440(10)63557-2; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Talantov D, 2006, J MOL DIAGN, V8, P320, DOI 10.2353/jmoldx.2006.050136; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANDUIN M, 2007, GENOME RES, V118, P130; Varadhachary GR, 2004, CANCER-AM CANCER SOC, V100, P1776, DOI 10.1002/cncr.20202; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	34	750	822	0	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					462	469		10.1038/nbt1392	http://dx.doi.org/10.1038/nbt1392			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18362881				2022-12-25	WOS:000254782500029
J	Barreiro, LB; Laval, G; Quach, H; Patin, E; Quintana-Murci, L				Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis			Natural selection has driven population differentiation in modern humans	NATURE GENETICS			English	Article							HUMAN GENOME; POSITIVE SELECTION; HAPLOTYPE MAP; SIGNATURES; REGIONS; POLYMORPHISM; PATTERNS; SNPS	The considerable range of observed phenotypic variation in human populations may reflect, in part, distinctive processes of natural selection and adaptation to variable environmental conditions. Although recent genome-wide studies have identified candidate regions under selection(1-5), it is not yet clear how natural selection has shaped population differentiation. Here, we have analyzed the degree of population differentiation at 2.8 million Phase II HapMap single-nucleotide polymorphisms(6). We find that negative selection has globally reduced population differentiation at amino acid-altering mutations, particularly in disease-related genes. Conversely, positive selection has ensured the regional adaptation of human populations by increasing population differentiation in gene regions, primarily at nonsynonymous and 5'-UTR variants. Our analyses identify a fraction of loci that have contributed, and probably still contribute, to the morphological and disease-related phenotypic diversity of current human populations.	[Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, 25 Rue Dr Roux, F-75015 Paris, France.	quintana@pasteur.fr	Quintana-Murci, Lluis/AAB-7468-2022; Patin, Etienne/G-6768-2012; Barreiro, Luis/I-7772-2015	Patin, Etienne/0000-0002-9911-4459; Barreiro, Luis/0000-0001-9456-367X; Quach, Helene/0000-0002-3493-0973; Quintana-Murci, Lluis/0000-0003-2429-6320				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; EXCOFFIER L, 1992, GENETICS, V131, P491; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	30	406	416	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					340	345		10.1038/ng.78	http://dx.doi.org/10.1038/ng.78			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246066				2022-12-25	WOS:000253548400026
J	Davis, AV; O'Halloran, TV				Davis, Anna V.; O'Halloran, Thomas V.			A place for thioether chemistry in cellular copper ion recognition and trafficking	NATURE CHEMICAL BIOLOGY			English	Editorial Material							CYTOCHROME-C-OXIDASE; N-TERMINAL DOMAIN; X-RAY-ABSORPTION; METHIONINE INTERACTIONS; PROTEIN; CHAPERONE; CU(I); COORDINATION; BINDING; METALLOCHAPERONE	Over the last decade, cysteine thiolate ligands have been shown to be critical to the Cu(I) (cuprous) binding chemistry of many cytosolic metallochaperone and metalloregulatory proteins involved in copper physiology. More recently, the thioether group of methionine has begun to emerge as an important Cu(I) ligand for trafficking proteins in more oxidizing cellular environments.	Northwestern Univ, Dept Chem & Biochem, Evanston, IL 60208 USA; Northwestern Univ, Dept Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem & Biochem, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	O'Halloran, Thomas/ABE-6125-2021	O'Halloran, Thomas/0000-0001-8732-5059	NIGMS NIH HHS [GM 38784, F32 GM071129, R37 GM038784-20, R01 GM038784, R37 GM038784, GM 071129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038784, R29GM038784, R01GM038784, F32GM071129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abajian C, 2004, J BIOL CHEM, V279, P53584, DOI 10.1074/jbc.M408099200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Banci L, 2003, BIOCHEMISTRY-US, V42, P2467, DOI 10.1021/bi0205810; Banci L, 2007, STRUCTURE, V15, P1132, DOI 10.1016/j.str.2007.07.011; Borrelly GPM, 2004, BIOCHEM J, V378, P293, DOI 10.1042/BJ20031669; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen K, 2003, J AM CHEM SOC, V125, P12088, DOI 10.1021/ja036070y; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fujisawa K, 1998, INORG CHEM, V37, P168, DOI 10.1021/ic971317b; GARNER CD, 1984, INORG CHEM, V23, P2148, DOI 10.1021/ic00182a032; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Peariso K, 2003, J AM CHEM SOC, V125, P342, DOI 10.1021/ja028935y; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Ralle M, 1998, J AM CHEM SOC, V120, P13525, DOI 10.1021/ja982990i; Rorabacher DB, 2004, CHEM REV, V104, P651, DOI 10.1021/cr020630e; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Zeevi S, 2007, EUR J INORG CHEM, P5369, DOI 10.1002/ejic.200700710; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	31	184	184	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					148	151		10.1038/nchembio0308-148	http://dx.doi.org/10.1038/nchembio0308-148			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18277969	Green Accepted			2022-12-25	WOS:000253417400003
J	Bartlett, NW; Walton, RP; Edwards, MR; Aniscenko, J; Caramori, G; Zhu, J; Glanville, N; Choy, KJ; Jourdan, P; Burnet, J; Tuthill, TJ; Pedrick, MS; Hurle, MJ; Plumpton, C; Sharp, NA; Bussell, JN; Swallow, DM; Schwarze, J; Guy, B; WAlmond, J; Jeffery, PK; Lloyd, CM; Papi, A; Killington, RA; Rowlands, DJ; Blair, ED; Clarke, NJ; Johnston, SL				Bartlett, Nathan W.; Walton, Ross P.; Edwards, Michael R.; Aniscenko, Juliya; Caramori, Gaetano; Zhu, Jie; Glanville, Nicholas; Choy, Katherine J.; Jourdan, Patrick; Burnet, Jerome; Tuthill, Tobias J.; Pedrick, Michael S.; Hurle, Michael J.; Plumpton, Chris; Sharp, Nigel A.; Bussell, James N.; Swallow, Dallas M.; Schwarze, Jurgen; Guy, Bruno; WAlmond, Jeffrey; Jeffery, Peter K.; Lloyd, Clare M.; Papi, Alberto; Killington, Richard A.; Rowlands, David J.; Blair, Edward D.; Clarke, Neil J.; Johnston, Sebastian L.			Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation	NATURE MEDICINE			English	Article							BRONCHIAL EPITHELIAL-CELLS; POTENT ANTIVIRAL ACTIVITY; VIRUS-INDUCED ASTHMA; EFFICIENT REPLICATION; IN-VIVO; INFECTION; EXPRESSION; CHILDREN; ICAM-1; SEVERITY	Rhinoviruses cause serious morbidity and mortality as the major etiological agents of asthma exacerbations and the common cold. A major obstacle to understanding disease pathogenesis and to the development of effective therapies has been the lack of a small-animal model for rhinovirus infection. Of the 100 known rhinovirus serotypes, 90% (the major group) use human intercellular adhesion molecule-1 (ICAM-1) as their cellular receptor and do not bind mouse ICAM-1; the remaining 10% (the minor group) use a member of the low-density lipoprotein receptor family and can bind the mouse counterpart. Here we describe three novel mouse models of rhinovirus infection: minor-group rhinovirus infection of BALB/c mice, major-group rhinovirus infection of transgenic BALB/c mice expressing a mouse-human ICAM-1 chimera and rhinovirus- induced exacerbation of allergic airway inflammation. These models have features similar to those observed in rhinovirus infection in humans, including augmentation of allergic airway inflammation, and will be useful in the development of future therapies for colds and asthma exacerbations.	[Bartlett, Nathan W.; Walton, Ross P.; Edwards, Michael R.; Aniscenko, Juliya; Glanville, Nicholas; Jourdan, Patrick; Burnet, Jerome; Schwarze, Jurgen; Johnston, Sebastian L.] Wright Fleming Inst Infect & Immun, UK Natl Heart & Lung Inst, Dept Resp Med, London W2 1PG, England; [Bartlett, Nathan W.; Walton, Ross P.; Edwards, Michael R.; Aniscenko, Juliya; Glanville, Nicholas; Jourdan, Patrick; Burnet, Jerome; Schwarze, Jurgen; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, UK Ctr Allerg Mech Asthma, Med Res Council & Asthma, London W2 1PG, England; [Caramori, Gaetano; Papi, Alberto] Univ Ferrara, Res Ctr Asthma & Chron Obstruct Pulm Dis, I-44100 Ferrara, Italy; [Jeffery, Peter K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Populat Genet & Gene Therapy, London SW3 6NP, England; [Choy, Katherine J.; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England; [Tuthill, Tobias J.; Killington, Richard A.; Rowlands, David J.] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Pedrick, Michael S.; Hurle, Michael J.; Plumpton, Chris; Sharp, Nigel A.; Bussell, James N.; Blair, Edward D.; Clarke, Neil J.] Galxosmithkline Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Swallow, Dallas M.] UCL, Dept Biol, Galton Lab, London WC1E 6BT, England; [WAlmond, Jeffrey] Sanofi Pasteur, F-69007 Lyon, France	Imperial College London; Imperial College London; University of Ferrara; Imperial College London; Imperial College London; University of Leeds; GlaxoSmithKline; University of London; University College London	Johnston, SL (corresponding author), Wright Fleming Inst Infect & Immun, UK Natl Heart & Lung Inst, Dept Resp Med, Norflok Pl, London W2 1PG, England.	s.johnston@imperial.ac.uk	Caramori, Gaetano/AAS-8611-2020; Johnston, Sebastian Lennox/I-2423-2012; Schwarze, Jürgen/F-7396-2011; Papi, alberto/AAC-1888-2019	Caramori, Gaetano/0000-0002-9807-327X; Johnston, Sebastian Lennox/0000-0003-3009-9200; Schwarze, Jurgen/0000-0002-6899-748X; Edwards, Michael Robert/0000-0001-6837-0532; Glanville, Nicholas/0000-0003-0946-5050; PAPI, ALBERTO/0000-0002-6924-4500; Lloyd, Clare/0000-0001-8977-6726; Bartlett, Nathan/0000-0002-2715-5163	Medical Research Council [G0400503B, G9900991B] Funding Source: researchfish; Wellcome Trust [087618, 057704] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Bertino JS, 2002, AM J MED, V112, p42S; Chauhan AJ, 2003, LANCET, V361, P1939, DOI 10.1016/S0140-6736(03)13582-9; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Groneberg DA, 2002, HISTOPATHOLOGY, V40, P367, DOI 10.1046/j.1365-2559.2002.01378.x; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Harris JR, 2003, J VIROL, V77, P4773, DOI 10.1128/JVI.77.8.4773-4780.2003; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Inoue D, 2006, RESP PHYSIOL NEUROBI, V154, P484, DOI 10.1016/j.resp.2005.11.006; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Liao F, 1999, J IMMUNOL, V162, P186; LOMAX NB, 1989, J VIROL, V63, P2396, DOI 10.1128/JVI.63.5.2396-2399.1989; MURPHY BR, 1990, VIRUS RES, V16, P153, DOI 10.1016/0168-1702(90)90019-8; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Nakayama T, 2001, INT IMMUNOL, V13, P95, DOI 10.1093/intimm/13.1.95; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; REGISTER RB, 1991, J VIROL, V65, P6589, DOI 10.1128/JVI.65.12.6589-6596.1991; STAUNTON DE, 1992, J IMMUNOL, V148, P3271; Tuthill TJ, 2003, J GEN VIROL, V84, P2829, DOI 10.1099/vir.0.19109-0; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901	30	277	285	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					199	204		10.1038/nm1713	http://dx.doi.org/10.1038/nm1713			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18246079	Green Accepted			2022-12-25	WOS:000252946700030
J	Fujikado, N; Saijo, S; Yonezawa, T; Shimamori, K; Ishii, A; Sugai, S; Kotaki, H; Sudo, K; Nose, M; Iwakura, Y				Fujikado, Noriyuki; Saijo, Shinobu; Yonezawa, Tomo; Shimamori, Kazusuke; Ishii, Akina; Sugai, Sho; Kotaki, Hayato; Sudo, Katsuko; Nose, Masato; Iwakura, Yoichiro			Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells	NATURE MEDICINE			English	Article							RESEMBLING RHEUMATOID-ARTHRITIS; MOTH-EATEN; T-CELLS; RECEPTOR; SUPPRESSION; MUTATIONS; INDUCTION; ITIM	The dendritic cell immunoreceptor (official gene symbol Clec4a2, called Dcir here) is a C-type lectin receptor expressed mainly in dendritic cells (DCs) that has a carbohydrate recognition domain in its extracellular portion and an immunoreceptor tyrosine-based inhibitory motif, which transduces negative signals into cells, in its cytoplasmic portion(1). We found high Dcir expression in the joints of two mouse rheumatoid arthritis models(2-4). Because the structural characteristics of Dcir suggest that it may have an immune regulatory role, and because autoimmune-related genes are mapped to the DCIR locus in humans, we generated Dcir(-/-) mice to learn more about the pathological roles of this molecule. We found that aged Dcir(-/-) mice spontaneously develop sialadenitis and enthesitis associated with elevated serum autoantibodies. Dcir(-/-) mice showed a markedly exacerbated response to collagen-induced arthritis. The DC population was expanded excessively in aged and type II collagen-immunized Dcir(-/-) mice. Upon treatment with granulocyte-macrophage colony-stimulating factor, Dcir(-/-) mouse-derived bone marrow cells (BMCs) differentiated into DCs more efficiently than did wild-type BMCs, owing to enhanced signal transducer and activator of transcription-5 phosphorylation. These observations indicate that Dcir is a negative regulator of DC expansion and has a crucial role in maintaining the homeostasis of the immune system.	[Fujikado, Noriyuki; Saijo, Shinobu; Yonezawa, Tomo; Shimamori, Kazusuke; Ishii, Akina; Sugai, Sho; Sudo, Katsuko; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 108, Japan; [Yonezawa, Tomo] Genodive Pharma, Kanagawa 2591144, Japan; [Nose, Masato] Ehime Univ, Grad Sch Med, Dept Pathol, Toon, Ehime 7910295, Japan	University of Tokyo; Ehime University	Iwakura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.	iwakura@ims.u-tokyo.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Fujikado, Noriyuki/0000-0002-3183-5866; Fujikado, Noriyuki/0000-0002-0415-5929				Bates EEM, 1999, J IMMUNOL, V163, P1973; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Franceschini F, 2005, AUTOIMMUNITY, V38, P55, DOI 10.1080/08916930400022954; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Helenius LMJ, 2001, ANN RHEUM DIS, V60, P744, DOI 10.1136/ard.60.8.744; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Huang X, 2001, BIOCHEM BIOPH RES CO, V281, P131, DOI 10.1006/bbrc.2001.4322; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Richard M, 2006, MOL IMMUNOL, V43, P1716, DOI 10.1016/j.molimm.2005.10.006; Saijo S, 2002, ARTHRITIS RHEUM-US, V46, P533, DOI 10.1002/art.10172; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Zhao PL, 2006, EXP HEMATOL, V34, P951, DOI 10.1016/j.exphem.2006.04.015	23	151	157	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					176	180		10.1038/nm1697	http://dx.doi.org/10.1038/nm1697			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18204462				2022-12-25	WOS:000252946700026
J	Hollyfield, JG; Bonilha, VL; Rayborn, ME; Yang, XP; Shadrach, KG; Lu, L; Ufret, RL; Salomon, RG; Perez, VL				Hollyfield, Joe G.; Bonilha, Vera L.; Rayborn, Mary E.; Yang, Xiaoping; Shadrach, Karen G.; Lu, Liang; Ufret, Rafael L.; Salomon, Robert G.; Perez, Victor L.			Oxidative damage-induced inflammation initiates age-related macular degeneration	NATURE MEDICINE			English	Article							FACTOR-H POLYMORPHISM; CIGARETTE-SMOKING; BRUCHS MEMBRANE; DRUSEN; LIPIDS; MODEL; RISK; MICE; PHOSPHOLIPIDS; PATHOGENESIS	Oxidative damage and inflammation are postulated to be involved in age-related macular degeneration (AMD). However, the molecular signal(s) linking oxidation to inflammation in this late-onset disease is unknown. Here we describe AMD-like lesions in mice after immunization with mouse serum albumin adducted with carboxyethylpyrrole, a unique oxidation fragment of docosahexaenoic acid that has previously been found adducting proteins in drusen from AMD donor eye tissues(1) and in plasma samples(2) from individuals with AMD. Immunized mice develop antibodies to this hapten, fix complement component-3 in Bruch's membrane, accumulate drusen below the retinal pigment epithelium during aging, and develop lesions in the retinal pigment epithelium mimicking geographic atrophy, the blinding end-stage condition characteristic of the dry form of AMD. We hypothesize that these mice are sensitized to the generation of carboxyethylpyrrole adducts in the outer retina, where docosahexaenoic acid is abundant and conditions for oxidative damage are permissive. This new model provides a platform for dissecting the molecular pathology of oxidative damage in the outer retina and the immune response contributing to AMD.	[Hollyfield, Joe G.; Bonilha, Vera L.; Rayborn, Mary E.; Yang, Xiaoping; Shadrach, Karen G.; Ufret, Rafael L.; Perez, Victor L.] Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Lu, Liang; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Hollyfield, JG (corresponding author), Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA.	hollyfj@ccf.org; vperez4@med.miami.edu	Bonilha, Vera/AAS-8566-2020; Salomon, Robert G/C-3463-2008; Mohammed, Imran/J-8271-2012; Perez, Victor L./AAY-8633-2020	Bonilha, Vera/0000-0002-6166-5124; Mohammed, Imran/0000-0002-8412-0768; Salomon, Robert/0000-0001-9456-3557	NATIONAL EYE INSTITUTE [R56EY014240, R24EY015638, R01EY014240, R21EY017153, K08EY014912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER; NEI NIH HHS [K08EY014912, R21 EY017153, K08 EY014912, R21EY017153, R56 EY014240, R01 EY014240-06, R01 EY014240, R56EY10240, R24 EY015638, R24 EY015638-05, R01EY014240, R56 EY014240-06, R24EY015638] Funding Source: Medline; NIGMS NIH HHS [R01GM21249, R01 GM021249] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; ANDERSON RE, 1970, EXP EYE RES, V10, P339, DOI 10.1016/S0014-4835(70)80046-X; ANDERSON RE, 1976, EXP EYE RES, V23, P149, DOI 10.1016/0014-4835(76)90198-6; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Cousins SW, 2002, EXP EYE RES, V75, P543, DOI 10.1006/exer.2002.2047; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; GOTTSCH JD, 1993, ARCH OPHTHALMOL-CHIC, V111, P126, DOI 10.1001/archopht.1993.01090010130039; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Javitt JC, 2003, OPHTHALMOLOGY, V110, P1534, DOI 10.1016/S0161-6420(03)00495-0; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Klein R, 1999, PROG RETIN EYE RES, V18, P371, DOI 10.1016/S1350-9462(98)00025-1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PEAKMAN M, 1989, J CLIN PATHOL, V42, P1018, DOI 10.1136/jcp.42.10.1018; PERCOPO CM, 1990, J IMMUNOL, V145, P4101; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	29	537	587	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					194	198		10.1038/nm1709	http://dx.doi.org/10.1038/nm1709			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18223656	Green Accepted			2022-12-25	WOS:000252946700029
J	Men, SZ; Boutte, Y; Ikeda, Y; Li, XG; Palme, K; Stierhof, YD; Hartmann, MA; Moritz, T; Grebe, M				Men, Shuzhen; Boutte, Yohann; Ikeda, Yoshihisa; Li, Xugang; Palme, Klaus; Stierhof, York-Dieter; Hartmann, Marie-Andree; Moritz, Thomas; Grebe, Markus			Sterol-dependent endocytosis mediates post-cytokinetic acquisition of PIN2 auxin efflux carrier polarity	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; TRANSPORT; PROTEIN; GRAVITROPISM; TRAFFICKING; IDENTIFICATION; PURIFICATION; MICRODOMAINS	The polarization of yeast and animal cells relies on membrane sterols for polar targeting of proteins to the plasma membrane, their polar endocytic recycling and restricted lateral diffusion(1-4). However, little is known about sterol function in plant-cell polarity(5). Directional root growth along the gravity vector requires polar transport of the plant hormone auxin. In Arabidopsis, asymmetric plasma membrane localization of the PIN-FORMED2 (PIN2) auxin transporter directs root gravitropism(6-10). Although the composition of membrane sterols influences gravitropism and localization of two other PIN proteins(11), it remains unknown how sterols contribute mechanistically to PIN polarity. Here, we show that correct membrane sterol composition is essential for the acquisition of PIN2 polarity. Polar PIN2 localization is defective in the sterol-biosynthesis mutant cyclopropylsterol isomerase1-1 (cpi1-1) which displays altered sterol composition, PIN2 endocytosis, and root gravitropism. At the end of cytokinesis, PIN2 localizes initially to both newly formed membranes but subsequently disappears from one. By contrast, PIN2 frequently remains at both daughter membranes in endocytosis-defective cpi1-1 cells. Hence, sterol composition affects post-cytokinetic acquisition of PIN2 polarity by endocytosis, suggesting a mechanism for sterol action on establishment of asymmetric protein localization.	[Men, Shuzhen; Boutte, Yohann; Ikeda, Yoshihisa; Moritz, Thomas; Grebe, Markus] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden; [Li, Xugang; Palme, Klaus] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Hartmann, Marie-Andree] Univ Strasbourg, CNRS, UPR 2357, IBMP,Inst Plant Mol Biol, F-67083 Strasbourg, France	Swedish University of Agricultural Sciences; University of Freiburg; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grebe, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden.	markus.grebe@plantphys.umu.e	Ikeda, Yoshihisa/B-4614-2013; BOUTTE, Yohann/GVC-8653-2022; BOUTTE, Yohann/AAY-5188-2021; Palme, Klaus/A-9524-2013	BOUTTE, Yohann/0000-0002-7555-074X; Palme, Klaus/0000-0002-2728-3835; Grebe, Markus/0000-0001-7571-0670; Men, Shuzhen/0000-0001-6472-6829; Moritz, Thomas/0000-0002-4258-3190				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Betts H, 2003, CURR BIOL, V13, pR781, DOI 10.1016/j.cub.2003.09.023; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; GU J, 1994, BIOTECHNIQUES, V17, P257; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; HARTMANN MA, 1987, METHOD ENZYMOL, V148, P632; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jang JC, 2000, GENE DEV, V14, P1485; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lovato MA, 2000, J BIOL CHEM, V275, P13394, DOI 10.1074/jbc.275.18.13394; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Muller I, 2003, NAT CELL BIOL, V5, P531, DOI 10.1038/ncb991; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pichler H, 2004, BBA-BIOMEMBRANES, V1666, P51, DOI 10.1016/j.bbamem.2004.05.011; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	56	254	266	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					237	U124		10.1038/ncb1686	http://dx.doi.org/10.1038/ncb1686			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18223643				2022-12-25	WOS:000252897800020
J	Schoeftner, S; Blasco, MA				Schoeftner, Stefan; Blasco, Maria A.			Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II	NATURE CELL BIOLOGY			English	Article							EPIGENETIC REGULATION; DOSAGE COMPENSATION; POSITION; LENGTH; PROTEINS; METHYLATION; ACTIVATION; EXPRESSION; COMPLEX; GENOME	Mammalian telomeres consist of non-coding TTAGGG repeats that are bound by the multi-protein complex 'shelterin', thus protecting chromosome ends from DNA repair mechanisms and degradation(1). Mammalian telomeric chromatin is enriched for the constitutive heterochromatin marks H3K9me3, H4K20me3 and HP1 (refs 2-7). Similar to pericentric heterochromatin, telomeric heterochromatin is thought to be fundamental for the maintenance of chromosomal integrity(8). Here, we report that telomeric repeats are transcribed by DNA-dependent RNA polymerase II, which, in turn, interacts with the TRF1 shelterin protein. Telomeric RNAs (TelRNAs) contain UUAGGG repeats, are polyadenylated and are transcribed from the telomeric C-rich strand. Transcription of mammalian telomeres is regulated by several mechanisms, including developmental status, telomere length, cellular stress, tumour stage and chromatin structure. Using RNA-flourescent in situ hybridization ( FISH), we show that TelRNAs are novel structural components of telomeric chromatin. Importantly, we provide evidence that TelRNAs block the activity of telomerase in vitro, suggesting that TelRNAs may regulate telomerase activity at chromosome ends. Our results indicate that TelRNAs are novel components of mammalian telomeres, which are anticipated to be fundamental for understanding telomere biology and telomere-related diseases, such as cancer and ageing.	[Schoeftner, Stefan; Blasco, Maria A.] CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; SCHOEFTNER, Stefan/0000-0002-8918-6627				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Cohen HR, 2007, CHROMOSOMA, V116, P373, DOI 10.1007/s00412-007-0100-1; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	33	559	579	1	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					228	U106		10.1038/ncb1685	http://dx.doi.org/10.1038/ncb1685			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18157120				2022-12-25	WOS:000252897800019
J	Chang, TC; Yu, DN; Lee, YS; Wentzel, EA; Arking, DE; West, KM; Dang, CV; Thomas-Tikhonenko, A; Mendell, JT				Chang, Tsung-Cheng; Yu, Duonan; Lee, Yun-Sil; Wentzel, Erik A.; Arking, Dan E.; West, Kristin M.; Dang, Chi V.; Thomas-Tikhonenko, Andrei; Mendell, Joshua T.			Widespread microRNA repression by Myc contributes to tumorigenesis	NATURE GENETICS			English	Article							HUMAN LUNG CANCERS; C-MYC; TRANSCRIPTIONAL REPRESSION; GENES; EXPRESSION; ACTIVATION; TARGET; TRANSACTIVATION; IDENTIFICATION; TRANSFORMATION	The c-Myc oncogenic transcription factor (Myc) is pathologically activated in many human malignancies. Myc is known to directly upregulate a pro-tumorigenic group of microRNAs (miRNAs) known as the miR-17 - 92 cluster. Through the analysis of human and mouse models of B cell lymphoma, we show here that Myc regulates a much broader set of miRNAs than previously anticipated. Unexpectedly, the predominant consequence of activation of Myc is widespread repression of miRNA expression. Chromatin immunoprecipitation reveals that much of this repression is likely to be a direct result of Myc binding to miRNA promoters. We further show that enforced expression of repressed miRNAs diminishes the tumorigenic potential of lymphoma cells. These results demonstrate that extensive reprogramming of the miRNA transcriptome by Myc contributes to tumorigenesis.	[Chang, Tsung-Cheng; Lee, Yun-Sil; Wentzel, Erik A.; Arking, Dan E.; West, Kristin M.; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Dept Pediat, Sch Med, Baltimore, MD 21205 USA; [Yu, Duonan] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Can Ctr, Baltimore, MD 21205 USA; [Arking, Dan E.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	andreit@mail.vet.upenn.edu; jmendell@jhmi.edu	Thomas-Tikhonenko, Andrei/E-5329-2011; Chang, Tsung-Cheng/C-2761-2008; Dang, Chi/Y-3375-2019	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206; Chang, Tsung-Cheng/0000-0003-4706-0468; Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [R01 CA120185, R01 CA122334, R01 CA122334-02, R01 CA102709-02, R01 CA102709-03, R01 CA102709, R01 CA102709-01, R01 CA122334-01A1, R01 CA102709-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120185, R01CA102709, R01CA122334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Izumi H, 2001, J CELL SCI, V114, P1533; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LS, 1998, J IMMUNOL, V161, P1284; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Yu DN, 2005, CANCER RES, V65, P5454, DOI 10.1158/0008-5472.CAN-04-4197; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	51	1031	1083	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					43	50		10.1038/ng.2007.30	http://dx.doi.org/10.1038/ng.2007.30			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066065	Green Accepted			2022-12-25	WOS:000252118600017
J	Jones, C; Roper, VC; Foucher, I; Qian, D; Banizs, B; Petit, C; Yoder, BK; Chen, P				Jones, Chonnettia; Roper, Venus C.; Foucher, Isabelle; Qian, Dong; Banizs, Boglarka; Petit, Christine; Yoder, Bradley K.; Chen, Ping			Ciliary proteins link basal body polarization to planar cell polarity regulation	NATURE GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT; CONVERGENT EXTENSION; HAIR-CELLS; DISEASE GENE; LOCALIZATION; REGENERATION; CILIOGENESIS; ORIENTATION; STEREOCILIA; DEFECTS	Planar cell polarity (PCP) refers to coordinated polarization of cells within the plane of a cell sheet. A conserved signaling pathway is required for the establishment of PCP in epithelial tissues and for polarized cellular rearrangements known as convergent extension. During PCP signaling, core PCP proteins are sorted asymmetrically along the polarization axis; this sorting is thought to direct coordinated downstream morphogenetic changes across the entire tissue. Here, we show that a gene encoding a ciliary protein (a 'ciliary gene'), Ift88, also known as Polaris, is required for establishing epithelial PCP and for convergent extension of the cochlear duct of Mus musculus. We also show that the proper positioning of ciliary basal bodies and the formation of polarized cellular structures are disrupted in mice with mutant ciliary proteins('ciliary mutants'), whereas core PCP proteins are partitioned normally along the polarization axis. Thus, our data uncover a distinct requirement for ciliary genes in basal body positioning and morphological polarization during PCP regulation.	[Jones, Chonnettia; Qian, Dong; Chen, Ping] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Roper, Venus C.; Banizs, Boglarka; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Petit, Christine] Inst Pasteur, Unite Genet Deficits Sensoriels,Coll France, INSERM, UMRS 587, F-75724 Paris, France	Emory University; University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Bordeaux	Chen, P (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 615 Michael St, Atlanta, GA 30322 USA.	ping.chen@emory.edu		Petit, Christine/0000-0002-9069-002X; Jones, Chonnettia/0000-0003-3430-8110	NIDCD NIH HHS [R01 DC007423, F32DC008731, DC007423, R01 DC005213] Funding Source: Medline; NIDDK NIH HHS [P30 DK074038, DK065655] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065655, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005213, F32DC008731, R01DC007423] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Badea TC, 2003, J NEUROSCI, V23, P2314; Beech PL, 1996, J CELL SCI, V109, P889; Beisson J, 1999, BIOL CELL, V91, P367, DOI 10.1016/S0248-4900(99)80097-5; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Hagiwara H, 2000, HISTOCHEM J, V32, P669, DOI 10.1023/A:1004163315822; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kikuchi K, 1965, Acta Otolaryngol, V60, P207, DOI 10.3109/00016486509127003; KIKUCHI T, 1988, ACTA OTO-LARYNGOL, V106, P200, DOI 10.3109/00016488809106426; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; SANDOZ D, 1988, BIOL CELL, V63, P183, DOI 10.1016/0248-4900(88)90057-3; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SOBKOWICZ HM, 1995, J NEUROCYTOL, V24, P633, DOI 10.1007/BF01179815; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	49	249	252	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					69	77		10.1038/ng.2007.54	http://dx.doi.org/10.1038/ng.2007.54			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066062				2022-12-25	WOS:000252118600020
J	Yui, PB; Hong, CC; Sachidanandan, C; Babitt, JL; Deng, DY; Hoyng, SA; Lin, HY; Bloch, KD; Peterson, RT				Yui, Paul B.; Hong, Charles C.; Sachidanandan, Chetana; Babitt, Jodie L.; Deng, Donna Y.; Hoyng, Stefan A.; Lin, Herbert Y.; Bloch, Kenneth D.; Peterson, Randall T.			Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; DORSOVENTRAL PATTERN-FORMATION; HEPCIDIN EXPRESSION; ZEBRAFISH EMBRYO; SMAD PROTEINS; MUSCLE-CELLS; RECEPTOR; MOUSE; LIVER; OVERLOAD	Bone morphogenetic protein (BMP) signals coordinate developmental patterning and have essential physiological roles in mature organisms. Here we describe the first known small-molecule inhibitor of BMP signaling-dorsomorphin, which we identified in a screen for compounds that perturb dorsoventral axis formation in zebrafish. We found that dorsomorphin selectively inhibits the BMP type I receptors ALK2, ALK3 and ALK6 and thus blocks BMP-mediated SMAD1/5/8 phosphorylation, target gene transcription and osteogenic differentiation. Using dorsomorphin, we examined the role of BMP signaling in iron homeostasis. in vitro, dorsomorphin inhibited BMP-, hemojuvelin- and interleukin 6-stimulated expression of the systemic iron regulator hepcidin, which suggests that BMP receptors regulate hepcidin induction by all of these stimuli. In vivo, systemic challenge with iron rapidly induced SMADI/5/8 phosphorylation and hepcidin expression in the liver, whereas treatment with dorsomorphin blocked SMAD1/5/8 phosphorylation, normalized hepcidin expression and increased serum iron levels. These findings suggest an essential physiological role for hepatic BMP signaling in iron-hepcidin homeostasis.	[Yui, Paul B.; Hong, Charles C.; Sachidanandan, Chetana; Deng, Donna Y.; Hoyng, Stefan A.; Bloch, Kenneth D.; Peterson, Randall T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Yui, Paul B.; Hong, Charles C.; Sachidanandan, Chetana; Deng, Donna Y.; Hoyng, Stefan A.; Bloch, Kenneth D.; Peterson, Randall T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, Charlestown, MA 02129 USA; [Yui, Paul B.; Peterson, Randall T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Babitt, Jodie L.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Membrane Biol, Boston, MA 02114 USA; [Babitt, Jodie L.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Nephrol, Boston, MA 02114 USA; [Bloch, Kenneth D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bloch, KD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.	kdbloch@partners.org; peterson@cvrc.mgh.harvard.edu	Yu, Paul B./J-7540-2019; Girelli, Domenico/B-1183-2008; Hong, Charles/C-9989-2010	Yu, Paul B./0000-0003-2145-4944; Girelli, Domenico/0000-0001-9684-1899; Peterson, Randall/0000-0003-0727-3469; Hoyng, Stefan/0000-0001-8371-3871	NCI NIH HHS [R01 CA118498, CA118498] Funding Source: Medline; NHLBI NIH HHS [HL079267, K08 HL079943-02, HL081535, K08 HL081535-04, HL079943, K08 HL081535, R01 HL079267, R01 HL074352, HL074352, K08 HL079943] Funding Source: Medline; NIDDK NIH HHS [DK071837, R01 DK071837, K08 DK075846-02, DK075846, K08 DK075846] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA118498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, R01HL074352, R01HL079267, K08HL081535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071837, K08DK075846] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Fraley ME, 2002, BIOORG MED CHEM LETT, V12, P2767, DOI 10.1016/S0960-894X(02)00525-5; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Leung AYH, 2005, DEV BIOL, V277, P235, DOI 10.1016/j.ydbio.2004.09.032; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; LITTLE SC, 2006, C EMBRYO TODAY, V78, P224; Mintzer KA, 2001, DEVELOPMENT, V128, P859; MIYAZONO K, 2002, SCI STKE, pPE40; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Shimizu A, 1998, GENES CELLS, V3, P125, DOI 10.1046/j.1365-2443.1998.00174.x; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Takabe K, 2003, HEPATOLOGY, V38, P1107, DOI 10.1053/jhep.2003.50483; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WESTERFIELD M, 1993, ZEBRAFISH BOOK GUIDE, P1; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	793	848	1	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					33	41		10.1038/nchembio.2007.54	http://dx.doi.org/10.1038/nchembio.2007.54			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18026094	Green Accepted			2022-12-25	WOS:000251990000011
J	Ahmad, R; Raina, D; Trivedi, V; Ren, J; Rajabi, H; Kharbanda, S; Kufe, D				Ahmad, Rehan; Raina, Deepak; Trivedi, Vishal; Ren, Jian; Rajabi, Hasan; Kharbanda, Surender; Kufe, Donald			MUC1 oncoprotein activates the I kappa B kinase beta complex and constitutive NF-kappa B signalling	NATURE CELL BIOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; MAMMARY EPITHELIAL-CELLS; FACTOR-ALPHA; TNF; CANCER; IKK; MORPHOGENESIS; RECEPTOR-1; PATHWAY; GROWTH	Nuclear factor-kappa B ( NF-kappa B) is constitutively activated in diverse human malignancies by mechanisms that are not understood(1,2). The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas and, similarly to NF-kappa B, blocks apoptosis and induces transformation(3-6). This study demonstrates that overexpression of MUC1 in human carcinoma cells is associated with constitutive activation of NF-kappa B p65. We show that MUC1 interacts with the high-molecular-weight I kappa B kinase (IKK) complex in vivo and that the MUC1 cytoplasmic domain binds directly to IKK beta and IKK gamma. Interaction of MUC1 with both IKK beta and IKK gamma is necessary for IKK beta activation, resulting in phosphorylation and degradation of I kappa B alpha. Studies in non-malignant epithelial cells show that MUC1 is recruited to the TNF-R1 complex and interacts with IKK eta-IKK gamma in response to TNF alpha stimulation. TNF alpha-induced recruitment of MUC1 is dependent on TRADD and TRAF2, but not the death-domain kinase RIP1. In addition, MUC1-mediated activation of IKK beta is dependent on TAK1 and TAB2. These findings indicate that MUC1 is important for physiological activation of IKK beta and that overexpression of MUC1, as found in human cancers, confers sustained induction of the IKK beta-NF kappa B p65 pathway.	Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Kufe, D (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		NATIONAL CANCER INSTITUTE [R01CA042802, R01CA097098, P50CA100707] Funding Source: NIH RePORTER; NCI NIH HHS [CA42802, R01 CA042802, R01 CA097098, P50 CA100707, CA97098, CA100707] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Brantley DM, 2000, MECH DEVELOP, V97, P149, DOI 10.1016/S0925-4773(00)00405-6; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dyomin VG, 2000, BLOOD, V95, P2666; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lee PPH, 2000, ENDOCRINOLOGY, V141, P3764, DOI 10.1210/en.141.10.3764; Li Q, 2004, BIOCHEM BIOPH RES CO, V315, P471, DOI 10.1016/j.bbrc.2004.01.075; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P2558, DOI 10.1210/en.142.6.2558; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; SOULE HD, 1990, CANCER RES, V50, P6075; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varela LM, 1996, ENDOCRINOLOGY, V137, P4915, DOI 10.1210/en.137.11.4915; Varela LM, 1997, ENDOCRINOLOGY, V138, P3891, DOI 10.1210/en.138.9.3891; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	35	154	164	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1419	U146		10.1038/ncb1661	http://dx.doi.org/10.1038/ncb1661			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037881	Green Accepted			2022-12-25	WOS:000251317300015
J	Croker, B; Crozat, K; Berger, M; Xia, Y; Sovath, S; Schaffer, L; Eleftherianos, I; Imler, JL; Beutler, B				Croker, Ben; Crozat, Karine; Berger, Michael; Xia, Yu; Sovath, Sosathya; Schaffer, Lana; Eleftherianos, Ioannis; Imler, Jean-Luc; Beutler, Bruce			ATP-sensitive potassium channels mediate survival during infection in mammals and insects	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; DOUBLE-STRANDED-RNA; NEGATIVE REGULATOR; TNF-ALPHA; RIG-I; CYTOMEGALOVIRUS-INFECTION; MOUSE-CYTOMEGALOVIRUS; ENDOTOXIN TOLERANCE; ANTIVIRAL RESPONSE; VIRAL-INFECTION	Specific homeostatic mechanisms confer stability in innate immune responses, preventing injury or death from infection. Here we identify, from a screen of N-ethyl-N-nitrosourea-mutagenized mice, a mutation causing both profound susceptibility to infection by mouse cytomegalovirus and similar to 20,000-fold sensitization to lipopolysaccharide ( LPS), poly( I. C) and immunostimulatory ( CpG) DNA. The LPS hypersensitivity phenotype is not suppressed by mutations in Myd88, Trif, Tnf, Tnfrsf1a, Ifnb, Ifng or Stat1, genes contributing to LPS responses, and results from an abnormality extrinsic to hematopoietic cells. The phenotype is due to a null allele of Kcnj8, encoding Kir6.1, a protein that combines with SUR2 to form an ATP-sensitive potassium channel ( KATP) expressed in coronary artery smooth muscle and endothelial cells. In Drosophila melanogaster, suppression of dSUR by RNA interference similarly causes hypersensitivity to infection by flock house virus. Thus, KATP evolved to serve a homeostatic function during infection, and in mammals it prevents coronary artery vasoconstriction induced by cytokines dependent on TLR and/ or MDA5 immunoreceptors.	Scripps Res Inst, Dept Genet, IMM 31, La Jolla, CA 92037 USA; Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA; CNRS, Inst Biol Mol Cellulaire, UPR 9022, F-67084 Strasbourg, France	Scripps Research Institute; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, IMM 31, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Imler, Jean-Luc/GXH-4323-2022; Crozat, Karine/L-7297-2019	Crozat, Karine/0000-0003-4761-3675; Croker, Ben/0000-0002-0885-3599	NIAID NIH HHS [AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; HAUSMANN EHS, 1994, INFECT IMMUN, V62, P3625, DOI 10.1128/IAI.62.9.3625-3632.1994; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KEPPLER DOR, 1982, BIOCHEM J, V206, P139, DOI 10.1042/bj2060139; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LEIST M, 1994, J IMMUNOL, V153, P1778; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Muchamuel T, 1997, J IMMUNOL, V158, P2898; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Rutschmann S, 2006, J IMMUNOL, V176, P7525, DOI 10.4049/jimmunol.176.12.7525; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	49	51	53	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1453	1460		10.1038/ng.2007.25	http://dx.doi.org/10.1038/ng.2007.25			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026101				2022-12-25	WOS:000251267400012
J	Kim, E; Goraksha-Hicks, P; Li, L; Neufeld, TP; Guan, KL				Kim, Eunjung; Goraksha-Hicks, Pankuri; Li, Li; Neufeld, Thomas P.; Guan, Kun-Liang			Regulation of TORC1 by Rag GTPases in nutrient response	NATURE CELL BIOLOGY			English	Article							AMINO-ACID SUFFICIENCY; GTP-BINDING PROTEINS; P70 S6 KINASE; CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; TUBEROUS SCLEROSIS; SIGNALING PATHWAY; MAMMALIAN TARGET; FAT-BODY	TORC1 (target of rapamycin complex 1) has a crucial role in the regulation of cell growth and size. A wide range of signals, including amino acids, is known to activate TORC1. Here, we report the identification of Rag GTPases as activators of TORC1 in response to amino acid signals. Knockdown of Rag gene expression suppressed the stimulatory effect of amino acids on TORC1 in Drosophila melanogaster S2 cells. Expression of constitutively active (GTP-bound) Rag in mammalian cells activated TORC1 in the absence of amino acids, whereas expression of dominant-negative Rag blocked the stimulatory effects of amino acids on TORC1. Genetic studies in Drosophila also show that Rag GTPases regulate cell growth, autophagy and animal viability during starvation. Our studies establish a function of Rag GTPases in TORC1 activation in response to amino acid signals.	[Kim, Eunjung; Li, Li; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Eunjung; Li, Li; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Goraksha-Hicks, Pankuri; Neufeld, Thomas P.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	neufe003@umn.edu; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Neufeld, Thomas/0000-0001-5659-4811	NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509, R01GM062694] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA108941-05, R01 CA108941, CA108941] Funding Source: Medline; NIGMS NIH HHS [GM62509, R01 GM062694, R01 GM062694-09, R01 GM062509-08, R01 GM062509, GM62694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BUN YM, 1992, MOL CELL BIOL, V12, P2958; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hirose E, 1998, J CELL SCI, V111, P11; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kwiatkowski DJ, 2003, CANCER BIOL THER, V2, P471, DOI 10.4161/cbt.2.5.446; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nakashima N, 1999, GENETICS, V152, P853; Nakashima N, 1996, J CELL SCI, V109, P2311; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	48	928	966	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					935	945		10.1038/ncb1753	http://dx.doi.org/10.1038/ncb1753			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604198	Green Accepted			2022-12-25	WOS:000258147100011
J	Yan, D; Lin, XH				Yan, Dong; Lin, Xinhua			Opposing roles for glypicans in Hedgehog signalling	NATURE CELL BIOLOGY			English	Editorial Material							DALLY-LIKE; DROSOPHILA; BINDING; PATHWAY; ENDOCYTOSIS; RECEPTOR		[Yan, Dong; Lin, Xinhua] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yan, D (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	xinhua.lin@cchmc.org						Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Callejo A, 2008, P NATL ACAD SCI USA, V105, P912, DOI 10.1073/pnas.0705603105; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	16	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					761	763		10.1038/ncb0708-761	http://dx.doi.org/10.1038/ncb0708-761			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18591969				2022-12-25	WOS:000257268400006
J	Rathert, P; Dhayalan, A; Murakami, M; Zhang, X; Tamas, R; Jurkowska, R; Komatsu, Y; Shinkai, Y; Cheng, XD; Jeltsch, A				Rathert, Philipp; Dhayalan, Arunkumar; Murakami, Marie; Zhang, Xing; Tamas, Raluca; Jurkowska, Renata; Komatsu, Yasuhiko; Shinkai, Yoichi; Cheng, Xiaodong; Jeltsch, Albert			Protein lysine methyltransferase G9a acts on non-histone targets	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE H3 TAIL; SUBSTRATE-SPECIFICITY; PEPTIDE ARRAYS; METHYLATION; COMPLEX	By methylation of peptide arrays, we determined the specificity profile of the protein methyltransferase G9a. We show that it mostly recognizes an Arg-Lys sequence and that its activity is inhibited by methylation of the arginine residue. Using the specificity profile, we identified new non-histone protein targets of G9a, including CDYL1, WIZ, ACINUS and G9a (automethylation), as well as peptides derived from CSB. We demonstrate potential downstream signaling pathways for methylation of non-histone proteins.	[Rathert, Philipp; Dhayalan, Arunkumar; Tamas, Raluca; Jurkowska, Renata; Jeltsch, Albert] Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Murakami, Marie; Shinkai, Yoichi] Kyoto Univ, Res Ctr Infect Dis, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Murakami, Marie; Shinkai, Yoichi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068507, Japan; [Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Tamas, Raluca] Jacobs Univ Bremen, Sch Sci & Engn, Biochem & Cell Biol Program, D-28759 Bremen, Germany; [Komatsu, Yasuhiko] Adv Life Sci Inst Inc, R&D Div, Wako, Saitama 3510112, Japan	Jacobs University; Kyoto University; Kyoto University; Emory University; Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Shinkai, Yoichi/N-3909-2014; Jurkowska, Renata/AAE-2504-2020; Jeltsch, Albert/O-7404-2014	Shinkai, Yoichi/0000-0002-6051-2484; Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Dhayalan, Arunkumar/0000-0003-2588-9865; Komatsu, Yasuhiko/0000-0003-1739-8222; Rathert, Philipp/0000-0003-1477-136X	NIGMS NIH HHS [R01 GM068680, GM068680, R01 GM068680-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chin HG, 2005, BIOCHEMISTRY-US, V44, P12998, DOI 10.1021/bi0509907; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Ikegami K, 2007, GENES CELLS, V12, P1, DOI 10.1111/j.1365-2443.2006.01029.x; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200	18	258	274	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					344	346		10.1038/nchembio.88	http://dx.doi.org/10.1038/nchembio.88			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18438403	Green Accepted			2022-12-25	WOS:000256068600010
J	Zhao, XD; Heng, JIT; Guardavaccaro, D; Jiang, R; Pagano, M; Guillemot, F; Iavarone, A; Lasorella, A				Zhao, Xudong; Heng, Julian Ik-Tsen; Guardavaccaro, Daniele; Jiang, Richeng; Pagano, Michele; Guillemot, Francois; Iavarone, Antonio; Lasorella, Anna			The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; C-MYC; NEURONAL DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; NEUROBLASTOMA-CELLS; DEGRADATION; PROTEIN; TARGET; PROTEASOME	Development of the nervous system requires that timely withdrawal from the cell cycle be coupled with initiation of differentiation. Ubiquitin-mediated degradation of the N-Myc oncoprotein in neural stem/ progenitor cells is thought to trigger the arrest of proliferation and begin differentiation. Here we report that the HECT-domain ubiquitin ligase Huwe1 ubiquitinates the N-Myc oncoprotein through Lys 48-mediated linkages and targets it for destruction by the proteasome. This process is physiologically implemented by embryonic stem (ES) cells differentiating along the neuronal lineage and in the mouse brain during development. Genetic and RNA interference-mediated inactivation of the Huwe1 gene impedes N-Myc degradation, prevents exit from the cell cycle by opposing the expression of Cdk inhibitors and blocks differentiation through persistent inhibition of early and late markers of neuronal differentiation. Silencing of N-myc in cells lacking Huwe1 restores neural differentiation of ES cells and rescues cell-cycle exit and differentiation of the mouse cortex, demonstrating that Huwe1 restrains proliferation and enables neuronal differentiation by mediating the degradation of N-Myc. These findings indicate that Huwe1 links destruction of N-Myc to the quiescent state that complements differentiation in the neural tissue.	[Zhao, Xudong; Jiang, Richeng; Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Heng, Julian Ik-Tsen; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Guardavaccaro, Daniele; Pagano, Michele] NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Zhao, Xudong] Shanghai Res Ctr Model Organisms, Shanghai 201203, Peoples R China	Columbia University; Columbia University; Columbia University; Columbia University; MRC National Institute for Medical Research; New York University	Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu; al2179@columbia.edu	Guillemot, Francois/AAV-1482-2021	pagano, michele/0000-0003-3210-2442; Heng, Julian Ik-Tsen/0000-0002-0378-7078; Iavarone, Antonio/0000-0002-0683-4634; Guardavaccaro, Daniele/0000-0002-4517-1765; zhao, zhao xu dong/0000-0001-9126-7365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; MRC [MC_U117570528] Funding Source: UKRI; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U117570528] Funding Source: Medline; NIGMS NIH HHS [R01 GM057587-11, R01 GM057587] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; BERNARD O, 1992, NEURON, V9, P1217, DOI 10.1016/0896-6273(92)90079-S; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOGENMANN E, 1995, ONCOGENE, V10, P1915; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CIECHANOVER A, 1991, PROG CLIN BIOL RES, V366, P37; Cotta Claudiu V, 2008, Cancer, V112, P552, DOI 10.1002/cncr.23196; Deb-Basu D, 2006, CELL CYCLE, V5, P1348, DOI 10.4161/cc.5.12.2860; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fortunel NO, 2003, SCIENCE, V302, P393; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Galvin KE, 2007, DEV BIOL, V308, P331, DOI 10.1016/j.ydbio.2007.05.031; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; Peverali FA, 1996, ONCOGENE, V12, P457; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Seeger R C, 1988, Prog Clin Biol Res, V271, P41; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; STANTON BR, 1992, BRAIN PATHOL, V2, P71; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	48	203	214	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					643	653		10.1038/ncb1727	http://dx.doi.org/10.1038/ncb1727			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488021	Green Accepted			2022-12-25	WOS:000256350100011
J	Kawauchi, K; Araki, K; Tobiume, K; Tanaka, N				Kawauchi, Keiko; Araki, Keigo; Tobiume, Kei; Tanaka, Nobuyuki			P53 regulates glucose metabolism through an IKK-NF-kappa B pathway and inhibits cell transformation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; CANCER-CELLS; ALPHA; PHOSPHORYLATION; APOPTOSIS; TRANSPORTERS; GLYCOLYSIS	Cancer cells use aerobic glycolysis preferentially for energy provision(1,2) and this metabolic change is important for tumour growth(3,4). Here, we have found a link between the tumour suppressor p53, the transcription factor NF-kappa B and glycolysis. In p53-deficient primary cultured cells, kinase activities of IKK alpha and IKK beta and subsequent NF-kappa B activity were enhanced. Activation of NF-kappa B, by loss of p53, caused an increase in the rate of aerobic glycolysis and upregulation of Glut3. Oncogenic Ras-induced cell transformation and acceleration of aerobic glycolysis in p53-deficient cells were suppressed in the absence of p65/ NF-kappa B expression, and were restored by GLUT3 expression. It was also shown that a glycolytic inhibitor diminished the enhanced IKK activity in p53-deficient cells. Moreover, in Ras-expressing p53-deficient cells, IKK activity was suppressed by p65 deficiency and restored by GLUT3 expression. Taken together, these data indicate that p53 restricts activation of the IKK - NF-kappa B pathway through suppression of glycolysis. These results suggest that a positivefeedback loop exists, whereby glycolysis drives IKK - NF-kappa B activation, and that hyperactivation of this loop by loss of p53 is important in oncogene- induced cell transformation.	[Kawauchi, Keiko; Araki, Keigo; Tobiume, Kei; Tanaka, Nobuyuki] Nippon Med Coll, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Nippon Medical School	Tanaka, N (corresponding author), Nippon Med Coll, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kosugi Cho 1-396, Kawasaki, Kanagawa 2118533, Japan.	nobuta@nms.ac.jp	Kawauchi, Keiko/G-4198-2010	Tanaka, Nobuyuki/0000-0002-6373-2220				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2005, CANCER RES, V65, P177; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Meller J, 2007, J NUCL MED, V48, P35; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WARBURG O, 1956, SCIENCE, V124, P269; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	30	457	472	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					611	618		10.1038/ncb1724	http://dx.doi.org/10.1038/ncb1724			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18391940				2022-12-25	WOS:000255502400018
J	McLachlan, JB; Shelburne, CP; Hart, JP; Pizzo, SV; Goyal, R; Brooking-Dixon, R; Staats, HF; Abraham, SN				McLachlan, James B.; Shelburne, Christopher P.; Hart, Justin P.; Pizzo, Salvatore V.; Goyal, Rajen; Brooking-Dixon, Rhea; Staats, Herman F.; Abraham, Soman N.			Mast cell activators: a new class of highly effective vaccine adjuvants	NATURE MEDICINE			English	Article							NASAL IMMUNIZATION; MUCOSAL IMMUNITY; DENDRITIC CELLS; PROTECTIVE ANTIGEN; CHOLERA-TOXIN; IN-VIVO; RESPONSES; MIGRATION; HETEROGENEITY; INDUCTION	Mast cells ( MCs) have recently received recognition as prominent effectors in the regulation of immune cell migration to draining lymph nodes and lymphocyte activation. However, their role in the development of humoral immune responses is not clear. Here, we demonstrate that subcutaneous or nasal administration of small-molecule MC activators with vaccine antigens evokes large increases in antigen-specific serum immunoglobulin G ( IgG) responses. These responses were MC dependent and correlated with increased dendritic cell and lymphocyte recruitment to draining lymph nodes. Nasal instillation of these formulations also evoked antigen-specific secretory IgA and provided protection against anthrax lethal toxin challenge in vitro and against vaccinia virus infection in vivo. Collectively, these results define the MC as an integral sensory arm of the adaptive immune system. Moreover, they highlight MC activators as a new class of vaccine adjuvants, capable of inducing protective antigen-specific immune responses through needle-free routes of administration.	[McLachlan, James B.; Shelburne, Christopher P.; Hart, Justin P.; Pizzo, Salvatore V.; Goyal, Rajen; Brooking-Dixon, Rhea; Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Staats, Herman F.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	soman.abraham@duke.edu		Staats, Herman/0000-0003-1039-1087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059591, R01AI050021, R56AI074751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077159, R37DK050814, R21DK077307] Funding Source: NIH RePORTER; NIAID NIH HHS [R56 AI074751, R01-AI50021, R21 AI059591, R21 AI059591-01A1, R01 AI050021] Funding Source: Medline; NIDDK NIH HHS [R01 DK077159, R01-DK077159, R37-DK50814, R37 DK050814, R21 DK077307] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham SN, 1998, SEMIN IMMUNOL, V10, P373, DOI 10.1006/smim.1998.0140; ARIDOR M, 1993, SCIENCE, V262, P1569, DOI 10.1126/science.7504324; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BEFUS AD, 1982, J IMMUNOL, V128, P2475; Boyaka PN, 2003, J IMMUNOL, V170, P5636, DOI 10.4049/jimmunol.170.11.5636; BRUNET C, 1988, J ALLERGY CLIN IMMUN, V82, P398, DOI 10.1016/0091-6749(88)90011-5; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; DOR PJ, 1983, J ALLERGY CLIN IMMUN, V71, P363, DOI 10.1016/0091-6749(83)90063-5; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Ferry X, 2002, PEPTIDES, V23, P1507, DOI 10.1016/S0196-9781(02)00090-6; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gaur R, 2002, VACCINE, V20, P2836, DOI 10.1016/S0264-410X(02)00207-4; Gelfand EW, 2004, J ALLERGY CLIN IMMUN, V114, pS135, DOI 10.1016/j.jaci.2004.08.043; Hanna P, 1999, J APPL MICROBIOL, V87, P285, DOI 10.1046/j.1365-2672.1999.00891.x; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kruger PG, 2002, ANN NY ACAD SCI, V971, P349; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Palker TJ, 1996, VIROLOGY, V224, P415, DOI 10.1006/viro.1996.0548; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; PEARCE FL, 1986, PHARMACOLOGY, V32, P61, DOI 10.1159/000138153; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; SNIDER DP, 1994, J IMMUNOL, V153, P647; Staats HF, 1999, J IMMUNOL, V162, P6141; Staats HF, 2001, J IMMUNOL, V167, P5386, DOI 10.4049/jimmunol.167.9.5386; Staats HF, 1996, J IMMUNOL, V157, P462; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	36	158	168	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2008	14	5					536	541		10.1038/nm1757	http://dx.doi.org/10.1038/nm1757			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	298IQ	18425129	Bronze			2022-12-25	WOS:000255681800034
J	Sato, Y; Murase, K; Kato, J; Kobune, M; Sato, T; Kawano, Y; Takimoto, R; Takada, K; Miyanishi, K; Matsunaga, T; Takayama, T; Niitsu, Y				Sato, Yasushi; Murase, Kazuyuki; Kato, Junji; Kobune, Masayoshi; Sato, Tsutomu; Kawano, Yutaka; Takimoto, Rishu; Takada, Kouichi; Miyanishi, Koji; Matsunaga, Takuya; Takayama, Tetsuji; Niitsu, Yoshiro			Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone	NATURE BIOTECHNOLOGY			English	Article							RETINOL-BINDING-PROTEIN; HEPATIC STELLATE CELLS; FAT-STORING CELLS; RAT-LIVER; MOLECULAR CHAPERONE; FIBROSIS; GENE; EXPRESSION; SERUM; MICE	There are currently no approved antifibrotic therapies for liver cirrhosis. We used vitamin A-coupled liposomes to deliver small interfering RNA (siRNA) against gp46, the rat homolog of human heat shock protein 47, to hepatic stellate cells. Our approach exploits the key roles of these cells in both fibrogenesis as well as uptake and storage of vitamin A. Five treatments with the siRNA-bearing vitamin A-coupled liposomes almost completely resolved liver fibrosis and prolonged survival in rats with otherwise lethal dimethylnitrosamine-induced liver cirrhosis in a dose-and duration-dependent manner. Rescue was not related to off-target effects or associated with recruitment of innate immunity. Receptor-specific siRNA delivery was similarly effective in suppressing collagen secretion and treating fibrosis induced by CCl4 or bile duct ligation. The efficacy of the approach using both acute and chronic models of liver fibrosis suggests its therapeutic potential for reversing human liver cirrhosis.	[Sato, Yasushi; Murase, Kazuyuki; Kato, Junji; Kobune, Masayoshi; Sato, Tsutomu; Kawano, Yutaka; Takimoto, Rishu; Takada, Kouichi; Miyanishi, Koji; Matsunaga, Takuya; Takayama, Tetsuji; Niitsu, Yoshiro] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University	Niitsu, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido 0608543, Japan.	niitsu@sapmed.ac.jp		Miyanishi, Koji/0000-0002-6466-3458; Sato, Yasushi/0000-0002-6776-4609				Arthur MJP, 2002, GASTROENTEROLOGY, V122, P1525, DOI 10.1053/gast.2002.33367; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; BLOMHOFF R, 1988, P NATL ACAD SCI USA, V85, P3455, DOI 10.1073/pnas.85.10.3455; FARBER JL, 1975, AM J PATHOL, V81, P237; FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P327, DOI 10.1016/S0167-4838(00)00169-2; Fortuna VA, 2003, J CELL BIOCHEM, V90, P792, DOI 10.1002/jcb.10703; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Fuja TJ, 2006, MATRIX BIOL, V25, P59, DOI 10.1016/j.matbio.2005.08.005; Gerling B, 1996, J HEPATOL, V25, P79, DOI 10.1016/S0168-8278(96)80331-X; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; JEZEQUEL AM, 1987, J HEPATOL, V5, P174, DOI 10.1016/S0168-8278(87)80570-6; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kikuchi A, 1999, HUM GENE THER, V10, P947, DOI 10.1089/10430349950018346; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; MURAKAMI K, 1995, LAB INVEST, V72, P731; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; NOY N, 1990, BIOCHEMISTRY-US, V29, P3883, DOI 10.1021/bi00468a013; Osaka G, 1996, J PHARM SCI, V85, P612, DOI 10.1021/js9504494; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; SAUK JJ, 1994, J BIOL CHEM, V269, P3491; SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411; SENOO H, 1990, J LIPID RES, V31, P1229; SENOO H, 1993, P NATL ACAD SCI USA, V90, P3616, DOI 10.1073/pnas.90.8.3616; Serikawa T, 2000, BBA-BIOMEMBRANES, V1467, P419, DOI 10.1016/S0005-2736(00)00239-X; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Takahashi N, 2003, BIOL PHARM BULL, V26, P1060; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; Williams EJ, 2001, GUT, V49, P577, DOI 10.1136/gut.49.4.577; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Zhang X, 2004, WORLD J GASTROENTERO, V10, P610, DOI 10.3748/wjg.v10.i4.610; Zhou XY, 2004, LIVER INT, V24, P492, DOI 10.1111/j.1478-3231.2004.0946.x; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	49	430	483	7	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					431	442		10.1038/nbt1396	http://dx.doi.org/10.1038/nbt1396			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18376398				2022-12-25	WOS:000254782500026
J	Kawasaki, Y; Xu, ZZ; Wang, X; Park, JY; Zhuang, ZY; Tan, PH; Gao, YJ; Roy, K; Corfas, G; Lo, EH; Ji, RR				Kawasaki, Yasuhiko; Xu, Zhen-Zhong; Wang, Xiaoying; Park, Jong Yeon; Zhuang, Zhi-Ye; Tan, Ping-Heng; Gao, Yong-Jing; Roy, Kristine; Corfas, Gabriel; Lo, Eng H.; Ji, Ru-Rong			Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain	NATURE MEDICINE			English	Article							SPINAL NERVE LIGATION; ACTIVATED PROTEIN-KINASE; MECHANICAL ALLODYNIA; RAT MODEL; MICROGLIA; CONTRIBUTES; NEURONS; INHIBITION; ASTROCYTES; GENERATION	Treatment of neuropathic pain, triggered by multiple insults to the nervous system, is a clinical challenge because the underlying mechanisms of neuropathic pain development remain poorly understood(1-4). Most treatments do not differentiate between different phases of neuropathic pain pathophysiology and simply focus on blocking neurotransmission, producing transient pain relief. Here, we report that early- and late-phase neuropathic pain development in rats and mice after nerve injury require different matrix metalloproteinases (MMPs). After spinal nerve ligation, MMP-9 shows a rapid and transient upregulation in injured dorsal root ganglion (DRG) primary sensory neurons consistent with an early phase of neuropathic pain, whereas MMP-2 shows a delayed response in DRG satellite cells and spinal astrocytes consistent with a late phase of neuropathic pain. Local inhibition of MMP-9 by an intrathecal route inhibits the early phase of neuropathic pain, whereas inhibition of MMP-2 suppresses the late phase of neuropathic pain. Further, intrathecal administration of MMP-9 or MMP-2 is sufficient to produce neuropathic pain symptoms. After nerve injury, MMP-9 induces neuropathic pain through interleukin-1 beta cleavage and microglial activation at early times, whereas MMP-2 maintains neuropathic pain through interleukin-1b cleavage and astrocyte activation at later times. Inhibition of MMP may provide a novel therapeutic approach for the treatment of neuropathic pain at different phases.	[Kawasaki, Yasuhiko; Xu, Zhen-Zhong; Park, Jong Yeon; Zhuang, Zhi-Ye; Tan, Ping-Heng; Gao, Yong-Jing; Ji, Ru-Rong] Brigham & Womens Hosp, Dept Anesthesiol, Pain Res Ctr, Boston, MA 02115 USA; [Kawasaki, Yasuhiko; Xu, Zhen-Zhong; Park, Jong Yeon; Zhuang, Zhi-Ye; Tan, Ping-Heng; Gao, Yong-Jing; Roy, Kristine; Corfas, Gabriel; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wang, Xiaoying; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Wang, Xiaoying; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Wang, Xiaoying; Lo, Eng H.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Roy, Kristine; Corfas, Gabriel] Harvard Univ, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital	Ji, RR (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol, Pain Res Ctr, 75 Francis St, Boston, MA 02115 USA.	rrji@zeus.bwh.harvard.edu	Park, Jong Yeon/AAF-8743-2021; Ji, Ru-Rong/L-7070-2017; Gao, Yong-Jing/E-6939-2015; Corfas, Gabriel/AAH-2378-2020	Ji, Ru-Rong/0000-0002-9355-3688; Gao, Yong-Jing/0000-0002-7432-7458; Corfas, Gabriel/0000-0001-5412-9473; Xu, Zhen-Zhong/0000-0001-6578-211X; Park, Jong Yeon/0000-0003-0588-1903	FOGARTY INTERNATIONAL CENTER [R03TW007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS054362, R01NS048422, R01NS056458, R01NS054932, R37NS037074, R01NS035884, P01NS055104, R01NS037074, P50NS010828] Funding Source: NIH RePORTER; FIC NIH HHS [TW7180, R03 TW007180, R03 TW007180-03] Funding Source: Medline; NIDCR NIH HHS [R01 DE017794, R01 DE017794-02, R01-DE17794] Funding Source: Medline; NINDS NIH HHS [R01 NS037074, R01 NS056458-02, P01 NS055104, P50 NS010828, R01 NS048422-03, R01 NS054932-01A1, R37 NS037074, P50-NS10828, F30 NS054362, R01-NS54362, P01-NS55104, R01 NS056458, R01-NS56458, R01 NS093415, R01 NS035884, R01-NS37074, R01-NS48422, R01 NS037074-08, R01 NS048422, R01 NS054932] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Jin SX, 2003, J NEUROSCI, V23, P4017; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P2975, DOI 10.1016/S0960-894X(01)00601-1; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x; Sweitzer S, 2001, NEUROSCIENCE, V103, P529, DOI 10.1016/S0306-4522(00)00574-1; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	29	546	564	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2008	14	3					331	336		10.1038/nm1723	http://dx.doi.org/10.1038/nm1723			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18264108	Green Accepted			2022-12-25	WOS:000253815700040
J	Darabi, R; Gehlbach, K; Bachoo, RM; Kamath, S; Osawa, M; Kamm, KE; Kyba, M; Perlingeiro, RCR				Darabi, Radbod; Gehlbach, Kimberly; Bachoo, Robert M.; Kamath, Shwetha; Osawa, Mitsujiro; Kamm, Kristine E.; Kyba, Michael; Perlingeiro, Rita C. R.			Functional skeletal muscle regeneration from differentiating embryonic stem cells	NATURE MEDICINE			English	Article							SATELLITE CELLS; PROGENITOR CELLS; MUSCULAR-DYSTROPHY; MYOBLAST TRANSFER; PRECURSOR CELLS; MDX MYOFIBERS; IN-VITRO; EXPRESSION; MYOGENESIS; TRANSPLANTATION	Little progress has been made toward the use of embryonic stem (ES) cells to study and isolate skeletal muscle progenitors. This is due to the paucity of paraxial mesoderm formation during embryoid body (EB) in vitro differentiation and to the lack of reliable identification and isolation criteria for skeletal muscle precursors. Here we show that expression of the transcription factor Pax3 during embryoid body differentiation enhances both paraxial mesoderm formation and the myogenic potential of the cells within this population. Transplantation of Pax3-induced cells results in teratomas, however, indicating the presence of residual undifferentiated cells. By sorting for the PDGF-alpha receptor, a marker of paraxial mesoderm, and for the absence of Flk-1, a marker of lateral plate mesoderm, we derive a cell population from differentiating ES cell cultures that has substantial muscle regeneration potential. Intramuscular and systemic transplantation of these cells into dystrophic mice results in extensive engraftment of adult myofibers with enhanced contractile function without the formation of teratomas. These data demonstrate the therapeutic potential of ES cells in muscular dystrophy.	[Darabi, Radbod; Gehlbach, Kimberly; Kamath, Shwetha; Osawa, Mitsujiro; Kyba, Michael; Perlingeiro, Rita C. R.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Bachoo, Robert M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Kamm, Kristine E.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Perlingeiro, RCR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	rita.perlingeiro@utsouthwestern.edu		Kyba, Michael/0000-0002-5579-7534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081186] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081186] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Armour C, 1999, EXP CELL RES, V251, P79, DOI 10.1006/excr.1999.4567; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560; Bailey P, 2001, CURR OPIN CELL BIOL, V13, P679, DOI 10.1016/S0955-0674(00)00271-4; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bhagavati S, 2005, BIOCHEM BIOPH RES CO, V333, P644, DOI 10.1016/j.bbrc.2005.05.135; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Denetclaw WF, 1997, DEVELOPMENT, V124, P1601; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; GOULDING M, 1994, DEVELOPMENT, V120, P957; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Partridge T, 1998, NAT MED, V4, P1208, DOI 10.1038/3167; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; ROBERTSON EJ, 1986, TRENDS GENET, V2, P9, DOI 10.1016/0168-9525(86)90161-7; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Tortorella LL, 2001, J BIOL CHEM, V276, P13709, DOI 10.1074/jbc.M100091200; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025; YU J, 2007, SCIENCE	49	247	263	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					134	143		10.1038/nm1705	http://dx.doi.org/10.1038/nm1705			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18204461				2022-12-25	WOS:000252946700021
J	Pinner, S; Sahai, E				Pinner, Sophie; Sahai, Erik			PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE	NATURE CELL BIOLOGY			English	Article							SIGNALING PATHWAYS; KINASE; MIGRATION; INVASION; ACTIN; PHOSPHORYLATION; EXPRESSION; FAMILY; MEMBER; TRANSFORMATION	In three-dimensional matrices cancer cells move with a rounded, amoeboid morphology that is controlled by ROCK-dependent contraction of acto-myosin. In this study, we show that PDK1 is required for phosphorylation of myosin light chain and cell motility, both on deformable gels and in vivo. Depletion of PDK1 alters the localization of ROCK1 and reduces its ability to drive cortical acto-myosin contraction. This form of ROCK1 regulation does not require PDK1 kinase activity, but instead involves direct binding of PDK1 to ROCK1 at the plasma membrane; PDK1 competes directly with RhoE for binding to ROCK1. In the absence of PDK1, negative regulation by RhoE predominates, causing reduced acto-myosin contractility and motility. This work uncovers a novel non-catalytic role for PDK1 in regulating cortical acto-myosin and cell motility.	[Pinner, Sophie; Sahai, Erik] Canc Res UK, London Res Inst, Tumor Cell Biol Lab, London WC2A 3PX, England	Cancer Research UK	Sahai, E (corresponding author), Canc Res UK, London Res Inst, Tumor Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Erik.Sahai@cancer.org.uk	Acton, Sophie/G-9784-2012	Acton, Sophie/0000-0003-2704-716X; Sahai, Erik/0000-0002-3932-5086				Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Friedl P, 2003, BIOCHEM SOC SYMP, V70, P277, DOI 10.1042/bss0700277; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Miyazaki K, 2006, CELL BIOCHEM BIOPHYS, V45, P243, DOI 10.1385/CBB:45:3:243; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	44	201	211	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					127	U16		10.1038/ncb1675	http://dx.doi.org/10.1038/ncb1675			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18204440				2022-12-25	WOS:000252897800008
J	Lee, YS; Huang, KX; Quiocho, FA; O'Shea, EK				Lee, Young-Sam; Huang, Kexin; Quiocho, Florante A.; O'Shea, Erin K.			Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate	NATURE CHEMICAL BIOLOGY			English	Article							HIGH-AFFINITY BINDING; SACCHAROMYCES-CEREVISIAE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; TELOMERE LENGTH; PROTEIN-KINASES; PHOSPHORYLATION; PHO80-PHO85; POLYPHOSPHATES; TRANSCRIPTION; INHIBITOR	When Saccharomyces cerevisiae cells are starved of inorganic phosphate, the Pho80-Pho85 cycl in-cycl in-dependent kinase (CDK) is inactivated by the Pho81 CDK inhibitor (CKI). The regulation of Pho80-Pho85 is distinct from previously characterized mechanisms of CDK regulation: the Pho81 CKI is constitutively associated with Pho80-Pho85, and a small-molecule ligand, inositol heptakisphosphate (IP7), is required for kinase inactivation. We investigated the molecular basis of the IP7- and Pho81-dependent Pho80-Pho85 inactivation using electrophoretic mobility shift assays, enzyme kinetics and fluorescence spectroscopy. We found that IP7 interacts noncovalently with Pho80-Pho85-Pho81 and induces additional interactions between Pho81 and Pho80-Pho85 that prevent substrates from accessing the kinase active site. Using synthetic peptides corresponding to Pho81, we define regions of Pho81 responsible for constitutive Pho80-Pho85 binding and IP7-regulated interaction and inhibition. These findings expand our understanding of the mechanisms of cyclin-CDK regulation and of the biochemical mechanisms of IP7 action.	[Lee, Young-Sam; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Fac Arts & Sci,Ctr Syst Biol, Cambridge, MA 02138 USA; [Lee, Young-Sam; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Fac Arts & Sci,Ctr Syst Biol, Cambridge, MA 02138 USA; [Huang, Kexin; Quiocho, Florante A.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Baylor College of Medicine	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Fac Arts & Sci,Ctr Syst Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Lee, Young-Sam/A-2499-2013		NIGMS NIH HHS [R01 GM051377, R01 GM051377-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Bhandari R, 2007, CELL METAB, V5, P321, DOI 10.1016/j.cmet.2007.04.008; Byrne M, 2004, J MOL BIOL, V335, P57, DOI 10.1016/j.jmb.2003.10.035; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; FALCK JR, 1995, J AM CHEM SOC, V117, P12172, DOI 10.1021/ja00154a017; FERSHT A, 1987, ENZYME STRUCTURE MEC, P107; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Huang CC, 2001, CANC DRUG DISC DEV, V8, P21; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JAYARAMAN PS, 1994, EMBO J, V13, P2192, DOI 10.1002/j.1460-2075.1994.tb06496.x; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Marangoni A. G., 2002, ENZYME KINETICS MODE; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; OGAWA N, 1993, MOL GEN GENET, V238, P444, DOI 10.1007/BF00292004; OGAWA N, 1995, MOL CELL BIOL, V15, P997; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	36	118	123	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					25	32		10.1038/nchembio.2007.52	http://dx.doi.org/10.1038/nchembio.2007.52			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18059263	Green Accepted			2022-12-25	WOS:000251990000010
J	van Es, MA; van Vught, PW; Blauw, HM; Franke, L; Saris, CG; Van Den Bosch, L; de Jong, SW; de Jong, V; Baas, F; van't Slot, R; Lemmens, R; Schelhaas, HJ; Birve, A; Sleegers, K; Van Broeckhoven, C; Schymick, JC; Traynor, BJ; Wokke, JH; Wijmenga, C; Robberecht, W; Andersen, PM; Veldink, JH; Ophoff, RA; van den Berg, LH				van Es, Michael A.; van Vught, Paul Wj; Blauw, Hylke M.; Franke, Lude; Saris, Christiaan G. J.; Van Den Bosch, Ludo; de Jong, Sonja W.; de Jong, Vianney; Baas, Frank; van't Slot, Ruben; Lemmens, Robin; Schelhaas, Helenius J.; Birve, Anna; Sleegers, Kristel; Van Broeckhoven, Christine; Schymick, Jennifer C.; Traynor, Bryan J.; Wokke, John H. J.; Wijmenga, Cisca; Robberecht, Wim; Andersen, Peter M.; Veldink, Jan H.; Ophoff, Roel A.; van den Berg, Leonard H.			Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							SPORADIC ALS; MUTATIONS	We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04x10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18 - 1.43). Our finding is the first report of a genome-wide significant association with sporadic ALS and may be a target for future functional studies.	[van Es, Michael A.; van Vught, Paul Wj; Blauw, Hylke M.; Saris, Christiaan G. J.; de Jong, Sonja W.; Wokke, John H. J.; Veldink, Jan H.; van den Berg, Leonard H.] Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Franke, Lude; van't Slot, Ruben; Wijmenga, Cisca] Univ Med Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3584 CX Utrecht, Netherlands; [Van Den Bosch, Ludo; Robberecht, Wim] Univ Hosp Gasthuisberg, Dept Neurol, B-3000 Louvain, Belgium; [de Jong, Vianney] Univ Amsterdam, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Baas, Frank] Univ Amsterdam, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Schelhaas, Helenius J.] Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 GA Nijmegen, Netherlands; [Birve, Anna] Umea Univ Hosp, Inst Clin Neurosci, SE-90185 Umea, Sweden; [Baas, Frank; Sleegers, Kristel] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp VIB, B-2610 Antwerp, Belgium; [Schymick, Jennifer C.] NIA, Neurogenet Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; [Traynor, Bryan J.] NIMH, Sect Dev Genet Epidemiol, Bethesda, MD 20892 USA; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; KU Leuven; University Hospital Leuven; University of Amsterdam; University of Amsterdam; Radboud University Nijmegen; Umea University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	van den Berg, LH (corresponding author), Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	Ophoff@ucla.edu; L.H.vandenBerg@umcutrecht.nl	Van Broeckhoven, Christine/M-7853-2019; van+Es, Michael/AAC-5772-2021; Traynor, Bryan J/G-5690-2010; Van Broeckhoven, Christine/G-8362-2017; Wijmenga, Cisca/D-2173-2009; Saris, C.G.J./L-4623-2015; Schelhaas, Helenius Jurgen/E-2815-2010; Van Den Bosch, Ludo/B-7258-2012; Franke, Lude/P-7036-2016; Wijmenga, Cisca/AAE-7719-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Baas, Frank/F-9574-2010; Sander-Effron, Samuel/AAX-2231-2020	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Baas, Frank/0000-0003-3912-5428; Van Den Bosch, Ludo/0000-0003-0104-4067; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Lemmens, Robin/0000-0002-4948-5956	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000933, ZIAAG000933] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68875] Funding Source: Medline; NIMH NIH HHS [MH078075] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Saeed M, 2006, NEUROLOGY, V67, P771, DOI 10.1212/01.wnl.0000227187.52002.88; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Veldink JH, 2005, NEUROLOGY, V65, P820, DOI 10.1212/01.wnl.0000174472.03292.dd; WADA K, 1993, MAMM GENOME, V4, P234, DOI 10.1007/BF00417570; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109	14	176	180	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					29	31		10.1038/ng.2007.52	http://dx.doi.org/10.1038/ng.2007.52			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084291				2022-12-25	WOS:000252118600014
J	Mi, W; Pawlik, M; Sastre, M; Jung, SS; Radvinsky, DS; Klein, AM; Sommer, J; Schmidt, SD; Nixon, RA; Mathews, PM; Levy, E				Mi, Weiqian; Pawlik, Monika; Sastre, Magdalena; Jung, Sonia S.; Radvinsky, David S.; Klein, Andrew M.; Sommer, John; Schmidt, Stephen D.; Nixon, Ralph A.; Mathews, Paul M.; Levy, Efrat			Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models	NATURE GENETICS			English	Article						`	CEREBRAL-HEMORRHAGE; ANGIOPATHY; PROTEIN; VARIANT; STROKE	Using transgenic mice expressing human cystatin C ( encoded by CST3), we show that cystatin C binds soluble amyloid-beta peptide and inhibits cerebral amyloid deposition in amyloid-beta precursor protein ( APP) transgenic mice. Cystatin C expression twice that of the endogenous mouse cystatin C was sufficient to substantially diminish amyloid-beta deposition. Thus, cystatin C has a protective role in Alzheimer's disease pathogenesis, and modulation of cystatin C concentrations may have therapeutic implications for the disease.	Nathan S Kline Inst, Orangeburg, NY 10962 USA; NYU, Sch Med, New York, NY 10016 USA; Centocor Res & Dev Inc, Radnor, PA 19087 USA	Nathan Kline Institute for Psychiatric Research; New York University; Johnson & Johnson; Johnson & Johnson USA	Levy, E (corresponding author), Nathan S Kline Inst, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012	Mathews, Paul/0000-0003-1742-7687	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER; NIA NIH HHS [AG017617] Funding Source: Medline; NINDS NIH HHS [NS42029] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; VINTERS HV, 1990, AM J PATHOL, V137, P233	15	142	148	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1440	1442		10.1038/ng.2007.29	http://dx.doi.org/10.1038/ng.2007.29			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026100				2022-12-25	WOS:000251267400010
J	Myers, AJ; Gibbs, JR; AWebster, J; Rohrer, K; Zhao, A; Marlowe, L; Kaleem, M; Leung, D; Bryden, L; Nath, P; Zismann, VL; Joshipura, K; Huentelman, MJ; Hu-Lince, D; Coon, KD; Craig, DW; Pearson, JV; Holmans, P; Heward, CB; Reiman, EM; Stephan, D; Hardy, J				Myers, Amanda J.; Gibbs, J. Raphael; AWebster, Jennifer; Rohrer, Kristen; Zhao, Alice; Marlowe, Lauren; Kaleem, Mona; Leung, Doris; Bryden, Leslie; Nath, Priti; Zismann, Victoria L.; Joshipura, Keta; Huentelman, Matthew J.; Hu-Lince, Diane; Coon, Keith D.; Craig, David W.; Pearson, John V.; Holmans, Peter; Heward, Christopher B.; Reiman, Eric M.; Stephan, Dietrich; Hardy, John			A survey of genetic human cortical gene expression	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; ALZHEIMERS-DISEASE; ALLELIC EXPRESSION; BRAIN; HAPLOTYPE; INFERENCE; MICE; APOE	It is widely assumed that genetic differences in gene expression underpin much of the difference among individuals and many of the quantitative traits of interest to geneticists. Despite this, there has been little work on genetic variability in human gene expression and almost none in the human brain, because tools for assessing this genetic variability have not been available. Now, with whole-genome SNP genotyping arrays and whole-transcriptome expression arrays, such experiments have become feasible. We have carried out whole-genome genotyping and expression analysis on a series of 193 neuropathologically normal human brain samples using the Affymetrix GeneChip Human Mapping 500K Array Set and Illumina HumanRefseq-8 Expression BeadChip platforms. Here we present data showing that 58% of the transcriptome is cortically expressed in at least 5% of our samples and that of these cortically expressed transcripts, 21% have expression profiles that correlate with their genotype. These genetic-expression effects should be useful in determining the underlying biology of associations with common diseases of the human brain and in guiding the analysis of the genomic regions involved in the control of normal gene expression.	NIH, NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Univ Miami, Miller Sch Med, Dept Psychiat & Biobehav Sci, Div Neurosci, Miami, FL 33136 USA; Reta Lila Weston Inst, Neurol Inst, Dept Mol Neurosci & Neurodegenerat Dis, London WC1N 3BG, England; Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA; St Josephs Hosp, Med Ctr, Div Thorac Oncol Res, Phoenix, AZ 85013 USA; Cardiff Univ, Dept Psychol Med, Bioinformat Unit, Cardiff CF14 4XN, Wales; Kronos Sci Lab, Phoenix, AZ 85016 USA; Banner Alzheimers Inst, Phoenix, AZ 85006 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Miami; University of London; University College London; Translational Genomics Research Institute; St. Joseph's Hospital and Medical Center; Cardiff University; Banner Research; Banner Health; Banner Alzheimer's Institute	Myers, AJ (corresponding author), NIH, NIA, Neurogenet Lab, Bldg 10,Main Campus,Porter Neurosci Bldg, Bethesda, MD 20892 USA.	amyers@med.miami.edu	Pearson, John/AAT-4211-2020; Hardy, John/C-2451-2009; Holmans, Peter/F-4518-2015; Pearson, John V/F-2249-2011; Craig, David Wesley/K-6961-2019; Leung, Doris G/R-5447-2016; Myers, Amanda J/B-1796-2010; Gibbs, J. Raphael/A-3984-2010	Hardy, John/0000-0002-3122-0423; Holmans, Peter/0000-0003-0870-9412; Pearson, John V/0000-0003-0904-4598; Craig, David Wesley/0000-0003-2040-1955; Leung, Doris G/0000-0002-2558-7798; Myers, Amanda J/0000-0002-3100-9396; Gibbs, J. Raphael/0000-0002-6985-0658	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051872, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P30AG013846, P50AG005136, P30AG019610, P50AG016570, P50AG005146, U01AG016976, P50AG005144, P50AG008671, P30AG010161] Funding Source: NIH RePORTER; Medical Research Council [G9810900, G0701075] Funding Source: Medline; NHLBI NIH HHS [UO1HL084744] Funding Source: Medline; NIA NIH HHS [P50 AG05136, AG10161, P30 AG19610, AG05144, P30-AG13846, P50AG05681, AG05146, P50 AG16570, U01 AG016976, AG05128, P50-AG08671] Funding Source: Medline; NIMH NIH HHS [MH60451] Funding Source: Medline; NINDS NIH HHS [NS39764, U24NS051872] Funding Source: Medline; MRC [G9810900, G0701075] Funding Source: UKRI	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Falush D, 2003, GENETICS, V164, P1567; GILBERT JM, 1981, J NEUROCHEM, V36, P976, DOI 10.1111/j.1471-4159.1981.tb01689.x; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tukey JW, 1977, EXPLORATORY DATA ANA; WORKMAN C, 2002, GENOME BIOL, V0003	20	387	394	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1494	1499		10.1038/ng.2007.16	http://dx.doi.org/10.1038/ng.2007.16			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982457				2022-12-25	WOS:000251267400018
J	Vincent, KA; Li, X; Blanford, CF; Belsey, NA; Weiner, JH; Armstrong, FA				Vincent, Kylie A.; Li, Xiang; Blanford, Christopher F.; Belsey, Natalie A.; Weiner, Joel H.; Armstrong, Fraser A.			Enzymatic catalysis on conducting graphite particles	NATURE CHEMICAL BIOLOGY			English	Article							ELECTRON-TRANSFER; PYROLYTIC-GRAPHITE; NITRATE REDUCTASE; ESCHERICHIA-COLI; SURFACE	A new concept for enzyme-catalyzed redox transformations features pairs of electron donor and acceptor enzymes attached to conducting particles. Electrons furnished by oxidation at one enzyme are used at the other. Graphite microparticles modified with hydrogenase and nitrate reductase or fumarate reductase catalyze reductions of nitrate or fumarate (1) by H-2.	Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada	University of Oxford; University of Alberta	Armstrong, FA (corresponding author), Univ Oxford, Inorgan Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	fraser.armstrong@chem.ox.ac.uk	Belsey, Natalie/I-2053-2015; Blanford, Christopher/C-1061-2008; Vincent, Kylie/H-1224-2011	Belsey, Natalie/0000-0001-7773-0966; Blanford, Christopher/0000-0002-0112-7818; Vincent, Kylie/0000-0001-6444-9382	Engineering and Physical Sciences Research Council [EP/D047943/1] Funding Source: researchfish; EPSRC [EP/D047943/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D52222X/1] Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], [No title captured]; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blanford CF, 2007, CHEM COMMUN, P1710, DOI 10.1039/b703114a; Blanford CF, 2006, J SOLID STATE ELECTR, V10, P826, DOI 10.1007/s10008-006-0183-2; Elliott SJ, 2004, BIOCHEMISTRY-US, V43, P799, DOI 10.1021/bi035869j; GOLDSTEIN JI, 1992, SCANNING ELECT MICRO, P79; Hudson JM, 2005, J AM CHEM SOC, V127, P6977, DOI 10.1021/ja043404q; Landis D., 1996, HDB INTERCULTURAL TR, V2nd; Leger C, 2003, BIOCHEMISTRY-US, V42, P8653, DOI 10.1021/bi034789c; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; YAJIMA S, 1969, J MATER SCI, V4, P692, DOI 10.1007/BF00742425	14	58	59	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					760	761		10.1038/nchembio.2007.47	http://dx.doi.org/10.1038/nchembio.2007.47			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17994012				2022-12-25	WOS:000251028600008
J	da Silva, FP; Aloulou, M; Skurnik, D; Benhamou, M; Andremont, A; Velasco, IT; Chiamolera, M; Verbeek, JS; Launay, P; Monteiro, RC				da Silva, Fabiano Pinheiro; Aloulou, Meryem; Skurnik, David; Benhamou, Marc; Andremont, Antoine; Velasco, Irineu T.; Chiamolera, Murilo; Verbeek, J. Sjef; Launay, Pierre; Monteiro, Renato C.			CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation	NATURE MEDICINE			English	Article							DEFICIENT MICE; RECEPTOR MARCO; RESPONSES; MACROPHAGES; MONOCYTES; DAP12; COMPLEXES; INFECTION; 3-KINASE; SHOCK	Sepsis, a leading cause of death worldwide, involves proinflammatory responses and inefficient bacterial clearance(1,2). Phagocytic cells play a crucial part in the prevention of sepsis by clearing bacteria through host innate receptors(3). Here we show that the FcR gamma adaptor, an immunoreceptor tyrosine-based activation motif (ITAM)-bearing signal transduction subunit of the Fc receptor family, has a deleterious effect on sepsis. FcR gamma(-/-) mice show increased survival during peritonitis, owing to markedly increased E. coli phagocytosis and killing and to lower production of the proinflammatory cytokine tumor necrosis factor (TNF)-alpha. The FcR gamma-associated receptor that inhibits E. coli phagocytosis is Fc gamma RIII (also called CD16), and its absence protects mice from sepsis. Fc gamma RIII binds E. coli, and this interaction induces FcR gamma phosphorylation, recruitment of the tyrosine phosphatase SHP-1 and phosphatidylinositide-3 kinase (PI3K) dephosphorylation. Decreased PI3K activity inhibits E. coli phagocytosis and increases TNF-alpha production through Toll-like receptor 4. We identified the phagocytic receptor negatively regulated by FcR gamma on macrophages as the class A scavenger receptor MARCO. E. coli-Fc gamma RIII interaction induces the recruitment of SHP-1 to MARCO, thereby inhibiting E. coli phagocytosis. Thus, by binding FccRIII, E. coli triggers an inhibitory FcR gamma pathway that both impairs MARCO-mediated bacterial clearance and activates TNF-a secretion.	Univ Paris 07, INSERM, U699, F-75018 Paris, France; Univ Paris 07, Bichat Med Sch, F-75018 Paris, France; Univ Sao Paulo, Dept Emergency Med, BR-01246903 Sao Paulo, Brazil; Univ Paris 07, Bichat Claude Bernard Hosp, Dept Bacteriol, F-75018 Paris, France; Univ Paris 07, EA 6934, F-75018 Paris, France; Univ Sao Paulo, Div Rheumatol, BR-01246903 Sao Paulo, Brazil; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Equipe Avenir Inst Natl Sante & Rech Med, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm)	Monteiro, RC (corresponding author), Univ Paris 07, INSERM, U699, 16 Rue Henri Huchard, F-75018 Paris, France.	monteiro@bichat.inserm.fr	da Silva, Fabiano Pinheiro/F-3464-2011; chiamolera, murilo/T-7817-2019; Aloulou, Meryem/AAA-6713-2020; Launay, Pierre/AAH-7076-2019; Monteiro, Renato C/U-8633-2017	da Silva, Fabiano Pinheiro/0000-0003-2673-2202; Aloulou, Meryem/0000-0003-4590-230X; Monteiro, Renato C/0000-0001-5202-5646; Benhamou, Marc/0000-0001-7763-3795				Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Daeron M, 2006, ADV IMMUNOL, V89, P39, DOI 10.1016/S0065-2776(05)89002-9; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Kraal G, 2000, MICROBES INFECT, V2, P313, DOI 10.1016/S1286-4579(00)00296-3; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; LEIJH PCJ, 1979, J CLIN INVEST, V63, P772, DOI 10.1172/JCI109362; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Opal SM, 2001, CRIT CARE MED, V29, P13, DOI 10.1097/00003246-200101000-00003; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Pinheiro-da-Silva F, 2006, SHOCK, V25, P61, DOI 10.1097/01.shk.0000196496.72553.78; SALMON JE, 1987, J EXP MED, V166, P1798, DOI 10.1084/jem.166.6.1798; Sano H, 1998, J BIOL CHEM, V273, P8630, DOI 10.1074/jbc.273.15.8630; Skinner NA, 2005, CLIN EXP IMMUNOL, V141, P270, DOI 10.1111/j.1365-2249.2005.02839.x; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; SUNG SSJ, 1985, J IMMUNOL, V135, P1981; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449	30	98	99	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1368	1374		10.1038/nm1665	http://dx.doi.org/10.1038/nm1665			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17934470				2022-12-25	WOS:000250736900031
J	Hanes, JW; Keresztes, I; Begley, TP				Hanes, Jeremiah W.; Keresztes, Ivan; Begley, Tadhg P.			C-13 NMR snapshots of the complex reaction coordinate of pyridoxal phosphate synthase	NATURE CHEMICAL BIOLOGY			English	Article							5'-PHOSPHATE SYNTHASE; CHROMOPHORIC INTERMEDIATE; VITAMIN-B6 BIOSYNTHESIS; PLASMODIUM-FALCIPARUM; BACILLUS-SUBTILIS; PATHWAY; ENZYMES; ARABIDOPSIS; MECHANISM; INSIGHTS	The predominant biosynthetic route to vitamin B6 is catalyzed by a single enzyme. The synthase subunit of this enzyme, Pdx1, operates in concert with the glutaminase subunit, Pdx2, to catalyze the complex condensation of ribose 5- phosphate, glutamine and glyceraldehyde 3-phosphate to form pyridoxal 5'-phosphate, the active form of vitamin B6. In previous studies it became clear that many if not all of the reaction intermediates were covalently bound to the synthase subunit, thus making them difficult to isolate and characterize. Here we show that it is possible to follow a single turnover reaction by heteronuclear NMR using C-13- and N-15-labeled substrates as well as N-15-labeled synthase. By denaturing the enzyme at points along the reaction coordinate, we solved the structures of three covalently bound intermediates. This analysis revealed a new 1,5 migration of the lysine amine linking the intermediate to the enzyme during the conversion of ribose 5-phosphate to pyridoxal 5'-phosphate.	[Hanes, Jeremiah W.; Keresztes, Ivan; Begley, Tadhg P.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab 120, Ithaca, NY 14853 USA	Cornell University	Begley, TP (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Baker Lab 120, Ithaca, NY 14853 USA.	tpb2@cornell.edu	Begley, Tadhg/B-5801-2015		NIGMS NIH HHS [GM069618] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069618] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; ANDERSON KS, 1990, BIOCHEMISTRY-US, V29, P1460, DOI 10.1021/bi00458a017; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; Dong YX, 2004, EUR J BIOCHEM, V271, P745, DOI 10.1111/j.1432-1033.2003.03973.x; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Flicker K, 2007, J MOL BIOL, V374, P732, DOI 10.1016/j.jmb.2007.09.038; Garrido-Franco M, 2003, BBA-PROTEINS PROTEOM, V1647, P92, DOI 10.1016/S1570-9639(03)00065-7; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; Hanes JW, 2008, ANGEW CHEM INT EDIT, V47, P2102, DOI 10.1002/anie.200704390; Neuwirth M, 2007, BIOCHEMISTRY-US, V46, P5131, DOI 10.1021/bi602602x; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Tambasco-Studart M, 2007, PLANT PHYSIOL, V144, P915, DOI 10.1104/pp.107.096784; Wetzel DK, 2004, FEBS LETT, V564, P143, DOI 10.1016/S0014-5793(04)00329-1; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y	24	22	23	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					425	430		10.1038/nchembio.93	http://dx.doi.org/10.1038/nchembio.93			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18516049				2022-12-25	WOS:000256929900013
J	Mueller, JL; Mahadevaiah, SK; Park, PJ; Warburton, PE; Page, DC; Turner, JMA				Mueller, Jacob L.; Mahadevaiah, Shantha K.; Park, Peter J.; Warburton, Peter E.; Page, David C.; Turner, James M. A.			The mouse X chromosome is enriched for multicopy testis genes showing postmeiotic expression	NATURE GENETICS			English	Article							DIFFERENTIAL EXPRESSION; SEX-CHROMOSOMES; HUMAN GENOME; INACTIVATION; HETEROCHROMATIN; CHROMATIN	According to the prevailing view, mammalian X chromosomes are enriched in spermatogenesis genes expressed before meiosis(1-3) and deficient in spermatogenesis genes expressed after meiosis(2,3).The paucity of postmeiotic genes on the X chromosome has been interpreted as a consequence of meiotic sex chromosome inactivation (MSCI)-the complete silencing of genes on the XY bivalent at meiotic prophase(4,5). Recent studies have concluded that MSCI-initiated silencing persists beyond meiosis(6-8) and that most genes on the X chromosome remain repressed in round spermatids(7). Here, we report that 33 multicopy gene families, representing similar to 273 mouse X-linked genes, are expressed in the testis and that this expression is predominantly in postmeiotic cells. RNA FISH and microarray analysis show that the maintenance of X chromosome postmeiotic repression is incomplete. Furthermore, X-linked multicopy genes exhibit a similar degree of expression as autosomal genes. Thus, not only is the mouse X chromosome enriched for spermatogenesis genes functioning before meiosis, but in addition, similar to 18% of mouse X-linked genes are expressed in postmeiotic cells.	[Mueller, Jacob L.; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Mueller, Jacob L.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Mahadevaiah, Shantha K.; Turner, James M. A.] Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, London NW7 1AA, England; [Park, Peter J.] Harvard Partners Ctr Genet & Genom, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Warburton, Peter E.] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); MRC National Institute for Medical Research; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai	Mueller, JL (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jmueller@wi.mit.edu; jturner@nimr.mrc.ac.uk		Park, Peter/0000-0001-9378-960X; Mueller, Jacob L./0000-0003-1232-0303	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U117588498] Funding Source: Medline; NICHD NIH HHS [F32 HD052379, F32HD052379, HD000257, F32 HD052379-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD052379] Funding Source: NIH RePORTER; MRC [MC_U117588498] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Reinke V, 2004, NAT GENET, V36, P548, DOI 10.1038/ng0604-548; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Westbrook VA, 2006, MOL HUM REPROD, V12, P703, DOI 10.1093/molehr/gal079; Westbrook VA, 2000, BIOL REPROD, V63, P469, DOI 10.1093/biolreprod/63.2.469	21	220	223	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					794	799		10.1038/ng.126	http://dx.doi.org/10.1038/ng.126			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454149	Green Accepted			2022-12-25	WOS:000256212000023
J	Savaskan, NE; Heckel, A; Hahnen, E; Engelhorn, T; Doerfler, A; Ganslandt, O; Nimsky, C; Buchfelder, M; Eyupoglu, IY				Savaskan, Nicolai E.; Heckel, Alexandra; Hahnen, Eric; Engelhorn, Tobias; Doerfler, Arnd; Ganslandt, Oliver; Nimsky, Christopher; Buchfelder, Michael; Eyuepoglu, Ilker Y.			Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema	NATURE MEDICINE			English	Article							HUMAN GLIOBLASTOMA; GLUTAMATE; GROWTH; TUMORS; CYSTINE; CELLS; MICE	Neurodegeneration and brain edema are hallmarks of human malignant brain tumors. Here we show that genetic or pharmacological inhibition of the glutamate transporter xCT (X-c(-) system, encoded by SLC7a11) in vivo leads to abrogated neurodegeneration, attenuated perifocal edema and prolonged survival. These results show a crucial role for xCT in glioma-induced neurodegeneration and brain edema, corroborating the concept that edema formation may be in part a consequence of peritumoral cell death.	[Savaskan, Nicolai E.] Swiss Fed Inst Technol, Brain Res Inst, CH-8057 Zurich, Switzerland; [Savaskan, Nicolai E.] Univ Zurich, CH-8057 Zurich, Switzerland; [Savaskan, Nicolai E.] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; [Heckel, Alexandra; Ganslandt, Oliver; Nimsky, Christopher; Buchfelder, Michael; Eyuepoglu, Ilker Y.] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany; [Hahnen, Eric] Univ Cologne, Inst Genet, Inst Human Genet, D-50674 Cologne, Germany; [Hahnen, Eric] Univ Cologne, Ctr Mol Med Colonge, D-50674 Cologne, Germany; [Hahnen, Eric] Univ Erlangen Nurnberg, Dept Neuropathol, D-91054 Erlangen, Germany; [Engelhorn, Tobias; Doerfler, Arnd] Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Netherlands Cancer Institute; University of Erlangen Nuremberg; University of Cologne; University of Cologne; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Savaskan, NE (corresponding author), Swiss Fed Inst Technol, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	savaskan@gmx.net; ilker.eyupoglu@uk-erlangen.de	Nimsky, Christopher/E-3702-2014; Savaskan, Nicolai/D-2923-2018	Nimsky, Christopher/0000-0002-8216-9410; Savaskan, Nicolai/0000-0003-1348-094X; Eyupoglu, Ilker/0000-0002-8185-7764				Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Wick W, 2004, ONKOLOGIE, V27, P261, DOI 10.1159/000077976; Ye ZC, 1999, CANCER RES, V59, P4383	15	136	137	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					629	632		10.1038/nm1772	http://dx.doi.org/10.1038/nm1772			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18469825				2022-12-25	WOS:000256468700028
J	Ji, WZ; Foo, JN; O'Roak, BJ; Zhao, H; Larson, MG; Simon, DB; Newton-Cheh, C; State, MW; Levy, D; Lifton, RP				Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Larson, Martin G.; Simon, David B.; Newton-Cheh, Christopher; State, Matthew W.; Levy, Daniel; Lifton, Richard P.			Rare independent mutations in renal salt handling genes contribute to blood pressure variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NA-CL COTRANSPORTER; CORONARY-HEART-DISEASE; BARTTERS-SYNDROME; HYPOKALEMIC ALKALOSIS; RISK; HYPERCALCIURIA; SUSCEPTIBILITY; MECHANISMS; EXPRESSION	The effects of alleles in many genes are believed to contribute to common complex diseases such as hypertension. Whether risk alleles comprise a small number of common variants or many rare independent mutations at trait loci is largely unknown. We screened members of the Framingham Heart Study (FHS) for variation in three genes-SLC12A3 (NCCT), SLC12A1 (NKCC2) and KCNJ1 (ROMK)- causing rare recessive diseases featuring large reductions in blood pressure. Using comparative genomics, genetics and biochemistry, we identified subjects with mutations proven or inferred to be functional. These mutations, all heterozygous and rare, produce clinically significant blood pressure reduction and protect from development of hypertension. Our findings implicate many rare alleles that alter renal salt handling in blood pressure variation in the general population, and identify alleles with health benefit that are nonetheless under purifying selection. These findings have implications for the genetic architecture of hypertension and other common complex traits.	[Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Simon, David B.; State, Matthew W.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ji, Weizhen; Foo, Jia Nee; Simon, David B.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Larson, Martin G.; Newton-Cheh, Christopher; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, New Haven, CT 06520 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Yale University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	richard.lifton@yale.edu	State, Matthew/W-2256-2019; Foo, Jia Nee/D-6069-2014; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Foo, Jia Nee/0000-0001-9899-2308; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; State, Matthew/0000-0003-1624-8302; O'Roak, Brian/0000-0002-4141-0095	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007, ZIAHL006001] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [N01-HC-25195, P50 HL055007, N01HC25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Cruz DN, 2001, NEPHROL DIAL TRANSPL, V16, P691, DOI 10.1093/ndt/16.4.691-a; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; He J, 1999, AM HEART J, V138, pS211, DOI 10.1016/S0002-8703(99)70312-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Murphy KM, 2003, EXPERT REV MOL DIAGN, V3, P811, DOI 10.1586/14737159.3.6.811; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; RUDIN A, 1988, ACTA MED SCAND, V224, P165; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaer AJ, 2001, AM J MED SCI, V322, P316, DOI 10.1097/00000441-200112000-00004; SIECK UV, 1984, OBSTET GYNECOL, V63, pS22; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Syren Marie-Louise, 2002, Hum Mutat, V20, P78, DOI 10.1002/humu.9045; Takahashi N, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133604; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	46	588	631	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					592	599		10.1038/ng.118	http://dx.doi.org/10.1038/ng.118			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391953	Green Accepted			2022-12-25	WOS:000255366700027
J	Johansson, CB; Youssef, S; Koleckar, K; Holbrook, C; Doyonnas, R; Corbel, SY; Steinman, L; Rossi, FMV; Blau, HM				Johansson, Clas B.; Youssef, Sawsan; Koleckar, Kassie; Holbrook, Colin; Doyonnas, Regis; Corbel, Stephane Y.; Steinman, Lawrence; Rossi, Fabio M. V.; Blau, Helen M.			Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation	NATURE CELL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BLOOD-BRAIN-BARRIER; BONE-MARROW; SKELETAL-MUSCLE; STEM-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MYELOMONOCYTIC PRECURSORS; MULTIPLE-SCLEROSIS; REGENERATION	Transplanted bone marrow-derived cells (BMDCs) have been reported to fuse with cells of diverse tissues(1-13), but the extremely low frequency of fusion has led to the view that such events are biologically insignificant. Nonetheless, in mice with a lethal recessive liver disease ( tyrosinaemia), transplantation of wildtype BMDCs restored liver function by cell fusion and prevented death(3,9), indicating that cell fusion can have beneficial effects. Here we report that chronic inflammation resulting from severe dermatitis or autoimmune encephalitis leads to robust fusion of BMDCs with Purkinje neurons and formation of hundreds of binucleate heterokaryons per cerebellum, a 10-100- fold higher frequency than previously reported(8,10,11,14). Single haematopoietic stem-cell transplants showed that the fusogenic cell is from the haematopoietic lineage and parabiosis experiments revealed that fusion can occur without irradiation. Transplantation of rat bone marrow into mice led to activation of dormant rat Purkinje neuron-specific genes in BMDC nuclei after fusion with mouse Purkinje neurons, consistent with nuclear reprogramming. The precise neurological role of these heterokaryons awaits elucidation, but their frequency in brain after inflammation is clearly much higher than previously appreciated.	[Youssef, Sawsan; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Corbel, Stephane Y.; Rossi, Fabio M. V.] UBC, Biomed Res Ctr, Vancouver, BC V6T 1C7, Canada; [Johansson, Clas B.; Koleckar, Kassie; Doyonnas, Regis; Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University; University of British Columbia; Stanford University	Johansson, CB (corresponding author), Karolinska Inst, CMM, SE-17176 Stockholm, Sweden.	clas.johansson@ki.se; hblau2@stanford.edu	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620; Doyonnas, Regis/0000-0002-3818-0807; Steinman, Lawrence/0000-0002-2437-2250	NIA NIH HHS [R37 AG009521, R01 AG009521, AG024987, AG020961, R01 AG024987, AG009521, R01 AG020961] Funding Source: Medline; NICHD NIH HHS [R01 HD018179, HD018179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG024987, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Fendrick SE, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-9; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hall KU, 1999, J BIOL CHEM, V274, P3485, DOI 10.1074/jbc.274.6.3485; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ikarashi K, 2005, KIDNEY INT, V67, P1925, DOI 10.1111/j.1523-1755.2005.00291.x; ILDSTAD ST, 1991, J EXP MED, V174, P467, DOI 10.1084/jem.174.2.467; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pachter JS, 2003, J NEUROPATH EXP NEUR, V62, P593, DOI 10.1093/jnen/62.6.593; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Sacco T, 2006, MOL CELL NEUROSCI, V33, P170, DOI 10.1016/j.mcn.2006.07.006; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; Vassilopoulos G, 2003, NATURE; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043	40	171	179	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					575	583		10.1038/ncb1720	http://dx.doi.org/10.1038/ncb1720			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425116	Green Accepted			2022-12-25	WOS:000255502400014
J	Speier, S; Nyqvist, D; Cabrera, O; Yu, J; Molano, RD; Pileggi, A; Moede, T; Kohler, M; Wilbertz, J; Leibiger, B; Ricordi, C; Leibiger, IB; Caicedo, A; Berggren, PO				Speier, Stephan; Nyqvist, Daniel; Cabrera, Over; Yu, Jia; Molano, R. Damaris; Pileggi, Antonello; Moede, Tilo; Kohler, Martin; Wilbertz, Johannes; Leibiger, Barbara; Ricordi, Camillo; Leibiger, Ingo B.; Caicedo, Alejandro; Berggren, Per-Olof			Noninvasive in vivo imaging of pancreatic islet cell biology	NATURE MEDICINE			English	Article							ANTERIOR EYE CHAMBER; BETA-CELL; TRANSPLANTED ISLETS; RAT; APOPTOSIS; INSULIN; LANGERHANS; TISSUE; PROTEIN; HUMANS	the study of complex biological processes at the cellular level in biomedical research. Here, we introduce a new technical platform for noninvasive in vivo fluorescence imaging of pancreatic islets using the anterior chamber of the eye as a natural body window. Islets transplanted into the mouse eye engrafted on the iris, became vascularized, retained cellular composition, responded to stimulation and reverted diabetes. Laser-scanning microscopy allowed repetitive in vivo imaging of islet vascularization, beta cell function and death at cellular resolution. Our results thus establish the basis for noninvasive in vivo investigations of complex cellular processes, like beta cell stimulus-response coupling, which can be performed longitudinally under both physiological and pathological conditions.	[Cabrera, Over; Molano, R. Damaris; Pileggi, Antonello; Ricordi, Camillo; Caicedo, Alejandro; Berggren, Per-Olof] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Speier, Stephan; Nyqvist, Daniel; Yu, Jia; Moede, Tilo; Kohler, Martin; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Univ Hosp L1, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Wilbertz, Johannes] Karolinska Inst, Dept Cellular & Mol Biol, SE-17177 Stockholm, Sweden	University of Miami; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Caicedo, A (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, NW 10th Ave, Miami, FL 33136 USA.	acaicedo@med.miami.edu; Per-Olof.Berggren@ki.se	Molano, Ruth Damaris/B-8633-2015; RICORDI, CAMILLO/AAA-4740-2019; Pileggi, Antonello/A-2394-2008; Speier, Stephan/E-8525-2010; Caicedo, Alejandro/AAC-8544-2020; Caicedo, Alejandro/F-1202-2010	Molano, Ruth Damaris/0000-0002-6132-8750; Pileggi, Antonello/0000-0001-7819-2813; Speier, Stephan/0000-0002-4561-7085; Ricordi, Camillo/0000-0001-8092-7153; Kohler, Martin/0000-0001-6487-4303; Moede, Tilo/0000-0002-2045-9244; Berggren, Per-Olof/0000-0001-8991-413X; Nyqvist, Daniel/0000-0002-6527-6716	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058508, R03DK075487] Funding Source: NIH RePORTER; NIDDK NIH HHS [R03 DK075487, R03 DK075487-02, R01 DK058508, R03 DK075487-01, DK-075487, DK-58508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adeghate E, 2001, EUR J MORPHOL, V39, P257, DOI 10.1076/ejom.39.5.0257; ADEGHATE E, 1990, PANCREAS, V5, P298, DOI 10.1097/00006676-199005000-00009; Berggren PO, 2006, NUTR METAB CARDIOVAS, V16, pS7, DOI 10.1016/j.numecd.2005.11.005; Berney T, 2001, TRANSPLANTATION, V71, P125, DOI 10.1097/00007890-200101150-00020; Boersma HH, 2005, J NUCL MED, V46, P2035; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; HOFFER B, 1974, BRAIN RES, V79, P165, DOI 10.1016/0006-8993(74)90409-0; KATOH N, 1991, CELL TISSUE RES, V266, P259, DOI 10.1007/BF00318181; Kohler M, 2003, DIABETES, V52, P2943, DOI 10.2337/diabetes.52.12.2943; Kohler Martin, 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P281, DOI 10.2174/1568013043357275; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Medarova Z, 2005, DIABETES, V54, P1780, DOI 10.2337/diabetes.54.6.1780; Meier JJ, 2006, DIABETES, V55, P2324, DOI 10.2337/db06-0069; Menger MD, 2001, WORLD J SURG, V25, P509, DOI 10.1007/s002680020345; MENGER MD, 1992, J CLIN INVEST, V90, P1361, DOI 10.1172/JCI116002; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Paty BW, 2004, TRANSPLANTATION, V77, P1133, DOI 10.1097/01.TP.0000113231.90613.0E; PORKSEN N, 1994, J CLIN INVEST, V94, P219, DOI 10.1172/JCI117310; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Ricordi C, 2003, DIABETES, V52, P1595, DOI 10.2337/diabetes.52.7.1595; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Szkudelski T, 2001, PHYSIOL RES, V50, P537; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; VETTERLEIN F, 1987, MICROVASC RES, V34, P231, DOI 10.1016/0026-2862(87)90056-2; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596	30	194	202	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2008	14	5					574	578		10.1038/nm1701	http://dx.doi.org/10.1038/nm1701			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	298IQ	18327249	Green Accepted			2022-12-25	WOS:000255681800039
J	Leitch, CC; Zaghloul, NA; Davis, EE; Stoetzel, C; Diaz-Font, A; Rix, S; Al-Fadhel, M; Lewis, RA; Eyaid, W; Banin, E; Dollfus, H; Beales, PL; Badano, JL; Katsanis, N				Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Stoetzel, Corinne; Diaz-Font, Anna; Rix, Suzanne; Al-Fadhel, Majid; Lewis, Richard Alan; Eyaid, Wafaa; Banin, Eyal; Dollfus, Helene; Beales, Philip L.; Badano, Jose L.; Katsanis, Nicholas			Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome	NATURE GENETICS			English	Article							MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEIN; JOUBERT-SYNDROME; BBS LOCUS; DISSECTION; DISRUPTION; RPGRIP1L; CILIUM; MKS3	Meckel-Gruber syndrome (MKS) is a genetically heterogeneous, neonatally lethal malformation and the most common form of syndromic neural tube defect (NTD). To date, several MKS-associated genes have been identified whose protein products affect ciliary function(1-5). Here we show that mutations in MKS1, MKS3 and CEP290 (also known as NPHP6) either can cause Bardet-Biedl syndrome (BBS) or may have a potential epistatic effect on mutations in known BBS-associated loci. Five of six families with both MKS1 and BBS mutations manifested seizures, a feature that is not a typical component of either syndrome. Functional studies in zebrafish showed that mks1 is necessary for gastrulation movements and that it interacts genetically with known bbs genes. Similarly, we found two families with missense or splice mutations in MKS3, in one of which the affected individual also bears a homozygous nonsense mutation in CEP290 that is likely to truncate the C terminus of the protein. These data extend the genetic stratification of ciliopathies and suggest that BBS and MKS, although distinct clinically, are allelic forms of the same molecular spectrum.	[Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Badano, Jose L.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg 1, Fac Med Strasbourg, Med Genet Lab, Equipe Avenir INSERM EA 34390, F-67085 Strasbourg, France; [Diaz-Font, Anna; Rix, Suzanne; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Lewis, Richard Alan; Banin, Eyal] King Fahad Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Banin, Eyal] Hadassah Hebrew Univ Hosp, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Badano, Jose L.] Inst Pasteur, Montevideo 11400, Uruguay	Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Hospital - National Guard; Baylor College of Medicine; Baylor College of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652; Davis, Erica/0000-0002-2412-8397; Dollfus, Helene/0000-0002-2249-895X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079541, R01DK072301] Funding Source: NIH RePORTER; Medical Research Council [G0801843] Funding Source: Medline; NICHD NIH HHS [R01HD04260] Funding Source: Medline; NIDDK NIH HHS [F32 DK079541-01, R01DK072301] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Helou J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715	28	302	312	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					443	448		10.1038/ng.97	http://dx.doi.org/10.1038/ng.97			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327255				2022-12-25	WOS:000254388100015
J	Tabar, V; Tomishima, M; Panagiotakos, G; Wakayama, S; Menon, J; Chan, B; Mizutani, E; Al-Shamy, G; Ohta, H; Wakayama, T; Studer, L				Tabar, Viviane; Tomishima, Mark; Panagiotakos, Georgia; Wakayama, Sayaka; Menon, Jayanthi; Chan, Bill; Mizutani, Eiji; Al-Shamy, George; Ohta, Hiroshi; Wakayama, Teruhiko; Studer, Lorenz			Therapeutic cloning in individual parkinsonian mice	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; FERTILIZATION; BLASTOCYSTS; DISEASE; LINES; MODEL	Cell transplantation with embryonic stem (ES) cell progeny requires immunological compatibility with host tissue. 'Therapeutic cloning' is a strategy to overcome this limitation by generating nuclear transfer (nt) ES cells that are genetically matched to an individual. Here we establish the feasibility of treating individual mice via therapeutic cloning. Derivation of 187 ntES cell lines from 24 parkinsonian mice, dopaminergic differentiation, and transplantation into individually matched host mice showed therapeutic efficacy and lack of immunological response.	[Tabar, Viviane; Panagiotakos, Georgia; Menon, Jayanthi; Chan, Bill; Al-Shamy, George; Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA; [Tabar, Viviane] Cornell Univ, Weil Med Coll, Dept Neurosurg, New York, NY 10065 USA; [Tomishima, Mark; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Wakayama, Sayaka; Mizutani, Eiji; Ohta, Hiroshi; Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; RIKEN	Tabar, V (corresponding author), Sloan Kettering Inst, Dept Neurosurg, 1275 York Ave, New York, NY 10065 USA.	tabarv@mskcc.org; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021; Ohta, Hiroshi/C-3375-2009	Studer, Lorenz/0000-0003-0741-7987; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480	NINDS NIH HHS [R21 NS044231-01, R01 NS052671-03, R01 NS052671-01A2, R21 NS044231, R21 NS044231-02, R01 NS052671-02, R21NS44231, R01 NS052671, R01NS052671] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044231, R01NS052671] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; *JACK LAB, 1991, HDB GENETICALLY STAN; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Sortwell CE, 2001, EXP NEUROL, V169, P23, DOI 10.1006/exnr.2001.7644; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632	15	79	85	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					379	381		10.1038/nm1732	http://dx.doi.org/10.1038/nm1732			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376409	Green Accepted			2022-12-25	WOS:000254674100023
J	Musaro, M; Ciapponi, L; Fasulo, B; Gatti, M; Cenci, G				Musaro, Mariarosaria; Ciapponi, Laura; Fasulo, Barbara; Gatti, Maurizio; Cenci, Giovanni			Unprotected Drosophila melanogaster telomeres activate the spindle assembly checkpoint	NATURE GENETICS			English	Article							DNA-DAMAGE; PATHWAYS; PROTEIN; MAINTENANCE; ATM; PROTECTION; PREVENT; STABILITY; MUTANTS; HOMOLOG	In both yeast and mammals, uncapped telomeres activate the DNA damage response (DDR) and undergo end-to-end fusion(1,2). Previous work has shown that the Drosophila HOAP protein, encoded by the caravaggio (cav) gene, is required to prevent telomeric fusions(3). Here we show that HOAP-depleted telomeres activate both the DDR and the spindle assembly checkpoint (SAC). The cell cycle arrest elicited by the DDR was alleviated by mutations in mei-41 (encoding ATR), mus304 (ATRIP), grp (Chk1) and rad50 but not by mutations in tefu (ATM). The SAC was partially overridden by mutations in zw10 (also known as mit(1) 15) and bubR1, and also by mutations in mei-41, mus304, rad50, grp and tefu. As expected from SAC activation, the SAC proteins Zw10, Zwilch, BubR1 and Cenp-meta (Cenp-E) accumulated at the kinetochores of cav mutant cells. Notably, BubR1 also accumulated at cav mutant telomeres in a mei-41-, mus304-, rad50-, grp- and tefu-dependent manner. Our results collectively suggest that recruitment of BubR1 by dysfunctional telomeres inhibits Cdc20-APC function, preventing the metaphase-to-anaphase transition.	[Musaro, Mariarosaria; Cenci, Giovanni] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali DiSTeBA, I-73100 Lecce, Italy; [Fasulo, Barbara] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Musaro, Mariarosaria; Ciapponi, Laura; Gatti, Maurizio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Musaro, Mariarosaria; Ciapponi, Laura; Gatti, Maurizio] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, I-00185 Rome, Italy	University of Salento; University of California System; University of California Santa Cruz; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Cenci, G (corresponding author), Univ Aquila, Dipartimento Biol Base Applicata, I-67010 Laquila, Italy.	giovanni.cenci@cc.univaq.it	Ciapponi, Laura/H-6867-2013; Gatti, Maurizio/S-2877-2019; Gatti, Maurizio/J-9703-2013	Gatti, Maurizio/0000-0003-3777-300X; Cenci, Giovanni/0000-0002-9628-1411; CIAPPONI, LAURA/0000-0002-0817-1862; fasulo, barbara/0000-0001-7000-2974	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP07200] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Bast RC, 2000, INT J GYNECOL CANCER, V10, P2, DOI 10.1046/j.1525-1438.2000.99502.x; Bentley AM, 2002, J CELL SCI, V115, P949; Bi XL, 2005, P NATL ACAD SCI USA, V102, P15167, DOI 10.1073/pnas.0504981102; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Brodsky MH, 2000, GENE DEV, V14, P666; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; Ciapponi L, 2006, GENETICS, V173, P1447, DOI 10.1534/genetics.106.058081; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Lydall D, 2003, J CELL SCI, V116, P4057, DOI 10.1242/jcs.00765; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oikemus SR, 2006, PLOS GENET, V2, P693, DOI 10.1371/journal.pgen.0020071; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Royou A, 2005, CURR BIOL, V15, P334, DOI 10.1016/j.cub.2005.02.026; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30	29	35	37	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					362	366		10.1038/ng.2007.64	http://dx.doi.org/10.1038/ng.2007.64			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246067				2022-12-25	WOS:000253548400030
J	Kwan, T; Benovoy, D; Dias, C; Gurd, S; Provencher, C; Beaulieu, P; Hudson, TJ; Sladek, R; Majewski, J				Kwan, Tony; Benovoy, David; Dias, Christel; Gurd, Scott; Provencher, Cathy; Beaulieu, Patrick; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek			Genome-wide analysis of transcript isoform variation in humans	NATURE GENETICS			English	Article							MESSENGER-RNA; GENE-EXPRESSION; LARGE-SCALE; POLYADENYLATION; ASSOCIATION; DISCOVERY; VARIANTS; DISEASE; MOUSE; IRF5	We have performed a genome- wide analysis of common genetic variation controlling differential expression of transcript isoforms in the CEU HapMap population using a comprehensive exon tiling microarray covering 17,897 genes. We detected 324 genes with significant associations between flanking SNPs and transcript levels. Of these, 39% reflected changes in whole gene expression and 55% reflected transcript isoform changes such as splicing variants (exon skipping, alternative splice site use, intron retention), differential 5' UTR (initiation of transcription) use, and differential 3' UTR (alternative polyadenylation) use. These results demonstrate that the regulatory effects of genetic variation in a normal human population are far more complex than previously observed. This extra layer of molecular diversity may account for natural phenotypic variation and disease susceptibility.	[Kwan, Tony; Benovoy, David; Dias, Christel; Gurd, Scott; Provencher, Cathy; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A4, Canada; [Kwan, Tony; Benovoy, David; Gurd, Scott; Provencher, Cathy; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Beaulieu, Patrick] Hop St Justine, Div Hematol Oncol, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Hudson, Thomas J.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada	McGill University; Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Majewski, J (corresponding author), McGill Univ, Dept Human Genet, 740 Dr Penfield,Room 7210, Montreal, PQ H3A 1A4, Canada.	jacek.majewski@mcgill.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204				Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Field LL, 2005, DIABETES, V54, P1588, DOI 10.2337/diabetes.54.5.1588; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nissim-Rafinia M, 2005, TRENDS GENET, V21, P480, DOI 10.1016/j.tig.2005.07.005; Qu HQ, 2007, DIABETES, V56, P270, DOI 10.2337/db06-0865; Rozen S, 2000, Methods Mol Biol, V132, P365; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	30	241	257	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					225	231		10.1038/ng.2007.57	http://dx.doi.org/10.1038/ng.2007.57			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193047				2022-12-25	WOS:000252732900022
J	Bohrer, RA				Bohrer, Robert A.			Reach-through claims for drug target patents: Rx for pharmaceutical policy	NATURE BIOTECHNOLOGY			English	Editorial Material								Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy.	Calif Weatern Sch Law, San Diego, CA 92101 USA		Bohrer, RA (corresponding author), Calif Weatern Sch Law, 225 Cedar St, San Diego, CA 92101 USA.	rab@cwsl.edu						*AM HOSP FORM SERV, 2002, 2406 AM HOSP FORM SE; Angell M., 2004, TRUTH DRUG CO THEY D; Avorn J, 2004, POWERFUL MED BENEFIT; Bohrer RA, 2000, NEW ENGL J MED, V343, P1416; *TRIL COOP, 2001, MUT UND SEARCH EX CO; *US C, 1998, INCR COMP GEN DRUGS	6	6	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					55	57		10.1038/nbt0108-55	http://dx.doi.org/10.1038/nbt0108-55			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183015				2022-12-25	WOS:000252222500019
J	Pasqualucci, L; Bhagat, G; Jankovic, M; Compagno, M; Smith, P; Muramatsu, M; Honjo, T; Morse, HC; Nussenzweig, MC; Dalla-Favera, R				Pasqualucci, Laura; Bhagat, Govind; Jankovic, Mila; Compagno, Mara; Smith, Paula; Muramatsu, Masamichi; Honjo, Tasuku; Morse, Herbert C., III; Nussenzweig, Michel C.; Dalla-Favera, Riccardo			AID is required for germinal center-derived lymphomagenesis	NATURE GENETICS			English	Article							CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CENTER B-CELLS; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; EXPRESSION; TRANSLOCATIONS; PHENOTYPE; REGION	Most human B cell non-Hodgkin's lymphomas (B-NHLs) derive from germinal centers (GCs), the structure in which B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR) before being selected for high-affinity antibody production(1). The pathogenesis of B-NHL is associated with distinct genetic lesions, including chromosomal translocations and aberrant SHM, which arise from mistakes occurring during CSR and SHM2-4. A direct link between these DNA remodeling events and GC lymphoma development, however, has not been demonstrated. Here we have crossed three mouse models of B cell lymphoma driven by oncogenes (Myc, Bcl6 and Myc/Bcl6; refs. 5,6) with mice lacking activation-induced cytidine deaminase (AID), the enzyme required for both CSR and SHM7,8. We show that AID deficiency prevents Bcl6-dependent, GC-derived B-NHL, but has no impact on Myc-driven, pre-GC lymphomas. Accordingly, abrogation of AID is associated with the disappearance of CSR- and SHM-mediated structural alterations. These results show that AID is required for GC-derived lymphomagenesis, supporting the notion that errors in AID-mediated antigen-receptor gene modification processes are principal contributors to the pathogenesis of human B-NHL.	[Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Jankovic, Mila; Muramatsu, Masamichi] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa 9208640, Japan; [Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan; [Morse, Herbert C., III] NIAID, NIH, Immunopathol Lab, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Rockefeller University; Kanazawa University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Rockefeller University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015; Bhagat, Govind/AAE-9493-2021; Nussenzweig, Michel/AAE-7292-2019	Muramatsu, Masamichi/0000-0002-0153-3533; Bhagat, Govind/0000-0001-6250-048X; Morse, Herbert/0000-0002-9331-3705	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000858, ZIAAI000858] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; DALLAFAVERA R, 2004, NON HODGKINS LYMPHOM, P825; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Mollejo M, 2005, HEMATOL ONCOL, V23, P108, DOI 10.1002/hon.762; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953	30	284	294	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					108	112		10.1038/ng.2007.35	http://dx.doi.org/10.1038/ng.2007.35			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066064				2022-12-25	WOS:000252118600026
J	Fox, JL				Fox, Jeffrey L.			Antivirals become a broader enterprise	NATURE BIOTECHNOLOGY			English	Article																			0	20	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1395	1402		10.1038/nbt1207-1395	http://dx.doi.org/10.1038/nbt1207-1395			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18066034	Green Published			2022-12-25	WOS:000251457800027
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Magnusson, KP; Manolescu, A; Karason, A; Palsson, A; Thorleifsson, G; Jakobsdottir, M; Steinberg, S; Palsson, S; Jonasson, F; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Magnusson, Kristinn P.; Manolescu, Andrei; Karason, Ari; Palsson, Arnar; Thorleifsson, Gudmar; Jakobsdottir, Margret; Steinberg, Stacy; Palsson, Snaebjorn; Jonasson, Fridbert; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augie; Thorsteinsdottir, Unnur; Stefansson, Kari			Genetic determinants of hair, eye and skin pigmentation in Europeans	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; GENOMIC CONTROL; CONFERS RISK; RED HAIR; COLOR; SIGNATURES; EVOLUTION; HAPLOTYPE; POLYMORPHISM; DIFFERENCE	Hair, skin and eye colors are highly heritable and visible traits in humans. We carried out a genome-wide association scan for variants associated with hair and eye pigmentation, skin sensitivity to sun and freckling among 2,986 Icelanders. We then tested the most closely associated SNPs from six regions-four not previously implicated in the normal variation of human pigmentation-and replicated their association in a second sample of 2,718 Icelanders and a sample of 1,214 Dutch. The SNPs from all six regions met the criteria for genome-wide significance. A variant in SLC24A4 is associated with eye and hair color, a variant near KITLG is associated with hair color, two coding variants in TYR are associated with eye color and freckles, and a variant on 6p25.3 is associated with freckles. The fifth region provided refinements to a previously reported association in OCA2, and the sixth encompasses previously described variants in MC1R.	DeCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Dermatol, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Plast Surg, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Anatomopathol, Reykjavik, Iceland; Radboud Univ Nijmegen, Comprehens Canc Ctr E, Dept Epidemiol & Biostat, Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Magnusson, Kristinn P Pétur/X-4907-2019; Sigurgeirsson, Bardur/AAP-7755-2020; Jonasson, Fridbert/ABA-9889-2021; Magnusson, Kristinn/A-6479-2011; Stefansson, Kari/AAE-7187-2019; Palsson, Snaebjorn/J-9113-2012; Kiemeney, Lambertus A./D-3357-2009; Manolescu, Andrei/G-4565-2014; Aben, Katja KH/G-9686-2016; Sigurgeirsson, Bárður/B-6130-2011; Palsson, Arnar/M-2742-2015; Helgason, Agnar/K-1522-2015	Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Magnusson, Kristinn/0000-0003-4528-6826; Kiemeney, Lambertus A./0000-0002-2368-1326; Manolescu, Andrei/0000-0002-0713-4664; Aben, Katja KH/0000-0002-0214-2147; Palsson, Arnar/0000-0002-6525-8112; Sigurgeirsson, Bardur/0000-0002-9733-9742; Palsson, Snaebjorn/0000-0002-4297-3500; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; BRAUER G, 1978, J ANTHROPOL ANZ, V36, P109; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; EIBERG H, 1987, CLIN GENET, V32, P125; Eiberg H, 1996, EUR J HUM GENET, V4, P237; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Frudakis T, 2003, GENETICS, V165, P2071; GALTON F, 1886, NATURE, V34, P137; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; MANTEL N, 1959, J NATL CANCER I, V22, P719; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Posthuma D, 2006, BEHAV GENET, V36, P12, DOI 10.1007/s10519-005-9007-x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seitz JJ, 1999, MAMM GENOME, V10, P710, DOI 10.1007/s003359901076; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	50	509	534	1	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1443	1452		10.1038/ng.2007.13	http://dx.doi.org/10.1038/ng.2007.13			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17952075				2022-12-25	WOS:000251267400011
J	Tanentzapf, G; Devenport, D; Godt, D; Brown, NH				Tanentzapf, Guy; Devenport, Danelle; Godt, Dorothea; Brown, Nicholas H.			Integrin-dependent anchoring of a stem-cell niche	NATURE CELL BIOLOGY			English	Article							DROSOPHILA; CADHERIN; MORPHOGENESIS; PROLIFERATION; NEIGHBORS; ADHESION; OOCYTE	Interactions between stem cells and their surrounding microenvironment, or niche, are critical for the establishment and maintenance of stem-cell properties(1). the adult Drosophila testis contains a morphologically discrete stem-cell niche, the 'hub'(2-4). the small cluster of non-dividing, somatic hub cells at the anterior tip of the fly testis is contacted by the germline stem cells (GsCs)(5), which retain their stem-cell character through the direct association with the hub(6). Here we show that integrin-mediated adhesion is important for maintaining the correct position of embryonic hub cells during gonad morphogenesis. the misplaced hub in integrin-deficient embryos directs the orientation of cell divisions in the presumptive GsCs, a hallmark of the active germline stem-cell niche. A decrease in integrin-mediated adhesion in adult testes, which resulted in a loss of the hub and the stem-cell population, revealed the importance of hub-cell anchoring. Finally, we show that an extracellular matrix (ECM) is present around the gonad during late embryogenesis and that this ECM is defective in integrin-deficient gonads. On the basis of our data, we propose that integrins are required for the attachment of the hub cells to the ECM, which is essential for maintaining the stem-cell niche.	Univ Cambridge, Gurdon Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England; Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; Univ British Columbia, Life Sci Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Rockefeller Univ, Lab Mammalian Genet & Dev, New York, NY 10021 USA	University of Cambridge; University of Toronto; University of British Columbia; Rockefeller University	Tanentzapf, G (corresponding author), Univ Cambridge, Gurdon Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England.	guy.tanentzapf@ubc.ca	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; Devenport, Danelle/0000-0002-5464-259X; Brown, Nicholas/0000-0002-8958-7017	Wellcome Trust [069943, 69943, 72817] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Chou TB, 1996, GENETICS, V144, P1673; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	31	163	170	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1413	U127		10.1038/ncb1660	http://dx.doi.org/10.1038/ncb1660			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17982446	Green Accepted			2022-12-25	WOS:000251317300014
J	Weckmann, M; Collison, A; Simpson, JL; Kopp, MV; Wark, PAB; Smyth, MJ; Yagita, H; Matthaei, KI; Hansbro, N; Whitehead, B; Gibson, PG; Foster, PS; Mattes, J				Weckmann, Markus; Collison, Adam; Simpson, Jodie L.; Kopp, Matthias V.; Wark, Peter A. B.; Smyth, Mark J.; Yagita, Hideo; Matthaei, Klaus I.; Hansbro, Nicole; Whitehead, Bruce; Gibson, Peter G.; Foster, Paul S.; Mattes, Joerg			Critical link between TRAIL and CCL20 for the activation of T(H)2 cells and the expression of allergic airway disease	NATURE MEDICINE			English	Article							APOPTOSIS-INDUCING LIGAND; DENDRITIC CELLS; IN-VIVO; EXPERIMENTAL ASTHMA; TUMOR-METASTASIS; INHALED ANTIGEN; ATOPIC ASTHMA; HYPERREACTIVITY; INFLAMMATION; IL-13	The role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in immune responses mediated by T-helper 2 (T(H)2) lymphocytes is unknown. Here we characterize the development of allergic airway disease in TRAIL-deficient (Tnfsf10(-/-)) mice and in mice exposed to short interfering RNA targeting TRAIL. We show that TRAIL is abundantly expressed in the airway epithelium of allergic mice and that inhibition of signaling impairs production of the chemokine CCL20 and homing of myeloid dendritic cells and T cells expressing CCR6 and CD4 to the airways. Attenuated homing limits TH2 cytokine release, inflammation, airway hyperreactivity and expression of the transcriptional activator STAT6. Activation of STAT6 by interleukin-13 restores airway hyperreactivity in Tnfsf10(-/-) mice. Recombinant TRAIL induces pathognomic features of asthma and stimulates the production of CCL20 in primary human bronchial epithelium cells. TRAIL is also increased in sputum of asthmatics. The function of TRAIL in the airway epithelium identifies this molecule as a target for the treatment of asthma.	Univ Freiburg, Dept Paediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Newcastle, Fac Hlth, Sch Biomed Sci, CARD, Newcastle, NSW 2301, Australia; Hunter Med Res Inst, Newcastle, NSW 2301, Australia; Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW 2305, Australia; Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia; John Hunter Childrens Hosp, Dept Paediat, Newcastle, NSW 2305, Australia	University of Freiburg; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Peter Maccallum Cancer Center; Juntendo University; Australian National University; John Curtin School of Medical Research	Mattes, J (corresponding author), Univ Freiburg, Dept Paediat & Adolescent Med, D-79106 Freiburg, Germany.	joerg.mattes@newcastle.edu.au	Smyth, Mark J/H-8709-2014; Weckmann, Markus/GXG-3428-2022; MATTES, JOERG/M-5179-2019; Wark, Peter/G-7037-2013; SIMPSON, JODIE LOUISE/G-7639-2013; Klaus, Matthaei/D-8691-2011; Foster, Paul/G-5057-2013; gibson, peter/G-6194-2014; Collison, Adam/G-7718-2013	Smyth, Mark J/0000-0001-7098-7240; Weckmann, Markus/0000-0001-5342-979X; Wark, Peter/0000-0001-5676-6126; SIMPSON, JODIE LOUISE/0000-0002-3626-680X; gibson, peter/0000-0001-5865-489X; Collison, Adam/0000-0002-3074-3046				Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; BENTLEY AM, 1993, AM J RESP CELL MOL, V8, P35, DOI 10.1165/ajrcmb/8.1.35; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Busse WW, 1998, J ALLERGY CLIN IMMUN, V102, pS17, DOI 10.1016/S0091-6749(98)70002-8; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Daigle I, 2001, SWISS MED WKLY, V131, P231; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Mattes J, 1999, EUR RESPIR J, V13, P1391, DOI 10.1183/09031936.99.13613969; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; van Rift LS, 2004, J ALLERGY CLIN IMMUN, V114, P166, DOI 10.1016/j.jaci.2004.03.044; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138; Zhang YY, 2004, JNCI-J NATL CANCER I, V96, P201, DOI 10.1093/jnci/djh024; 1987, AM REV RESP DIS, V136, P225	50	98	103	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1308	1315		10.1038/nm1660	http://dx.doi.org/10.1038/nm1660			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17934471				2022-12-25	WOS:000250736900023
J	You, ZS; Bailis, JM; Johnson, SA; Dilworth, SM; Hunter, T				You, Zhongsheng; Bailis, Julie M.; Johnson, Sam A.; Dilworth, Stephen M.; Hunter, Tony			Rapid activation of ATM on DNA flanking double-strand breaks	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; IN-VIVO; MRE11-RAD50-NBS1 COMPLEX; REPLICATION CHECKPOINT; DAMAGE-RESPONSE; PHOSPHATASE 2A; REQUIRES ATM; AUTOPHOSPHORYLATION; MDC1; NBS1	The tumour-suppressor gene ATM, mutations in which cause the human genetic disease ataxia telangiectasia ( A-T), encodes a key protein kinase that controls the cellular response to DNA double-strand breaks ( DSBs)(1,2). DNA DSBs caused by ionizing radiation or chemicals result in rapid ATM autophosphorylation, leading to checkpoint activation and phosphorylation of substrates that regulate cell-cycle progression, DNA repair, transcription and cell death(3). However, the precise mechanism by which damaged DNA induces ATM and checkpoint activation remains unclear. Here, we demonstrate that linear DNA fragments added to Xenopus egg extracts mimic DSBs in genomic DNA and provide a platform for ATM autophosphorylation and activation. ATM autophosphorylation and phosphorylation of its substrate NBS1 are dependent on DNA fragment length and the concentration of DNA ends. The minimal DNA length required for efficient ATM autophosphorylation is similar to 200 base pairs, with cooperative autophosphorylation induced by DNA fragments of at least 400 base pairs. Importantly, full ATM activation requires it to bind to DNA regions flanking DSB ends. These findings reveal a direct role for DNA flanking DSB ends in ATM activation.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Metab Med, London W12 0NN, England	Salk Institute; Imperial College London	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu	You, Zhongsheng/F-5404-2012	You, Zhongsheng/0000-0002-9719-8791	Biotechnology and Biological Sciences Research Council [C19979, BBS/B/06962] Funding Source: Medline; NCI NIH HHS [CA80100, CA14195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080100, P30CA014195] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; ALMOUZNI G, 1988, EMBO J, V7, P4355, DOI 10.1002/j.1460-2075.1988.tb03334.x; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Costanzo Vincenzo, 2004, Methods Mol Biol, V280, P213; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson SA, 2007, DNA REPAIR, V6, P1277, DOI 10.1016/j.dnarep.2007.02.025; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; McSherry TD, 2004, MOL CELL BIOL, V24, P9968, DOI 10.1128/MCB.24.22.9968-9985.2004; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Robertson K, 1999, ONCOGENE, V18, P7070, DOI 10.1038/sj.onc.1203194; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200	40	71	75	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					311	U193		10.1038/ncb1651	http://dx.doi.org/10.1038/ncb1651			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952060				2022-12-25	WOS:000250659600017
J	Yuzwa, SA; Macauley, MS; Heinonen, JE; Shan, XY; Dennis, RJ; He, YA; Whitworth, GE; Stubbs, KA; McEachern, EJ; Davies, GJ; Vocadlo, DJ				Yuzwa, Scott A.; Macauley, Matthew S.; Heinonen, Julia E.; Shan, Xiaoyang; Dennis, Rebecca J.; He, Yuan; Whitworth, Garrett E.; Stubbs, Keith A.; McEachern, Ernest J.; Davies, Gideon J.; Vocadlo, David J.			A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo	NATURE CHEMICAL BIOLOGY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; NEUROFIBRILLARY TANGLES; CYTOSOLIC PROTEINS; D-GLUCOSAMINIDASE; NAG-THIAZOLINE; NUCLEAR; PUGNAC; ACETYL; HYPERPHOSPHORYLATION; GLYCOSYLATION	Pathological hyperphosphorylation of the microtubule-associated protein tau is characteristic of Alzheimer's disease (AD) and the associated tauopathies. The reciprocal relationship between phosphorylation and O-GlcNAc modification of tau and reductions in O-GlcNAc levels on tau in AD brain offers motivation for the generation of potent and selective inhibitors that can effectively enhance O-GlcNAc in vertebrate brain. We describe the rational design and synthesis of such an inhibitor (thiamet-G, K-i = 21 nM; 1) of human O-GlcNAcase. Thiamet-G decreased phosphorylation of tau in PC-12 cells at pathologically relevant sites including Thr231 and Ser396. Thiamet-G also efficiently reduced phosphorylation of tau at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus, which reveals the rapid and dynamic relationship between O-GlcNAc and phosphorylation of tau in vivo. We anticipate that thiamet-G will find wide use in probing the functional role of O-GlcNAc in vertebrate brain, and it may also offer a route to blocking pathological hyperphosphorylation of tau in AD.	[Yuzwa, Scott A.; Shan, Xiaoyang; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Macauley, Matthew S.; Heinonen, Julia E.; Whitworth, Garrett E.; Stubbs, Keith A.; McEachern, Ernest J.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Dennis, Rebecca J.; He, Yuan; Davies, Gideon J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	He, Yuan/GQP-4216-2022; Davies, Gideon J/A-9042-2011; Vocadlo, David J/E-5508-2014; Stubbs, Keith/H-5909-2014	Davies, Gideon J/0000-0002-7343-776X; Vocadlo, David J/0000-0001-6897-5558; Macauley, Matthew/0000-0003-4579-1048; Stubbs, Keith/0000-0001-6899-402X; He, Yuan/0000-0002-1712-0776; McEachern, Ernest/0000-0001-8415-3351	BBSRC [BB/F007124/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007124/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Farook VS, 2002, MOL GENET METAB, V77, P189, DOI 10.1016/S1096-7192(02)00127-0; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; KASAI K, 1992, ANAL SCI, V8, P161, DOI 10.2116/analsci.8.161; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Knapp S, 1997, SYNLETT, P435; Knapp S, 2007, ORG LETT, V9, P2321, DOI 10.1021/ol0706814; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Scaffidi A, 2007, ORG BIOMOL CHEM, V5, P3013, DOI 10.1039/b709681j; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shanmugasundaram B, 2006, CHEM COMMUN, P4372, DOI 10.1039/b612154c; Stubbs KA, 2006, ORG BIOMOL CHEM, V4, P839, DOI 10.1039/b516273d; TORRES CR, 1984, J BIOL CHEM, V259, P3308; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zou LY, 2007, SHOCK, V27, P402, DOI 10.1097/01.shk.0000245031.31859.29	48	480	529	2	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2008	4	8					483	490		10.1038/nchembio.96	http://dx.doi.org/10.1038/nchembio.96			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329FO	18587388				2022-12-25	WOS:000257852500014
J	Huangfu, DW; Maehr, R; Guo, WJ; Eijkelenboom, A; Snitow, M; Chen, AE; Melton, DA				Huangfu, Danwei; Maehr, Rene; Guo, Wenjun; Eijkelenboom, Astrid; Snitow, Melinda; Chen, Alice E.; Melton, Douglas A.			Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds	NATURE BIOTECHNOLOGY			English	Article							MOUSE; FIBROBLASTS; GENERATION; MYC	Reprogramming of mouse and human somatic cells can be achieved by ectopic expression of transcription factors, but with low efficiencies. We report that DNA methyltransferase and histone deacetylase ( HDAC) inhibitors improve reprogramming efficiency. In particular, valproic acid (VPA), an HDAC inhibitor, improves reprogramming efficiency by more than 100-fold, using Oct4-GFP as a reporter. VPA also enables efficient induction of pluripotent stem cells without introduction of the oncogene c-Myc.	[Huangfu, Danwei; Maehr, Rene; Eijkelenboom, Astrid; Snitow, Melinda; Chen, Alice E.; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Guo, Wenjun] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Eijkelenboom, Astrid] Univ Utrecht, NL-3508 TC Utrecht, Netherlands	Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Utrecht University	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012; Wilson, Matthew H/K-3193-2013	Young, Richard A/0000-0001-8855-8647; Huangfu, Danwei/0000-0002-1145-6199	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	14	1206	1462	2	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					795	797		10.1038/nbt1418	http://dx.doi.org/10.1038/nbt1418			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18568017	Green Accepted			2022-12-25	WOS:000257491600024
J	Isbell, TS; Sun, CW; Wu, LC; Teng, XJ; Vitturi, DA; Branch, BG; Kevil, CG; Peng, N; Wyss, JM; Ambalavanan, N; Schwiebert, L; Ren, JX; Pawlik, KM; Renfrow, MB; Patel, RP; Townes, TM				Isbell, T. Scott; Sun, Chiao-Wang; Wu, Li-Chen; Teng, Xinjun; Vitturi, Dario A.; Branch, Billy G.; Kevil, Christopher G.; Peng, Ning; Wyss, J. Michael; Ambalavanan, Namasivayam; Schwiebert, Lisa; Ren, Jinxiang; Pawlik, Kevin M.; Renfrow, Matthew B.; Patel, Rakesh P.; Townes, Tim M.			SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation	NATURE MEDICINE			English	Article							NITRIC-OXIDE; S-NITROSOHEMOGLOBIN; FLOW REGULATION; OXYGEN; DISEASE; NO; NITROSOTHIOLS; BIOACTIVITY; DEFICIENCY; BINDING	The coupling of hemoglobin sensing of physiological oxygen gradients to stimulation of nitric oxide ( NO) bioactivity is an established principle of hypoxic blood flow. One mechanism proposed to explain this oxygen-sensing-NO bioactivity linkage postulates an essential role for the conserved Cys93 residue of the hemoglobin beta-chain (beta Cys93) and, specifically, for S-nitrosation of beta Cys93 to form S-nitrosohemoglobin (SNO-Hb)(1). The SNO-Hb hypothesis, which conceptually links hemoglobin and NO biology, has been debated intensely in recent years(2,3). This debate has precluded a consensus on physiological mechanisms and on assessment of the potential role of SNO-Hb in pathology. Here we describe new mouse models that exclusively express either human wild-type hemoglobin or human hemoglobin in which the beta Cys93 residue is replaced with alanine to assess the role of SNO-Hb in red blood cell-mediated hypoxic vasodilation. Substitution of this residue, precluding hemoglobin S-nitrosation, did not change total red blood cell S-nitrosothiol abundance but did shift S-nitrosothiol distribution to lower molecular weight species, consistent with the loss of SNO-Hb. Loss of beta Cys93 resulted in no deficits in systemic or pulmonary hemodynamics under basal conditions and, notably, did not affect isolated red blood cell dependent hypoxic vasodilation. These results demonstrate that SNO-Hb is not essential for the physiologic coupling of erythrocyte deoxygenation with increased NO bioactivity in vivo.	[Isbell, T. Scott; Teng, Xinjun; Vitturi, Dario A.; Patel, Rakesh P.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Isbell, T. Scott; Teng, Xinjun; Vitturi, Dario A.; Patel, Rakesh P.] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Sun, Chiao-Wang; Wu, Li-Chen; Ren, Jinxiang; Pawlik, Kevin M.; Renfrow, Matthew B.; Townes, Tim M.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Branch, Billy G.; Kevil, Christopher G.] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71130 USA; [Peng, Ning; Wyss, J. Michael; Ambalavanan, Namasivayam] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Ambalavanan, Namasivayam] Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; [Schwiebert, Lisa] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Patel, RP (corresponding author), Univ Alabama, Dept Pathol, 901 19th St S, Birmingham, AL 35294 USA.	rakeshp@uab.edu; ttownes@uab.edu	Ambalavanan, Namasivayam/AAI-4088-2020; Kevil, Christopher/G-9318-2011; Vitturi, Dario/Z-3469-2019; Ambalavanan, Namasivayam/AAL-3832-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092; Kevil, Christopher/0000-0003-0863-7260; Patel, Rakesh/0000-0002-1526-4303; Vitturi, Dario/0000-0003-0354-4567; Isbell, Timothy/0000-0003-0979-0582; Wyss, J Michael/0000-0003-1094-2934; Renfrow, Matthew B./0000-0002-4193-7305	NHLBI NIH HHS [R01 HL057619-11, HL057619, R01 HL057619-10, R01 HL057619] Funding Source: Medline; NINDS NIH HHS [NS 057098, P30 NS057098] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057098] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Chen YF, 2006, LIFE SCI, V79, P1357, DOI 10.1016/j.lfs.2006.03.051; Cheng Y, 2002, BIOCHEMISTRY-US, V41, P11901, DOI 10.1021/bi0202880; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Crawford JH, 2004, ANTIOXID REDOX SIGN, V6, P992, DOI 10.1089/ars.2004.6.992; Crawford JH, 2004, BLOOD, V104, P1375, DOI 10.1182/blood-2004-03-0880; Datta B, 2004, CIRCULATION, V109, P1339, DOI 10.1161/01.CIR.0000124450.07016.1D; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Ellsworth ML, 2000, ACTA PHYSIOL SCAND, V168, P551, DOI 10.1046/j.1365-201x.2000.00708.x; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gonzalez-Alonso J, 2001, J PHYSIOL-LONDON, V530, P331, DOI 10.1111/j.1469-7793.2001.0331l.x; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; McMahon TJ, 2005, P NATL ACAD SCI USA, V102, P14801, DOI 10.1073/pnas.0506957102; Palmer LA, 2007, J CLIN INVEST, V117, P2592, DOI 10.1172/JCI29444; Patel RP, 1999, J BIOL CHEM, V274, P15487, DOI 10.1074/jbc.274.22.15487; Pawloski JR, 2005, P NATL ACAD SCI USA, V102, P2531, DOI 10.1073/pnas.0409876102; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812	30	115	119	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					773	777		10.1038/nm1771	http://dx.doi.org/10.1038/nm1771			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18516054	Green Accepted			2022-12-25	WOS:000257452700026
J	Ji, P; Jayapal, SR; Lodish, HF				Ji, Peng; Jayapal, Senthil Raja; Lodish, Harvey F.			Enucleation of cultured mouse fetal erythroblasts requires Rac GTPases and mDia2	NATURE CELL BIOLOGY			English	Article							MATURATION; CELLS; ERYTHROPOIETIN; DIFFERENTIATION; MECHANISM; FORMINS; DESIGN; RED	Mammalian erythroid cells undergo enucleation, an asymmetric cell division involving extrusion of a pycnotic nucleus enveloped by the plasma membrane(1-3). The mechanisms that power and regulate the enucleation process have remained obscure. Here, we show that deregulation of Rac GTPase during a late stage of erythropoiesis completely blocks enucleation of cultured mouse fetal erythroblasts without affecting their proliferation or differentiation. Formation of the contractile actin ring (CAR) on the plasma membrane of enucleating erythroblasts was disrupted by inhibition of Rac GTPases. Furthermore, we demonstrate that mDia2, a downstream effector of Rho GTPases and a formin protein required for nucleation of unbranched actin filaments(4-6), is also required for enucleation of mouse fetal erythroblasts. We show that Rac1 and Rac2 bind to mDia2 in a GTP-dependent manner and that downregulation of mDia2, but not mDia1, by small interfering RNA ( siRNA) during the late stages of erythropoiesis blocked both CAR formation and erythroblast enucleation. Additionally, overexpression of a constitutively active mutant of mDia2 rescued the enucleation defects induced by the inhibition of Rac GTPases. These results reveal important roles for Rac GTPases and their effector mDia2 in enucleation of mammalian erythroblasts.	[Ji, Peng; Jayapal, Senthil Raja; Lodish, Harvey F.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lodish, HF (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, 9 Cambridge Ctr,Floor 6, Cambridge, MA 02142 USA.	lodish@wi.mit.edu		Jayapal, Senthil Raja/0000-0002-0670-7766	NHLBI NIH HHS [P01 HL 32262] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; KOURY MJ, 1988, J CELL PHYSIOL, V137, P65, DOI 10.1002/jcp.1041370108; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Repasky E A, 1981, Prog Clin Biol Res, V55, P679; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	26	150	151	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					314	U39		10.1038/ncb1693	http://dx.doi.org/10.1038/ncb1693			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264091				2022-12-25	WOS:000253778300013
J	Vignuzzi, M; Wendt, E; Andino, R				Vignuzzi, Marco; Wendt, Emily; Andino, Raul			Engineering attenuated virus vaccines by controlling replication fidelity	NATURE MEDICINE			English	Article							GENETIC-CHARACTERIZATION; POLIO ERADICATION; RNA; NEUROVIRULENCE; EVOLUTION; FITNESS; DEOPTIMIZATION; PATHOGENESIS; RESISTANCE; EXCRETION	Long-lasting protection against viral infection is best achieved by vaccination with attenuated viruses. Obtaining stably attenuated vaccine strains has traditionally been an empirical process, which greatly restricts the number of effective vaccines for viral diseases. Here we describe a rational approach for engineering stably attenuated viruses that can serve as safe and effective vaccines. Our approach exploits the observation that restricting viral population diversity by increasing replication fidelity greatly reduces viral tissue tropism and pathogenicity. We show that poliovirus variants with reduced genetic diversity elicit a protective immune response in an animal model of infection. Indeed, these novel vaccine candidates are comparable in efficacy to the currently available Sabin type 1 vaccine strain, but have the added advantage of being more stable, as their increased replication fidelity prevents reversion to the pathogenic wild-type phenotype. We propose that restricting viral quasispecies diversity provides a general approach for the rational design of stable, attenuated vaccines for a wide variety of viruses.	[Vignuzzi, Marco; Wendt, Emily; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St, San Francisco, CA 94143 USA.	raul.andino@ucsf.edu		Vignuzzi, Marco/0000-0002-4400-771X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040085, R21AI036178, R01AI040085, R01AI036178] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; ADA GL, 1989, FUNDAMENTAL IMMUNOLO, P985; Agol VI, 2005, NATURE, V435, P881, DOI 10.1038/435881b; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; CANN AJ, 1984, NUCLEIC ACIDS RES, V12, P7787, DOI 10.1093/nar/12.20.7787; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P641; Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0; CONTRERAS G, 1992, BIOLOGICALS, V20, P15, DOI 10.1016/S1045-1056(05)80003-X; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gromeier M, 1998, J VIROL, V72, P5056, DOI 10.1128/JVI.72.6.5056-5060.1998; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Holmes EC, 2006, P NATL ACAD SCI USA, V103, P4803, DOI 10.1073/pnas.0601166103; Holmes EC, 2004, PLOS BIOL, V2, P1267, DOI 10.1371/journal.pbio.0020307; Macadam AJ, 2006, J VIROL, V80, P8653, DOI 10.1128/JVI.00370-06; Minor PD, 2005, J MED VIROL, V75, P153, DOI 10.1002/jmv.20250; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; MINOR PD, 1986, J GEN VIROL, V67, P693, DOI 10.1099/0022-1317-67-4-693; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; OGRA PL, 1989, CURR TOP MICROBIOL, V146, P73; Ohka S, 1998, VIROLOGY, V250, P67, DOI 10.1006/viro.1998.9360; Palmenberg Ann C., 2002, P149; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Racaniello VR, 2000, B WORLD HEALTH ORGAN, V78, P359; Rotbart HA, 2002, ANTIVIR RES, V53, P83, DOI 10.1016/S0166-3542(01)00206-6; Sauder CJ, 2006, VIROLOGY, V350, P48, DOI 10.1016/j.virol.2006.01.035; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; SUTTER RW, 1999, LIVE ATTENUATED POLI, P364; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Vabret A, 2006, J GEN VIROL, V87, P3349, DOI 10.1099/vir.0.82065-0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; World Health Organization Occupational and Environmental Health Team, 2006, WORLD HEAL ORGAN FOO, DOI DOI 10.1016/0004-6981(88)90109-6; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	49	211	221	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					154	161		10.1038/nm1726	http://dx.doi.org/10.1038/nm1726			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18246077	Bronze			2022-12-25	WOS:000252946700023
J	Rosendahl, J; Witt, H; Szmola, R; Bhatia, E; Ozsvari, B; Landt, O; Schulz, HU; Gress, TM; Pfuetzer, R; Loehr, M; Kovacs, P; Blueher, M; Stumvoll, M; Choudhuri, G; Hegyi, P; Morsche, RHT; Drenth, JP; Truninger, K; Macek, M; Puhl, G; Witt, U; Schmidt, H; Buening, C; Ockenga, J; Kage, A; Groneberg, DA; Nickel, R; Berg, T; Wiedenmann, B; Boedeker, H; Keim, V; Moessner, J; Teich, N; Sahin-Toth, M				Rosendahl, Jonas; Witt, Heiko; Szmola, Richard; Bhatia, Eesh; Ozsvari, Bela; Landt, Olfert; Schulz, Hans-Ulrich; Gress, Thomas M.; Pfuetzer, Roland; Loehr, Matthias; Kovacs, Peter; Blueher, Matthias; Stumvoll, Michael; Choudhuri, Gourdas; Hegyi, Peter; Morsche, Rene Hm te; Drenth, Joost P. H.; Truninger, Kaspar; Macek, Milan, Jr.; Puhl, Gero; Witt, Ulrike; Schmidt, Hartmut; Buening, Carsten; Ockenga, Johann; Kage, Andreas; Groneberg, David Alexander; Nickel, Renate; Berg, Thomas; Wiedenmann, Bertram; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels; Sahin-Toth, Miklos			Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis	NATURE GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; TROPICAL CALCIFIC PANCREATITIS; HEREDITARY PANCREATITIS; MISSENSE MUTATIONS; INHIBITOR GENE; DEGRADATION; PRSS1	Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls ( odds ratio (OR)=4.6; confidence interval (CI)=2.6 - 8.0; P=1.3x10(-7)). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 ( 0.7%) subjects with alcoholic liver disease (OR=4.2; CI=1.2 - 15.5; P=0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR=13.6; CI=1.7 - 109.2; P=0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.	[Szmola, Richard; Ozsvari, Bela; Sahin-Toth, Miklos] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Rosendahl, Jonas; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels] Univ Leipzig, Dept Gastroenterol & Hepatol, D-04103 Leipzig, Germany; [Witt, Heiko; Berg, Thomas; Boedeker, Hans] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India; [Ozsvari, Bela; Hegyi, Peter] Univ Szeged, Dept Med 1, H-6720 Szeged, Hungary; [Landt, Olfert] TIB MOLBIOL, D-12103 Berlin, Germany; [Schulz, Hans-Ulrich] Otto VonGuericke Univ Magdegurg, Dept Surg, D-39120 Magdeburg, Germany; [Gress, Thomas M.] Univ Marburg, Fac Med, Dept Gastroenterol Endocrinol & Metab, D-35043 Marburg, Germany; [Pfuetzer, Roland] Univ Heidelberg, Med Fac Mannheim, Dept Med 2 Gastroenterol Hepatol Infect Dis, D-68167 Mannheim, Germany; [Loehr, Matthias] Karoliniska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, D-04103 Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Endocrinol, D-04103 Leipzig, Germany; [Choudhuri, Gourdas] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Morsche, Rene Hm te; Drenth, Joost P. H.] Univ Nijmegen, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Truninger, Kaspar] Inselspital Bern, Gastroenterol Clin, CH-3010 Bern, Switzerland; [Macek, Milan, Jr.] Charles Univ Prague, Sch Med 2, CZ-15006 Prague 5, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Inst Biol & Med Genet Cyst, CZ-15006 Prague 5, Czech Republic; [Puhl, Gero] Dept Surg Charie, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Schmidt, Hartmut] Univ Hosp Munster, D-48149 Munster, Germany; [Buening, Carsten; Ockenga, Johann] Charite Univ Med Berlin, Dept Gastroenterol Hepatol Endocrinol, D-10008 Berlin, Germany; [Kage, Andreas] Charite Univ Med Berlin, Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Groneberg, David Alexander] Charite Univ Med Berlin, Inst Occupat Med, D-12207 Berlin, Germany; [Nickel, Renate] Charite Univ Med Berlin, Dept Pediat, D-13353 Berlin, Germany	Boston University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Szeged University; Otto von Guericke University; Philipps University Marburg; Ruprecht Karls University Heidelberg; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Leipzig University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Radboud University Nijmegen; University of Bern; University Hospital of Bern; Charles University Prague; Motol University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sahin-Toth, M (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans St, Boston, MA 02118 USA.	miklos@bu.edu	Drenth, Joost/V-7436-2019; Teich, Niels/AAF-5104-2019; te Morsche, R/P-9143-2015; Drenth, J.P.H./H-8025-2014; Löhr, Matthias/A-3692-2012; Groneberg, David/A-5132-2018; Stumvoll, Michael/ABE-1121-2021	Löhr, Matthias/0000-0002-7647-198X; Groneberg, David/0000-0001-8551-6556; Stumvoll, Michael/0000-0001-6225-8240; Gress, Thomas/0000-0002-9333-5461; Wiedenmann, Bertram/0000-0002-7890-2552; Berg, Thomas/0000-0003-0003-6241; Kovacs, Peter/0000-0002-0290-5423; Sahin-Toth, Miklos/0000-0003-4513-9922	NIDDK NIH HHS [R01 DK058088, R01 DK058088-06, R01 DK058088-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Schneider A, 2002, GASTROENTEROLOGY, V123, P1026, DOI 10.1053/gast.2002.36059; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	18	263	275	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					78	82		10.1038/ng.2007.44	http://dx.doi.org/10.1038/ng.2007.44			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059268	Green Accepted			2022-12-25	WOS:000252118600021
J	Smits, G; Mungall, AJ; Griffiths-Jones, S; Smith, P; Beury, D; Matthews, L; Rogers, J; Pask, AJ; Shaw, G; VandeBerg, JL; McCarrey, JR; Renfree, MB; Reik, W; Dunham, I				Smits, Guillaume; Mungall, Andrew J.; Griffiths-Jones, Sam; Smith, Paul; Beury, Delphine; Matthews, Lucy; Rogers, Jane; Pask, Andrew J.; Shaw, Geoff; VandeBerg, John L.; McCarrey, John R.; Renfree, Marilyn B.; Reik, Wolf; Dunham, Ian		SAVOIR Consortium	Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians	NATURE GENETICS			English	Article							INSULATOR PROTEIN CTCF; DIFFERENTIAL METHYLATION; CHROMATIN INSULATOR; DNA METHYLATION; GENE; MOUSE; IGF2; EXPRESSION; MAMMALS; SEQUENCES	Comparisons between eutherians and marsupials suggest limited conservation of the molecular mechanisms that control genomic imprinting in mammals. We have studied the evolution of the imprinted IGF2-H19 locus in therians. Although marsupial orthologs of protein-coding exons were easily identified, the use of evolutionarily conserved regions and low-stringency Bl2seq comparisons was required to delineate a candidate H19 noncoding RNA sequence. The therian H19 orthologs show miR-675 and exon structure conservation, suggesting functional selection on both features. Transcription start site sequences and poly(A) signals are also conserved. As in eutherians, marsupial H19 is maternally expressed and paternal methylation upstream of the gene originates in the male germline, encompasses a CTCF insulator, and spreads somatically into the H19 gene. The conservation in all therians of the mechanism controlling imprinting of the IGF2-H19 locus suggests a sequential model of imprinting evolution.	[Smits, Guillaume; Smith, Paul; Beury, Delphine; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Mungall, Andrew J.; Matthews, Lucy; Rogers, Jane; Dunham, Ian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Griffiths-Jones, Sam] Univ Manchester, Fac Life Sci, Manchester M13 9PL, England; [Pask, Andrew J.; Shaw, Geoff; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Victoria 3010, Australia; [VandeBerg, John L.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of Manchester; University of Melbourne; Texas Biomedical Research Institute; University of Texas System; University of Texas at San Antonio (UTSA)	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk; dunham@ebi.ac.uk	Reik, Wolf/I-6794-2012; Mungall, Andrew J./U-7067-2018; Shaw, Geoff/A-6916-2012; Griffiths-Jones, Sam/H-2998-2014	Mungall, Andrew J./0000-0002-0905-2742; Shaw, Geoff/0000-0002-7421-7136; Smits, Guillaume/0000-0003-2845-6758; Renfree, Marilyn/0000-0002-4589-0436; Griffiths-Jones, Sam/0000-0001-6043-807X; Pask, Andrew/0000-0002-1900-2263; Dunham, Ian/0000-0003-2525-5598; Reik, Wolf/0000-0003-0216-9881; Beury, Delphine/0000-0002-4163-0362; Steward, Charles/0000-0001-8829-5349	MRC [G0400154] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S119, BBS/E/B/0000C214] Funding Source: Medline; Medical Research Council [G0400154] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ager E, 2007, DEV BIOL, V309, P317, DOI 10.1016/j.ydbio.2007.07.025; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Butler CM, 2008, J ANAT, V212, P55, DOI 10.1111/j.1469-7580.2007.00837.x; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Griffiths-Jones S, 2005, BIOINFORMATICS, V21, P257, DOI 10.1093/bioinformatics/bth489; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schmid J, 2003, COMP BIOCHEM PHYS A, V136, P903, DOI 10.1016/S1095-6433(03)00240-X; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weidman JR, 2006, EPIGENETICS-US, V1, P49; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817	50	139	149	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					971	976		10.1038/ng.168	http://dx.doi.org/10.1038/ng.168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587395				2022-12-25	WOS:000258026900013
J	Kato, N; Sakata, T; Breton, G; Le Roch, KG; Nagle, A; Andersen, C; Bursulaya, B; Henson, K; Johnson, J; Kumar, KA; Marr, F; Mason, D; McNamara, C; Plouffe, D; Ramachandran, V; Spooner, M; Tuntland, T; Zhou, Y; Peters, EC; Chatterjee, A; Schultz, PG; Ward, GE; Gray, N; Harper, J; Winzeler, EA				Kato, Nobutaka; Sakata, Tomoyo; Breton, Ghislain; Le Roch, Karine G.; Nagle, Advait; Andersen, Carsten; Bursulaya, Badry; Henson, Kerstin; Johnson, Jeffrey; Kumar, Kota Arun; Marr, Felix; Mason, Daniel; McNamara, Case; Plouffe, David; Ramachandran, Vandana; Spooner, Muriel; Tuntland, Tove; Zhou, Yingyao; Peters, Eric C.; Chatterjee, Arnab; Schultz, Peter G.; Ward, Gary E.; Gray, Nathanael; Harper, Jeffrey; Winzeler, Elizabeth A.			Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility	NATURE CHEMICAL BIOLOGY			English	Article							MYOSIN-A; MALARIA PARASITES; GLIDING MOTILITY; CELL INVASION; CALCIUM; COMPLEX; IDENTIFICATION; DISCHARGE; ONTOLOGY; NETWORK	Calcium-dependent protein kinases play a crucial role in intracellular calcium signaling in plants, some algae and protozoa. In Plasmodium falciparum, calcium-dependent protein kinase 1 (PfCDPK1) is expressed during schizogony in the erythrocytic stage as well as in the sporozoite stage. It is coexpressed with genes that encode the parasite motor complex, a cellular component required for parasite invasion of host cells, parasite motility and potentially cytokinesis. A targeted gene-disruption approach demonstrated that pfcdpk1 seems to be essential for parasite viability. An in vitro biochemical screen using recombinant PfCDPK1 against a library of 20,000 compounds resulted in the identification of a series of structurally related 2,6,9-trisubstituted purines. Compound treatment caused sudden developmental arrest at the late schizont stage in P. falciparum and a large reduction in intracellular parasites in Toxoplasma gondii, which suggests a possible role for PfCDPK1 in regulation of parasite motility during egress and invasion.	[Kato, Nobutaka; Breton, Ghislain; Henson, Kerstin; Johnson, Jeffrey; Marr, Felix; Ramachandran, Vandana; Schultz, Peter G.; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kato, Nobutaka; Sakata, Tomoyo; Le Roch, Karine G.; Nagle, Advait; Andersen, Carsten; Bursulaya, Badry; Henson, Kerstin; Mason, Daniel; McNamara, Case; Plouffe, David; Spooner, Muriel; Tuntland, Tove; Zhou, Yingyao; Peters, Eric C.; Chatterjee, Arnab; Schultz, Peter G.; Gray, Nathanael; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Kumar, Kota Arun] NYU, Sch Med, Dept Pathol, Michael Heidelberger Div Immunol, New York, NY 10016 USA; [Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Harper, Jeffrey] Univ Nevada, Dept Biochem, Reno, NV 89557 USA	Scripps Research Institute; Novartis; New York University; University of Vermont; Nevada System of Higher Education (NSHE); University of Nevada Reno	Winzeler, EA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,ICND202, La Jolla, CA 92037 USA.	winzeler@scripps.edu	Winzeler, Elizabeth/AAP-6752-2020; Peters, Eric/W-2739-2019; Breton, Ghislain/F-7266-2016	Winzeler, Elizabeth/0000-0002-4049-2113; Breton, Ghislain/0000-0001-6400-3858; Tuntland, Tove/0000-0001-5831-1723; Ward, Gary/0000-0003-4138-3055	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059472, R01AI054961, R56AI054961] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054961, R01 AI059472, AI054961, AI059472-02] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; [Anonymous], 1999, HDB ANIMAL MODELS IN; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Barrera L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-42; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; CHULAY JD, 1983, EXP PARASITOL, V55, P138, DOI 10.1016/0014-4894(83)90007-3; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fotie J, 2006, J NAT PROD, V69, P62, DOI 10.1021/np050315y; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Garcia CRS, 1999, PARASITOL TODAY, V15, P488, DOI 10.1016/S0169-4758(99)01571-9; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Heintzelman MB, 2006, INT REV CYTOL, V251, P79, DOI 10.1016/S0074-7696(06)51003-4; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kugelstadt D, 2007, MOL BIOCHEM PARASIT, V151, P111, DOI 10.1016/j.molbiopara.2006.10.012; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	50	177	187	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					347	356		10.1038/nchembio.87	http://dx.doi.org/10.1038/nchembio.87			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18454143				2022-12-25	WOS:000256068600011
J	Stiber, J; Hawkins, A; Zhang, ZS; Wang, S; Burch, J; Graham, V; Ward, CC; Seth, M; Finch, E; Malouf, N; Williams, RS; Eu, JP; Rosenberg, P				Stiber, Jonathan; Hawkins, April; Zhang, Zhu-Shan; Wang, Sunny; Burch, Jarrett; Graham, Victoria; Ward, Cary C.; Seth, Malini; Finch, Elizabeth; Malouf, Nadia; Williams, R. Sanders; Eu, Jerry P.; Rosenberg, Paul			STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle	NATURE CELL BIOLOGY			English	Article							CA2+ ENTRY; CRAC CHANNELS; PORE SUBUNIT; C-ELEGANS; DEPLETION; ORAI1; RELEASE; SENSOR; ACTIVATION; CURRENTS	It is now well established that stromal interaction molecule 1 (STIM1) is the calcium sensor of endoplasmic reticulum stores required to activate store-operated calcium entry (SOC) channels at the surface of non-excitable cells. However, little is known about STIM1 in excitable cells, such as striated muscle, where the complement of calcium regulatory molecules is rather disparate from that of non-excitable cells. Here, we show that STIM1 is expressed in both myotubes and adult skeletal muscle. Myotubes lacking functional STIM1 fail to show SOC and fatigue rapidly. Moreover, mice lacking functional STIM1 die perinatally from a skeletal myopathy. In addition, STIM1 haploinsufficiency confers a contractile defect only under conditions where rapid refilling of stores would be needed. These findings provide insight into the role of STIM1 in skeletal muscle and suggest that STIM1 has a universal role as an ER/SR calcium sensor in both excitable and non-excitable cells.	[Stiber, Jonathan; Hawkins, April; Zhang, Zhu-Shan; Wang, Sunny; Burch, Jarrett; Graham, Victoria; Ward, Cary C.; Seth, Malini; Finch, Elizabeth; Williams, R. Sanders; Eu, Jerry P.; Rosenberg, Paul] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Malouf, Nadia] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill	Rosenberg, P (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.	rosen029@mc.duke.edu	Tuluc, Petronel/C-2527-2011	Rosenberg, Paul/0000-0002-5659-160X	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [K08-HL077520, K08 HL077520-02, K08 HL071841-04, K08 HL077520, K08 HL071841, K08 HL071841-03, K08-HL-071841-04, K08 HL077520-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077520, K08HL071841] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Lorenzon P, 2000, J PHYSIOL-LONDON, V525, P499, DOI 10.1111/j.1469-7793.2000.00499.x; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Lorin-Nebel C, 2007, J PHYSIOL-LONDON, V580, P67, DOI 10.1113/jphysiol.2006.124883; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Maclennan DH, 2004, J MUSCLE RES CELL M, V25, P600; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; SCUHYNA TM, 2007, J PHYSL, V581, P369; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Whitehead NP, 2006, NEUROMUSCULAR DISORD, V16, P845, DOI 10.1016/j.nmd.2006.07.024; Williams RS, 2002, COLD SPRING HARB SYM, V67, P339, DOI 10.1101/sqb.2002.67.339; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	50	278	284	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					688	697		10.1038/ncb1731	http://dx.doi.org/10.1038/ncb1731			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488020	Green Accepted, Green Submitted			2022-12-25	WOS:000256350100015
J	Taddei, I; Deugnier, MA; Faraldo, MM; Petit, V; Bouvard, D; Medina, D; Fassler, R; Thiery, JP; Glukhova, MA				Taddei, Ilaria; Deugnier, Marie-Ange; Faraldo, Marisa M.; Petit, Valerie; Bouvard, Daniel; Medina, Daniel; Faessler, Reinhard; Thiery, Jean Paul; Glukhova, Marina A.			beta 1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; GLAND; DIFFERENTIATION; INTEGRIN; LINE; MORPHOGENESIS; EXPRESSION; REGULATOR; REVEALS; GATA-3	The mammary gland epithelium comprises two major cell types: basal and luminal. Basal cells interact directly with the extracellular matrix (ECM) and express higher levels of the ECM receptors, integrins, than luminal cells. We show that deletion of beta 1 integrin from basal cells abolishes the regenerative potential of the mammary epithelium and affects mammary gland development. The mutant epithelium was characterized by an abnormal ductal branching pattern and aberrant morphogenesis in pregnancy, although at the end of gestation, the secretory alveoli developed from beta 1 integrin-positive progenitors. Lack of beta 1 integrin altered the orientation of the basal-cell division axis and in mutant epithelium, in contrast to control tissue, the progeny of beta 1 integrin-null basal cells, identified by a genetic marker, was found in the luminal compartment. These results reveal, for the first time, the essential role of the basal mammary epithelial cell-ECM interactions mediated by beta 1 integrins in the maintenance of a functional stem cell population, mammary morphogenesis and segregation of the two major mammary cell lineages.	[Taddei, Ilaria; Deugnier, Marie-Ange; Faraldo, Marisa M.; Petit, Valerie; Thiery, Jean Paul; Glukhova, Marina A.] Inst Curie, CNRS, Ctr Rech, UMR144, F-75248 Paris 05, France; [Thiery, Jean Paul] ASTAR, IMCB, Singapore 138673, Singapore; [Medina, Daniel] Baylor Coll Med, Houston, TX 77030 USA; [Bouvard, Daniel; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Baylor College of Medicine; Max Planck Society	Glukhova, MA (corresponding author), Inst Curie, CNRS, Ctr Rech, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	Marina.Glukhova@curie.fr	Bouvard, Daniel/B-1260-2017; Deugnier, Marie-Ange/M-7556-2018; Bouvard, Daniel/M-2727-2013; Martin-Faraldo, Maria-Luisa/M-5811-2018; Deugnier, Marie-Ange/AAF-5877-2021; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Bouvard, Daniel/0000-0002-0845-6681; Deugnier, Marie-Ange/0000-0002-2199-1099; Thiery, Jean Paul/0000-0003-0478-5020; Faraldo, Marisa/0000-0001-9497-1171; PETIT, Valerie/0000-0003-1645-9396				Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; DEOME KB, 1959, CANCER RES, V19, P515; Deugnier MA, 2002, J CELL BIOL, V159, P453, DOI 10.1083/jcb.200207138; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Faraldo MM, 1998, EMBO J, V17, P2139, DOI 10.1093/emboj/17.8.2139; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Wagner KU, 2002, DEVELOPMENT, V129, P1377; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025	29	187	194	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					716	722		10.1038/ncb1734	http://dx.doi.org/10.1038/ncb1734			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469806	Green Submitted, Green Accepted			2022-12-25	WOS:000256350100018
J	Tasdemir, E; Maiuri, MC; Galluzzi, L; Vitale, I; Djavaheri-Mergny, M; D'Amelio, M; Criollo, A; Morselli, E; Zhu, CL; Harper, F; Nannmark, U; Samara, C; Pinton, P; Vicencio, JM; Carnuccio, R; Moll, UM; Madeo, F; Paterlini-Brechot, P; Rizzuto, R; Szabadkai, G; Pierron, G; Blomgren, K; Tavernarakis, N; Codogno, P; Cecconi, F; Kroemer, G				Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Djavaheri-Mergny, Mojgan; D'Amelio, Marcello; Criollo, Alfredo; Morselli, Eugenia; Zhu, Changlian; Harper, Francis; Nannmark, Ulf; Samara, Chrysanthi; Pinton, Paolo; Vicencio, Jose Miguel; Carnuccio, Rosa; Moll, Ute M.; Madeo, Frank; Paterlini-Brechot, Patrizia; Rizzuto, Rosario; Szabadkai, Gyorgy; Pierron, Gerard; Blomgren, Klas; Tavernarakis, Nektarios; Codogno, Patrice; Cecconi, Francesco; Kroemer, Guido			Regulation of autophagy by cytoplasmic p53	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-SURVIVAL; APOPTOSIS; STRESS; INHIBITION; PATHWAY; RESTORATION; DISRUPTION; CLEARANCE; INDUCTION	Multiple cellular stressors, including activation of the tumour suppressor p53, can stimulate autophagy. Here we show that knockout, knockdown or pharmacological inhibition of p53 can induce autophagy in human, mouse and nematode cells. Enhanced autophagy improved the survival of p53-deficient cancer cells under conditions of hypoxia and nutrient depletion, allowing them to maintain high ATP levels. Inhibition of p53 led to autophagy in enucleated cells, and cytoplasmic, not nuclear, p53 was able to repress the enhanced autophagy of p53(-/-)cells. Many different inducers of autophagy (for example, starvation, rapamycin and toxins affecting the endoplasmic reticulum) stimulated proteasome-mediated degradation of p53 through a pathway relying on the E3 ubiquitin ligase HDM2. Inhibition of p53 degradation prevented the activation of autophagy in several cell lines, in response to several distinct stimuli. These results provide evidence of a key signalling pathway that links autophagy to the cancer-associated dysregulation of p53.	[Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Tasdemir, Ezgi; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Maiuri, M. Chiara; Carnuccio, Rosa] Univ Naples Federico II, Sch Biotechnol Sci, I-80131 Naples, Italy; [Maiuri, M. Chiara; Carnuccio, Rosa] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy; [Djavaheri-Mergny, Mojgan; Codogno, Patrice] Univ Paris 11, Fac Pharm, INSERM, U756, F-92290 Chatenay Malabry, France; [Szabadkai, Gyorgy] UCL, Dept Physiol, London WC1E 6BT, England; [Paterlini-Brechot, Patrizia; Szabadkai, Gyorgy] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, INSERM U807, F-75015 Paris, France; [D'Amelio, Marcello; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy; [D'Amelio, Marcello; Cecconi, Francesco] IRCCS, Fondaz Santa Lucia, I-00133 Rome, Italy; [Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Pinton, Paolo; Rizzuto, Rosario] Univ Ferrara, ICSI, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Samara, Chrysanthi; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Nannmark, Ulf] Gothenburg Univ, Inst Biomed, Dept Med Biochem & Cell Biol, S-41124 Gothenburg, Sweden; [Harper, Francis; Pierron, Gerard] Inst Andre Lwoff, CNRS, FRE 2937, F-94801 Villejuif, France; [Zhu, Changlian; Blomgren, Klas] Gothenburg Univ, Queen Silvia Childrens Hosp, Dept Pediat Oncol, Inst Neurosci & Physiol,Ctr Brain Repair & Rehabi, Gothenburg, Sweden	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Naples Federico II; University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Rome Tor Vergata; IRCCS Santa Lucia; University of Graz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Ferrara; Foundation for Research & Technology - Hellas (FORTH); University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); Queen Silvia Children's Hospital; University of Gothenburg	Kroemer, G (corresponding author), INSERM, U848, F-94805 Villejuif, France.	kroemer@igr.fr	Zhu, Changlian/AAN-6205-2020; Codogno, Patrice/G-1384-2013; Cecconi, Francesco/K-3969-2016; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Vitale, Ilio/M-3960-2017; Tavernarakis, Nektarios/B-9684-2013; Pinton, Paolo/J-8025-2012; Djavaheri-Mergny, Mojgan/L-3890-2019; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; Djavaheri-Mergny, Mojgan/N-6315-2017	Codogno, Patrice/0000-0002-5492-3180; Cecconi, Francesco/0000-0002-5614-4359; KROEMER, Guido/0000-0002-9334-4405; Vitale, Ilio/0000-0002-5918-1841; Tavernarakis, Nektarios/0000-0002-5253-1466; Pinton, Paolo/0000-0001-7108-6508; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Galluzzi, Lorenzo/0000-0003-2257-8500; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Madeo, Frank/0000-0002-5070-1329; Criollo, Alfredo/0000-0002-2737-7751; Blomgren, Klas/0000-0002-0476-7271; Szabadkai, Gyorgy/0000-0002-3006-3577; Paterlini- Brechot, Patrizia/0000-0001-7981-6325; Rizzuto, Rosario/0000-0001-7044-5097; Zhu, Changlian/0000-0002-5029-6730; D'Amelio, Marcello/0000-0001-6526-1832	NIA NIH HHS [P01 AG025532-01A10002, P01 AG025532-020002] Funding Source: Medline; Telethon [TCP99038] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vater CA, 1996, ONCOGENE, V13, P739; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	50	857	921	7	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					676	687		10.1038/ncb1730	http://dx.doi.org/10.1038/ncb1730			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454141	Green Accepted			2022-12-25	WOS:000256350100014
J	Tailford, LE; Offen, WA; Smith, NL; Dumon, C; Morland, C; Gratien, J; Heck, MP; Stick, RV; Bleriot, Y; Vasella, A; Gilbert, HJ; Davies, GJ				Tailford, Louise E.; Offen, Wendy A.; Smith, Nicola L.; Dumon, Claire; Morland, Carl; Gratien, Julie; Heck, Marie-Pierre; Stick, Robert V.; Bleriot, Yves; Vasella, Andrea; Gilbert, Harry J.; Davies, Gideon J.			Structural and biochemical evidence for a boat-like transition state in beta-mannosidases	NATURE CHEMICAL BIOLOGY			English	Article							DIFFERENT CONFORMATIONAL ITINERARIES; GLYCOSIDASE INHIBITORS; SUBSTRATE DISTORTION; ANALOG INHIBITORS; BINDING; MECHANISM; ISOFAGOMINE; AMIDINE; GLUCOSIDASES; NOEUROMYCIN	Enzyme inhibition through mimicry of the transition state is a major area for the design of new therapeutic agents. Emerging evidence suggests that many retaining glycosidases that are active on alpha- or beta-mannosides harness unusual B-2,B-5 (boat) transition states. Here we present the analysis of 25 putative beta-mannosidase inhibitors, whose K-i values range from nanomolar to millimolar, on the Bacteroides thetaiotaomicron b-mannosidase BtMan2A. B-2,B-5 or closely related conformations were observed for all tightly binding compounds. Subsequent linear free energy relationships that correlate log K-i with log K-m/K-cat for a series of active center variants highlight aryl-substituted mannoimidazoles as powerful transition state mimics in which the binding energy of the aryl group enhances both binding and the degree of transition state mimicry. Support for a B-2,B-5 transition state during enzymatic beta-mannosidase hydrolysis should also facilitate the design and exploitation of transition state mimics for the inhibition of retaining alpha-mannosidases-an area that is emerging for anticancer therapeutics.	[Tailford, Louise E.; Smith, Nicola L.; Dumon, Claire; Morland, Carl; Gilbert, Harry J.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Offen, Wendy A.; Davies, Gideon J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Gratien, Julie; Heck, Marie-Pierre] Inst Biol & Technol Sacley, Serv Chim Bioorgan Marquage, Direct Sci Vivant, Commissariat Energie Atom Ctr Sacley, F-91191 Gif Sur Yvette, France; [Stick, Robert V.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Chem M313, Crawley, WA 6009, Australia; [Bleriot, Yves] Univ Paris 06, CNRS,UMR 7611, Chim Organ Lab, Inst Chim Mol,Fed Res 2769, F-75005 Paris, France; [Vasella, Andrea] ETH, HCI H317, Chim Organ Lab, CH-8093 Zurich, Switzerland	Newcastle University - UK; University of York - UK; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Western Australia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gilbert, HJ (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	h.j.gilbert@ncl.ac.uk; davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011; Claire, Dumon/AAI-2553-2021; Blériot, Yves/ABI-8403-2020	Davies, Gideon J/0000-0002-7343-776X; Claire, Dumon/0000-0003-4925-7336; Blériot, Yves/0000-0002-3209-9282	Biotechnology and Biological Sciences Research Council [BB/E000568/1, BBS/B/05974] Funding Source: Medline; BBSRC [BB/E000568/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Amorim L, 2006, TETRAHEDRON LETT, V47, P8887, DOI 10.1016/j.tetlet.2006.10.046; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTLETT PA, 1983, BIOCHEMISTRY-US, V22, P4618, DOI 10.1021/bi00289a002; BERLAND CR, 1995, BIOCHEMISTRY-US, V34, P10153, DOI 10.1021/bi00032a008; Best WM, 2002, CAN J CHEM, V80, P857, DOI 10.1139/V02-060; Bohm M, 2003, HELV CHIM ACTA, V86, P3818, DOI 10.1002/hlca.200390321; CAPON B, 1969, CHEM REV, V69, P407, DOI 10.1021/cr60260a001; Crich D, 2004, ANGEW CHEM INT EDIT, V43, P5386, DOI 10.1002/anie.200453688; Crich D, 2007, J ORG CHEM, V72, P1681, DOI 10.1021/jo062294y; DAVIES G, 1997, COMPREHENSIVE BIOL C, V1, P119; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gloster TM, 2007, J AM CHEM SOC, V129, P2345, DOI 10.1021/ja066961g; Gloster TM, 2006, BIOCHEMISTRY-US, V45, P11879, DOI 10.1021/bi060973x; Goddard-Borger ED, 2007, AUST J CHEM, V60, P211, DOI 10.1071/CH07016; Granovsky M, 2000, NAT MED, V6, P306; Heck MP, 2004, J AM CHEM SOC, V126, P1971, DOI 10.1021/ja037822r; HOOS R, 1993, HELV CHIM ACTA, V76, P2666, DOI 10.1002/hlca.19930760723; LEGLER G, 1984, CARBOHYD RES, V128, P61, DOI 10.1016/0008-6215(84)85084-3; Li B, 2004, CHEMBIOCHEM, V5, P1220, DOI 10.1002/cbic.200300842; Liu HZ, 2001, J AM CHEM SOC, V123, P5116, DOI 10.1021/ja010240u; Macdonald JM, 2004, AUST J CHEM, V57, P449, DOI 10.1071/CH03228; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; Meloncelli PJ, 2006, AUST J CHEM, V59, P827, DOI 10.1071/CH06241; Money VA, 2006, ANGEW CHEM INT EDIT, V45, P5136, DOI 10.1002/anie.200600802; Mosi R, 1998, BIOCHEMISTRY-US, V37, P17192, DOI 10.1021/bi981109a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; PAPANDREOU G, 1993, J AM CHEM SOC, V115, P11682, DOI 10.1021/ja00078a004; Shah N, 2003, BIOCHEMISTRY-US, V42, P13812, DOI 10.1021/bi034742r; Snider MJ, 2001, BIOCHEMISTRY-US, V40, P11364, DOI 10.1021/bi011189+; Stoddart J.F., 1971, STEREOCHEMISTRY CARB; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Terinek M, 2003, HELV CHIM ACTA, V86, P3482, DOI 10.1002/hlca.200390293; TONG MK, 1990, J AM CHEM SOC, V112, P6137, DOI 10.1021/ja00172a045; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; WALASZEK Z, 1982, CARBOHYD RES, V106, P193, DOI 10.1016/S0008-6215(00)81073-3; Wen X, 2005, BIOCHEMISTRY-US, V44, P6729, DOI 10.1021/bi0500426; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Withers S. G., 1999, IMINOSUGARS GLYCOSID, P188; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h; Zechel DL, 2003, BIOCHEMISTRY-US, V42, P7195, DOI 10.1021/bi034329j	46	94	94	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2008	4	5					306	312		10.1038/nchembio.81	http://dx.doi.org/10.1038/nchembio.81			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291CM	18408714				2022-12-25	WOS:000255170400011
J	Prozorovski, T; Schulze-Topphoff, U; Glumm, R; Baumgart, J; Schroter, F; Ninnemann, O; Siegert, E; Bendix, I; Brustle, O; Nitsch, R; Zipp, F; Aktas, O				Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Baumgart, Jan; Schroeter, Friederike; Ninnemann, Olaf; Siegert, Elise; Bendix, Ivo; Bruestle, Oliver; Nitsch, Robert; Zipp, Frauke; Aktas, Orhan			Sirt1 contributes critically to the redox-dependent fate of neural progenitors	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; CENTRAL-NERVOUS-SYSTEM; LIFE-SPAN; MULTIPLE-SCLEROSIS; BHLH REPRESSORS; STEM-CELL; KAPPA-B; EGF; PROTEIN; BRAIN	Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a failure to replenish neurons and by astrogliosis. The underlying molecular pathways, however, are poorly understood. Here, we show that subtle alterations of the redox state, found in different brain pathologies, regulate the fate of mouse neural progenitor cells ( NPCs) through the histone deacetylase ( HDAC) Sirt1. Mild oxidation or direct activation of Sirt1 suppressed proliferation of NPCs and directed their differentiation towards the astroglial lineage at the expense of the neuronal lineage, whereas reducing conditions had the opposite effect. Under oxidative conditions in vitro and in vivo, Sirt1 was upregulated in NPCs, bound to the transcription factor Hes1 and subsequently inhibited pro-neuronal Mash1. In utero shRNA-mediated knockdown of Sirt1 in NPCs prevented oxidation-mediated suppression of neurogenesis and caused upregulation of Mash1 in vivo. Our results provide evidence for an as yet unknown metabolic master switch that determines the fate of neural progenitors.	[Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany; [Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Max Delbruck Ctr Mol Med, D-10117 Berlin, Germany; [Baumgart, Jan; Ninnemann, Olaf; Nitsch, Robert] Charite Univ Med Berlin, Inst Cell & Neurobiol, D-10117 Berlin, Germany; [Bruestle, Oliver] Univ Bonn, Med Ctr, Inst Reconstruct Neurobiol, D-53105 Bonn, Germany; [Bruestle, Oliver] Hertie Fdn, D-53105 Bonn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn	Zipp, F (corresponding author), Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany.	frauke.zipp@charite.de	Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015; Nitsch, Robert/AAI-9129-2021	Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Bendix, Ivo/0000-0002-9751-3640; Baumgart, Jan/0000-0003-1996-4267; Siegert, Elise/0000-0002-9594-0446				Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Merad-Saidoune M, 1999, EXP NEUROL, V158, P428, DOI 10.1006/exnr.1999.7108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wernig M, 2002, J NEUROPATH EXP NEUR, V61, P101, DOI 10.1093/jnen/61.2.101; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	362	372	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					385	U35		10.1038/ncb1700	http://dx.doi.org/10.1038/ncb1700			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344989				2022-12-25	WOS:000254561700008
J	Tsai, WB; Chung, YM; Takahashi, Y; Xu, ZH; Hu, MCT				Tsai, Wen-Bin; Chung, Young Min; Takahashi, Yoko; Xu, Zhaohui; Hu, Mickey C. -T.			Functional interaction between FOXO3a and ATM regulates DNA damage response	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR FOXO3A; ATAXIA-TELANGIECTASIA; G(2)-M CHECKPOINT; MICE LACKING; CELL-CYCLE; ACTIVATION; KINASE; PROTEIN; REPAIR; GENE	The maintenance of genomic stability in cells is relentlessly challenged by environmental stresses that induce DNA breaks, which activate the DNA-damage pathway mediated by ataxia-telangiectasia mutated ( ATM) and its downstream mediators to control damage-induced cell-cycle checkpoints and DNA repair(1-3). Here, we show that FOXO3a interacts with ATM to promote phosphorylation of ATM at Ser 1981 and prompting its downstream mediators to form nuclear foci in response to DNA damage. Silencing FOXO3a in cells abrogates the formation of ATM-pS1981 and phospho-histone H2AX foci after DNA damage. Increasing FOXO3a in cells promotes ATM-regulated signalling, the intra-S-phase or G2-M cell-cycle checkpoints, and the repair of damaged DNA, whereas cells lacking FOXO3a did not trigger the DNA-repair mechanism after DNA damage. The carboxy-terminal domain of FOXO3a binds to the FAT domain of ATM, thereby contributing to the activation of ATM. These results suggest that ATM may be regulated directly by FOXO3a in the DNA-damage response.	[Tsai, Wen-Bin; Chung, Young Min; Takahashi, Yoko; Xu, Zhaohui; Hu, Mickey C. -T.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hu, Mickey C. -T.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hu, MCT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	michu@mdanderson.org	Chung, Young Min/AAV-7656-2020		NCI NIH HHS [CA16772, R01 CA113859-03, R01 CA113859] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113859] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Matijasevic Z, 2001, CARCINOGENESIS, V22, P661, DOI 10.1093/carcin/22.4.661; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mu L, 2005, INT J PHARMACEUT, V306, P142, DOI 10.1016/j.ijpharm.2005.08.026; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Opanasopit P, 2007, COLLOID SURFACE B, V60, P117, DOI 10.1016/j.colsurfb.2007.06.001; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; TRA H, 2003, SCI STKE, pRE5; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	50	145	147	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					460	U215		10.1038/ncb1709	http://dx.doi.org/10.1038/ncb1709			48	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344987	Green Accepted			2022-12-25	WOS:000254561700017
J	Weinberger, LS; Dar, RD; Simpson, ML				Weinberger, Leor S.; Dar, Roy D.; Simpson, Michael L.			Transient-mediated fate determination in a transcriptional circuit of HIV	NATURE GENETICS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ESCHERICHIA-COLI; TYPE-1 INFECTION; GENE-EXPRESSION; T-CELLS; RESERVOIR; LATENCY; NOISE; TAT	Steady-state behavior and bistability have been proposed as mechanisms for decision making in gene circuits(1-3). However, transient gene expression has also been proposed to control cell fate(4,5), with the decision arbitrated by the duration of a transient gene expression pulse. Here, using an HIV-1 model system, we directly quantify transcriptional feedback strength and its effects on both the duration of HIV-1 Tat transcriptional pulses and the fate of HIV-infected cells. By measuring shifts in the autocorrelation of noise inherent to gene expression, we found that transcriptional positive feedback extends the single-cell Tat expression lifetime two-to sixfold for both minimal Tat circuits and full length, actively replicating HIV-1. Notably, artificial weakening of Tat positive feedback shortened the duration of Tat expression transients and biased the probability in favor of latency. Thus, transcriptional positive feedback can modulate transient expression lifetime to a greater extent than protein half-life modulation, and it has a critical role in the cell-fate decision in HIV.	[Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dar, Roy D.; Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Dar, Roy D.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Weinberger, LS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr 0314, La Jolla, CA 92093 USA.	lsw@ucsd.edu; simpsonml1@ornl.gov	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888				Alon U, 2007, INTRO SYSTEMS BIOL D; Arkin A, 1998, GENETICS, V149, P1633; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2003, J VIROL, V77, P10028, DOI 10.1128/JVI.77.18.10028-10036.2003; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006	30	144	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					466	470		10.1038/ng.116	http://dx.doi.org/10.1038/ng.116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18344999				2022-12-25	WOS:000254388100019
J	Genevieve, D; Proulle, V; Isidor, B; Bellais, S; Serre, V; Djouadi, F; Picard, C; Vignon-Savoye; Bader-Meunier, B; Blanche, S; de Vernejoul, MC; Legeai-Mallet, L; Fischer, AM; Le Merrer, M; Dreyfus, M; Gaussem, P; Munnich, A; Cormier-Daire, V				Genevieve, David; Proulle, Valerie; Isidor, Bertrand; Bellais, Samuel; Serre, Valerie; Djouadi, Fatima; Picard, Capucine; Vignon-Savoye, Capucine; Bader-Meunier, Brigitte; Blanche, Stephane; de Vernejoul, Marie-Christine; Legeai-Mallet, Laurence; Fischer, Anne-Marie; Le Merrer, Martine; Dreyfus, Marie; Gaussem, Pascale; Munnich, Arnold; Cormier-Daire, Valerie			Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)	NATURE GENETICS			English	Article							SYNTHETASE; CELLS	Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A(2) (TXA(2)). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. We also found that TXAS and TXA2 modulated expression of TNFSF11 and TNFRSF11B (encoding RANKL and osteoprotegerin (OPG), respectively) in primary cultured osteoblasts.	[Genevieve, David; Isidor, Bertrand; Bellais, Samuel; Serre, Valerie; Legeai-Mallet, Laurence; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, AP HP,Hop Necker Enfants Malades, Dept Genet, INSERM,Unite U781, F-75015 Paris, France; [Proulle, Valerie; Dreyfus, Marie] Univ Paris Sud, Hop Kremlin Bicetre, AP HP,Lab Hematol, F-94275 Le Kremlin Bicetre, France; [Djouadi, Fatima] CNRS, UPR9078, F-75015 Paris, France; [Picard, Capucine; Blanche, Stephane] Hop Necker Enfants Malad, AP HP,Unite Immunohematol & Rhumatol, F-75015 Paris, France; [Vignon-Savoye, Capucine] Ctr Hosp Intercommunal Le Raincy Montfermeil, Serv Pediat, F-93370 Montfermeil, France; [Bader-Meunier, Brigitte] Hop Robert Debre, AP HP, Serv Hematol Pediat, F-75019 Paris, France; [de Vernejoul, Marie-Christine] Hop Lariboisiere, AP HP, Dept Rhumatol, F-75010 Paris, France; [Fischer, Anne-Marie; Gaussem, Pascale] Hop Europeen Georges Pompidou, AP HP, Lab Hematol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, AP HP,Hop Necker Enfants Malades, Dept Genet, INSERM,Unite U781, F-75015 Paris, France.	cormier@necker.fr	Gaussem, Pascale/AGY-9723-2022; Isidor, Bertrand/L-2435-2015; Picard, Capucine/H-3914-2017; Gaussem, P./ABA-1222-2020; Legeai-Mallet, Laurence/E-6112-2016; Gaussem, Pascale/ABA-2228-2020; Isidor, Bertrand/AAJ-3456-2021; DJOUADI, Fatima/C-6187-2019; proulle, valerie/A-5911-2018; cormier-daire, valerie/H-6520-2017	Isidor, Bertrand/0000-0001-6480-126X; Picard, Capucine/0000-0001-8788-5056; Gaussem, P./0000-0002-9139-2147; Legeai-Mallet, Laurence/0000-0003-4989-5856; Isidor, Bertrand/0000-0001-6480-126X; bader-meunier, brigitte/0000-0001-8476-8196; Djouadi, Fatima/0000-0003-0350-0935; cormier-daire, valerie/0000-0002-2839-9856; proulle, valerie/0000-0003-3620-9570				DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; GHOSAL SP, 1988, J PEDIATR-US, V113, P49, DOI 10.1016/S0022-3476(88)80527-4; Gruber R, 2002, BONE, V30, P726, DOI 10.1016/S8756-3282(02)00697-X; Hsu PY, 2000, ARCH BIOCHEM BIOPHYS, V383, P119, DOI 10.1006/abbi.2000.2041; Isidor B, 2007, HUM GENET, V121, P269, DOI 10.1007/s00439-006-0311-1; JORGENSEN HR, 1988, ACTA ORTHOP SCAND, V4, P464; MESTEL F, 1980, LANCET, V1, P157; PILBEAN CC, 2002, PRINCIPLE BONE BIOL, pCH54; Raisz LG, 2003, PROSTAG OTH LIPID M, V71, P287, DOI 10.1016/S1098-8823(03)00049-2; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; TANIGUCHI S, 1989, KIDNEY INT, V36, P712, DOI 10.1038/ki.1989.251; Watkins BA, 2001, PROG LIPID RES, V40, P125, DOI 10.1016/S0163-7827(00)00016-3; WEISS HJ, 1977, LANCET, V1, P760; Yu IS, 2004, BLOOD, V104, P135, DOI 10.1182/blood-2003-10-3661	15	47	48	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					284	286		10.1038/ng.2007.66	http://dx.doi.org/10.1038/ng.2007.66			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264100				2022-12-25	WOS:000253548400017
J	Eggert, US; Superti-Furga, G				Eggert, Ulrike S.; Superti-Furga, Giulio			Drugs in action	NATURE CHEMICAL BIOLOGY			English	Editorial Material							INHIBITORS; KINASE; CYTOKINESIS; REVEALS	How do drugs work? What molecular changes do they cause in cells and in organisms? Is there a paradigm shift in the way we can predict and appreciate the impact of small molecules on biological systems in the 21st century? These were some of the questions addressed at a meeting in Vienna in August 2007.	[Eggert, Ulrike S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Superti-Furga, Giulio] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Austrian Academy of Sciences	Eggert, US (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dana Farber Canc Inst, 250 Longwood Ave, Boston, MA 02115 USA.	ulrike_eggert@dfci.harvard.edu; gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Superti-Furga, Giulio/0000-0002-0570-1768; Eggert, Ulrike/0000-0003-0932-5525				Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Freiberg C, 2006, MOL CELL PROTEOMICS, V5, P2326, DOI 10.1074/mcp.M600127-MCP200; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011	20	4	4	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					7	11		10.1038/nchembio0108-7	http://dx.doi.org/10.1038/nchembio0108-7			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18084271				2022-12-25	WOS:000251990000003
J	Tager, AM; LaCamera, P; Shea, BS; Campanella, GS; Selman, M; Zhao, Z; Polosukhin, V; Wain, J; Karimi-Shah, BA; Kim, ND; Hart, WK; Pardo, A; Blackwell, TS; Xu, Y; Chun, J; Luster, AD				Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.			The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak	NATURE MEDICINE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; EDG-FAMILY; RHO-KINASE; FIBROCYTES; EXPRESSION; MIGRATION; CELLS; IDENTIFICATION; INFLAMMATION; REQUIREMENT	Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathologic responses have yet to be fully identified. We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA(1), are markedly protected from fibrosis and mortality in this model. The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury. In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid. LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.	[Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Luster, Andrew D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Div Rheumatol Allergy & Im, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Karimi-Shah, Banu A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02129 USA; [Selman, Moises] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Zhao, Zhenwen; Xu, Yan] Indiana Univ, Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Polosukhin, Vasiliy; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Wain, John] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Thorac Surg, Boston, MA 02114 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Chun, Jerold] Scripps Res Inst, Helen L Dorris Inst Neurol & Psychiat Disorders, Dept Mol Biol, La Jolla, CA 92037 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidad Nacional Autonoma de Mexico; Scripps Research Institute	Luster, AD (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Div Rheumatol Allergy & Im, Ctr Immunol & Inflammatory Dis, CNY149-8301,149 13th St, Boston, MA 02129 USA.	aluster@mgh.harvard.edu	Pardo, Annie/A-4746-2008; Chun, Jerold/Y-4670-2019; Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NCI NIH HHS [R01-CA89228, R01-CA69212, R01-CA095042] Funding Source: Medline; NIMH NIH HHS [K02-MH01723, R01-MH51699] Funding Source: Medline; NINDS NIH HHS [R01-NS048478] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095042, R01CA069212, R01CA089228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699, K02MH001723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; BASSET F, 1986, AM J PATHOL, V122, P443; BEHR J, 1993, THORAX, V48, P736, DOI 10.1136/thx.48.7.736; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chambers RC, 2002, BIOCHEM SOC T, V30, P194, DOI 10.1042/BST0300194; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; DiNubile MJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1240, DOI 10.1152/ajpcell.00007.2007; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fireman E, 2001, LUNG, V179, P105, DOI 10.1007/s004080000051; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; HONDA Y, 1988, LUNG, V166, P293, DOI 10.1007/BF02714060; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Martinez A, 1997, ANN HEMATOL, V75, P81, DOI 10.1007/s002770050318; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Medoff BD, 2005, J EXP MED, V202, P97, DOI 10.1084/jem.20042481; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Neidlinger NA, 2006, J BIOL CHEM, V281, P775, DOI 10.1074/jbc.M505790200; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; PICKER LJ, 1990, J IMMUNOL, V145, P3247; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sugimoto N, 2006, EXP CELL RES, V312, P1899, DOI 10.1016/j.yexcr.2006.02.020; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; ZHANG K, 1994, AM J PATHOL, V145, P114; ZHOU D, 1995, J BIOL CHEM, V270, P25549, DOI 10.1074/jbc.270.43.25549	50	545	597	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					45	54		10.1038/nm1685	http://dx.doi.org/10.1038/nm1685			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18066075				2022-12-25	WOS:000252222400021
J	Hodges, E; Xuan, Z; Balija, V; Kramer, M; Molla, MN; Smith, SW; Middle, CM; Rodesch, MJ; Albert, TJ; Hannon, GJ; McCombie, WR				Hodges, Emily; Xuan, Zhenyu; Balija, Vivekanand; Kramer, Melissa; Molla, Michael N.; Smith, Steven W.; Middle, Christina M.; Rodesch, Matthew J.; Albert, Thomas J.; Hannon, Gregory J.; McCombie, W. Richard			Genome-wide in situ exon capture for selective resequencing	NATURE GENETICS			English	Article							HUMAN CANCER; SEQUENCES; PROTEINS	Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-proteincoding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.	Cold Spring Harbor Lab, Warson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY USA; NimbleGlen Syst Inc, Madison, WI 53711 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Roche Holding; Roche NimbleGen	McCombie, WR (corresponding author), Cold Spring Harbor Lab, Warson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	McCombie@cshl.edu	Hannon, Gregory/AAB-3568-2019	Hodges, Emily/0000-0001-6513-610X; McCombie, W. Richard/0000-0003-1899-0682; Xuan, Zhenyu/0000-0001-9344-8493				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Futreal PA, 2005, COLD SH Q B, V70, P43, DOI 10.1101/sqb.2005.70.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439	17	463	546	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1522	1527		10.1038/ng.2007.42	http://dx.doi.org/10.1038/ng.2007.42			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982454				2022-12-25	WOS:000251267400023
J	Sackton, TB; Lazzaro, BP; Schlenke, TA; Evans, JD; Hultmark, D; Clark, AG				Sackton, Timothy B.; Lazzaro, Brian P.; Schlenke, Todd A.; Evans, Jay D.; Hultmark, Dan; Clark, Andrew G.			Dynamic evolution of the innate immune system in Drosophila	NATURE GENETICS			English	Article							MOLECULAR POPULATION-GENETICS; DETECTING POSITIVE SELECTION; ANTIMICROBIAL PEPTIDES; TRANSMEMBRANE PROTEIN; ADAPTIVE EVOLUTION; SIGNALING PATHWAYS; GENES; FAMILY; PATTERN; PHAGOCYTOSIS	The availability of complete genome sequence from 12 Drosophila species presents the opportunity to examine how natural selection has affected patterns of gene family evolution and sequence divergence among different components of the innate immune system. We have identified orthologs and paralogs of 245 Drosophila melanogaster immune-related genes in these recently sequenced genomes. Genes encoding effector proteins, and to a lesser extent genes encoding recognition proteins, are much more likely to vary in copy number across species than genes encoding signaling proteins. Furthermore, we can trace the apparent recent origination of several evolutionarily novel immune-related genes and gene families. Using codon-based likelihood methods, we show that immune-system genes, and especially those encoding recognition proteins, evolve under positive darwinian selection. Positively selected sites within recognition proteins cluster in domains involved in recognition of microorganisms, suggesting that molecular interactions between hosts and pathogens may drive adaptive evolution in the Drosophila immune system.	Cornell Univ, New York, NY 14853 USA; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; USDA, Agr Res Serv Bee Res Lab, Beltsville, MD 20705 USA; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Emory University; United States Department of Agriculture (USDA); Umea University; Cornell University	Sackton, TB (corresponding author), Cornell Univ, New York, NY 14853 USA.	tbs7@cornell.edu	Hultmark, Dan/C-5058-2013; Evans, Jay D/C-8408-2012	Hultmark, Dan/0000-0002-6506-5855; Evans, Jay D/0000-0002-0036-4651; Sackton, Timothy/0000-0003-1673-9216; Clark, Andrew/0000-0001-7159-8511; Schlenke, Todd/0000-0003-3091-3057	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067504] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM067504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Begun DJ, 2000, GENETICS, V154, P1231; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; CHEN CI, 2006, SCIENCE, V311, P1761; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark AG, 1997, GENETICS, V147, P713; Daibo S, 2001, GENE, V278, P177, DOI 10.1016/S0378-1119(01)00713-2; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; *DROS 12 GEN CONS, 2007, NATURE, DOI DOI 10.1038/06341; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ramos-Onsins S, 1998, GENETICS, V150, P157; Schlenke TA, 2003, GENETICS, V164, P1471; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	50	310	319	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1461	1468		10.1038/ng.2007.60	http://dx.doi.org/10.1038/ng.2007.60			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17987029				2022-12-25	WOS:000251267400013
J	Goodsell, DS				Goodsell, David S.			Making the step from chemistry to biology and back	NATURE CHEMICAL BIOLOGY			English	Editorial Material							LIVING CELL; ANATOMY		Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Goodsell, DS (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goodsell@scripps.edu						Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Goodsell DS, 2005, STRUCTURE, V13, P347, DOI 10.1016/j.str.2005.01.012; Goodsell DS, 2003, CHEMBIOCHEM, V4, P1293, DOI 10.1002/cbic.200300747; GOODSELL DS, 1992, AM SCI, V80, P457; GOODSELL DS, 1992, MACHINERY LIFE; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Marsh BJ, 2005, BBA-MOL CELL RES, V1744, P273, DOI 10.1016/j.bbamcr.2005.04.002; Ottino JM, 2003, NATURE, V421, P474, DOI 10.1038/421474a; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030	11	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					681	684		10.1038/nchembio1107-681	http://dx.doi.org/10.1038/nchembio1107-681			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17948010				2022-12-25	WOS:000250311500002
J	Lombardo, A; Genovese, P; Beausejour, CM; Colleoni, S; Lee, YL; Kim, KA; Ando, D; Urnov, FD; Galli, C; Gregory, PD; Holmes, MC; Naldini, L				Lombardo, Angelo; Genovese, Pietro; Beausejour, Christian M.; Colleoni, Silvia; Lee, Ya-Li; Kim, Kenneth A.; Ando, Dale; Urnov, Fyodor D.; Galli, Cesare; Gregory, Philip D.; Holmes, Michael C.; Naldini, Luigi			Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery	NATURE BIOTECHNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; IN-VITRO; TRANSGENE EXPRESSION; MOUSE MODEL; VIRAL-DNA; THERAPY; GENOME; GENOTOXICITY	Achieving the full potential of zinc-finger nucleases (ZFNs) for genome engineering in human cells requires their efficient delivery to the relevant cell types. Here we exploited the infectivity of integrase-defective lentiviral vectors (IDLV) to express ZFNs and provide the template DNA for gene correction in different cell types. IDLV-mediated delivery supported high rates (13-39%) of editing at the IL-2 receptor common gamma-chain gene (IL2RG) across different cell types. IDLVs also mediated sitespecific gene addition by a process that required ZFN cleavage and homologous template DNA, thus establishing a platform that can target the insertion of transgenes into a predetermined genomic site. Using IDLV delivery and ZFNs targeting distinct loci, we observed high levels of gene addition (up to 50%)in a panel of human cell lines, as well as human embryonic stem cells (5%), allowing rapid, selection-free isolation of clonogenic cells with the desired genetic modification.	Univ Milan, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; Univ Milan, I-20132 Milan, Italy; Sangamo BioSci Inc, Pt Richmond Tech Ctr, Richmond, CA 94804 USA; Ist Sperimentale Italiano Lazzaro Spallanzani, I-26100 Cremona, Italy; Univ Bologna, Dipartimento Clin Vet, I-40064 Ozzano Dell Emilia, Italy; Ctr Rech, CHU Ste Justin, Dept Pharmacol, Quebec City, PQ H3T 1C5, Canada	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Milan; University of Milan; Sangamo Therapeutics, Inc.; IRCCS Lazzaro Spallanzani; University of Bologna	Naldini, L (corresponding author), Univ Milan, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy.	naldini.luigi@hsr.it	lombardo, angelo/J-6241-2016; Wilson, Matthew H/K-3193-2013; Naldini, Luigi/E-9083-2012; Genovese, Pietro/H-3710-2018	lombardo, angelo/0000-0001-8262-042X; Genovese, Pietro/0000-0001-9507-9003; Gregory, Philip/0000-0001-9249-2468; NALDINI, Luigi/0000-0002-7835-527X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NHLBI NIH HHS [2 P01 HL053750-11] Funding Source: Medline; Telethon [TGT06S01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 1997, J VIROL, V71, P458, DOI 10.1128/JVI.71.1.458-464.1997; Calos MP, 2006, CURR GENE THER, V6, P633, DOI 10.2174/156652306779010642; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Cavazzana-Calvo Marina, 2005, Annu Rev Med, V56, P585, DOI 10.1146/annurev.med.56.090203.104142; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Evans MJ, 2001, NAT MED, V7, P1081, DOI 10.1038/nm1001-1081; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hatada S, 2000, P NATL ACAD SCI USA, V97, P13807, DOI 10.1073/pnas.240462897; Hendrie PC, 2005, MOL THER, V12, P9, DOI 10.1016/j.ymthe.2005.04.006; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Lim JK, 2006, TRENDS IMMUNOL, V27, P308, DOI 10.1016/j.it.2006.05.007; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Smithies O, 2001, NAT MED, V7, P1083, DOI 10.1038/nm1001-1083; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tahara M, 2004, NAT MED, V10, P835, DOI 10.1038/nm1086; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Tan WJ, 2006, J VIROL, V80, P1939, DOI 10.1128/JVI.80.4.1939-1948.2006; Thrasher AJ, 2006, NATURE, V443, pE5, DOI 10.1038/nature05219; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	53	666	820	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1298	1306		10.1038/nbt1353	http://dx.doi.org/10.1038/nbt1353			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17965707				2022-12-25	WOS:000251086500031
J	Maeder, CI; Hink, MA; Kinkhabwala, A; Mayr, R; Bastiaens, PIH; Knop, M				Maeder, Celine I.; Hink, Mark A.; Kinkhabwala, Ali; Mayr, Reinhard; Bastiaens, Philippe I. H.; Knop, Michael			Spatial regulation of Fus3 MAP kinase activity through a reaction-diffusion mechanism in yeast pheromone signalling	NATURE CELL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; CORRELATION SPECTROSCOPY; STE5 SCAFFOLD; FLUCTUATION SPECTROSCOPY; MITOTIC SPINDLE; GENE-EXPRESSION; BUDDING YEAST; CELL POLARITY; ACTIN CABLES	Signal transduction through mitogen-activated protein kinase ( MAPK) cascades is thought to occur through the assembly of macromolecular complexes. We quantified the abundance of complexes in the cytoplasm among the MAPKs Ste11, Ste7, Fus3 and the scaffold protein Ste5 in yeast pheromone signalling using fluorescence cross-correlation spectroscopy ( FCCS). Significant complex concentrations were observed that remained unchanged on pheromone stimulation, demonstrating that global changes in complex abundances do not contribute to the transmission of signal through the cytoplasm. On the other hand, investigation of the distribution of active Fus3 ( Fus3(PP)) across the cytoplasm using fluorescence lifetime imaging microscopy ( FLIM) revealed a gradient of Fus3PP activity emanating from the tip of the mating projection. Spatial partitioning of Fus3 activating kinases to this site and deactivating phosphatases in the cytoplasm maintain this Fus3(PP)-activity distribution. Propagation of signalling from the shmoo is, therefore, spatially constrained by a gradient-generating reaction-diffusion mechanism.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bastiaens@mpi-dortmund.mpg.de; knop@embl.de						Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 2005, BIOPHYS J, V88, P4366, DOI 10.1529/biophysj.105.059170; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Delon A, 2004, J FLUORESC, V14, P255, DOI 10.1023/B:JOFL.0000024557.73246.f9; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Eid JS, 2000, REV SCI INSTRUM, V71, P361, DOI 10.1063/1.1150208; Elion EA, 2001, J CELL SCI, V114, P3967; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Fink GR, 1991, METHOD ENZYMOL, V194, P663; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Guthrie C., 1991, METHOD ENZYMOL, V194, P429; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Lew DJ, 2005, CURR BIOL, V15, pR994, DOI 10.1016/j.cub.2005.11.048; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Qi MS, 2005, J CELL SCI, V118, P2837, DOI 10.1242/jcs.02418; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Valtz N, 1997, METHOD ENZYMOL, V283, P350; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Wang YM, 2003, MOL BIOL CELL, V14, P2543, DOI 10.1091/mbc.E02-10-0699; Wang ZX, 2002, BIOCHEMISTRY-US, V41, P7849, DOI 10.1021/bi025776m; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhan XL, 1999, GENE DEV, V13, P2811, DOI 10.1101/gad.13.21.2811; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	57	189	190	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1319	U226		10.1038/ncb1652	http://dx.doi.org/10.1038/ncb1652			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952059				2022-12-25	WOS:000250659600018
J	Pravenec, M; Churchill, PC; Churchill, MC; Viklicky, O; Kazdova, L; Aitman, TJ; Petretto, E; Hubner, N; Wallace, CA; Zimdahl, H; Zidek, V; Landa, V; Dunbar, J; Bidani, A; Griffin, K; Qi, N; Maxova, M; Kren, V; Mlejnek, P; Wang, J; Kurtz, TW				Pravenec, Michal; Churchill, Paul C.; Churchill, Monique C.; Viklicky, Ondrej; Kazdova, Ludmila; Aitman, Timothy J.; Petretto, Enrico; Hubner, Norbert; Wallace, Caroline A.; Zimdahl, Heike; Zidek, Vaclav; Landa, Vladimir; Dunbar, Joseph; Bidani, Anil; Griffin, Karen; Qi, Nathan; Maxova, Martina; Kren, Vladimir; Mlejnek, Petr; Wang, Jiaming; Kurtz, Theodore W.			Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; DEFICIENCY; EXPRESSION; GENES; ACID; RATS	To identify renally expressed genes that influence risk for hypertension, we integrated expression quantitative trait locus (QTL) analysis of the kidney with genome-wide correlation analysis of renal expression profiles and blood pressure in recombinant inbred strains derived from the spontaneously hypertensive rat (SHR). This strategy, together with renal transplantation studies in SHR progenitor, transgenic and congenic strains, identified deficient renal expression of Cd36 encoding fatty acid translocase as a genetically determined risk factor for spontaneous hypertension.	[Wang, Jiaming; Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA; [Pravenec, Michal; Zidek, Vaclav; Landa, Vladimir; Kren, Vladimir; Mlejnek, Petr] Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic; Acad Sci Czech Republic, Ctr Appl Genom, Prague 14220, Czech Republic; [Pravenec, Michal; Kren, Vladimir] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800, Czech Republic; Charles Univ Prague, Gen Teaching Hosp, Prague 12800, Czech Republic; [Churchill, Paul C.; Churchill, Monique C.] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA; [Viklicky, Ondrej; Kazdova, Ludmila; Maxova, Martina] Inst Clin & Expt Med, Prague 14021, Czech Republic; [Aitman, Timothy J.; Petretto, Enrico; Wallace, Caroline A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London W12 ONN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W12 ONN, England; [Hubner, Norbert; Zimdahl, Heike] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bidani, Anil; Griffin, Karen] Loyola Univ, Dept Internal Med, Maywood, IL 60153 USA; Hines VA Hosp, Maywood, IL 60153 USA; [Qi, Nathan] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague; Wayne State University; Institute for Clinical & Experimental Medicine (IKEM); Imperial College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Michigan System; University of Michigan	Kurtz, TW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.	KurtzT@Labmed2.ucsf.edu	Pravenec, Michal/B-1666-2012; Mlejnek, Petr/C-2305-2012; Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012	Pravenec, Michal/0000-0001-9197-5871; Mlejnek, Petr/0000-0002-4218-8983; Viklicky, Ondrej/0000-0003-1049-2195; Aitman, Timothy/0000-0002-7875-4502	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline; MRC [MC_U120061454] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BORDESSOULE D, 1993, BRIT J HAEMATOL, V83, P370, DOI 10.1111/j.1365-2141.1993.tb04659.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kincer JF, 2002, J BIOL CHEM, V277, P23525, DOI 10.1074/jbc.M202465200; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Lifton Richard P, 2004, Harvey Lect, V100, P71; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Pravenec M, 2003, PHYSIOL RES, V52, P681; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200; Zou A P, 1999, Curr Hypertens Rep, V1, P178, DOI 10.1007/s11906-999-0016-7	15	78	81	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					952	954		10.1038/ng.164	http://dx.doi.org/10.1038/ng.164			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587397				2022-12-25	WOS:000258026900010
J	Brown, KM; MacGregor, S; Montgomery, GW; Craig, DW; Zhao, ZZ; Iyadurai, K; Henders, AK; Homer, N; Campbell, MJ; Stark, M; Thomas, S; Schmid, H; Holland, EA; Gillanders, EM; Duffy, DL; Maskiell, JA; Jetann, J; Ferguson, M; Stephan, DA; Cust, AE; Whiteman, D; Green, A; Olsson, H; Puig, S; Ghiorzo, P; Hansson, J; Demenais, F; Goldstein, AM; Gruis, NA; Elder, DE; Bishop, JN; Kefford, RF; Giles, GG; Armstrong, BK; Aitken, JF; Hopper, JL; Martin, NG; Trent, JM; Mann, GJ; Hayward, NK				Brown, Kevin M.; MacGregor, Stuart; Montgomery, Grant W.; Craig, David W.; Zhao, Zhen Zhen; Iyadurai, Kelly; Henders, Anjali K.; Homer, Nils; Campbell, Megan J.; Stark, Mitchell; Thomas, Shane; Schmid, Helen; Holland, Elizabeth A.; Gillanders, Elizabeth M.; Duffy, David L.; Maskiell, Judith A.; Jetann, Jodie; Ferguson, Megan; Stephan, Dietrich A.; Cust, Anne E.; Whiteman, David; Green, Adele; Olsson, Hakan; Puig, Susana; Ghiorzo, Paola; Hansson, Johan; Demenais, Florence; Goldstein, Alisa M.; Gruis, Nelleke A.; Elder, David E.; Bishop, Julia Newton; Kefford, Richard F.; Giles, Graham G.; Armstrong, Bruce K.; Aitken, Joanne F.; Hopper, John L.; Martin, Nicholas G.; Trent, Jeffrey M.; Mann, Graham J.; Hayward, Nicholas K.			Common sequence variants on 20q11.22 confer melanoma susceptibility	NATURE GENETICS			English	Article							GENE; ASSOCIATION; PIGMENTATION; POLYMORPHISM; POPULATION; PHENOTYPE; ARRAYS; ASIP; RISK	We conducted a genome-wide association pooling study for cutaneous melanoma and performed validation in samples totaling 2,019 cases and 2,105 controls. Using pooling, we identified a new melanoma risk locus on chromosome 20 (rs910873 and rs1885120), with replication in two further samples (combined P < 1 x 10(-15)). The per allele odds ratio was 1.75 (1.53, 2.01), with evidence for stronger association in early-onset cases.	[MacGregor, Stuart; Montgomery, Grant W.; Zhao, Zhen Zhen; Henders, Anjali K.; Campbell, Megan J.; Stark, Mitchell; Thomas, Shane; Duffy, David L.; Whiteman, David; Green, Adele; Martin, Nicholas G.; Hayward, Nicholas K.] Queensland Inst Med Res, Populat Studies & Genet Div, Brisbane, Qld 4029, Australia; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85028 USA; [Craig, David W.; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85028 USA; [Homer, Nils] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Millennium Inst, Sydney Melanoma Unit, Westmead, NSW 2145, Australia; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, Natl Inst Hlth, Baltimore, MD 21224 USA; [Maskiell, Judith A.; Cust, Anne E.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3052, Australia; [Jetann, Jodie; Ferguson, Megan; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld 4004, Australia; [Olsson, Hakan] Univ Hosp, Lund Canc Ctr, Dept Oncol, SE-22185 Lund, Sweden; [Puig, Susana] Univ Barcelona, Hosp Clin, Inst Invest Biomed August P & Sune, Dermatol Dept,Melanoma Unit, E-08036 Barcelona, Spain; [Ghiorzo, Paola] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Hansson, Johan] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Hansson, Johan] Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Demenais, Florence] Fdn Jean Dausset CEPH, INSERM, U794, F-75010 Paris, France; [Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, Genet Epidemiol Branch, Bethesda, MD 20892 USA; [Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands; [Elder, David E.] Univ Pennsylvania, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bishop, Julia Newton] Univ Leeds, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Armstrong, Bruce K.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Trent, Jeffrey M.] Translat Genom Res Inst, Genet Basis Human Dis Div, Phoenix, AZ 85028 USA	QIMR Berghofer Medical Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; University of California System; University of California Los Angeles; University of Sydney; Westmead Institute for Medical Research; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Melbourne; Cancer Council Queensland; Lund University; Skane University Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Genoa; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; University of Leeds; Cancer Council Victoria; University of Sydney; Translational Genomics Research Institute	MacGregor, S (corresponding author), Queensland Inst Med Res, Populat Studies & Genet Div, Brisbane, Qld 4029, Australia.	stuart.macgregor@qimr.edu.au	Ghiorzo, Paola/CAG-0673-2022; Craig, David Wesley/K-6961-2019; Macgregor, Stuart/C-6442-2009; Green, Adele C/B-5324-2011; Aitken, Joanne F/C-5289-2009; Cust, Anne/J-1797-2019; Montgomery, Grant W/B-7148-2008; Whiteman, David C/P-2728-2014; Stark, Mitchell/K-3874-2019; hayward, nicholas k/C-1367-2015; Stark, Mitchell S/E-3542-2010; Puig, Susana/AAB-2091-2020; hayward, nick/AAV-8802-2020; Green, Adele C/P-2736-2014; Duffy, David L/B-7392-2013; Armstrong, Bruce K/K-9464-2015; Stark, Mitchell/K-6794-2019; Mann, Graham J/G-4758-2014; Demenais, Florence/G-3298-2013; Henders, Anjali/E-3126-2017	Ghiorzo, Paola/0000-0002-3651-8173; Craig, David Wesley/0000-0003-2040-1955; Macgregor, Stuart/0000-0001-6731-8142; Cust, Anne/0000-0002-5331-6370; Montgomery, Grant W/0000-0002-4140-8139; Whiteman, David C/0000-0003-2563-9559; hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell S/0000-0002-4510-2161; Puig, Susana/0000-0003-1337-9745; Green, Adele C/0000-0002-2753-4841; Duffy, David L/0000-0001-7227-632X; Armstrong, Bruce K/0000-0001-8940-7525; Stark, Mitchell/0000-0002-4510-2161; Mann, Graham J/0000-0003-1301-405X; Demenais, Florence/0000-0001-8361-0936; Henders, Anjali/0000-0003-3672-1451; Bishop, Tim/0000-0002-8752-8785; Gruis, Nelleke/0000-0002-5210-9150; Giles, Graham/0000-0003-4946-9099; Kefford, Richard/0000-0001-9251-9229; Jetann, Jodie/0000-0002-9760-3099; Martin, Nicholas/0000-0003-4069-8020; Newton-Bishop, Julia/0000-0001-9147-6802; Olsson, Hakan/0000-0002-8794-9635; Campbell, Megan/0000-0002-6056-6140; Aitken, Joanne Frances/0000-0001-6859-2186	NATIONAL CANCER INSTITUTE [R01CA109544, R01CA088363, R01CA083115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA088363-07, R01 CA083115-08, R01 CA109544, R01 CA088363, CA083115, CA83115, CA88363, R01 CA083115, CA109544] Funding Source: Medline; NHLBI NIH HHS [HL086528, U01 HL086528] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; de Snoo FA, 2005, CANCER LETT, V230, P153, DOI 10.1016/j.canlet.2004.12.033; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711	11	169	172	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					838	840		10.1038/ng.163	http://dx.doi.org/10.1038/ng.163			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488026	Green Accepted			2022-12-25	WOS:000257166500017
J	Wang, ZB; Zang, CZ; Rosenfeld, JA; Schones, DE; Barski, A; Cuddapah, S; Cui, KR; Roh, TY; Peng, WQ; Zhang, MQ; Zhao, KJ				Wang, Zhibin; Zang, Chongzhi; Rosenfeld, Jeffrey A.; Schones, Dustin E.; Barski, Artem; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Peng, Weiqun; Zhang, Michael Q.; Zhao, Keji			Combinatorial patterns of histone acetylations and methylations in the human genome	NATURE GENETICS			English	Article							CHROMATIN DOMAINS; GENE-EXPRESSION; TRANSCRIPTION; ENHANCERS; LANGUAGE; COMPLEX	Histones are characterized by numerous posttranslational modifications that influence gene transcription(1,2). However, because of the lack of global distribution data in higher eukaryotic systems(3), the extent to which gene-specific combinatorial patterns of histone modifications exist remains to be determined. Here, we report the patterns derived from the analysis of 39 histone modifications in human CD4(+) T cells. Our data indicate that a large number of patterns are associated with promoters and enhancers. In particular, we identify a common modification module consisting of 17 modifications detected at 3,286 promoters. These modifications tend to colocalize in the genome and correlate with each other at an individual nucleosome level. Genes associated with this module tend to have higher expression, and addition of more modifications to this module is associated with further increased expression. Our data suggest that these histone modifications may act cooperatively to prepare chromatin for transcriptional activation.	[Wang, Zhibin; Schones, Dustin E.; Barski, Artem; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Zhao, Keji] NHLBI, Lab Mol Immunol, US NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Rosenfeld, Jeffrey A.; Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, Dept Biol, New York, NY 10003 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; Cold Spring Harbor Laboratory; New York University	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, US NIH, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Zang, Chongzhi/D-1445-2011; /AAI-2516-2019; Cuddapah, Suresh/AAU-4288-2021	Zang, Chongzhi/0000-0003-4812-3627; Barski, Artem/0000-0002-1861-5316; Peng, Weiqun/0000-0001-5521-9091; Roh, Tae-Young/0000-0001-5833-0844; Cuddapah, Suresh/0000-0002-4556-2029	Intramural NIH HHS [Z01 HL005801-05] Funding Source: Medline; NHGRI NIH HHS [R01 HG001696-05, HG001696, R01 HG001696] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005801, ZICHL006018] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kim HP, 2005, J BIOL CHEM, V280, P34042, DOI 10.1074/jbc.M505833200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	30	1635	1671	1	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					897	903		10.1038/ng.154	http://dx.doi.org/10.1038/ng.154			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552846	Green Accepted			2022-12-25	WOS:000257166500026
J	Leiden, JM				Leiden, Jeffrey M.			Canaries, coal mines and the drug supply	NATURE BIOTECHNOLOGY			English	Editorial Material								The heparin safety crisis sends a strong signal that urgent changes in regulatory and manufacturing oversight are needed to ensure the safety of the global drug supply.	Clarus Ventures, Cambridge, MA 02142 USA		Leiden, JM (corresponding author), Clarus Ventures, 101 Main St,Suite 1210, Cambridge, MA 02142 USA.	jleiden@clarusventures.com						Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; CROSSE M, 2007, DRUG SAFETY PRELIMIN; *FDA SCI BOARD SUB, 2007, FDA SCI MISS RISK RE; GUERRINI M, 2008, NAT BIOTECHNOL  0423; KISHIMOTO TK, 2008, N ENGL J MED    0423; SUMMARY FDAS FY 2009	6	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					624	626		10.1038/nbt0608-624	http://dx.doi.org/10.1038/nbt0608-624			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18536681	Bronze			2022-12-25	WOS:000256611900017
J	Akinc, A; Zumbuehl, A; Goldberg, M; Leshchiner, ES; Busini, V; Hossain, N; Bacallado, SA; Nguyen, DN; Fuller, J; Alvarez, R; Borodovsky, A; Borland, T; Constien, R; de Fougerolles, A; Dorkin, JR; Jayaprakash, KN; Jayaraman, M; John, M; Koteliansky, V; Manoharan, M; Nechev, L; Qin, J; Racie, T; Raitcheva, D; Rajeev, KG; Sah, DWY; Soutschek, J; Toudjarska, I; Vornlocher, HP; Zimmermann, TS; Langer, R; Anderson, DG				Akinc, Akin; Zumbuehl, Andreas; Goldberg, Michael; Leshchiner, Elizaveta S.; Busini, Valentina; Hossain, Naushad; Bacallado, Sergio A.; Nguyen, David N.; Fuller, Jason; Alvarez, Rene; Borodovsky, Anna; Borland, Todd; Constien, Rainer; de Fougerolles, Antonin; Dorkin, J. Robert; Jayaprakash, K. Narayanannair; Jayaraman, Muthusamy; John, Matthias; Koteliansky, Victor; Manoharan, Muthiah; Nechev, Lubomir; Qin, June; Racie, Timothy; Raitcheva, Denitza; Rajeev, Kallanthottathil G.; Sah, Dinah W. Y.; Soutschek, Juergen; Toudjarska, Ivanka; Vornlocher, Hans-Peter; Zimmermann, Tracy S.; Langer, Robert; Anderson, Daniel G.			A combinatorial library of lipid-like materials for delivery of RNAi therapeutics	NATURE BIOTECHNOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INHIBITS TUMOR-GROWTH; IN-VIVO DELIVERY; CATIONIC LIPOSOMES; NONHUMAN-PRIMATES; SYSTEMIC DELIVERY; MAMMALIAN-CELLS; MODIFIED SIRNAS; MEDIATED SIRNA; GENE	The safe and effective delivery of RNA interference (RNAi) therapeutics remains an important challenge for clinical development. The diversity of current delivery materials remains limited, in part because of their slow, multi-step syntheses. Here we describe a new class of lipid-like delivery molecules, termed lipidoids, as delivery agents for RNAi therapeutics. Chemical methods were developed to allow the rapid synthesis of a large library of over 1,200 structurally diverse lipidoids. From this library, we identified lipidoids that facilitate high levels of specific silencing of endogenous gene transcripts when formulated with either double-stranded small interfering RNA (siRNA) or single-stranded antisense 2'-O-methyl (2'-OMe) oligoribonucleotides targeting microRNA (miRNA). The safety and efficacy of lipidoids were evaluated in three animal models: mice, rats and nonhuman primates. The studies reported here suggest that these materials may have broad utility for both local and systemic delivery of RNA therapeutics.	[Akinc, Akin; Alvarez, Rene; Borodovsky, Anna; Borland, Todd; de Fougerolles, Antonin; Dorkin, J. Robert; Jayaprakash, K. Narayanannair; Jayaraman, Muthusamy; Koteliansky, Victor; Manoharan, Muthiah; Nechev, Lubomir; Qin, June; Racie, Timothy; Raitcheva, Denitza; Rajeev, Kallanthottathil G.; Sah, Dinah W. Y.; Toudjarska, Ivanka; Zimmermann, Tracy S.] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Zumbuehl, Andreas] Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland; [Goldberg, Michael; Langer, Robert] MIT, Dept Chem, Cambridge, MA 02139 USA; [Constien, Rainer; John, Matthias; Soutschek, Juergen; Vornlocher, Hans-Peter] Alnylam Europe AG, D-95326 Kulmbach, Germany; [Akinc, Akin; Zumbuehl, Andreas; Leshchiner, Elizaveta S.; Busini, Valentina; Hossain, Naushad; Bacallado, Sergio A.; Nguyen, David N.; Fuller, Jason; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Dept Chem Engn, Cambridge, MA 02139 USA	University of Geneva; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	Leshchiner, Elizaveta/F-3312-2010; Busini, Valentina/E-7703-2012; Zumbuehl, Andreas/C-5324-2008	Busini, Valentina/0000-0001-5159-6279; Zumbuehl, Andreas/0000-0002-8003-4432	NIBIB NIH HHS [R01 EB00244, R37 EB000244, R01 EB000244, R01 EB000244-27] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Griesenbach U, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-26; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Miller AD, 1998, ANGEW CHEM INT EDIT, V37, P1769; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Muratovska A, 2004, FEBS LETT, V558, P63, DOI 10.1016/S0014-5793(03)01505-9; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pal A, 2005, INT J ONCOL, V26, P1087; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Semple SC, 2001, BBA-BIOMEMBRANES, V1510, P152, DOI 10.1016/S0005-2736(00)00343-6; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425; Zhang YJ, 2006, MOL THER, V14, P336, DOI 10.1016/j.ymthe.2006.04.001; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	34	877	1020	18	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2008	26	5					561	569		10.1038/nbt1402	http://dx.doi.org/10.1038/nbt1402			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	299LJ	18438401	Green Accepted			2022-12-25	WOS:000255756800029
J	Tafer, H; Ameres, SL; Obernosterer, G; Gebeshuber, CA; Schroeder, R; Martinez, J; Hofacker, IL				Tafer, Hakim; Ameres, Stefan L.; Obernosterer, Gregor; Gebeshuber, Christoph A.; Schroeder, Renee; Martinez, Javier; Hofacker, Ivo L.			The impact of target site accessibility on the design of effective siRNAs	NATURE BIOTECHNOLOGY			English	Article							RNA SECONDARY STRUCTURE; ENZYME COMPLEX; INTERFERENCE; PREDICTION; SELECTION; MEDIATE	Small-interfering RNAs (siRNAs) assemble into RISC, the RNA-induced silencing complex, which cleaves complementary mRNAs. Despite their fluctuating efficacy, siRNAs are widely used to assess gene function. Although this limitation could be ascribed, in part, to variations in the assembly and activation of RISC, downstream events in the RNA interference (RNAi) pathway, such as target site accessibility, have so far not been investigated extensively. In this study we present a comprehensive analysis of target RNA structure effects on RNAi by computing the accessibility of the target site for interaction with the siRNA. Based on our observations, we developed a novel siRNA design tool, RNAxs, by combining known siRNA functionality criteria with target site accessibility. We calibrated our method on two data sets comprising 573 siRNAs for 38 genes, and tested it on an independent set of 360 siRNAs targeting four additional genes. Overall, RNAxs proves to be a robust siRNA selection tool that substantially improves the prediction of highly efficient siRNAs.	[Tafer, Hakim; Hofacker, Ivo L.] Univ Vienna, Inst Theoret Biochem, A-1090 Vienna, Austria; [Ameres, Stefan L.; Schroeder, Renee] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Obernosterer, Gregor; Gebeshuber, Christoph A.; Martinez, Javier] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria	University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Hofacker, IL (corresponding author), Univ Vienna, Inst Theoret Biochem, Wahringerstr 17, A-1090 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; ivo@tbi.univie.ac.at	Ameres, Stefan Ludwig/B-4046-2012; Hofacker, Ivo L/A-2378-2013; Ameres, Stefan/G-3775-2010	Ameres, Stefan Ludwig/0000-0002-8248-3098; Hofacker, Ivo L/0000-0001-7132-0800; Tafer, Hakim/0000-0002-6252-9802; Martinez, Javier/0000-0001-9152-7323; Gebeshuber, Christoph A/0000-0003-3293-4572				Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2001, NUCLEIC ACIDS RES, V29, P1034, DOI 10.1093/nar/29.5.1034; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J	21	195	199	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2008	26	5					578	583		10.1038/nbt1404	http://dx.doi.org/10.1038/nbt1404			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	299LJ	18438400				2022-12-25	WOS:000255756800031
J	Krieg, M; Arboleda-Estudillo, Y; Puech, PH; Kafer, J; Graner, F; Muller, DJ; Heisenberg, CP				Krieg, M.; Arboleda-Estudillo, Y.; Puech, P. -H.; Kaefer, J.; Graner, F.; Mueller, D. J.; Heisenberg, C. -P.			Tensile forces govern germ-layer organization in zebrafish	NATURE CELL BIOLOGY			English	Article							CELL-ADHESION; CORTICAL TENSION; N-CADHERIN; GASTRULATION; MORPHOGENESIS; MICROSCOPY; REARRANGEMENT; HYPOTHESIS; MOVEMENTS; WNT11	Understanding the factors that direct tissue organization during development is one of the most fundamental goals in developmental biology. Various hypotheses explain cell sorting and tissue organization on the basis of the adhesive and mechanical properties of the constituent cells(1). However, validating these hypotheses has been difficult due to the lack of appropriate tools to measure these parameters. Here we use atomic force microscopy ( AFM) to quantify the adhesive and mechanical properties of individual ectoderm, mesoderm and endoderm progenitor cells from gastrulating zebrafish embryos. Combining these data with tissue self-assembly in vitro and the sorting behaviour of progenitors in vivo, we have shown that differential actomyosin-dependent cell-cortex tension, regulated by Nodal/ TGF beta-signalling ( transforming growth factor beta), constitutes a key factor that directs progenitor-cell sorting. These results demonstrate a previously unrecognized role for Nodal-controlled cell-cortex tension in germ-layer organization during gastrulation.	[Krieg, M.; Arboleda-Estudillo, Y.; Mueller, D. J.] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Arboleda-Estudillo, Y.; Heisenberg, C. -P.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Puech, P. -H.] INSERM, UMR 600, CNRS UMR6212, Case 937, F-13288 Marseille, France; [Kaefer, J.; Graner, F.] UJF Grenoble 1, UMR 5588, Spectrometrie Phys Lab, F-38402 St Martin Dheres, France; [Kaefer, J.; Graner, F.] Ecole Natl Super Electrochim & Electrome Grenoble, Thermodynam & Physicochim Met Lab, CNRS, F-38402 St Martin Dheres, France	Technische Universitat Dresden; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Muller, DJ (corresponding author), Tech Univ Dresden, BIOTEC, Tatzberg 47-51, D-01307 Dresden, Germany.	mueller@biotec.tu-dresden.de; heisenberg@mpi-cbg.de	Käfer, Jos/AAR-1547-2021; Müller, Daniel J./A-5967-2010; Puech, Pierre-henri/G-1744-2013; Käfer, Jos/E-7714-2017	Käfer, Jos/0000-0002-0561-8008; Müller, Daniel J./0000-0003-3075-0665; Puech, Pierre-henri/0000-0002-8521-0685; Käfer, Jos/0000-0002-0561-8008; Krieg, Michael/0000-0003-0501-5036; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Aoki TO, 2002, DEVELOPMENT, V129, P275; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; GEIGER B, 1990, J CELL SCI, V97, P607; GRANER F, 1993, J THEOR BIOL, V164, P455, DOI 10.1006/jtbi.1993.1167; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lomakina EB, 2004, BIOPHYS J, V87, P4246, DOI 10.1529/biophysj.103.031765; MAREE AFM, 2007, CELLULAR POTTS BIOPH; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; SCHOTZ EM, IN PRESS QUANTITATIV; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Thoumine O, 1999, EUR BIOPHYS J BIOPHY, V28, P222, DOI 10.1007/s002490050203; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Zhang XH, 2004, AM J PHYSIOL-HEART C, V286, pH359, DOI 10.1152/ajpheart.00491.2003	36	565	576	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					429	U122		10.1038/ncb1705	http://dx.doi.org/10.1038/ncb1705			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364700				2022-12-25	WOS:000254561700013
J	Morison, IM; Cramer Borde, EM; Cheesman, EJ; Cheong, PL; Holyoake, AJ; Fichelson, S; Weeks, RJ; Lo, A; Davies, SMK; Wilbanks, SM; Fagerlund, RD; Ludgate, MW; Tatley, FMDS; Coker, MSA; Bockett, NA; Hughes, G; Pippig, DA; Smith, MP; Capron, C; Ledgerwood, EC				Morison, Ian M.; Cramer Borde, Elisabeth M.; Cheesman, Emma J.; Cheong, Pak Leng; Holyoake, Andrew J.; Fichelson, Serge; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Smith, Mark P.; Capron, Claude; Ledgerwood, Elizabeth C.			A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia	NATURE GENETICS			English	Article							PLATELET FORMATION; BONE-MARROW; MEGAKARYOCYTES; ACTIVATION	We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.	[Morison, Ian M.; Cheesman, Emma J.; Cheong, Pak Leng; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Ledgerwood, Elizabeth C.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Cramer Borde, Elisabeth M.; Capron, Claude] Univ Versailles, Fac Med Paris Ilede France Ouest, St Quentin en Yvelines, France; [Cramer Borde, Elisabeth M.; Fichelson, Serge; Capron, Claude] INSERM, Inst Cochin, U567, F-75014 Paris, France; [Holyoake, Andrew J.] Pacific Edge Biotechnol Ltd, Dunedin 9054, New Zealand; [Fichelson, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104,INSERM U567, Paris, France; [Smith, Mark P.] Caanterbury District Hlth Board, Christchurch 8140, New Zealand	University of Otago; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Morison, IM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	ian.morison@otago.ac.nz	Cheong, Pak Leng/D-3603-2013; Ledgerwood, Elizabeth/M-3939-2018; Capron, Claude/AAJ-2710-2021; Holyoake, Andrew/H-9570-2013; Weeks, Robert J/A-6876-2012; Morison, Ian M/A-1236-2008	Cheong, Pak Leng/0000-0002-0095-4459; Ledgerwood, Elizabeth/0000-0002-4956-6043; Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025; Cramer Borde, Elisabeth/0000-0001-7595-0885; Fagerlund, Robert/0000-0002-3939-1489; Bockett, Nicholas/0000-0002-7630-7637; Wilbanks, Sigurd/0000-0001-7565-8913				Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Cooper C. E., 1995, BIOENERGETICS PRACTI, P85; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sharonov GV, 2005, APOPTOSIS, V10, P797, DOI 10.1007/s10495-005-0366-9; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200	15	130	133	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					387	389		10.1038/ng.103	http://dx.doi.org/10.1038/ng.103			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18345000				2022-12-25	WOS:000254388100006
J	Lee, I; Lehner, B; Crombie, C; Wong, W; Fraser, AG; Marcotte, EM				Lee, Insuk; Lehner, Ben; Crombie, Catriona; Wong, Wendy; Fraser, Andrew G.; Marcotte, Edward M.			A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans	NATURE GENETICS			English	Article							PROTEIN INTERACTION NETWORK; ENHANCED RNA INTERFERENCE; GENOME-WIDE PREDICTION; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; INTERACTION DATASETS; FUNCTIONAL LINKAGES; LIFE-SPAN; DATABASE; YEAST	The fundamental aim of genetics is to understand how an organism's phenotype is determined by its genotype, and implicit in this is predicting how changes in DNA sequence alter phenotypes. A single network covering all the genes of an organism might guide such predictions down to the level of individual cells and tissues. To validate this approach, we computationally generated a network covering most C. elegans genes and tested its predictive capacity. Connectivity within this network predicts essentiality, identifying this relationship as an evolutionarily conserved biological principle. Critically, the network makes tissue-specific predictions-we accurately identify genes for most systematically assayed loss-of-function phenotypes, which span diverse cellular and developmental processes. Using the network, we identify 16 genes whose inactivation suppresses defects in the retinoblastoma tumor suppressor pathway, and we successfully predict that the dystrophin complex modulates EGF signaling. We conclude that an analogous network for human genes might be similarly predictive and thus facilitate identification of disease genes and rational therapeutic targets.	[Lehner, Ben; Crombie, Catriona; Wong, Wendy; Fraser, Andrew G.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Lee, Insuk; Marcotte, Edward M.] Univ Texas Austin, Inst Mol & Cellular Biol, Dept Chem & Biochem, Ctr Syst Synthet Biol, Austin, TX 78712 USA; [Lehner, Ben] Univ Pompeu Fabra, Ctr Genom Regulat, ICREA, Barcelona 08003, Spain; [Lehner, Ben] Univ Pompeu Fabra, EMBL, CRG, Syst Biol Unit, Barcelona 08003, Spain	Wellcome Trust Sanger Institute; University of Texas System; University of Texas Austin; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk; marcotte@icmb.utexas.edu	Lehner, Ben/L-3413-2014; Lee, Insuk/F-7722-2010; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Marcotte, Edward/0000-0001-8808-180X; Fraser, Andrew/0000-0001-9939-6014	ICREA Funding Source: Custom; NIGMS NIH HHS [GM06779-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline	ICREA(ICREA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Chen XH, 2005, CAN J STAT, V33, P389, DOI 10.1002/cjs.5540330306; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Chockalingam PS, 2002, AM J PHYSIOL-CELL PH, V283, pC500, DOI 10.1152/ajpcell.00529.2001; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; EFRON B, 1993, INTRO BOOTSTRAP, V439; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Romagnolo B, 2002, DEV BIOL, V247, P127, DOI 10.1006/dbio.2002.0692; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Segal SS, 2005, MICROCIRCULATION, V12, P1, DOI 10.1080/10739680590907114; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; SUNDARAM MV, 2005, WORMBOOK, V1; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Walker M G, 1999, Proc Int Conf Intell Syst Mol Biol, P282; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Yochem J, 1997, MOL CELL BIOL, V17, P2716, DOI 10.1128/MCB.17.5.2716; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	50	225	229	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					181	188		10.1038/ng.2007.70	http://dx.doi.org/10.1038/ng.2007.70			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18223650				2022-12-25	WOS:000252732900016
J	Sekita, Y; Wagatsuma, H; Nakamura, K; Ono, R; Kagami, M; Wakisaka, N; Hino, T; Suzuki-Migishima, R; Kohda, T; Ogura, A; Ogata, T; Yokoyama, M; Kaneko-Ishino, T; Ishino, F				Sekita, Yoichi; Wagatsuma, Hirotaka; Nakamura, Kenji; Ono, Ryuichi; Kagami, Masayo; Wakisaka, Noriko; Hino, Toshiaki; Suzuki-Migishima, Rika; Kohda, Takashi; Ogura, Atsuo; Ogata, Tsutomu; Yokoyama, Minesuke; Kaneko-Ishino, Tomoko; Ishino, Fumitoshi			Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; UNIPARENTAL DISOMY; JUNK DNA; MICE; MOUSE-CHROMOSOME-12; CHROMOSOME-12; EXPRESSION; EVOLUTION; SYNCYTIN; MAMMALS	Eutherian placenta, an organ that emerged in the course of mammalian evolution, provides essential architecture, the so-called feto-maternal interface, for fetal development by exchanging nutrition, gas and waste between fetal and maternal blood. Functional defects of the placenta cause several developmental disorders, such as intrauterine growth retardation in humans and mice. A series of new inventions and/ or adaptations must have been necessary to form and maintain eutherian chorioallantoic placenta, which consists of capillary endothelial cells and a surrounding trophoblast cell layer(s)(1). Although many placental genes have been identified(2), it remains unknown how the feto-maternal interface is formed and maintained during development, and how this novel design evolved. Here we demonstrate that retrotransposon-derived Rtl1 (retrotransposon-like 1), also known as Peg11 (paternally expressed 11), is essential for maintenance of the fetal capillaries, and that both its loss and its overproduction cause late-fetal and/or neonatal lethality in mice.	[Wakisaka, Noriko; Kaneko-Ishino, Tomoko] Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan; [Sekita, Yoichi; Ono, Ryuichi; Wakisaka, Noriko; Kohda, Takashi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo 1010062, Japan; [Wagatsuma, Hirotaka] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakamura, Kenji; Hino, Toshiaki; Suzuki-Migishima, Rika; Yokoyama, Minesuke] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Kagami, Masayo; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Setagaya Ku, Tokyo 1578535, Japan; [Ogura, Atsuo] RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	Tokai University; Tokyo Medical & Dental University (TMDU); Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Center for Child Health & Development - Japan; RIKEN	Kaneko-Ishino, T (corresponding author), Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan.	tkanekoi@is.icc.u-tokai.ac.jp; fishino.epgn@mri.tmd.ac.jp	Ogura, Atsuo/J-3916-2014; Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kagami, Masayo/0000-0003-3020-455X; Ogata, Tsutomu/0000-0001-7178-9991; SEKITA, YOICHI/0000-0002-6230-8719; Kohda, Takashi/0000-0002-6856-5601				Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; CATTANACH BM, 1993, MOUSE GENOME, V91, P858; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; KAGAMI M, 2008, NAT GENET       0106; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tevendale M, 2006, CYTOGENET GENOME RES, V113, P215, DOI 10.1159/000090835; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Youngson NA, 2005, J MOL EVOL, V61, P481, DOI 10.1007/s00239-004-0332-0	30	225	234	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					243	248		10.1038/ng.2007.51	http://dx.doi.org/10.1038/ng.2007.51			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176565				2022-12-25	WOS:000252732900025
J	Xue, Y; Davis, AV; Balakrishnan, G; Stasser, JP; Staehlin, BM; Focia, P; Spiro, TG; Penner-Hahn, JE; O'Halloran, TV				Xue, Yi; Davis, Anna V.; Balakrishnan, Gurusamy; Stasser, Jay P.; Staehlin, Benjamin M.; Focia, Pamela; Spiro, Thomas G.; Penner-Hahn, James E.; O'Halloran, Thomas V.			Cu(I) recognition via cation-pi and methionine interactions in CusF	NATURE CHEMICAL BIOLOGY			English	Article							RESISTANCE PROTEIN CUSF; ESCHERICHIA-COLI; COPPER(I); SYSTEM; COPC	Methionine-rich motifs have an important role in copper trafficking factors, including the CusF protein. Here we show that CusF uses a new metal recognition site wherein Cu(I) is tetragonally displaced from a Met(2)His ligand plane toward a conserved tryptophan. Spectroscopic studies demonstrate that both thioether ligation and strong cation-pi interactions with tryptophan stabilize metal binding. This novel active site chemistry affords mechanisms for control of adventitious metal redox and substitution chemistry.	[Xue, Yi; Davis, Anna V.; Staehlin, Benjamin M.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Balakrishnan, Gurusamy; Spiro, Thomas G.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Stasser, Jay P.; Penner-Hahn, James E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Stasser, Jay P.; Penner-Hahn, James E.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Focia, Pamela] Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [O'Halloran, Thomas V.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	Penner-Hahn, James/GYD-3750-2022; O'Halloran, Thomas/ABE-6125-2021	Penner-Hahn, James/0000-0003-0314-1274; O'Halloran, Thomas/0000-0001-8732-5059	NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071129, R29GM038047, R37GM038784, R01GM038784, R01GM025158, R29GM038784, R01GM038047] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA060553] Funding Source: Medline; NIGMS NIH HHS [R37 GM038784, GM 25158, R01 GM025158, R37 GM038784-21, R01 GM038047, GM 071129, R01 GM038784, F32 GM071129, GM 38784, GM 38047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Harada I., 1986, SPECTROSCOPY BIOL SY, P154; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Peariso K, 2003, J AM CHEM SOC, V125, P342, DOI 10.1021/ja028935y; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	15	187	189	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					107	109		10.1038/nchembio.2007.57	http://dx.doi.org/10.1038/nchembio.2007.57			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18157124	Green Accepted			2022-12-25	WOS:000252585400008
J	Kittler, R; Pelletier, L; Heninger, AK; Slabicki, M; Theis, M; Miroslaw, L; Poser, I; Lawo, S; Grabner, H; Kozak, K; Wagner, J; Surendranath, V; Richter, C; Bowen, W; Jackson, AL; Habermann, B; Hyman, AA; Buchholz, F				Kittler, Ralf; Pelletier, Laurence; Heninger, Anne-Kristine; Slabicki, Mikolaj; Theis, Mirko; Miroslaw, Lukasz; Poser, Ina; Lawo, Steffen; Grabner, Hannes; Kozak, Karol; Wagner, Jan; Surendranath, Vineeth; Richter, Constance; Bowen, Wayne; Jackson, Aimee L.; Habermann, Bianca; Hyman, Anthony A.; Buchholz, Frank			Genome-scale RNAi profiling of cell division in human tissue culture cells	NATURE CELL BIOLOGY			English	Article							SHORT INTERFERING RNAS; CYCLE PROGRESSION; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; OUTER KINETOCHORE; PROTEIN COMPLEX; C.-ELEGANS; GENES; CANCER; REPLICATION	Cell division is fundamental for all organisms. Here we report a genome-scale RNA-mediated interference screen in HeLa cells designed to identify human genes that are important for cell division. We have used a library of endoribonuclease-prepared short interfering RNAs for gene silencing and have used DNA content analysis to identify genes that induced cell cycle arrest or altered ploidy on silencing. Validation and secondary assays were performed to generate a nine-parameter loss-of-function phenoprint for each of the genes. These phenotypic signatures allowed the assignment of genes to specific functional classes by combining hierarchical clustering, cross-species analysis and proteomic data mining. We highlight the richness of our dataset by ascribing novel functions to genes in mitosis and cytokinesis. In particular, we identify two evolutionarily conserved transcriptional regulatory networks that govern cytokinesis. Our work provides an experimental framework from which the systematic analysis of novel genes necessary for cell division in human cells can begin.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; Technol Dev Studio, D-01307 Dresden, Germany; TTP LabTech Ltd, Melbourn SG8 6EE, Herts, England; Rosetta Inpharmat LLC, Seattle, WA 98109 USA; Scio Comp Innovat GmbH, D-01307 Dresden, Germany; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Max Planck Society; Merck & Company; University of Chicago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Buchholz, F (corresponding author), Max Planck Inst Cell Biol & Genet, Pfotenhauetstr 108, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Hyman, Tony/F-1923-2011; Kittler, Ralf/I-4662-2013; Richter, Constance/P-8714-2019; Pelletier, Laurence/F-8858-2013; Habermann, Bianca/N-4886-2016; Kittler, Ralf/AAD-4258-2020; Buchholz, Frank/B-4700-2017; Hyman, Anthony A/B-3917-2017	Kittler, Ralf/0000-0002-0098-6792; Habermann, Bianca/0000-0002-2457-7504; Kittler, Ralf/0000-0002-0098-6792; Buchholz, Frank/0000-0002-4577-3344; Hyman, Anthony A/0000-0003-3664-154X; Jackson, Aimee/0000-0002-3786-7391; Lawo, Steffen/0000-0002-9659-7416; Surendranath, Vineeth/0000-0003-1593-6461; Heninger, Anne-Kristin/0000-0003-3151-826X; Richter, Constance/0000-0003-3312-0941				Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chinwalla V, 2003, ONCOGENE, V22, P1400, DOI 10.1038/sj.onc.1206273; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A., 2005, SCI STKE, V2005; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Hauser BA, 2000, DEVELOPMENT, V127, P2219; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jepsen K, 2002, J CELL SCI, V115, P689; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; KITTLER R, 2004, NATURE METHODS, V4, P337; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Kuefer MU, 2003, ONCOGENE, V22, P1418, DOI 10.1038/sj.onc.1206272; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takimoto M, 2002, BRIT J CANCER, V86, P1757, DOI 10.1038/sj.bjc.6600328; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6	50	242	250	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1401	U116		10.1038/ncb1659	http://dx.doi.org/10.1038/ncb1659			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17994010				2022-12-25	WOS:000251317300013
J	Plenge, RM; Cotsapas, C; Davies, L; Price, AL; Bakker, PIW; Maller, J; Pe'er, I; Burtt, NP; Blumenstiel, B; DeFelice, M; Parkin, M; Barry, R; Winslow, W; Healy, C; Graham, RR; Neale, BM; Izmailova, E; Roubenoff, R; Parker, AN; Glass, R; Karlson, EW; Maher, N; Hafler, DA; Lee, DM; Seldin, MF; Remmers, EF; Lee, AT; Padyukov, L; Alfredsson, L; Coblyn, J; Weinblatt, ME; Gabriel, SB; Purcell, S; Klareskog, L; Gregersen, PK; Shadick, NA; Daly, MJ; Altshuler, D				Plenge, Robert M.; Cotsapas, Chris; Davies, Leela; Price, Alkes L.; Bakker, Paul I. Wde; Maller, Julian; Pe'er, Itsik; Burtt, Noel P.; Blumenstiel, Brendan; DeFelice, Matt; Parkin, Melissa; Barry, Rachel; Winslow, Wendy; Healy, Claire; Graham, Robert R.; Neale, Benjamin M.; Izmailova, Elena; Roubenoff, Ronenn; Parker, Alexander N.; Glass, Roberta; Karlson, Elizabeth W.; Maher, Nancy; Hafler, David A.; Lee, David M.; Seldin, Michael F.; Remmers, Elaine F.; Lee, Annette T.; Padyukov, Leonid; Alfredsson, Lars; Coblyn, Jonathan; Weinblatt, Michael E.; Gabriel, Stacey B.; Purcell, Shaun; Klareskog, Lars; Gregersen, Peter K.; Shadick, Nancy A.; Daly, Mark J.; Altshuler, David			Two independent alleles at 6q23 associated with risk of rheumatoid arthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; STRATIFICATION; VARIANT	To identify susceptibility alleles associated with rheumatoid arthritis, we genotyped 397 individuals with rheumatoid arthritis for 116,204 SNPs and carried out an association analysis in comparison to publicly available genotype data for 1,211 related individuals from the Framingham Heart Study(1). After evaluating and adjusting for technical and population biases, we identified a SNP at 6q23 ( rs10499194, similar to 150 kb from TNFAIP3 and OLIG3) that was reproducibly associated with rheumatoid arthritis both in the genome-wide association ( GWA) scan and in 5,541 additional case-control samples (P = 10(-3), GWA scan; P < 10(-6), replication; P = 10(-9), combined). In a concurrent study, the Wellcome Trust Case Control Consortium ( WTCCC) has reported strong association of rheumatoid arthritis susceptibility to a different SNP located 3.8 kb from rs10499194 ( rs6920220; P = 5 x 10(-6) in WTCCC)(2). We show that these two SNP associations are statistically independent, are each reproducible in the comparison of our data and WTCCC data, and define risk and protective haplotypes for rheumatoid arthritis at 6q23.	MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Harvard Med Sch, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02115 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; Coll London, London SE5 8AF, England; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Harvard Med Sch, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; NIAMSD, NIH, Genet Genom Branch, Bethesda, MD 20892 USA; N Shore Long Island Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Karilinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; University of London; University College London; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; Karolinska Institutet; Karolinska Institutet	Plenge, RM (corresponding author), MIT, Broad Inst Harvard, Program Med & Populat Genet, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	rplenge@partners.org	Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009; maller, julian B/A-9323-2009; Padyukov, Leonid/A-4890-2009; de Bakker, Paul IW/B-8730-2009; Alfredsson, Lars/AAC-9007-2019	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Padyukov, Leonid/0000-0003-2950-5670; de Bakker, Paul IW/0000-0001-7735-7858; Alfredsson, Lars/0000-0003-1688-6697; Izmailova, Elena/0000-0002-7150-1748; Maller, Julian/0000-0002-1565-9559; Healy, Claire M/0000-0001-7940-4611; Remmers, Elaine F/0000-0002-9522-1249; Roubenoff, Ronenn/0000-0002-3959-3179; Klareskog, Lars/0000-0001-9601-6186; Cotsapas, Chris/0000-0002-7772-5910	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422, Z01AR041139] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI055314-01A1, K08 AI055314, K08 AI055314-02, K08 AI055314-05, K08 AI055314-03, K08 AI055314-04, AI55314-3] Funding Source: Medline; NIAMS NIH HHS [N01-AR-2-2263, R01 AR044422, R01-AR44422] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	439	456	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1477	1482		10.1038/ng.2007.27	http://dx.doi.org/10.1038/ng.2007.27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982456	Green Accepted			2022-12-25	WOS:000251267400015
J	Mao, YB; Cai, WJ; Wang, JW; Hong, GJ; Tao, XY; Wang, LJ; Huang, YP; Chen, XY				Mao, Ying-Bo; Cai, Wen-Juan; Wang, Jia-Wei; Hong, Gao-Jie; Tao, Xiao-Yuan; Wang, Ling-Jian; Huang, Yong-Ping; Chen, Xiao-Ya			Silencing a cotton bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval tolerance of gossypol	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRANDED-RNA; HELICOVERPA-ARMIGERA HUBNER; INSECTICIDE RESISTANCE; POSSIBLE INVOLVEMENT; C-ELEGANS; CYTOCHROME-P450 MONOOXYGENASES; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; TRANSGENIC PLANTS; CDNA-CLONE	We identify a cytochrome P450 gene (CYP6AE14) from cotton bollworm (Helicoverpa armigera), which permits this herbivore to tolerate otherwise inhibitory concentrations of the cotton metabolite, gossypol. CYP6AE14 is highly expressed in the midgut and its expression correlates with larval growth when gossypol is included in the diet. When larvae are fed plant material expressing double-stranded RNA (dsRNA) specific to CYP6AE14, levels of this transcript in the midgut decrease and larval growth is retarded. Both effects are more dramatic in the presence of gossypol. As a glutathione-S-transferase gene (GST1) is silenced in GST1 dsRNA-expressing plants, feeding insects plant material expressing dsRNA may be a general strategy to trigger RNA interference and could find applications in entomological research and field control of insect pests.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key lab Plant Mol Genet, Beijing 100864, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Chen, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key lab Plant Mol Genet, Beijing 100864, Peoples R China.	xychen@sibs.ac.cn	Hong, Gaojie/AAP-1502-2021; Tao, Xiaoyuan/GRO-0164-2022	tao, Xiaoyuan/0000-0003-3191-9581; Mao, Ying-Bo/0000-0003-4599-3619; Tao, Xiao-Yuan/0000-0002-9012-4730; Chen, Xiaoya/0000-0002-2909-8414; Wang, Jia-Wei/0000-0003-3885-6296				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Benedict CR, 2004, PHYTOCHEMISTRY, V65, P1351, DOI 10.1016/j.phytochem.2004.03.032; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; ELEFTHERIANOS I, 2006, MOL BIOL, V36, P517; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Hodgson E, 1995, TOXICOL LETT, V82-3, P73, DOI 10.1016/0378-4274(95)03469-2; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; KONO Y, 1982, J BIOL CHEM, V257, P5751; Li W, 2004, INSECT MOL BIOL, V13, P603, DOI 10.1111/j.0962-1075.2004.00518.x; Li W, 2002, INSECT MOL BIOL, V11, P543, DOI 10.1046/j.1365-2583.2002.00363.x; Li XC, 2002, INSECT MOL BIOL, V11, P343, DOI 10.1046/j.1365-2583.2002.00341.x; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Luo P, 2001, PLANT J, V28, P95, DOI 10.1046/j.1365-313X.2001.01133.x; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Peng JY, 2005, CELL RES, V15, P187, DOI 10.1038/sj.cr.7290285; Ranasinghe C, 1998, INSECT BIOCHEM MOLEC, V28, P571, DOI 10.1016/S0965-1748(98)00045-9; Ranasinghe C, 1999, INSECT BIOCHEM MOLEC, V29, P145, DOI 10.1016/S0965-1748(98)00118-0; Sasabe M, 2004, GENE, V338, P163, DOI 10.1016/j.gene.2004.04.028; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tan XP, 2000, PLANTA, V210, P644, DOI 10.1007/s004250050055; Tenllado F, 2001, J VIROL, V75, P12288, DOI 10.1128/JVI.75.24.12288-12297.2001; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; WANG XP, 1995, INSECT BIOCHEM MOLEC, V25, P1001, DOI 10.1016/0965-1748(95)00033-R; WATERS LC, 1992, P NATL ACAD SCI USA, V89, P4855, DOI 10.1073/pnas.89.11.4855; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	49	848	1019	22	368	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1307	1313		10.1038/nbt1352	http://dx.doi.org/10.1038/nbt1352			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17982444				2022-12-25	WOS:000251086500032
J	Rother, RP; Rollins, SA; Mojcik, CF; Brodsky, RA; Bell, L				Rother, Russell P.; Rollins, Scott A.; Mojcik, Christopher F.; Brodsky, Robert A.; Bell, Leonard			Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria	NATURE BIOTECHNOLOGY			English	Article							HUMANIZED ANTI-C5 ANTIBODY; PIG-A GENE; AUTOIMMUNE MYASTHENIA-GRAVIS; QUALITY-OF-LIFE; NITRIC-OXIDE; TERMINAL COMPLEMENT; RHEUMATOID-ARTHRITIS; VASCULAR ENDOTHELIUM; MEMBRANE-PROTEIN; NATURAL-HISTORY	The complement system provides critical immunoprotective and immunoregulatory functions but uncontrolled complement activation can lead to severe pathology. In the rare hemolytic disease paroxysmal nocturnal hemoglobinuria (PNH), somatic mutations result in a deficiency of glycosylphosphatidylinositol-linked surface proteins, including the terminal complement inhibitor CD59, on hematopoietic stem cells. In a dysfunctional bone marrow background, these mutated progenitor blood cells expand and populate the periphery. Deficiency of CD59 on PNH red blood cells results in chronic complement-mediated intravascular hemolysis, a process central to the morbidity and mortality of PNH. A recently developed, humanized monoclonal antibody directed against complement component C5, eculizumab (Soliris; Alexion Pharmaceuticals Inc., Cheshire, CT, USA), blocks the proinflammatory and cytolytic effects of terminal complement activation. The recent approval of eculizumab as a first-in-class complement inhibitor for the treatment of PNH validates the concept of complement inhibition as an effective therapy and provides rationale for investigation of other indications in which complement plays a role.	Alex Pharmaceut Inc, Cheshire, CT 06410 USA; Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD 21205 USA	Johns Hopkins University	Rother, RP (corresponding author), Alex Pharmaceut Inc, 352 Knotter Dr, Cheshire, CT 06410 USA.	rotherr@alxn.com	Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768				Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Appel G, 2002, J AM SOC NEPHROL, V13, p668A; Araten DJ, 2005, THROMB HAEMOSTASIS, V93, P88, DOI 10.1160/TH04-06-0391; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007/s00415-005-0871-3; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; BIESECKER G, 1989, J IMMUNOL, V142, P2654; Bottomley A, 2005, LANCET ONCOL, V6, P287, DOI 10.1016/S1470-2045(05)70100-5; BRODSKY RA, 2005, HEMATOLOGY BASIC PRI; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Catani MV, 1998, BIOCHEM BIOPH RES CO, V249, P275, DOI 10.1006/bbrc.1998.9130; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; CHRISTADOSS P, 1988, J IMMUNOL, V140, P2589; Dacie J, 1980, Sangre (Barc), V25, P890; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; Hall C, 2003, BLOOD, V102, P3587, DOI 10.1182/blood-2003-01-0009; HANSCH GM, 1987, J CLIN INVEST, V80, P7, DOI 10.1172/JCI113065; Hill A, 2005, HAEMATOLOGICA, V90, P414; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hill A, 2006, BLOOD, V108, p292A; Hill A, 2006, BLOOD, V108, p294A; HILLMAN P, 2007, BLOOD, V16, DOI DOI 10.1182/BLOOD-2007-1106-095646; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172; Hu R, 2005, BLOOD, V105, P3848, DOI 10.1182/blood-2004-04-1472; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jain RI, 1999, ARTHRITIS RHEUM, V42, pS77; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kayanoki Y, 1999, METABOLISM, V48, P1136, DOI 10.1016/S0026-0495(99)90127-0; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; KLEIN R, 1993, EUR J IMMUNOL, V23, P3248, DOI 10.1002/eji.1830231231; Male D.K., 2006, IMMUNOLOGY; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; Morgan BP, 2006, CLIN EXP IMMUNOL, V146, P294, DOI 10.1111/j.1365-2249.2006.03205.x; MOTOYAMA N, 1992, EUR J IMMUNOL, V22, P2669, DOI 10.1002/eji.1830221029; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Mueller JP, 1997, MOL IMMUNOL, V34, P441, DOI 10.1016/S0161-5890(97)00042-4; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Muus P, 2007, HAEMATOL-HEMATOL J, V92, P137; Nishimura J, 2001, BLOOD, V97, P3004, DOI 10.1182/blood.V97.10.3004; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; OKADA N, 1990, CLIN EXP IMMUNOL, V80, P109; Olsen SB, 1996, CIRCULATION, V93, P327, DOI 10.1161/01.CIR.93.2.327; ONI SB, 1970, BLOOD-J HEMATOL, V36, P145, DOI 10.1182/blood.V36.2.145.145; Overturf GD, 2003, CLIN INFECT DIS, V36, P189, DOI 10.1086/345527; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Peng T, 2005, J CLIN INVEST, V115, P1590, DOI 10.1172/JCI22906; Platonov AE, 2003, VACCINE, V21, P4437, DOI 10.1016/S0264-410X(03)00440-7; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Rawstron AC, 1999, BRIT J HAEMATOL, V107, P148; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROSENFELD SI, 1986, J EXP MED, V164, P981, DOI 10.1084/jem.164.4.981; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rother RP, 2004, LUPUS, V13, P328, DOI 10.1191/0961203303lu1021oa; ROTHER RP, 1994, BLOOD, V84, P2604; ROTOLI B, 1989, SEMIN HEMATOL, V26, P201; SAWANTMANE S, 1991, ANN NEUROL, V29, P397, DOI 10.1002/ana.410290410; SCHREZENMEIER H, 2007, HAEMATOLOGICA, V92, P1696; Shao J, 2001, J AM SOC NEPHROL, V12, P2088, DOI 10.1681/ASN.V12102088; SMITH RIF, 1995, J IMMUNOL, V154, P2226; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Tesser J, 2001, ARTHRITIS RHEUM, V44, pS274; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang H, 2005, TRANSPLANTATION, V79, P1121, DOI 10.1097/01.TP.0000161218.58276.9A; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; WENG NP, 1992, J IMMUNOL, V149, P2518; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Willison HJ, 2006, ACTA NEUROL SCAND, V113, P14, DOI 10.1111/j.1600-0404.2006.00607.x; Wisloff F, 2005, EUR J HAEMATOL, V75, P293, DOI 10.1111/j.1600-0609.2005.00509.x; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; YONEMURA Y, 1990, BRIT J HAEMATOL, V74, P108, DOI 10.1111/j.1365-2141.1990.tb02546.x	88	482	573	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1256	1264		10.1038/nbt1344	http://dx.doi.org/10.1038/nbt1344			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17989688				2022-12-25	WOS:000251086500026
J	Yang, YH; Fu, W; Chen, JD; Olashaw, N; Zhang, XH; Nicosia, SV; Bhalla, K; Bai, WL				Yang, Yonghua; Fu, Wei; Chen, Jiandong; Olashaw, Nancy; Zhang, Xiaohong; Nicosia, Santo V.; Bhalla, Kapil; Bai, Wenlong			SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DNA-DAMAGE; LIFE-SPAN; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; PROTEIN DEACETYLASES; HISTONE DEACETYLASE; NAD; LONGEVITY	SIRT1 is the closest mammalian homologue of yeast SIR2, an important ageing regulator that prolongs lifespan in response to caloric restriction. Despite its importance, the mechanisms that regulate SIRT1 activity are unclear. Our study identifies a novel post-translational modification of SIRT1, namely sumoylation at Lys 734. In vitro sumoylation of SIRT1 increased its deacetylase activity. Conversely, mutation of SIRT1 at Lys 734 or desumoylation by SENP1, a nuclear desumoylase, reduced its deacetylase activity. Stress-inducing agents promoted the association of SIRT1 with SENP1 and cells depleted of SENP1 ( but not of SENP1 and SIRT1) were more resistant to stress-induced apoptosis than control cells. We suggest that stress-inducing agents counteract the anti-apoptotic activity of SIRT1 by recruiting SENP1 to SIRT1, which results in the desumoylation and inactivation of SIRT1 and the consequent acetylation and activation of apoptotic proteins.	Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Cell Biol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA; Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University System of Georgia; Augusta University	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	wbai@health.usf.edu	Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Bhalla, Kapil/0000-0001-5209-5126; Fu, Wei/0000-0003-0506-5594	NCI NIH HHS [R01 CA093666, R01 CA111334, CA93666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093666, R01CA111334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buschmann T, 2001, J BIOL CHEM, V276, P40389, DOI 10.1074/jbc.M103786200; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Moschos SJ, 2006, J MOL HISTOL, V37, P309, DOI 10.1007/s10735-006-9030-0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	37	251	261	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1253	U80		10.1038/ncb1645	http://dx.doi.org/10.1038/ncb1645			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17934453	Green Accepted			2022-12-25	WOS:000250659600011
J	Su, EJ; Fredriksson, L; Geyer, M; Folestad, E; Cale, J; Andrae, J; Gao, Y; Pietras, K; Mann, K; Yepes, M; Strickland, DK; Betsholtz, C; Eriksson, U; Lawrence, DA				Su, Enming J.; Fredriksson, Linda; Geyer, Melissa; Folestad, Erika; Cale, Jacqueline; Andrae, Johanna; Gao, Yamei; Pietras, Kristian; Mann, Kris; Yepes, Manuel; Strickland, Dudley K.; Betsholtz, Christer; Eriksson, Ulf; Lawrence, Daniel A.			Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke	NATURE MEDICINE			English	Article							RECEPTOR-RELATED PROTEIN; CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; TPA-DEFICIENT MICE; HEMORRHAGIC TRANSFORMATION; NEURONAL DEGENERATION; ALPHA-RECEPTOR; WILD-TYPE; T-PA; NEUROSERPIN	Thrombolytic treatment of ischemic stroke with tissue plasminogen activator (tPA) is markedly limited owing to concerns about hemorrhagic complications and the requirement that tPA be administered within 3 h of symptoms. Here we report that tPA activation of latent platelet-derived growth factor-CC (PDGF-CC) may explain these limitations. Intraventricular injection of tPA or active PDGF-CC, in the absence of ischemia, leads to significant increases in cerebrovascular permeability. In contrast, co-injection of neutralizing antibodies to PDGF-CC with tPA blocks this increased permeability, indicating that PDGF-CC is a downstream substrate of tPA within the neurovascular unit. These effects are mediated through activation of PDGF-alpha receptors (PDGFR-alpha) on perivascular astrocytes, and treatment of mice with the PDGFR-alpha antagonist imatinib after ischemic stroke reduces both cerebrovascular permeability and hemorrhagic complications associated with late administration of thrombolytic tPA. These data demonstrate that PDGF signaling regulates blood-brain barrier permeability and suggest potential new strategies for stroke treatment.	[Fredriksson, Linda; Folestad, Erika; Andrae, Johanna; Pietras, Kristian; Eriksson, Ulf] Karolinska Inst, Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden; [Su, Enming J.; Geyer, Melissa; Cale, Jacqueline; Lawrence, Daniel A.] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Andrae, Johanna; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Lab Vasc Biol, S-17177 Stockholm, Sweden; [Gao, Yamei; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gao, Yamei; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg & Physiol, Baltimore, MD 21201 USA; [Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Karolinska Institutet; Ludwig Institute for Cancer Research; University of Michigan System; University of Michigan; Karolinska Institutet; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Emory University; Emory University	Eriksson, U (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Stockholm Branch, POB 240, S-17177 Stockholm, Sweden.	ulf.eriksson@licr.ki.se; dlawrenc@umich.edu	Andrae, Johanna/L-3875-2014; Pietras, Kristian/ABE-8727-2020; Pietras, Kristian/ABG-2097-2021; Yepes, Manuel/C-3576-2011	Pietras, Kristian/0000-0001-6738-4705; Fredriksson, Linda/0000-0003-4952-2742; Lawrence, Daniel/0000-0003-3126-1935	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784, R01HL055747, R01HL055374, P01HL057346, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049478, R01NS079331, R01NS062073] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54710, HL55747, R01 HL055374-12, P01 HL054710-11A10006, R01 HL055747-10, R01 HL055374, P01 HL054710-11A1, P01 HL054710-120006, P01 HL054710, P01 HL054710-12, R01 HL050784-09, HL57346, R01 HL055374-10, HL55374, R01 HL055747, R01 HL055374-11A1, R01 HL050784, R01 HL055374-09, R01 HL055747-11, P01 HL057346-11A18577, P01 HL057346, HL50784] Funding Source: Medline; NINDS NIH HHS [R01 NS049478, R01 NS079331, R01 NS091201, NS49478, R01 NS049478-04, R01 NS062073] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Breedveld P, 2005, CANCER RES, V65, P2577, DOI 10.1158/0008-5472.CAN-04-2416; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Fredriksson L, 2005, J BIOL CHEM, V280, P26856, DOI 10.1074/jbc.M503388200; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hao ZF, 2006, BLOOD, V108, P200, DOI 10.1182/blood-2005-12-4884; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Hou ST, 2002, INT REV CYTOL, V221, P93; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Marler JR, 2003, SCIENCE, V301, P1677, DOI 10.1126/science.1090270; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Nagai N, 2002, J CEREBR BLOOD F MET, V22, P648, DOI 10.1097/00004647-200206000-00002; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Thomalla G, 2007, STROKE, V38, P313, DOI 10.1161/01.STR.0000254565.51807.22; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1997, J NEUROSCI, V17, P543; Vora NA, 2007, AM J NEURORADIOL, V28, P1391, DOI 10.3174/ajnr.A0575; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WILLNOW TE, 1994, J CELL SCI, V107, P719; WOLF BB, 1992, AM J PATHOL, V141, P37; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569; Yu H, 2001, EUR J NEUROSCI, V14, P799, DOI 10.1046/j.0953-816x.2001.01700.x; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	44	331	344	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					731	737		10.1038/nm1787	http://dx.doi.org/10.1038/nm1787			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18568034	Green Accepted			2022-12-25	WOS:000257452700020
J	Donia, MS; Ravel, J; Schmidt, EW				Donia, Mohamed S.; Ravel, Jacques; Schmidt, Eric W.			A global assembly line for cyanobactins	NATURE CHEMICAL BIOLOGY			English	Article							LISSOCLINUM-PATELLA; CYCLIC-PEPTIDES; TRUNKAMIDE-A; ASCIDIANS; BIOSYNTHESIS; PATHWAY	More than 100 cyclic peptides harboring heterocyclized residues are known from marine ascidians, sponges and different genera of cyanobacteria. Here, we report an assembly line responsible for the biosynthesis of these diverse peptides, now called cyanobactins, both in symbiotic and free-living cyanobacteria. By comparing five new cyanobactin biosynthetic clusters, we produced the prenylated antitumor preclinical candidate trunkamide in Escherichia coli culture using genetic engineering.	[Donia, Mohamed S.; Schmidt, Eric W.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Ravel, Jacques] Univ Maryland, Dept Microbiol & Immunol, Inst Genome Sci, Sch Med, Baltimore, MD 21201 USA	Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	Schmidt, EW (corresponding author), Univ Utah, Dept Med Chem, 30 S 2000 E,Room 201, Salt Lake City, UT 84112 USA.	ews1@utah.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071425, R01 GM071425-02, R01 GM071425-03, R01 GM071425-01A1, R01 GM071425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banker R, 1998, J NAT PROD, V61, P1248, DOI 10.1021/np980138j; Carroll AR, 1996, AUST J CHEM, V49, P659, DOI 10.1071/CH9960659; DAVIDSON BS, 1993, CHEM REV, V93, P1771, DOI 10.1021/cr00021a006; DEGNAN BM, 1989, J MED CHEM, V32, P1349, DOI 10.1021/jm00126a034; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; IRELAND CM, 1982, J ORG CHEM, V47, P1807, DOI 10.1021/jo00349a002; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Long PF, 2005, CHEMBIOCHEM, V6, P1760, DOI 10.1002/cbic.200500210; Milne BF, 2006, ORG BIOMOL CHEM, V4, P631, DOI 10.1039/b515938e; Salvatella  X, 2003, J ORG CHEM, V68, P211, DOI 10.1021/jo026464s; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sudek S, 2006, APPL ENVIRON MICROB, V72, P4382, DOI 10.1128/AEM.00380-06; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; ZABRISKIE TM, 1990, J AM CHEM SOC, V112, P8080, DOI 10.1021/ja00178a035; Ziemert N, 2008, APPL ENVIRON MICROB, V74, P1791, DOI 10.1128/AEM.02392-07	15	216	221	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					341	343		10.1038/nchembio.84	http://dx.doi.org/10.1038/nchembio.84			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18425112	Green Accepted			2022-12-25	WOS:000256068600009
J	Meloni, G; Sonois, V; Delaine, T; Guilloreau, L; Gillet, A; Teissie, J; Faller, P; Vasak, M				Meloni, Gabriele; Sonois, Vanessa; Delaine, Tamara; Guilloreau, Luc; Gillet, Audrey; Teissie, Justin; Faller, Peter; Vasak, Milan			Metal swap between Zn(7)-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-INHIBITORY FACTOR; ALZHEIMER A-BETA; NEURODEGENERATIVE DISORDERS; METALLOTHIONEIN-III; OXIDATIVE DAMAGE; COPPER-BINDING; DISEASE BRAIN; IN-VITRO; PEPTIDE; ZINC	Aberrant interactions of copper and zinc ions with the amyloid-beta peptide (A beta) potentiate Alzheimer's disease (AD) by participating in the aggregation process of Ab and in the generation of reactive oxygen species (ROS). The ROS production and the neurotoxicity of Ab are associated with copper binding. Metallothionein-3 (Zn(7)MT-3), an intra- and extracellularly occurring metalloprotein, is highly expressed in the brain and downregulated in AD. This protein protects, by an unknown mechanism, cultured neurons from the toxicity of Ab. Here, we show that a metal swap between Zn(7)MT-3 and soluble and aggregated A beta(1-40)-Cu(II) abolishes the ROS production and the related cellular toxicity. In this process, copper is reduced by the protein thiolates forming Cu(I)(4)Zn(4)MT-3, in which an air-stable Cu(I)(4)-thiolate cluster and two disulfide bonds are present. The discovered protective effect of Zn(7)MT-3 from the copper-mediated A beta(1-40) toxicity may lead to new therapeutic strategies for treating AD.	[Meloni, Gabriele; Vasak, Milan] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Sonois, Vanessa; Delaine, Tamara; Guilloreau, Luc; Gillet, Audrey; Faller, Peter] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Sonois, Vanessa; Teissie, Justin] Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Vasak, M (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	peter.faller@lcc-toulouse.fr; mvasak@bioc.uzh.ch	Faller, Peter/B-9614-2018; Teissie, Justin/AAA-5697-2019	Faller, Peter/0000-0001-8013-0806; Teissie, Justin/0000-0002-7588-8062; Meloni, Gabriele/0000-0003-4976-1401				Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Belle C, 2005, J INORG BIOCHEM, V99, P1929, DOI 10.1016/j.jinorgbio.2005.06.013; BUSH AI, 1995, SCIENCE, V268, P1921, DOI 10.1126/science.268.5219.1921; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cardoso SM, 2005, NEUROTOX RES, V7, P273, DOI 10.1007/BF03033885; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Dikalov SI, 2004, FREE RADICAL BIO MED, V36, P340, DOI 10.1016/j.freeradbiomed.2003.11.004; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; Faller P, 1999, BIOCHEMISTRY-US, V38, P10158, DOI 10.1021/bi990489c; FAWCETT TG, 1980, J AM CHEM SOC, V102, P2598, DOI 10.1021/ja00528a013; Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasler DW, 2000, BIOCHEMISTRY-US, V39, P14567, DOI 10.1021/bi001569f; Hou LM, 2006, J AM CHEM SOC, V128, P9260, DOI 10.1021/ja046032u; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; House E, 2004, J ALZHEIMERS DIS, V6, P291; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Irie Y, 2001, BIOCHEM BIOPH RES CO, V282, P416, DOI 10.1006/bbrc.2001.4594; Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028; Kontush A, 2001, FREE RADICAL BIO MED, V31, P1120, DOI 10.1016/S0891-5849(01)00688-8; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; Mekmouche Y, 2005, CHEMBIOCHEM, V6, P1663, DOI 10.1002/cbic.200500057; Meloni G, 2007, J BIOL CHEM, V282, P16068, DOI 10.1074/jbc.M701357200; Ohta T, 2000, INORG CHEM, V39, P4358, DOI 10.1021/ic000018a; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Oz G, 2001, BIOCHEMISTRY-US, V40, P11433, DOI 10.1021/bi010827l; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Uchida Y, 2002, J BIOL CHEM, V277, P32353, DOI 10.1074/jbc.M111263200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Wang H, 2006, FEBS LETT, V580, P795, DOI 10.1016/j.febslet.2005.12.099; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	48	168	174	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					366	372		10.1038/nchembio.89	http://dx.doi.org/10.1038/nchembio.89			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18454142	Green Accepted			2022-12-25	WOS:000256068600013
J	Alves, D; Li, HT; Codrington, R; Orte, A; Ren, XJ; Klenerman, D; Balasubramanian, S				Alves, David; Li, Haitao; Codrington, Rosalind; Orte, Angel; Ren, Xiaojun; Klenerman, David; Balasubramanian, Shankar			Single-molecule analysis of human telomerase monomer	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVE HUMAN TELOMERASE; FUNCTIONAL MULTIMERIZATION; CATALYTIC SUBUNIT; IMMORTAL CELLS; IDENTIFICATION; ENZYME	Human telomerase is a ribonucleoprotein that is minimally comprised of protein (hTERT) and RNA (hTR) components. We have applied single-molecule fluorescence two-color coincidence detection to characterize complex formation between fluorophore-labeled components in solution. By systematic labeling and in vitro assembly of hTERT, hTR and telomerase's DNA substrate, we have established that catalytically functional human telomerase comprises a stable hTERT: hTR: substrate interaction in a 1:1:1 absolute stoichiometry.	[Alves, David; Li, Haitao; Codrington, Rosalind; Orte, Angel; Ren, Xiaojun; Klenerman, David; Balasubramanian, Shankar] Univ Cambridge, Univ Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	dk10012@cam.ac.uk; sb10031@cam.ac.uk	Orte, Angel/J-4810-2012; Balasubramanian, Shankar/C-1671-2009	Orte, Angel/0000-0003-1905-4183; Balasubramanian, Shankar/0000-0002-0281-5815; Klenerman, David/0000-0001-7116-6954; Ren, Xiaojun/0000-0002-3931-7625				Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Bryan TM, 2003, MOL BIOL CELL, V14, P4794, DOI 10.1091/mbc.E03-07-0474; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Kim M, 2003, EXP CELL RES, V288, P277, DOI 10.1016/S0014-4827(03)00217-9; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Li HT, 2003, ANAL CHEM, V75, P1664, DOI 10.1021/ac026367z; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526	15	49	51	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2008	4	5					287	289		10.1038/nchembio.82	http://dx.doi.org/10.1038/nchembio.82			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291CM	18391947				2022-12-25	WOS:000255170400008
J	Sanchez-Diaz, A; Marchesi, V; Murray, S; Jones, R; Pereira, G; Edmondson, R; Allen, T; Labib, K				Sanchez-Diaz, Alberto; Marchesi, Vanessa; Murray, Stephen; Jones, Richard; Pereira, Gislene; Edmondson, Ricky; Allen, Terry; Labib, Karim			Inn1 couples contraction of the actomyosin ring to membrane ingression during cytokinesis in budding yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; KINETOCHORE BIORIENTATION; ELECTRON MICROSCOPY; MITOTIC SPINDLE; CLEAVAGE FURROW; CELL CORTEX; COMPLEX; PROTEIN; TRAFFICKING; ANILLIN	By rapidly depleting each of the essential budding yeast proteins of unknown function, we identified a novel factor that we call Inn1, which associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. We show that Inn1 has a C2 domain at the amino terminus of the protein that is required for ingression of the plasma membrane, whereas the remainder of the protein recruits Inn1 to the actomyosin ring. The lethal effects of deleting the INN1 gene can be suppressed by artificial fusion of the C2 domain to other components of the actomyosin ring, restoring membrane ingression on contraction of the actomyosin ring. Our data indicate that recruitment of the C2 domain of Inn1 to the contractile actomyosin ring is crucial for ingression of the plasma membrane during cytokinesis in budding yeast.	[Sanchez-Diaz, Alberto; Marchesi, Vanessa; Murray, Stephen; Pereira, Gislene; Allen, Terry; Labib, Karim] Univ Manchester, Canc Res UK, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Jones, Richard; Edmondson, Ricky] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; US Food & Drug Administration (FDA)	Labib, K (corresponding author), Univ Manchester, Canc Res UK, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	klabib@picr.man.ac.uk	Pereira, Gislene/D-4024-2014; Sanchez-Diaz, Alberto/L-2320-2014	Sanchez-Diaz, Alberto/0000-0002-3308-4824	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roh DH, 2002, MOL BIOL CELL, V13, P2747, DOI 10.1091/mbc.E02-03-0158; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Strickland LI, 2004, TRENDS CELL BIOL, V14, P115, DOI 10.1016/j.tcb.2004.01.006; Tolliday N, 2001, CURR OPIN MICROBIOL, V4, P690, DOI 10.1016/S1369-5274(01)00270-3; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang G, 2006, J CELL BIOL, V174, P207, DOI 10.1083/jcb.200604094; Zhao WM, 2005, J BIOL CHEM, V280, P33516, DOI 10.1074/jbc.M504657200	46	58	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					395	U58		10.1038/ncb1701	http://dx.doi.org/10.1038/ncb1701			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344988				2022-12-25	WOS:000254561700009
J	Tran, PV; Haycraft, CJ; Besschetnova, TY; Turbe-Doan, A; Stottmann, RW; Herron, BJ; Chesebro, AL; Qiu, H; Scherz, PJ; Shah, JV; Yoder, BK; Beier, DR				Tran, Pamela V.; Haycraft, Courtney J.; Besschetnova, Tatiana Y.; Turbe-Doan, Annick; Stottmann, Rolf W.; Herron, Bruce J.; Chesebro, Allyson L.; Qiu, Haiyan; Scherz, Paul J.; Shah, Jagesh V.; Yoder, Bradley K.; Beier, David R.			THM1 negatively modulates mouse sonic hedgehog signal transduction and affects retrograde intraflagellar transport in cilia	NATURE GENETICS			English	Article							REPRESSOR FUNCTIONS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; VERTEBRATE LIMB; SPINAL-CORD; PROTEIN; GLI3; ACTIVATOR; CHAIN; CHLAMYDOMONAS	Characterization of previously described intraflagellar transport (IFT) mouse mutants has led to the proposition that normal primary cilia are required for mammalian cells to respond to the sonic hedgehog (SHH) signal. Here we describe an N-ethyl-N-nitrosourea-induced mutant mouse, alien (aln), which has abnormal primary cilia and shows overactivation of the SHH pathway. The aln locus encodes a novel protein, THM1 (tetratricopeptide repeat-containing hedgehog modulator-1), which localizes to cilia. aln-mutant cilia have bulb-like structures at their tips in which IFT proteins (such as IFT88) are sequestered, characteristic of Chlamydomonas reinhardtii and Caenorhabditis elegans retrograde IFT mutants. RNA-interference knockdown of Ttc21b (which we call Thm1 and which encodes THM1) in mouse inner medullary collecting duct cells expressing an IFT88-enhanced yellow fluorescent protein fusion recapitulated the aln-mutant cilial phenotype, and live imaging of these cells revealed impaired retrograde IFT. In contrast to previously described IFT mutants, Smoothened and full-length glioblastoma (GLI) proteins localize to aln-mutant cilia. We hypothesize that the aln retrograde IFT defect causes sequestration of IFT proteins in aln-mutant cilia and leads to the overactivated SHH signaling phenotype. Specifically, the aln mutation uncouples the roles of anterograde and retrograde transport in SHH signaling, suggesting that anterograde IFT is required for GLI activation and that retrograde IFT modulates this event.	[Tran, Pamela V.; Turbe-Doan, Annick; Stottmann, Rolf W.; Herron, Bruce J.; Chesebro, Allyson L.; Qiu, Haiyan; Beier, David R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Haycraft, Courtney J.; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Besschetnova, Tatiana Y.; Shah, Jagesh V.] Harvard Univ, Sch Med, Harvard Inst Med, Div Renal,Brigham & Womens Hosp, Boston, MA 02115 USA; [Scherz, Paul J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Beier, DR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	beier@receptor.med.harvard.edu	Stottmann, Rolf/U-6589-2019; Stottmann, Rolf/GRO-3453-2022	Stottmann, Rolf/0000-0003-4512-6806; Chesebro, Allyson/0000-0002-9880-2743	NICHD NIH HHS [R01HD056030, R01 HD036404, F32 HD053198, R01 HD056030, F32 HD053198-01A2, R01HD36404, F32 HD053198-02] Funding Source: Medline; NIDDK NIH HHS [P50 DK074030-019001, P50DK074030, P30 DK074038, P50 DK074030-029001, P50 DK074030] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404, R01HD056030] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030, P30DK074038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Houde C, 2006, DEV BIOL, V300, P523, DOI 10.1016/j.ydbio.2006.09.001; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KARLIN S, 1985, P NATL ACAD SCI USA, V82, P8597, DOI 10.1073/pnas.82.24.8597; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mo R, 1997, DEVELOPMENT, V124, P113; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Sloboda RD, 2005, J CELL BIOCHEM, V94, P266, DOI 10.1002/jcb.20323; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	45	242	246	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					403	410		10.1038/ng.105	http://dx.doi.org/10.1038/ng.105			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327258	Green Accepted			2022-12-25	WOS:000254388100010
J	Aujla, SJ; Chan, YR; Zheng, MQ; Fei, MJ; Askew, DJ; Pociask, DA; Reinhart, TA; McAllister, F; Edeal, J; Gaus, K; Husain, S; Kreindler, JL; Dubin, PJ; Pilewski, JM; Myerburg, MM; Mason, CA; Iwakura, Y; Kolls, JK				Aujla, Shean J.; Chan, Yvonne R.; Zheng, Mingquan; Fei, Mingjian; Askew, David J.; Pociask, Derek A.; Reinhart, Todd A.; McAllister, Florencia; Edeal, Jennifer; Gaus, Kristi; Husain, Shahid; Kreindler, James L.; Dubin, Patricia J.; Pilewski, Joseph M.; Myerburg, Mike M.; Mason, Carol A.; Iwakura, Yoichiro; Kolls, Jay K.			IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia	NATURE MEDICINE			English	Article							T-HELPER-CELLS; ESCHERICHIA-COLI INFECTION; COLONY-STIMULATING FACTOR; GROWTH-FACTOR-BETA; NEUTROPHIL RECRUITMENT; IL-17 PRODUCTION; INFLAMMATION; DIFFERENTIATION; IMMUNITY; RECEPTOR	Emerging evidence supports the concept that T helper type 17 (T(H)17) cells, in addition to mediating autoimmunity, have key roles in mucosal immunity against extracellular pathogens. Interleukin-22 (IL-22) and IL-17A are both effector cytokines produced by the T(H)17 lineage, and both were crucial for maintaining local control of the Gram-negative pulmonary pathogen, Klebsiella pneumoniae. Although both cytokines regulated CXC chemokines and granulocyte colony-stimulating factor production in the lung, only IL-22 increased lung epithelial cell proliferation and increased transepithelial resistance to injury. These data support the concept that the T(H)17 cell lineage and its effector molecules have evolved to effect host defense against extracellular pathogens at mucosal sites.	[Aujla, Shean J.; Zheng, Mingquan; Fei, Mingjian; Pociask, Derek A.; McAllister, Florencia; Edeal, Jennifer; Kreindler, James L.; Dubin, Patricia J.; Kolls, Jay K.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Chan, Yvonne R.; Pilewski, Joseph M.; Myerburg, Mike M.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Askew, David J.] Univ Pittsburgh, Med Ctr, Newborn Med Program, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Askew, David J.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Reinhart, Todd A.; Gaus, Kristi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Husain, Shahid] Univ Pittsburgh, Med Ctr, Div Infect Dis, Transplant Infect Dis Unit, Pittsburgh, PA 15213 USA; [Mason, Carol A.] Louisiana Hlth Sci Ctr, Div Pulm & Crit Care Med, New Orleans, LA 70112 USA; [Iwakura, Yoichiro] Univ Tokyo, Ctr Med Expt, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Tokyo	Kolls, JK (corresponding author), Childrens Hosp Pittsburgh, Suite 3765,3705 5th Ave, Pittsburgh, PA 15213 USA.	jay.kolls@chp.edu	Pilewski, Joseph/AAF-5149-2021; Dubin, Patricia/AAB-9951-2020; Chan, Yvonne R/A-2513-2011; Kolls, Jay/AAH-1829-2019; Iwakura, Yoichiro/E-5457-2011	Kolls, Jay/0000-0001-5151-6304; Iwakura, Yoichiro/0000-0002-9934-5775; Husain, Shahid/0000-0002-9216-5229	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [P50HL084932, R01 HL079142, P50 HL084932, R01 HL079142-04, R37 HL079142, R01 HL061271, R01 HL061271-04, 5R01HL079142] Funding Source: Medline; NIDDK NIH HHS [P30 DK072506, P30DK072506] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079142, R37HL079142, R01HL061271, P50HL084932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chakinala MM, 2005, CLIN CHEST MED, V26, P113, DOI 10.1016/j.ccm.2004.10.010; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Fallert BA, 2002, J VIROL METHODS, V99, P23, DOI 10.1016/S0166-0934(01)00378-0; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Franks TJ, 2003, HUM PATHOL, V34, P743, DOI 10.1016/S0046-8177(03)00367-8; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; TASWELL C, 1981, J IMMUNOL, V126, P1614; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	40	897	956	3	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					275	281		10.1038/nm1710	http://dx.doi.org/10.1038/nm1710			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18264110	Green Accepted			2022-12-25	WOS:000253815700033
J	Engin, FZ; Yao, ZQ; Yang, T; Zhou, G; Bertin, T; Jiang, MM; Chen, YQ; Wang, L; Zheng, H; Sutton, RE; Boyce, BF; Lee, B				Engin, Feyza; Yao, Zhenqiang; Yang, Tao; Zhou, Guang; Bertin, Terry; Jiang, Ming Ming; Chen, Yuqing; Wang, Lisa; Zheng, Hui; Sutton, Richard E.; Boyce, Brendan F.; Lee, Brendan			Dimorphic effects of Notch signaling in bone homeostasis	NATURE MEDICINE			English	Article							OSTEOBLASTIC CELL-DIFFERENTIATION; POSTMENOPAUSAL WOMEN; WNT/BETA-CATENIN; MINERAL DENSITY; OSTEOPROTEGERIN; RUNX2; WNT; EXPRESSION; MASS; SKELETOGENESIS	Notch signaling is a key mechanism in the control of embryogenesis. However, its in vivo function during mesenchymal cell differentiation, and, specifically, in bone homeostasis, remains largely unknown. Here, we show that osteoblast-specific gain of Notch function causes severe osteosclerosis owing to increased proliferation of immature osteoblasts. Under these pathological conditions, Notch stimulates early osteoblastic proliferation by upregulating the genes encoding cyclin D, cyclin E and Sp7 (osterix). The intracellular domain of Notch1 also regulates terminal osteoblastic differentiation by directly binding Runx2 and repressing its transactivation function. In contrast, loss of all Notch signaling in osteoblasts, generated by deletion of the genes encoding presenilin-1 and presenilin-2 in bone, is associated with late-onset, age-related osteoporosis, which in turn results from increased osteoblast-dependent osteoclastic activity due to decreased osteoprotegerin mRNA expression in these cells. Together, these findings highlight the potential dimorphic effects of Notch signaling in bone homeostasis and may provide direction for novel therapeutic applications.	[Engin, Feyza; Yang, Tao; Zhou, Guang; Bertin, Terry; Jiang, Ming Ming; Chen, Yuqing; Zheng, Hui; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yao, Zhenqiang; Boyce, Brendan F.] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Yao, Zhenqiang; Boyce, Brendan F.] Univ Rochester, Med Ctr, Lab Med, Rochester, NY 14642 USA; [Jiang, Ming Ming; Chen, Yuqing; Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA; [Wang, Lisa] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Sutton, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; University of Rochester; University of Rochester; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl, Houston, TX 77030 USA.	blee@bcm.tmc.edu		Engin, Feyza/0000-0002-7987-5381	NIAMS NIH HHS [AR43510, R01 AR043510] Funding Source: Medline; NICHD NIH HHS [P01 HD022657, HD22657] Funding Source: Medline; NIDCR NIH HHS [DE016990, R01 DE016990, R01 DE016990-04] Funding Source: Medline; NIEHS NIH HHS [ES11253, P01 ES011253] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arko B, 2005, MATURITAS, V51, P270, DOI 10.1016/j.maturitas.2004.08.006; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Boyce BF, 2006, NAT MED, V12, P1356, DOI 10.1038/nm1206-1356; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Choi JY, 2005, CALCIFIED TISSUE INT, V77, P152, DOI 10.1007/s00223-004-0264-0; Dai C, 2004, J VIROL, V78, P6209, DOI 10.1128/JVI.78.12.6209-6221.2004; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Fahrleitner-Pammer A, 2003, WIEN KLIN WOCHENSCHR, V115, P291, DOI 10.1007/BF03040334; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Mezquita-Raya P, 2005, OSTEOPOROSIS INT, V16, P1368, DOI 10.1007/s00198-005-1844-1; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Pratap J, 2003, CANCER RES, V63, P5357; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Segall HI, 2003, MOL THER, V8, P118, DOI 10.1016/S1525-0016(03)00134-5; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Sutton RE, 1998, J VIROL, V72, P5781, DOI 10.1128/JVI.72.7.5781-5788.1998; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Wang LL, 2005, CANCER J, V11, P294, DOI 10.1097/00130404-200507000-00005; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	37	289	322	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					299	305		10.1038/nm1712	http://dx.doi.org/10.1038/nm1712			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18297084	Green Accepted			2022-12-25	WOS:000253815700036
J	Owusu-Ansah, E; Yavari, A; Mandal, S; Banerjee, U				Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal			Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FOXO3A; DROSOPHILA EYE; OXIDATIVE STRESS; PROLIFERATION; APOPTOSIS; OXYGEN; JNK; SUPEROXIDE; ACTIVATION; EXPRESSION	During electron transport, the mitochondrion generates ATP and reactive oxygen species (ROS), a group of partially reduced and highly reactive metabolites of oxygen(1). In this in vivo genetic analysis in Drosophila melanogaster, we establish that disruption of complex I of the mitochondrial electron transport chain specifically retards the cell cycle during the G1-S transition. The mechanism involves a specific signaling cascade initiated by ROS and transduced by ASK-1, JNK, FOXO and the Drosophila p27 homolog, Dacapo. On the basis of our data combined with previous analyses of the system(2), we conclude that mitochondrial dysfunction activates at least two retrograde signals to specifically enforce a G1-S cell cycle checkpoint. One such signal involves an increase in AMP production and downregulation of cyclin E protein; another independent pathway involves increased ROS and upregulation of Dacapo. Thus, our results indicate that the mitochondrion can use AMP and ROS at sublethal concentrations as independent signaling molecules to modulate cell cycle progression.	[Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu		Mandal, Sudip/0000-0002-2211-483X	NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY00852, R01 EY008152] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDWARD EOA, 2008, NAT PROTOC; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Newsome TP, 2000, DEVELOPMENT, V127, P851; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOLFF T, 1991, DEVELOPMENT, V113, P841; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	28	270	275	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					356	361		10.1038/ng.2007.50	http://dx.doi.org/10.1038/ng.2007.50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246068				2022-12-25	WOS:000253548400029
J	Song, XT; Evel-Kabler, K; Shen, L; Rollins, L; Huang, XF; Chen, SY				Song, Xiao-Tong; Evel-Kabler, Kevin; Shen, Lei; Rollins, Lisa; Huang, Xue F.; Chen, Si-Yi			A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression	NATURE MEDICINE			English	Article							NF-KAPPA-B; DENDRITIC CELLS; ANTITUMOR IMMUNITY; TUMOR-IMMUNITY; CUTTING EDGE; CANCER-IMMUNOTHERAPY; LYMPHOCYTE ANTIGEN-4; B16 MELANOMA; ACTIVATION; BLOCKADE	Regulatory T cells (T-reg cells) suppress autoreactive immune responses and limit the efficacy of tumor vaccines; however, it remains a challenge to selectively eliminate or inhibit T-reg cells. In this study, the zinc-finger A20, a negative regulator of the Toll-like receptor and tumor necrosis factor receptor signaling pathways, was found to play a crucial part in controlling the maturation, cytokine production and immunostimulatory potency of dendritic cells (DCs). A20-silenced DCs showed spontaneous and enhanced expression of costimulatory molecules and proinflammatory cytokines and had different effects on T cell subsets: they inhibited T-reg cells and hyperactivated tumor-infiltrating cytotoxic T lymphocytes and T helper cells that produced interleukin-6 and tumor necrosis factor-alpha and were refractory to T-reg cell-mediated suppression. Hence, this study identifies A20 as an antigen presentation attenuator in control of antitumor immune responses during both the priming and the effector phases and provides a strategy to overcome T-reg cell-mediated suppression in an antigen-specific manner, reducing the need to directly target T-reg cells.	[Song, Xiao-Tong; Evel-Kabler, Kevin; Shen, Lei; Rollins, Lisa; Huang, Xue F.; Chen, Si-Yi] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Baylor College of Medicine; University of Southern California	Chen, SY (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, 1 Baylor Plaza, Houston, TX 77030 USA.	siyichen@usc.edu	Song, Xiao-Tong/AAI-8424-2020		NATIONAL CANCER INSTITUTE [R01CA100841, R01CA116677, R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068472] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090427-02, R01CA90427, R01 CA116677-04, R01 CA090427-03, R01 CA090427-05, R01 CA116677, R01 CA116677-05, R01 CA100841, R01 CA090427-04, R01 CA090427, R01CA116677] Funding Source: Medline; NIAID NIH HHS [R01 AI068472-05, R01 AI068472, R01 AI068472-04, R01AI68472] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLOUCHE M, 1990, LEUKEMIA RES, V14, P353, DOI 10.1016/0145-2126(90)90163-4; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Evel-Kabler K, 2006, MOL THER, V13, P850, DOI 10.1016/j.ymthe.2006.02.009; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Maker AV, 2005, J IMMUNOL, V175, P7746, DOI 10.4049/jimmunol.175.11.7746; Overwijk WW, 2005, CURR OPIN IMMUNOL, V17, P187, DOI 10.1016/j.coi.2005.01.011; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Schroers Roland, 2004, Methods Mol Biol, V246, P451; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Shimizu J, 1999, J IMMUNOL, V163, P5211; Siegel S, 2003, BRIT J HAEMATOL, V122, P911, DOI 10.1046/j.1365-2141.2003.04535.x; So T, 2007, J IMMUNOL, V179, P1427, DOI 10.4049/jimmunol.179.3.1427; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woo EY, 2001, CANCER RES, V61, P4766; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	46	135	149	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					258	265		10.1038/nm1721	http://dx.doi.org/10.1038/nm1721			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18311150	Green Accepted			2022-12-25	WOS:000253815700031
J	Bekar, L; Libionka, W; Tian, GF; Xu, QW; Torres, A; Wang, XH; Lovatt, D; Williams, E; Takano, TH; Schnermann, J; Bakos, R; Nedergaard, M				Bekar, Lane; Libionka, Witold; Tian, Guo-Feng; Xu, Qiwu; Torres, Arnulfo; Wang, Xiaohai; Lovatt, Ditte; Williams, Erika; Takano, Takahiro; Schnermann, Jurgen; Bakos, Robert; Nedergaard, Maiken			Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor	NATURE MEDICINE			English	Article							HARMALINE-INDUCED TREMOR; ATP RELEASE; RAT; INHIBITION; DISORDERS; SYNAPSES; MICE	Deep brain stimulation (DBS) is a widely used neurosurgical approach to treating tremor and other movement disorders(1-3). In addition, the use of DBS in a number of psychiatric diseases, including obsessive-compulsive disorders and depression, is currently being tested(4-6). Despite the rapid increase in the number of individuals with surgically implanted stimulation electrodes, the cellular pathways involved in mediating the effects of DBS remain unknown(1). Here we show that DBS is associated with a marked increase in the release of ATP, resulting in accumulation of its catabolic product, adenosine. Adenosine A1 receptor activation depresses excitatory transmission in the thalamus and reduces both tremor-and DBS-induced side effects. Intrathalamic infusion of A1 receptor agonists directly reduces tremor, whereas adenosine A1 receptor-null mice show involuntary movements and seizure at stimulation intensities below the therapeutic level. Furthermore, our data indicate that endogenous adenosine mechanisms are active in tremor, thus supporting the clinical notion that caffeine, a nonselective adenosine receptor antagonist, can trigger or exacerbate essential tremor(7). Our findings suggest that nonsynaptic mechanisms involving the activation of A1 receptors suppress tremor activity and limit stimulation-induced side effects, thereby providing a new pharmacological target to replace or improve the efficacy of DBS.	[Bekar, Lane; Libionka, Witold; Tian, Guo-Feng; Xu, Qiwu; Torres, Arnulfo; Wang, Xiaohai; Lovatt, Ditte; Williams, Erika; Takano, Takahiro; Bakos, Robert; Nedergaard, Maiken] Univ Rochester, Dept Neurosurg, Div Glial Dis & Therapeut, Rochester, NY 14642 USA; [Schnermann, Jurgen] NIDDKD, Natl Inst Hlth, Bethesda, MD 20892 USA	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bekar, L (corresponding author), Univ Rochester, Dept Neurosurg, Div Glial Dis & Therapeut, 601 Elmwood Ave, Rochester, NY 14642 USA.	lane_bekar@urmc.rochester.edu; nedergaard@urmc.rochester.edu	Bekar, Lane K./AAI-2645-2021	Bekar, Lane/0000-0001-5083-0967; Takano, Takahiro/0000-0002-6235-6673; Wang, Xiaohai/0000-0001-5814-4072	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043413, Z01DK043413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030007, R01NS039559, R29NS030007, P01NS050315] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39559, NS30007, NS050315] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson TR, 2006, J NEUROSCI, V26, P841, DOI 10.1523/JNEUROSCI.3523-05.2006; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; Boulet S, 2006, J NEUROSCI, V26, P10768, DOI 10.1523/JNEUROSCI.3065-06.2006; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cousins MS, 1997, EUR J PHARMACOL, V322, P137, DOI 10.1016/S0014-2999(97)00008-3; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; JOLICOEUR FB, 1991, BRAIN RES BULL, V26, P317, DOI 10.1016/0361-9230(91)90245-F; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Louis ED, 2004, MOVEMENT DISORD, V19, P499, DOI 10.1002/mds.20035; Lozano Andres M, 2004, Suppl Clin Neurophysiol, V57, P733; Marks William J, 2005, Curr Treat Options Neurol, V7, P237, DOI 10.1007/s11940-005-0017-z; Martin FC, 2005, MOVEMENT DISORD, V20, P298, DOI 10.1002/mds.20331; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, J CLIN NEUROPHYSIOL, V21, P40, DOI 10.1097/00004691-200401000-00006; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; MILNER TE, 1995, J NEUROPHYSIOL, V73, P2568, DOI 10.1152/jn.1995.73.6.2568; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Wall MJ, 2007, J PHYSIOL-LONDON, V581, P553, DOI 10.1113/jphysiol.2006.126417; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Wilms H, 1999, MOVEMENT DISORD, V14, P557, DOI 10.1002/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	30	194	204	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					75	80		10.1038/nm1693	http://dx.doi.org/10.1038/nm1693			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157140				2022-12-25	WOS:000252222400025
J	Pinkston-Gosse, J; Kenyon, C				Pinkston-Gosse, Julie; Kenyon, Cynthia			DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans	NATURE GENETICS			English	Article							LIFE-SPAN; SUPPRESSOR GENE; CELL-GROWTH; CANCER; OVEREXPRESSION; PROLIFERATION; DOWNSTREAM; LONGEVITY; TRANSPORT; ADENOSINE	Cancer is an age-related disease, and inhibiting insulin/insulinlike growth factor 1 (IGF-1) signaling extends lifespan and increases tumor resistance in C. elegans and mammals. To investigate how the insulin/IGF-1 pathway couples these two processes, we analyzed putative transcriptional targets of the C. elegans FOXO transcription factor DAF-16, which promotes both longevity and tumor resistance. Twenty-nine of 734 genes tested influenced germline-tumor cell proliferation or p53-dependent apoptosis. About half of these genes also affected normal aging, thereby linking these two processes mechanistically. Many of these 29 genes are orthologs of known human tumor suppressors or oncogenes, suggesting that others may be as well. Our findings implicate nuclear-pore modification in p53-dependent cell death, because inhibiting nuclear-pore genes that are upregulated by DAF-16 blocks p53-dependent cell death in the tumor, but not normal, p53-independent, germline cell death.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; DELPUECH O, 2007, MOL CELL BIOL; Fahrenkrog B, 2006, CAN J PHYSIOL PHARM, V84, P279, DOI 10.1139/Y05-100; FRANCIS R, 1995, GENETICS, V139, P579; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garigan D, 2002, GENETICS, V161, P1101; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kenyon C, 2006, NAT GENET, V38, P397, DOI 10.1038/ng0406-397; LAWLESS JF, 1998, MODELS METHODS LIFET; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Madi L, 2004, CLIN CANCER RES, V10, P4472, DOI 10.1158/1078-0432.CCR-03-0651; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Milner AE, 1997, ONCOGENE, V15, P1815, DOI 10.1038/sj.onc.1201355; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Qi J, 2005, BIOCHEM BIOPH RES CO, V328, P517, DOI 10.1016/j.bbrc.2005.01.014; Ramsey MM, 2002, ENDOCRINOLOGY, V143, P4139, DOI 10.1210/en.2002-220717; Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shimada H, 2000, BLOOD, V96, P655; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wechsler DS, 1997, CANCER RES, V57, P4905; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025	30	106	157	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1403	1409		10.1038/ng.2007.1	http://dx.doi.org/10.1038/ng.2007.1			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934462				2022-12-25	WOS:000250575900026
J	Yang, G; Houghtaling, BR; Gaetz, J; Liu, JZ; Danuser, G; Kapoor, TM				Yang, Ge; Houghtaling, Benjamin R.; Gaetz, Jedidiah; Liu, Jenny Z.; Danuser, Gaudenz; Kapoor, Tarun M.			Architectural dynamics of the meiotic spindle revealed by single-fluorophore imaging	NATURE CELL BIOLOGY			English	Article							MICROTUBULE DYNAMICS; KINETOCHORE MICROTUBULES; MITOTIC SPINDLE; POLEWARD FLUX; EGG EXTRACTS; LENGTH; ACTIN; VISUALIZATION	Bipolarity of the meiotic spindle, required for proper chromosome segregation, is maintained throughout cell division despite rapid microtubule turnover. How this is achieved has remained mysterious, as determining the organization of individual spindle microtubules has been difficult. Here, we develop single-fluorophore speckle imaging to examine microtubule organization in the vertebrate meiotic spindle. We find that the mean length of microtubules is similar to 40% of spindle length. Long and short filaments distribute randomly throughout the spindle and those in close proximity can move in the same direction with highly heterogeneous velocities. The ratio between microtubule and spindle lengths remains unchanged as spindles elongate upon dynein-dynactin inhibition. However, maintaining this ratio depends on proper kinesin-5 function. Our data suggest that force transmission within the spindle must be understood in terms of the crosslinking dynamics of a tiled array of individual filaments, most of which do not span the distance from the pole to the metaphase plate.	Scripps Res Inst, Lab Computat Cell Biol, La Jolla, CA 92037 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Scripps Research Institute; Rockefeller University	Danuser, G (corresponding author), Scripps Res Inst, Lab Computat Cell Biol, 10550 N Torrey Pines Rd,Mail Box CB 167, La Jolla, CA 92037 USA.	gdanuser@scripps.edu; kapoor@rockefeller.edu		Danuser, Gaudenz/0000-0001-8583-2014; Gaetz, Jedidiah/0000-0002-7103-6241	NIGMS NIH HHS [R01 GM65933, R01 GM0678] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr DR, 1999, AM STAT, V53, P357, DOI 10.2307/2686057; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Desai A, 1999, METHOD CELL BIOL, V61, P385; Do Carmo P., 1976, DIFFERENTIAL GEOMETR; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; HALLETT FR, 1985, BIOPOLYMERS, V24, P2403, DOI 10.1002/bip.360241216; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HILL T, 1987, LINEARY AGGREGATION; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maly IV, 2002, B MATH BIOL, V64, P213, DOI 10.1006/bulm.2001.0265; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mitchison TJ, 2004, MOL BIOL CELL, V15, P5603, DOI 10.1091/mbc.E04-05-0440; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; OHBA S, 1993, BIOCHIM BIOPHYS ACTA, V1158, P323, DOI 10.1016/0304-4165(93)90031-3; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; PAPOULIS A, 2002, PROBABILTY RANDOM VA; Pierce DW, 1999, METHOD CELL BIOL, V58, P49; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yang G., 2005, 2005 IEEE COMP SOC C, P138, DOI [DOI 10.1109/CVPR.2005.519, 10.1109/CVPR.2005.519]	41	82	82	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1233	U45		10.1038/ncb1643	http://dx.doi.org/10.1038/ncb1643			37	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17934454				2022-12-25	WOS:000250659600009
J	Gudbjartsson, DF; Sulem, P; Stacey, SN; Goldstein, AM; Rafnar, T; Sigurgeirsson, B; Benediktsdottir, KR; Thorisdottir, K; Ragnarsson, R; Sveinsdottir, SG; Magnusson, V; Lindblom, A; Kostulas, K; Botella-Estrada, R; Soriano, V; Juberias, P; Grasa, M; Saez, B; Andres, R; Scherer, D; Rudnai, P; Gurzau, E; Koppova, K; Kiemeney, LA; Jakobsdottir, M; Steinberg, S; Helgason, A; Gretarsdottir, S; Tucker, MA; Mayordomo, JI; Nagore, E; Kumar, R; Hansson, J; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Sulem, Patrick; Stacey, Simon N.; Goldstein, Alisa M.; Rafnar, Thorunn; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Sveinsdottir, Steinunn G.; Magnusson, Veronica; Lindblom, Annika; Kostulas, Konstantinos; Botella-Estrada, Rafael; Soriano, Virtudes; Juberias, Pablo; Grasa, Matilde; Saez, Berta; Andres, Raquel; Scherer, Dominique; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Kiemeney, Lambertus A.; Jakobsdottir, Margret; Steinberg, Stacy; Helgason, Agnar; Gretarsdottir, Solveig; Tucker, Margaret A.; Mayordomo, Jose I.; Nagore, Eduardo; Kumar, Rajiv; Hansson, Johan; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma	NATURE GENETICS			English	Article							MELANOCORTIN-1 RECEPTOR MC1R; NONMELANOMA SKIN-CANCER; RISK-FACTORS; GENE VARIANTS; CONFERS RISK; EYE-COLOR; POLYMORPHISM; AGOUTI; HAIR; SUSCEPTIBILITY	Fair color increases risk of cutaneous melanoma (CM) and basal cell carcinoma (BCC). Recent genome-wide association studies have identified variants affecting hair, eye and skin pigmentation in Europeans. Here, we assess the effect of these variants on risk of CM and BCC in European populations comprising 2,121 individuals with CM, 2,163 individuals with BCC and over 40,000 controls. A haplotype near ASIP, known to affect a similar spectrum of pigmentation traits as MC1R variants, conferred significant risk of CM (odds ratio (OR) 1.45, P = 1.2 x 10(-9)) and BCC (OR = 1.33, P = 1.2 x 10(-6)). The variant in TYR encoding the R402Q amino acid substitution, previously shown to affect eye color and tanning response, conferred risk of CM (OR = 1.21, P = 2.8 x 10(-7)) and BCC (OR = 1.14, P = 6.1 x 10(-4)). An eye color variant in TYRP1 was associated with risk of CM (OR = 1.15, P = 4.6 x 10(-4)). The association of all three variants is robust with respect to adjustment for the effect of pigmentation.	[Gudbjartsson, Daniel F.; Sulem, Patrick; Stacey, Simon N.; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Helgason, Agnar; Gretarsdottir, Solveig; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Benediktsdottir, Kristrun R.; Thorisdottir, Kristin] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Sveinsdottir, Steinunn G.] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Magnusson, Veronica] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Lindblom, Annika] Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; [Kostulas, Konstantinos] Karolinska Univ Hosp, Karolinska Inst, Dept Neurol, S-14186 Huddinge, Sweden; [Botella-Estrada, Rafael] Inst Valenciano Oncol, Dept Dermatol, Valencia 46009, Spain; [Soriano, Virtudes; Nagore, Eduardo] Inst Valenciano Oncol, Dept Oncol, Valencia 46009, Spain; [Juberias, Pablo; Grasa, Matilde] Univ Hosp, Div Dermatol, Zaragoza 50009, Spain; [Saez, Berta] Hlth Sci Inst, Zaragoza 50009, Spain; [Andres, Raquel; Mayordomo, Jose I.] Hlth Sci Inst, Div Med Oncol, Zaragoza 50009, Spain; [Scherer, Dominique; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, RO Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, SK-97576 Banska Bystr, Slovakia; [Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Instituto Valenciano De Oncologia; Instituto Valenciano De Oncologia; Miguel Servet University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Radboud University Nijmegen; Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Sigurgeirsson, Bárður/B-6130-2011; Tucker, Margaret A/B-4297-2015; Sigurgeirsson, Bardur/AAP-7755-2020; Höiom, Veronica/F-4153-2012; Mayordomo, Jose/K-3453-2013; Nagore, Eduardo/Z-2126-2019; Stefansson, Kari/AAE-7187-2019; Kiemeney, Lambertus A./D-3357-2009; Kumar, Rajiv/H-6431-2019; Helgason, Agnar/K-1522-2015	Nagore, Eduardo/0000-0003-3433-8707; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Rajiv/0000-0002-6093-0395; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Gurzau, Eugen/0000-0002-8688-6118	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02-CP-91026] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Frudakis T, 2003, GENETICS, V165, P2071; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2006, INT J CANCER, V119, P1976, DOI 10.1002/ijc.22074; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Madan V, 2006, BRIT J DERMATOL, V154, P5, DOI 10.1111/j.1365-2133.2006.07229.x; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Oliveria SA, 2006, ARCH DIS CHILD, V91, P131, DOI 10.1136/adc.2005.086918; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Rees J, 2006, J INVEST DERMATOL, V126, P1691, DOI 10.1038/sj.jid.5700345; Scherer D, 2008, INT J CANCER, V122, P1787, DOI 10.1002/ijc.23257; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; SULEM P, NAT GENET       0525; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021	30	250	260	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					886	891		10.1038/ng.161	http://dx.doi.org/10.1038/ng.161			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488027				2022-12-25	WOS:000257166500024
J	Grewal, PK; Uchiyama, S; Ditto, D; Varki, N; Le, DT; Nizet, V; Marth, JD				Grewal, Prabhjit K.; Uchiyama, Satoshi; Ditto, David; Varki, Nissi; Le, Dzung T.; Nizet, Victor; Marth, Jamey D.			The Ashwell receptor mitigates the lethal coagulopathy of sepsis	NATURE MEDICINE			English	Article							LIVER ASIALOGLYCOPROTEIN RECEPTOR; PLATELET SIALIC-ACID; STREPTOCOCCUS-PNEUMONIAE; MICE LACKING; RESPIRATORY-TRACT; LIGAND-BINDING; MAJOR SUBUNIT; NEURAMINIDASE; SURFACE; GLYCOPROTEINS	The Ashwell receptor, the major lectin of hepatocytes, rapidly clears from blood circulation glycoproteins bearing glycan ligands that include galactose and N-acetylgalactosamine. This asialoglycoprotein receptor activity remains a key factor in the development and administration of glycoprotein pharmaceuticals, yet a biological purpose of the Ashwell receptor has remained elusive. We have identified endogenous ligands of the Ashwell receptor as glycoproteins and regulatory components in blood coagulation and thrombosis that include von Willebrand factor (vWF) and platelets. The Ashwell receptor normally modulates vWF homeostasis and is responsible for thrombocytopenia during systemic Streptococcus pneumoniae infection by eliminating platelets desialylated by the bacterium's neuraminidase. Hemostatic adaptation by the Ashwell receptor moderates the onset and severity of disseminated intravascular coagulation during sepsis and improves the probability of host survival.	[Grewal, Prabhjit K.; Marth, Jamey D.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Grewal, Prabhjit K.; Marth, Jamey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Uchiyama, Satoshi; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ditto, David; Varki, Nissi; Le, Dzung T.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jmarth@ucsd.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL-57345, P01 HL057345-110006, P01 HL057345-109004, P01 HL057345, P01 HL057345-100001] Funding Source: Medline; NIAID NIH HHS [AI-051796] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2003, Wkly Epidemiol Rec, V78, P97; Ashwell G, 1978, Methods Enzymol, V50, P287; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; BRAITERMAN LT, 1989, J BIOL CHEM, V264, P1682; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Bryant AE, 2003, CLIN MICROBIOL REV, V16, P451, DOI 10.1128/CMR.16.3.451-462.2003; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; DRICKAMER K, 1984, J BIOL CHEM, V259, P770; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Franchini M, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-4; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HONG WJ, 1988, HEPATOLOGY, V8, P553, DOI 10.1002/hep.1840080320; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Mandic R, 2002, THROMB RES, V106, P137, DOI 10.1016/S0049-3848(02)00087-7; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Nakamura M, 1998, J HEPATOL, V28, P991, DOI 10.1016/S0168-8278(98)80348-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PAIETTA E, 1992, J BIOL CHEM, V267, P11078; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2004, J BIOL CHEM, V279, P40954, DOI 10.1074/jbc.M406647200; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rice KG, 2003, METHOD ENZYMOL, V363, P90; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Ruiz NI, 1996, GLYCOBIOLOGY, V6, P551, DOI 10.1093/glycob/6.5.551; Rumjantseva V, 2006, BLOOD, V108, p438A, DOI 10.1182/blood.V108.11.1523.1523; Saxena A, 2002, J BIOL CHEM, V277, P35297, DOI 10.1074/jbc.M205653200; Shakhnovich EA, 2002, INFECT IMMUN, V70, P7161, DOI 10.1128/IAI.70.12.7161-7164.2002; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Soukharev S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e21; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; STRATTON JR, 1989, J NUCL MED, V30, P629; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; TAKEZAWA R, 1993, BIOCHIM BIOPHYS ACTA, V1172, P220, DOI 10.1016/0167-4781(93)90300-3; Tong HH, 2002, ACTA OTO-LARYNGOL, V122, P413, DOI 10.1080/00016480260000111; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; VANDENHA.CJ, 1970, J BIOL CHEM, V245, P4397; Wahrenbrock MG, 2006, CANCER RES, V66, P2433, DOI 10.1158/0008-5472.CAN-05-3851; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; Winter AJ, 1997, INFECT IMMUN, V65, P4411, DOI 10.1128/IAI.65.11.4411-4418.1997; ZALIK SE, 1991, ANAT EMBRYOL, V183, P521	52	261	272	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2008	14	6					648	655		10.1038/nm1760	http://dx.doi.org/10.1038/nm1760			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18488037	Green Accepted			2022-12-25	WOS:000256468700031
J	Behmoaras, J; Bhangal, G; Smith, J; McDonald, K; Mutch, B; Lai, PC; Domin, J; Game, L; Salama, A; Foxwell, BM; Pusey, CD; Cook, HT; Aitman, TJ				Behmoaras, Jacques; Bhangal, Gurjeet; Smith, Jennifer; McDonald, Kylie; Mutch, Brenda; Lai, Ping Chin; Domin, Jan; Game, Laurence; Salama, Alan; Foxwell, Brian M.; Pusey, Charles D.; Cook, H. Terence; Aitman, Timothy J.			Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility	NATURE GENETICS			English	Article							ANTI-GBM GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; AP-1 ACTIVATION; PATHOGENIC ROLE; RENAL INJURY; EXPRESSION; CELLS	Crescentic glomerulonephritis is an important cause of human kidney failure for which the underlying molecular basis is largely unknown. In previous studies, we mapped several susceptibility loci, Crgn1-Crgn7, for crescentic glomerulonephritis in the Wistar Kyoto ( WKY) rat(1). Here we show by combined congenic, linkage and microarray studies that the activator protein-1 ( AP-1) transcription factor JunD is a major determinant of macrophage activity and is associated with glomerulonephritis susceptibility. Introgression of Crgn2 from the nonsusceptible Lewis strain onto the WKY background leads to significant reductions in crescent formation, macrophage infiltration, Fc receptor-mediated macrophage activation and cytokine production. Haplotype analysis restricted the Crgn2 linkage interval to a 430-kb interval containing Jund, which is markedly overexpressed in WKY macrophages and glomeruli. Jund knockdown in rat and human primary macrophages led to significantly reduced macrophage activity and cytokine secretion, indicating conservation of JunD function in macrophage activation in rats and humans and suggesting in vivo inhibition of Jund as a possible new therapeutic strategy for diseases characterized by inflammation and macrophage activation.	[Behmoaras, Jacques; McDonald, Kylie; Aitman, Timothy J.] MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; [Mutch, Brenda; Foxwell, Brian M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England; [Lai, Ping Chin] Chang Gung Univ, Sch Med, Dept Nephrol, Chang Gung Mem Hosp,Kidney Inst, Taipei, Taiwan; [Game, Laurence] Univ London Imperial Coll Sci Technol & Med, Microarray Ctr, Ctr Clin Sci, London W12 0NN, England; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Histopathol, London W12 0NN, England; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Mol Genet & Rheumatol, London W12 0NN, England	Imperial College London; University of Oxford; Chang Gung Memorial Hospital; Chang Gung University; Imperial College London; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), MRC, Ctr Clin Sci, Physiol Genom & Med Grp, Du Cane Rd, London W12 0NN, England.	t.aitman@imperial.ac.uk		Aitman, Timothy/0000-0002-7875-4502	MRC [G0500936, G0400116, MC_U120061454] Funding Source: UKRI; Medical Research Council [G0500936, G0400116, MC_U120061454] Funding Source: Medline; Wellcome Trust [081462] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Andersson A, 2004, J LEUKOCYTE BIOL, V76, P1118, DOI 10.1189/jlb.0704385; BHAN AK, 1978, J EXP MED, V148, P246, DOI 10.1084/jem.148.1.246; CATTELL V, 1994, KIDNEY INT, V45, P945, DOI 10.1038/ki.1994.128; Cook HT, 1999, KIDNEY INT, V55, P1319, DOI 10.1046/j.1523-1755.1999.00354.x; COOK HT, 1989, AM J PATHOL, V134, P431; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Flanc RS, 2007, KIDNEY INT, V72, P698, DOI 10.1038/sj.ki.5002404; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Ikezumi Y, 2004, J AM SOC NEPHROL, V15, P1775, DOI 10.1097/01.ASN.0000131272.06958.DE; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Kluth DC, 2007, KIDNEY INT, V72, P234, DOI 10.1038/sj.ki.5002332; Lai PC, 2001, J AM SOC NEPHROL, V12, P2310, DOI 10.1681/ASN.V12112310; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Sakurai H, 1998, BIOCHEM MOL BIOL INT, V45, P831; Sakurai H, 1997, BBA-MOL BASIS DIS, V1362, P252, DOI 10.1016/S0925-4439(97)00068-9; Smith J, 2007, J AM SOC NEPHROL, V18, P1816, DOI 10.1681/ASN.2006070733; Tam FWK, 1999, NEPHROL DIAL TRANSPL, V14, P1658, DOI 10.1093/ndt/14.7.1658; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567	25	68	70	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					553	559		10.1038/ng.137	http://dx.doi.org/10.1038/ng.137			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443593	Green Published, Green Accepted			2022-12-25	WOS:000255366700021
J	Tatham, MH; Geoffroy, MC; Shen, L; Plechanovova, A; Hattersley, N; Jaffray, EG; Palvimo, JJ; Hay, RT				Tatham, Michael H.; Geoffroy, Marie-Claude; Shen, Linnan; Plechanovova, Anna; Hattersley, Neil; Jaffray, Ellis G.; Palvimo, Jorma J.; Hay, Ronald T.			RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation	NATURE CELL BIOLOGY			English	Article							NUCLEAR-BODIES; SNURF RNF4; PROTEIN; IDENTIFICATION; APOPTOSIS; TRIOXIDE; COREGULATOR; MOTIF	In acute promyelocytic leukaemia (APL), the promyelocytic leukaemia (PML) protein is fused to the retinoic acid receptor a (RAR). This disease can be treated effectively with arsenic, which induces PML modification by small ubiquitin-like modifiers ( SUMO) and proteasomal degradation. Here we demonstrate that the RING-domain-containing ubiquitin E3 ligase, RNF4 ( also known as SNURF), targets poly-SUMO-modified proteins for degradation mediated by ubiquitin. RNF4 depletion or proteasome inhibition led to accumulation of mixed, polyubiquitinated, poly-SUMO chains. PML protein accumulated in RNF4-depleted cells and was ubiquitinated by RNF4 in a SUMO-dependent fashion in vitro. In the absence of RNF4, arsenic failed to induce degradation of PML and SUMO-modified PML accumulated in the nucleus. These results demonstrate that poly-SUMO chains can act as discrete signals from mono-SUMOylation, in this case targeting a poly-SUMOylated substrate for ubiquitin-mediated proteolysis.	[Tatham, Michael H.; Geoffroy, Marie-Claude; Shen, Linnan; Plechanovova, Anna; Hattersley, Neil; Jaffray, Ellis G.; Hay, Ronald T.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Palvimo, Jorma J.] Univ Kuopio, Dept Med Biochem, FI-70211 Kuopio, Finland	University of Dundee; University of Eastern Finland	Hay, RT (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	r.t.hay@dundee.ac.uk	Tatham, Michael H/E-9622-2010; Hay, Ronald T/F-9338-2011; Hay, Ronald/S-3233-2019	Tatham, Michael H/0000-0001-6986-1691; Hay, Ronald T/0000-0001-7113-9024; Hay, Ronald/0000-0001-7113-9024; Geoffroy, Marie-Claude/0000-0001-8298-467X; Palvimo, Jorma/0000-0003-2373-0578	Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen GQ, 1996, BLOOD, V88, P1052; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Duprez E, 1999, J CELL SCI, V112, P381; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Muller S, 1998, BLOOD, V92, P4308, DOI 10.1182/blood.V92.11.4308.423k36_4308_4316; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	29	628	648	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					538	546		10.1038/ncb1716	http://dx.doi.org/10.1038/ncb1716			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18408734	Green Submitted			2022-12-25	WOS:000255502400010
J	Graham, DSC; Graham, RR; Manku, H; Wong, AK; Whittaker, JC; Gaffney, PM; Moser, KL; Rioux, JD; Altshuler, D; Behrens, TW; Vyse, TJ				Graham, Deborah S. Cunninghame; Graham, Robert R.; Manku, Harinder; Wong, Andrew K.; Whittaker, John C.; Gaffney, Patrick M.; Moser, Kathy L.; Rioux, John D.; Altshuler, David; Behrens, Timothy W.; Vyse, Timothy J.			Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus	NATURE GENETICS			English	Article							OX40 LIGAND; T-CELLS; LINKAGE DISEQUILIBRIUM; OX-40 LIGAND; HAPLOTYPE; EXPRESSION; IDENTIFICATION; ASSOCIATION; GENOME; FAMILY	Systemic lupus erythematosus (SLE) is a multisystem complex autoimmune disease of uncertain etiology (OMIM 152700). Over recent years a genetic component to SLE susceptibility has been established(1 - 3). Recent successes with association studies in SLE have identified genes including IRF5 (refs. 4,5) and FCGR3B(6). Two tumor necrosis factor (TNF) superfamily members located within intervals showing genetic linkage with SLE are TNFSF4 (also known as OX40L; 1q25), which is expressed on activated antigen-presenting cells (APCs)(7,8) and vascular endothelial cells(9), and also its unique receptor, TNFRSF4 ( also known as OX40; 1p36), which is primarily expressed on activated CD4(+) T cells(10). TNFSF4 produces a potent co-stimulatory signal for activated CD4(+) T cells after engagement of TNFRSF4 (ref. 11). Using both a family-based and a case-control study design, we show that the upstream region of TNFSF4 contains a single risk haplotype for SLE, which is correlated with increased expression of both cell-surface TNFSF4 and the TNFSF4 transcript. We hypothesize that increased expression of TNFSF4 predisposes to SLE either by quantitatively augmenting T cell - APC interaction or by influencing the functional consequences of T cell activation via TNFRSF4.	[Graham, Deborah S. Cunninghame; Manku, Harinder; Wong, Andrew K.; Vyse, Timothy J.] Hammersmith Hosp, Imperial Coll Fac Med, Sect Mol Genet & Rheumatol, London W12 0NN, England; [Graham, Robert R.; Altshuler, David] MIT, Cambridge, MA 02142 USA; [Graham, Robert R.; Altshuler, David] Broad Inst Harvard, Programme Med & Populat Genet, Cambridge, MA 02142 USA; [Whittaker, John C.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Gaffney, Patrick M.; Behrens, Timothy W.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Moser, Kathy L.] Genentech Inc, San Francisco, CA 94080 USA	Imperial College London; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding; Genentech	Vyse, TJ (corresponding author), Hammersmith Hosp, Imperial Coll Fac Med, Sect Mol Genet & Rheumatol, Du Cane Rd, London W12 0NN, England.	t.vyse@imperial.ac.uk	Whittaker, John C/B-8609-2012; Rioux, John D/A-9599-2015; Altshuler, David M/A-4476-2009; Wong, Andrew/M-8899-2016; Wong, Andrew/AAE-6995-2019	Whittaker, John C/0000-0002-3529-2379; Rioux, John D/0000-0001-7560-8326; Altshuler, David M/0000-0002-7250-4107; Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Gaffney, Patrick/0000-0002-1580-869X	NCRR NIH HHS [U54 RR020278-01, U54 RR020278] Funding Source: Medline; NIAID NIH HHS [P01 AI065687, AI067152, AI065687, U19 AI067152] Funding Source: Medline; NIDDK NIH HHS [R01 DK064869, DK064869, U01 DK062432, DK062432] Funding Source: Medline; Wellcome Trust [051276, 068545/Z/02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Graham DSC, 2006, HUM MOL GENET, V15, P3195, DOI 10.1093/hmg/ddl395; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gramaglia I, 1998, J IMMUNOL, V161, P6510; HILL WG, 1994, AM J HUM GENET, V54, P705; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATZA U, 1994, EUR J IMMUNOL, V24, P677, DOI 10.1002/eji.1830240329; LEWONTIN RC, 1964, GENETICS, V49, P49; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storm Niels, 2003, Methods Mol Biol, V212, P241; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524	28	164	173	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					83	89		10.1038/ng.2007.47	http://dx.doi.org/10.1038/ng.2007.47			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059267	Green Accepted			2022-12-25	WOS:000252118600022
J	Qian, XM; Peng, XH; Ansari, DO; Yin-Goen, Q; Chen, GZ; Shin, DM; Yang, L; Young, AN; Wang, MD; Nie, SM				Qian, Ximei; Peng, Xiang-Hong; Ansari, Dominic O.; Yin-Goen, Qiqin; Chen, Georgia Z.; Shin, Dong M.; Yang, Lily; Young, Andrew N.; Wang, May D.; Nie, Shuming			In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags	NATURE BIOTECHNOLOGY			English	Article							SEMICONDUCTOR QUANTUM DOTS; GOLD NANOPARTICLES; COLLOIDAL GOLD; CANCER-THERAPY; DRUG-DELIVERY; LUNG-CANCER; SCATTERING; MOLECULES; NANOTECHNOLOGY; NANOCRYSTALS	We describe biocompatible and nontoxic nanoparticles for in vivo tumor targeting and detection based on pegylated gold nanoparticles and surface-enhanced Raman scattering (SERS). Colloidal gold has been safely used to treat rheumatoid arthritis for 50 years, and has recently been found to amplify the efficiency of Raman scattering by 14-15 orders of magnitude. Here we show that large optical enhancements can be achieved under in vivo conditions for tumor detection in live animals. An important finding is that small-molecule Raman reporters such as organic dyes were not displaced but were stabilized by thiolmodified polyethylene glycols. These pegylated SERS nanoparticles were considerably brighter than semiconductor quantum dots with light emission in the near-infrared window. When conjugated to tumor-targeting ligands such as single-chain variable fragment (ScFv) antibodies, the conjugated nanoparticles were able to target tumor biomarkers such as epidermal growth factor receptors on human cancer cells and in xenograft tumor models.	[Qian, Ximei; Ansari, Dominic O.; Nie, Shuming] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Ansari, Dominic O.; Nie, Shuming] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Qian, Ximei; Ansari, Dominic O.; Nie, Shuming] Georgia Inst Technol, Atlanta, GA 30322 USA; [Peng, Xiang-Hong; Chen, Georgia Z.; Shin, Dong M.; Yang, Lily] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Yin-Goen, Qiqin; Young, Andrew N.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Yang, Lily] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Wang, May D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Wang, May D.] Georgia Inst Technol, Dept Elect & Comp Engn, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Nie, SM (corresponding author), Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA.	snie@emory.edu	Ray, Dana M/C-3470-2013; Wang, May Dongmei/AAF-2065-2021; Nie, Shuming/E-4843-2011; Shin, Dong Moon/G-9649-2013	Wang, May Dongmei/0000-0003-3961-3608; Shin, Dong Moon/0000-0002-8245-4174	NATIONAL CANCER INSTITUTE [P50CA128613, R01CA108468, U54CA119338] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA108468, U54 CA119338, U54CA119338, P50CA128613] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Couvreur P, 2006, PHARM RES-DORDR, V23, P1417, DOI 10.1007/s11095-006-0284-8; Doering WE, 2003, ANAL CHEM, V75, P6171, DOI 10.1021/ac034672u; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; James WD, 2007, J RADIOANAL NUCL CH, V271, P455, DOI 10.1007/s10967-007-0230-1; JIANG JD, 1986, PHYS REV LETT, V57, P1793, DOI 10.1103/PhysRevLett.57.1793; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Krug JT, 1999, J AM CHEM SOC, V121, P9208, DOI 10.1021/ja992058n; Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mahmood U, 2003, MOL CANCER THER, V2, P489; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McCarthy JR, 2007, NANOMEDICINE-UK, V2, P153, DOI 10.2217/17435889.2.2.153; Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486; Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123; Michaels AM, 1999, J AM CHEM SOC, V121, P9932, DOI 10.1021/ja992128q; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Moore BD, 2004, NAT BIOTECHNOL, V22, P1133, DOI 10.1038/nbt1003; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Paciotti GF, 2006, DRUG DEVELOP RES, V67, P47, DOI 10.1002/ddr.20066; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Reuter CWM, 2007, BRIT J CANCER, V96, P408, DOI 10.1038/sj.bjc.6603566; Rhyner MN, 2006, NANOMEDICINE-UK, V1, P209, DOI 10.2217/17435889.1.2.209; ROOT SW, 1954, CANCER, V7, P856, DOI 10.1002/1097-0142(195409)7:5<856::AID-CNCR2820070506>3.0.CO;2-A; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Tian JH, 2006, J AM CHEM SOC, V128, P14748, DOI 10.1021/ja0648615; Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; WOODLE MC, 2005, NANO TODAY, P34; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Wuelfing WP, 1998, J AM CHEM SOC, V120, P12696, DOI 10.1021/ja983183m; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	57	1924	1991	37	1791	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					83	90		10.1038/nbt1377	http://dx.doi.org/10.1038/nbt1377			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18157119				2022-12-25	WOS:000252222500027
J	Richter, CD; Nietlispach, D; Broadhurst, RW; Weissman, KJ				Richter, Carsten D.; Nietlispach, Daniel; Broadhurst, R. William; Weissman, Kira J.			Multienzyme docking in hybrid megasynthetases	NATURE CHEMICAL BIOLOGY			English	Article							MODULAR POLYKETIDE SYNTHASES; NONRIBOSOMAL PEPTIDE ANTIBIOTICS; PROTEIN-PROTEIN INTERACTIONS; BIOSYNTHETIC GENE-CLUSTER; NMR-SPECTROSCOPY; COMBINATORIAL BIOSYNTHESIS; MEDIATING DOMAINS; COMMUNICATION; MODEL; INTERFACES	Hybrid multienzyme systems composed of polyketide synthase (PKS) and nonribosomal polypeptide synthetase (NRPS) modules direct the biosynthesis of clinically valuable natural products in bacteria. The fidelity of this process depends on specific recognition between successive polypeptides in each assembly line-interactions that are mediated by terminal 'docking domains'. We have identified a new family of N-terminal docking domains, exemplified by TubCdd from the tubulysin system of Angiococcus disciformis An d48. TubCdd is homodimeric, which suggests that NRPS subunits in mixed systems self-associate to interact with partner PKS homodimers. The NMR structure of TubCdd reveals a new fold featuring an exposed P-hairpin that serves as the binding site for the C-terminal docking domain of the partner polypeptide. The pattern of charged residues on the contact surface of the p-hairpin is a key determinant of the interaction and seems to constitute a 'docking code' that can be used to alter binding affinity.	[Richter, Carsten D.; Nietlispach, Daniel; Broadhurst, R. William; Weissman, Kira J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Richter, CD (corresponding author), Bohmann & Loosen, Anwaltssozieetat Nymphenburger Str 1, D-80335 Munich, Germany.	c.d.richter.03@cantab.net; r.w.broadhurst@bioc.cam.ac.uk; k.weissman@mx.uni-saarland.de	Broadhurst, Bill William/J-6710-2017	Broadhurst, Bill William/0000-0002-0264-4593; Nietlispach, Daniel/0000-0003-4364-9291	Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		APARICIO JF, 1994, J BIOL CHEM, V269, P8524; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donadio S, 2003, COMB CHEM HIGH T SCR, V6, P489; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Feng ZY, 2005, BIOSCI BIOTECH BIOCH, V69, P1372, DOI 10.1271/bbb.69.1372; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Gaitatzis N, 2002, J BIOL CHEM, V277, P13082, DOI 10.1074/jbc.M111738200; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hahn M, 2006, P NATL ACAD SCI USA, V103, P275, DOI 10.1073/pnas.0508409103; Hillson NJ, 2003, BIOCHEMISTRY-US, V42, P766, DOI 10.1021/bi026903h; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu F, 2004, CHEM BIOL, V11, P1533, DOI 10.1016/j.chembiol.2004.08.017; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Muller R, 2004, CHEM BIOL, V11, P4, DOI 10.1016/S1074-5521(04)00006-7; O'Connor SE, 2003, ANGEW CHEM INT EDIT, V42, P3917, DOI 10.1002/anie.200352077; Sandmann A, 2004, CHEM BIOL, V11, P1071, DOI 10.1016/j.chembiol.2004.05.014; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Sieber SA, 2002, CHEM BIOL, V9, P997, DOI 10.1016/S1074-5521(02)00214-4; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weinig S, 2003, CHEM BIOL, V10, P939, DOI 10.1016/j.chembiol.2003.09.012; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wu N, 2002, BIOCHEMISTRY-US, V41, P5056, DOI 10.1021/bi012086u; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	47	58	58	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					75	81		10.1038/nchembio.2007.61	http://dx.doi.org/10.1038/nchembio.2007.61			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18066054				2022-12-25	WOS:000251990000016
J	Muse, GW; Gilchrist, DA; Nechaev, S; Shah, R; Parker, JS; Grissom, SF; Zeitlinger, J; Adelman, K				Muse, Ginger W.; Gilchrist, Daniel A.; Nechaev, Sergei; Shah, Ruchir; Parker, Joel S.; Grissom, Sherry F.; Zeitlinger, Julia; Adelman, Karen			RNA polymerase is poised for activation across the genome	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; IN-VIVO; DROSOPHILA-MELANOGASTER; HSP70 GENE; HEAT-SHOCK; PROMOTER; COMPLEX; CELLS; NELF; INITIATION	Regulation of gene expression is integral to the development and survival of all organisms. Transcription begins with the assembly of a pre-initiation complex at the gene promoter(1), followed by initiation of RNA synthesis and the transition to productive elongation(2-4). In many cases, recruitment of RNA polymerase II ( Pol II) to a promoter is necessary and sufficient for activation of genes. However, there are a few notable exceptions to this paradigm, including heat shock genes and several proto-oncogenes, whose expression is attenuated by regulated stalling of polymerase elongation within the promoter-proximal region(5-13). To determine the importance of polymerase stalling for transcription regulation, we carried out a genome-wide search for Drosophila melanogaster genes with Pol II stalled within the promoter-proximal region. Our data show that stalling is widespread, occurring at hundreds of genes that respond to stimuli and developmental signals. This finding indicates a role for regulation of polymerase elongation in the transcriptional responses to dynamic environmental and developmental cues.	Natl Inst Hlth, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; Constella Grp, Durham, NC 27713 USA; Natl Inst Hlth, Natl Inst Environm Hlth Sci, Microarray Grp, Res Triangle Pk, NC 27709 USA; Express Anal, Durham, NC 27713 USA; Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT); Whitehead Institute; Stowers Institute for Medical Research	Adelman, K (corresponding author), Natl Inst Hlth, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Parker, Joel/AAG-1108-2019; Nechaev, Sergei/AAQ-3450-2021	Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES101987-02] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Luse DS, 1998, COLD SPRING HARB SYM, V63, P289, DOI 10.1101/sqb.1998.63.289; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Raschke EE, 1999, J IMMUNOL, V163, P4375; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002	30	559	569	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1507	1511		10.1038/ng.2007.21	http://dx.doi.org/10.1038/ng.2007.21			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994021	Green Accepted, Green Submitted			2022-12-25	WOS:000251267400020
J	Rawson, PM; Molette, C; Videtta, M; Altieri, L; Franceschini, D; Donato, T; Finocchi, L; Propato, A; Paroli, M; Meloni, F; Mastroianni, CM; d'Ettorre, G; Sidney, J; Sette, A; Barnaba, V				Rawson, Pisana Moroni; Molette, Caroline; Videtta, Melissa; Altieri, Laura; Franceschini, Debora; Donato, Tiziana; Finocchi, Luigi; Propato, Antonella; Paroli, Marino; Meloni, Francesca; Mastroianni, Claudio M.; d'Ettorre, Gabriella; Sidney, John; Sette, Alessandro; Barnaba, Vincenzo			Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection	NATURE MEDICINE			English	Article							HEAT-SHOCK PROTEINS; CD8(+) T-CELLS; DENDRITIC CELLS; IMMUNE ACTIVATION; IN-VIVO; B-CELLS; LYMPHOCYTES; DEATH; IDENTIFICATION; MOLECULES	We found that the proteome of apoptotic T cells includes prominent fragments of cellular proteins generated by caspases and that a high proportion of distinct T cell epitopes in these fragments is recognized by CD8(+) T cells during HIV infection. The frequencies of effector CD8(+) T cells that are specific for apoptosis-dependent epitopes correlate with the frequency of circulating apoptotic CD4(+) T cells in HIV-1-infected individuals. We propose that these self-reactive effector CD8(+) T cells may contribute to the systemic immune activation during chronic HIV infection. The caspase-dependent cleavage of proteins associated with apoptotic cells has a key role in the induction of self-reactive CD8(+) T cell responses, as the caspase-cleaved fragments are efficiently targeted to the processing machinery and are cross-presented by dendritic cells. These findings demonstrate a previously undescribed role for caspases in immunopathology.	Univ Roma La Sapienza, Fdn Andrea Cesalpino, Dipartimento Med Interna, I-00161 Rome, Italy; Univ Roma La Sapienza, Dipartimento Malattie Infett & Trop, I-00161 Rome, Italy; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Univ Roma La Sapienza, Ist Pasteur Cenci Bolognetti, I-00161 Rome, Italy	Sapienza University Rome; Sapienza University Rome; La Jolla Institute for Immunology; Fondazione Cenci Bolognetti; Sapienza University Rome	Barnaba, V (corresponding author), Univ Roma La Sapienza, Fdn Andrea Cesalpino, Dipartimento Med Interna, Piazzale Aldo Moro 5, I-00161 Rome, Italy.	vincenzo.barnaba@uniroma1.it	Barnaba, Vincenzo/AAB-1945-2019; Sette, Alessandro/AFO-8916-2022; d'Ettorre, Gabriella/K-4511-2016; MASTROIANNI, Claudio Maria/O-9741-2019	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; d'Ettorre, Gabriella/0000-0002-3571-5677; PAROLI, Marino/0000-0001-7919-9128				Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Adrain C, 2004, J BIOL CHEM, V279, P36923, DOI 10.1074/jbc.M402638200; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chernysheva AD, 2002, J IMMUNOL, V169, P1241, DOI 10.4049/jimmunol.169.3.1241; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Francavilla V, 2004, EUR J IMMUNOL, V34, P427, DOI 10.1002/eji.200324539; Graham KL, 2005, CURR OPIN RHEUMATOL, V17, P513, DOI 10.1097/01.bor.0000171215.87993.6b; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Propato A, 2001, NAT MED, V7, P807, DOI 10.1038/89930; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scognamiglio P, 1999, J IMMUNOL, V162, P6681; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Silvestri G, 2003, J CLIN INVEST, V112, P821, DOI 10.1172/JCI200319799; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Summers Donald F., 1996, P699, DOI 10.1007/978-1-60327-259-9_121; Thiede B, 2004, MASS SPECTROM REV, V23, P333, DOI 10.1002/mas.10079; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	49	66	71	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1431	1439		10.1038/nm1679	http://dx.doi.org/10.1038/nm1679			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18026114				2022-12-25	WOS:000251445400017
J	Lee, HJ; Pyo, JO; Oh, Y; Kim, HJ; Hong, SH; Jeon, YJ; Kim, H; Cho, DH; Woo, HN; Song, S; Nam, JH; Kim, HJ; Kim, KS; Jung, YK				Lee, Ho-June; Pyo, Jong-Ok; Oh, Yumin; Kim, Hyo-Jin; Hong, Se-Hoon; Jeon, Young-Jun; Kim, Hyunjoo; Cho, Dong-Hyung; Woo, Ha-Na; Song, Sungmin; Nam, Jung-Hyun; Kim, Hyo Joon; Kim, Key-Sun; Jung, Yong-Keun			AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10	NATURE CELL BIOLOGY			English	Article							FAS-ASSOCIATED PROTEIN; DEATH DOMAIN; ADENYLATE KINASE; MEDIATED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; PHOSPHORYLATION; FADD/MORT1; RECEPTOR; PERMEABILIZATION	Mitochondrial proteins function as essential regulators in apoptosis. Here, we show that mitochondrial adenylate kinase 2 ( AK2) mediates mitochondrial apoptosis through the formation of an AK2-FADD-caspase-10 (AFAC10) complex. Downregulation of AK2 attenuates etoposide- or staurosporine-induced apoptosis in human cells, but not that induced by tumour-necrosis-factor-related apoptosis-inducing ligand ( TRAIL) or Fas ligand ( FasL). During intrinsic apoptosis, AK2 translocates to the cytoplasm, whereas this event is diminished in Apaf-1 knockdown cells and prevented by Bcl-2 or Bcl-X-L. Addition of purified AK2 protein to cell extracts first induces activation of caspase-10 via FADD and subsequently caspase-3 activation, but does not affect caspase-8. AFAC10 complexes are detected in cells undergoing intrinsic cell death and AK2 promotes the association of caspase-10 with FADD. In contrast, AFAC10 complexes are not detected in several etoposide-resistant human tumour cell lines. Taken together, these results suggest that, acting in concert with FADD and caspase-10, AK2 mediates a novel intrinsic apoptotic pathway that may be involved in tumorigenesis.	Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Seoul Natl Univ, Sch Biol Sci, BioMax Inst, Seoul 151742, South Korea; Hanyang Univ, Div Mol & Life Sci, Ansan 426791, Gyeonggi, South Korea; Korea Adv Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Hanyang University; Korea Advanced Institute of Science & Technology (KAIST)	Jung, YK (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, 261 Cheomdan Gwagiro, Kwangju 500712, South Korea.	ykjung@snu.ac.kr	Lee, Ho-June/D-8855-2014; Oh, Yumin/AAU-1302-2021; OH, YUMIN/M-6312-2017	Lee, Ho-June/0000-0002-7019-2533; Oh, Yumin/0000-0003-1456-4045; OH, YUMIN/0000-0003-1456-4045; Woo, Ha-Na/0000-0002-6771-8151; Jeon, Young-Jun/0000-0002-5998-9605; Jung, Yong-Keun/0000-0002-9686-3120				Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Bang S, 2000, J BIOL CHEM, V275, P36217, DOI 10.1074/jbc.M006620200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; KIM HJ, 1990, BIOCHEMISTRY-US, V29, P1107, DOI 10.1021/bi00457a002; Kim PKM, 2002, J BIOL CHEM, V277, P38855, DOI 10.1074/jbc.M203484200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Schlauderer GJ, 1996, PROTEIN SCI, V5, P434; Shimada K, 2002, JPN J CANCER RES, V93, P1164, DOI 10.1111/j.1349-7006.2002.tb01219.x; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	31	63	69	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1303	U176		10.1038/ncb1650	http://dx.doi.org/10.1038/ncb1650			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952061				2022-12-25	WOS:000250659600016
J	Benzinou, M; Creemers, JWM; Choquet, H; Lobbens, S; Dina, C; Durand, E; Guerardel, A; Boutin, P; Jouret, B; Heude, B; Balkau, B; Tichet, J; Marre, M; Potoczna, N; Horber, F; Le Stunff, C; Czernichow, S; Sandbaek, A; Lauritzen, T; Borch-Johnsen, K; Andersen, G; Kiess, W; Korner, A; Kovacs, P; Jacobson, P; Carlsson, LMS; Walley, AJ; Jorgensen, T; Hansen, T; Pedersen, O; Meyre, D; Froguel, P				Benzinou, Michael; Creemers, John W. M.; Choquet, Helene; Lobbens, Stephane; Dina, Christian; Durand, Emmanuelle; Guerardel, Audrey; Boutin, Philippe; Jouret, Beatrice; Heude, Barbara; Balkau, Beverley; Tichet, Jean; Marre, Michel; Potoczna, Natascha; Horber, Fritz; Le Stunff, Catherine; Czernichow, Sebastien; Sandbaek, Annelli; Lauritzen, Torsten; Borch-Johnsen, Knut; Andersen, Gitte; Kiess, Wieland; Koerner, Antje; Kovacs, Peter; Jacobson, Peter; Carlsson, Lena M. S.; Walley, Andrew J.; Jorgensen, Torben; Hansen, Torben; Pedersen, Oluf; Meyre, David; Froguel, Philippe			Common nonsynonymous variants in PCSK1 confer risk of obesity	NATURE GENETICS			English	Article							GENOME-WIDE SCAN; SUSCEPTIBILITY LOCUS; HYPERPHAGIA; CAUCASIANS	Mutations in PCSK1 cause monogenic obesity. To assess the contribution of PCSK1 to polygenic obesity risk, we genotyped tag SNPs in a total of 13,659 individuals of European ancestry from eight independent case-control or family-based cohorts. The nonsynonymous variants rs6232, encoding N221D, and rs6234-rs6235, encoding the Q665E-S690T pair, were consistently associated with obesity in adults and children (P = 7.27 x 10(-8) and P = 2.31 x 10(-12), respectively). Functional analysis showed a significant impairment of the N221D-mutant PC1/3 protein catalytic activity.	[Benzinou, Michael; Walley, Andrew J.; Froguel, Philippe] Hammersmith Hosp, Imperial Coll London, London W12 0NN, England; [Benzinou, Michael; Choquet, Helene; Lobbens, Stephane; Dina, Christian; Durand, Emmanuelle; Guerardel, Audrey; Boutin, Philippe; Meyre, David; Froguel, Philippe] CNRS 8090, Inst Biol, Inst Pasteur, F-59000 Lille, France; [Creemers, John W. M.] Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Jouret, Beatrice] Childrens Hosp, INSERM, U563, Inst Nacl Sante & Rech Med, F-31000 Toulouse, France; [Heude, Barbara; Balkau, Beverley] INSERM, U780, IFR69, Villejuif, France; Univ Paris Sud, Fac Med, F-94270 Le Kremlin Bicetre, France; [Tichet, Jean; Potoczna, Natascha] Reg Inst Hlth, F-37000 Tours, France; [Marre, Michel] INSERM, U695, F-75018 Paris, France; Univ Paris 07, F-75018 Paris, France; [Marre, Michel] Hop Bichat Claude Bernard, Dept Endocrinol Diabetol & Nutr, F-75870 Paris, France; [Horber, Fritz] Klin Lindberg, CH-8400 Winterthur, Switzerland; [Le Stunff, Catherine] Univ Paris 05, Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75014 Paris, France; Univ Paris 05, Hop St Vincent de Paul, INSERM, U561, F-75014 Paris, France; [Czernichow, Sebastien] Univ Paris 13, INSERM, U557, Inst Sci Rech Agronom INRA,U1125,CNAM EA3200, F-93017 Bobigny, France; Hop Avicenne, AP HP, F-93017 Bobigny, France; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Borch-Johnsen, Knut; Andersen, Gitte; Jorgensen, Torben; Hansen, Torben] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Dept Internal Med 3, D-04109 Leipzig, Germany; [Jacobson, Peter; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, SE-431 Gothenburg, Sweden; [Hansen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Aarhus University; Steno Diabetes Center; Aarhus University; Leipzig University; Leipzig University; University of Gothenburg; University of Copenhagen	Froguel, P (corresponding author), Hammersmith Hosp, Imperial Coll London, London W12 0NN, England.	p.froguel@imperial.ac.uk	Dina, Christian R/D-3535-2015; Pedersen, Oluf/Z-1731-2019; Carlsson, Lena/F-7570-2018; FROGUEL, Philippe/O-6799-2017; Jouret, Béatrice/AAC-8146-2019; Körner, Antje/B-3988-2015; Heude, Barbara/G-3095-2016; Walley, Andrew J/D-2573-2009; horber, Fritz/AAL-5419-2020; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/AAG-8015-2020; Heude, Barbara/GLU-9626-2022; LE STUNFF, CATHERINE/Y-3270-2018; Meyre, David/D-7315-2011	Dina, Christian R/0000-0002-7722-7348; Pedersen, Oluf/0000-0002-3321-3972; Carlsson, Lena/0000-0003-4145-6242; FROGUEL, Philippe/0000-0003-2972-0784; Körner, Antje/0000-0001-6001-0356; Heude, Barbara/0000-0002-1565-1629; Walley, Andrew J/0000-0001-7707-7549; Heude, Barbara/0000-0002-1565-1629; LE STUNFF, CATHERINE/0000-0001-8419-0451; Meyre, David/0000-0003-4850-7444; Jacobson, Peter/0000-0002-1769-1827; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Kovacs, Peter/0000-0002-0290-5423; Choquet, Helene/0000-0001-9839-8667; Marre, Michel/0000-0002-3071-1837	Medical Research Council [G0600331] Funding Source: Medline; MRC [G0600331] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; Chagnon YC, 2001, J APPL PHYSIOL, V90, P1777, DOI 10.1152/jappl.2001.90.5.1777; Chen G, 2005, INT J OBESITY, V29, P255, DOI 10.1038/sj.ijo.0802873; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	10	216	225	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					943	945		10.1038/ng.177	http://dx.doi.org/10.1038/ng.177			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604207				2022-12-25	WOS:000258026900007
J	Kolev, V; Mandinova, A; Guinea-Viniegra, J; Hu, B; Lefort, K; Lambertini, C; Neel, V; Dummer, R; Wagner, EF; Dotto, GP				Kolev, Vihren; Mandinova, Anna; Guinea-Viniegra, Juan; Hu, Bing; Lefort, Karine; Lambertini, Chiara; Neel, Victor; Dummer, Reinhard; Wagner, Erwin F.; Dotto, G. Paolo			EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer	NATURE CELL BIOLOGY			English	Article							EPIDERMAL-GROWTH; C-JUN; P53 EXPRESSION; RECEPTOR; PATHWAY; PHOSPHORYLATION; SUPPRESSION; PROGRESSION; INTEGRATION; MECHANISMS	The Notch1 gene has an important role in mammalian cell-fate decision and tumorigenesis. Upstream control mechanisms for transcription of this gene are still poorly understood. In a chemical genetics screen for small molecule activators of Notch signalling, we identified epidermal growth factor receptor ( EGFR) as a key negative regulator of Notch1 gene expression in primary human keratinocytes, intact epidermis and skin squamous cell carcinomas ( SCCs). The underlying mechanism for negative control of the Notch1 gene in human cells, as well as in a mouse model of EGFR-dependent skin carcinogenesis, involves transcriptional suppression of p53 by the EGFR effector c-Jun. Suppression of Notch signalling in cancer cells counteracts the differentiation-inducing effects of EGFR inhibitors while, at the same time, synergizing with these compounds in induction of apoptosis. Thus, our data reveal a key role of EGFR signalling in the negative regulation of Notch1 gene transcription, of potential relevance for combinatory approaches for cancer therapy.	[Kolev, Vihren; Mandinova, Anna; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Guinea-Viniegra, Juan; Wagner, Erwin F.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Hu, Bing; Lefort, Karine; Lambertini, Chiara; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Neel, Victor; Dotto, G. Paolo] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Harvard University; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Lausanne; Harvard University; Massachusetts General Hospital; University of Zurich; University Zurich Hospital	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	Gian-Paolo.Dotto@unil.ch	Hu, Bing/K-3541-2019	Wagner, Erwin F/0000-0001-7872-0196	NCI NIH HHS [P01 CA016038] Funding Source: Medline; NIAMS NIH HHS [AR39190, R01 AR054856-03, AR 054856, R01 AR054856, R01 AR039190-21, R01 AR039190] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Boggs K, 2007, J BIOL CHEM, V282, P7982, DOI 10.1074/jbc.M611675200; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Jost M, 2000, EUR J DERMATOL, V10, P505; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kang JH, 2001, LAB INVEST, V81, P573, DOI 10.1038/labinvest.3780266; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Reuter CWM, 2007, BRIT J CANCER, V96, P408, DOI 10.1038/sj.bjc.6603566; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schad K, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9075; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	44	150	161	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8								10.1038/ncb1750	http://dx.doi.org/10.1038/ncb1750			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604200	Green Submitted, Green Accepted			2022-12-25	WOS:000258147100008
J	Yao, XL; Rosen, MK; Gardner, KH				Yao, Xiaolan; Rosen, Michael K.; Gardner, Kevin H.			Estimation of the available free energy in a LOV2-J alpha photoswitch	NATURE CHEMICAL BIOLOGY			English	Article							PHOTOACTIVE YELLOW PROTEIN; IONOTROPIC GLUTAMATE-RECEPTOR; PLANT PHOTORECEPTOR DOMAIN; SIGNAL-TRANSDUCTION; LOV DOMAIN; FUNCTIONAL DYNAMICS; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; LIGHT	Protein photosensors are versatile tools for studying ligand-regulated allostery and signaling. Fundamental to these processes is the amount of energy that can be provided by a photosensor to control downstream signaling events. Such regulation is exemplified by the phototropins - plant serine/threonine kinases that are activated by blue light via conserved LOV (light, oxygen and voltage) domains. The core photosensor of oat phototropin 1 is a LOV domain that interacts in a light-dependent fashion with an adjacent alpha-helix (J alpha) to control kinase activity. We used solution NMR measurements to quantify the free energy of the LOV domain-J alpha-helix binding equilibrium in the dark and lit states. These data indicate that light shifts this equilibrium by similar to 3.8 kcal mol(-1), thus quantifying the energy available through LOV-J alpha for light-driven allosteric regulation. This study provides insight into the energetics of light sensing by phototropins and benchmark values for engineering photoswitchable systems based on the LOV-J alpha interaction.	[Yao, Xiaolan; Rosen, Michael K.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Rosen, Michael K.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gardner, KH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kevin.gardner@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Yao, Xiaolan/0000-0002-6570-3730	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W.L, 2002, PYMOL USERS MANUAL; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hausser M, 2007, NATURE, V446, P617, DOI 10.1038/446617a; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harigai M, 2003, BIOCHEMISTRY-US, V42, P13893, DOI 10.1021/bi034814e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Lee AL, 1997, J BIOMOL NMR, V9, P437, DOI 10.1023/A:1018311013338; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Skrynnikov NR, 2001, J AM CHEM SOC, V123, P4556, DOI 10.1021/ja004179p; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; van der Horst MA, 2001, FEBS LETT, V497, P26, DOI 10.1016/S0014-5793(01)02427-9; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	46	109	113	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2008	4	8					491	497		10.1038/nchembio.99	http://dx.doi.org/10.1038/nchembio.99			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329FO	18604202	Green Accepted			2022-12-25	WOS:000257852500015
J	Benny, O; Fainaru, O; Adini, A; Cassiola, F; Bazinet, L; Adini, I; Pravda, E; Nahmias, Y; Koirala, S; Corfas, G; D'Amato, RJ; Folkman, J				Benny, Ofra; Fainaru, Ofer; Adini, Avner; Cassiola, Flavia; Bazinet, Lauren; Adini, Irit; Pravda, Elke; Nahmias, Yaakov; Koirala, Samir; Corfas, Gabriel; D'Amato, Robert J.; Folkman, Judah			An orally delivered small-molecule formulation with antiangiogenic and anticancer activity	NATURE BIOTECHNOLOGY			English	Article							ANGIOGENESIS INHIBITOR TNP-470; BLOCK-COPOLYMER MICELLES; CELL-CYCLE INHIBITION; SOLID TUMORS; PHASE-I; POLYMERIC MICELLES; DRUG-DELIVERY; GROWTH; CANCER; AGM-1470	Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog, is among the most potent and broad-spectrum angiogenesis inhibitors. However, a major clinical limitation is its poor oral availability and short half-life, necessitating frequent, continuous parenteral administration. We have addressed these issues and report an oral formulation of TNP-470, named Lodamin. TNP-470 was conjugated to monomethoxy-polyethylene glycol polylactic acid to form nanopolymeric micelles. This conjugate can be absorbed by the intestine and selectively accumulates in tumors. Lodamin significantly inhibits tumor growth, without causing neurological impairment in tumor-bearing mice. Using the oral route of administration, it first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice. We show that Lodamin is an oral nontoxic antiangiogenic drug that can be chronically administered for cancer therapy or metastasis prevention.	[Benny, Ofra; Fainaru, Ofer; Adini, Avner; Cassiola, Flavia; Bazinet, Lauren; Adini, Irit; Pravda, Elke; D'Amato, Robert J.; Folkman, Judah] Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program, Boston, MA 02215 USA; [Nahmias, Yaakov] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Charlestown, MA 02129 USA; [Koirala, Samir; Corfas, Gabriel] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Univ, Sch Med, Childrens Hosp, Dept Ophthalmol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Benny, O (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program, 1 Blackfan Circle,St Karp Res Bldg, Boston, MA 02215 USA.	ofra.bennyratsaby@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020; Nahmias, Yaakov/H-4725-2013; Benny, Ofra/AAB-3294-2021; Nahmias, Yaakov/AAM-3872-2020	Corfas, Gabriel/0000-0001-5412-9473; Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X	NIDDK NIH HHS [K01 DK080241-01, K01 DK080241] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080241] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; BARBERAGUILLEM E, 1992, INT J CANCER, V52, P974, DOI 10.1002/ijc.2910520624; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Carter R, 2001, CAMBRIDGE GUIDE TEAC, P1; CERVI D, 2007, BLOOD; CrettonScott E, 1996, CANCER CHEMOTH PHARM, V38, P117, DOI 10.1007/s002800050458; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Edlund U, 2002, ADV POLYM SCI, V157, P67; Emoto M, 2007, CANCER SCI, V98, P929, DOI 10.1111/j.1349-7006.2007.00474.x; FOLKMAN J, 2003, CANC MED 6, V1, P161; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Herbst RS, 2002, J CLIN ONCOL, V20, P4440, DOI 10.1200/JCO.2002.04.006; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Kanamori M, 2007, J EXP CLIN CANC RES, V26, P101; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kruger EA, 2000, EXPERT OPIN INV DRUG, V9, P1383, DOI 10.1517/13543784.9.6.1383; Kudelka AP, 1997, CLIN CANCER RES, V3, P1501; Kudelka AP, 1998, NEW ENGL J MED, V338, P991, DOI 10.1056/NEJM199804023381412; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Logothetis CJ, 2001, CLIN CANCER RES, V7, P1198; Marler JJ, 2005, PEDIATRICS, V116, P38, DOI 10.1542/peds.2004-1518; Mauriz JL, 2007, TRANSL RES, V149, P46, DOI 10.1016/j.trsl.2006.07.004; Nahari D, 2007, MOL CANCER THER, V6, P1329, DOI 10.1158/1535-7163.MCT-06-0554; NAUMOV G, 2007, ANTIANGIOGENIC CANC, P3; Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006; Pierri E, 2005, J BIOMED MATER RES A, V75A, P639, DOI 10.1002/jbm.a.30490; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002; Shusterman S, 2001, CLIN CANCER RES, V7, P977; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Stadler WM, 1999, J CLIN ONCOL, V17, P2541, DOI 10.1200/JCO.1999.17.8.2541; TAKAMIYA Y, 1994, NEUROSURGERY, V34, P869, DOI 10.1227/00006123-199405000-00013; TAKAMIYA Y, 1993, J NEUROSURG, V78, P470, DOI 10.3171/jns.1993.78.3.0470; Torchilin VP, 2004, CELL MOL LIFE SCI, V61, P2549, DOI 10.1007/s00018-004-4153-5; Tran HT, 2004, CANCER CHEMOTH PHARM, V54, P308, DOI 10.1007/s00280-004-0816-z; YAMAOKA M, 1993, CANCER RES, V53, P5233; YANASE T, 1993, CANCER RES, V53, P2566; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	41	143	170	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					799	807		10.1038/nbt1415	http://dx.doi.org/10.1038/nbt1415			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18587385	Green Submitted, Green Accepted			2022-12-25	WOS:000257491600025
J	Fritsche, LG; Loenhardt, T; Janssen, A; Fisher, SA; Rivera, A; Keilhauer, CN; Weber, BHF				Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Fisher, Sheila A.; Rivera, Andrea; Keilhauer, Claudia N.; Weber, Bernhard H. F.			Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE	Age-related macular degeneration (AMD) is a prevalent multifactorial disorder of the central retina(1-3). Genetic variants at two chromosomal loci, 1q31 and 10q26, confer major disease risks, together accounting for more than 50% of AMD pathology(4-9). Signals at 10q26 center over two nearby genes, ARMS2 (age-related maculopathy susceptibility 2, also known as LOC387715)(8,9) and HTRA1 (high-temperature requirement factor A1)(10,11), suggesting two equally probable candidates. Here we show that a deletion-insertion polymorphism in ARMS2 (NM_001099667.1: c.*372_815del443ins54) is strongly associated with AMD, directly affecting the transcript by removing the polyadenylation signal and inserting a 54-bp element known to mediate rapid mRNA turnover. As a consequence, expression of ARMS2 in homozygous carriers of the indel variant is not detectable. Confirming previous findings(12), we demonstrate a mitochondrial association of the normal protein and further define its retinal localization to the ellipsoid region of the photoreceptors. Our data suggest that ARMS2 has a key role in AMD, possibly through mitochondria-related pathways.	[Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Rivera, Andrea; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Fisher, Sheila A.] St Thomas Hosp, London WC2R 2LS, England; [Fisher, Sheila A.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Keilhauer, Claudia N.] Univ Wurzburg, Dept Ophthalmol, D-97080 Wurzburg, Germany	University of Regensburg; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Wurzburg	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; DUDBRIDGE F, 2006, 5 MRC BIOST UN; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	28	306	319	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					892	896		10.1038/ng.170	http://dx.doi.org/10.1038/ng.170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511946				2022-12-25	WOS:000257166500025
J	Yamamoto, S; Shimizu, S; Kiyonaka, S; Takahashi, N; Wajima, T; Hara, Y; Negoro, T; Hiroi, T; Kiuchi, Y; Okada, T; Kaneko, S; Lange, I; Fleig, A; Penner, R; Nishi, M; Takeshima, H; Mori, Y				Yamamoto, Shinichiro; Shimizu, Shunichi; Kiyonaka, Shigeki; Takahashi, Nobuaki; Wajima, Teruaki; Hara, Yuji; Negoro, Takaharu; Hiroi, Toshihito; Kiuchi, Yuji; Okada, Takaharu; Kaneko, Shuji; Lange, Ingo; Fleig, Andrea; Penner, Reinhold; Nishi, Miyuki; Takeshima, Hiroshi; Mori, Yasuo			TRPM2-mediated Ca(2+) influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration	NATURE MEDICINE			English	Article							SODIUM-INDUCED COLITIS; NF-KAPPA-B; OXIDATIVE STRESS; ADP-RIBOSE; ULCERATIVE-COLITIS; GENE-EXPRESSION; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; BOWEL-DISEASE; TRP CHANNELS	Reactive oxygen species (ROS) induce chemokines responsible for the recruitment of inflammatory cells to sites of injury or infection. Here we show that the plasma membrane Ca(2+)-permeable channel TRPM2 controls ROS-induced chemokine production in monocytes. In human U937 monocytes, hydrogen peroxide (H(2)O(2)) evokes Ca(2+) influx through TRPM2 to activate Ca(2+)-dependent tyrosine kinase Pyk2 and amplify Erk signaling via Ras GTPase. This elicits nuclear translocation of nuclear factor-kappa B essential for the production of the chemokine interleukin-8 (CXCL8). In monocytes from Trpm2-deficient mice, H(2)O(2)-induced Ca(2+) influx and production of the macrophage inflammatory protein-2 (CXCL2), the mouse CXCL8 functional homolog, were impaired. In the dextran sulfate sodium-induced colitis inflammation model, CXCL2 expression, neutrophil infiltration and ulceration were attenuated by Trpm2 disruption. Thus, TRPM2 Ca(2+) influx controls the ROS-induced signaling cascade responsible for chemokine production, which aggravates inflammation. We propose functional inhibition of TRPM2 channels as a new therapeutic strategy for treating inflammatory diseases.	[Yamamoto, Shinichiro; Kiyonaka, Shigeki; Takahashi, Nobuaki; Wajima, Teruaki; Hara, Yuji; Okada, Takaharu; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synth Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Negoro, Takaharu] Showa Univ, Sch Pharmaceut Sci, Dept Med Informat, Shinagawa Ku, Tokyo 1428555, Japan; [Shimizu, Shunichi; Hiroi, Toshihito; Kiuchi, Yuji] Showa Univ, Dept Pathophysiol, Tokyo 1428555, Japan; [Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; [Lange, Ingo; Fleig, Andrea; Penner, Reinhold] Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signalling, Honolulu, HI 96813 USA; [Lange, Ingo; Fleig, Andrea; Penner, Reinhold] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Showa University; Showa University; Kyoto University; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Kyoto University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synth Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Kaneko, Shuji/AAR-1005-2021; Takahashi, Nobuaki/AAG-9411-2019; Okada, Takaharu/N-7931-2015; Kiyonaka, Shigeki/AAM-7303-2021	Takahashi, Nobuaki/0000-0002-0606-3921; Lange, Ingo/0000-0002-6703-0015; Fleig, Andrea/0000-0001-8396-7249; Takeshima, Hiroshi/0000-0003-4525-3725; Kaneko, Shuji/0000-0001-5152-5809; Penner, Reinhold/0000-0002-5366-1537	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063954] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NIGMS NIH HHS [R01 GM063954-06, R01 GM063954] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anezaki K, 1998, INTERNAL MED, V37, P253, DOI 10.2169/internalmedicine.37.253; Araki Y, 2006, INT J MOL MED, V17, P331; Barnes PJ, 2004, CURR OPIN PHARMACOL, V4, P263, DOI 10.1016/j.coph.2004.03.001; Blackburn AC, 1998, FREE RADICAL BIO MED, V25, P305, DOI 10.1016/S0891-5849(98)00068-9; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Cavaillon JM, 2005, CRIT CARE MED, V33, pS506, DOI 10.1097/01.CCM.0000185502.21012.37; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuzzocrea S, 2007, FREE RADICAL BIO MED, V42, P90, DOI 10.1016/j.freeradbiomed.2006.09.025; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Grip Olof, 2003, Current Drug Targets - Inflammation and Allergy, V2, P155, DOI 10.2174/1568010033484179; Han XB, 2004, AM J PHYSIOL-GASTR L, V287, pG1220, DOI 10.1152/ajpgi.00231.2004; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hasko G, 2002, MOL MED, V8, P283, DOI 10.1007/BF03402154; Henricks PAJ, 2001, PULM PHARMACOL THER, V14, P409, DOI 10.1006/pupt.2001.0319; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; Jaramillo M, 2002, J IMMUNOL, V169, P7026, DOI 10.4049/jimmunol.169.12.7026; Josse C, 2001, BIOCHEM J, V360, P321, DOI 10.1042/0264-6021:3600321; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P704, DOI 10.1111/j.1572-0241.1999.00940.x; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Korenaga D, 2002, J SURG RES, V102, P144, DOI 10.1006/jsre.2001.6314; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee KM, 2001, CELL SIGNAL, V13, P645, DOI 10.1016/S0898-6568(01)00178-4; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; Mendez-Samperio P, 2004, MEDIAT INFLAMM, V13, P45, DOI 10.1080/09629350410001664743; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Ohtsuka Y, 2003, PEDIATR RES, V53, P143, DOI 10.1203/01.PDR.0000041519.16507.06; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; SEIMIYA H, 1993, CELL GROWTH DIFFER, V4, P1033; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Videla LA, 2003, BIOMETALS, V16, P103, DOI 10.1023/A:1020707811707; WILSON L, 1993, FEBS LETT, V325, P295, DOI 10.1016/0014-5793(93)81092-E; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006	50	425	446	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					738	747		10.1038/nm1758	http://dx.doi.org/10.1038/nm1758			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18542050	Green Accepted			2022-12-25	WOS:000257452700021
J	Finberg, KE; Heeney, MM; Campagna, DR; Aydinok, Y; Pearson, HA; Hartman, KR; Mayo, MM; Samuel, SM; Strouse, JJ; Markianos, K; Andrews, NC; Fleming, MD				Finberg, Karin E.; Heeney, Matthew M.; Campagna, Dean R.; Aydinok, Yesim; Pearson, Howard A.; Hartman, Kip R.; Mayo, Mary M.; Samuel, Stewart M.; Strouse, John J.; Markianos, Kyriacos; Andrews, Nancy C.; Fleming, Mark D.			Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)	NATURE GENETICS			English	Article							MICROCYTIC ANEMIA; MALABSORPTION; METABOLISM; HEPCIDIN	Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.	[Finberg, Karin E.] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Heeney, Matthew M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Campagna, Dean R.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Aydinok, Yesim] Ege Univ, Fac Med, Dept Pediat Hematol, TR-35100 Izmir, Turkey; [Pearson, Howard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Hartman, Kip R.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Mayo, Mary M.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Samuel, Stewart M.] Pediat Hlth Associates PC, New York, NY 11803 USA; [Strouse, John J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Markianos, Kyriacos] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Markianos, Kyriacos; Andrews, Nancy C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Fleming, Mark D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Finberg, Karin E.; Heeney, Matthew M.; Andrews, Nancy C.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Ege University; Yale University; Uniformed Services University of the Health Sciences - USA; Saint Louis University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Andrews, NC (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA.	Nancy.Andrews@duke.edu; Mark.Fleming@childrens.harvard.edu	Strouse, J/A-2690-2008; Aydinok, Yesim/G-5410-2010; Heeney, Matthew/J-6838-2015	Strouse, J/0000-0003-0341-1457; Markianos, Kyriacos/0000-0003-0214-6014; Fleming, Mark/0000-0003-0948-4024; Andrews, Nancy/0000-0003-0243-4462; Heeney, Matthew/0000-0002-1104-6843	NCI NIH HHS [T32 CA009216] Funding Source: Medline; NHLBI NIH HHS [K12 HL087164] Funding Source: Medline; NIDDK NIH HHS [R01 DK066373, DK053813, R01 DK080011, R01 DK053813, R01 DK053813-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053813, R01DK066373, R01DK080011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 1997, YALE J BIOL MED, V70, P219; BROWN AC, 1988, AM J HEMATOL, V27, P1, DOI 10.1002/ajh.2830270102; BUCHANAN GR, 1981, J PEDIATR-US, V98, P723, DOI 10.1016/S0022-3476(81)80831-1; Hartman KR, 1996, AM J HEMATOL, V51, P269, DOI 10.1002/(SICI)1096-8652(199604)51:4<269::AID-AJH4>3.0.CO;2-U; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Mayo M M, 2001, Clin Lab Sci, V14, P135; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Pearson HA, 1999, J PEDIAT HEMATOL ONC, V21, P412, DOI 10.1097/00043426-199909000-00014; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200	9	480	514	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					569	571		10.1038/ng.130	http://dx.doi.org/10.1038/ng.130			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408718	Green Accepted			2022-12-25	WOS:000255366700023
J	Teichgraber, V; Ulrich, M; Endlich, N; Riethmuller, J; Wilker, B; De Oliveira-Munding, CC; van Heeckeren, AM; Barr, ML; von Kurthy, G; Schmid, KW; Weller, M; Tummler, B; Lang, F; Grassme, H; Doring, G; Gulbins, E				Teichgraeber, Volker; Ulrich, Martina; Endlich, Nicole; Riethmueller, Joachim; Wilker, Barbara; De Oliveira-Munding, Cheyla Conceicao; van Heeckeren, Anna M.; Barr, Mark L.; von Kuerthy, Gabriele; Schmid, Kurt W.; Weller, Michael; Tuemmler, Burkhard; Lang, Florian; Grassme, Heike; Doering, Gerd; Gulbins, Erich			Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis	NATURE MEDICINE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; NF-KAPPA-B; PSEUDOMONAS-AERUGINOSA; ACID SPHINGOMYELINASE; MICE; ACIDIFICATION; DISEASE; CFTR; ACTIVATION	Microbial lung infections are the major cause of morbidity and mortality in the hereditary metabolic disorder cystic fibrosis, yet the molecular mechanisms leading from the mutation of cystic fibrosis transmembrane conductance regulator ( CFTR) to lung infection are still unclear. Here, we show that ceramide age-dependently accumulates in the respiratory tract of uninfected Cftr-deficient mice owing to an alkalinization of intracellular vesicles in Cftr-deficient cells. This change in pH results in an imbalance between acid sphingomyelinase ( Asm) cleavage of sphingomyelin to ceramide and acid ceramidase consumption of ceramide, resulting in the higher levels of ceramide. The accumulation of ceramide causes Cftr-deficient mice to suffer from constitutive age-dependent pulmonary inflammation, death of respiratory epithelial cells, deposits of DNA in bronchi and high susceptibility to severe Pseudomonas aeruginosa infections. Partial genetic deficiency of Asm in Cftr(-/-) Smpd1(+/-) mice or pharmacological treatment of Cftr-deficient mice with the Asm blocker amitriptyline normalizes pulmonary ceramide and prevents all pathological findings, including susceptibility to infection. These data suggest inhibition of Asm as a new treatment strategy for cystic fibrosis.	[Teichgraeber, Volker; Wilker, Barbara; Grassme, Heike; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany; [Ulrich, Martina; De Oliveira-Munding, Cheyla Conceicao; Doering, Gerd] Inst Med Microbiol & Hyg, D-72074 Tubingen, Germany; [Endlich, Nicole] Ernst Moritz Arndt Univ Greifswald, Dept Anat, D-17487 Greifswald, Germany; [Riethmueller, Joachim] Childrens Clin, D-72076 Tubingen, Germany; [van Heeckeren, Anna M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Barr, Mark L.] Univ So Calif, Dept Cardiothorac Surg, Los Angeles, CA 90033 USA; [von Kuerthy, Gabriele; Weller, Michael] Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany; [Schmid, Kurt W.] Univ Duisburg Essen, Dept Pathol & Neuropathol, D-45122 Essen, Germany; [Tuemmler, Burkhard] Med Univ Sch, D-30625 Hannover, Germany; [Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany	University of Duisburg Essen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ernst Moritz Arndt Universitat Greifswald; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Case Western Reserve University; University of Southern California; Eberhard Karls University of Tubingen; University of Duisburg Essen; Eberhard Karls University of Tubingen	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Hufelandstr 55, D-45122 Essen, Germany.	erich.gulbins@uni-due.de	Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Weller, Michael/0000-0002-1748-174X				BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BHUVANESWARAN C, 1985, EUR J CELL BIOL, V73, P98; Borowitz D, 2005, J PEDIATR GASTR NUTR, V41, P273, DOI 10.1097/01.mpg.0000178439.64675.8d; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Coleman FT, 2003, P NATL ACAD SCI USA, V100, P1949, DOI 10.1073/pnas.0437901100; Cottart CH, 2007, PEDIATR RES, V62, P528, DOI 10.1203/PDR.0b013e318155a61d; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Dbaibo GS, 1998, APOPTOSIS, V3, P317, DOI 10.1023/A:1009668802718; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; FORBES AR, 1977, ANESTHESIOLOGY, V46, P319, DOI 10.1097/00000542-197705000-00002; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hariharan K, 1996, NAHRUNG, V40, P325, DOI 10.1002/food.19960400607; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Hogg JC, 2002, THORAX, V57, P830, DOI 10.1136/thorax.57.9.830; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Maiuri L, 1997, FEBS LETT, V408, P225, DOI 10.1016/S0014-5793(97)00347-5; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; MOL MJ, 1986, LANCET, V328, P936; MOSCONI C, 1988, ATHEROSCLEROSIS, V72, P129, DOI 10.1016/0021-9150(88)90073-1; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Seksek O, 1996, J BIOL CHEM, V271, P15542, DOI 10.1074/jbc.271.26.15542; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Zahm JM, 1997, AM J PHYSIOL-CELL PH, V272, pC853, DOI 10.1152/ajpcell.1997.272.3.C853	50	428	443	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					382	391		10.1038/nm1748	http://dx.doi.org/10.1038/nm1748			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376404	Green Accepted			2022-12-25	WOS:000254674100024
J	Hauck, L; Harms, C; An, JF; Rohne, J; Gertz, K; Dietz, R; Endres, M; von Harsdorf, R				Hauck, Ludger; Harms, Christoph; An, Junfeng; Rohne, Jens; Gertz, Karen; Dietz, Rainer; Endres, Matthias; von Harsdorf, Ruediger			Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart	NATURE MEDICINE			English	Article							DEPENDENT-KINASE; INHIBITOR P27(KIP1); MICE LACKING; REGULATES PROTEOLYSIS; UBIQUITIN LIGASE; MAMMALIAN-CELLS; P27; PHOSPHORYLATION; DEGRADATION; CDK	p27(Kip1) (p27) blocks cell proliferation through the inhibition of cyclin-dependent kinase-2 (Cdk2). Despite its robust expression in the heart, little is known about both the function and regulation of p27 in this and other nonproliferative tissues, in which the expression of its main target, cyclin E-Cdk2, is known to be very low. Here we show that angiotensin II, a major cardiac growth factor, induces the proteasomal degradation of p27 through protein kinase CK2-alpha'-dependent phosphorylation. Conversely, unphosphorylated p27 potently inhibits CK2-alpha'. Thus, the p27-CK2-alpha' interaction is regulated by hypertrophic signaling events and represents a regulatory feedback loop in differentiated cardiomyocytes analogous to, but distinct from, the feedback loop arising from the interaction of p27 with Cdk2 that controls cell proliferation. Our data show that extracellular growth factor signaling regulates p27 stability in postmitotic cells, and that inactivation of p27 by CK2-alpha' is crucial for agonist- and stress-induced cardiac hypertrophic growth.	[Hauck, Ludger; von Harsdorf, Ruediger] Univ Network Hosp, Div Cardiol, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada; [Hauck, Ludger; von Harsdorf, Ruediger] Toronto Geb Res Inst, Toronto, ON M5G 2C4, Canada; [Hauck, Ludger; von Harsdorf, Ruediger] McEwen Ctr Regenerat Med, Toronto, ON M5G 2C4, Canada; [Endres, Matthias] Charite, Ctr Stroke Res Berlin, D-10117 Berlin, Germany; [Harms, Christoph; Gertz, Karen; Endres, Matthias] Charite, Dept Neurol, D-10117 Berlin, Germany; [An, Junfeng; Rohne, Jens; Dietz, Rainer] Humboldt Univ, Dept Cardiol, Charite, D-13353 Berlin, Germany; [Dietz, Rainer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	University of Toronto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	von Harsdorf, R (corresponding author), Univ Network Hosp, Div Cardiol, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	rudiger.vonharsdorf@uhn.on.ca	Harms, Christoph/HIK-2989-2022; Harms, Christoph/AAD-7895-2021; Gertz, Karen/J-1603-2015	Harms, Christoph/0000-0002-2063-2860; Gertz, Karen/0000-0002-1203-641X; Endres, Matthias/0000-0001-6520-3720				Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Berthet C, 2007, ONCOGENE, V26, P4469, DOI 10.1038/sj.onc.1210243; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729	50	82	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2008	14	3					315	324		10.1038/nm1729	http://dx.doi.org/10.1038/nm1729			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18311148				2022-12-25	WOS:000253815700038
J	Lawrence, S				Lawrence, Stacy			Brazil surpasses US in new transgenic crop plantings	NATURE BIOTECHNOLOGY			English	News Item																			0	6	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2008	26	3					260	260		10.1038/nbt0308-260	http://dx.doi.org/10.1038/nbt0308-260			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	276EF	18327226				2022-12-25	WOS:000254123400007
J	Osafune, K; Caron, L; Borowiak, M; Martinez, RJ; Fitz-Gerald, CS; Sato, Y; Cowan, CA; Chien, KR; Melton, DA				Osafune, Kenji; Caron, Leslie; Borowiak, Malgorzata; Martinez, Rita J.; Fitz-Gerald, Claire S.; Sato, Yasunori; Cowan, Chad A.; Chien, Kenneth R.; Melton, Douglas A.			Marked differences in differentiation propensity among human embryonic stem cell lines	NATURE BIOTECHNOLOGY			English	Article							ENDODERM; DISTINCT; LIVER; GENE; MICE	The differentiation potential of 17 human embryonic stem (hES) cell lines was compared. Some lines exhibit a marked propensity to differentiate into specific lineages, often with > 100-fold differences in lineage-specific gene expression. For example, HUES 8 is best for pancreatic differentiation and HUES 3 for cardiomyocyte generation. These non-trivial differences in developmental potential among hES cell lines point to the importance of screening and deriving lines for lineage-specific differentiation.	[Osafune, Kenji; Caron, Leslie; Borowiak, Malgorzata; Martinez, Rita J.; Fitz-Gerald, Claire S.; Cowan, Chad A.; Chien, Kenneth R.; Melton, Douglas A.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Borowiak, Malgorzata; Martinez, Rita J.; Fitz-Gerald, Claire S.; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Osafune, Kenji] Japan Sci & Technol Agcy, ICORP Organ Regenerat Project, Meguro Ku, Tokyo 1538902, Japan; [Caron, Leslie; Cowan, Chad A.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Sato, Yasunori] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cowan, Chad A.] Stowers Med Inst, Boston, MA 02114 USA; [Chien, Kenneth R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Japan Science & Technology Agency (JST); Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Stowers Institute for Medical Research; Harvard University; Harvard Medical School	Melton, DA (corresponding author), Harvard Univ, Stem Cell Inst, 42 Church St, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012; Caron, Leslie/AAE-3511-2022	Young, Richard A/0000-0001-8855-8647; Caron, Leslie/0000-0003-4118-2974; Borowiak, Malgorzata/0000-0002-5829-1213	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; BILIR BM, 1993, HEPATOLOGY, V18, P1009, DOI 10.1002/hep.1840180437; CASCIO S, 1991, DEVELOPMENT, V113, P217; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim SE, 2007, MOL CELLS, V23, P49; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Loebel DAF, 2005, NAT BIOTECHNOL, V23, P1491, DOI 10.1038/nbt1205-1491; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Westfall MV, 1996, DEV DYNAM, V206, P24, DOI 10.1002/(SICI)1097-0177(199605)206:1<24::AID-AJA3>3.0.CO;2-2	15	609	645	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2008	26	3					313	315		10.1038/nbt1383	http://dx.doi.org/10.1038/nbt1383			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	276EF	18278034				2022-12-25	WOS:000254123400024
J	Tabashnik, BE; Gassmann, AJ; Crowder, DW; Carriere, Y				Tabashnik, Bruce E.; Gassmann, Aaron J.; Crowder, David W.; Carriere, Yves			Insect resistance to Bt crops: evidence versus theory	NATURE BIOTECHNOLOGY			English	Article							BACILLUS-THURINGIENSIS TOXIN; HELICOVERPA-ZEA LEPIDOPTERA; EASTERN NORTH-CAROLINA; SESAMIA-NONAGRIOIDES; HELIOTHIS-VIRESCENS; TRANSGENIC COTTON; FIELD POPULATIONS; PINK-BOLLWORM; NOCTUIDAE; ARMIGERA	Evolution of insect resistance threatens the continued success of transgenic crops producing Bacillus thuringiensis (Bt) toxins that kill pests. The approach used most widely to delay insect resistance to Bt crops is the refuge strategy, which requires refuges of host plants without Bt toxins near Bt crops to promote survival of susceptible pests. However, large-scale tests of the refuge strategy have been problematic. Analysis of more than a decade of global monitoring data reveals that the frequency of resistance alleles has increased substantially in some field populations of Helicoverpa zea, but not in five other major pests in Australia, China, Spain and the United States. The resistance of H. zea to Bt toxin Cry1Ac in transgenic cotton has not caused widespread crop failures, in part because other tactics augment control of this pest. The field outcomes documented with monitoring data are consistent with the theory underlying the refuge strategy, suggesting that refuges have helped to delay resistance.	[Tabashnik, Bruce E.; Gassmann, Aaron J.; Crowder, David W.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@ag.arizona.edu		Crowder, David/0000-0002-3720-1581				Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; Andreadis SS, 2007, J ECON ENTOMOL, V100, P195, DOI 10.1603/0022-0493(2007)100[195:FORTBT]2.0.CO;2; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; BURD A, 2000, P BELTW COTT RES C N, V2, P923; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Downes S, 2007, J INVERTEBR PATHOL, V95, P208, DOI 10.1016/j.jip.2007.03.010; Farinos GP, 2004, ENTOMOL EXP APPL, V110, P23, DOI 10.1111/j.0013-8703.2004.00116.x; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gustafson DI, 2006, J ECON ENTOMOL, V99, P2116, DOI 10.1603/0022-0493-99.6.2116; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; Jackson RE, 2004, J ENTOMOL SCI, V39, P46, DOI 10.18474/0749-8004-39.1.46; JAMES C, 2006, ISAAA BRIEFS, V35, P1; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Luttrell R, 2007, P 2007 BELTW COTT C; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; *MONS CO, 2007, MONS BIOT TRAIT ACR; *NAT RES COUNC, 1986, PEST RES STRAT TACT; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Stodola TJ, 2006, J ECON ENTOMOL, V99, P502, DOI 10.1603/0022-0493-99.2.502; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; US EPA, 1998, EPA PUBL; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012; Wu KM, 2006, J ECON ENTOMOL, V99, P893, DOI 10.1603/0022-0493-99.3.893; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	35	541	607	5	262	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					199	202		10.1038/nbt1382	http://dx.doi.org/10.1038/nbt1382			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18259177				2022-12-25	WOS:000253193000021
J	Verhasselt, V; Milcent, V; Cazareth, J; Kanda, A; Fleury, S; Dombrowicz, D; Glaichenhaus, N; Julia, V				Verhasselt, Valerie; Milcent, Valerie; Cazareth, Julie; Kanda, Akira; Fleury, Sebastien; Dombrowicz, David; Glaichenhaus, Nicolas; Julia, Valerie			Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; IMMUNE-RESPONSES; INHALED ANTIGEN; ORAL TOLERANCE; MICE; PROTEIN; ABSORPTION; EXPRESSION	Allergic asthma is a chronic disease characterized by airway obstruction in response to allergen exposure. It results from an inappropriate T helper type 2 response to environmental airborne antigens and affects 300 million individuals(1). Its prevalence has increased markedly in recent decades, most probably as a result of changes in environmental factors(2). Exposure to environmental antigens during infancy is crucial to the development of asthma(3). Epidemiological studies on the relationship between breastfeeding and allergic diseases have reached conflicting results(4-8). Here, we have investigated whether the exposure of lactating mice to an airborne allergen affects asthma development in progeny. We found that airborne antigens were efficiently transferred from the mother to the neonate through milk and that tolerance induction did not require the transfer of immunoglobulins. Breastfeeding-induced tolerance relied on the presence of transforming growth factor (TGF)-beta during lactation, was mediated by regulatory CD4(+) T lymphocytes and depended on TGF-beta signaling in T cells. In conclusion, breast milk-mediated transfer of an antigen to the neonate resulted in oral tolerance induction leading to antigen-specific protection from allergic airway disease. This study may pave the way for the design of new strategies to prevent the development of allergic diseases.	[Verhasselt, Valerie; Milcent, Valerie; Glaichenhaus, Nicolas; Julia, Valerie] Univ Nice Sophie Antipolis, U924, INSERM, F-06560 Valbonne, France; [Cazareth, Julie] Univ Nice Sophie Antipolis, UMR 6097, CNRS, F-06560 Valbonne, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Univ Lille, Inst Pasteur, INSERM, U547, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Verhasselt, V (corresponding author), Univ Nice Sophie Antipolis, U924, INSERM, 660 Route Lucioles, F-06560 Valbonne, France.	verhasselt@unice.fr; vjulia@unice.fr	Verhasselt, Valerie/AAO-2373-2020; Dombrowicz, David/F-7044-2013; Eckhardt, Erik/G-1567-2010	Dombrowicz, David/0000-0002-0485-8923; Fleury, Sebastien/0000-0002-0679-3086; verhasselt, valerie/0000-0002-5732-9048				Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; BENSCH KG, 1967, SCIENCE, V157, P1204, DOI 10.1126/science.157.3793.1204; BRALEY JF, 1978, J CLIN INVEST, V61, P1240, DOI 10.1172/JCI109040; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2003, J AUTOIMMUN, V20, P135, DOI 10.1016/S0896-8411(02)00112-9; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Gdalevich M, 2001, J PEDIATR-US, V139, P261, DOI 10.1067/mpd.2001.117006; Guilbert TW, 2007, AM J RESP CRIT CARE, V176, P843, DOI 10.1164/rccm.200610-1507OC; HANSON DG, 1981, J IMMUNOL, V127, P1518; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kramer MS, 2007, BMJ-BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE; Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; MILLER A, 1994, EUR J IMMUNOL, V24, P1026, DOI 10.1002/eji.1830240503; Palmer DJ, 2006, CURR OPIN CLIN NUTR, V9, P284, DOI 10.1097/01.mco.0000222113.46042.50; Penttila I, 2006, PEDIATR RES, V59, P650, DOI 10.1203/01.pdr.0000203149.75465.74; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; STROBEL S, 1984, PEDIATR RES, V18, P588, DOI 10.1203/00006450-198407000-00004; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137	30	299	308	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					170	175		10.1038/nm1718	http://dx.doi.org/10.1038/nm1718			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18223654				2022-12-25	WOS:000252946700025
J	Saal, LH; Gruvberger-Saal, SK; Persson, C; Loevgren, K; Jumppanen, M; Staaf, J; Jonsson, G; Pires, MM; Maurer, M; Holm, K; Koujak, S; Subramaniyam, S; Vallon-Christersson, J; Olsson, H; Su, T; Memeo, L; Ludwig, T; Ethier, SP; Krogh, M; Szabolcs, M; Murty, VV; Isola, J; Hibshoosh, H; Parsons, R; Borg, A				Saal, Lao H.; Gruvberger-Saal, Sofia K.; Persson, Camilla; Loevgren, Kristina; Jumppanen, Mervi; Staaf, Johan; Jonsson, Goeran; Pires, Maira M.; Maurer, Matthew; Holm, Karolina; Koujak, Susan; Subramaniyam, Shivakumar; Vallon-Christersson, Johan; Olsson, Hakan; Su, Tao; Memeo, Lorenzo; Ludwig, Thomas; Ethier, Stephen P.; Krogh, Morten; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Isola, Jorma; Hibshoosh, Hanina; Parsons, Ramon; Borg, Ake			Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair	NATURE GENETICS			English	Article							CELL-LINES; PROSTATE-CANCER; BRCA1; INSTABILITY; PHENOTYPE; CARCINOMA; PATTERNS; SUBTYPES; MICE	Basal-like breast cancer (BBC) is a subtype of breast cancer with poor prognosis(1 - 3). Inherited mutations of BRCA1, a cancer susceptibility gene involved in double-strand DNA break (DSB) repair, lead to breast cancers that are nearly always of the BBC subtype(3 - 5); however, the precise molecular lesions and oncogenic consequences of BRCA1 dysfunction are poorly understood. Here we show that heterozygous inactivation of the tumor suppressor gene Pten leads to the formation of basal-like mammary tumors in mice, and that loss of PTEN expression is significantly associated with the BBC subtype in human sporadic and BRCA1-associated hereditary breast cancers. In addition, we identify frequent gross PTEN mutations, involving intragenic chromosome breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient tumors. These data provide an example of a specific and recurrent oncogenic consequence of BRCA1-dependent dysfunction in DNA repair and provide insight into the pathogenesis of BBC with therapeutic implications. These findings also argue that obtaining an accurate census of genes mutated in cancer will require a systematic examination for gross gene rearrangements, particularly in tumors with deficient DSB repair.	[Saal, Lao H.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Persson, Camilla; Loevgren, Kristina; Staaf, Johan; Jonsson, Goeran; Holm, Karolina; Vallon-Christersson, Johan; Olsson, Hakan; Borg, Ake] Lund Univ, Dept Clin Sci, Div Oncol, S-22185 Lund, Sweden; [Jumppanen, Mervi] Seinajoki Cent Hosp, Dept Pathol, Seinajoki 60220, Finland; [Jumppanen, Mervi; Isola, Jorma] Tampere Univ, Inst Med Technol, Tampere 33014, Finland; [Pires, Maira M.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Dept Med, New York, NY 10032 USA; [Subramaniyam, Shivakumar; Ludwig, Thomas; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Memeo, Lorenzo] Mediterranean Inst Oncol, Pathol Unit, I-95029 Catania, Italy; [Ethier, Stephen P.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Krogh, Morten] Lund Univ, Dept Theoret, S-22362 Lund, Sweden; [Borg, Ake] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, S-22185 Lund, Sweden; [Saal, Lao H.; Gruvberger-Saal, Sofia K.; Maurer, Matthew; Koujak, Susan; Murty, Vundavalli V. V. S.; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Columbia University; Lund University; Seinajoki Central Hospital; Tampere University; Columbia University; Columbia University; Columbia University; Columbia University; Mediterranean Institute of Oncology; Barbara Ann Karmanos Cancer Institute; Wayne State University; Lund University; Lund University; Columbia University	Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rep15@columbia.edu	SUBRAMANIYAM, SHIVAKUMAR/HCI-4231-2022; Califano, Andrea/F-7239-2012; Su, Tao/T-4411-2019; Saal, Lao H/A-2919-2011; Ludwig, Thomas/Q-6484-2016; Jönsson, Göran/D-1212-2014	Su, Tao/0000-0002-9148-6127; Saal, Lao H/0000-0002-0815-1896; Ludwig, Thomas/0000-0003-3461-2585; Vallon-Christersson, Johan/0000-0002-2195-0385; Memeo, Lorenzo/0000-0003-4251-7203; Parsons, Ramon/0000-0002-6656-3514; Olsson, Hakan/0000-0002-8794-9635	NATIONAL CANCER INSTITUTE [R01CA082783, P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082783-08, R01 CA082783-06, P01 CA097403, R01 CA082783-07, R01 CA082783, CA097403, CA082783] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07367-29, T32 GM007367] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Greenblatt MS, 2001, CANCER RES, V61, P4092; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Janzen V, 2006, NATURE, V441, P418, DOI 10.1038/441418b; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Laakso M, 2005, MODERN PATHOL, V18, P1321, DOI 10.1038/modpathol.3800456; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2002, GENOME BIOL, V3; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; SILVA LD, 2007, J CLIN PATHOL   0511; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STAAF J, IN PRESS HUM MUTAT; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	30	273	283	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					102	107		10.1038/ng.2007.39	http://dx.doi.org/10.1038/ng.2007.39			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066063	Green Accepted, Green Published			2022-12-25	WOS:000252118600025
J	Liang, CY; Lee, JS; Inn, KS; Gack, MU; Li, QL; Roberts, EA; Vergne, I; Deretic, V; Feng, PH; Akazawa, C; Jung, JU				Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Roberts, Esteban A.; Vergne, Isabelle; Deretic, Vojo; Feng, Pinghui; Akazawa, Chihiro; Jung, Jae U.			Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking	NATURE CELL BIOLOGY			English	Article							HOMOTYPIC VACUOLE FUSION; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; PROTEIN-TRANSPORT; DEEP-ORANGE; YEAST; LYSOSOMES; HOMOLOG; RAB7	Autophagic and endocytic pathways are tightly regulated membrane rearrangement processes that are crucial for homeostasis, development and disease. Autophagic cargo is delivered from autophagosomes to lysosomes for degradation through a complex process that topologically resembles endosomal maturation. Here, we report that a Beclin1-binding autophagic tumour suppressor, UVRAG, interacts with the class C Vps complex, a key component of the endosomal fusion machinery. This interaction stimulates Rab7 GTPase activity and autophagosome fusion with late endosomes/lysosomes, thereby enhancing delivery and degradation of autophagic cargo. Furthermore, the UVRAG-class-C-Vps complex accelerates endosome-endosome fusion, resulting in rapid degradation of endocytic cargo. Remarkably, autophagosome/endosome maturation mediated by the UVRAG-class-C-Vps complex is genetically separable from UVRAG-Beclin1-mediated autophagosome formation. This result indicates that UVRAG functions as a multivalent trafficking effector that regulates not only two important steps of autophagy autophagosome formation and maturation-but also endosomal fusion, which concomitantly promotes transport of autophagic and endocytic cargo to the degradative compartments.	[Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Jung, Jae U.] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Jung, Jae U.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Tumor Virol, Southborough, MA 01772 USA; [Roberts, Esteban A.; Vergne, Isabelle; Deretic, Vojo] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Feng, Pinghui] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Akazawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1138519, Japan	University of Southern California; Harvard University; Harvard University; University of New Mexico; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU)	Jung, JU (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	jaeujung@usc.edu	Li, Qinglin/K-2570-2015; Inn, Kyung-Soo/AAJ-4118-2020	Li, Qinglin/0000-0002-4125-1944; Deretic, Vojo/0000-0002-3624-5208; LIANG, CHENGYU/0000-0001-6082-2143; Lee, Jong-Soo/0000-0001-5119-0711; Vergne, Isabelle/0000-0003-1924-9474	NATIONAL CANCER INSTITUTE [R01CA031363, R01CA091819, R01CA082057, R01CA106156] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168, K26RR000168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042999, R01AI069345, R01AI073099] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106156, CA106156, R01 CA091819, CA91819, CA82057, R01 CA082057, CA31363, R01 CA031363] Funding Source: Medline; NCRR NIH HHS [P51 RR000168, RR00168, K26 RR000168] Funding Source: Medline; NHLBI NIH HHS [R01 HL110609] Funding Source: Medline; NIAID NIH HHS [R37 AI042999, R01 AI073099, AI069345, AI 42999, R01 AI042999, R01 AI073099-02, R01 AI069345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; EMANS N, 1995, BIOPHYS J, V69, P716, DOI 10.1016/S0006-3495(95)79947-7; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim BY, 2003, BIOCHEM BIOPH RES CO, V311, P577, DOI 10.1016/j.bbrc.2003.10.030; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Lucocq J, 1997, EUR J CELL BIOL, V72, P307; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; ROBINSON JS, 1991, MOL CELL BIOL, V11, P5813, DOI 10.1128/MCB.11.12.5813; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu JF, 2006, PIGM CELL RES, V19, P628, DOI 10.1111/j.1600-0749.2006.00346.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	46	563	605	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					776	787		10.1038/ncb1740	http://dx.doi.org/10.1038/ncb1740			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552835	Green Accepted			2022-12-25	WOS:000257268400008
J	Ben-Porath, I; Thomson, MW; Carey, VJ; Ge, R; Bell, GW; Regev, A; Weinberg, RA				Ben-Porath, Ittai; Thomson, Matthew W.; Carey, Vincent J.; Ge, Ruping; Bell, George W.; Regev, Aviv; Weinberg, Robert A.			An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors	NATURE GENETICS			English	Article							BREAST-CANCER PATIENTS; BASAL-LIKE SUBTYPE; C-MYC; METAANALYSIS; CARCINOMAS; SUBCLASSES; POLYCOMB; PATTERNS; RENEWAL; GRADE	Cancer cells possess traits reminiscent of those ascribed to normal stem cells. It is unclear, however, whether these phenotypic similarities reflect the activity of common molecular pathways. Here, we analyze the enrichment patterns of gene sets associated with embryonic stem ( ES) cell identity in the expression profiles of various human tumor types. We find that histologically poorly differentiated tumors show preferential overexpression of genes normally enriched in ES cells, combined with preferential repression of Polycomb- regulated genes. Moreover, activation targets of Nanog, Oct4, Sox2 and c-Myc are more frequently overexpressed in poorly differentiated tumors than in well-differentiated tumors. In breast cancers, this ES-like signature is associated with high-grade estrogen receptor ( ER)-negative tumors, often of the basal-like subtype, and with poor clinical outcome. The ES signature is also present in poorly differentiated glioblastomas and bladder carcinomas. We identify a subset of ES cell-associated transcription regulators that are highly expressed in poorly differentiated tumors. Our results reveal a previously unknown link between genes associated with ES cell identity and the histopathological traits of tumors and support the possibility that these genes contribute to stem cell-like phenotypes shown by many tumors.	[Ben-Porath, Ittai; Thomson, Matthew W.; Regev, Aviv; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ben-Porath, Ittai; Weinberg, Robert A.] MIT, Ludwig Ctr Canc Res, Cambridge, MA 02142 USA; [Thomson, Matthew W.; Regev, Aviv] MIT, Broad Inst Harvard, Cambridge, MA 02142 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Dept Med Oncol, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Ben-Porath, Ittai; Ge, Ruping; Bell, George W.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu			NCI NIH HHS [R01 CA078461, R01 CA078461-10A1] Funding Source: Medline; NHGRI NIH HHS [P41 HG004059, P41 HG 004059] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004059] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li XL, 2004, INT J ONCOL, V24, P257; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	50	1854	1920	4	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					499	507		10.1038/ng.127	http://dx.doi.org/10.1038/ng.127			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443585	Green Accepted			2022-12-25	WOS:000255366700013
J	Boyden, LM; Lewis, JM; Barbee, SD; Bas, A; Girardi, M; Hayday, AC; Tigelaar, RE; Lifton, RP				Boyden, Lynn M.; Lewis, Julia M.; Barbee, Susannah D.; Bas, Anna; Girardi, Michael; Hayday, Adrian C.; Tigelaar, Robert E.; Lifton, Richard P.			Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gamma delta T cells	NATURE GENETICS			English	Article							ANTIGEN RECEPTORS; VIRUS-INFECTION; BOVINE SKIN; IMMUNITY; MICE; LYMPHOCYTES; REPERTOIRE; GENOME	B cells, alpha beta T cells and gamma delta T cells are conserved lymphocyte subtypes encoding their antigen receptors from somatically rearranged genes. ab T cells undergo positive selection in the thymus by engagement of their T cell receptors (TCRs) with self-peptides presented by major histocompatibility complex molecules(1). The molecules that select gamma delta T cells are unknown(2-4). V gamma 5(+)V delta 1(+) cells comprise 90% of mouse epidermal gamma delta T cells(4). By mapping and genetic complementation using a strain showing loss of Vc5(+)Vd1(+) cells due to a failure of thymic selection, we show that this defect is caused by mutation in Skint1, a newly identified gene expressed in thymus and skin that encodes a protein with immunoglobulin-like and transmembrane domains. Skint1 is the prototypic member of a rapidly evolving family of at least 11 genes in mouse, with greatest similarity to the butyrophilin genes. These findings define a new family of proteins mediating key epithelial-immune interactions.	[Boyden, Lynn M.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lewis, Julia M.; Girardi, Michael; Tigelaar, Robert E.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Barbee, Susannah D.; Bas, Anna; Hayday, Adrian C.] Kings Coll London, Sch Med, Peter Gorer Dept Immunobiol, Guys Hosp, London SE1 9RT, England; [Tigelaar, Robert E.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHM 1-308, New Haven, CT 06510 USA.	richard.lifton@yale.edu		Girardi, Michael/0000-0003-1887-9343; HAYDAY, ADRIAN/0000-0002-9495-5793	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA102703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA102703] Funding Source: Medline; NIAMS NIH HHS [K08 AR002072] Funding Source: Medline; NICHD NIH HHS [T32 HD007149] Funding Source: Medline; NIDDK NIH HHS [P30 DK079310] Funding Source: Medline; Wellcome Trust [071534] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; BOS JD, 1990, J INVEST DERMATOL, V94, P37, DOI 10.1111/1523-1747.ep12873333; DSouza CD, 1997, J IMMUNOL, V158, P1217; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Fujiwara K, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-39; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hein WR, 1997, IMMUNOLOGY, V91, P58, DOI 10.1046/j.1365-2567.1997.00224.x; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Janeway CA, 2001, IMMUNOBIOLOGY; King DP, 1999, J IMMUNOL, V162, P5033; Kuhnlein P, 1996, EUR J IMMUNOL, V26, P3092, DOI 10.1002/eji.1830261240; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Peng SL, 1996, J IMMUNOL, V157, P5689; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; TIGELAAR RE, 1990, J INVEST DERMATOL, V94, pS58, DOI 10.1111/1523-1747.ep12875138; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zachariadis O, 2006, INFECT IMMUN, V74, P1837, DOI 10.1128/IAI.74.3.1837-1845.2006	30	217	234	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					656	662		10.1038/ng.108	http://dx.doi.org/10.1038/ng.108			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408721	Green Accepted			2022-12-25	WOS:000255366700036
J	Martinez, D; Berka, RM; Henrissat, B; Saloheimo, M; Arvas, M; Baker, SE; Chapman, J; Chertkov, O; Coutinho, PM; Cullen, D; Danchin, EGJ; Grigoriev, IV; Harris, P; Jackson, M; Kubicek, CP; Han, CS; Ho, I; Larrondo, LF; de Leon, AL; Magnuson, JK; Merino, S; Misra, M; Nelson, B; Putnam, N; Robbertse, B; Salamov, AA; Schmoll, M; Terry, A; Thayer, N; Westerholm-Parvinen, A; Schoch, CL; Yao, J; Barbote, R; Nelson, MA; Detter, C; Bruce, D; Kuske, CR; Xie, G; Richardson, P; Rokhsar, DS; Lucas, SM; Rubin, EM; Dunn-Coleman, N; Ward, M; Brettin, TS				Martinez, Diego; Berka, Randy M.; Henrissat, Bernard; Saloheimo, Markku; Arvas, Mikko; Baker, Scott E.; Chapman, Jarod; Chertkov, Olga; Coutinho, Pedro M.; Cullen, Dan; Danchin, Etienne G. J.; Grigoriev, Igor V.; Harris, Paul; Jackson, Melissa; Kubicek, Christian P.; Han, Cliff S.; Ho, Isaac; Larrondo, Luis F.; de Leon, Alfredo Lopez; Magnuson, Jon K.; Merino, Sandy; Misra, Monica; Nelson, Beth; Putnam, Nicholas; Robbertse, Barbara; Salamov, Asaf A.; Schmoll, Monika; Terry, Astrid; Thayer, Nina; Westerholm-Parvinen, Ann; Schoch, Conrad L.; Yao, Jian; Barbote, Ravi; Nelson, Mary Anne; Detter, Chris; Bruce, David; Kuske, Cheryl R.; Xie, Gary; Richardson, Paul; Rokhsar, Daniel S.; Lucas, Susan M.; Rubin, Edward M.; Dunn-Coleman, Nigel; Ward, Michael; Brettin, Thomas S.			Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina)	NATURE BIOTECHNOLOGY			English	Article							ELECTROPHORETIC KARYOTYPE; CELL-WALL; WILD-TYPE; CELLULASE; EVOLUTIONARY; ENZYMES; PROTEIN; LIGNOCELLULOSE; FUMIGATUS; REVEALS	Trichoderma reesei is the main industrial source of cellulases and hemicellulases used to depolymerize biomass to simple sugars that are converted to chemical intermediates and biofuels, such as ethanol. We assembled 89 scaffolds (sets of ordered and oriented contigs) to generate 34 Mbp of nearly contiguous T. reesei genome sequence comprising 9,129 predicted gene models. Unexpectedly, considering the industrial utility and effectiveness of the carbohydrate-active enzymes of T. reesei, its genome encodes fewer cellulases and hemicellulases than any other sequenced fungus able to hydrolyze plant cell wall polysaccharides. Many T. reesei genes encoding carbohydrate-active enzymes are distributed nonrandomly in clusters that lie between regions of synteny with other Sordariomycetes. Numerous genes encoding biosynthetic pathways for secondary metabolites may promote survival of T. reesei in its competitive soil habitat, but genome analysis provided little mechanistic insight into its extraordinary capacity for protein secretion. Our analysis, coupled with the genome sequence data, provides a roadmap for constructing enhanced T. reesei strains for industrial applications such as biofuel production.	[Martinez, Diego; Chertkov, Olga; Jackson, Melissa; Han, Cliff S.; Misra, Monica; Thayer, Nina; Barbote, Ravi; Detter, Chris; Bruce, David; Kuske, Cheryl R.; Xie, Gary] Los Alamos Natl Lab, Joint Genome Inst, Los Alamos, NM 87545 USA; [Berka, Randy M.; Harris, Paul; de Leon, Alfredo Lopez; Merino, Sandy; Nelson, Beth] Novozymes Inc, Davis, CA 95618 USA; [Henrissat, Bernard; Coutinho, Pedro M.; Danchin, Etienne G. J.] Univ Aix Marseille 1, AFMB, CNRS, UMR 6098,Case 932, F-13288 Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.; Danchin, Etienne G. J.] Univ Aix Marseille 2, AFMB, CNRS, UMR 6098,Case 932, F-13288 Marseille, France; [Saloheimo, Markku; Arvas, Mikko; Westerholm-Parvinen, Ann] VTT Tech Res Ctr Finland, Espoo 02044, Finland; [Baker, Scott E.; Magnuson, Jon K.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Chapman, Jarod; Grigoriev, Igor V.; Ho, Isaac; Putnam, Nicholas; Salamov, Asaf A.; Terry, Astrid; Richardson, Paul; Rokhsar, Daniel S.; Lucas, Susan M.; Rubin, Edward M.; Brettin, Thomas S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Cullen, Dan] US Forest Serv, USDA, Forest Prod Lab, Madison, WI 53726 USA; [Kubicek, Christian P.; Schmoll, Monika] Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1060 Vienna, Austria; [Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago, Chile; [Larrondo, Luis F.] Millenium Inst Fundamental & Appl Biol, Santiago, Chile; [Robbertse, Barbara; Schoch, Conrad L.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Yao, Jian; Ward, Michael] Genencor Int, Palo Alto, CA 94304 USA; [Dunn-Coleman, Nigel] AlerGenetiCa SL, Tenerife, Spain; [Martinez, Diego; Nelson, Mary Anne] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Novozymes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; VTT Technical Research Center Finland; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); United States Forest Service; Technische Universitat Wien; Pontificia Universidad Catolica de Chile; Oregon State University; University of New Mexico	Martinez, D (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	admar@unm.edu	Terry, Astrid Y/A-2538-2011; Putnam, Nicholas/B-9968-2008; Henrissat, Bernard/J-2475-2012; Arvas, Mikko/A-4757-2011; Baker, Scott E./ABB-1635-2020; Coutinho, Pedro M/C-4473-2008; Barabote, Ravi/B-8727-2011; Danchin, Etienne G.J./A-6648-2008; Danchin, Etienne GJ/X-6969-2019; Schoch, Conrad L./J-4825-2012; Cullen, Daniel/AAN-5484-2020; Arvas, Mikko/AAA-7438-2021; Schmoll, Monika/I-6541-2016; Baker, Scott E/X-2065-2018; Barabote, Ravi/C-1299-2017; Larrondo, Luis/J-1086-2016	Terry, Astrid Y/0000-0002-5234-1224; Putnam, Nicholas/0000-0002-1315-782X; Henrissat, Bernard/0000-0002-3434-8588; Arvas, Mikko/0000-0002-6902-8488; Baker, Scott E./0000-0001-5085-3106; Danchin, Etienne G.J./0000-0003-4146-5608; Danchin, Etienne GJ/0000-0003-4146-5608; Schoch, Conrad L./0000-0003-1839-5322; Arvas, Mikko/0000-0002-6902-8488; Schmoll, Monika/0000-0003-3918-0574; Baker, Scott E/0000-0001-5085-3106; Grigoriev, Igor/0000-0002-3136-8903; Magnuson, Jon/0000-0001-7712-7024; Han, Cliff/0000-0003-1972-0692; Barabote, Ravi/0000-0002-0403-246X; xie, gary/0000-0002-9176-924X; Larrondo, Luis/0000-0002-8832-7109	NIGMS NIH HHS [GM060201] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARORA DK, 2006, BIOINFORMATICS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bashkirova EV, 2005, APPL MYCOL BIOTECH, V5, P275; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; CARTER GL, 1992, MOL MICROBIOL, V6, P2167, DOI 10.1111/j.1365-2958.1992.tb01390.x; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Coutinho PM, 1999, ROY SOC CH, P3; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Detter JC, 2002, GENOMICS, V80, P691, DOI 10.1006/geno.2002.7020; Diener SE, 2004, FUNGAL GENET BIOL, V41, P1077, DOI 10.1016/j.fgb.2004.08.007; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Druzhinina IS, 2006, APPL ENVIRON MICROB, V72, P2126, DOI 10.1128/AEM.72.3.2126-2133.2006; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; HERRERAESTRELLA A, 1993, MOL MICROBIOL, V7, P515, DOI 10.1111/j.1365-2958.1993.tb01142.x; Hoberman R, 2005, J COMPUT BIOL, V12, P1083, DOI 10.1089/cmb.2005.12.1083; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MANDELS M, 1957, J BACTERIOL, V73, P269, DOI 10.1128/JB.73.2.269-278.1957; MANTYLA AL, 1992, CURR GENET, V21, P471, DOI 10.1007/BF00351657; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; NEVALAINEN H, 1994, J BIOTECHNOL, V37, P193, DOI 10.1016/0168-1656(94)90126-0; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Patel-Predd P, 2006, ENVIRON SCI TECHNOL, V40, P4052, DOI 10.1021/es062725u; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Rosgaard L, 2006, BIOTECHNOL PROGR, V22, P493, DOI 10.1021/bp050361o; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; SHAPIRO H, 2005, LBNL58236; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tholudur A, 1999, BIOTECHNOL BIOENG, V66, P1, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;1::AID-BIT1&gt;3.0.CO;2-K; Valkonen M, 2007, J BIOL CHEM, V282, P22775, DOI 10.1074/jbc.M700916200; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; [No title captured]	49	841	957	9	243	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2008	26	5					553	560		10.1038/nbt1403	http://dx.doi.org/10.1038/nbt1403			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	299LJ	18454138	hybrid, Green Submitted			2022-12-25	WOS:000255756800028
J	Kamena, F; Tamborrini, M; Liu, XY; Kwon, YU; Thompson, F; Pluschke, G; Seeberger, PH				Kamena, Faustin; Tamborrini, Marco; Liu, Xinyu; Kwon, Yong-Uk; Thompson, Fiona; Pluschke, Gerd; Seeberger, Peter H.			Synthetic GPI array to study antitoxic malaria response	NATURE CHEMICAL BIOLOGY			English	Article							PLASMODIUM-FALCIPARUM GLYCOSYLPHOSPHATIDYLINOSITOLS; ASEXUAL ERYTHROCYTIC STAGES; MEMBRANE ANCHOR; ASSOCIATION; ANTIBODIES; PATHOGENESIS; PARASITE; IMMUNITY; CHILDREN	Parasite glycosylphosphatidylinositol (GPI) is an important toxin in malaria disease, and people living in malaria-endemic regions often produce high levels of anti-GPI antibodies. The natural anti-GPI antibody response needs to be understood to aid the design of an efficient carbohydrate-based antitoxin vaccine. We present a versatile approach based on a synthetic GPI glycan array to correlate anti-GPI antibody levels and protection from severe malaria.	[Kamena, Faustin; Liu, Xinyu; Kwon, Yong-Uk; Seeberger, Peter H.] ETH, Organ Chem Lab, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Tamborrini, Marco; Pluschke, Gerd] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Thompson, Fiona] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Clin Med, Oxford OX3 7LJ, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Tropical & Public Health Institute; University of Oxford	Seeberger, PH (corresponding author), ETH, Organ Chem Lab, Swiss Fed Inst Technol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	seeberger@org.chem.ethz.ch	Liu, Xinyu/A-8933-2013					Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Borrow R, 2001, J INFECT DIS, V184, P377, DOI 10.1086/322024; Boutlis CS, 2002, INFECT IMMUN, V70, P5052, DOI 10.1128/IAI.70.9.5052-5057.2002; de Souza JB, 2002, INFECT IMMUN, V70, P5045, DOI 10.1128/IAI.70.9.5045-5051.2002; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Schmidt A, 1998, EXP PARASITOL, V88, P95, DOI 10.1006/expr.1998.4241; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Singh N, 1996, J BIOL CHEM, V271, P12879, DOI 10.1074/jbc.271.22.12879; Suguitan AL, 2004, INFECT IMMUN, V72, P5267, DOI 10.1128/IAI.72.9.5267-5273.2004	15	99	103	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					238	240		10.1038/nchembio.75	http://dx.doi.org/10.1038/nchembio.75			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18311131				2022-12-25	WOS:000254268300010
J	Park, CC; Ahn, S; Bloom, JS; Lin, A; Wang, RT; Wu, T; Sekar, A; Khan, AH; Farr, CJ; Lusis, AJ; Leahy, RM; Lange, K; Smith, DJ				Park, Christopher C.; Ahn, Sangtae; Bloom, Joshua S.; Lin, Andy; Wang, Richard T.; Wu, Tongtong; Sekar, Aswin; Khan, Arshad H.; Farr, Christine J.; Lusis, Aldons J.; Leahy, Richard M.; Lange, Kenneth; Smith, Desmond J.			Fine mapping of regulatory loci for mammalian gene expression using radiation hybrids	NATURE GENETICS			English	Article							FALSE DISCOVERY RATE; MAXIMUM-LIKELIHOOD; LINKAGE ANALYSIS; MICROARRAY DATA; EM ALGORITHM; WHOLE GENOME; MOUSE GENOME; YEAST; MAP; IDENTIFICATION	We mapped regulatory loci for nearly all protein-coding genes in mammals using comparative genomic hybridization and expression array measurements from a panel of mouse-hamster radiation hybrid cell lines. The large number of breaks in the mouse chromosomes and the dense genotyping of the panel allowed extremely sharp mapping of loci. As the regulatory loci result from extra gene dosage, we call them copy number expression quantitative trait loci, or ceQTLs. The -2log(10)P support interval for the ceQTLs was <150 kb, containing an average of <2-3 genes. We identified 29,769 trans ceQTLs with -log(10)P>4, including 13 hotspots each regulating >100 genes in trans. Further, this work identifies 2,761 trans ceQTLs harboring no known genes, and provides evidence for a mode of gene expression autoregulation specific to the X chromosome.	[Park, Christopher C.; Bloom, Joshua S.; Lin, Andy; Wang, Richard T.; Sekar, Aswin; Khan, Arshad H.; Smith, Desmond J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ahn, Sangtae; Leahy, Richard M.] Univ So Calif, Viterbi Sch Engn, Dept Elect Engn, Inst Signal & Image Proc, Los Angeles, CA 90089 USA; [Wu, Tongtong] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Farr, Christine J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Dept Med, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lange, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California Los Angeles; University of Cambridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	DSmith@mednet.ucla.edu		Farr, Christine/0000-0002-5357-5962; Park, Christopher/0000-0002-2579-6039; Wang, Richard/0000-0002-2483-3205	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG002536] Funding Source: Medline; NHLBI NIH HHS [P01 HL030568, P01 HL028481-25, P01 HL030568-220009, P01 HL028481] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avner P, 2001, NAT GENET, V29, P194, DOI 10.1038/ng1001-194; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behboudi A, 2002, GENOMICS, V79, P844, DOI 10.1006/geno.2002.6785; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hudson TJ, 2001, NAT GENET, V29, P201, DOI 10.1038/ng1001-201; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; JANSEN RC, 1993, BIOMETRICS, V49, P227, DOI 10.2307/2532616; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; McCarthy LC, 1996, TRENDS GENET, V12, P491, DOI 10.1016/S0168-9525(96)30110-8; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	42	25	25	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					421	429		10.1038/ng.113	http://dx.doi.org/10.1038/ng.113			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362883	Green Published, Green Accepted			2022-12-25	WOS:000254388100012
J	Kitamura, T; Asai, N; Enomoto, A; Maeda, K; Kato, T; Ishida, M; Jiang, P; Watanabe, T; Usukura, J; Kondo, T; Costantini, F; Murohara, T; Takahashi, M				Kitamura, Tomoya; Asai, Naoya; Enomoto, Atsushi; Maeda, Kengo; Kato, Takuya; Ishida, Maki; Jiang, Ping; Watanabe, Takashi; Usukura, Jiro; Kondo, Takahisa; Costantini, Frank; Murohara, Toyoaki; Takahashi, Masahide			Regulation of VeGF-mediated angiogenesis by the Akt/PKB substrate Girdin	NATURE CELL BIOLOGY			English	Article							PATHOLOGICAL ANGIOGENESIS; ENDOTHELIAL-CELLS; AKT SIGNAL; GROWTH; KINASE; RAC; PERMEABILITY; MIGRATION; PATHWAY	The serine/threonine protein kinase Akt is involved in a variety of cellular processes including cell proliferation, survival, metabolism and gene expression. It is essential in vascular endothelial growth factor (VEGF)-mediated angiogenesis; however, it is not known how Akt regulates the migration of endothelial cells, a crucial process for vessel sprouting, branching and the formation of networks during angiogenesis. Here we report that Akt-mediated phosphorylation of Girdin, an actin-binding protein, promotes VEGF-dependent migration of endothelial cells and tube formation by these cells. We found that exogenously delivered adenovirus harbouring Girdin short interfering RNA in Matrigel embedded in mice, markedly inhibited VEGF-mediated angiogenesis. Targeted disruption of the Girdin gene in mice impaired vessel remodelling in the retina and angiogenesis from aortic rings, whereas Girdin was dispensable for embryonic vasculogenesis. These findings demonstrate that the Akt/Girdin signalling pathway is essential in VEGF-mediated postneonatal angiogenesis.	[Asai, Naoya; Enomoto, Atsushi; Kato, Takuya; Ishida, Maki; Jiang, Ping; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kitamura, Tomoya; Maeda, Kengo; Kondo, Takahisa; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Watanabe, Takashi] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi; Watanabe, Takashi] Nagoya Univ, Chikusa Ku, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Usukura, Jiro] Nagoya Univ, Div Associated Res Projects, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Costantini, Frank] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Div Mol Pathol, Ctr Neurol Dis & Canc,Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Columbia University; Nagoya University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mtakaha@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Enomoto, Atsushi/I-7272-2014	Takahashi, Masahide/0000-0002-2803-2683; Watanabe, Takashi/0000-0002-9015-5246; Takagishi, Maki/0000-0002-6745-3982; Usukura, Jiro/0000-0003-2286-5403; Enomoto, Atsushi/0000-0002-9206-6116				Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	27	174	195	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					329	U62		10.1038/ncb1695	http://dx.doi.org/10.1038/ncb1695			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264090				2022-12-25	WOS:000253778300015
J	Li, J; Wang, CY				Li, Jiong; Wang, Cun-Yu			TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis	NATURE CELL BIOLOGY			English	Article							RECEPTOR-RELATED PROTEIN-5; CELL FACTOR; C-MYC; PATHWAY; APC; APOPTOSIS; COMPLEX; EXPRESSION; REPRESSOR; DEFECTS	Aberrant Wnt signalling promotes oncogenesis by increasing the nuclear accumulation of beta-catenin to activate downstream target genes. However, the mechanism of beta-catenin recruitment to the Wnt target-gene promoter, a critical step for removing the co-repressor complex, is largely unknown. Here, we report that transducin beta-like protein 1 (TBL1) and its highly related family member TBLR1 were required for Wnt-beta-catenin-mediated transcription. Wnt signalling induced the interaction between beta-catenin and TBL1-TBLR1, as well as their binding to Wnt target genes. Importantly, the recruitment of TBL1-TBLR1 and beta-catenin to Wnt target-gene promoters was mutually dependent on each other. Furthermore, the depletion of TBL1-TBLR1 significantly inhibited Wnt-beta-catenin-induced gene expression and oncogenic growth in vitro and in vivo. Our results unravel two new components required for nuclear beta-catenin function, and have important implications in developing new strategies for inhibiting Wnt-beta-catenin-mediated tumorigenesis.	[Li, Jiong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu						Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; ZENG W, 1998, NATURE, V403, P789; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	41	134	138	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					160	U36		10.1038/ncb1684	http://dx.doi.org/10.1038/ncb1684			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193033				2022-12-25	WOS:000252897800011
J	Szent-Gyorgyi, C; Schmidt, BA; Creeger, Y; Fisher, GW; Zakel, KL; Adler, S; Fitzpatrick, JAJ; Woolford, CA; Yan, Q; Vasilev, KV; Berget, PB; Bruchez, MP; Jarvik, JW; Waggoner, A				Szent-Gyorgyi, Christopher; Schmidt, Brigitte A.; Creeger, Yehuda; Fisher, Gregory W.; Zakel, Kelly L.; Adler, Sally; Fitzpatrick, James A. J.; Woolford, Carol A.; Yan, Qi; Vasilev, Kalin V.; Berget, Peter B.; Bruchez, Marcel P.; Jarvik, Jonathan W.; Waggoner, Alan			Fluorogen-activating single-chain antibodies for imaging cell surface proteins	NATURE BIOTECHNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DISPLAY LIBRARY; LIVING CELLS; DYES; SECRETION; EVOLUTION; DYNAMICS; AFFINITY	Imaging of live cells has been revolutionized by genetically encoded fluorescent probes, most famously green and other fluorescent proteins, but also peptide tags that bind exogenous fluorophores(1). We report here the development of protein reporters that generate fluorescence from otherwise dark molecules (fluorogens). Eight unique fluorogen activating proteins (FAPs) have been isolated by screening a library of human single-chain antibodies (scFvs) using derivatives of thiazole orange and malachite green. When displayed on yeast or mammalian cell surfaces, these FAPs bind fluorogens with nanomolar affinity, increasing green or red fluorescence thousands-fold to brightness levels typical of fluorescent proteins. Spectral variation can be generated by combining different FAPs and fluorogen derivatives. Visualization of FAPs on the cell surface or within the secretory apparatus of mammalian cells can be achieved by choosing membrane permeant or impermeant fluorogens. The FAP technique is extensible to a wide variety of nonfluorescent dyes.	[Szent-Gyorgyi, Christopher; Schmidt, Brigitte A.; Creeger, Yehuda; Fisher, Gregory W.; Zakel, Kelly L.; Fitzpatrick, James A. J.; Bruchez, Marcel P.; Waggoner, Alan] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Adler, Sally; Woolford, Carol A.; Yan, Qi; Vasilev, Kalin V.; Berget, Peter B.; Jarvik, Jonathan W.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Szent-Gyorgyi, C (corresponding author), Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, 4400 5th Ave, Pittsburgh, PA 15213 USA.	css@andrew.cmu.edu; waggoner@andrew.cmu	Fitzpatrick, James/C-2268-2009; Bruchez, Marcel P/C-2271-2009	Fitzpatrick, James/0000-0002-7907-3602; Bruchez, Marcel P/0000-0002-7370-4848; Berget, Peter/0000-0002-4502-2647; Woolford, Carol/0000-0001-6261-3468	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NCRR NIH HHS [7 U54 RR022241] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Babendure JR, 2003, J AM CHEM SOC, V125, P14716, DOI 10.1021/ja037994o; Baptista MS, 1998, J PHYS CHEM B, V102, P4678, DOI 10.1021/jp981185n; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Huang D, 2005, BIOTECHNOL PROGR, V21, P349, DOI 10.1021/bp0497482; IWAKI T, 1993, BIOCHEMISTRY-US, V32, P7589, DOI 10.1021/bi00080a034; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; KUBIN RF, 1982, J LUMIN, V27, P455, DOI 10.1016/0022-2313(82)90045-X; Lacowicz J.R., 1999, PRINCIPLES FLUORESCE; Marks KM, 2006, NAT METHODS, V3, P591, DOI 10.1038/NMETH906; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MUELLER WHI, 1981, NUCLEIC ACIDS RES, V95, P95; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Nygren J, 1998, BIOPOLYMERS, V46, P39, DOI 10.1002/(SICI)1097-0282(199807)46:1<39::AID-BIP4>3.0.CO;2-Z; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Rozinov MN, 1998, CHEM BIOL, V5, P713, DOI 10.1016/S1074-5521(98)90664-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Simeonov A, 2000, SCIENCE, V290, P307, DOI 10.1126/science.290.5490.307; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	36	286	300	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					235	240		10.1038/nbt1368	http://dx.doi.org/10.1038/nbt1368			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18157118				2022-12-25	WOS:000253193000027
J	Yang, JY; Zong, CS; Xia, WY; Yamaguchi, H; Ding, QQ; Xie, XM; Lang, JY; Lai, CC; Chang, CJ; Huang, WC; Huang, H; Kuo, HP; Lee, DF; Li, LY; Lien, HC; Cheng, XY; Chang, KJ; Hsiao, CD; Tsai, FJ; Tsai, CH; Sahin, AA; Muller, WJ; Mills, GB; Yu, DH; Hortobagyi, GN; Hung, MC				Yang, Jer-Yen; Zong, Cong S.; Xia, Weiya; Yamaguchi, Hirohito; Ding, Qingqing; Xie, Xiaoming; Lang, Jing-Yu; Lai, Chien-Chen; Chang, Chun-Ju; Huang, Wei-Chien; Huang, Hsin; Kuo, Hsu-Ping; Lee, Dung-Fang; Li, Long-Yuan; Lien, Huang-Chun; Cheng, Xiaoyun; Chang, King-Jen; Hsiao, Chwan-Deng; Tsai, Fuu-Jen; Tsai, Chang-Hai; Sahin, Aysegul A.; Muller, William J.; Mills, Gordon B.; Yu, Dihua; Hortobagyi, Gabriel N.; Hung, Mien-Chie			ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation	NATURE CELL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR P53; UBIQUITIN LIGASE; BETA-CATENIN; CELL-CYCLE; BREAST-CANCER; KAPPA-B; MDM2; EXPRESSION; RAS	The RAS-ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that ERK downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylated FOXO3a degrades via an MDM2-mediated ubiquitin-proteasome pathway. However, the non-phosphorylated FOXO3a mutant is resistant to the interaction and degradation by murine double minute 2 (MDM2), thereby resulting in a strong inhibition of cell proliferation and tumorigenicity. Taken together, our study elucidates a novel pathway in cell growth and tumorigenesis through negative regulation of FOXO3a by RAS-ERK and MDM2.	[Yang, Jer-Yen; Zong, Cong S.; Xia, Weiya; Yamaguchi, Hirohito; Ding, Qingqing; Xie, Xiaoming; Lang, Jing-Yu; Chang, Chun-Ju; Huang, Wei-Chien; Huang, Hsin; Kuo, Hsu-Ping; Lee, Dung-Fang; Cheng, Xiaoyun; Yu, Dihua; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Jer-Yen; Kuo, Hsu-Ping; Lee, Dung-Fang; Cheng, Xiaoyun; Yu, Dihua; Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lai, Chien-Chen; Li, Long-Yuan; Tsai, Fuu-Jen; Tsai, Chang-Hai; Hung, Mien-Chie] China Med Univ Hosp, Taichung 404, Taiwan; [Huang, Hsin] Univ Calif Davis, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA; [Li, Long-Yuan; Tsai, Chang-Hai; Hung, Mien-Chie] Asian Univ, Taichung 413, Taiwan; [Lien, Huang-Chun] Natl Taiwan Univ, Dept Pathol, Taipei 106, Taiwan; [Chang, King-Jen] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 106, Taiwan; [Chang, King-Jen] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 106, Taiwan; [Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Sahin, Aysegul A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Muller, William J.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Muller, William J.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California Davis; Asia University Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; University of Texas System; UTMD Anderson Cancer Center; McGill University; McGill University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mhung@mdanderson.org	Hsiao, Chwan-Deng/AAZ-8869-2021; Tsai, Fuu-Jen/J-4140-2015; Cheng, Xiaoyun/HDM-5535-2022; Huang, Wei-Chien/D-1740-2012; Hung, Mien-Chie/ABD-5911-2021; /AGZ-4617-2022; Huang, Wei-Chien/H-3126-2019	Hsiao, Chwan-Deng/0000-0002-7012-1532; Huang, Wei-Chien/0000-0001-6467-8716; Hung, Mien-Chie/0000-0003-4317-4740; /0000-0002-7133-8266; Huang, Wei-Chien/0000-0001-6467-8716; Li, Long-Yuan/0000-0001-7472-8318; Yu, Dihua/0000-0001-6231-9381; Chang, King jen/0000-0001-9811-3422; LIEN, HUANG-CHUN/0000-0003-1472-1231; Lee, Dung-Fang/0000-0003-2387-597X; Chang, Chunju/0000-0003-2887-9603	NATIONAL CANCER INSTITUTE [P50CA116199, P30CA016672, P01CA099031, R01CA109311] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA099031, P30 CA016672, P50 CA116199, R01 CA109311, CA116199, P01 CA099031-01, CA16672, P50 CA116199-01, P01 CA 099031, P01 CA099031-010001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hu Mickey C-T, 2005, Future Oncol, V1, P67, DOI 10.1517/14796694.1.1.67; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Phelps M, 2005, J BIOL CHEM, V280, P16651, DOI 10.1074/jbc.M412334200; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Scholl FA, 2005, CANCER LETT, V230, P1, DOI 10.1016/j.canlet.2004.12.013; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Terry DE, 2004, J AM SOC MASS SPECTR, V15, P784, DOI 10.1016/j.jasms.2004.02.005; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; TRAN H, 2003, SCI STKE RE, V5; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINBERG RA, 1984, BLOOD, V64, P1143; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang JY, 2006, INT J ONCOL, V29, P643; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	41	501	524	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					138	U22		10.1038/ncb1676	http://dx.doi.org/10.1038/ncb1676			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18204439	Green Accepted			2022-12-25	WOS:000252897800009
J	Joffre, O; Santolaria, T; Calise, D; Al Saati, T; Hudrisier, D; Romagnoli, P; van Meerwijk, JPM				Joffre, Olivier; Santolaria, Thibault; Calise, Denis; Al Saati, Talal; Hudrisier, Denis; Romagnoli, Paola; van Meerwijk, Joost P. M.			Prevention of acute and chronic allograft rejection with CD4(+)CD25(+)Foxp3(+) regulatory T lymphocytes	NATURE MEDICINE			English	Article							TRANSPLANTATION TOLERANCE; MIXED CHIMERISM; MARROW-TRANSPLANTATION; AUTOIMMUNE-DISEASE; IN-VIVO; CELLS; INDUCTION	A major challenge in transplantation medicine is controlling the very strong immune responses to foreign antigens that are responsible for graft rejection. Although immunosuppressive drugs efficiently inhibit acute graft rejection, a substantial proportion of patients suffer chronic rejection that ultimately leads to functional loss of the graft(1). Induction of immunological tolerance to transplants would avoid rejection and the need for lifelong treatment with immunosuppressive drugs(1,2). Tolerance to self-antigens is ensured naturally by several mechanisms(3); one major mechanism depends on the activity of regulatory T lymphocytes(4,5). Here we show that in mice treated with clinically acceptable levels of irradiation, regulatory CD4(+)CD25(+)Foxp3(+) T cells stimulated in vitro with alloantigens induced long-term tolerance to bone marrow and subsequent skin and cardiac allografts. Regulatory T cells specific for directly presented donor antigens prevented only acute rejection, despite hematopoietic chimerism. By contrast, regulatory T cells specific for both directly and indirectly presented alloantigens prevented both acute and chronic rejection. Our findings demonstrate the potential of appropriately stimulated regulatory T cells for future cell-based therapeutic approaches to induce lifelong immunological tolerance to allogeneic transplants.	[Joffre, Olivier; Santolaria, Thibault; Hudrisier, Denis; Romagnoli, Paola; van Meerwijk, Joost P. M.] INSERM, U563, Tolerance & Autoimmun Sect, F-31300 Toulouse, France; [Joffre, Olivier; Santolaria, Thibault; Hudrisier, Denis; Romagnoli, Paola; van Meerwijk, Joost P. M.] Univ Toulouse 3, F-31400 Toulouse, France; [Calise, Denis] INSERM, Inst Louis Bugnard, Inst Fed Rech 31, F-31403 Toulouse, France; [Al Saati, Talal] INSERM, Inst Claude Preval, Inst Fed Rech 30, F-31300 Toulouse, France; [van Meerwijk, Joost P. M.] Inst Univ France, F-75000 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France	van Meerwijk, JPM (corresponding author), INSERM, U563, Tolerance & Autoimmun Sect, F-31300 Toulouse, France.	joost.van-meerwijk@toulouse.inserm.fr	van Meerwijk, Joost P.M./K-1345-2014; Joffre, Olivier P/K-1235-2014; Romagnoli, Paola/K-2237-2014	van Meerwijk, Joost P.M./0000-0001-8231-1897; Joffre, Olivier P/0000-0003-1168-8165; Hudrisier, Denis/0000-0002-3631-9561				Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; BOYSE EA, 1970, NATURE, V227, P901, DOI 10.1038/227901a0; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Cosimi AB, 2004, TRANSPLANTATION, V77, P943, DOI 10.1097/01.TP.0000117779.23431.3F; Coudert RD, 2002, J IMMUNOL, V169, P2979, DOI 10.4049/jimmunol.169.6.2979; Fudaba Y, 2006, AM J TRANSPLANT, V6, P2121, DOI 10.1111/j.1600-6143.2006.01434.x; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; ILDSTAD ST, 1985, J EXP MED, V162, P231, DOI 10.1084/jem.162.1.231; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jiang SP, 2003, BLOOD, V102, P2180, DOI 10.1182/blood-2003-04-1164; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Joffre O, 2006, SEMIN IMMUNOL, V18, P128, DOI 10.1016/j.smim.2006.01.005; Le Moine A, 1999, J CLIN INVEST, V103, P1659, DOI 10.1172/JCI5504; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Luo B, 2007, EUR J IMMUNOL, V37, P1233, DOI 10.1002/eji.200636938; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salama AD, 2007, J IMMUNOL, V178, P5419, DOI 10.4049/jimmunol.178.9.5419; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Stockinger B, 1999, Adv Immunol, V71, P229; Sykes M, 2001, IMMUNITY, V14, P417, DOI 10.1016/S1074-7613(01)00122-4; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Vriesendorp HM, 2003, EXP HEMATOL, V31, P844, DOI 10.1016/S0301-472X(03)00229-7; Waldmann H, 2004, SCIENCE, V305, P209, DOI 10.1126/science.1099538	30	405	434	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					88	92		10.1038/nm1688	http://dx.doi.org/10.1038/nm1688			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18066074	Green Accepted, Green Submitted			2022-12-25	WOS:000252222400027
J	Ng, RK; Gurdon, JB				Ng, Ray Kit; Gurdon, J. B.			Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription	NATURE CELL BIOLOGY			English	Article							CELL; METHYLATION; EXPRESSION; VARIANTS; LYSINE-4; POLYCOMB; CAPACITY	The remarkable stability of gene expression in somatic cells is exemplified by the way memory of an active gene state is retained when an endoderm cell nucleus is transplanted to an enucleated egg(1). Here we analyse the mechanism of a similar example of epigenetic memory. We find that memory can persist through 24 cell divisions in the absence of transcription and applies to the expression of the myogenic gene MyoD in non-muscle cell lineages of nuclear transplant embryos. We show that memory is not explained by the methylation of promoter DNA. However, we demonstrate that epigenetic memory correlates with the association of histone H3.3 with the MyoD promoter in embryos that display memory but not in those where memory has been lost. The association of a mutated histone H3.3 ( H3.3 E4, which lacks the methylatable H3.3 lysine 4) with promoter DNA eliminates memory, indicating a requirement of H3.3 K4 for memory. We also show that overexpression of H3.3 can enhance memory in transplanted nuclei. We therefore conclude that the association of histone H3.3 with the MyoD promoter makes a necessary contribution to this example of memory. Hence, we suggest that epigenetic memory helps to stabilize gene expression in normal development; it might also help to account for the inefficient reprogramming in some transplanted nuclei.	[Ng, Ray Kit; Gurdon, J. B.] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Ng, Ray Kit; Gurdon, J. B.] Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England	University of Cambridge	Gurdon, JB (corresponding author), Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	j.gurdon@gurdon.cam.ac.uk		GURDON, JOHN/0000-0002-5621-3799	Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Feng YQ, 2006, PLOS GENET, V2, P461, DOI 10.1371/journal.pgen.0020065; GEHRING WJ, 1978, GENETICS BIOL DROS C, V2, P511; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; HADORN E, 1965, BROOKHAVEN SYM BIOL, P148; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Stewart MD, 2006, MOL CELL BIOL, V26, P6890, DOI 10.1128/MCB.00948-06; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	30	239	248	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					102	U83		10.1038/ncb1674	http://dx.doi.org/10.1038/ncb1674			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066050				2022-12-25	WOS:000252116100018
J	Onouchi, Y; Gunji, T; Burns, JC; Shimizu, C; Newburger, JW; Yashiro, M; Nakamura, Y; Yanagawa, H; Wakui, K; Fukushima, Y; Kishi, F; Hamamoto, K; Terai, M; Sato, Y; Ouchi, K; Saji, T; Nariai, A; Kaburagi, Y; Yoshikawa, T; Suzuki, K; Tanaka, T; Nagai, T; Cho, H; Fujino, A; Sekine, A; Nakamichi, R; Tsunoda, T; Kawasaki, T; Nakamura, Y; Hata, A				Onouchi, Yoshihiro; Gunji, Tomohiko; Burns, Jane C.; Shimizu, Chisato; Newburger, Jane W.; Yashiro, Mayumi; Nakamura, Yoshikazu; Yanagawa, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Kishi, Fumio; Hamamoto, Kunihiro; Terai, Masaru; Sato, Yoshitake; Ouchi, Kazunobu; Saji, Tsutomu; Nariai, Akiyoshi; Kaburagi, Yoichi; Yoshikawa, Tetsushi; Suzuki, Kyoko; Tanaka, Takeo; Nagai, Toshiro; Cho, Hideo; Fujino, Akihiro; Sekine, Akihiro; Nakamichi, Reiichiro; Tsunoda, Tatsuhiko; Kawasaki, Tomisaku; Nakamura, Yusuke; Hata, Akira			ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms	NATURE GENETICS			English	Article							BASE-PAIR SUBSTITUTIONS; T-LYMPHOCYTES; HUMAN GENES; REGULATORY ELEMENTS; SIGNAL-TRANSDUCTION; MESSENGER; RNA; CONSEQUENCES; PREDICTION; EXPRESSION	Kawasaki disease is a pediatric systemic vasculitis of unknown etiology for which a genetic influence is suspected. We identified a functional SNP (itpkc_3) in the inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene on chromosome 19q13.2 that is significantly associated with Kawasaki disease susceptibility and also with an increased risk of coronary artery lesions in both Japanese and US children. Transfection experiments showed that the C allele of itpkc_3 reduces splicing efficiency of the ITPKC mRNA. ITPKC acts as a negative regulator of T-cell activation through the Ca2+/NFAT signaling pathway, and the C allele may contribute to immune hyper-reactivity in Kawasaki disease. This finding provides new insights into the mechanisms of immune activation in Kawasaki disease and emphasizes the importance of activated T cells in the pathogenesis of this vasculitis.	[Onouchi, Yoshihiro; Gunji, Tomohiko; Hata, Akira] RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan; [Gunji, Tomohiko] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Burns, Jane C.; Shimizu, Chisato] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Shimizu, Chisato] Rady Childrens Hosp, La Jolla, CA 92093 USA; [Newburger, Jane W.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Yashiro, Mayumi; Nakamura, Yoshikazu] Jichi Med Sch, Dept Publ Hlth, Minamimaki, Tochigi 3290498, Japan; [Yanagawa, Hiroshi] Saitama Prefectural Univ, Koshigaya, Saitama 3438540, Japan; [Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Prevent Med, Matsumoto, Nagano 3908621, Japan; [Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, Kurashiki, Okayama 7010192, Japan; [Hamamoto, Kunihiro] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 8318501, Japan; [Terai, Masaru] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Chiba 2768524, Japan; [Sato, Yoshitake] Fuji Heavy Ind Co Ltd, Dept Pediat, Fuji Heavy Ind Ltd, Gunma 3738585, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch, Dept Pediat, Okayama 7010192, Japan; [Saji, Tsutomu] Toho Univ, Sch Med, Dept Pediat, Tokyo 1438541, Japan; [Nariai, Akiyoshi; Kaburagi, Yoichi] Yokohama Minami Kyousai Hosp, Dept Pediat, Yokohama, Kanagawa 2360037, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Suzuki, Kyoko] Toyokawa Citizens Hosp, Dept Pediat, Aichi 4428561, Japan; [Tanaka, Takeo] Kure Med Ctr, NAtl Hosp Org, Dept Pediat, Okayama 7370023, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Cho, Hideo] Kawasaki Municipal Hosp, Dept Pediat, Kawasaki, Kanagawa 2100013, Japan; [Fujino, Akihiro] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Sekine, Akihiro] RIKEN, Lab Genotyping, Kanagawa 2300045, Japan; [Nakamichi, Reiichiro; Tsunoda, Tatsuhiko] RIKEN, SNP Res Ctr, Lab Med Informat, Kanagawa 2300045, Japan; [Kawasaki, Tomisaku] Japan Kawasaki Dis Res Ctr, Tokyo 1110031, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, SNP Res Ctr, Kanagawa 2300045, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Harvard University; Boston Children's Hospital; Jichi Medical University; Shinshu University; Kawasaki Medical School; Fukuoka University; Tokyo Women's Medical University; Subaru Corporation; Kawasaki Medical School; Toho University; Fujita Health University; Dokkyo Medical University; Keio University; RIKEN; RIKEN; University of Tokyo; RIKEN	Onouchi, Y (corresponding author), RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan.	onouchi@src.riken.jp	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015; Tsunoda, Tatsuhiko/K-2061-2014; Fujino, Akihiro/AAH-2243-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Fujino, Akihiro/0000-0003-2987-5081; Shimizu, Chisato/0000-0002-3149-2699	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069413-08, R01 HL069413, HL69413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COOK DH, 1989, CAN J CARDIOL, V5, P389; Dergun M, 2005, ARCH PEDIAT ADOL MED, V159, P876, DOI 10.1001/archpedi.159.9.876; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; FUJITA Y, 1989, PEDIATRICS, V84, P666; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T., 1967, PEDIATR INFECT DIS J, V16, P178; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MORISAKI H, 1993, J CLIN INVEST, V91, P2275, DOI 10.1172/JCI116455; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Raman V, 2001, PEDIATR INFECT DIS J, V20, P635, DOI 10.1097/00006454-200106000-00022; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; von Ahsen N, 2004, BLOOD, V103, P586, DOI 10.1182/blood-2003-02-0419; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x	40	315	335	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					35	42		10.1038/ng.2007.59	http://dx.doi.org/10.1038/ng.2007.59			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084290	Green Accepted			2022-12-25	WOS:000252118600016
J	Young, DW; Bender, A; Hoyt, J; McWhinnie, E; Chirn, GW; Tao, CY; Tallarico, JA; Labow, M; Jenkins, JL; Mitchison, TJ; Feng, Y				Young, Daniel W.; Bender, Andreas; Hoyt, Jonathan; McWhinnie, Elizabeth; Chirn, Gung-Wei; Tao, Charles Y.; Tallarico, John A.; Labow, Mark; Jenkins, Jeremy L.; Mitchison, Timothy J.; Feng, Yan			Integrating high-content screening and ligand-target prediction to identify mechanism of action	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-INHIBITION; DESCRIPTORS; SIMILARITY; PROLIFERATION; OUABAIN; CELLS; 2D	High-content screening is transforming drug discovery by enabling simultaneous measurement of multiple features of cellular phenotype that are relevant to therapeutic and toxic activities of compounds. High-content screening studies typically generate immense datasets of image-based phenotypic information, and how best to mine relevant phenotypic data is an unsolved challenge. Here, we introduce factor analysis as a data-driven tool for defining cell phenotypes and profiling compound activities. This method allows a large data reduction while retaining relevant information, and the data-derived factors used to quantify phenotype have discernable biological meaning. We used factor analysis of cells stained with fluorescent markers of cell cycle state to profile a compound library and cluster the hits into seven phenotypic categories. We then compared phenotypic profiles, chemical similarity and predicted protein binding activities of active compounds. By integrating these different descriptors of measured and potential biological activity, we can effectively draw mechanism-of-action inferences.	[Young, Daniel W.; Bender, Andreas; Hoyt, Jonathan; McWhinnie, Elizabeth; Chirn, Gung-Wei; Tao, Charles Y.; Tallarico, John A.; Labow, Mark; Jenkins, Jeremy L.; Feng, Yan] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Young, Daniel W.; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Harvard University; Harvard Medical School	Jenkins, JL (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	eremy.jenkins@novartis.com; yan.feng@novartis.com	Bender, Andreas/C-6942-2009	Bender, Andreas/0000-0002-6683-7546; Jenkins, Jeremy/0000-0001-9795-0771	NATIONAL CANCER INSTITUTE [P01CA078048] Funding Source: NIH RePORTER; NCI NIH HHS [CA78048] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bender A, 2004, J CHEM INF COMP SCI, V44, P1708, DOI 10.1021/ci0498719; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2005, J CHEM INF MODEL, V45, P1369, DOI 10.1021/ci0500177; Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; Blake RA, 2007, METH MOL B, V356, P367; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carrieri A, 2001, PROTEINS, V43, P382, DOI 10.1002/prot.1051; Carroll JB, 1951, REV EDUC RES, V21, P368; Checchi PM, 2003, TRENDS PHARMACOL SCI, V24, P361, DOI 10.1016/S0165-6147(03)00161-5; Clemons PA, 2004, CURR OPIN CHEM BIOL, V8, P334, DOI 10.1016/j.cbpa.2004.04.002; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Giuliano KA, 2003, ASSAY DRUG DEV TECHN, V1, P565, DOI 10.1089/154065803322302826; Glen RC, 2006, IDRUGS, V9, P199; GRAFE U, 1995, J ANTIBIOT, V48, P119; Haggarty SJ, 2005, CURR OPIN CHEM BIOL, V9, P296, DOI 10.1016/j.cbpa.2005.04.006; Hert J, 2006, J CHEM INF MODEL, V46, P462, DOI 10.1021/ci050348j; Horiuchi S, 2005, EXP CELL RES, V305, P233, DOI 10.1016/j.yexcr.2005.01.003; Jenkins J.L., 2006, DRUG DISCOV TODAY, V3, P413, DOI DOI 10.1016/J.DDTEC.2006.12.008; Johnson M, 1989, Prog Clin Biol Res, V291, P167; Johnson R.A., 2002, APPL MULTIVARIATE ST, P426; KAWASHIMA J, 1994, J ANTIBIOT, V47, P1562, DOI 10.7164/antibiotics.47.1562; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; LI LP, 1994, J MED CHEM, V37, P3400, DOI 10.1021/jm00046a025; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Maggiora GM, 2006, J CHEM INF MODEL, V46, P1535, DOI 10.1021/ci060117s; Malinowski E. R., 2002, FACTOR ANAL CHEM, P1; MANABE T, 1993, J CELL PHYSIOL, V157, P445, DOI 10.1002/jcp.1041570303; Matsumoto N, 1998, J ANTIBIOT, V51, P1087, DOI 10.7164/antibiotics.51.1087; Mitchison TJ, 2005, CHEMBIOCHEM, V6, P33, DOI 10.1002/cbic.200400272; Nettles JH, 2006, J MED CHEM, V49, P6802, DOI 10.1021/jm060902w; Nichols A, 2007, METH MOL B, V356, P379; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; OLAH M, 2004, CHEMOINFORMATICS DRU; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pauw PG, 2000, IN VITRO CELL DEV-AN, V36, P133; Ramirez-Ortega M, 2006, EUR J PHARMACOL, V534, P71, DOI 10.1016/j.ejphar.2006.01.035; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Schaper KJ, 1999, QUANT STRUCT-ACT REL, V18, P354, DOI 10.1002/(SICI)1521-3838(199910)18:4<354::AID-QSAR354>3.0.CO;2-2; SCHWEIGHOFFER T, 1991, HISTOCHEMISTRY, V96, P93, DOI 10.1007/BF00266767; Shi Q, 1998, CURR PHARM DESIGN, V4, P219; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; STEWART DW, 1981, J MARKETING RES, V18, P51, DOI 10.2307/3151313; TINSLEY HEA, 1987, J COUNS PSYCHOL, V34, P414, DOI 10.1037/0022-0167.34.4.414; Tong YG, 2006, MOL PHARMACOL, V69, P1226, DOI 10.1124/mol.105.020537; Yuan Y, 2004, J AM CHEM SOC, V126, P14720, DOI 10.1021/ja0447154	47	260	278	3	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					59	68		10.1038/nchembio.2007.53	http://dx.doi.org/10.1038/nchembio.2007.53			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18066055	Bronze			2022-12-25	WOS:000251990000014
J	Gaggioli, C; Hooper, S; Hidalgo-Carcedo, C; Grosse, R; Marshall, JF; Harrington, K; Sahai, E				Gaggioli, Cedric; Hooper, Steven; Hidalgo-Carcedo, Cristina; Grosse, Robert; Marshall, John F.; Harrington, Kevin; Sahai, Erik			Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells	NATURE CELL BIOLOGY			English	Article							STROMAL FIBROBLASTS; TENASCIN-C; RHO; CANCER; MIGRATION; PHOSPHORYLATION; MYOFIBROBLASTS; MELANOMA; CULTURE; GROWTH	Imaging of collectively invading cocultures of carcinoma cells and stromal fibroblasts reveals that the leading cell is always a fibroblast and that carcinoma cells move within tracks in the extracellular matrix behind the fibroblast. The generation of these tracks by fibroblasts is sufficient to enable the collective invasion of the squamous cell carcinoma ( SCC) cells and requires both protease- and force-mediated matrix remodelling. Force-mediated matrix remodelling depends on integrins alpha 3 and alpha 5, and Rho-mediated regulation of myosin light chain ( MLC) activity in fibroblasts, but these factors are not required in carcinoma cells. Instead, carcinoma cells use Cdc42 and MRCK ( myotonic dystrophy kinase-related CDC42-binding protein kinases) mediated regulation of MLC to follow the tracks generated by fibroblasts.	Canc Res UK London Res Inst, London WC2A 3PX, England; Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Barts & London Med & Dent Sch, Queen Marys Coll, Canc Res UK Clin Ctr, Tumour Biol Ctr, London EC1M 6BQ, England; Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, London SW3 6JB, England	Cancer Research UK; Ruprecht Karls University Heidelberg; Cancer Research UK; University of London; Queen Mary University London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Sahai, E (corresponding author), Canc Res UK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Erik.Sahai@cancer.org.uk	Gaggioli, Cedric/F-3658-2011; Gaggioli, Cedric/Q-2642-2019; hidalgo carcedo, cristina/M-6908-2015; Hidalgo-Carcedo, Cristina/K-8876-2017; gaggioli, cedric/L-5363-2019	Gaggioli, Cedric/0000-0002-4710-1605; Gaggioli, Cedric/0000-0002-4710-1605; hidalgo carcedo, cristina/0000-0003-3571-2449; Hidalgo-Carcedo, Cristina/0000-0003-3571-2449; Sahai, Erik/0000-0002-3932-5086; Marshall, John/0000-0002-0494-2295; Harrington, Kevin/0000-0002-6014-348X; Grosse, Robert/0000-0002-3380-5273				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Costea DE, 2006, AM J PATHOL, V168, P1889, DOI 10.2353/ajpath.2006.050843; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Cukierman Edna, 2004, V294, P79; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; DICOSTANZO D, 1990, AM J SURG PATHOL, V14, P12, DOI 10.1097/00000478-199001000-00002; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Kaarianen E, 2006, J PATHOL, V210, P181, DOI 10.1002/path.2045; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; Mackenzie IC, 2004, J ORAL PATHOL MED, V33, P71, DOI 10.1111/j.1600-0714.2004.00157.x; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M	32	1023	1048	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1392	U92		10.1038/ncb1658	http://dx.doi.org/10.1038/ncb1658			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037882				2022-12-25	WOS:000251317300012
J	Hartl, D; Latzin, P; Hordijk, P; Marcos, V; Rudolph, C; Woischnik, M; Krauss-Etschmann, S; Koller, B; Reinhardt, D; Roscher, AA; Roos, D; Griese, M				Hartl, Dominik; Latzin, Philipp; Hordijk, Peter; Marcos, Veronica; Rudolph, Carsten; Woischnik, Markus; Krauss-Etschmann, Susanne; Koller, Barbara; Reinhardt, Dietrich; Roscher, Adelbert A.; Roos, Dirk; Griese, Matthias			Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease	NATURE MEDICINE			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; CHEMOKINE RECEPTORS; PHOSPHOLIPASE-D; NADPH-OXIDASE; SEVERE ASTHMA; GRO-ALPHA; EXPRESSION; INFLAMMATION; ELASTASE; PSEUDOMONAS	Interleukin-8 (IL-8) activates neutrophils via the chemokine receptors CXCR1 and CXCR2. However, the airways of individuals with cystic fibrosis are frequently colonized by bacterial pathogens, despite the presence of large numbers of neutrophils and IL-8. Here we show that IL-8 promotes bacterial killing by neutrophils through CXCR1 but not CXCR2. Unopposed proteolytic activity in the airways of individuals with cystic fibrosis cleaved CXCR1 on neutrophils and disabled their bacterial-killing capacity. These effects were protease concentration-dependent and also occurred to a lesser extent in individuals with chronic obstructive pulmonary disease. Receptor cleavage induced the release of glycosylated CXCR1 fragments that were capable of stimulating IL-8 production in bronchial epithelial cells via Toll-like receptor 2. In vivo inhibition of proteases by inhalation of alpha 1-antitrypsin restored CXCR1 expression and improved bacterial killing in individuals with cystic fibrosis. The cleavage of CXCR1, the functional consequences of its cleavage, and the identification of soluble CXCR1 fragments that behave as bioactive components represent a new pathophysiologic mechanism in cystic fibrosis and other chronic lung diseases.	Univ Munich, Childrens Hosp, Res Ctr, D-80337 Munich, Germany; Yale Univ, Sch Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA; Univ Bern, Childrens Hosp, CH-3010 Bern, Switzerland; Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1066 Amsterdam, Netherlands; Natl Res Ctr Environm & Hlth, Gesellschaft Strahlenforshung, D-85764 Munich, Germany	University of Munich; Yale University; University of Bern; University Hospital of Bern; University of Amsterdam; University of Munich	Hartl, D (corresponding author), Univ Munich, Childrens Hosp, Res Ctr, D-80337 Munich, Germany.	dhartl@med.uni-muenchen.de	Krauss-Etschmann, Susanne/H-5198-2018; Rudolph, Carsten/B-9379-2011; Latzin, Philipp/F-2206-2017	Krauss-Etschmann, Susanne/0000-0001-5945-5702; Latzin, Philipp/0000-0002-5239-1571; Hordijk, Peter/0000-0002-3348-078X				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; BERGER M, 1989, J CLIN INVEST, V84, P1302, DOI 10.1172/JCI114298; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; DANIELS RH, 1992, IMMUNOLOGY, V75, P157; DJEU JY, 1990, J IMMUNOL, V144, P2205; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Khandaker MH, 1999, BLOOD, V93, P2173, DOI 10.1182/blood.V93.7.2173.407a06_2173_2185; Khandaker MH, 1998, J IMMUNOL, V161, P1930; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Konstan MW, 1997, PEDIATR PULM, V24, P137, DOI 10.1002/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.0.CO;2-3; LHEUREUX GP, 1995, BLOOD, V85, P522, DOI 10.1182/blood.V85.2.522.bloodjournal852522; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Panina P, 2006, CURR DRUG TARGETS, V7, P669, DOI 10.2174/138945006777435272; Pease James E, 2002, Am J Respir Med, V1, P19; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pignatti P, 2005, J ALLERGY CLIN IMMUN, V115, P88, DOI 10.1016/j.jaci.2004.08.048; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Richardson RM, 1998, J BIOL CHEM, V273, P10690, DOI 10.1074/jbc.273.17.10690; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; STOCKLEY RA, 1994, AM J RESP CRIT CARE, V150, pS190; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; TOSI MF, 1990, J CLIN INVEST, V86, P300, DOI 10.1172/JCI114699; Tsang KW, 2000, CHEST, V117, P420, DOI 10.1378/chest.117.2.420; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; vanPelt LJ, 1996, J IMMUNOL METHODS, V191, P187, DOI 10.1016/0022-1759(96)00024-5; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Wuyts A, 1998, EUR J BIOCHEM, V255, P67, DOI 10.1046/j.1432-1327.1998.2550067.x	50	244	247	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1423	1430		10.1038/nm1690	http://dx.doi.org/10.1038/nm1690			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18059279				2022-12-25	WOS:000251445400016
J	Wan, YH; Chong, LW; Evans, RM				Wan, Yihong; Chong, Ling-Wa; Evans, Ronald M.			PPAR-gamma regulates osteoclastogenesis in mice	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; BONE-RESORPTION; INSULIN-RESISTANCE; IN-VIVO; C-FOS; ROSIGLITAZONE; DIFFERENTIATION; AGONIST; HEMATOPOIESIS; DISEASE	Osteoclasts are bone-resorbing cells derived from hematopoietic precursors of the monocyte-macrophage lineage. Regulation of osteoclast function is central to the understanding of bone diseases such as osteoporosis, rheumatoid arthritis and osteopetrosis(1). Although peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has been shown to inhibit osteoblast differentiation(2,3), its role, if any, in osteoclasts is unknown. This is a clinically crucial question because PPAR-gamma agonists, ''such as thiazolidinediones-'' a class of insulin-sensitizing drugs, have been reported to cause a higher rate of fractures in human patients(4,5). Here we have uncovered a pro-osteoclastogenic effect of PPAR-gamma by using a Tie2Cre/flox mouse model in which PPAR-gamma is deleted in osteoclasts but not in osteoblasts. These mice develop osteopetrosis characterized by increased bone mass, reduced medullary cavity space and extramedullary hematopoiesis in the spleen. These defects are the result of impaired osteoclast differentiation and compromised receptor activator of nuclear factor-kappa B ligand signaling and can be rescued by bone marrow transplantation. Moreover, ligand activation of PPAR-gamma by rosiglitazone exacerbates osteoclast differentiation in a receptor-dependent manner. Our examination of the underlying mechanisms suggested that PPAR-gamma functions as a direct regulator of c-fos expression, an essential mediator of osteoclastogenesis(6). Therefore, PPAR-gamma and its ligands have a previously unrecognized role in promoting osteoclast differentiation and bone resorption.	Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL569898, HL07770] Funding Source: Medline; NIDDK NIH HHS [DK57978] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; GREY A, 2007, OSTEOPOROS INT  0928; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li M, 2006, BONE, V39, P796, DOI 10.1016/j.bone.2006.04.008; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Sottile V, 2004, CALCIFIED TISSUE INT, V75, P329, DOI 10.1007/s00223-004-0224-8; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207	30	410	438	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1496	1503		10.1038/nm1672	http://dx.doi.org/10.1038/nm1672			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18059282				2022-12-25	WOS:000251445400025
J	Schneiker, S; Perlova, O; Kaiser, O; Gerth, K; Alici, A; Altmeyer, MO; Bartels, D; Bekel, T; Beyer, S; Bode, E; Bode, HB; Bolten, CJ; Choudhuri, JV; Doss, S; Elnakady, YA; Frank, B; Gaigalat, L; Goesmann, A; Groeger, C; Gross, F; Jelsbak, L; Jelsbak, L; Kalinowski, J; Kegler, C; Knauber, T; Konietzny, S; Kopp, M; Krause, L; Krug, D; Linke, B; Mahmud, T; Martinez-Arias, R; McHardy, AC; Merai, M; Meyer, F; Mormann, S; Munoz-Dorado, J; Perez, J; Pradella, S; Rachid, S; Raddatz, G; Rosenau, F; Rueckert, C; Sasse, F; Scharfe, M; Schuster, SC; Suen, G; Treuner-Lange, A; Velicer, GJ; Vorholter, FJ; Weissman, KJ; DWelch, R; Wenzel, SC; Whitworth, DE; Wilhelm, S; Wittmann, C; Blocker, H; Puhler, A; Mueller, R				Schneiker, Susanne; Perlova, Olena; Kaiser, Olaf; Gerth, Klaus; Alici, Aysel; Altmeyer, Matthias O.; Bartels, Daniela; Bekel, Thomas; Beyer, Stefan; Bode, Edna; Bode, Helge B.; Bolten, Christoph J.; Choudhuri, Jomuna V.; Doss, Sabrina; Elnakady, Yasser A.; Frank, Bettina; Gaigalat, Lars; Goesmann, Alexander; Groeger, Carolin; Gross, Frank; Jelsbak, Lars; Jelsbak, Lotte; Kalinowski, Joern; Kegler, Carsten; Knauber, Tina; Konietzny, Sebastian; Kopp, Maren; Krause, Lutz; Krug, Daniel; Linke, Bukhard; Mahmud, Taifo; Martinez-Arias, Rosa; McHardy, Alice C.; Merai, Michelle; Meyer, Folker; Mormann, Sascha; Munoz-Dorado, Jose; Perez, Juana; Pradella, Silke; Rachid, Shwan; Raddatz, Guenter; Rosenau, Frank; Rueckert, Christian; Sasse, Florenz; Scharfe, Maren; Schuster, Stephan C.; Suen, Garret; Treuner-Lange, Anke; Velicer, Gregory J.; Vorhoelter, Frank-Joerg; Weissman, Kira J.; DWelch, Roy; Wenzel, Silke C.; Whitworth, David E.; Wilhelm, Susanne; Wittmann, Christoph; Bloecker, Helmut; Puehler, Alfred; Mueller, Rolf			Complete genome sequence of the myxobacterium Sorangium cellulosum	NATURE BIOTECHNOLOGY			English	Article							MYXOCOCCUS-XANTHUS; STREPTOMYCES-COELICOLOR; GLIDING MOTILITY; PROTEIN-KINASES; GENE-CLUSTER; IDENTIFICATION; BIOSYNTHESIS; PHOSPHOPEPTIDES; ANNOTATION; POLYKETIDE	The genus Sorangium synthesizes approximately half of the secondary metabolites isolated from myxobacteria, including the anti-cancer metabolite epothilone. We report the complete genome sequence of the model Sorangium strain S. cellulosum So ce56, which produces several natural products and has morphological and physiological properties typical of the genus. The circular genome, comprising 13,033,779 base pairs, is the largest bacterial genome sequenced to date. No global synteny with the genome of Myxococcus xanthus is apparent, revealing an unanticipated level of divergence between these myxobacteria. A large percentage of the genome is devoted to regulation, particularly post-translational phosphorylation, which probably supports the strain's complex, social lifestyle. This regulatory network includes the highest number of eukaryotic protein kinase-like kinases discovered in any organism. Seventeen secondary metabolite loci are encoded in the genome, as well as many enzymes with potential utility in industry.	Univ Bielefeld, Dept Genet, Lehrstuhl Genet, D-33501 Bielefeld, Germany; Univ Saarland, Dept Pharmaceut Biotechnol, D-66041 Saarbrucken, Germany; Helmholtz Ctr Infect Res, German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; Univ Bielefeld, Ctr Biotechnol, D-33501 Bielefeld, Germany; Univ Saarland, D-66041 Saarbrucken, Germany; Univ Giessen, Dept Microbiol & Mol Biol, D-35392 Giessen, Germany; Tech Univ Denmark, Infect Microbiol Grp, Lyngby, Denmark; Univ Copenhagen, Dept Vet Pathol, DK-1870 Frederiksberg, Denmark; Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain; Univ Tubingen, Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Dusseldorf, Inst Mol Enzyme Technol, D-52426 Julich, Germany; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Warwick, Dept Sci Biol, Coventry CV4 7AL, W Midlands, England	University of Bielefeld; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bielefeld; Saarland University; Justus Liebig University Giessen; Technical University of Denmark; University of Copenhagen; Oregon State University; University of Granada; Eberhard Karls University of Tubingen; Max Planck Society; Heinrich Heine University Dusseldorf; Max Planck Society; Syracuse University; Indiana University System; Indiana University Bloomington; University of Warwick	Mueller, R (corresponding author), Univ Bielefeld, Dept Genet, Lehrstuhl Genet, PO Box 10013, D-33501 Bielefeld, Germany.	rom@mx.uni-saarland.de	Whitworth, David/D-1360-2010; Elnakady, Yasser Abbass/GYJ-1602-2022; Mahmud, Taifo/A-1492-2015; Krause, Lutz/G-6283-2013; Krause, Lutz/M-7305-2015; Müller, Rolf/B-1559-2008; Suen, Garret/B-3296-2008; McHardy, Alice C/K-9377-2018; Elnakady, Yasser A./N-6882-2019; McHardy, Alice/ABF-2322-2020; Suen, Garret/AAF-2080-2019; Munoz-Dorado, Jose/N-6840-2016; Bode, Helge B/F-7022-2014; Treuner-Lange, Anke U/AFQ-5368-2022; Jelsbak, Lars/B-6195-2013; Rosenau, Frank/AAM-8062-2020; Torres, Juana Pérez/H-2480-2015	Mahmud, Taifo/0000-0001-9639-526X; Krause, Lutz/0000-0003-3806-0845; Krause, Lutz/0000-0003-3806-0845; Müller, Rolf/0000-0002-1042-5665; McHardy, Alice C/0000-0003-2370-3430; McHardy, Alice/0000-0003-2370-3430; Suen, Garret/0000-0002-6170-711X; Munoz-Dorado, Jose/0000-0001-7765-5687; Bode, Helge B/0000-0001-6048-5909; Treuner-Lange, Anke U/0000-0001-6435-5642; Jelsbak, Lars/0000-0002-5759-9769; Torres, Juana Pérez/0000-0001-8073-9398; Whitworth, David/0000-0002-0302-7722; Ruckert-Reed, Christian/0000-0002-9722-4435; Rachid, Shwan/0000-0003-0834-5153; Rosenau, Frank/0000-0002-9297-6419; Wittmann, Christoph/0000-0002-7952-985X; Jelsbak, Lotte/0000-0002-6642-7424; Goesmann, Alexander/0000-0002-7086-2568; Konietzny, Sebastian/0000-0002-3763-2111; Meyer, Folker/0000-0003-1112-2284; Puhler, Alfred/0000-0003-4723-2960; Welch, Roy/0000-0002-9946-108X; Krug, Daniel/0000-0002-3664-1884				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartels D, 2005, BIOINFORMATICS, V21, P853, DOI 10.1093/bioinformatics/bti091; Bode HB, 2003, PLANT PHYSIOL, V132, P1153, DOI 10.1104/pp.102.019760; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Choudhuri JV, 2004, BIOINFORMATICS, V20, P1964, DOI 10.1093/bioinformatics/bth161; COUCKE P, 1968, ANN I PASTEUR PARIS, V115, P549; DAVIDSON GS, 2007, P IEEE S INF VIS 200, P23; Dickschat JS, 2005, J ORG CHEM, V70, P5174, DOI 10.1021/jo050449g; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gaitatzis N, 2005, CHEMBIOCHEM, V6, P365, DOI 10.1002/cbic.200400206; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; GERTH K, IN PRESS MULTICELLUL; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; INOUYE S, IN PRESS MULTICELLUL; Irschik H, 2007, J NAT PROD, V70, P1060, DOI 10.1021/np070115h; Jiang JY, 2006, J AM CHEM SOC, V128, P8128, DOI 10.1021/ja062669x; Kaiser O, 2003, J BIOTECHNOL, V106, P121, DOI 10.1016/j.jbiotec.2003.08.008; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; Kroutil W, 2004, CURR OPIN CHEM BIOL, V8, P120, DOI 10.1016/j.cbpa.2004.02.005; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Petrickova K, 2003, MICROBIOL-SGM, V149, P1609, DOI 10.1099/mic.0.26275-0; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Rachid S, 2007, MOL MICROBIOL, V63, P1783, DOI 10.1111/j.1365-2958.2007.05627.x; Reichenbach H., 2005, BERGEYS MANUAL SYSTE, V2, P1059; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; Schley C, 2006, J PROTEOME RES, V5, P2760, DOI 10.1021/pr0602489; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Srinivasan BS, 2005, NAT BIOTECHNOL, V23, P691, DOI 10.1038/nbt1098; Tholey A, 1999, J MASS SPECTROM, V34, P117, DOI 10.1002/(SICI)1096-9888(199902)34:2<117::AID-JMS769>3.0.CO;2-V; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; UEDA K, 1995, J ANTIBIOT, V48, P638, DOI 10.7164/antibiotics.48.638; Wang L, 2002, FEMS MICROBIOL LETT, V217, P155, DOI 10.1016/S0378-1097(02)01052-2; WATSON BF, 1968, J BACTERIOL, V96, P1465, DOI 10.1128/JB.96.5.1465-1473.1968; WENZEL SC, IN PRESS NAT PROD RE; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x	50	289	516	0	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2007	25	11					1281	1289		10.1038/nbt1354	http://dx.doi.org/10.1038/nbt1354			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233JF	17965706	hybrid, Green Published			2022-12-25	WOS:000251086500029
J	Wang, LR; Chen, S; Xu, TG; Taghizadeh, K; Wishnok, JS; Zhou, XF; You, DL; Deng, ZX; Dedon, PC				Wang, Lianrong; Chen, Shi; Xu, Tiegang; Taghizadeh, Koli; Wishnok, John S.; Zhou, Xiufen; You, Delin; Deng, Zixin; Dedon, Peter C.			Phosphorothioation of DNA in bacteria by dnd genes	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-LIVIDANS; MODIFICATION SITES; SULFUR; 4-THIOURIDINE; SEQUENCE; IRON	Modifications of the canonical structures of DNA and RNA play critical roles in cell physiology, DNA replication, transcription and translation in all organisms. We now report that bacterial dnd gene clusters incorporate sulfur into the DNA backbone as a sequence-selective, stereospecific phosphorothioate modification. To our knowledge, unlike any other DNA or RNA modification systems, DNA phosphorothioation by dnd gene clusters is the first physiological modification described on the DNA backbone.	Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Lab Microbial Metab, Shanghai 200030, Peoples R China; MIT, Dept Chem, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	Shanghai Jiao Tong University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dedon, PC (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Lab Microbial Metab, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	zxdeng@sjtu.edu.cn; pcdedon@mit.edu		Dedon, Peter/0000-0003-0011-3067; wang, lianrong/0000-0003-1669-6340				Boybek A, 1998, NUCLEIC ACIDS RES, V26, P3364, DOI 10.1093/nar/26.14.3364; Dyson P, 1998, NUCLEIC ACIDS RES, V26, P1248, DOI 10.1093/nar/26.5.1248; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Liang JD, 2007, NUCLEIC ACIDS RES, V35, P2944, DOI 10.1093/nar/gkm176; Mueller EG, 1998, NUCLEIC ACIDS RES, V26, P2606, DOI 10.1093/nar/26.11.2606; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; VOSBERG HP, 1977, BIOCHEMISTRY-US, V16, P3633, DOI 10.1021/bi00635a020; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; ZHOU XF, 1988, NUCLEIC ACIDS RES, V16, P4341, DOI 10.1093/nar/16.10.4341; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	12	191	218	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2007	3	11					709	710		10.1038/nchembio.2007.39	http://dx.doi.org/10.1038/nchembio.2007.39			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222QH	17934475				2022-12-25	WOS:000250311500011
J	Ulanovskaya, OA; Janjic, J; Suzuki, M; Sabharwal, SS; Schumacker, PT; Kron, SJ; Kozmin, SA				Ulanovskaya, Olesya A.; Janjic, Jelena; Suzuki, Masato; Sabharwal, Simran S.; Schumacker, Paul T.; Kron, Stephen J.; Kozmin, Sergey A.			Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide	NATURE CHEMICAL BIOLOGY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; TUMOR-CELLS; INHIBITOR; SEGMENT; RESPIRATION; UBIQUINONE; MOLECULES; MACROLIDE; CANCER	Leucascandrolide A and neopeltolide are structurally homologous marine natural products that elicit potent antiproliferative profiles in mammalian cells and yeast. The scarcity of naturally available material has been a significant barrier to their biochemical and pharmacological evaluation. We developed practical synthetic access to this class of natural products that enabled the determination of their mechanism of action. We demonstrated effective cellular growth inhibition in yeast, which was substantially enhanced by substituting glucose with galactose or glycerol. These results, along with genetic analysis of determinants of drug sensitivity, suggested that leucascandrolide A and neopeltolide may inhibit mitochondrial ATP synthesis. Evaluation of the activity of the four mitochondrial electron transport chain complexes in yeast and mammalian cells revealed cytochrome bc(1) complex as the principal cellular target. This result provided the molecular basis for the potent antiproliferative activity of this class of marine macrolides, thus identifying them as new biochemical tools for investigation of eukaryotic energy metabolism.	[Ulanovskaya, Olesya A.; Janjic, Jelena; Suzuki, Masato; Kozmin, Sergey A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Sabharwal, Simran S.; Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Kron, Stephen J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA	University of Chicago; Northwestern University; University of Chicago	Kozmin, SA (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	skozmin@uchicago.edu		Kron, Stephen/0000-0003-1518-2436; Schumacker, Paul T/0000-0001-9591-2034	NCI NIH HHS [R01 CA093457-04, R01 CA093457-03S1, R01 CA093457, R01 CA093457-03, R01 CA93457, R01 CA093457-02, R01 CA093457-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM060443-07, R01 GM60443, R01 GM060443-05, R01 GM060443-03, R01 GM060443-06A2, R01 GM060443-02, R01 GM060443, R01 GM060443-04, R01 GM060443-02S1, R01 GM060443-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060443] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; BERRY EA, 1991, J BIOL CHEM, V266, P9064; BOWYER JR, 1982, J BIOL CHEM, V257, P8321; BROWN J, 1962, METABOLISM, V11, P1098; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; CHEN KM, 1987, TETRAHEDRON LETT, V28, P155, DOI 10.1016/S0040-4039(00)95673-9; Crimmins MT, 2003, ORG LETT, V5, P4641, DOI 10.1021/ol035797o; Custar DW, 2008, J AM CHEM SOC, V130, P804, DOI 10.1021/ja710080q; DAmbrosio M, 1996, HELV CHIM ACTA, V79, P51, DOI 10.1002/hlca.19960790107; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Evans DA, 1997, J ORG CHEM, V62, P788, DOI 10.1021/jo962417m; Ferrie L, 2007, ORG LETT, V9, P2461, DOI 10.1021/ol070670a; Fettes A, 2002, ANGEW CHEM INT EDIT, V41, P4098, DOI 10.1002/1521-3773(20021104)41:21<4098::AID-ANIE4098>3.0.CO;2-P; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; Hornberger KR, 2000, J AM CHEM SOC, V122, P12894, DOI 10.1021/ja003593m; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JANJIC J, 2006, LEUCASCANDROLIDE SYN; Jung HH, 2007, ANGEW CHEM INT EDIT, V46, P8464, DOI 10.1002/anie.200702999; Kopecky DJ, 2001, J AM CHEM SOC, V123, P8420, DOI 10.1021/ja011377n; Kozmin SA, 2001, ORG LETT, V3, P755, DOI 10.1021/ol015514x; Linnett P E, 1979, Methods Enzymol, V55, P472; Liu H, 2001, BIOCHEMISTRY-US, V40, P5542, DOI 10.1021/bi002426w; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; NAGATA I, 1975, J BIOCHEM-TOKYO, V78, P1353, DOI 10.1093/oxfordjournals.jbchem.a131033; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Paterson I, 2003, ANGEW CHEM INT EDIT, V42, P343, DOI 10.1002/anie.200390112; Paterson I, 1996, TETRAHEDRON LETT, V37, P8585, DOI 10.1016/0040-4039(96)01962-4; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Su QB, 2005, ANGEW CHEM INT EDIT, V44, P1223, DOI 10.1002/anie.200462408; THIERBACH G, 1981, BIOCHIM BIOPHYS ACTA, V638, P282, DOI 10.1016/0005-2728(81)90238-3; THIERBACH G, 1984, BIOCHIM BIOPHYS ACTA, V765, P227, DOI 10.1016/0005-2728(84)90017-3; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; Wang Y, 2005, PURE APPL CHEM, V77, P1161, DOI 10.1351/pac200577071161; Wang Y, 2002, J AM CHEM SOC, V124, P13670, DOI 10.1021/ja028428g; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Williams DR, 2003, ANGEW CHEM INT EDIT, V42, P3934, DOI 10.1002/anie.200351817; Wipf P, 2002, CHEM COMMUN, P2066, DOI 10.1039/b207383h; Wright AE, 2007, J NAT PROD, V70, P412, DOI 10.1021/np060597h; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Youngsaye W, 2007, ANGEW CHEM INT EDIT, V46, P9211, DOI 10.1002/anie.200704122; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	50	77	80	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					418	424		10.1038/nchembio.94	http://dx.doi.org/10.1038/nchembio.94			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18516048	Green Accepted			2022-12-25	WOS:000256929900012
J	Kang, JS; Saunier, EF; Akhurst, RJ; Derynck, R				Kang, Jong Seok; Saunier, Elise F.; Akhurst, Rosemary J.; Derynck, Rik			The type I TGF-beta receptor is covalently modified and regulated by sumoylation	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; SUMO-1 MODIFICATION; SIGNALING PATHWAYS; HUMAN CANCER; C-JUN; SMAD3; P53; TRANSCRIPTION; DEGRADATION; METASTASIS	Post- translational sumoylation, the covalent attachment of a small ubiquitin-like modifier (SUMO), regulates the functions of proteins engaged in diverse processes. Often associated with nuclear and perinuclear proteins, such as transcription factors, it is not known whether SUMO can conjugate to cell-surface receptors for growth factors to regulate their functions. Here we show that the type I transforming growth factor-beta (TGF-beta) receptor, T beta RI, is sumoylated in response to TGF-beta and that its sumoylation requires the kinase activities of both T beta RI and the type II TGF-beta receptor, T beta RII. Sumoylation of T beta RI enhances receptor function by facilitating the recruitment and phosphorylation of Smad3, consequently regulating TGF-beta-induced transcription and growth inhibition. T beta RI sumoylation modulates the dissemination of transformed cells in a mouse model of T beta RI-stimulated metastasis. T beta RI sumoylation therefore controls responsiveness to TGF-beta, with implications for tumour progression. Sumoylation of cell-surface receptors may regulate other growth factor responses.	[Kang, Jong Seok; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA; [Saunier, Elise F.; Akhurst, Rosemary J.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Akhurst, Rosemary J.; Derynck, Rik] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Akhurst, Rosemary J.] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu		AKHURST, ROSEMARY/0000-0002-4474-9668	NCI NIH HHS [R01-CA63101, R21 CA125190, R01 CA063101, R01 CA116019-03, R01 CA116019, R21-CA125190, R21 CA125190-02, R21 CA125190-01] Funding Source: Medline; NHLBI NIH HHS [R01 HL078564] Funding Source: Medline; NIAMS NIH HHS [P01 AR050440] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063101, R01CA116019, R21CA125190] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chen TP, 1998, CANCER RES, V58, P4805; Chen TP, 2001, INT J CANCER, V93, P653, DOI 10.1002/ijc.1381; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Goto D, 1998, FEBS LETT, V430, P201, DOI 10.1016/S0014-5793(98)00658-9; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1989, BIOTECHNIQUES, V7, P984; MILLER AD, 1989, BIOTECHNIQUES, V7, P989; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, SCIENCE, V8, P2879; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x	45	107	113	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					654	664		10.1038/ncb1728	http://dx.doi.org/10.1038/ncb1728			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469808	Green Accepted			2022-12-25	WOS:000256350100012
J	Schilling, O; Overall, CM				Schilling, Oliver; Overall, Christopher M.			Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites	NATURE BIOTECHNOLOGY			English	Article							MATRIX METALLOPROTEINASES; COMBINATORIAL APPROACH; SUBSTRATE-SPECIFICITY; GELATINASE-A; ACTIVE-SITE; IDENTIFICATION; ACTIVATION; DISCOVERY; MMP-2; PUMP	We introduce human proteome-derived, database-searchable peptide libraries for characterizing sequence-specific protein interactions. To identify endoprotease cleavage sites, we used peptides in such libraries with protected primary amines to simultaneously determine sequence preferences on the N-terminal (nonprime P) and C-terminal (prime P') sides of the scissile bond. Prime-side cleavage products were tagged with biotin, isolated and identified by tandem mass spectrometry, and the corresponding nonprime-side sequences were derived from human proteome databases using bioinformatics. Identification of hundreds to over 1,000 individual cleaved peptides allows the consensus protease cleavage site and subsite cooperativity to be readily determined from P6 to P6'. For the highly specific GluC protease, > 95% of the 558 cleavage sites identified displayed the canonical selectivity. For the broad-specificity matrix metalloproteinase 2, > 1,200 peptidic cleavage sites were identified. Profiling of HIV protease 1, caspase 3, caspase 7, cathepsins K and G, elastase and thrombin showed that this approach is broadly applicable to all mechanistic classes of endoproteases.	[Schilling, Oliver; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Schilling, Oliver; Overall, Christopher M.] Univ British Columbia, Life Sci Inst 4 401, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Schilling, O (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	chris.overall@ubc.ca	Schilling, O/AAC-8302-2019	Schilling, Oliver/0000-0001-7678-7653				Bigg HF, 2001, CANCER RES, V61, P3610; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris J, 2004, CHEM BIOL, V11, P1361, DOI 10.1016/j.chembiol.2004.08.008; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Salisbury CM, 2002, J AM CHEM SOC, V124, P14868, DOI 10.1021/ja027477q; Schechter I, 2005, CURR PROTEIN PEPT SC, V6, P501, DOI 10.2174/138920305774933286; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stephan C, 2006, PROTEOMICS, V6, P5015, DOI 10.1002/pmic.200600294; STEPHENS AW, 1988, J BIOL CHEM, V263, P15849; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P1353; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Winssinger N, 2004, CHEM BIOL, V11, P1351, DOI 10.1016/j.chembiol.2004.07.015	49	302	313	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					685	694		10.1038/nbt1408	http://dx.doi.org/10.1038/nbt1408			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18500335				2022-12-25	WOS:000256611900028
J	Hsiung, PL; Hardy, J; Friedland, S; Soetikno, R; Du, CB; Wu, AP; Sahbaie, P; Crawford, JM; Lowe, AW; Contag, CH; Wang, TD				Hsiung, Pei-Lin; Hardy, Jonathan; Friedland, Shai; Soetikno, Roy; Du, Christine B.; Wu, Amy P.; Sahbaie, Peyman; Crawford, James M.; Lowe, Anson W.; Contag, Christopher H.; Wang, Thomas D.			Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy	NATURE MEDICINE			English	Article							COLORECTAL-CANCER; PHAGE DISPLAY; CARCINOEMBRYONIC ANTIGEN; PEPTIDE; ENDOSCOPY; EXPRESSION; DIAGNOSIS; ANTIBODY; RECEPTOR; LIBRARY	A combination of targeted probes and new imaging technologies provides a powerful set of tools with the potential to improve the early detection of cancer. To develop a probe for detecting colon cancer, we screened phage display peptide libraries against fresh human colonic adenomas for high- affinity ligands with preferential binding to premalignant tissue. We identified a specific heptapeptide sequence, VRPMPLQ, which we synthesized, conjugated with fluorescein and tested in patients undergoing colonoscopy. We imaged topically administered peptide using a fluorescence confocal microendoscope delivered through the instrument channel of a standard colonoscope. In vivo images were acquired at 12 frames per second with 50-mu m working distance and 2.5-mu m ( transverse) and 20-mu m ( axial) resolution. The fluorescein- conjugated peptide bound more strongly to dysplastic colonocytes than to adjacent normal cells with 81% sensitivity and 82% specificity. This methodology represents a promising diagnostic imaging approach for the early detection of colorectal cancer and potentially of other epithelial malignancies.	[Friedland, Shai; Soetikno, Roy; Sahbaie, Peyman; Wang, Thomas D.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Hsiung, Pei-Lin; Hardy, Jonathan; Du, Christine B.; Wu, Amy P.; Contag, Christopher H.] Stanford Univ, Sch Med, Dept Pediat Radiol & Microbiol & Immunol, Stanford, CA 94305 USA; [Friedland, Shai; Soetikno, Roy; Lowe, Anson W.; Wang, Thomas D.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Crawford, James M.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; State University System of Florida; University of Florida	Wang, TD (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave,Bldg 100, Palo Alto, CA 94304 USA.	thomaswa@umich.edu	Hardy, Jonathan/AAO-9306-2020	Contag, Christopher/0000-0002-1011-8278	NATIONAL CANCER INSTITUTE [U54CA136429, U54CA105296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK075603, P30DK056339, K08DK067618] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA136429-01, U54 CA136429, U54 CA105296] Funding Source: Medline; NIDDK NIH HHS [P30 DK56339, K08 DK067618-06, R03 DK075603-03, K08 DK067618, R03 DK075603, P30 DK056339] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000964; American Cancer Society, 2006, CANC FACTS FIG 2007; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Carson-Walter EB, 2001, CANCER RES, V61, P6649; FOLLI S, 1992, P NATL ACAD SCI USA, V89, P7973, DOI 10.1073/pnas.89.17.7973; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Garcea G, 2003, EUR J CANCER, V39, P1041, DOI 10.1016/S0959-8049(03)00027-3; Goldsmith SJ, 1997, SEMIN NUCL MED, V27, P85, DOI 10.1016/S0001-2998(97)80041-4; Haringsma J, 2001, GASTROINTEST ENDOSC, V53, P642, DOI 10.1067/mge.2001.114419; HO SB, 1993, CANCER RES, V53, P641; Keller R, 2002, ENDOSCOPY, V34, P801, DOI 10.1055/s-2002-34254; Kelly K, 2004, CANCER RES, V64, P6247, DOI 10.1158/0008-5472.CAN-04-0817; Kelly KA, 2003, NEOPLASIA, V5, P437, DOI 10.1016/S1476-5586(03)80046-5; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Mayer R, 1999, DIS COLON RECTUM, V42, P343, DOI 10.1007/BF02236351; Messmann H, 1999, GASTROINTEST ENDOSC, V49, P97, DOI 10.1016/S0016-5107(99)70453-0; Moore A, 2004, CANCER RES, V64, P1821, DOI 10.1158/0008-5472.CAN-03-3230; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Wang TD, 1996, GASTROENTEROLOGY, V111, P1182, DOI 10.1053/gast.1996.v111.pm8898631; Wang TD, 2007, CLIN GASTROENTEROL H, V5, P1300, DOI 10.1016/j.cgh.2007.07.013; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zangani D, 1999, DIFFERENTIATION, V64, P91, DOI 10.1046/j.1432-0436.1999.6420091.x	30	351	371	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					454	458		10.1038/nm1692	http://dx.doi.org/10.1038/nm1692			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18345013	Green Accepted			2022-12-25	WOS:000254674100034
J	Katajisto, P; Vaahtomeri, K; Ekman, N; Ventela, E; Ristimaki, A; Bardeesy, N; Feil, R; DePinho, RA; Makela, TP				Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Bardeesy, Nabeel; Feil, Robert; DePinho, Ronald A.; Makela, Tomi P.			LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis	NATURE GENETICS			English	Article							PEUTZ-JEGHERS-SYNDROME; SMOOTH-MUSCLE; GROWTH-FACTORS; TGF-BETA; DIFFERENTIATION; FIBROBLASTS; CANCER; MYOFIBROBLASTS; LUNG	Germline mutations in STK11 (also known as LKB1) are found in individuals with Peutz-Jeghers syndrome (PJS)(1) manifesting with gastrointestinal polyps that contain a prominent stromal component. Epithelia in polyps of Stk11(+/-) mice can retain a functional copy of Stk11 (refs. 2,3), and loss of heterozygosity is not an obligate feature of human polyps(4), raising the possibility of non-epithelial origins in tumorigenesis. Here we show that either monoallelic or biallelic loss of murine Stk11 limited to Tagln-expressing mesenchymal cells results in premature postnatal death as a result of gastrointestinal polyps indistinguishable from those in PJS. Stk11-deficient mesenchymal cells produced less TGF beta, and defective TGF beta signaling to epithelial cells coincided with epithelial proliferation. We also noted TGF beta signaling defects in polyps of individuals with PJS, suggesting that the identified stromal-derived mechanism of tumor suppression is also relevant in PJS.	[Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland; [Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Ctr Appl Canc Sci Belfer Inst Inno, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Ctr Appl Canc Sci Belfer Inst Innovat Ca, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet,Ctr Appl Canc Sci Belfer Inst Innovat, Boston, MA 02115 USA	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Makela, TP (corresponding author), Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland.	tomi.makela@helsinki.fi	makela, tomi/B-3734-2009; Feil, Robert/B-8918-2014	makela, tomi/0000-0002-4869-8044; Feil, Robert/0000-0002-7335-4841; Katajisto, Pekka/0000-0002-3033-4189; Vaahtomeri, Kari/0000-0001-7829-3518; DePinho, Ronald/0000-0002-5625-577X				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesten LSM, 2006, CELL DEATH DIFFER, V13, P2089, DOI 10.1038/sj.cdd.4401973; Entius MM, 1997, GUT, V41, P320, DOI 10.1136/gut.41.3.320; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hernan I, 2004, CLIN GENET, V66, P58, DOI 10.1111/j.0009-9163.2004.00266.x; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kuemmerle JF, 1997, GASTROENTEROLOGY, V113, P817, DOI 10.1016/S0016-5085(97)70176-8; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; KUROKOWA M, 1987, BIOCHEM BIOPH RES CO, V142, P775, DOI 10.1016/0006-291X(87)91481-1; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	25	84	92	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					455	459		10.1038/ng.98	http://dx.doi.org/10.1038/ng.98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311138				2022-12-25	WOS:000254388100017
J	Millay, DP; Sargent, MA; Osinska, H; Baines, CP; Barton, ER; Vuagniaux, G; Sweeney, HL; Robbins, J; Molkentin, JD				Millay, Douglas P.; Sargent, Michelle A.; Osinska, Hanna; Baines, Christopher P.; Barton, Elisabeth R.; Vuagniaux, Gregoire; Sweeney, H. Lee; Robbins, Jeffrey; Molkentin, Jeffery D.			Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy	NATURE MEDICINE			English	Article							PERMEABILITY TRANSITION PORE; CYCLOPHILIN-D; GLYCOPROTEIN COMPLEX; CELL-DEATH; MOUSE MODELS; MDX MICE; MUSCLE; DYSFUNCTION; APOPTOSIS; CALCIUM	Muscular dystrophies comprise a diverse group of genetic disorders that lead to muscle wasting and, in many instances, premature death(-1). Many mutations that cause muscular dystrophy compromise the support network that connects myofilament proteins within the cell to the basal lamina outside the cell, rendering the sarcolemma more permeable or leaky. Here we show that deletion of the gene encoding cyclophilin D ( Ppif) rendered mitochondria largely insensitive to the calcium overload - induced swelling associated with a defective sarcolemma, thus reducing myofiber necrosis in two distinct models of muscular dystrophy. Mice lacking delta- sarcoglycan ( Scgd(-/-) mice) showed markedly less dystrophic disease in both skeletal muscle and heart in the absence of Ppif. Moreover, the premature lethality associated with deletion of Lama2, encoding the alpha- 2 chain of laminin- 2, was rescued, as were other indices of dystrophic disease. Treatment with the cyclophilin inhibitor Debio- 025 similarly reduced mitochondrial swelling and necrotic disease manifestations in mdx mice, a model of Duchenne muscular dystrophy, and in Scgd(-/-) mice. Thus, mitochondrial- dependent necrosis represents a prominent disease mechanism in muscular dystrophy, suggesting that inhibition of cyclophilin D could provide a new pharmacologic treatment strategy for these diseases.	[Millay, Douglas P.; Sargent, Michelle A.; Osinska, Hanna; Baines, Christopher P.; Robbins, Jeffrey; Molkentin, Jeffery D.] Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Millay, Douglas P.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Vuagniaux, Gregoire] DebioPharm SA Chemin Messidor, CH-1002 Lausanne, Switzerland; [Sweeney, H. Lee] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Pennsylvania; Debiopharm; University of Pennsylvania	Molkentin, JD (corresponding author), Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org	Sweeney, H Lee/F-1862-2010; Tuluc, Petronel/C-2527-2011	Baines, Christopher/0000-0002-4473-3869; Molkentin, Jeffery/0000-0002-3558-6529	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [5 T32 HL07382, R01 HL062927-10A1, P01 HL069779, P50 HL077101-050004, R01 HL060562, R01 HL081104, P50 HL077101, R01 HL081104-04, T32 HL007382, R01 HL060562-11, R01 HL062927, P01 HL069779-06A10003] Funding Source: Medline; NIAMS NIH HHS [U54 AR052646] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060562, P50HL077101, P01HL069779, T32HL007382, R01HL062927, R01HL081104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fewell JG, 1997, AM J PHYSIOL-HEART C, V273, pH1595, DOI 10.1152/ajpheart.1997.273.3.H1595; Flisiak R, 2006, HEPATOLOGY, V44, p609A; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Hack AA, 2000, J CELL SCI, V113, P2535; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Stupka N, 2004, ACTA NEUROPATHOL, V107, P299, DOI 10.1007/s00401-003-0807-x; Stupka N, 2006, J PHYSIOL-LONDON, V575, P645, DOI 10.1113/jphysiol.2006.108472; SUZUKI K, 2001, CIRCULATION S1, V104, P308; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	30	255	270	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					442	447		10.1038/nm1736	http://dx.doi.org/10.1038/nm1736			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18345011	Green Accepted			2022-12-25	WOS:000254674100032
J	Lerou, PH; Yabuuchi, A; Huo, H; Takeuchi, A; Shea, J; Cimini, T; Ince, TA; Ginsburg, E; Racowsky, C; Daley, GQ				Lerou, Paul H.; Yabuuchi, Akiko; Huo, Hongguang; Takeuchi, Ayumu; Shea, Jessica; Cimini, Tina; Ince, Tan A.; Ginsburg, Elizabeth; Racowsky, Catherine; Daley, George Q.			Human embryonic stem cell derivation from poor-quality embryos	NATURE BIOTECHNOLOGY			English	Article							LINES	During in vitro fertilization, embryos deemed clinically useless based on poor morphology are typically discarded. Here we demonstrate a statistical correlation between the developmental stage of such poor-quality embryos and the yield of human embryonic stem (hES) cell lines. Early-arrested or highly fragmented embryos only rarely yield cell lines, whereas those that have achieved blastocyst stage are a robust source of normal hES cells.	[Lerou, Paul H.; Yabuuchi, Akiko; Huo, Hongguang; Takeuchi, Ayumu; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Lerou, Paul H.] Brigham & Womens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Shea, Jessica] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cimini, Tina; Ginsburg, Elizabeth; Racowsky, Catherine] Harvard Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02115 USA; [Ince, Tan A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol,Div Womens & Perinatal Pathol, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lerou, Paul H.; Yabuuchi, Akiko; Huo, Hongguang; Takeuchi, Ayumu; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Ince, Tan/0000-0003-0315-6425				Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; *CDC, 2005 ASS REPR TECHN; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daphnis DD, 2005, HUM REPROD, V20, P129, DOI 10.1093/humrep/deh554; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; GARDNER DK, 1999, IN VITRO DEV HUMAN B; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Landry DW, 2004, J CLIN INVEST, V114, P1184, DOI 10.1172/JCI200423065; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Racowsky Catherine, 2003, Reprod Biomed Online, V6, P323; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	18	70	72	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					212	214		10.1038/nbt1378	http://dx.doi.org/10.1038/nbt1378			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18223642				2022-12-25	WOS:000253193000024
J	Russo, MJ; Balekdjian, D				Russo, Michael J.; Balekdjian, David			Weighing the outcomes	NATURE BIOTECHNOLOGY			English	Editorial Material									[Russo, Michael J.; Balekdjian, David] Bruckner Grp, Wakefield, MA 01880 USA		Russo, MJ (corresponding author), Bruckner Grp, 27 Water St,Suite 409, Wakefield, MA 01880 USA.	dbalekdjian@brucknergroup.com						*IMS HLTH, 2007, IMS HLTH REP GLOB PH	1	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					173	182		10.1038/nbt0208-173	http://dx.doi.org/10.1038/nbt0208-173			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18259169				2022-12-25	WOS:000253193000015
J	Courtine, G; Song, BB; Roy, RR; Zhong, H; Herrmann, JE; Ao, Y; Qi, JW; Edgerton, VR; Sofroniew, MV				Courtine, Gregoire; Song, Bingbing; Roy, Roland R.; Zhong, Hui; Herrmann, Julia E.; Ao, Yan; Qi, Jingwei; Edgerton, V. Reggie; Sofroniew, Michael V.			Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury	NATURE MEDICINE			English	Article							QUADRUPEDAL LOCOMOTION; FUNCTIONAL RECOVERY; NEURONS CONTRIBUTE; ADULT RATS; PLASTICITY; REGENERATION; PROJECTIONS; SYSTEMS; RHESUS	l Spinal cord injuries (SCIs) in humans(1,2) and experimental animals(3-6) are often associated with varying degrees of spontaneous functional recovery during the first months after injury. Such recovery is widely attributed to axons spared from injury that descend from the brain and bypass incomplete lesions, but its mechanisms are uncertain. To investigate the neural basis of spontaneous recovery, we used kinematic, physiological and anatomical analyses to evaluate mice with various combinations of spatially and temporally separated lateral hemisections with or without the excitotoxic ablation of intrinsic spinal cord neurons. We show that propriospinal relay connections that bypass one or more injury sites are able to mediate spontaneous functional recovery and supraspinal control of stepping, even when there has been essentially total and irreversible interruption of long descending supraspinal pathways in mice. Our findings show that pronounced functional recovery can occur after severe SCI without the maintenance or regeneration of direct projections from the brain past the lesion and can be mediated by the reorganization of descending and propriospinal connections(4,7-9). Targeting interventions toward augmenting the remodeling of relay connections may provide new therapeutic strategies to bypass lesions and restore function after SCI and in other conditions such as stroke and multiple sclerosis.	[Song, Bingbing; Herrmann, Julia E.; Ao, Yan; Qi, Jingwei; Sofroniew, Michael V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Courtine, Gregoire; Roy, Roland R.; Zhong, Hui; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Roy, Roland R.; Edgerton, V. Reggie; Sofroniew, Michael V.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	courtine, gregoire/AAJ-1694-2020; Sofroniew, Michael/ABE-8857-2020	courtine, gregoire/0000-0002-5744-4142; 	NIBIB NIH HHS [R01 EB007615] Funding Source: Medline; NINDS NIH HHS [P01 NS016333-26, NS16333, P01 NS016333] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016333] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASBAUM AI, 1973, EXP NEUROL, V40, P699, DOI 10.1016/0014-4886(73)90105-2; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; DUFFY MT, 1990, J COMP NEUROL, V293, P208, DOI 10.1002/cne.902930205; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fong AJ, 2005, J NEUROSCI, V25, P11738, DOI 10.1523/JNEUROSCI.1523-05.2005; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; JANE JA, 1964, J NEUROSURG, V21, P167, DOI 10.3171/jns.1964.21.3.0167; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Leblond H, 2003, J NEUROSCI, V23, P11411; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Nantwi KD, 1999, NEUROREHAB NEURAL RE, V13, P225, DOI 10.1177/154596839901300404; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Recktenwald MR, 1999, J NEUROPHYSIOL, V81, P2451, DOI 10.1152/jn.1999.81.5.2451; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664; STELZNER DJ, 1991, EXP NEUROL, V114, P193, DOI 10.1016/0014-4886(91)90036-C; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Zaporozhets E, 2006, J PHYSIOL-LONDON, V572, P443, DOI 10.1113/jphysiol.2005.102376	30	505	516	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					69	74		10.1038/nm1682	http://dx.doi.org/10.1038/nm1682			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157143	Green Accepted			2022-12-25	WOS:000252222400024
J	McKinnell, IW; Ishibashi, J; Le Grand, F; Punch, VGJ; Addicks, GC; Greenblatt, JF; Dilworth, FJ; Rudnicki, MA				McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Greenblatt, Jack F.; Dilworth, F. Jeffrey; Rudnicki, Michael A.			Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex	NATURE CELL BIOLOGY			English	Article							PROGENITOR CELLS; SATELLITE CELLS; H3; RECOGNITION; METHYLATION; DISTINCT; MENIN; MYOD; DIFFERENTIATION; POPULATION	Satellite cells purified from adult skeletal muscle can participate extensively in muscle regeneration and can also re-populate the satellite cell pool, suggesting that they have direct therapeutic potential for treating degenerative muscle diseases(1,2). The paired-box transcription factor Pax7 is required for satellite cells to generate committed myogenic progenitors(3). In this study we undertook a multi-level approach to define the role of Pax7 in satellite cell function. Using comparative microarray analysis, we identified several novel and strongly regulated targets; in particular, we identified Myf5 as a gene whose expression was regulated by Pax7. Using siRNA, fluorescence-activated cell sorting (FACS) and chromatin immunoprecipitation (ChIP) studies we confirmed that Myf5 is directly regulated by Pax7 in myoblasts derived from satellite cells. Tandem affinity purification (TAP) and mass spectrometry were used to purify Pax7 together with its co-factors. This revealed that Pax7 associates with the Wdr5-Ash2L-MLL2 histone methyltransferase (HMT) complex that directs methylation of histone H3 lysine 4 ( H3K4, refs 4-10). Binding of the Pax7-HMT complex to Myf5 resulted in H3K4 tri-methylation of surrounding chromatin. Thus, Pax7 induces chromatin modifications that stimulate transcriptional activation of target genes to regulate entry into the myogenic developmental programme.	[McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Dilworth, F. Jeffrey; Rudnicki, Michael A.] Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Dilworth, F. Jeffrey; Rudnicki, Michael A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada; [Greenblatt, Jack F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249; Dilworth, F. Jeffrey/0000-0002-6265-8102	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044031, R01 AR044031-12] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Buchberger A, 2007, DEVELOPMENT, V134, P1171, DOI 10.1242/dev.02798; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	34	271	287	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					77	U60		10.1038/ncb1671	http://dx.doi.org/10.1038/ncb1671			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066051	Green Accepted			2022-12-25	WOS:000252116100015
J	Turner, DJ; Miretti, M; Rajan, D; Fiegler, H; Carter, NP; Blayney, ML; Beck, S; Hurles, ME				Turner, Daniel J.; Miretti, Marcos; Rajan, Diana; Fiegler, Heike; Carter, Nigel P.; Blayney, Martyn L.; Beck, Stephan; Hurles, Matthew E.			Germline rates of de novo meiotic deletions and duplications causing several genomic disorders	NATURE GENETICS			English	Article							EXPRESSIVE-LANGUAGE DELAY; RECOMBINATION HOT-SPOT; WILLIAMS-BEUREN LOCUS; COPY NUMBER VARIATION; HUMAN Y-CHROMOSOME; HOMOLOGOUS RECOMBINATION; DEVELOPMENTAL DELAY; REARRANGEMENTS; HOTSPOT; REGION	Meiotic recombination between highly similar duplicated sequences (nonallelic homologous recombination, NAHR) generates deletions, duplications, inversions and translocations, and it is responsible for genetic diseases known as 'genomic disorders', most of which are caused by altered copy number of dosage-sensitive genes. NAHR hot spots have been identified within some duplicated sequences. We have developed sperm-based assays to measure the de novo rate of reciprocal deletions and duplications at four NAHR hot spots. We used these assays to dissect the relative rates of NAHR between different pairs of duplicated sequences. We show that (i) these NAHR hot spots are specific to meiosis, (ii) deletions are generated at a higher rate than their reciprocal duplications in the male germline and (iii) some of these genomic disorders are likely to have been underascertained clinically, most notably that resulting from the duplication of 7q11, the reciprocal of the deletion causing Williams-Beuren syndrome.	[Turner, Daniel J.; Miretti, Marcos; Rajan, Diana; Fiegler, Heike; Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Genom Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Blayney, Martyn L.] Bourn Hall Clin, Cambridge CB23 2TN, England; [Beck, Stephan] UCL, Inst Canc, London WC1E 6DD, England	Wellcome Trust Sanger Institute; University of London; University College London	Hurles, ME (corresponding author), Wellcome Trust Genom Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Miretti, Marcos M./AAY-5895-2020	Miretti, Marcos M./0000-0001-8179-1606	Wellcome Trust [077008, 077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Bosch E, 2003, HUM MOL GENET, V12, P341, DOI 10.1093/hmg/ddg031; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; Infante J, 2001, MUSCLE NERVE, V24, P1149, DOI 10.1002/mus.1126; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirchhoff M, 2007, EUR J MED GENET, V50, P33, DOI 10.1016/j.ejmg.2006.10.002; Kriek M, 2006, EUR J HUM GENET, V14, P180, DOI 10.1038/sj.ejhg.5201540; Kumar N, 1999, ANN NY ACAD SCI, V883, P344, DOI 10.1111/j.1749-6632.1999.tb08596.x; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Long FL, 1998, J MED GENET, V35, P425, DOI 10.1136/jmg.35.5.425; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Thomas NS, 2006, EUR J HUM GENET, V14, P831, DOI 10.1038/sj.ejhg.5201617; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Torniero C, 2007, EUR J HUM GENET, V15, P62, DOI 10.1038/sj.ejhg.5201730	32	227	233	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					90	95		10.1038/ng.2007.40	http://dx.doi.org/10.1038/ng.2007.40			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059269	Green Accepted			2022-12-25	WOS:000252118600023
J	Yadava, RS; Frenzel-McCardell, CD; Yu, Q; Srinivasan, V; Tucker, AL; Puymirat, J; Thornton, CA; Prall, OW; Harvey, RP; Mahadevan, MS				Yadava, Ramesh S.; Frenzel-McCardell, Carla D.; Yu, Qing; Srinivasan, Varadamurthy; Tucker, Amy L.; Puymirat, Jack; Thornton, Charles A.; Prall, Owen W.; Harvey, Richard P.; Mahadevan, Mani S.			RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; CARDIAC CONDUCTION; SKELETAL-MUSCLE; TRANSGENIC MICE; GAP-JUNCTIONS; TRANSCRIPTION; DIFFERENTIATION; MUTATION; CELLS; MODEL	Myotonic muscular dystrophy (DM1) is the most common inherited neuromuscular disorder in adults and is considered the first example of a disease caused by RNA toxicity. Using a reversible transgenic mouse model of RNA toxicity in DM1, we provide evidence that DM1 is associated with induced NKX2-5 expression. Transgene expression resulted in cardiac conduction defects, increased expression of the cardiac-specific transcription factor NKX2-5 and profound disturbances in connexin 40 and connexin 43. Notably, overexpression of the DMPK 3' UTR mRNA in mouse skeletal muscle also induced transcriptional activation of Nkx2-5 and its targets. In human muscles, these changes were specific to DM1 and were not present in other muscular dystrophies. The effects on NKX2-5 and its downstream targets were reversed by silencing toxic RNA expression. Furthermore, using Nkx2-5(+/-) mice, we show that NKX2-5 is the first genetic modifier of DM1-associated RNA toxicity in the heart.	[Yadava, Ramesh S.; Frenzel-McCardell, Carla D.; Yu, Qing; Srinivasan, Varadamurthy; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Tucker, Amy L.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Puymirat, Jack] Univ Laval, Human Genet Res Unit, Quebec City, PQ G1V 4G2, Canada; [Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Prall, Owen W.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	University of Virginia; University of Virginia; Laval University; University of Rochester; Victor Chang Cardiac Research Institute	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021	Yadava, Ramesh S/0000-0002-0092-5033; Harvey, Richard/0000-0002-9950-9792	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049077, R01AR052771, R01AR045992] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR045992, AR052771, R01 AR052771-03, R01 AR049077, R01 AR052771] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2002, J CELL BIOL, V159, P419, DOI 10.1083/jcb.200206020; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen ZF, 2002, INORG CHEM COMMUN, V5, P35, DOI 10.1016/S1387-7003(01)00341-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Gaussin V, 2004, ANAT REC PART A, V280A, P1022, DOI 10.1002/ar.a.20074; Gorbe A, 2005, HISTOCHEM CELL BIOL, V123, P573, DOI 10.1007/s00418-004-0745-2; Harper P.S., 1989, MYOTONIC DYSTROPHY; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kasahara H, 2001, J CLIN INVEST, V108, P189, DOI 10.1172/JCI200112694; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 1999, DEVELOPMENT, V126, P75; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CW, 2000, CIRC RES, V87, P346; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pelargonio G, 2002, HEART, V88, P665, DOI 10.1136/heart.88.6.665; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Tanaka M, 2002, COLD SPRING HARB SYM, V67, P317, DOI 10.1101/sqb.2002.67.317; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Teunissen BEJ, 2003, GENE, V322, P123, DOI 10.1016/j.gene.2003.08.011; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Wakimoto H, 2003, GENESIS, V37, P144, DOI 10.1002/gene.10236; Wakimoto H, 2002, J CARDIOVASC ELECTR, V13, P682, DOI 10.1046/j.1540-8167.2002.00682.x	50	59	65	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					61	68		10.1038/ng.2007.28	http://dx.doi.org/10.1038/ng.2007.28			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084293	Green Accepted			2022-12-25	WOS:000252118600019
J	Guo, DC; Pannu, H; Tran-Fadulu, V; Papke, CL; Yu, RK; Avidan, N; Bourgeois, S; Estrera, AL; Safi, HJ; Sparks, E; Amor, D; Ades, L; McConnell, V; Willoughby, CE; Abuelo, D; Willing, M; Lewis, RA; Kim, DH; Scherer, S; Tung, PP; Ahn, C; Buja, LM; Raman, CS; Shete, SS; Milewicz, DM				Guo, Dong-Chuan; Pannu, Hariyadarshi; Tran-Fadulu, Van; Papke, Christina L.; Yu, Robert K.; Avidan, Nili; Bourgeois, Scott; Estrera, Anthony L.; Safi, Hazim J.; Sparks, Elizabeth; Amor, David; Ades, Lesley; McConnell, Vivienne; Willoughby, Colin E.; Abuelo, Dianne; Willing, Marcia; Lewis, Richard A.; Kim, Dong H.; Scherer, Steve; Tung, Poyee P.; Ahn, Chul; Buja, L. Maximilian; Raman, C. S.; Shete, Sanjay S.; Milewicz, Dianna M.			Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENETIC-BASIS; PROTEINS; BINDING; MYOSIN; MYOPATHY	The major function of vascular smooth muscle cells ( SMCs) is contraction to regulate blood pressure and flow. SMC contractile force requires cyclic interactions between SMC alpha-actin ( encoded by ACTA2) and the beta-myosin heavy chain ( encoded by MYH11). Here we show that missense mutations in ACTA2 are responsible for 14% of inherited ascending thoracic aortic aneurysms and dissections ( TAAD). Structural analyses and immunofluorescence of actin filaments in SMCs derived from individuals heterozygous for ACTA2 mutations illustrate that these mutations interfere with actin filament assembly and are predicted to decrease SMC contraction. Aortic tissues from affected individuals showed aortic medial degeneration, focal areas of medial SMC hyperplasia and disarray, and stenotic arteries in the vasa vasorum due to medial SMC proliferation. These data, along with the previously reported MYH11 mutations causing familial TAAD(1), indicate the importance of SMC contraction in maintaining the structural integrity of the ascending aorta.	Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Cardiothorac & Vasc Surg, Houston, TX 77030 USA; Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Royal Childrens Hosp, Genet Hlth Serv Victoria, Clin Genet Res Grp, Parkville, Vic 3052, Australia; Univ Sydney, Childrens Hosp Westmead, Dept Pediat & Child Hlth, Sydney, NSW 2006, Australia; No Ireland Reg Genet Serv, Dept Genet, Hosp Trust, Belfast BT97 AB, Antrim, North Ireland; Queens Univ Belfast, Sch Biomed Sci, Ctr Vis Sci, Belfast BT12 6BA, Antrim, North Ireland; Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; Univ Iowa Hosp & Clin, Dept Pediat, Iowa City, IA 52242 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Brigham & Womens Hosp, Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Human Mol Genet, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Struct Biol Ctr, Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Royal Children's Hospital Melbourne; University of Sydney; Queens University Belfast; Lifespan Health Rhode Island; Rhode Island Hospital; University of Iowa; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Estrera, Anthony/ABG-4175-2021; Amor, David J/A-6478-2018	Amor, David J/0000-0001-7191-8511; Kim, Dong/0000-0002-1523-6396; Rui, Yanning/0000-0002-4482-5579; Raman, C. S./0000-0002-1036-3193; Willoughby, Colin/0000-0002-1246-4166; Buja, Louis Maximilian/0000-0001-8386-7029	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, P50HL083794] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024148] Funding Source: Medline; NHLBI NIH HHS [P50HL083794-01, R01 HL62594] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Bixler D, 1976, Birth Defects Orig Artic Ser, V12, P229; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; FINKBOHNER R, 1995, CIRCULATION, V91, P728, DOI 10.1161/01.CIR.91.3.728; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guo DC, 2001, CIRCULATION, V103, P2461; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; LEWIS RA, 1995, ARCH OPHTHALMOL-CHIC, V113, P1330, DOI 10.1001/archopht.1995.01100100118041; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pannu H, 2006, ANN NY ACAD SCI, V1085, P242, DOI 10.1196/annals.1383.024; Poindexter Brian J, 2005, J Burns Wounds, V4, pe7; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	30	561	582	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1488	1493		10.1038/ng.2007.6	http://dx.doi.org/10.1038/ng.2007.6			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994018				2022-12-25	WOS:000251267400017
J	Wang, R; Braughton, KR; Kretschmer, D; Bach, THL; Queck, SY; Li, M; Kennedy, AD; Dorward, DW; Klebanoff, SJ; Peschel, A; Deleo, FR; Otto, M				Wang, Rong; Braughton, Kevin R.; Kretschmer, Dorothee; Bach, Thanh-Huy L.; Queck, Shu Y.; Li, Min; Kennedy, Adam D.; Dorward, David W.; Klebanoff, Seymour J.; Peschel, Andreas; DeLeo, Frank R.; Otto, Michael			Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA	NATURE MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; NECROTIZING PNEUMONIA; GENOME; EPIDERMIDIS; EVOLUTION; STRAINS; INFECTIONS; INSIGHTS; DISEASE	Methicillin-resistant Staphylococcus aureus (MRSA) remains a major human pathogen. Traditionally, MRSA infections occurred exclusively in hospitals and were limited to immunocompromised patients or individuals with predisposing risk factors. However, recently there has been an alarming epidemic caused by community-associated (CA)-MRSA strains, which can cause severe infections that can result in necrotizing fasciitis or even death in otherwise healthy adults outside of healthcare settings(1,2). In the US, CA-MRSA is now the cause of the majority of infections that result in trips to the emergency room(3). It is unclear what makes CA-MRSA strains more successful in causing human disease compared with their hospital-associated counterparts. Here we describe a class of secreted staphylococcal peptides that have a remarkable ability to recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against S. aureus infection. These peptides are produced at high concentrations by standard CA-MRSA strains and contribute significantly to the strains' ability to cause disease in animal models of infection. Our study reveals a previously uncharacterized set of S. aureus virulence factors that account at least in part for the enhanced virulence of CA-MRSA.	NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, US NIH, Hamilton, MT 59840 USA; Univ Tubingen, Cellular & Mol Microbiol Unit, Med Microbiol & Hyg Dept, D-72076 Tubingen, Germany; NIAID, Microscopy Unit, Res Technol Sect, Rocky Mt Labs,US NIH, Hamilton, MT 59840 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Otto, M (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, US NIH, 903 S 4th St, Hamilton, MT 59840 USA.	motto@niaid.nih.gov		Otto, Michael/0000-0002-2222-4115; DeLeo, Frank/0000-0003-3150-2516	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000904, ZIAAI001079, ZIAAI000904, Z01AI001079] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; GROJEC PL, 1981, ZBL BAKT-INT J MED M, V250, P446; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kravitz GR, 2005, CLIN INFECT DIS, V40, P941, DOI 10.1086/428573; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; MELLOR IR, 1988, BIOCHIM BIOPHYS ACTA, V942, P280, DOI 10.1016/0005-2736(88)90030-2; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000	27	757	796	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1510	1514		10.1038/nm1656	http://dx.doi.org/10.1038/nm1656			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	17994102				2022-12-25	WOS:000251445400027
J	Taddei, A; Giampietro, C; Conti, A; Orsenigo, F; Breviario, F; Pirazzoli, V; Potente, M; Daly, C; Dimmeler, S; Dejana, E				Taddei, Andrea; Giampietro, Costanza; Conti, Annarita; Orsenigo, Fabrizio; Breviario, Ferruccio; Pirazzoli, Valentina; Potente, Michael; Daly, Christopher; Dimmeler, Stefanie; Dejana, Elisabetta			Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5	NATURE CELL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; BETA-CATENIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; MOLECULAR-BASIS; GROWTH-FACTOR; FKHR FOXO1; IN-VIVO; ANGIOGENESIS	Intercellular junctions mediate adhesion and communication between adjoining cells. Although formed by different molecules, tight junctions (TJs) and adherens junctions (AJs) are functionally and structurally linked, but the signalling pathways behind this interaction are unknown. Here we describe a cell-specific mechanism of crosstalk between these two types of structure. We show that endothelial VE-cadherin at AJs upregulates the gene encoding the TJ adhesive protein claudin-5. This effect requires the release of the inhibitory activity of forkhead box factor FoxO1 and the Tcf-4-beta-catenin transcriptional repressor complex. Vascular endothelial (VE)-cadherin acts by inducing the phosphorylation of FoxO1 through Akt activation and by limiting the translocation of beta-catenin to the nucleus. These results offer a molecular basis for the link between AJs and TJs and explain why VE-cadherin inhibition may cause a marked increase in permeability.	[Taddei, Andrea; Giampietro, Costanza; Conti, Annarita; Orsenigo, Fabrizio; Pirazzoli, Valentina; Dejana, Elisabetta] FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Breviario, Ferruccio; Dejana, Elisabetta] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy; [Potente, Michael; Dimmeler, Stefanie] Univ Frankfurt, Dept Internal Med 3, D-60590 Frankfurt, Germany; [Daly, Christopher] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Dejana, Elisabetta] Univ Milan, Sch Sci, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Goethe University Frankfurt; Regeneron; University of Milan	Dejana, E (corresponding author), FIRC Inst Mol Oncol, I-20139 Milan, Italy.	elisabetta.dejana@ifom-ieo-campus.it	Giampietro, Costanza/D-4643-2016	Giampietro, Costanza/0000-0001-5229-3835; Orsenigo, Fabrizio/0000-0001-9135-8478; Daly, Christopher/0000-0003-3800-8174; DEJANA, ELISABETTA/0000-0002-0007-0426; Potente, Michael/0000-0002-5689-0036; Dimmeler, Stefanie/0000-0002-1045-2436	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Grueneberg DA, 2003, MOL CELL BIOL, V23, P3936, DOI 10.1128/MCB.23.11.3936-3950.2003; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	50	448	460	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					923	934		10.1038/ncb1752	http://dx.doi.org/10.1038/ncb1752			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604199				2022-12-25	WOS:000258147100010
J	Clack, NG; Salaita, K; Groves, JT				Clack, Nathan G.; Salaita, Khalid; Groves, Jay T.			Electrostatic readout of DNA microarrays with charged microspheres	NATURE BIOTECHNOLOGY			English	Article							LABEL-FREE; RESOLUTION; HYBRIDIZATION; DIAGNOSTICS; MEDICINE; BIOLOGY; FUTURE	DNA microarrays are used for gene-expression profiling, single-nucleotide polymorphism detection and disease diagnosis(1-3). A persistent challenge in this area is the lack of microarray screening technology suitable for integration into routine clinical care(4,5). Here, we describe a method for sensitive and label-free electrostatic readout of DNA or RNA hybridization on microarrays. The electrostatic properties of the microarray are measured from the position and motion of charged microspheres randomly dispersed over the surface. We demonstrate nondestructive electrostatic imaging with 10-mu m lateral resolution over centimeter-length scales, which is four-orders of magnitude larger than that achievable with conventional scanning electrostatic force microscopy. Changes in surface charge density as a result of specific hybridization can be detected and quantified with 50-pM sensitivity, single base-pair mismatch selectivity and in the presence of complex background. Because the naked eye is sufficient to read out hybridization, this approach may facilitate broad application of multiplexed assays.	[Clack, Nathan G.; Groves, Jay T.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Salaita, Khalid; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	salaita, khalid/C-4414-2008		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Aitman TJ, 2001, BRIT MED J, V323, P611, DOI 10.1136/bmj.323.7313.611; Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Cassell AM, 2001, LANGMUIR, V17, P260, DOI 10.1021/la001273a; Clack NG, 2005, LANGMUIR, V21, P6430, DOI 10.1021/la050372r; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; de Gans BJ, 2003, MACROMOL RAPID COMM, V24, P659, DOI 10.1002/marc.200350010; Despont M, 2004, J MICROELECTROMECH S, V13, P895, DOI 10.1109/JMEMS.2004.835769; DOVE A, 2007, SCIENCE, V318, P473; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Fan CH, 2003, P NATL ACAD SCI USA, V100, P9134, DOI 10.1073/pnas.1633515100; Fang SP, 2006, J AM CHEM SOC, V128, P14044, DOI 10.1021/ja065223p; Fritz J, 2002, P NATL ACAD SCI USA, V99, P14142, DOI 10.1073/pnas.232276699; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Heyries KA, 2007, LANGMUIR, V23, P4523, DOI 10.1021/la070018o; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; McGuire AL, 2007, SCIENCE, V317, P1687, DOI 10.1126/science.1147475; Nilsson KPR, 2003, NAT MATER, V2, P419, DOI 10.1038/nmat899; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Russel W.B., 1991, COLLOIDAL DISPERSION; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Schilling J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021901; Sinensky AK, 2007, NAT NANOTECHNOL, V2, P653, DOI 10.1038/nnano.2007.293; Steinmetz LM, 2004, NAT REV GENET, V5, P190, DOI 10.1038/nrg1293; 't Hoen PAC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng020; Winssinger N, 2007, TOP CURR CHEM, V278, P311, DOI 10.1007/128_2007_109; Yu AA, 2005, J AM CHEM SOC, V127, P16774, DOI 10.1021/ja055762e; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134; Zhou DJ, 2003, ANGEW CHEM INT EDIT, V42, P4934, DOI 10.1002/anie.200352178; 2006, NATURE, V444, P681	34	40	41	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					825	830		10.1038/nbt1416	http://dx.doi.org/10.1038/nbt1416			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18587384	Green Accepted, Green Submitted			2022-12-25	WOS:000257491600028
J	Stark, KL; Xu, B; Bagchi, A; Lai, WS; Liu, H; Hsu, R; Wan, X; Pavlidis, P; Mills, AA; Karayiorgou, M; Gogos, JA				Stark, Kimberly L.; Xu, Bin; Bagchi, Anindya; Lai, Wen-Sung; Liu, Hui; Hsu, Ruby; Wan, Xiang; Pavlidis, Paul; Mills, Alea A.; Karayiorgou, Maria; Gogos, Joseph A.			Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model	NATURE GENETICS			English	Article							22Q11 DELETION SYNDROME; CARDIO-FACIAL SYNDROME; PREPULSE INHIBITION; GENETIC-VARIATION; SYNDROME REGION; MICE; SCHIZOPHRENIA; MEMORY; DISORDER; SYSTEM	Individuals with 22q11.2 microdeletions show behavioral and cognitive deficits and are at high risk of developing schizophrenia. We analyzed an engineered mouse strain carrying a chromosomal deficiency spanning a segment syntenic to the human 22q11.2 locus. We uncovered a previously unknown alteration in the biogenesis of microRNAs (miRNAs) and identified a subset of brain miRNAs affected by the microdeletion. We provide evidence that the abnormal miRNA biogenesis emerges because of haploinsufficiency of the Dgcr8 gene, which encodes an RNA-binding moiety of the 'microprocessor' complex and contributes to the behavioral and neuronal deficits associated with the 22q11.2 microdeletion.	[Xu, Bin; Lai, Wen-Sung; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, New York, NY 10032 USA; [Stark, Kimberly L.; Liu, Hui; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Bagchi, Anindya; Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hsu, Ruby; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, Coll Phys & Surg, New York, NY 10032 USA; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Bioinformat Ctr, Vancouver, BC V6T 1Z4, Canada	Columbia University; Columbia University; Cold Spring Harbor Laboratory; Columbia University; University of British Columbia; University of British Columbia	Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Lai, Wen-Sung/0000-0001-6918-5531	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH077235] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067068, MH077235] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gothelf D, 2004, AM J MED GENET B, V126B, P116, DOI 10.1002/ajmg.b.20144; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jurata LW, 2006, SCHIZOPHR RES, V88, P251, DOI 10.1016/j.schres.2006.07.017; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Schratt GM, 2006, NATURE, V441, P902, DOI 10.1038/nature04909; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	50	438	456	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					751	760		10.1038/ng.138	http://dx.doi.org/10.1038/ng.138			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469815	Green Submitted			2022-12-25	WOS:000256212000017
J	Sayed, AA; Simeonov, A; Thomas, CJ; Inglese, J; Austin, CP; Williams, DL				Sayed, Ahmed A.; Simeonov, Anton; Thomas, Craig J.; Inglese, James; Austin, Christopher P.; Williams, David L.			Identification of oxadiazoles as new drug leads for the control of schistosomiasis	NATURE MEDICINE			English	Article							TROPICAL DISEASES; MANSONI; RESISTANCE; INFECTION; PRAZIQUANTEL; THIOREDOXIN; FUROXANS; METAANALYSIS; GLUTATHIONE; LIBRARIES	Treatment for schistosomiasis, which is responsible for more than 280,000 deaths annually, depends almost exclusively on praziquantel. Millions of people are treated annually with praziquantel, and drug- resistant parasites thus are likely to evolve. Phosphinic amides and oxadiazole 2- oxides, identified from a quantitative high- throughput screen, were shown to inhibit a parasite enzyme, thioredoxin glutathione reductase ( TGR), with activities in the low micromolar to low nanomolar range. Incubation of parasites with these compounds led to rapid inhibition of TGR activity and parasite death. The activity of the oxadiazole 2- oxides was associated with a donation of nitric oxide. Treatment of schistosome- infected mice with 4- phenyl- 1,2,5- oxadiazole- 3-carbonitrile- 2- oxide led to marked reductions in worm burdens from treatments against multiple parasite stages and egg- associated pathologies. The compound was active against the three major schistosome species infecting humans. These protective effects exceed benchmark activity criteria set by the World Health Organization for lead compound development for schistosomiasis.	[Sayed, Ahmed A.; Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA; [Simeonov, Anton; Thomas, Craig J.; Inglese, James; Austin, Christopher P.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA	Illinois State University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Williams, DL (corresponding author), Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA.	austinc@mail.nih.gov; dlwilli@ilstu.edu		Thomas, Craig/0000-0001-9386-9001	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065622, R01AI030026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076449] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG200319-04] Funding Source: Medline; NIAID NIH HHS [N01AI30026, R01 AI065622, R01 AI065622-02, R01AI065622] Funding Source: Medline; NIMH NIH HHS [R03 MH076449, R03MH076449] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Aguirre G, 2006, PHARMAZIE, V61, P54; AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Moreira LSA, 2007, T ROY SOC TROP MED H, V101, P385, DOI 10.1016/j.trstmh.2006.06.006; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Bergmeyer HU., 1974, METHODS ENZYMATIC AN, P574, DOI [10.1016/B978-0-12-091302-2.50010-4, DOI 10.1016/B978-0-12-091302-2.50010-4]; Cerecetto H, 2005, MINI-REV MED CHEM, V5, P57, DOI 10.2174/1389557053402864; CIOLI D, 1993, PARASITOL TODAY, V9, P162, DOI 10.1016/0169-4758(93)90138-6; FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83; FEELISCH M, 1992, BIOCHEM PHARMACOL, V44, P1149, DOI 10.1016/0006-2952(92)90379-W; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; HERWALDT BL, 1995, CLIN INFECT DIS, V20, P309, DOI 10.1093/clinids/20.2.309; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; JAMES SL, 1989, J IMMUNOL, V143, P4208; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lewis R, 1998, CAN REV AM STUD, V28, P1, DOI 10.3138/CRAS-028-02-01; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; MEDANA C, 1994, J MED CHEM, V37, P4412, DOI 10.1021/jm00051a020; MurraySmith SQ, 1996, MED J AUSTRALIA, V165, P458, DOI 10.5694/j.1326-5377.1996.tb138598.x; Nims Raymond W., 1995, Methods (Orlando), V7, P48, DOI 10.1006/meth.1995.1007; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53; SABAH AA, 1986, EXP PARASITOL, V61, P294, DOI 10.1016/0014-4894(86)90184-0; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Xiao SH, 2000, PARASITOL INT, V49, P19, DOI 10.1016/S1383-5769(00)00028-3	36	214	233	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					407	412		10.1038/nm1737	http://dx.doi.org/10.1038/nm1737			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18345010	Green Accepted			2022-12-25	WOS:000254674100027
J	Eeles, RA; Kote-Jarai, Z; Giles, GG; Al Olama, AA; Guy, M; Jugurnauth, SK; Mulholland, S; Leongamornlert, DA; Edwards, SM; Morrison, J; Field, HI; Southey, MC; Severi, G; Donovan, JL; Hamdy, FC; Dearnaley, DP; Muir, KR; Smith, C; Bagnato, M; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Gehr-Swain, BN; Wilkinson, RA; Cox, A; Lewis, S; Brown, PM; Jhavar, SG; Tymrakiewicz, M; Lophatananon, A; Bryant, SL; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Fisher, C; Jamieson, C; Cooper, CS; English, DR; Hopper, JL; Neal, DE; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Giles, Graham G.; Al Olama, Ali Amin; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Morrison, Jonathan; Field, Helen I.; Southey, Melissa C.; Severi, Gianluca; Donovan, Jenny L.; Hamdy, Freddie C.; Dearnaley, David P.; Muir, Kenneth R.; Smith, Charmaine; Bagnato, Melisa; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Cox, Angie; Lewis, Sarah; Brown, Paul M.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Lophatananon, Artitaya; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles; Cooper, Colin S.; English, Dallas R.; Hopper, John L.; Neal, David E.; Easton, Douglas F.		Uk Genetic Prostate Canc Study Col; British Assoc Urological Surg Sect; Uk ProtecT Study Collaborators	Multiple newly identified loci associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; AUSTRALIAN CASE-CONTROL; RADICAL PROSTATECTOMY; ANTIGEN LEVELS; RISK LOCUS; GENE; MEN; POLYMORPHISMS; VARIANTS; PROMOTER	Prostate cancer is the most common cancer affecting males in developed countries. It shows consistent evidence of familial aggregation, but the causes of this aggregation are mostly unknown. To identify common alleles associated with prostate cancer risk, we conducted a genome-wide association study (GWAS) using blood DNA samples from 1,854 individuals with clinically detected prostate cancer diagnosed at <= 60 years or with a family history of disease, and 1,894 population-screened controls with a low prostate-specific antigen (PSA) concentration (< 0.5 ng/ml). We analyzed these samples for 541,129 SNPs using the Illumina Infinium platform. Initial putative associations were confirmed using a further 3,268 cases and 3,366 controls. We identified seven loci associated with prostate cancer on chromosomes 3, 6, 7, 10, 11, 19 and X (P = 2.7 x 10(-8) to P = 8.7 x 10(-29)). We confirmed previous reports of common loci associated with prostate cancer at 8q24 and 17q. Moreover, we found that three of the newly identified loci contain candidate susceptibility genes: MSMB, LMTK2 and KLK3.	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Dearnaley, David P.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Giles, Graham G.; Severi, Gianluca; Smith, Charmaine; Bagnato, Melisa] Canc Epidemiol Ctr, Canc Council Vic, Melbourne, Vic 3053, Australia; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.; Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Strangeways Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; [Field, Helen I.] Univ Cambridge, Strangeways Lab, Dept Oncol, Cambridge CB1 8RN, England; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Donovan, Jenny L.; Lewis, Sarah] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hamdy, Freddie C.; Cox, Angie] Univ Sheffield, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England; [Muir, Kenneth R.; Lophatananon, Artitaya] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Council Victoria; University of Melbourne; Cancer Research UK; University of Cambridge; University of Cambridge; University of Melbourne; University of Bristol; University of Sheffield; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Eeles, RA (corresponding author), Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	rosalind.eeles@icr.ac.uk	Severi, Gianluca/Q-1824-2019; McNicholas, Tom A/C-2268-2014; English, Dallas/AAH-5005-2019; Severi, Gianluca/H-3774-2018; Dearnaley, David P/J-2318-2014	Severi, Gianluca/0000-0001-7157-419X; McNicholas, Tom A/0000-0001-9971-8765; English, Dallas/0000-0001-7828-8188; Severi, Gianluca/0000-0001-7157-419X; Dearnaley, David P/0000-0002-3954-2806; Eeles, Rosalind/0000-0002-3698-6241; Leongamornlert, Daniel/0000-0002-3486-3168; Hamdy, Freddie/0000-0003-2627-2154; Neal, David/0000-0002-6033-5086; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005; huddart, robert/0000-0003-3604-1990; Cox, Angela/0000-0002-5138-1099; Lewis, Sarah/0000-0003-4311-6890	MRC [G0500966, G0501019] Funding Source: UKRI; Cancer Research UK [10118] Funding Source: Medline; Medical Research Council [G0500966, G0501019] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Cramer SD, 2003, JNCI-J NATL CANCER I, V95, P1044, DOI 10.1093/jnci/95.14.1044; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 1999, PROSTATE CANCER P D, V2, P9, DOI 10.1038/sj.pcan.4500279; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; MacInnis RJ, 2003, CANCER EPIDEM BIOMAR, V12, P1417; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P86, DOI 10.1158/1055-9965.EPI-05-0633; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1142, DOI 10.1158/1055-9965.EPI-05-0984; Steuber T, 2006, INT J CANCER, V118, P1234, DOI 10.1002/ijc.21474; Steuber T, 2007, WORLD J UROL, V25, P111, DOI 10.1007/s00345-007-0160-0; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	672	695	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					316	321		10.1038/ng.90	http://dx.doi.org/10.1038/ng.90			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264097				2022-12-25	WOS:000253548400022
J	Aragones, J; Schneider, M; Van Geyte, K; Fraisl, P; Dresselaers, T; Mazzone, M; Dirkx, R; Zacchigna, S; Lemieux, H; Jeoung, NH; Lambrechts, D; Bishop, T; Lafuste, P; Diez-Juan, A; Harten, SK; Van Noten, P; De Bock, K; Willam, C; Tjwa, M; Grosfeld, A; Navet, R; Moons, L; Vandendriessche, T; Deroose, C; Wijeyekoon, B; Nuyts, J; Jordan, B; Silasi-Mansat, R; Lupu, F; Dewerchin, M; Pugh, C; Salmon, P; Mortelmans, L; Gallez, B; Gorus, F; Buyse, J; Sluse, F; Harris, RA; Gnaiger, E; Hespel, P; Van Hecke, P; Schuit, F; Van Veldhoven, P; Ratcliffe, P; Baes, M; Maxwell, P; Carmeliet, P				Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Dresselaers, Tom; Mazzone, Massimiliano; Dirkx, Ruud; Zacchigna, Serena; Lemieux, Helene; Jeoung, Nam Ho; Lambrechts, Diether; Bishop, Tammie; Lafuste, Peggy; Diez-Juan, Antonio; Harten, Sarah K.; Van Noten, Pieter; De Bock, Katrien; Willam, Carsten; Tjwa, Marc; Grosfeld, Alexandra; Navet, Rachel; Moons, Lieve; Vandendriessche, Thierry; Deroose, Christophe; Wijeyekoon, Bhathiya; Nuyts, Johan; Jordan, Benedicte; Silasi-Mansat, Robert; Lupu, Florea; Dewerchin, Mieke; Pugh, Chris; Salmon, Phil; Mortelmans, Luc; Gallez, Bernard; Gorus, Frans; Buyse, Johan; Sluse, Francis; Harris, Robert A.; Gnaiger, Erich; Hespel, Peter; Van Hecke, Paul; Schuit, Frans; Van Veldhoven, Paul; Ratcliffe, Peter; Baes, Myriam; Maxwell, Patrick; Carmeliet, Peter			Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; EXPRESSION; ALPHA; HIF; INCREASES; MICE; RESPIRATION; HIF-1-ALPHA; HOMEOSTASIS; ADAPTATION	HIF prolyl hydroxylases (PHD1-3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner. Here, we show that loss of Phd1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metabolism from oxidative to more anaerobic ATP production through activation of a Ppar alpha pathway. This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia. Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Phd1-deficient myofibers to preserve mitochondrial respiration. Hypoxia tolerance relies primarily on Hif-2 alpha and was not observed in heterozygous Phd2-deficient or homozygous Phd3-deficient mice. Of medical importance, conditional knockdown of Phd1 also rapidly induces hypoxia tolerance. These findings delineate a new role of Phd1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.	[Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lemieux, Helene; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Dresselaers, Tom; Van Hecke, Paul] Katholieke Univ Leuven, Biomed MRI Unit, B-3000 Louvain, Belgium; [Dirkx, Ruud; Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, B-3000 Louvain, Belgium; [Lemieux, Helene; Gnaiger, Erich] Med Univ Innsbruck, Dept Transplant Surg, D Swarovski Res Lab, A-6020 Innsbruck, Austria; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Bishop, Tammie; Willam, Carsten; Grosfeld, Alexandra; Wijeyekoon, Bhathiya; Pugh, Chris; Ratcliffe, Peter] Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England; [Harten, Sarah K.; Maxwell, Patrick] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England; [Van Noten, Pieter; De Bock, Katrien; Hespel, Peter] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Exercise & Hlth Lab, B-3001 Louvain, Belgium; [Navet, Rachel; Sluse, Francis] Univ Liege, Dept Life Sci, Lab Bioenerget & Mol Physiol, B-4000 Liege, Belgium; [Deroose, Christophe; Nuyts, Johan; Mortelmans, Luc] Katholieke Univ Leuven, Univ Hosp, Dept Nucl Med, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Catholic Univ Louvain, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium; [Silasi-Mansat, Robert; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Res Program, Oklahoma City, OK 73104 USA; [Salmon, Phil] Skyscan NV, B-2630 Aartselaar, Belgium; [Gorus, Frans] Free Univ Brussels, Diabet Res Ctr, B-1090 Brussels, Belgium; [Buyse, Johan] Katholieke Univ Leuven, Dept Biosyst, Lab Physiol Immunol & Genet Domest Anim, B-3001 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Van Veldhoven, Paul] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Dept Mol Cell Biol, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Medical University of Innsbruck; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oxford; Imperial College London; KU Leuven; University of Liege; KU Leuven; Universite Catholique Louvain; Oklahoma Medical Research Foundation; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; KU Leuven; KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Lupu, Florea/C-3162-2009; Grosfeld, Alexandra/R-1404-2017; De Bock, Katrien/L-2273-2013; Carmeliet, Peter/AAQ-5140-2020; De Bock, Katrien/B-7208-2012; Deroose, Christophe/AAG-7385-2020; Diez Juan, Antonio/D-3695-2018; Grosfeld, Alexandra/AAH-3510-2020; Schneider, Martin/H-3745-2011; , Van Veldhoven Paul/U-6359-2019; Maxwell, Patrick H/C-5557-2008; Lambrechts, Diether/AAJ-3167-2020; Lupu, Florea/AAV-3257-2021; Verdrengh, Evelien/H-4571-2012; Diez-Juan, Antonio/H-5464-2015; ZACCHIGNA, SERENA/E-9496-2017	Lupu, Florea/0000-0003-1249-9278; Grosfeld, Alexandra/0000-0002-9508-036X; De Bock, Katrien/0000-0001-8232-4663; Carmeliet, Peter/0000-0001-7961-1821; Deroose, Christophe/0000-0002-6080-1577; , Van Veldhoven Paul/0000-0002-4478-2564; Maxwell, Patrick H/0000-0002-0338-2679; Lambrechts, Diether/0000-0002-3429-302X; Lupu, Florea/0000-0003-1249-9278; Pugh, Chris/0000-0002-5170-1662; Baes, Myriam/0000-0002-2525-2269; Silasi, Robert/0000-0001-9590-6160; Diez-Juan, Antonio/0000-0002-0166-1869; Vandendriessche, Thierry/0000-0003-4230-745X; Mazzone, Massimiliano/0000-0001-8824-4015; Hespel, Peter/0000-0003-1283-2229; Bishop, Tammie/0000-0003-3308-9139; Gnaiger, Erich/0000-0003-3647-5895; Lafuste, Peggy/0000-0001-8239-3482; Wilkinson, Sarah/0000-0002-1912-8384; Nuyts, Johan/0000-0003-1923-6198; ZACCHIGNA, SERENA/0000-0001-6705-3076; Gorus, Frans/0000-0002-9007-6177; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Wijeyekoon, Jananath/0000-0003-3414-4304; Dresselaers, Tom/0000-0002-0884-5142; Aragones Lopez, Julian/0000-0002-0193-4679; Jeoung, Nam Ho/0000-0002-7584-3761; Ratcliffe, Peter/0000-0002-2853-806X	Medical Research Council [G84/6411] Funding Source: Medline; NIDDK NIH HHS [12R01DK47844] Funding Source: Medline; NIGMS NIH HHS [5R01GM037704] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037704] Funding Source: NIH RePORTER; MRC [G84/6411] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Buyse J, 1998, BRIT POULTRY SCI, V39, P264, DOI 10.1080/00071669889231; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hochachka PW, 1998, J EXP BIOL, V201, P1243; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jordan BF, 2002, CANCER RES, V62, P3555; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RERNIREZ JM, 2007, ANNU REV PHYSIOL, V69, P113; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399; Wouters BG, 2004, DRUG RESIST UPDATE, V7, P25, DOI 10.1016/j.drup.2003.12.004; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	49	380	393	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					170	180		10.1038/ng.2007.62	http://dx.doi.org/10.1038/ng.2007.62			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176562	Green Accepted, Green Published			2022-12-25	WOS:000252732900015
J	Ott, HC; Matthiesen, TS; Goh, SK; Black, LD; Kren, SM; Netoff, TI; Taylor, DA				Ott, Harald C.; Matthiesen, Thomas S.; Goh, Saik-Kia; Black, Lauren D.; Kren, Stefan M.; Netoff, Theoden I.; Taylor, Doris A.			Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart	NATURE MEDICINE			English	Article							CARDIAC TISSUE; RECELLULARIZATION; SCAFFOLD	About 3,000 individuals in the United States are awaiting a donor heart; worldwide, 22 million individuals are living with heart failure. A bioartificial heart is a theoretical alternative to transplantation or mechanical left ventricular support. Generating a bioartificial heart requires engineering of cardiac architecture, appropriate cellular constituents and pump function. We decellularized hearts by coronary perfusion with detergents, preserved the underlying extracellular matrix, and produced an acellular, perfusable vascular architecture, competent acellular valves and intact chamber geometry. To mimic cardiac cell composition, we reseeded these constructs with cardiac or endothelial cells. To establish function, we maintained eight constructs for up to 28 d by coronary perfusion in a bioreactor that simulated cardiac physiology. By day 4, we observed macroscopic contractions. By day 8, under physiological load and electrical stimulation, constructs could generate pump function (equivalent to about 2% of adult or 25% of 16-week fetal heart function) in a modified working heart preparation.	[Matthiesen, Thomas S.; Goh, Saik-Kia; Kren, Stefan M.; Taylor, Doris A.] Univ Minnesota, Ctr Cardiovasc Repair, Minneapolis, MN 55455 USA; [Ott, Harald C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Black, Lauren D.; Netoff, Theoden I.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Taylor, Doris A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Taylor, DA (corresponding author), Univ Minnesota, Ctr Cardiovasc Repair, 312 Church St SE,7-105A NHH, Minneapolis, MN 55455 USA.	dataylor@umn.edu	Sano, Michael/E-1715-2011; aksel, hacer/H-1572-2015	Kren, Stefan/0000-0001-8015-543X; Black, Lauren/0000-0002-7486-5811; Netoff, Theoden/0000-0002-0115-1930				BODNAR E, 1986, THORAC CARDIOV SURG, V34, P82, DOI 10.1055/s-2007-1020381; Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070; COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602; Dellgren G, 2002, EUR J CARDIO-THORAC, V22, P912, DOI 10.1016/S1010-7940(02)00584-5; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70; Gerecht-Nir S, 2006, INT J DEV BIOL, V50, P233, DOI 10.1387/ijdb.052041sg; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grabow N, 2004, ARTIF ORGANS, V28, P971, DOI 10.1111/j.1525-1594.2004.00007.x; Johnson P, 2000, HEART, V84, P59, DOI 10.1136/heart.84.1.59; Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athoracsur.2004.09.033; Kobashigawa JA, 2006, NAT CLIN PRACT CARD, V3, P203, DOI 10.1038/ncpcardio0510; Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763; Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; OSSIPOW V, 1993, NUCLEIC ACIDS RES, V21, P6040, DOI 10.1093/nar/21.25.6040; Park H, 2005, IN VITRO CELL DEV-AN, V41, P188; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PRESS WH, 1992, NUMERICAL RECIPES C, pCH12; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436; Roy S, 2005, AM J PHYSIOL-HEART C, V289, pH1567, DOI 10.1152/ajpheart.00564.2004; RUSS JC, 2002, IMAGE PROCESSING HDB, pCH4; Sekine H, 2006, J HEART LUNG TRANSPL, V25, P324, DOI 10.1016/j.healun.2005.09.017; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	26	1862	2017	11	503	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					213	221		10.1038/nm1684	http://dx.doi.org/10.1038/nm1684			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18193059				2022-12-25	WOS:000252946700032
J	Hakes, L; Pinney, JW; Robertson, DL; Lovell, SC				Hakes, Luke; Pinney, John W.; Robertson, David L.; Lovell, Simon C.			Protein-protein interaction networks and biology - what's the connection?	NATURE BIOTECHNOLOGY			English	Article							SCALE-FREE NETWORKS; SACCHAROMYCES-CEREVISIAE; HUB PROTEINS; YEAST; TOPOLOGY; EVOLUTIONARY; MODULARITY; MODEL	Analysis of protein-protein interaction networks is an increasingly popular means to infer biological insight, but is close enough attention being paid to data handling protocols and the degree of bias in the data?.	[Hakes, Luke; Pinney, John W.; Robertson, David L.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Hakes, L (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	simon.lovell@manchester.ac.uk		Lovell, Simon/0000-0002-4092-8458	Biotechnology and Biological Sciences Research Council [BB/F007620/1, BB/C515412/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/F007620/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aloy P, 2002, FEBS LETT, V530, P253, DOI 10.1016/S0014-5793(02)03427-0; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Bersini H, 2006, J THEOR BIOL, V241, P488, DOI 10.1016/j.jtbi.2005.12.012; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Brandes U., 2005, NETWORK ANAL; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Hakes L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-131; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Pereira-Leal JB, 2005, MOL BIOL EVOL, V22, P421, DOI 10.1093/molbev/msi024; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Salathe M, 2005, J ROY SOC INTERFACE, V2, P533, DOI 10.1098/rsif.2005.0072; Stumpf MPH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036118; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Suthram S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-360; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145	35	138	142	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					69	72		10.1038/nbt0108-69	http://dx.doi.org/10.1038/nbt0108-69			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183023				2022-12-25	WOS:000252222500025
J	Stratton, MR; Rahman, N				Stratton, Michael R.; Rahman, Nazneen			The emerging landscape of breast cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; ATAXIA-TELANGIECTASIA; PROSTATE-CANCER; BRCA2; MUTATIONS; GENE; VARIANT; PROTEIN; RISK	The genetic basis of inherited predisposition to breast cancer has been assiduously investigated for the past two decades and has been the subject of several recent discoveries. Three reasonably well-defined classes of breast cancer susceptibility alleles with different levels of risk and prevalence in the population have become apparent: rare high-penetrance alleles, rare moderate-penetrance alleles and common low-penetrance alleles. The contribution of each component to breast cancer predisposition is still to be fully explored, as are the phenotypic characteristics of the cancers associated with them, the ways in which they interact, much of their biology and their clinical utility. These recent advances herald a new chapter in the exploration of susceptibility to breast cancer and are likely to provide insights relevant to other common, heterogeneous diseases.	[Stratton, Michael R.] Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, Cambridge CB10 1SA, England; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, 15 Cotswold Rd, Cambridge CB10 1SA, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tommiska J, 2006, INT J CANCER, V118, P2911, DOI 10.1002/ijc.21738; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; van Puijenbroek M, 2005, J PATHOL, V206, P198, DOI 10.1002/path.1764; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	55	346	358	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					17	22		10.1038/ng.2007.53	http://dx.doi.org/10.1038/ng.2007.53			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18163131				2022-12-25	WOS:000252118600011
J	Seki, E; De Minicis, S; Osterreicher, CH; Kluwe, J; Osawa, Y; Brenner, DA; Schwabe, RF				Seki, Ekihiro; De Minicis, Samuele; Oesterreicher, Christoph H.; Kluwe, Johannes; Osawa, Yosuke; Brenner, David A.; Schwabe, Robert F.			TLR4 enhances TGF-beta signaling and hepatic fibrosis	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTOR-4; DIFFERENTIATION FACTOR-88; GENE-EXPRESSION; STELLATE CELLS; KUPFFER CELLS; CUTTING EDGE; LIVER-INJURY; ACTIVATION; LIPOPOLYSACCHARIDE; IDENTIFICATION	Hepatic injury is associated with a defective intestinal barrier and increased hepatic exposure to bacterial products. Here we report that the intestinal bacterial microflora and a functional Toll-like receptor 4 (TLR4), but not TLR2, are required for hepatic fibrogenesis. Using Tlr4-chimeric mice and in vivo lipopolysaccharide (LPS) challenge, we demonstrate that quiescent hepatic stellate cells (HSCs), the main precursors for myofibroblasts in the liver, are the predominant target through which TLR4 ligands promote fibrogenesis. In quiescent HSCs, TLR4 activation not only upregulates chemokine secretion and induces chemotaxis of Kupffer cells, but also downregulates the transforming growth factor (TGF)-beta pseudoreceptor Bambi to sensitize HSCs to TGF-beta induced signals and allow for unrestricted activation by Kupffer cells. LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappa B-dependent pathway. Accordingly, Myd88-deficient mice have decreased hepatic fibrosis. Thus, modulation of TGF-beta signaling by a TLR4-MyD88-NF-kappa B axis provides a novel link between proinflammatory and profibrogenic signals.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Columbia University; University of California System; University of California San Diego	Schwabe, RF (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	rfs2102@columbia.edu	Schwabe, Robert/AAY-6506-2021; Kluwe, Johannes/CAF-7810-2022; Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM041804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Isayama F, 2006, AM J PHYSIOL-GASTR L, V290, pG1318, DOI 10.1152/ajpgi.00405.2005; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; MAGILAVY DB, 1988, J EXP MED, V168, P789, DOI 10.1084/jem.168.2.789; Muhlbauer M, 2004, BIOCHEM BIOPH RES CO, V325, P191, DOI 10.1016/j.bbrc.2004.10.020; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Sasaki T, 2004, ONCOL REP, V11, P1219; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Thurman RG, 1998, J GASTROEN HEPATOL, V13, pS39, DOI 10.1111/jgh.1998.13.s1.39; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115	47	1375	1451	7	197	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2007	13	11					1324	1332		10.1038/nm1663	http://dx.doi.org/10.1038/nm1663			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17952090				2022-12-25	WOS:000250736900025
J	Ukai, H; Kobayashi, TJ; Nagano, M; Masumoto, K; Sujino, M; Kondo, T; Yagita, K; Shigeyoshi, Y; Ueda, HR				Ukai, Hideki; Kobayashi, Tetsuya J.; Nagano, Mamoru; Masumoto, Koh-hei; Sujino, Mitsugu; Kondo, Takao; Yagita, Kazuhiro; Shigeyoshi, Yasufumi; Ueda, Hiroki R.			Melanopsin-dependent photo-perturbation reveals desynchronization underlying the singularity of mammalian circadian clocks	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; CELLS; OSCILLATORS; RHYTHMS; RAT; SYNCHRONIZATION; SUPPRESSION; BEHAVIOR	Singularity behaviour in circadian clocks(1,2) - the loss of robust circadian rhythms following exposure to a stimulus such as a pulse of bright light - is one of the fundamental but mysterious properties of clocks. To quantitatively perturb and accurately measure the dynamics of cellular clocks(3,4), we synthetically produced photo-responsiveness within mammalian cells by exogenously introducing the photoreceptor melanopsin(5-8) and continuously monitoring the effect of photo-perturbation on the state of cellular clocks. Here we report that a critical light pulse drives cellular clocks into singularity behaviour. Our theoretical analysis consistently predicts and subsequent single-cell level observation directly proves that desynchronization of individual cellular clocks underlies singularity behaviour. Our theoretical framework also explains why singularity behaviours have been experimentally observed in various organisms, and it suggests that desynchronization is a plausible mechanism for the observable singularity of circadian clocks. Importantly, these in vitro and in silico findings are further supported by in vivo observations that desynchronization underlies the multicell-level amplitude decrease in the rat suprachiasmatic nucleus induced by critical light pulses.	RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; Osaka Univ, Grad Sch Sci, Dept Biosci, Osaka 5600043, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 5898511, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST & SORST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Chikusa Ku, Dept Biol Sci,Div Mol Genet,COE Unit Circadian Sy, Nagoya, Aichi 4648602, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan	RIKEN; RIKEN; Osaka University; Kindai University (Kinki University); Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Osaka University	Ueda, HR (corresponding author), RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176				Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Ban Y, 1997, J NEUROSCI, V17, P3920; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Forger DB, 2004, J THEOR BIOL, V230, P521, DOI 10.1016/j.jtbi.2004.04.043; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; HONNA S, 1999, AM JPHYSL, V276, pR1390; HUANG G, 2006, EMBO J; JEWETT ME, 1991, NATURE, V350, P59, DOI 10.1038/350059a0; Johnson Carl Hirschie, 2004, P67; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; JOHNSON CH, 1992, J BIOL RHYTHM, V7, P313, DOI 10.1177/074873049200700405; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 2001, AM J PHYSIOL-REG I, V280, pR1206, DOI 10.1152/ajpregu.2001.280.4.R1206; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagano M, 2003, J NEUROSCI, V23, P6141; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; WINFREE AT, 1975, NATURE, V253, P315, DOI 10.1038/253315a0; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	41	91	94	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1327	U280		10.1038/ncb1653	http://dx.doi.org/10.1038/ncb1653			54	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952058				2022-12-25	WOS:000250659600019
J	Wernig, M; Lengner, CJ; Hanna, J; Lodato, MA; Steine, E; Foreman, R; Staerk, J; Markoulaki, S; Jaenisch, R				Wernig, Marius; Lengner, Christopher J.; Hanna, Jacob; Lodato, Michael A.; Steine, Eveline; Foreman, Ruth; Staerk, Judith; Markoulaki, Styliani; Jaenisch, Rudolf			A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; REGULATORY CIRCUITRY; MOUSE; FIBROBLASTS; GENERATION; EXPRESSION; INDUCTION; MYC	The study of induced pluripotency is complicated by the need for infection with high-titer retroviral vectors, which results in genetically heterogeneous cell populations. We generated genetically homogeneous 'secondary' somatic cells that carry the reprogramming factors as defined doxycycline (dox)-inducible transgenes. These cells were produced by infecting fibroblasts with dox-inducible lentiviruses, reprogramming by dox addition, selecting induced pluripotent stem cells and producing chimeric mice. Cells derived from these chimeras reprogram upon dox exposure without the need for viral infection with efficiencies 25- to 50-fold greater than those observed using direct infection and drug selection for pluripotency marker reactivation. We demonstrate that (i) various induction levels of the reprogramming factors can induce pluripotency, (ii) the duration of transgene activity directly correlates with reprogramming efficiency, (iii) cells from many somatic tissues can be reprogrammed and (iv) different cell types require different induction levels. This system facilitates the characterization of reprogramming and provides a tool for genetic or chemical screens to enhance reprogramming.	[Wernig, Marius; Lengner, Christopher J.; Hanna, Jacob; Lodato, Michael A.; Steine, Eveline; Foreman, Ruth; Staerk, Judith; Markoulaki, Styliani; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lodato, Michael A.; Foreman, Ruth; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Lodato, Michael/AAX-9211-2021; Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Lengner, Christopher/0000-0002-0574-5189; Staerk, Judith/0000-0001-8698-6998; Lodato, Michael/0000-0003-4175-1073	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA084198, R37 CA084198-09] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-06] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOI T, 2008, SCIENCE         0214, DOI DOI 10.1126/SCIENCE.1154884; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vescovi Angelo L, 2002, Methods Mol Biol, V198, P115; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	326	380	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					916	924		10.1038/nbt1483	http://dx.doi.org/10.1038/nbt1483			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18594521	Green Accepted			2022-12-25	WOS:000258325500026
J	Crasta, K; Lim, HH; Giddings, TH; Winey, M; Surana, U				Crasta, Karen; Lim, Hong Hwa; Giddings, Thomas H., Jr.; Winey, Mark; Surana, Uttam			Inactivation of Cdh1 by synergistic action of Cdk1 and polo kinase is necessary for proper assembly of the mitotic spindle	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST; CENTROSOME; CYCLIN; PHOSPHORYLATION; MITOSIS; PLK1; SEPARATION; MACHINERY; REVEALS; COMPLEX	Separation of duplicated centrosomes (spindle-pole bodies or SPBs in yeast) is a crucial step in the biogenesis of the mitotic spindle. In vertebrates, centrosome separation requires the BimC family kinesin Eg5 and the activities of Cdk1 and polo kinase; however, the roles of these kinases are not fully understood. In Saccharomyces cerevisiae, SPB separation also requires activated Cdk1 and the plus-end kinesins Cin8 (homologous to vertebrate Eg5) and Kip1. Here we report that polo kinase has a role in the separation of SPBs. We show that adequate accumulation of Cin8 and Kip1 requires inactivation of the anaphase-promoting complex-activator Cdh1 through sequential phosphorylation by Cdk1 and polo kinase. In this process, Cdk1 functions as a priming kinase in that Cdk1-mediated phosphorylation creates a binding site for polo kinase, which further phosphorylates Cdh1. Thus, Cdh1 inactivation through the synergistic action of Cdk1 and polo kinase provides a new model for inactivation of cell-cycle effectors.	[Crasta, Karen; Lim, Hong Hwa; Surana, Uttam] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Giddings, Thomas H., Jr.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Colorado System; University of Colorado Boulder	Surana, U (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbucs@imcb.a-star.edu.sg	Crasta, Karen C/F-8752-2015; Surana, Uttam/H-1142-2011	Lim, Hong Hwa/0000-0002-0951-7220; Surana, Uttam/0000-0002-4785-6514; Crasta, Karen/0000-0001-9849-6080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051312, R01 GM051312-14, GM51312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartholomew CR, 2001, MOL CELL BIOL, V21, P4949, DOI 10.1128/MCB.21.15.4949-4959.2001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; Dai W, 2002, ONCOGENE, V21, P6195, DOI 10.1038/sj.onc.1205710; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	28	51	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					665	675		10.1038/ncb1729	http://dx.doi.org/10.1038/ncb1729			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18500339	Green Accepted			2022-12-25	WOS:000256350100013
J	Kim, EY; Battaile, JT; Patel, AC; You, Y; Agapov, E; Grayson, MH; Benoit, LA; Byers, DE; Alevy, Y; Tucker, J; Swanson, S; Tidwell, R; Tyner, JW; Morton, JD; Castro, M; Polineni, D; Patterson, GA; Schwendener, RA; Allard, JD; Peltz, G; Holtzman, MJ				Kim, Edy Y.; Battaile, John T.; Patel, Anand C.; You, Yingjian; Agapov, Eugene; Grayson, Mitchell H.; Benoit, Loralyn A.; Byers, Derek E.; Alevy, Yael; Tucker, Jennifer; Swanson, Suzanne; Tidwell, Rose; Tyner, Jeffrey W.; Morton, Jeffrey D.; Castro, Mario; Polineni, Deepika; Patterson, G. Alexander; Schwendener, Reto A.; Allard, John D.; Peltz, Gary; Holtzman, Michael J.			Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease	NATURE MEDICINE			English	Article							KILLER T-CELLS; V(ALPHA)14 NKT CELLS; AIRWAY INFLAMMATION; GENETIC SEGREGATION; EXPERIMENTAL ASTHMA; ALLERGIC-ASTHMA; IL-13; PATHWAY; MICE; HYPERREACTIVITY	To understand the pathogenesis of chronic inflammatory disease, we analyzed an experimental mouse model of chronic lung disease with pathology that resembles asthma and chronic obstructive pulmonary disease ( COPD) in humans. In this model, chronic lung disease develops after an infection with a common type of respiratory virus is cleared to only trace levels of noninfectious virus. Chronic inflammatory disease is generally thought to depend on an altered adaptive immune response. However, here we find that this type of disease arises independently of an adaptive immune response and is driven instead by interleukin-13 produced by macrophages that have been stimulated by CD1d-dependent T cell receptor-invariant natural killer T (NKT) cells. This innate immune axis is also activated in the lungs of humans with chronic airway disease due to asthma or COPD. These findings provide new insight into the pathogenesis of chronic inflammatory disease with the discovery that the transition from respiratory viral infection into chronic lung disease requires persistent activation of a previously undescribed NKT cell-macrophage innate immune axis.	[Kim, Edy Y.; Battaile, John T.; You, Yingjian; Agapov, Eugene; Grayson, Mitchell H.; Benoit, Loralyn A.; Byers, Derek E.; Alevy, Yael; Tucker, Jennifer; Swanson, Suzanne; Tidwell, Rose; Tyner, Jeffrey W.; Morton, Jeffrey D.; Castro, Mario; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Polineni, Deepika; Patterson, G. Alexander] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Schwendener, Reto A.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Allard, John D.; Peltz, Gary] Dept Genet & Gen, Palo Alto, CA 94304 USA; [Holtzman, Michael J.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Zurich; Washington University (WUSTL)	Holtzman, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	holtzmanm@wustl.edu	Schwendener, Reto A/F-6373-2011; Patel, Anand/B-1441-2009; Kim, Edy/ABF-7592-2021; Grayson, Mitchell H/A-3693-2008; Grayson, Mitchell/AAX-3674-2020	Patel, Anand/0000-0002-6570-8582; Kim, Edy/0000-0002-9095-3109; Grayson, Mitchell H/0000-0002-4673-2122; Grayson, Mitchell/0000-0002-4673-2122; Tyner, Jeffrey/0000-0002-2133-0960; Byers, Derek/0000-0001-7371-9153	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083095, T32HL007317, R01HL073159, P50HL084922] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007317-28, P50 HL084922-02, K08 HL083095-02, T32 HL007317, R01 HL073159-03, R01 HL073159-01, T32 HL007317-30, R01 HL073159-02, K08 HL083095, T32 HL007317-31, P50 HL084922-020004, T32 HL007317-29, R01 HL073159, T32 HL007317-26, R01 HL073159-04, T32 HL007317-27, P50 HL084922-01, P50 HL084922, P50 HL084922-010004] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cheng L, 2007, J IMMUNOL, V178, P2755, DOI 10.4049/jimmunol.178.5.2755; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Grayson MH, 2007, J IMMUNOL, V179, P1438, DOI 10.4049/jimmunol.179.3.1438; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hegde S, 2007, J LEUKOCYTE BIOL, V81, P1224, DOI 10.1189/jlb.1206718; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Holtzman MJ, 1996, AM J RESP CELL MOL, V14, P316, DOI 10.1165/ajrcmb.14.4.8600934; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Pouladi MA, 2004, AM J RESP CELL MOL, V30, P84, DOI 10.1165/rcmb.2003-0051OC; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; Zhong WM, 2000, J IMMUNOL, V164, P3274, DOI 10.4049/jimmunol.164.6.3274; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	37	395	418	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2008	14	6					633	640		10.1038/nm1770	http://dx.doi.org/10.1038/nm1770			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18488036	Green Accepted			2022-12-25	WOS:000256468700029
J	Al-Nedawi, K; Meehan, B; Micallef, J; Lhotak, V; May, L; Guha, A; Rak, J				Al-Nedawi, Khalid; Meehan, Brian; Micallef, Johann; Lhotak, Vladimir; May, Linda; Guha, Abhijit; Rak, Janusz			Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells	NATURE CELL BIOLOGY			English	Article							ACTIVATED PLATELETS; CANCER; EXPRESSION; ANGIOGENESIS	Aggressive human brain tumours ( gliomas) often express a truncated and oncogenic form of the epidermal growth factor receptor, known as EGFRvIII. Within each tumour only a small percentage of glioma cells may actually express EGFRvIII; however, most of the cells exhibit a transformed phenotype(1). Here we show that EGFRvIII can be 'shared' between glioma cells by intercellular transfer of membrane-derived microvesicles ('oncosomes'). EGFRvIII expression in indolent glioma cells stimulates formation of lipid-raft related microvesicles containing EGFRvIII. Microvesicles containing this receptor are then released to cellular surroundings and blood of tumour-bearing mice, and can merge with the plasma membranes of cancer cells lacking EGFRvIII. This event leads to the transfer of oncogenic activity, including activation of transforming signalling pathways ( MAPK and Akt), changes in expression of EGFRvIII-regulated genes (VEGF, Bcl- x(L), p27), morphological transformation and increase in anchorage-independent growth capacity. Thus, membrane microvesicles of cancer cells can contribute to a horizontal propagation of oncogenes and their associated transforming phenotype among subsets of cancer cells.	[Al-Nedawi, Khalid; Meehan, Brian; Rak, Janusz] McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Lhotak, Vladimir; May, Linda] McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; [Micallef, Johann; Guha, Abhijit] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatts Brain Tumor Ctr, Toronto, ON M5G 1L7, Canada	McGill University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rak, J (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, 4060 Ste Catherine W, Montreal, PQ H3Z 2Z3, Canada.	janusz.rak@mcgill.ca		Rak, Janusz/0000-0002-2912-5566; , Khalid/0000-0001-5140-3799				Al-Nedawi K, 2005, ARTERIOSCL THROM VAS, V25, P1744, DOI 10.1161/01.ATV.0000172007.86541.76; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cavenee WK, 2002, CARCINOGENESIS, V23, P683, DOI 10.1093/carcin/23.5.683; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; VILORIAPETIT AM, 1997, AM J PATHOL, V151, P1523; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	14	1340	1420	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					619	U24		10.1038/ncb1725	http://dx.doi.org/10.1038/ncb1725			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425114				2022-12-25	WOS:000255502400019
J	Monti, J; Fischer, J; Paskas, S; Heinig, M; Schulz, H; Gosele, C; Heuser, A; Fischer, R; Schmidt, C; Schirdewan, A; Gross, V; Hummel, O; Maatz, H; Patone, G; Saar, K; Vingron, M; Weldon, SM; Lindpaintner, K; Hammock, BD; Rohde, K; Dietz, R; Cook, SA; Schunck, WH; Luft, FC; Hubner, N				Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Schirdewan, Alexander; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Vingron, Martin; Weldon, Steven M.; Lindpaintner, Klaus; Hammock, Bruce D.; Rohde, Klaus; Dietz, Rainer; Cook, Stuart A.; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert			Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE REGULATION; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; EJECTION FRACTION; NERVOUS-SYSTEM; IDENTIFICATION; MOUSE; MICE; ASSOCIATION	We aimed to identify genetic variants associated with heart failure by using a rat model of the human disease. We performed invasive cardiac hemodynamic measurements in F-2 crosses between spontaneously hypertensive heart failure ( SHHF) rats and reference strains. We combined linkage analyses with genome-wide expression profiling and identified Ephx2 as a heart failure susceptibility gene in SHHF rats. Specifically, we found that cis variation at Ephx2 segregated with heart failure and with increased transcript expression, protein expression and enzyme activity, leading to a more rapid hydrolysis of cardioprotective epoxyeicosatrienoic acids. To confirm our results, we tested the role of Ephx2 in heart failure using knockout mice. Ephx2 gene ablation protected from pressure overload-induced heart failure and cardiac arrhythmias. We further demonstrated differential regulation of EPHX2 in human heart failure, suggesting a cross-species role for Ephx2 in this complex disease.	[Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Rohde, Klaus; Dietz, Rainer; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Monti, Jan; Heuser, Arnd; Fischer, Robert; Schirdewan, Alexander; Dietz, Rainer] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Clin & Mol Cardiol, D-13125 Berlin, Germany; [Heinig, Matthias; Vingron, Martin] Max Planck Inst Mol Genet, Dept Bioinformat, D-14195 Berlin, Germany; [Weldon, Steven M.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Lindpaintner, Klaus] F Hoffmann La Roche, CH-4070 Basel, Switzerland; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Luft, Friedrich C.] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Nephrol Hypertens, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Boehringer Ingelheim; Roche Holding; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Imperial College London; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	nhuebner@mdc-berlin.de	Cook, Stuart/G-9567-2011	Heinig, Matthias/0000-0002-5612-1720; Paskas, Svetlana/0000-0002-1206-5376; Saar, Kathrin/0000-0002-4483-1557; Fischer-Sternjak, Judith/0000-0003-0398-7720; Heuser, Arnd/0000-0002-3334-960X; Luft, Friedrich/0000-0002-8635-1199; Cook, Stuart/0000-0001-6628-194X	MRC [MC_U120085815] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002710] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U120085815] Funding Source: Medline; NIEHS NIH HHS [R37 ES002710, R37 ES02710] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Health		Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Bergman MR, 1999, AM J PHYSIOL-HEART C, V277, pH543, DOI 10.1152/ajpheart.1999.277.2.H543; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Fiala-Beer E, 2007, INT J BIOCHEM CELL B, V39, P1235, DOI 10.1016/j.biocel.2007.03.019; Frantz S, 2003, CARDIOVASC RES, V57, P749, DOI 10.1016/S0008-6363(02)00723-X; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; HAMMOCK BD, 1980, LIFE SCI, V27, P1635, DOI 10.1016/0024-3205(80)90636-0; Heyen JRR, 2002, AM J PHYSIOL-HEART C, V283, pH1775, DOI 10.1152/ajpheart.00305.2002; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2006, CARDIOVASC DRUG REV, V24, P169, DOI 10.1111/j.1527-3466.2006.00169.x; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; McCune SA, 1990, ILAR J, V32, P23; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PFEFFER MA, 1973, CIRC RES, V32, P28; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Slama M, 2004, AM J PHYSIOL-HEART C, V286, pH181, DOI 10.1152/ajpheart.00642.2003; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103	49	141	150	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					529	537		10.1038/ng.129	http://dx.doi.org/10.1038/ng.129			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443590	Green Accepted			2022-12-25	WOS:000255366700018
J	Weedon, MN; Lango, H; Lindgren, CM; Wallace, C; Evans, DM; Mangino, M; Freathy, RM; Perry, JRB; Stevens, S; Hall, AS; Samani, NJ; Shields, B; Prokopenko, I; Farrall, M; Dominiczak, A; Johnson, T; Bergmann, S; Beckmann, JS; Vollenweider, P; Waterworth, DM; Mooser, V; Palmer, CNA; Morris, AD; Ouwehand, WH; Caulfield, M; Munroe, PB; Hattersley, AT; McCarthy, MI; Frayling, TM				Weedon, Michael N.; Lango, Hana; Lindgren, Cecilia M.; Wallace, Chris; Evans, David M.; Mangino, Massimo; Freathy, Rachel M.; Perry, John R. B.; Stevens, Suzanne; Hall, Alistair S.; Samani, Nilesh J.; Shields, Beverly; Prokopenko, Inga; Farrall, Martin; Dominiczak, Anna; Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.; Vollenweider, Peter; Waterworth, Dawn M.; Mooser, Vincent; Palmer, Colin N. A.; Morris, Andrew D.; Ouwehand, Willem H.; Caulfield, Mark; Munroe, Patricia B.; Hattersley, Andrew T.; McCarthy, Mark I.; Frayling, Timothy M.		Diabet Genetics Initiat; Wellcome Trust Case Control Consor; Cambridge GEM Consortium	Genome-wide association analysis identifies 20 loci that influence adult height	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; BODY HEIGHT; SUSCEPTIBILITY; POPULATION; STRATIFICATION; OSTEOARTHRITIS; HERITABILITY; EXPRESSION; STATURE; COHORTS	Adult height is a model polygenic trait, but there has been limited success in identifying the genes underlying its normal variation. To identify genetic variants influencing adult human height, we used genome-wide association data from 13,665 individuals and genotyped 39 variants in an additional 16,482 samples. We identified 20 variants associated with adult height ( P < 5 x 10(-7), with 10 reaching P < 1 iota x 10(-10)). Combined, the 20 SNPs explain similar to 3% of height variation, with a similar to 5 cm difference between the 6.2% of people with iota 7 or fewer 'tall' alleles compared to the 5.5% with 27 or more 'tall' alleles. The loci we identified implicate genes in Hedgehog signaling ( IHH, HHIP, PTCH1), extracellular matrix ( EFEMP1, ADAMTSL3, ACAN) and cancer ( CDK6, HMGA2, DLEU7) pathways, and provide new insights into human growth and developmental processes. Finally, our results provide insights into the genetic architecture of a classic quantitative trait.	[Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Shields, Beverly; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Wallace, Chris; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [Evans, David M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Mangino, Massimo; Stevens, Suzanne; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Dominiczak, Anna] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Johnson, Toby] CHU Vaudois, Inst Univ Med Sociale & Prevent, CH-1011 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Vollenweider, Peter] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut, Dundee DD1 9SY, Scotland; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 2BT, England; [Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 2BT, England	University of Exeter; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; Queen Mary University London; University of Bristol; University of Leicester; University of Leeds; University of Oxford; Wellcome Centre for Human Genetics; University of Glasgow; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Dundee; University of Dundee; University of Cambridge; NHS Blood & Transplant (NHSBT)	Frayling, TM (corresponding author), Penn Med Sch, Inst Biomed & Clin Sci, Genet Complex Traits,Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Dominiczak, Anna F/P-9390-2017; Evans, David M/H-6325-2013; Prokopenko, Inga/AAU-9895-2020; Cambridge, G/N-3776-2015; Hall, Alistair/K-1953-2019; Mangino, Massimo/F-5134-2011; Allen, Hana Lango/G-9026-2012; Prokopenko, Inga/H-3241-2014; Study, GoDARTS/K-9448-2016; Colaus, PsyColaus/K-6607-2013; Palmer, Colin NA/C-7053-2008; Dominiczak, Anna F/D-2262-2009; Beckmann, Jacques S/A-9772-2008; Morris, Andrew D/C-2837-2009; Deloukas, Panos/B-2922-2013; Loos, Ruth/Q-2862-2016; McCarthy, Mark/M-3763-2015	Dominiczak, Anna F/0000-0003-4913-3608; Evans, David M/0000-0003-0663-4621; Cambridge, G/0000-0002-6022-6322; Mangino, Massimo/0000-0002-2167-7470; Allen, Hana Lango/0000-0002-7803-8688; Prokopenko, Inga/0000-0003-1624-7457; Palmer, Colin NA/0000-0002-6415-6560; Beckmann, Jacques S/0000-0002-9741-1900; Deloukas, Panos/0000-0001-9251-070X; Bergmann, Sven/0000-0002-6785-9034; Caulfield, Mark/0000-0001-9295-3594; Lindgren, Cecilia/0000-0002-4903-9374; Frayling, Timothy/0000-0001-8362-2603; Inouye, Michael/0000-0001-9413-6520; Johnson, Toby/0000-0002-5998-3270; Wallace, Chris/0000-0001-9755-1703; Hall, Alistair/0000-0003-0306-7887; Weedon, Michael/0000-0002-6174-6135; Munroe, Patricia/0000-0002-4176-2947; Loos, Ruth/0000-0002-8532-5087; McCarthy, Mark/0000-0002-4393-0510; Soranzo, Nicole/0000-0003-1095-3852; Hattersley, Andrew/0000-0001-5620-473X; Barroso, Ines/0000-0001-5800-4520; Freathy, Rachel/0000-0003-4152-2238; Wheeler, Eleanor/0000-0002-8616-6444	British Heart Foundation [PG02/128, PG/02/128/14470, FS/05/061/19501] Funding Source: Medline; Medical Research Council [G0701863, MC_U106188470, G9521010(63660), G0600705, G9521010D, G9521010] Funding Source: Medline; Wellcome Trust [077016, 076113, 090532, 077011] Funding Source: Medline; MRC [MC_U106188470, G0701863, G9521010, G0600705] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fisher R. A., 1918, PHILOS T ROYAL SOC E, V52, DOI DOI 10.1017/S0080456800012163; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; LETTRE G, 2008, NAT GENET; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MARQUESVIDAL P, 2007, EUR J CLIN NUTR ADV; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; STIRLING WD, 1982, STATISTICIAN, V31, P211; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	27	609	627	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					575	583		10.1038/ng.121	http://dx.doi.org/10.1038/ng.121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391952	Green Accepted, Green Published			2022-12-25	WOS:000255366700025
J	Bae, W; Lee, YJ; Kim, DH; Lee, J; Kim, S; Sohn, EJ; Hwang, I				Bae, Wonsil; Lee, Yong Jik; Kim, Dae Heon; Lee, Junho; Kim, Soojin; Sohn, Eun Ju; Hwang, Inhwan			AKr2A-mediated import of chloroplast outer membrane proteins is essential for chloroplast biogenesis	NATURE CELL BIOLOGY			English	Article							ENVELOPE MEMBRANE; RECEPTOR; DOMAIN; TRANSLOCATION; ATTOC159; SYSTEM; MUTANT; SIGNAL; PLAYS; OEP14	In plant cells, chloroplasts have essential roles in many biochemical reactions and physiological responses(1). Chloroplasts require numerous protein components, but only a fraction of these proteins are encoded by the chloroplast genome. Instead, most are encoded by the nuclear genome and imported into chloroplasts from the cytoplasm post-translationally(2-5). Membrane proteins located in the chloroplast outer envelope membrane (OEM) have a critical function in the import of proteins into the chloroplast. However, the biogenesis of chloroplast OEM proteins remains poorly understood. Here, we report that an Arabidopsis ankyrin repeat protein, AKR2A, plays an essential role in the biogenesis of the chloroplast OEM proteins. AKR2A binds to chloroplast OEM protein targeting signals, as well as to chloroplasts. It also displays chaperone activity towards chloroplast OEM proteins, and facilitates the targeting of OEP7 to chloroplasts in vitro. AKR2A RNAi in plants with an akr2b knockout background showed greatly reduced levels of chloroplast proteins, including OEM proteins, and chloroplast biogenesis was also defective. Thus, AKR2A functions as a cytosolic mediator for sorting and targeting of nascent chloroplast OEM proteins to the chloroplast.	[Bae, Wonsil; Lee, Yong Jik; Kim, Dae Heon; Lee, Junho; Kim, Soojin; Sohn, Eun Ju; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Hwang, I (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	ihhwang@postech.ac.kr						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hofmann NR, 2005, TRENDS PLANT SCI, V10, P450, DOI 10.1016/j.tplants.2005.07.009; Jarvis P, 2004, CURR BIOL, V14, pR317, DOI 10.1016/j.cub.2004.03.054; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Keegstra K, 1999, CURR OPIN PLANT BIOL, V2, P471, DOI 10.1016/S1369-5266(99)00021-7; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lee YJ, 2004, MOL CELLS, V17, P281; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; LI HM, 1991, PLANT CELL, V3, P709, DOI 10.1105/tpc.3.7.709; Li HM, 1996, PLANT CELL, V8, P2117, DOI 10.1105/tpc.8.11.2117; Schleiff E, 2000, PLANTA, V211, P449, DOI 10.1007/s004250000357; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Tu SL, 2000, PLANT CELL, V12, P1951, DOI 10.1105/tpc.12.10.1951; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WILSE RR, 2006, STRUCTURE FUNCTION P; Yan JQ, 2002, PLANT J, V29, P193, DOI 10.1046/j.0960-7412.2001.01205.x; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051	30	100	105	5	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					220	U101		10.1038/ncb1683	http://dx.doi.org/10.1038/ncb1683			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193034				2022-12-25	WOS:000252897800018
J	Dupre, A; Boyer-Chatenet, L; Sattler, RM; Modi, AP; Lee, JH; Nicolette, ML; Kopelovich, L; Jasin, M; Baer, R; Paull, TT; Gautier, J				Dupre, Aude; Boyer-Chatenet, Louise; Sattler, Rose M.; Modi, Ami P.; Lee, Ji-Hoon; Nicolette, Matthew L.; Kopelovich, Levy; Jasin, Maria; Baer, Richard; Paull, Tanya T.; Gautier, Jean			A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex	NATURE CHEMICAL BIOLOGY			English	Article							ATM ACTIVATION; DNA-DAMAGE; DEPENDENT PHOSPHORYLATION; MRE11 COMPLEX; CHECKPOINT; KINASE; REPLICATION; REPAIR; AUTOPHOSPHORYLATION; IDENTIFICATION	The MRN (Mre11-Rad50-Nbs1)-ATM (ataxia-telangiectasia mutated) pathway is essential for sensing and signaling from DNA double-strand breaks. The MRN complex acts as a DNA damage sensor, maintains genome stability during DNA replication, promotes homology-dependent DNA repair and activates ATM. MRN is essential for cell viability, which has limited functional studies of the complex. Small-molecule inhibitors of MRN could circumvent this experimental limitation and could also be used as cellular radio- and chemosensitization compounds. Using cell-free systems that recapitulate faithfully the MRN-ATM signaling pathway, we designed a forward chemical genetic screen to identify inhibitors of the pathway, and we isolated 6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (mirin, 1) as an inhibitor of MRN. Mirin prevents MRN-dependent activation of ATM without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Consistent with its ability to target the MRN complex, mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells.	[Dupre, Aude; Boyer-Chatenet, Louise; Sattler, Rose M.; Modi, Ami P.; Baer, Richard; Gautier, Jean] Columbia Univ, Inst Canc Genet, Irving Canc Res Ctr, New York, NY 10032 USA; [Lee, Ji-Hoon; Nicolette, Matthew L.; Paull, Tanya T.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Lee, Ji-Hoon; Nicolette, Matthew L.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Kopelovich, Levy] NCI, Div Canc Prevent & Control, Bethesda, MD 20892 USA; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA	Columbia University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center	Gautier, J (corresponding author), Columbia Univ, Inst Canc Genet, Irving Canc Res Ctr, 1130 St Nicholas Ave,Room 602, New York, NY 10032 USA.	jg130@columbia.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NATIONAL CANCER INSTITUTE [R01CA092245, P01CA097403, R01CA095866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA092245, R01 CA095866, CA92245, CA95866, R01 CA092245-06, P01 CA097403, CA97403] Funding Source: Medline; NIGMS NIH HHS [R01 GM054668-11, GM54668, R01 GM054668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Peterson JR, 2001, P NATL ACAD SCI USA, V98, P10624, DOI 10.1073/pnas.201393198; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Wignall SM, 2004, CHEM BIOL, V11, P135, DOI 10.1016/j.chembiol.2003.12.019; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	39	282	286	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					119	125		10.1038/nchembio.63	http://dx.doi.org/10.1038/nchembio.63			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18176557	Green Accepted			2022-12-25	WOS:000252585400011
J	Corbit, KC; Shyer, AE; Dowdle, WE; Gaulden, J; Singla, V; Reiter, JF				Corbit, Kevin C.; Shyer, Amy E.; Dowdle, William E.; Gaulden, Julie; Singla, Veena; Reiter, Jeremy F.			Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; PRIMARY CILIUM; KINESIN-II; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MORPHOGENESIS; DROSOPHILA; TRANSPORT	Primary cilia are microtubule-based organelles involved in signal transduction and project from the surface of most vertebrate cells(1). Proteins that can localize to the cilium, for example, Inversin and Bardet-Biedl syndrome (BBS) proteins, are implicated in both beta-catenin-dependent and -independent Wnt signalling(2-4). Given that Inversin and BBS proteins are found both at the cilium and elsewhere in the cell, the role of the cilium itself in Wnt signalling is not clear. Using three separate mutations that disrupt ciliogenesis (affecting Kif3a, Ift88 and Ofd1)(5-7), we show in this study that the primary cilium restricts the activity of the canonical Wnt pathway in mouse embryos, primary fibroblasts, and embryonic stem cells. Interestingly, unciliated cells activate transcription only in response to Wnt stimulation, but do so much more robustly than ciliated cells. Loss of Kif3a, but not other ciliogenic genes, causes constitutive phosphorylation of Dishevelled (Dvl). Blocking the activity of casein kinase I (CKI) reverses this constitutive Dvl phosphorylation and abrogates pathway hyper-responsiveness. These results suggest that Kif3a restrains canonical Wnt signalling both by restricting the CKI-dependent phosphorylation of Dvl and through a separate ciliary mechanism. More generally, these findings reveal that, in contrast to its role in promoting Hedgehog (Hh) signalling, the cilium restrains canonical Wnt signalling.	[Corbit, Kevin C.; Shyer, Amy E.; Dowdle, William E.; Gaulden, Julie; Singla, Veena; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	jreiter@biochem.ucsf.edu	Dowdle, William/F-3424-2011	Singla, Veena/0000-0002-5107-0717	NIDDK NIH HHS [P30 DK063720] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Ulloa F, 2007, CURR BIOL, V17, P545, DOI 10.1016/j.cub.2007.01.062; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	31	378	394	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					70	U54		10.1038/ncb1670	http://dx.doi.org/10.1038/ncb1670			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084282				2022-12-25	WOS:000252116100014
J	Konno, D; Shioi, G; Shitamukai, A; Mori, A; Kiyonari, H; Miyata, T; Matsuzaki, F				Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Kiyonari, Hiroshi; Miyata, Takaki; Matsuzaki, Fumio			Neuroepithelial progenitors undergo LGN-dependent planar divisions to maintain self-renewability during mammalian neurogenesis	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; RADIAL GLIA; SPINDLE ORIENTATION; CORTICAL-NEURONS; MOUSE NEOCORTEX; PRECURSOR CELLS; G-PROTEIN; DROSOPHILA; FATE; DIFFERENTIATION	During mammalian development, neuroepithelial cells function as mitotic progenitors, which self-renew and generate neurons. Although spindle orientation is important for such polarized cells to undergo symmetric or asymmetric divisions(1,2), its role in mammalian neurogenesis remains unclear. Here we show that control of spindle orientation is essential in maintaining the population of neuroepithelial cells, but dispensable for the decision to either proliferate or differentiate. Knocking out LGN, (the G protein regulator)(3,4), randomized the orientation of normally planar neuroepithelial divisions. The resultant loss of the apical membrane from daughter cells frequently converted them into abnormally localized progenitors without affecting neuronal production rate. Furthermore, overexpression of Inscuteable(5) to induce vertical neuroepithelial divisions shifted the fate of daughter cells. Our results suggest that planar mitosis ensures the self-renewal of neuroepithelial progenitors by one daughter inheriting both apical and basal compartments during neurogenesis.	[Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Matsuzaki, Fumio] RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Matsuzaki, Fumio] RIKEN, Japan Sci & Technol Corp, CREST, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Japan Sci & Technol Corp, Showa Ku,Dept Anat & Cell Biol, Aichi 4668550, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Japan Sci & Technol Corp, CREST,Showa Ku, Aichi 4668550, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN; RIKEN; Japan Science & Technology Agency (JST); Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Matsuzaki, F (corresponding author), RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	fumio@cdb.riken.jp	Shitamukai, Atsunori/C-6817-2014; Kiyonari, Hiroshi/N-7936-2015; MIYATA, TAKAKI/I-7066-2014; Shitamukai, Atsunori/AAT-8802-2021	Shitamukai, Atsunori/0000-0003-4216-927X				Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2007, CURR BIOL, V17, P146, DOI 10.1016/j.cub.2006.11.023; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ochiai W, 2007, NEUROSCI RES, V57, P326, DOI 10.1016/j.neures.2006.10.015; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	38	368	373	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					93	U78		10.1038/ncb1673	http://dx.doi.org/10.1038/ncb1673			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084280				2022-12-25	WOS:000252116100017
J	Shirey, JK; Xiang, ZX; Orton, D; Brady, AE; Johnson, KA; Williams, R; Ayalai, JE; Rodriguez, AL; Wess, J; Weaver, D; Niswender, CM; Conn, PJ				Shirey, Jana K.; Xiang, Zixiu; Orton, Darren; Brady, Ashley E.; Johnson, Kari A.; Williams, Richard; Ayalai, Jennifer E.; Rodriguez, Alice L.; Wess, Juergen; Weaver, David; Niswender, Colleen M.; Conn, P. Jeffrey			An allosteric potentiator of M-4 mAChR modulates hippocampal synaptic transmission	NATURE CHEMICAL BIOLOGY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; DOUBLE-BLIND; PRESYNAPTIC INHIBITION; CHOLINERGIC MECHANISMS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ANTIPSYCHOTIC-LIKE; PYRAMIDAL CELLS; DEMENTIA; PROTEIN	Muscarinic acetylcholine receptors (mAChRs) provide viable targets for the treatment of multiple central nervous system disorders. We have used cheminformatics and medicinal chemistry to develop new, highly selective M-4 allosteric potentiators. VU10010, the lead compound, potentiates the M-4 response to acetylcholine 47-fold while having no activity at other mAChR subtypes. This compound binds to an allosteric site on the receptor and increases affinity for acetylcholine and coupling to G proteins. Whole-cell patch clamp recordings revealed that selective potentiation of M-4 with VU10010 increases carbachol-induced depression of transmission at excitatory but not inhibitory synapses in the hippocampus. The effect was not mimicked by an inactive analog of VU 10010 and was absent in M-4 knockout mice. Selective regulation of excitatory transmission by M4 suggests that targeting of individual mAChR subtypes could be used to differentially regulate specific aspects of mAChR modulation of function in this important forebrain structure.	[Shirey, Jana K.; Xiang, Zixiu; Brady, Ashley E.; Johnson, Kari A.; Ayalai, Jennifer E.; Rodriguez, Alice L.; Weaver, David; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Program Drug Discovery, Dept Pharmacol, Nashville, TN 37232 USA; [Orton, Darren; Williams, Richard; Rodriguez, Alice L.; Weaver, David; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Orton, Darren; Williams, Richard] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Wess, Juergen] NIDDK, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Conn, PJ (corresponding author), Vanderbilt Program Drug Discovery, Dept Pharmacol, 23rd Ave S Pierce, Nashville, TN 37232 USA.	jeff.conn@vanderbilt.edu	Conn, Peter/D-7848-2012	Xiang, Zixiu/0000-0002-1678-209X; Williams, Rich/0000-0002-7710-2975	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BILKEY DK, 1985, BRAIN RES, V361, P99, DOI 10.1016/0006-8993(85)91279-X; Brown T., 1990, SYNAPTIC ORG BRAIN, P346; Bullock R, 2002, CURR MED RES OPIN, V18, P258, DOI 10.1185/030079902125000813; Bymaster FP, 2003, EUR J NEUROSCI, V17, P1403, DOI 10.1046/j.1460-9568.2003.02588.x; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Cooper JD, 1996, NEUROSCIENCE, V75, P29, DOI 10.1016/0306-4522(96)00240-0; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Dong BJ, 2005, CLIN THER, V27, P1725, DOI 10.1016/j.clinthera.2005.11.015; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Eglen RM, 1999, CURR OPIN CHEM BIOL, V3, P426, DOI 10.1016/S1367-5931(99)80063-5; Felder CC, 2000, J MED CHEM, V43, P4333, DOI 10.1021/jm990607u; Feldman H, 2002, INT PSYCHOGERIATR, V14, P3, DOI 10.1017/S1041610203008639; Fernandez de Sevilla D, 2003, EUR J NEUROSCI, V17, P555, DOI 10.1046/j.1460-9568.2003.02490.x; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; Galici R, 2006, J PHARMACOL EXP THER, V318, P173, DOI 10.1124/jpet.106.102046; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; HARTVIG P, 1989, TRENDS PHARMACOL SCI, P75; Katzenschlager R, 2003, Cochrane Database Syst Rev, pCD003735; Kaufer DI, 1998, NEUROLOGY, V51, P1512, DOI 10.1212/WNL.51.5.1512; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Lazareno S, 2004, MOL PHARMACOL, V65, P257, DOI 10.1124/mol.65.1.257; Lazareno S, 1998, MOL PHARMACOL, V53, P573, DOI 10.1124/mol.53.3.573; LEVEY AI, 1995, J COMP NEUROL, V351, P339, DOI 10.1002/cne.903510303; Marino MJ, 2006, CURR OPIN PHARMACOL, V6, P98, DOI 10.1016/j.coph.2005.09.006; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Messer WS, 2002, J MOL NEUROSCI, V19, P187, DOI 10.1007/s12031-002-0031-5; Mirza NR, 2003, CNS DRUG REV, V9, P159; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Okamoto H, 2002, BRIT J PHARMACOL, V135, P1765, DOI 10.1038/sj.bjp.0704642; PITLER TA, 1994, NEURON, V13, P1447; Qian J, 1997, BRIT J PHARMACOL, V122, P511, DOI 10.1038/sj.bjp.0701400; Raskind MA, 1999, J CLIN PSYCHIAT, V60, P318, DOI 10.4088/JCP.v60n0510; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rosler M, 2002, INT J CLIN PRACT, P20; Rouse ST, 2000, NEUROSCI LETT, V284, P182, DOI 10.1016/S0304-3940(00)01011-9; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; Rouse ST, 1999, LIFE SCI, V64, P501, DOI 10.1016/S0024-3205(98)00594-3; SHERIDAN RD, 1990, NEUROSCI LETT, V108, P273, DOI 10.1016/0304-3940(90)90653-Q; VALENTINO RJ, 1981, J NEUROSCI, V1, P784, DOI 10.1523/JNEUROSCI.01-07-00784.1981; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wilkinson D, 2001, INT J GERIATR PSYCH, V16, P852, DOI 10.1002/gps.409	46	130	136	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					42	50		10.1038/nchembio.2007.55	http://dx.doi.org/10.1038/nchembio.2007.55			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18059262				2022-12-25	WOS:000251990000012
J	Lengauer, T; Sander, O; Sierra, S; Thielen, A; Kaiser, R				Lengauer, Thomas; Sander, Oliver; Sierra, Saleta; Thielen, Alexander; Kaiser, Rolf			Bioinformatics prediction of HIV coreceptor usage	NATURE BIOTECHNOLOGY			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; CCR5; MARAVIROC; TRANSMISSION; POPULATION; MOTIVATE-1; INHIBITOR; PHENOTYPE; RECEPTOR; ENTRY		Max Planck Inst Informat Computat Biol & Appl Bio, D-66123 Saarbrucken, Germany; Univ Cologne, Inst Virol, D-50935 Cologne, Germany	Max Planck Society; University of Cologne	Lengauer, T (corresponding author), Max Planck Inst Informat Computat Biol & Appl Bio, Campus E14, D-66123 Saarbrucken, Germany.	lengauer@mpi-inf.mpg.de						Anonymous, 2005, Antiviral Chemistry & Chemotherapy, V16, P339; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Cahn P, 2007, LANCET, V369, P1235, DOI 10.1016/S0140-6736(07)60571-6; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Lehmann C, 2006, J CLIN VIROL, V37, P300, DOI 10.1016/j.jcv.2006.08.008; Lengauer T, 2006, NAT REV MICROBIOL, V4, P790, DOI 10.1038/nrmicro1477; Lewis M, 2007, ANTIVIR THER, V12, pS65; Liu SQ, 2003, J MOL MODEL, V9, P329, DOI 10.1007/s00894-003-0154-9; Low AJ, 2007, AIDS, V21, pF19, DOI 10.1097/QAD.0b013e3282ef81ea; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mori J, 2007, ANTIVIR THER, V12, pS12; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; Opar A, 2007, NAT REV DRUG DISCOV, V6, P258, DOI 10.1038/nrd2294; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Poveda E, 2007, AIDS, V21, P1487, DOI 10.1097/QAD.0b013e32826fb741; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Rusconi S, 2007, CURR TOP MED CHEM, V7, P1273; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SING T, 2004, P 1 INT WORKSH ROC A, P89; Sing T, 2007, ANTIVIR THER, V12, P1097; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	31	239	243	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1407	1410		10.1038/nbt1371	http://dx.doi.org/10.1038/nbt1371			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18066037				2022-12-25	WOS:000251457800030
J	Santoro, MM; Samuel, T; Mitchell, T; Reed, JC; Stainier, DYR				Santoro, Massimo M.; Samuel, Temesgen; Mitchell, Tracy; Reed, John C.; Stainier, Didier Y. R.			Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis	NATURE GENETICS			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; VASCULAR DEVELOPMENT; APOPTOSIS PROTEINS; SIGNALING COMPLEX; UBIQUITINATION; ANGIOGENESIS; INHIBITOR; CASPASES; PATHWAY	Integrity of the blood vessel wall is essential for vascular homeostasis and organ function(1,2).A dynamic balance between endothelial cell survival and apoptosis contributes to this integrity during vascular development and pathological angiogenesis(3-6). The genetic and molecular mechanisms regulating these processes in vivo are still largely unknown. Here, we show that Birc2 ( also known as clap1) is essential for maintaining endothelial cell survival and blood vessel homeostasis during vascular development. Using a forward-genetic approach, we identified a zebrafish null mutant for birc2, which shows severe hemorrhage and vascular regression due to endothelial cell integrity defects and apoptosis. Using genetic and molecular approaches, we show that Birc2 positively regulates the formation of the TNF receptor complex I in endothelial cells, thereby promoting NF- kappa B activation and maintaining vessel integrity and stabilization. In the absence of Birc2, a caspase-8-dependent apoptotic program takes place that leads to vessel regression. Our findings identify Birc2 and TNF signaling components as critical regulators of vascular integrity and endothelial cell survival, thereby providing an additional target pathway for the control of angiogenesis and blood vessel homeostasis during embryogenesis, regeneration and tumorigenesis.	Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Human Genet, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA; Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; Burnham Inst Med Res, La Jolla, CA 92037 USA; Tuskegee Univ, Coll Vet Med Nursing & Allied Hlth, Tuskegee, AL 36088 USA; Wyeth Res, Osteoarthritis Res Grp, Cambridge, MA 02140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Eastern Piedmont Amedeo Avogadro; Sanford Burnham Prebys Medical Discovery Institute; Tuskegee University; Pfizer	Santoro, MM (corresponding author), Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	massimo.santoro@ucsf.edu; didier.stainier@biochem.ucsf.edu		SANTORO, Massimo Mattia/0000-0003-4605-5085; Stainier, Didier/0000-0002-0382-0026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54737] Funding Source: Medline; NIA NIH HHS [AG-15402] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dimmeler S, 2000, CIRC RES, V87, P434; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Weinstein BM, 2002, SEMIN CELL DEV BIOL, V13, P515, DOI 10.1016/S1084952102001052; Winn RK, 2005, J THROMB HAEMOST, V3, P1815, DOI 10.1111/j.1538-7836.2005.01378.x	30	112	121	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1397	1402		10.1038/ng.2007.8	http://dx.doi.org/10.1038/ng.2007.8			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934460				2022-12-25	WOS:000250575900025
J	Rock, MJ; Prenen, J; Funari, VA; Funari, TL; Merriman, B; Nelson, SF; Lachman, RS; Wilcox, WR; Reyno, S; Quadrelli, R; Vaglio, A; Owsianik, G; Janssens, A; Voets, T; Ikegawa, S; Nagai, T; Rimoin, DL; Nilius, B; Cohn, DH				Rock, Matthew J.; Prenen, Jean; Funari, Vincent A.; Funari, Tara L.; Merriman, Barry; Nelson, Stanley F.; Lachman, Ralph S.; Wilcox, William R.; Reyno, Soraya; Quadrelli, Roberto; Vaglio, Alicia; Owsianik, Grzegorz; Janssens, Annelies; Voets, Thomas; Ikegawa, Shiro; Nagai, Toshiro; Rimoin, David L.; Nilius, Bernd; Cohn, Daniel H.			Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia	NATURE GENETICS			English	Article							CATION CHANNEL TRPV4; GENETIC-DISORDERS; DIFFERENTIATION; CHONDROCYTES; MODULATION; ACTIVATION; EXPRESSION; DYSPLASIA; SKELETON	The brachyolmias constitute a clinically and genetically heterogeneous group of skeletal dysplasias characterized by a short trunk, scoliosis and mild short stature(1). Here, we identify a locus for an autosomal dominant form of brachyolmia on chromosome 12q24.1-12q24.2. Among the genes in the genetic interval, we selected TRPV4, which encodes a calcium permeable cation channel of the transient receptor potential (TRP) vanilloid family, as a candidate gene because of its cartilage-selective gene expression pattern. In two families with the phenotype, we identified point mutations in TRPV4 that encoded R616Q and V620I substitutions, respectively. Patch clamp studies of transfected HEK cells showed that both mutations resulted in a dramatic gain of function characterized by increased constitutive activity and elevated channel activation by either mechano-stimulation or agonist stimulation by arachidonic acid or the TRPV4-specific agonist 4 alpha-phorbol 12,13-didecanoate (4 alpha PDD). This study thus defines a previously unknown mechanism, activation of a calcium-permeable TRP ion channel, in skeletal dysplasia pathogenesis.	[Rock, Matthew J.; Funari, Vincent A.; Funari, Tara L.; Lachman, Ralph S.; Wilcox, William R.; Rimoin, David L.; Cohn, Daniel H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Prenen, Jean; Owsianik, Grzegorz; Janssens, Annelies; Voets, Thomas; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium; [Merriman, Barry; Nelson, Stanley F.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Nelson, Stanley F.; Lachman, Ralph S.; Wilcox, William R.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lachman, Ralph S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Reyno, Soraya] Hosp Pereira Rossel, Serv Traumatol & Ortopedia, Montevideo, Uruguay; [Quadrelli, Roberto; Vaglio, Alicia] Hosp Italiano, Inst Med Genet, Montevideo, Uruguay; [Ikegawa, Shiro] RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo, Japan; [Nagai, Toshiro] Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	Cedars Sinai Medical Center; KU Leuven; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; Dokkyo Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	dan.cohn@cshs.org	Nelson, Stanley F/D-4771-2009; Voets, Thomas/E-2466-2012; Ikegawa, Shiro/N-6895-2015; Voets, Thomas/AAD-4389-2019	Nelson, Stanley F/0000-0002-2082-3114; Voets, Thomas/0000-0001-5526-5821; Ikegawa, Shiro/0000-0003-0316-2147; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD022657-25, P01 HD022657, HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Fontaine G, 1975, Arch Fr Pediatr, V32, P493; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; GARDI C, 1994, THORAX, V49, P312, DOI 10.1136/thx.49.4.312; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; HORTON WA, 1983, AM J MED GENET, V16, P201, DOI 10.1002/ajmg.1320160210; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kornak U, 2003, AM J HUM GENET, V73, P447, DOI 10.1086/377110; Lange K, 2001, AM J HUM GENET, V69, P504; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; OLSEN BR, 2005, ORAL BIOSCI MED, V2, P57; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; SHOHAT M, 1989, AM J MED GENET, V33, P209, DOI 10.1002/ajmg.1320330214; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TOLEDO SPA, 1978, AM J MED GENET, V2, P385, DOI 10.1002/ajmg.1320020408; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200	30	167	181	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					999	1003		10.1038/ng.166	http://dx.doi.org/10.1038/ng.166			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587396	Green Published, Green Accepted			2022-12-25	WOS:000258026900017
J	Jansson, EA; Huang, L; Malkey, R; Govoni, M; Nihlen, C; Olsson, A; Stensdotter, M; Petersson, J; Holm, L; Weitzberg, E; Lundberg, JO				Jansson, Emmelie A.; Huang, Liyue; Malkey, Ronny; Govoni, Mirco; Nihlen, Carina; Olsson, Annika; Stensdotter, Margareta; Petersson, Joel; Holm, Lena; Weitzberg, Eddie; Lundberg, Jon O.			A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis	NATURE CHEMICAL BIOLOGY			English	Article							ISCHEMIA-REPERFUSION INJURY; DIETARY NITRATE; XANTHINE OXIDOREDUCTASE; IN-VIVO; SIGNALING MOLECULE; HYPOXIC CONDITIONS; CONVENTIONAL RATS; BLOOD-PRESSURE; HUMAN SALIVA; HUMANS	Inorganic nitrite (NO2-) is emerging as a regulator of physiological functions and tissue responses to ischemia, whereas the more stable nitrate anion (NO3-) is generally considered to be biologically inert. Bacteria express nitrate reductases that produce nitrite, but mammals lack these specific enzymes. Here we report on nitrate reductase activity in rodent and human tissues that results in formation of nitrite and nitric oxide (NO) and is attenuated by the xanthine oxidoreductase inhibitor allopurinol. Nitrate administration to normoxic rats resulted in elevated levels of circulating nitrite that were again attenuated by allopurinol. Similar effects of nitrate were seen in endothelial NO synthase - deficient and germ-free mice, thereby excluding vascular NO synthase activation and bacteria as the source of nitrite. Nitrate pretreatment attenuated the increase in systemic blood pressure caused by NO synthase inhibition and enhanced blood flow during post-ischemic reperfusion. Our findings suggest a role for mammalian nitrate reduction in regulation of nitrite and NO homeostasis.	[Jansson, Emmelie A.; Huang, Liyue; Malkey, Ronny; Govoni, Mirco; Nihlen, Carina; Olsson, Annika; Stensdotter, Margareta; Petersson, Joel; Holm, Lena; Lundberg, Jon O.] Karolinska Inst, Dept Physiol & Pharmacol, Div Anesthesiol & Intens Care, S-17177 Stockholm, Sweden; [Weitzberg, Eddie] Uppsala Univ, Dept Med Cell Biol, SE-75123 Uppsala, Sweden	Karolinska Institutet; Uppsala University	Lundberg, JO (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Div Anesthesiol & Intens Care, Nanna Svartz Vag 2, S-17177 Stockholm, Sweden.	jon.lundberg@ki.se		Lundberg, Jon/0000-0002-0174-5210				ALIKULOV Z A, 1980, Biokhimiya, V45, P1714; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2004, BLOOD, V104, P1375, DOI 10.1182/blood-2004-03-0880; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FRITSCH P, 1985, FOOD CHEM TOXICOL, V23, P655, DOI 10.1016/0278-6915(85)90153-X; Gago B, 2007, FREE RADICAL BIO MED, V43, P1233, DOI 10.1016/j.freeradbiomed.2007.06.007; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; GUSTAFSSON BE, 1982, SCAND J GASTROENTERO, V17, P117; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jung KH, 2006, STROKE, V37, P2744, DOI 10.1161/01.STR.0000245116.40163.1c; Jungersten L, 1997, J APPL PHYSIOL, V82, P760, DOI 10.1152/jappl.1997.82.3.760; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2005, ARTERIOSCL THROM VAS, V25, P915, DOI 10.1161/01.ATV.0000161048.72004.c2; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2006, NITRIC OXIDE-BIOL CH, V15, P359, DOI 10.1016/j.niox.2006.01.013; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Peri L, 2005, FREE RADICAL BIO MED, V39, P668, DOI 10.1016/j.freeradbiomed.2005.04.021; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Sarnesto A, 1996, LAB INVEST, V74, P48; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sips AJAM, 2000, ORAL BIOAVAILABILITY; SPEIJERS GJA, 2006, WHO FOOD ADDITIVES S; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; Tripatara P, 2007, J AM SOC NEPHROL, V18, P570, DOI 10.1681/ASN.2006050450; WARD FW, 1990, FOOD ADDIT CONTAM, V7, P597, DOI 10.1080/02652039009373925; WARD FW, 1986, FOOD CHEM TOXICOL, V24, P17, DOI 10.1016/0278-6915(86)90258-9; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Weitzberg E, 1998, NITRIC OXIDE-BIOL CH, V2, P1, DOI 10.1006/niox.1997.0162; Zhang Zhi, 1997, Biochemical Society Transactions, V25, p524S; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	49	251	259	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					411	417		10.1038/nchembio.92	http://dx.doi.org/10.1038/nchembio.92			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18516050				2022-12-25	WOS:000256929900011
J	Labbaye, C; Spinello, I; Quaranta, MT; Pelosi, E; Pasquini, L; Petrucci, E; Biffoni, M; Nuzzolo, ER; Billi, M; Foa, R; Brunetti, E; Grignani, F; Testa, U; Peschle, C				Labbaye, Catherine; Spinello, Isabella; Quaranta, Maria Teresa; Pelosi, Elvira; Pasquini, Luca; Petrucci, Eleonora; Biffoni, Mauro; Nuzzolo, Eugenia Rosa; Billi, Monia; Foa, Robin; Brunetti, Ercole; Grignani, Francesco; Testa, Ugo; Peschle, Cesare			A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis	NATURE CELL BIOLOGY			English	Article							MYELOID CELLS; STEM-CELLS; HEMATOPOIETIC PROGENITORS; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; SDF-1-CXCR4 AXIS; DOWN-REGULATION; PLZF PROTEIN; PIVOTAL ROLE	MicroRNAs ( miRNAs or miRs) regulate diverse normal and abnormal cell functions. We have identified a regulatory pathway in normal megakaryopoiesis, involving the PLZF transcription factor, miR-146a and the SDF-1 receptor CXCR4. In leukaemic cell lines PLZF overexpression downmodulated miR-146a and upregulated CXCR4 protein, whereas PLZF knockdown induced the opposite effects. In vitro assays showed that PLZF interacts with and inhibits the miR-146a promoter, and that miR-146a targets CXCR4 mRNA, impeding its translation. In megakaryopoietic cultures of CD34(+) progenitors, PLZF was upregulated, whereas miR-146a expression decreased and CXCR4 protein increased. MiR-146a overexpression and PLZF or CXCR4 silencing impaired megakaryocytic (Mk) proliferation, differentiation and maturation, as well as Mk colony formation. Mir-146a knockdown induced the opposite effects. Rescue experiments indicated that the effects of PLZF and miR-146a are mediated by miR-146a and CXCR4, respectively. Our data indicate that megakaryopoiesis is controlled by a cascade pathway, in which PLZF suppresses miR-146a transcription and thereby activates CXCR4 translation.	[Labbaye, Catherine; Spinello, Isabella; Quaranta, Maria Teresa; Pelosi, Elvira; Pasquini, Luca; Petrucci, Eleonora; Biffoni, Mauro; Nuzzolo, Eugenia Rosa; Testa, Ugo; Peschle, Cesare] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Foa, Robin] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy; [Brunetti, Ercole] San Pietro FBF, Ctr Ric AFaR, I-00100 Rome, Italy; [Billi, Monia; Grignani, Francesco] Univ Perugia, Dept Gen Pathol, I-06122 Perugia, Italy; [Peschle, Cesare] IRCCS MultiMed, I-20138 Milan, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; University of Perugia; IRCCS Multimedica	Labbaye, C (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	catherine.labbaye@iss.it; cesare.peschle@iss.it	Testa, Ugo/J-6472-2016; SPINELLO, ISABELLA/J-8779-2016; PETRUCCI, ELEONORA/J-8778-2016; pelosi, elvira/J-7298-2016; Grignani, Francesco/AAC-2565-2022; Labbaye, Catherine/J-9930-2016; pasquini, luca/J-8319-2016; Biffoni, Mauro/J-8318-2016; Quaranta, Maria Teresa/AAC-2134-2019	Testa, Ugo/0000-0001-7900-8942; PETRUCCI, ELEONORA/0000-0001-6459-490X; pelosi, elvira/0000-0002-3043-6249; pasquini, luca/0000-0002-3484-6288; Biffoni, Mauro/0000-0002-1304-9060; Quaranta, Maria Teresa/0000-0002-5886-507X; Labbaye, Catherine/0000-0003-1255-4396; Billi, Monia/0000-0002-5284-7380	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Ball HJ, 1999, NUCLEIC ACIDS RES, V27, P4106, DOI 10.1093/nar/27.20.4106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cottler-Fox Michele H, 2003, Hematology Am Soc Hematol Educ Program, P419; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; de Almodovar CR, 2006, CELL, V124, P18, DOI 10.1016/j.cell.2005.12.023; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; GABBIANELLI M, 1990, SCIENCE, V249, P1561, DOI 10.1126/science.2218497; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Guerriero R, 2001, BLOOD, V97, P2587, DOI 10.1182/blood.V97.9.2587; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; HE L, 2004, NAT REV GENET, V5, P522; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; Parrado A, 2000, Hematol J, V1, P15, DOI 10.1038/sj.thj.6200012; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Quaranta MT, 2006, ONCOGENE, V25, P399, DOI 10.1038/sj.onc.1209060; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; TABILIO A, 1983, CANCER RES, V43, P4569; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tamamura H, 2005, EXPERT OPIN THER TAR, V9, P1267, DOI 10.1517/14728222.9.6.1267; Testa U, 1998, LEUKEMIA, V12, P563, DOI 10.1038/sj.leu.2400967; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	49	187	203	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					788	801		10.1038/ncb1741	http://dx.doi.org/10.1038/ncb1741			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18568019				2022-12-25	WOS:000257268400009
J	Sangiorgi, E; Capecchi, MR				Sangiorgi, Eugenio; Capecchi, Mario R.			Bmi1 is expressed in vivo in intestinal stem cells	NATURE GENETICS			English	Article							GENE; MICE; CRE; PROGENITORS; IDENTIFICATION; RECOMBINASE; MAINTENANCE; TISSUES; CANCER; MOUSE	Bmi1 plays an essential part in the self-renewal of hematopoietic and neural stem cells. To investigate its role in other adult stem cell populations, we generated a mouse expressing a tamoxifen-inducible Cre from the Bmi1 locus. We found that Bmi1 is expressed in discrete cells located near the bottom of crypts in the small intestine, predominantly four cells above the base of the crypt (+4 position). Over time, these cells proliferate, expand, self-renew and give rise to all the differentiated cell lineages of the small intestine epithelium. The induction of a stable form of beta-catenin in these cells was sufficient to rapidly generate adenomas. Moreover, ablation of Bmi1+ cells using a Rosa26 conditional allele, expressing diphtheria toxin, led to crypt loss. These experiments identify Bmi1 as an intestinal stem cell marker in vivo. Unexpectedly, the distribution of Bmi1-expressing stem cells along the length of the small intestine suggested that mammals use more than one molecularly distinguishable adult stem cell subpopulation to maintain organ homeostasis.	[Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Sangiorgi, Eugenio/AAP-9836-2020	Sangiorgi, Eugenio/0000-0001-9079-9175	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM021168-34, R01 GM021168] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Preston SL, 2003, CANCER RES, V63, P3819; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Wong MH, 1999, GASTROENTEROLOGY, V116, P208, DOI 10.1016/S0016-5085(99)70245-3; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236	29	893	921	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					915	920		10.1038/ng.165	http://dx.doi.org/10.1038/ng.165			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536716	Green Accepted			2022-12-25	WOS:000257166500029
J	Kohli, A; Christou, P				Kohli, Ajay; Christou, Paul			Stable transgenes bear fruit	NATURE BIOTECHNOLOGY			English	Editorial Material							HOMOLOGOUS RECOMBINATION; INTEGRATION; DNA; ORGANIZATION; GENOME; PLANTS; RICE; LOCI	Analysis of the transgenic papaya genome sequence suggests that transgenes generally stay put following integration and can achieve stable expression level from generation to generation.	[Kohli, Ajay] Univ Newcastle Upon Tyne, IRES, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Christou, Paul] Univ Lleida, ICREA, PVCF, E-25198 Lleida, Spain	Newcastle University - UK; ICREA; Universitat de Lleida	Kohli, A (corresponding author), Univ Newcastle Upon Tyne, IRES, Devonshire Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	christou@pvcf.udl.es	Christou, Paul/C-8645-2011	Christou, Paul/0000-0001-6358-7396; Kohli, Ajay/0000-0002-7325-5798	ICREA Funding Source: Custom	ICREA(ICREA)		D'Halluin K, 2008, PLANT BIOTECHNOL J, V6, P93, DOI 10.1111/j.1467-7652.2007.00305.x; Fu XD, 2000, TRANSGENIC RES, V9, P11, DOI 10.1023/A:1008993730505; Huang CY, 2004, P NATL ACAD SCI USA, V101, P9710, DOI 10.1073/pnas.0400853101; Kohli A, 1998, P NATL ACAD SCI USA, V95, P7203, DOI 10.1073/pnas.95.12.7203; Kohli A, 2003, PLANT MOL BIOL, V52, P247, DOI 10.1023/A:1023941407376; Makarevitch I, 2006, PLANT J, V48, P697, DOI 10.1111/j.1365-313X.2006.02915.x; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737	9	14	14	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					653	654		10.1038/nbt0608-653	http://dx.doi.org/10.1038/nbt0608-653			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18536688	Green Submitted			2022-12-25	WOS:000256611900023
J	Pihlak, A; Bauren, G; Hersoug, E; Lonnerberg, P; Metsis, A; Linnarsson, S				Pihlak, Arno; Bauren, Goran; Hersoug, Ellef; Lonnerberg, Peter; Metsis, Ats; Linnarsson, Sten			Rapid genome sequencing with short universal tiling probes	NATURE BIOTECHNOLOGY			English	Article							DNA; HYBRIDIZATION; AMPLIFICATION; ARRAYS	The increasing availability of high-quality reference genomic sequences has created a demand for ways to survey the sequence differences present in individual genomes. Here we describe a DNA sequencing method based on hybridization of a universal panel of tiling probes. Millions of shotgun fragments are amplified in situ and subjected to sequential hybridization with short fluorescent probes. Long fragments of 200 bp facilitate unique placement even in large genomes. The sequencing chemistry is simple, enzyme-free and consumes only dilute solutions of the probes, resulting in reduced sequencing cost and substantially increased speed. A prototype instrument based on commonly available equipment was used to resequence the Bacteriophage lambda and Escherichia coli genomes to better than 99.93% accuracy with a raw throughput of 320 Mbp/day, albeit with a significant number of small gaps attributed to losses in sample preparation.	[Pihlak, Arno; Hersoug, Ellef; Lonnerberg, Peter; Metsis, Ats; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, SE-17177 Stockholm, Sweden; [Pihlak, Arno; Bauren, Goran; Hersoug, Ellef; Lonnerberg, Peter; Metsis, Ats; Linnarsson, Sten] Genizon Svenska AB, SE-17177 Stockholm, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Scheeles Vag 1, SE-17177 Stockholm, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022					Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arratia R, 1996, J COMPUT BIOL, V3, P425, DOI 10.1089/cmb.1996.3.425; BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; BING DH, 1996, GENETIC IDENTITY C P; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CANARD B, 1994, GENE, V148, P1, DOI 10.1016/0378-1119(94)90226-7; Church G, 2006, NAT BIOTECHNOL, V24, P139, DOI 10.1038/nbt0206-139b; DONACHIE WD, 1993, ANNU REV MICROBIOL, V47, P199, DOI 10.1146/annurev.mi.47.100193.001215; DRMANAC R, 1989, GENOMICS, V4, P114; Drmanac Radoje, 2002, Adv Biochem Eng Biotechnol, V77, P75; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HYMAN ED, 1988, ANAL BIOCHEM, V174, P423, DOI 10.1016/0003-2697(88)90041-3; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; LUCKEY JA, 1990, NUCLEIC ACIDS RES, V18, P4417, DOI 10.1093/nar/18.15.4417; LYSOV YP, 1988, DOKL AKAD NAUK SSSR, V303, P1508; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; METZKER ML, 1994, NUCLEIC ACIDS RES, V22, P4259, DOI 10.1093/nar/22.20.4259; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pe'er I, 2002, P NATL ACAD SCI USA, V99, P15492, DOI 10.1073/pnas.232278299; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shamir R, 2002, J COMPUT BIOL, V9, P413, DOI 10.1089/10665270252935548; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	38	44	108	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					676	684		10.1038/nbt1405	http://dx.doi.org/10.1038/nbt1405			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18500336				2022-12-25	WOS:000256611900027
J	Watkins, DI; Burton, DR; Kallas, EG; Moore, JP; Koff, WC				Watkins, David I.; Burton, Dennis R.; Kallas, Esper G.; Moore, John P.; Koff, Wayne C.			Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans	NATURE MEDICINE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; ANKARA BOOST REGIMEN; I DOWN-REGULATION; RHESUS MACAQUES; ANTIVIRAL ACTIVITY; INFECTED-CELLS; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; SIVMAC239 INFECTION	The adenovirus type 5 (Ad5)-based vaccine developed by Merck failed to either prevent HIV-1 infection or suppress viral load in subsequently infected subjects in the STEP human Phase 2b efficacy trial. Analogous vaccines had previously also failed in the simian immunodeficiency virus (SIV) challenge-rhesus macaque model. In contrast, vaccine protection studies that used challenge with a chimeric simian-human immunodeficiency virus (SHIV89.6P) in macaques did not predict the human trial results. Ad5 vector -based vaccines did not protect macaques from infection after SHIV89.6P challenge but did cause a substantial reduction in viral load and a preservation of CD4(+) T cell counts after infection, findings that were not reproduced in the human trials. Although the SIV challenge model is incompletely validated, we propose that its expanded use can help facilitate the prioritization of candidate HIV-1 vaccines, ensuring that resources are focused on the most promising candidates. Vaccine designers must now develop T cell vaccine strategies that reduce viral load after heterologous challenge.	[Watkins, David I.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Med Sci Ctr 6152, Madison, WI 53706 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Lab Invest Med 60, BR-02146903 Sao Paulo, Brazil; [Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, BR-04044010 Sao Paulo, Brazil; [Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Koff, Wayne C.] IAVI, New York, NY 10038 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Cornell University; International AIDS Vaccine Initiative	Watkins, DI (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.	watkins@primate.wisc.edu	Kallas, Esper G/C-9539-2012	Kallas, Esper/0000-0003-2026-6925	NCRR NIH HHS [R24 RR015371, R24 RR016038] Funding Source: Medline; NIAID NIH HHS [R01 AI45463, R01 AI052056, R01 AI055332, U01 AI069420, R37 AI033292, R37 AI36082, R01 AI049120, R37 AI036082, U01 AI69420, R01 AI045463, R37 AI33292] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038, R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, R01AI049120, R01AI052056, R01AI045463, U01AI069420, R37AI033292, R01AI055332] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdel-Motal UM, 2005, VIROLOGY, V333, P226, DOI 10.1016/j.virol.2004.12.030; Ali A, 2004, J VIROL, V78, P561, DOI 10.1128/JVI.78.2.561-567.2004; Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; [Anonymous], 2007, Nature, V449, P390; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Benson J, 1998, J VIROL, V72, P4170, DOI 10.1128/JVI.72.5.4170-4182.1998; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Excler JL, 2007, AIDS, V21, P2259, DOI 10.1097/QAD.0b013e3282eee70c; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hel Z, 2006, J IMMUNOL, V176, P85, DOI 10.4049/jimmunol.176.1.85; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Hel Z, 2002, VIROLOGY, V304, P125, DOI 10.1006/viro.2002.1722; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lifson JD, 2002, NATURE, V415, P272, DOI 10.1038/415272b; Loffredo JT, 2005, J VIROL, V79, P14986, DOI 10.1128/JVI.79.23.14986-14991.2005; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McDermott AB, 2005, J VIROL, V79, P15556, DOI 10.1128/JVI.79.24.15556-15566.2005; McNeil JG, 2004, SCIENCE, V303, P961, DOI 10.1126/science.1096161; Nilsson C, 1998, AIDS, V12, P2261, DOI 10.1097/00002030-199817000-00006; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rollman E, 2007, J IMMUNOL, V179, P4571, DOI 10.4049/jimmunol.179.7.4571; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; THAKALLAPALLY R, 2000, HIV MOL IMMUNOLOGY 2, P73; Tomiyama H, 2005, J IMMUNOL, V174, P36, DOI 10.4049/jimmunol.174.1.36; Valentine LE, 2008, J VIROL, V82, P575, DOI 10.1128/JVI.00275-07; Van Baalen CA, 1998, J VIROL, V72, P6851, DOI 10.1128/JVI.72.8.6851-6857.1998; *VAXGEN, 2003, VAXGEN ANN RES ITS P; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Willis RA, 2006, P NATL ACAD SCI USA, V103, P12063, DOI 10.1073/pnas.0605130103; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2003, TRENDS IMMUNOL, V24, P67, DOI 10.1016/S1471-4906(02)00034-0; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	76	210	217	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					617	621		10.1038/nm.f.1759	http://dx.doi.org/10.1038/nm.f.1759			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18535579	Green Accepted			2022-12-25	WOS:000256468700026
J	Kutalik, Z; Beckmann, JS; Bergmann, S				Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven			A modular approach for integrative analysis of large-scale gene-expression and drug-response data	NATURE BIOTECHNOLOGY			English	Article							MOLECULAR PHARMACOLOGY; MULTIDRUG-RESISTANCE; BREAST-CANCER; NETWORKS; ACID; ORGANIZATION; MICROARRAY; DISCOVERY; PROFILES; PATTERNS	High-throughput technologies are now used to generate more than one type of data from the same biological samples. To properly integrate such data, we propose using co-modules, which describe coherent patterns across paired data sets, and conceive several modular methods for their identification. We first test these methods using in silico data, demonstrating that the integrative scheme of our Ping-Pong Algorithm uncovers drug-gene associations more accurately when considering noisy or complex data. Second, we provide an extensive comparative study using the gene-expression and drug-response data from the NCI-60 cell lines. Using information from the DrugBank and the Connectivity Map databases we show that the Ping-Pong Algorithm predicts drug-gene associations significantly better than other methods. Co-modules provide insights into possible mechanisms of action for a wide range of drugs and suggest new targets for therapy.	[Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kutalik, Zoltan; Bergmann, Sven] Univ Lausanne, Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bergmann, S (corresponding author), Univ Lausanne, Dept Med Genet, Rue Bugnon 27 DGM 328, CH-1005 Lausanne, Switzerland.	Sven.Bergmann@unil.ch	Beckmann, Jacques S/A-9772-2008; Kutalik, Zoltan/HHZ-5697-2022	Beckmann, Jacques S/0000-0002-9741-1900; Kutalik, Zoltan/0000-0001-8285-7523; Bergmann, Sven/0000-0002-6785-9034				Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benson M, 2006, CURR MOL MED, V6, P695, DOI 10.2174/156652406778195044; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Breedveld P, 2007, MOL PHARMACOL, V71, P240, DOI 10.1124/mol.106.028167; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; CHOMIENNE C, 1991, J CLIN INVEST, V88, P2150, DOI 10.1172/JCI115547; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; DOYLE LA, 1995, BRIT J CANCER, V72, P535, DOI 10.1038/bjc.1995.370; Gamberoni G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-6; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gasch AP, 2002, GENOME BIOL, V3; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Getz G, 2003, BIOINFORMATICS, V19, P1079, DOI 10.1093/bioinformatics/btf876; HANDE KR, 1992, SEMIN ONCOL, V19, P3; HARRIS AL, 1992, ACTA ONCOL, V31, P205, DOI 10.3109/02841869209088904; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Hu J, 2007, ADV CANCER RES, V98, P191, DOI 10.1016/S0065-230X(06)98006-3; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu XD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-283; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Melkonian G, 2002, J EXP ZOOL, V292, P241, DOI 10.1002/jez.10014; Neri LM, 2003, MOL CANCER RES, V1, P234; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Werner T, 2007, MECH AGEING DEV, V128, P168, DOI 10.1016/j.mad.2006.11.022; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; ZWEIG MH, 1993, CLIN CHEM, V39, P561	48	95	98	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2008	26	5					531	539		10.1038/nbt1397	http://dx.doi.org/10.1038/nbt1397			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	299LJ	18464786				2022-12-25	WOS:000255756800025
J	Minsky, N; Shema, E; Field, Y; Schuster, M; Segal, E; Oren, M				Minsky, Neri; Shema, Efrat; Field, Yair; Schuster, Meromit; Segal, Eran; Oren, Moshe			Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells	NATURE CELL BIOLOGY			English	Article							RNA-POLYMERASE-II; UBIQUITINATED HISTONE H2B; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; S-PHASE; UBIQUITYLATION; METHYLATION; DEUBIQUITYLATION; COMPLEX	Histone modifications have emerged as important regulators of transcription(1,2). Histone H2B monoubiquitination has also been implicated in transcription(3,4); however, better understanding of the biological significance of this modification in mammalian cells has been hindered by the lack of suitable reagents, particularly antibodies capable of specifically recognizing ubiquitinated H2B ( ubH2B). Here, we report the generation of anti-ubH2B monoclonal antibodies using a branched peptide as immunogen. These antibodies provide a powerful tool for exploring the biochemical functions of H2B monoubiquitination at both a genome-wide and gene-specific level. Application of these antibodies in high resolution chromatin immunoprecipitation ( ChIP)-chip experiments in human cells, using tiling arrays, revealed preferential association of ubiquitinated H2B with the transcribed regions of highly expressed genes. Unlike dimethylated H3K4, ubH2B was not associated with distal promoter regions. Furthermore, experimental modulation of the transcriptional activity of the tumour suppressor p53 was accompanied by rapid changes in the H2B ubiquitination status of its target gene p21, attesting to the dynamic nature of this process. It has recently been demonstrated that the apparent extent of gene expression often reflects elongation rather than initiation rates(5); thus, our findings suggest that H2B ubiquitination is intimately linked with global transcriptional elongation in mammalian cells.	[Minsky, Neri; Shema, Efrat; Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Field, Yair; Schuster, Meromit; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	moshe.oren@weizmann.ac.il	Segal, Eran/AAF-4855-2019; Shema, Efrat/AHC-5041-2022	Shema, Efrat/0000-0002-3718-593X; Segal, Eran/0000-0002-6859-1164; Oren, Moshe/0000-0003-4311-7172	NATIONAL CANCER INSTITUTE [R37CA040099] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA40099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; DAVIE JR, 1994, BIOCHEM BIOPH RES CO, V203, P344, DOI 10.1006/bbrc.1994.2188; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PLAUE S, 1989, J EXP MED, V169, P1607, DOI 10.1084/jem.169.5.1607; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, J BIOL CHEM, V281, P19045, DOI 10.1074/jbc.M513533200; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; THORNE AW, 1987, EMBO J, V6, P1005, DOI 10.1002/j.1460-2075.1987.tb04852.x; VASSILEV AP, 1995, J CELL SCI, V108, P1205; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	30	262	274	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					483	490		10.1038/ncb1712	http://dx.doi.org/10.1038/ncb1712			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344985				2022-12-25	WOS:000254561700020
J	Squires, TM; Messinger, RJ; Manalis, SR				Squires, Todd M.; Messinger, Robert J.; Manalis, Scott R.			Making it stick: convection, reaction and diffusion in surface-based biosensors	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; DNA HYBRIDIZATION; MASS-TRANSPORT; LABEL-FREE; MICROARRAYS; BINDING; IMMOBILIZATION; NANOWIRES; SCALE; FLUID	The past decade has seen researchers develop and apply novel technologies for biomolecular detection, at times approaching hard limits imposed by physics and chemistry. In nearly all sensors, the transport of target molecules to the sensor can play as critical a role as the chemical reaction itself in governing binding kinetics, and ultimately performance. Yet rarely does an analysis of the interplay between diffusion, convection and reaction motivate experimental design or interpretation. Here we develop a physically intuitive and practical understanding of analyte transport for researchers who develop and employ biosensors based on surface capture. We explore the qualitatively distinct behaviors that result, develop rules of thumb to quickly determine how a given system will behave, and derive order-of-magnitude estimates for fundamental quantities of interest, such as fluxes, collection rates and equilibration times. We pay particular attention to collection limits for micro- and nanoscale sensors, and highlight unexplained discrepancies between reported values and theoretical limits.	[Squires, Todd M.; Messinger, Robert J.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Manalis, Scott R.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Manalis, Scott R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	University of California System; University of California Santa Barbara; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Squires, TM (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	squires@engineering.ucsb.edu	Squires, Todd/Q-4661-2019; Messinger, Robert J./M-2471-2015	Messinger, Robert J./0000-0002-5537-3870; Squires, Todd/0000-0001-6609-9275	NCI NIH HHS [R01-CA119402] Funding Source: Medline; NIGMS NIH HHS [P50-GM68762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERBERG RC, 1978, J FLUID MECH, V86, P49, DOI 10.1017/S0022112078001007; Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Belosludtsev Y, 2001, BIOCHEM BIOPH RES CO, V282, P1263, DOI 10.1006/bbrc.2001.4728; Bender C.M., 1978, ADV MATH METHODS SCI; Benn JA, 2006, ANAL BIOCHEM, V348, P284, DOI 10.1016/j.ab.2005.10.033; Berg, 2018, RANDOM WALKS BIOL; BERGVELD P, 1972, IEEE T BIO-MED ENG, VBM19, P342, DOI 10.1109/TBME.1972.324137; Bird R. B., 2002, INTERPHASE TRANSPORT; Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Deen, 1998, ANAL TRANSPORT PHENO; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Gervais T, 2006, CHEM ENG SCI, V61, P1102, DOI 10.1016/j.ces.2005.06.024; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hinch EJ, 1991, PERTUBATION METHODS; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kartalov EP, 2006, BIOTECHNIQUES, V40, P85, DOI 10.2144/000112071; Leal L.G., 2007, ADV TRANSPORT PHENOM; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Milovic NM, 2006, P NATL ACAD SCI USA, V103, P13374, DOI 10.1073/pnas.0604471103; Morgan CL, 1996, CLIN CHEM, V42, P193; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Newman J, 1973, ELECTROANALYTICAL CH, P279; Peluso P, 2003, ANAL BIOCHEM, V312, P113, DOI 10.1016/S0003-2697(02)00442-6; Record MT, 1998, ADV PROTEIN CHEM, V51, P281; Rich RL, 2002, J MOL RECOGNIT, V15, P352, DOI 10.1002/jmr.598; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Sosnowski RG, 1997, P NATL ACAD SCI USA, V94, P1119, DOI 10.1073/pnas.94.4.1119; Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Vijayendran RA, 2003, LANGMUIR, V19, P1824, DOI 10.1021/la0262250; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Wang J, 1999, CHEM-EUR J, V5, P1681, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1681::AID-CHEM1681>3.0.CO;2-U; WANG YM, 2006, PHYS REV LETT, V34; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Xiao Y, 2006, P NATL ACAD SCI USA, V103, P16677, DOI 10.1073/pnas.0607693103; Yoon SK, 2006, LAB CHIP, V6, P1516, DOI 10.1039/b609289f; Zhang W, 1996, J PHYS CHEM-US, V100, P9462, DOI 10.1021/jp960027y; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; 2002, NAT GENET, V32, pS4; 1999, NAT GENET, V21, pS1	45	687	705	4	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					417	426		10.1038/nbt1388	http://dx.doi.org/10.1038/nbt1388			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18392027				2022-12-25	WOS:000254782500024
J	Yao, G; Lee, TJ; Mori, S; Nevins, JR; You, LC				Yao, Guang; Lee, Tae Jun; Mori, Seiichi; Nevins, Joseph R.; You, Lingchong			A bistable Rb-E2F switch underlies the restriction point	NATURE CELL BIOLOGY			English	Article							MYC PROTEIN STABILITY; MAMMALIAN-CELL CYCLE; TRANSCRIPTION FACTORS; NEGATIVE REGULATORS; PROTEASOME PATHWAY; POSITIVE-FEEDBACK; ESCHERICHIA-COLI; GENE-EXPRESSION; G(1) CONTROL; D1 COMPLEX	The restriction point ( R-point) marks the critical event when a mammalian cell commits to proliferation and becomes independent of growth stimulation. It is fundamental for normal differentiation and tissue homeostasis, and seems to be dysregulated in virtually all cancers(1,2). Although the R-point has been linked to various activities involved in the regulation of G1-S transition of the mammalian cell cycle(2-6), the underlying mechanism remains unclear(1,7). Using single-cell measurements, we show here that the Rb-E2F pathway functions as a bistable switch to convert graded serum inputs into all-or-none E2F responses. Once turned ON by sufficient serum stimulation, E2F can memorize and maintain this ON state independently of continuous serum stimulation. We further show that, at critical concentrations and duration of serum stimulation, bistable E2F activation correlates directly with the ability of a cell to traverse the R-point.	[Yao, Guang; Mori, Seiichi; Nevins, Joseph R.; You, Lingchong] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Yao, Guang; Mori, Seiichi; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Tae Jun; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Nevins, JR (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	j.nevins@duke.edu; you@duke.edu		, Guang/0000-0003-0167-777X	NCI NIH HHS [U54 CA112952, 5-U24-CA112952-03] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Doedel EJ., 1981, CONG NUMER, V30, P265; ERMENTROUT B, 2002, SIAM PRESS PHILADEPH; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Grafstrom RH, 1999, CARCINOGENESIS, V20, P193, DOI 10.1093/carcin/20.2.193; Hatzimanikatis V, 1999, BIOTECHNOL BIOENG, V65, P631; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; LEUNG JY, 2008, IN PRESS ONCOGENE; LOGAN J, 1981, VIROLOGY, V115, P419, DOI 10.1016/0042-6822(81)90126-4; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOTOKURA T, 1993, GENE CHROMOSOME CANC, V7, P89, DOI 10.1002/gcc.2870070205; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Qu ZL, 2003, BIOPHYS J, V85, P3600, DOI 10.1016/S0006-3495(03)74778-X; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Weinberg RA, 2007, BIOL CANC; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; You LC, 2003, BIOINFORMATICS, V19, P435, DOI 10.1093/bioinformatics/btg009; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	52	275	280	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					476	U255		10.1038/ncb1711	http://dx.doi.org/10.1038/ncb1711			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364697				2022-12-25	WOS:000254561700019
J	Shinohara, M; Oh, SD; Hunter, N; Shinohara, A				Shinohara, Miki; Oh, Steve D.; Hunter, Neil; Shinohara, Akira			Crossover assurance and crossover interference are distinctly regulated by the ZMM proteins during yeast meiosis	NATURE GENETICS			English	Article							MEIOTIC CHROMOSOME SYNAPSIS; DOUBLE-STRAND-BREAK; SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; HOLLIDAY JUNCTIONS; CHIASMA FORMATION; RECA HOMOLOGS; MUTS HOMOLOG; RECOMBINATION	Meiotic crossing-over is highly regulated such that each homolog pair typically receives at least one crossover (assurance) and adjacent crossovers are widely spaced (interference). Here we provide evidence that interference and assurance are mechanistically distinct processes that are separated by mutations in a new ZMM (Zip, Msh, Mer) protein from Saccharomyces cerevisiae, Spo16. Like other zmm mutants, spo16 cells have defects in both crossing-over and synaptonemal complex formation. Unlike in previously characterized zmm mutants, the residual crossovers in spo16 cells show interference comparable to that in the wild type. Spo16 interacts with a second ZMM protein, Spo22 (also known as Zip4), and spo22 mutants also show normal interference. Notably, assembly of the MutS homologs Msh4 and Msh5 on chromosomes occurs in both spo16 and spo22, but not in other zmm mutants. We suggest that crossover interference requires the normal assembly of recombination complexes containing Msh4 and Msh5 but does not require Spo16- and Spo22-dependent extension of synaptonemal complexes. In contrast, crossover assurance requires all ZMM proteins and full-length synaptonemal complexes.	[Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; [Shinohara, Akira] Osaka Univ, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis; Osaka University	Shinohara, A (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM074223] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; ISUBOUCHI I, 2005, SCIENCE, V308, P870; ISUBOUCHI T, 2006, DEV CELL, V10, P809; JONES G H, 1987, P213; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; MALAVASIC MJ, 1990, MOL CELL BIOL, V10, P2809, DOI 10.1128/MCB.10.6.2809; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Novak JE, 2001, GENETICS, V158, P1013; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; PAPAZIAN HP, 1952, GENETICS, V37, P175; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 2003, GENETICS, V163, P1273; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	49	136	140	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					299	309		10.1038/ng.83	http://dx.doi.org/10.1038/ng.83			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297071				2022-12-25	WOS:000253548400020
J	Ding, Y; Shen, SQ; Lino, AC; de Lafaille, MAC; Lafaille, JJ				Ding, Yi; Shen, Shiqian; Lino, Andreia C.; de lafaille, Maria A. Curotto; Lafaille, Juan J.			Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXP3; MYC-INDUCED APOPTOSIS; THYMOCYTE DEVELOPMENT; STEM-CELLS; IN-VIVO; BAX; PROTEIN; PROLIFERATION; POPULATIONS; SUPPRESSION	beta-catenin is a central molecule in the Wnt pathway. Expression of a stable form of beta-catenin on CD4(+)CD25(+) regulatory T (T-reg) cells resulted in a marked enhancement of survival of these cells in vitro. Furthermore, stable beta-catenin-expressing CD4(+)CD25(+) T-reg cells outcompeted control T-reg cells in vivo, and the number of T-reg cells necessary for protection against inflammatory bowel disease could be substantially reduced when stable beta-catenin-expressing CD4(+)CD25(+) T-reg cells were used instead of control T-reg cells. Expression of stable beta-catenin on potentially pathogenic CD4(+)CD25(-) T cells rendered these cells anergic, and the beta-catenin-mediated induction of anergy occurred even in Foxp3-deficient T cells. Thus, through enhanced survival of existing regulatory T cells, and through induction of unresponsiveness in precursors of T effector cells, beta-catenin stabilization has a powerful effect on the prevention of inflammatory disease.	[Ding, Yi; Shen, Shiqian; Lino, Andreia C.; de lafaille, Maria A. Curotto; Lafaille, Juan J.] NYU, Sch Med, Mol Pathogenesis Program, New York, NY 10016 USA; [Ding, Yi; Shen, Shiqian; Lino, Andreia C.; de lafaille, Maria A. Curotto; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Ding, Yi] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; [de lafaille, Maria A. Curotto; Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Lafaille, JJ (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, 540 1st Ave, New York, NY 10016 USA.	lafaille@saturn.med.nyu.edu	Lino, Andreia/GOV-5217-2022	Lino, Andreia C/0000-0002-3791-8232; Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777				Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Mitchell KO, 2000, CANCER RES, V60, P6318; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	39	152	163	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2008	14	2					162	169		10.1038/nm1707	http://dx.doi.org/10.1038/nm1707			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18246080				2022-12-25	WOS:000252946700024
J	Osakada, F; Ikeda, H; Mandai, M; Wataya, T; Watanabe, K; Yoshimura, N; Akaike, A; Sasai, Y; Takahashi, M				Osakada, Fumitaka; Ikeda, Hanako; Mandai, Michiko; Wataya, Takafumi; Watanabe, Kiichi; Yoshimura, Nagahisa; Akaike, Akiori; Sasai, Yoshiki; Takahashi, Masayo			Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							PIGMENT EPITHELIAL-CELLS; RETINAL PROGENITOR CELLS; HOMEOBOX GENE; EYE DEVELOPMENT; MAMMALIAN EYE; ES CELLS; IN-VIVO; DIFFERENTIATION; PRECURSORS; EXPRESSION	We previously reported the differentiation of mouse embryonic stem (ES) cells into retinal progenitors. However, these progenitors rarely differentiate into photoreceptors unless they are cultured with embryonic retinal tissues. Here we show the in vitro generation of putative rod and cone photoreceptors from mouse, monkey and human ES cells by stepwise treatments under defined culture conditions, in the absence of retinal tissues. With mouse ES cells, Crx(+) photoreceptor precursors were induced from Rx(+) retinal progenitors by treatment with a Notch signal inhibitor. Further application of fibroblast growth factors, Shh, taurine and retinoic acid yielded a greater number of rhodopsin(+) rod photoreceptors, in addition to default cone production. With monkey and human ES cells, feeder- and serum-free suspension culture combined with Wnt and Nodal inhibitors induced differentiation of Rx(+) or Mitf(+) retinal progenitors, which produced retinal pigment epithelial cells. Subsequent treatment with retinoic acid and taurine induced photoreceptor differentiation. These findings may facilitate the development of human ES cell-based transplantation therapies for retinal diseases.	[Osakada, Fumitaka; Ikeda, Hanako; Mandai, Michiko; Takahashi, Masayo] Ctr Dev Biol, RIKEN, Lab Retinal Regenerat, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Mandai, Michiko; Takahashi, Masayo] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 6068507, Japan; [Ikeda, Hanako; Wataya, Takafumi; Watanabe, Kiichi; Sasai, Yoshiki] Ctr Dev Biol, RIKEN, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Osakada, Fumitaka; Akaike, Akiori] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto 6068501, Japan; [Ikeda, Hanako; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan; Shiga Med Ctr Adults, Moriyama 5248524, Japan	RIKEN; Kyoto University; RIKEN; Kyoto University; Kyoto University	Takahashi, M (corresponding author), Ctr Dev Biol, RIKEN, Lab Retinal Regenerat, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mretina@cdb.riken.jp	Mandai, Michiko/E-7986-2011; Watanabe, Kiichi/ABA-4854-2020	Osakada, Fumitaka/0000-0002-9078-1458; Ikeda, Hanako/0000-0001-9572-8659				ALTSHULER D, 1992, DEVELOPMENT, V114, P947; Aramant RB, 1999, INVEST OPHTH VIS SCI, V40, P1557; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bora N, 1998, DEV DYNAM, V213, P283, DOI 10.1002/(SICI)1097-0177(199811)213:3<283::AID-AJA5>3.0.CO;2-H; BOULTON M, 1998, RETINAL PIGMENT EPIT, P68; BURKE JM, 1998, RETINAL PIGMENT EPIT, P86; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Haruta M, 2001, NAT NEUROSCI, V4, P1163, DOI 10.1038/nn762; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hyatt GA, 1997, INVEST OPHTH VIS SCI, V38, P1471; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Kaplan HJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P1168, DOI 10.1001/archopht.1997.01100160338012; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McGinnis JF, 1999, J NEUROSCI RES, V55, P252, DOI 10.1002/(SICI)1097-4547(19990115)55:2<252::AID-JNR13>3.0.CO;2-N; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Radke ND, 2004, ARCH OPHTHALMOL-CHIC, V122, P1159, DOI 10.1001/archopht.122.8.1159; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035; Suzuki T, 2007, CELL TRANSPLANT, V16, P493, DOI 10.3727/000000007783464966; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Young TL, 2004, NEURON, V41, P867, DOI 10.1016/S0896-6273(04)00141-2; Zhao X, 2002, BIOCHEM BIOPH RES CO, V297, P177, DOI 10.1016/S0006-291X(02)02126-5	48	445	500	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					215	224		10.1038/nbt1384	http://dx.doi.org/10.1038/nbt1384			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18246062				2022-12-25	WOS:000253193000025
J	Torres, J; Watt, FM				Torres, Josema; Watt, Fiona M.			Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NF kappa B and cooperating with Stat3	NATURE CELL BIOLOGY			English	Article							IN-VITRO; TRANSCRIPTION; MAINTENANCE; EPIBLAST; GENE; DIFFERENTIATION; HOMEOPROTEIN; NETWORK; OCT4	Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of blastocysts. Self-renewal of mouse ES cells depends on activation of Stat3 by leukaemia inhibitory factor (LIF) in collaboration with bone morphogenetic protein signalling(1-3). The transcription factor Nanog is essential in maintaining pluripotency(4,5) but the mechanisms involved are poorly understood. Here we examine the functional interactions of Nanog with the Stat3 and NF kappa B pathways. Nanog and Stat3 were found to bind to and synergistically activate Stat3-dependent promoters. We also found that Nanog binds to NF kappa B proteins; however, Nanog binding inhibited transcriptional activity of NF kappa B proteins. Endogenous NF kappa B activity and target-gene expression increased during differentiation of ES cells. Overexpression of NF kappa B proteins promoted differentiation, whereas inhibition of NF kappa B signalling, either by genetic ablation of the Ikbkg gene or overexpression of the I kappa B alpha super-repressor, increased expression of pluripotency markers. We conclude that Nanog represses the pro-differentiation activities of NF kappa B and cooperates with Stat3 to maintain pluripotency.	[Torres, Josema; Watt, Fiona M.] Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Watt, Fiona M.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Watt, FM (corresponding author), Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	Fiona.Watt@cancer.org.uk	Torres, Josema/F-7070-2013; Watt, Fiona/AHB-0226-2022	Torres, Josema/0000-0001-6906-7164; Watt, Fiona/0000-0001-9151-5154	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; EMRE N, CURR OPIN CHEM BIOL, V11, P252; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rasband W.S., 2006, IMAGEJ; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	34	110	120	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					194	U68		10.1038/ncb1680	http://dx.doi.org/10.1038/ncb1680			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18223644				2022-12-25	WOS:000252897800015
J	Delneri, D; Hoyle, DC; Gkargkas, K; Cross, EJM; Rash, B; Zeef, L; Leong, HS; Davey, HM; Hayes, A; Kell, DB; Griffith, GW; Oliver, SG				Delneri, Daniela; Hoyle, David C.; Gkargkas, Konstantinos; Cross, Emma J. M.; Rash, Bharat; Zeef, Leo; Leong, Hui-Sun; Davey, Hazel M.; Hayes, Andrew; Kell, Douglas B.; Griffith, Gareth W.; Oliver, Stephen G.			Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; HAPLOINSUFFICIENCY; ONTOLOGY; DELETION; STRAINS	Using competition experiments in continuous cultures grown in different nutrient environments (glucose limited, ammonium limited, phosphate limited and white grape juice), we identified genes that show haploinsufficiency phenotypes (reduced growth rate when hemizygous) or haploproficiency phenotypes (increased growth rate when hemizygous). Haploproficient genes (815, 1,194, 733 and 654 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) frequently show that phenotype in a specific environmental context. For instance, genes encoding components of the ubiquitination pathway or the proteasome show haploproficiency in nitrogen-limited conditions where protein conservation may be beneficial. Haploinsufficiency is more likely to be observed in all environments, as is the case with genes determining polar growth of the cell. Haploproficient genes seem randomly distributed in the genome, whereas haploinsufficient genes (685, 765, 1,277 and 217 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) are over-represented on chromosome III. This chromosome determines a yeast's mating type, and the concentration of haploinsufficient genes there may be a mechanism to prevent its loss.	Univ Manchester, Sch Med, NIBHI, Manchester M13 9PT, Lancs, England; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; Aberystwyth University; University of Manchester; University of Manchester; University of Manchester	Oliver, SG (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg,Tennis Court Rd, Cambridge, England.	steve.oliver@bioc.cam.ac.uk	Griffith, Gareth W./A-1970-2009; Kell, Douglas/E-8318-2011; Davey, Hazel/C-9055-2009; Oliver, Stephen/AAQ-5992-2021; Zeef, Leo/D-6922-2011	Griffith, Gareth W./0000-0001-6914-3745; Kell, Douglas/0000-0001-5838-7963; Oliver, Stephen/0000-0003-3410-6439; Delneri, Daniela/0000-0001-8070-411X; Hayes, Andy/0000-0002-9525-0306; Davey, Hazel/0000-0001-9185-0761; Hoyle, David/0000-0003-3483-5885	Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C505140/1, BB/C505140/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; OLIVER SG, 1991, BIOTECHNOLOGY HDB SA, P213; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Sherman F., 1981, METHODS YEAST GENETI; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	21	79	79	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					113	117		10.1038/ng.2007.49	http://dx.doi.org/10.1038/ng.2007.49			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157128				2022-12-25	WOS:000252118600027
J	Shankar, GM; Li, SM; Mehta, TH; Garcia-Munoz, A; Shepardson, NE; Smith, I; Brett, FM; Farrell, MA; Rowan, MJ; Lemere, CA; Regan, CM; Walsh, DM; Sabatini, BL; Selkoe, DJ				Shankar, Ganesh M.; Li, Shaomin; Mehta, Tapan H.; Garcia-Munoz, Amaya; Shepardson, Nina E.; Smith, Imelda; Brett, Francesca M.; Farrell, Michael A.; Rowan, Michael J.; Lemere, Cynthia A.; Regan, Ciaran M.; Walsh, Dominic M.; Sabatini, Bernardo L.; Selkoe, Dennis J.			Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; A-BETA; NATURAL OLIGOMERS; TRANSGENIC MICE; AREA CA1; DISEASE; DEPRESSION; HIPPOCAMPUS; EXPRESSION; A-BETA(1-42)	Alzheimer's disease constitutes a rising threat to public health. Despite extensive research in cellular and animal models, identifying the pathogenic agent present in the human brain and showing that it confers key features of Alzheimer's disease has not been achieved. We extracted soluble amyloid-beta protein (Ab) oligomers directly from the cerebral cortex of subjects with Alzheimer's disease. The oligomers potently inhibited long-term potentiation (LTP), enhanced long-term depression (LTD) and reduced dendritic spine density in normal rodent hippocampus. Soluble Ab from Alzheimer's disease brain also disrupted the memory of a learned behavior in normal rats. These various effects were specifically attributable to Ab dimers. Mechanistically, metabotropic glutamate receptors were required for the LTD enhancement, and N-methyl D-aspartate receptors were required for the spine loss. Co-administering antibodies to the Ab N-terminus prevented the LTP and LTD deficits, whereas antibodies to the midregion or C-terminus were less effective. Insoluble amyloid plaque cores from Alzheimer's disease cortex did not impair LTP unless they were first solubilized to release Ab dimers, suggesting that plaque cores are largely inactive but sequester Ab dimers that are synaptotoxic. We conclude that soluble Ab oligomers extracted from Alzheimer's disease brains potently impair synapse structure and function and that dimers are the smallest synaptotoxic species.	[Shankar, Ganesh M.; Li, Shaomin; Mehta, Tapan H.; Shepardson, Nina E.; Lemere, Cynthia A.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Shankar, Ganesh M.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Garcia-Munoz, Amaya; Regan, Ciaran M.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Smith, Imelda; Walsh, Dominic M.] Univ Coll Dublin, Lab Neurodegenerat Res, Dublin 4, Ireland; [Brett, Francesca M.; Farrell, Michael A.] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland; [Brett, Francesca M.; Farrell, Michael A.] Royal Coll Surgeons Ireland, Dublin 9, Ireland; [Rowan, Michael J.] Trinity Coll Dublin, Dept Pharmacol, Dublin 2, Ireland; [Regan, Ciaran M.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University College Dublin; University College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin	Selkoe, DJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Sancheti, Harsh/H-3538-2012	Brett, Francesca/0000-0002-7453-4027; Rowan, Michael Joseph/0000-0002-3867-9536	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027443] Funding Source: NIH RePORTER; NIA NIH HHS [AG R01 027443, R01 AG027443-03, R01 AG027443-04, R01 AG027443-01, R01 AG027443, R01 AG027443-02] Funding Source: Medline; NINDS NIH HHS [R01 NS046579, R01 NS046579-06A1] Funding Source: Medline; Wellcome Trust [067660] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; FOX GB, 1995, J NEUROCHEM, V65, P2796; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s	30	2761	2860	9	706	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2008	14	8					837	842		10.1038/nm1782	http://dx.doi.org/10.1038/nm1782			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18568035	Green Accepted			2022-12-25	WOS:000258237500030
J	Sen, N; Hara, MR; Kornberg, MD; Cascio, MB; Bae, BI; Shahani, N; Thomas, B; Dawson, TM; Dawson, VL; Snyder, SH; Sawa, A				Sen, Nilkantha; Hara, Makoto R.; Kornberg, Michael D.; Cascio, Matthew B.; Bae, Byoung-Il; Shahani, Neelam; Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira			Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis	NATURE CELL BIOLOGY			English	Article							NERVE GROWTH-FACTOR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; COACTIVATORS P300; CELL-DEATH; P53; CBP; TRANSCRIPTION; PROTEIN; INVOLVEMENT; CBP/P300	Besides its role in glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) initiates a cell death cascade(1-9). Diverse apoptotic stimuli activate inducible nitric oxide synthase ( iNOS) or neuronal NOS ( nNOS), with the generated nitric oxide ( NO) S-nitrosylating GAPDH, abolishing its catalytic activity and conferring on it the ability to bind to Siah1, an E3-ubiquitin-ligase with a nuclear localization signal (NLS). The GAPDH-Siah1 protein complex, in turn, translocates to the nucleus and mediates cell death; these processes are blocked by procedures that interfere with GAPDH-Siah1 binding. Nuclear events induced by GAPDH to kill cells have been obscure. Here we show that nuclear GAPDH is acetylated at Lys 160 by the acetyltransferase p300/CREB binding protein (CBP) through direct protein interaction, which in turn stimulates the acetylation and catalytic activity of p300/CBP. Consequently, downstream targets of p300/CBP, such as p53 (refs 10-15), are activated and cause cell death. A dominant-negative mutant GAPDH with the substitution of Lys 160 to Arg (GAPDH-K160R) prevents activation of p300/CBP, blocks induction of apoptotic genes and decreases cell death. Our findings reveal a pathway in which NO-induced nuclear GAPDH mediates cell death through p300/CBP.	[Sen, Nilkantha; Hara, Makoto R.; Kornberg, Michael D.; Cascio, Matthew B.; Bae, Byoung-Il; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Shahani, Neelam; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Hara, Makoto R.; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu; asawa1@jhmi.edu	Kornberg, Michael Davin/K-3329-2019; Dawson, Valina/Y-9757-2019; Sen, Nilkantha/AAW-9788-2020	Kornberg, Michael Davin/0000-0003-2588-7325; Dawson, Valina/0000-0002-2915-3970; BAE, BYOUNG-IL/0000-0002-9958-678X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS048206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, Z01DA000226, P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [K05 DA000074-29, K05 DA000074, P50 DA000266-37, DA-00074, DA-00266, P50 DA000266, DA-00226] Funding Source: Medline; NIMH NIH HHS [R01 MH069853, MH-069853] Funding Source: Medline; NINDS NIH HHS [NS-38377, P50 NS038377, R01 NS048206, NS-48206] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen RW, 1999, J NEUROSCI, V19, P9654; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dhakshinamoorthy S, 2007, NUCLEIC ACIDS RES, V35, P5439, DOI 10.1093/nar/gkm594; Frade JM, 1996, NATURE, V383, P166; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ishitani R, 1996, J NEUROCHEM, V66, P928; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Kung AL, 2000, GENE DEV, V14, P272; Li CQ, 2004, CANCER RES, V64, P3022, DOI 10.1158/0008-5472.CAN-03-1880; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648	38	301	317	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					866	873		10.1038/ncb1747	http://dx.doi.org/10.1038/ncb1747			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552833	Green Accepted			2022-12-25	WOS:000257268400016
J	Weerapana, E; Simon, GM; Cravatt, BF				Weerapana, Eranthie; Simon, Gabriel M.; Cravatt, Benjamin F.			Disparate proteome reactivity profiles of carbon electrophiles	NATURE CHEMICAL BIOLOGY			English	Article							COMPLEX PROTEOMES; FAMILIES; PROBES	Insights into the proteome reactivity of electrophiles are crucial for designing activity-based probes for enzymes lacking cognate affinity labels. Here, we show that different classes of carbon electrophiles exhibit markedly distinct amino acid labeling profiles in proteomes, ranging from selective reactivity with cysteine to adducts with several amino acids. These data specify electrophilic chemotypes with restricted and permissive reactivity profiles to guide the design of next-generation functional proteomics probes.	[Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem Phys, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu			NCI NIH HHS [R01 CA087660-08, R37 CA087660, CA087660, R01 CA087660] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam GC, 2004, J AM CHEM SOC, V126, P1363, DOI 10.1021/ja038441g; Chen G, 2003, J AM CHEM SOC, V125, P8130, DOI 10.1021/ja034287m; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shin NY, 2007, CHEM RES TOXICOL, V20, P859, DOI 10.1021/tx700031r; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012	15	186	192	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2008	4	7					405	407		10.1038/nchembio.91	http://dx.doi.org/10.1038/nchembio.91			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316DU	18488014	Green Accepted			2022-12-25	WOS:000256929900009
J	Buettner, C; Muse, ED; Cheng, A; Chen, L; Scherer, T; Pocai, A; Su, K; Cheng, B; Li, X; Harvey-White, J; Schwartz, GJ; Kunos, G; Rossetti, L				Buettner, Christoph; Muse, Evan D.; Cheng, Andrew; Chen, Linghong; Scherer, Thomas; Pocai, Alessandro; Su, Kai; Cheng, Bob; Li, Xiasong; Harvey-White, Judith; Schwartz, Gary J.; Kunos, George; Rossetti, Luciano			Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms	NATURE MEDICINE			English	Article							HORMONE-SENSITIVE LIPASE; ENERGY-BALANCE; PPAR-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL ACTIVATION; SYMPATHETIC DENERVATION; ENDOCANNABINOID SYSTEM; SKELETAL-MUSCLE; PROTEIN-KINASE; RISK-FACTORS	Leptin (encoded by Lep) controls body weight by regulating food intake and fuel partitioning. Obesity is characterized by leptin resistance and increased endocannabinoid tone. Here we show that leptin infused into the mediobasal hypothalamus (MBH) of rats inhibits white adipose tissue (WAT) lipogenesis, which occurs independently of signal transducer and activator of transcription-3 (STAT3) signaling. Correspondingly, transgenic inactivation of STAT3 signaling by mutation of the leptin receptor (s/s mice) leads to reduced adipose mass compared to db/db mice (complete abrogation of leptin receptor signaling). Conversely, the ability of hypothalamic leptin to suppress WAT lipogenesis in rats is lost when hypothalamic phosphoinositide 3-kinase signaling is prevented or when sympathetic denervation of adipose tissue is performed. MBH leptin suppresses the endocannabinoid anandamide in WAT, and, when this suppression of endocannabinoid tone is prevented by systemic CB1 receptor activation, MBH leptin fails to suppress WAT lipogenesis. These data suggest that the increased endocannabinoid tone observed in obesity is linked to a failure of central leptin signaling to restrain peripheral endocannabinoids.	[Buettner, Christoph; Chen, Linghong; Scherer, Thomas; Su, Kai; Cheng, Bob] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Muse, Evan D.; Cheng, Andrew; Rossetti, Luciano] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Cheng, Andrew; Pocai, Alessandro; Li, Xiasong; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Muse, Evan D.; Pocai, Alessandro; Li, Xiasong; Rossetti, Luciano] Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA; [Harvey-White, Judith; Kunos, George] US Natl Inst Hlth, US Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Buettner, C (corresponding author), Mt Sinai Sch Med, Dept Med, 1 Gustave L Levy Pl,Box 1005, New York, NY 10029 USA.	christoph.buettner@mssm.edu	Buettner, Christoph/F-5793-2013; su, kai/F-2072-2011	Buettner, Christoph/0000-0003-0412-4062; Scherer, Thomas/0000-0003-4980-706X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048321, R01DK048321, R01DK083658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000351, Z01AA000350] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AA000351-07] Funding Source: Medline; NIDDK NIH HHS [R01 DK083658, DK066618, R01 DK066618, P30 DK026687, K08 DK074873, R01 DK048321, DK048321, DK026687, DK074873, R37 DK048321] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; COUSIN B, 1993, ENDOCRINOLOGY, V133, P2255, DOI 10.1210/en.133.5.2255; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Giordano A, 2006, AM J PHYSIOL-REG I, V291, pR1243, DOI 10.1152/ajpregu.00679.2005; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kreier F, 2007, AM J PHYSIOL-REG I, V293, pR548, DOI 10.1152/ajpregu.00890.2006; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Muzumdar R, 2003, FASEB J, V17, P1130, DOI 10.1096/fj.02-0991fje; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rooks CR, 2005, AM J PHYSIOL-REG I, V289, pR92, DOI 10.1152/ajpregu.00858.2004; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Saha AK, 1997, AM J PHYSIOL-ENDOC M, V272, pE641, DOI 10.1152/ajpendo.1997.272.4.E641; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; Wang ZW, 1999, BIOCHEM BIOPH RES CO, V260, P653, DOI 10.1006/bbrc.1999.0918; Woods SC, 2007, AM J MED, V120, pS9, DOI 10.1016/j.amjmed.2006.11.013; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zvonic S, 2005, J BIOL CHEM, V280, P33856, DOI 10.1074/jbc.M508020200	50	253	261	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2008	14	6					667	675		10.1038/nm1775	http://dx.doi.org/10.1038/nm1775			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18516053	Green Accepted			2022-12-25	WOS:000256468700033
J	Chiarle, R; Martinengo, C; Mastini, C; Ambrogio, C; D'Escamard, V; Forni, G; Inghirami, G				Chiarle, Roberto; Martinengo, Cinzia; Mastini, Cristina; Ambrogio, Chiara; D'Escamard, Valentina; Forni, Guido; Inghirami, Giorgio			The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination	NATURE MEDICINE			English	Article							LARGE-CELL LYMPHOMA; TYROSINE KINASE; TUMOR-ANTIGEN; ALK PROTEIN; CANCER; VACCINES; IDENTIFICATION; IMMUNOTHERAPY; EXPRESSION; STRATEGIES	An ideal vaccination strategy against tumors relies on specific antigens that are required for tumor maintenance(1). For lymphoma, vaccination with subject-specific immunoglobulin idiotypes has had the most promising results(2,3). Here we show that DNA vaccination with plasmids encoding portions of the cytoplasmic domain of anaplastic lymphoma kinase (ALK), which has been translocated in different fusion proteins necessary for the growth of anaplastic large cell lymphoma (ALCL)(4), protects mice from local and systemic lymphoma growth. The protection is potent and long lasting and elicits ALK-specific interferon-c responses and CD8(+) T cell-mediated cytotoxicity. A combination of chemotherapy and vaccination significantly enhanced the survival of mice challenged with ALK(+) lymphomas. These findings indicate that ALK represents an ideal tumor antigen for vaccination-based therapies of ALCL and possibly other ALK(+) human tumors(4-7).	[Chiarle, Roberto; Martinengo, Cinzia; Mastini, Cristina; Ambrogio, Chiara; Inghirami, Giorgio] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy; [Chiarle, Roberto; Ambrogio, Chiara; Inghirami, Giorgio] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Mastini, Cristina; Forni, Guido] Univ Turin, Dept Clin & Biol Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy; [D'Escamard, Valentina; Inghirami, Giorgio] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [D'Escamard, Valentina; Inghirami, Giorgio] NYU, Sch Med, New York Canc Ctr, New York, NY 10016 USA	University of Turin; University of Turin; University of Turin; New York University; New York University	Chiarle, R (corresponding author), Univ Turin, Ctr Expt Res & Med Studies, Via Santena 7, I-10126 Turin, Italy.	roberto.chiarle@unito.it; giorgio.inghirami@unito.it		Ambrogio, Chiara/0000-0003-4122-701X; CHIARLE, Roberto/0000-0003-1564-8531	NCI NIH HHS [R01-CA90773] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090773] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ait-Tahar K, 2007, CANCER RES, V67, P1898, DOI 10.1158/0008-5472.CAN-06-4427; Ait-Taharl K, 2006, INT J CANCER, V118, P688, DOI 10.1002/ijc.21410; Biragyn A, 2000, NAT MED, V6, P966, DOI 10.1038/79649; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Dar Mohammed M, 2003, Curr Oncol Rep, V5, P380, DOI 10.1007/s11912-003-0022-x; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Egloff AM, 2006, CANCER RES, V66, P6, DOI 10.1158/0008-5472.CAN-05-3389; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Jaffe Elaine S, 2004, Am J Clin Pathol, V122 Suppl, pS110; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Passoni L, 2003, LEUKEMIA LYMPHOMA, V44, P1675, DOI 10.1080/1042819031000099625; Passoni L, 2002, BLOOD, V99, P2100, DOI 10.1182/blood.V99.6.2100; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V358, P399, DOI 10.1016/j.bbrc.2007.04.137; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Pulford K, 2000, BLOOD, V96, P1605, DOI 10.1182/blood.V96.4.1605.h8001605_1605_1607; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Radford KJ, 2005, PATHOLOGY, V37, P534, DOI 10.1080/00313020500376462; Rizvi MA, 2006, BLOOD, V107, P1255, DOI 10.1182/blood-2005-03-1306; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Scheich F, 2007, BLOOD, V110, P2556, DOI 10.1182/blood-2007-01-071001; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Williams DM, 2002, BRIT J HAEMATOL, V117, P812, DOI 10.1046/j.1365-2141.2002.03482.x; Yu M, 2006, CANCER IMMUNOL IMMUN, V55, P119, DOI 10.1007/s00262-005-0008-7	30	87	91	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2008	14	6					676	680		10.1038/nm1769	http://dx.doi.org/10.1038/nm1769			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	309NY	18469826				2022-12-25	WOS:000256468700034
J	Blewitt, ME; Gendrel, AV; Pang, ZY; Sparrow, DB; Whitelaw, N; Craig, JM; Apedaile, A; Hilton, DJ; Dunwoodie, SL; Brockdorff, N; Kay, GF; Whitelaw, E				Blewitt, Marnie E.; Gendrel, Anne-Valerie; Pang, Zhenyi; Sparrow, Duncan B.; Whitelaw, Nadia; Craig, Jeffrey M.; Apedaile, Anwyn; Hilton, Douglas J.; Dunwoodie, Sally L.; Brockdorff, Neil; Kay, Graham F.; Whitelaw, Emma			SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation	NATURE GENETICS			English	Article							TROPHOBLAST GIANT-CELLS; DOSAGE COMPENSATION; CONDENSIN SUBUNIT; MOUSE; GENE; METHYLATION; DNA; PROTEIN; DEFICIENT; COMPLEX	X-chromosome inactivation is the mammalian dosage compensation mechanism by which transcription of X-linked genes is equalized between females and males. In an N-ethyl-N-nitrosourea (ENU) mutagenesis screen on mice for modifiers of epigenetic reprogramming, we identified the MommeD1 (modifier of murine metastable epialleles) mutation as a semidominant suppressor of variegation. MommeD1 shows homozygous female-specific mid-gestation lethality and hypomethylation of the X-linked gene Hprt1, suggestive of a defect in X inactivation(1). Here we report that the causative point mutation lies in a previously uncharacterized gene, Smchd1 (structural maintenance of chromosomes hinge domain containing 1). We find that SmcHD1 is not required for correct Xist expression, but localizes to the inactive X and has a role in the maintenance of X inactivation and the hypermethylation of CpG islands associated with the inactive X. This finding links a group of proteins normally associated with structural aspects of chromosome biology with epigenetic gene silencing.	[Pang, Zhenyi; Whitelaw, Nadia; Kay, Graham F.; Whitelaw, Emma] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Blewitt, Marnie E.; Hilton, Douglas J.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; [Blewitt, Marnie E.; Hilton, Douglas J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Gendrel, Anne-Valerie; Apedaile, Anwyn; Brockdorff, Neil] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London SW7 2AZ, England; [Gendrel, Anne-Valerie; Apedaile, Anwyn; Brockdorff, Neil] Univ London Imperial Coll Sci Technol & Med, MRC, Fac Med, London SW7 2AZ, England; [Sparrow, Duncan B.] Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Whitelaw, Nadia] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Craig, Jeffrey M.] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	QIMR Berghofer Medical Research Institute; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London; Imperial College London; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of Queensland; Murdoch Children's Research Institute	Whitelaw, E (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	emma.whitelaw@qimr.edu.au	Blewitt, Marnie/B-1796-2012; Sparrow, Duncan/B-3994-2008; Kay, Graham F/A-4130-2011; Dunwoodie, Sally L/M-4019-2018; Gendrel, Anne-Valerie/E-5584-2017; Hilton, Douglas J/C-7250-2013; Craig, Jeffrey M/B-3484-2012	Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Gendrel, Anne-Valerie/0000-0003-4510-0024; Hilton, Douglas J/0000-0002-7698-2392; Craig, Jeffrey M/0000-0003-3979-7849; Blewitt, Marnie/0000-0002-2984-1474; Brockdorff, Neil/0000-0003-4838-2653	MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: Medline; Wellcome Trust [081385] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hakimi MA, 2002, J BIOL CHEM, V277, P36909, DOI 10.1074/jbc.C200434200; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; KANNO T, 2008, NAT GENET; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; VARMUZA S, 1988, DEVELOPMENT, V102, P127; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574	28	1415	1433	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					663	669		10.1038/ng.142	http://dx.doi.org/10.1038/ng.142			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425126				2022-12-25	WOS:000255366700037
J	Gestaut, DR; Graczyk, B; Cooper, J; Widlund, PO; Zelter, A; Wordeman, L; Asbury, CL; Davis, TN				Gestaut, Daniel R.; Graczyk, Beth; Cooper, Jeremy; Widlund, Per O.; Zelter, Alex; Wordeman, Linda; Asbury, Charles L.; Davis, Trisha N.			Phosphoregulation and depolymerization-driven movement of the Dam1 complex do not require ring formation	NATURE CELL BIOLOGY			English	Article							KINETOCHORE-MICROTUBULE INTERFACE; MITOTIC SPINDLE INTEGRITY; YEAST DASH COMPLEX; PROTEIN INTERACTIONS; DUO1P/DAM1P COMPLEX; KINASE; FORCE; MECHANISMS; ATTACHMENT; SUBUNITS	During mitosis, kinetochores form persistent attachments to microtubule tips and undergo corrective detachment in response to phosphorylation by Ipl1 ( Aurora B) kinase(1). the Dam1 complex is required to establish and maintain bi-oriented attachment to microtubule tips in vivo, and it contains multiple sites phosphorylated by Ipl1 ( refs 2-10). Moreover, a number of kinetochore-like functions can be reconstituted in vitro with pure Dam1 complex(11-14). these functions are believed to derive from the ability of the complex to self-assemble into rings(12,13,15-17). Here we show that rings are not necessary for dynamic microtubule attachment, Ipl1-dependent modulation of microtubule affinity or the ability of Dam1 to move processively with disassembling microtubule tips. Using two fluorescence-based assays, we found that the complex exhibited a high affinity for microtubules ( K-d of approximately 6 nM) that was reduced by phosphorylation at ser 20, a single Ipl1 target residue in Dam1. Moreover, individual complexes underwent one-dimensional diffusion along microtubules and detached 2.5-fold more frequently after phosphorylation by Ipl1. Particles consisting of one to four Dam1 complexes - too few to surround a microtubule - were captured and carried by disassembling tips. thus, even a small number of binding elements could provide a dynamic, phosphoregulated microtubule attachment and thereby facilitate accurate chromosome segregation.	[Gestaut, Daniel R.; Graczyk, Beth; Widlund, Per O.; Zelter, Alex; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Cooper, Jeremy; Wordeman, Linda; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Davis, TN (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	tdavis@u.washington.edu	Davis, Trisha/F-8584-2010; Widlund, Per/J-1238-2019	Widlund, Per/0000-0002-3645-0009; Wordeman, Linda/0000-0002-9444-0650; Davis, Trisha/0000-0003-4797-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, R01GM040506, R01GM069429] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM79373, R01 GM079373, R01 GM040506, R01GM69429, R01 GM069429, R01 GM040506-19, R01GM40506] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cantor C. R., 1980, BIOPHYSICAL CHEM, VI; CANTOR CR, 1980, BIOPHYSICAL CHEM, V3; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franco A, 2007, J CELL SCI, V120, P3345, DOI 10.1242/jcs.013698; Gunawardane RN, 2001, METHOD CELL BIOL, V67, P1; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Jones MH, 2001, P NATL ACAD SCI USA, V98, P13675, DOI 10.1073/pnas.241417098; Karp G., 2007, CELL MOL BIOL; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McIntosh JR, 2005, NAT STRUCT MOL BIOL, V12, P210, DOI 10.1038/nsmb0305-210; Miranda JJL, 2007, MOL BIOL CELL, V18, P2503, DOI 10.1091/mbc.E07-02-0135; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Press W.H., 1996, NUMERICAL RECIPES FO, Vsecond; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Wang HW, 2007, NAT STRUCT MOL BIOL, V14, P721, DOI 10.1038/nsmb1274; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	41	119	122	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					407	U70		10.1038/ncb1702	http://dx.doi.org/10.1038/ncb1702			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364702	Green Accepted			2022-12-25	WOS:000254561700010
J	Kornak, U; Reynders, E; Dimopoulou, A; van Reeuwijk, J; Fischer, B; Rajab, A; Budde, B; Nurnberg, P; Foulquier, F; Lefeber, D; Urban, Z; Gruenewald, S; Annaert, W; Brunner, HG; van Bokhoven, H; Wevers, R; Morava, E; Matthijs, G; Van Maldergem, L; Mundlos, S				Kornak, Uwe; Reynders, Ellen; Dimopoulou, Aikaterini; van Reeuwijk, Jeroen; Fischer, Bjoern; Rajab, Anna; Budde, Birgit; Nurnberg, Peter; Foulquier, Francois; Lefeber, Dirk; Urban, Zsolt; Gruenewald, Stephanie; Annaert, Wim; Brunner, Han G.; van Bokhoven, Hans; Wevers, Ron; Morava, Eva; Matthijs, Gert; Van Maldergem, Lionel; Mundlos, Stefan		ARCL Debre-type Study Grp	Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2	NATURE GENETICS			English	Article							CONGENITAL DISORDER; DEFICIENCY REVEALS; COMPLEX-FORMATION; V-ATPASE; DEFECTS; PATHWAY; PH	We identified loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, in several families with autosomal recessive cutis laxa type II or wrinkly skin syndrome. The mutations result in abnormal glycosylation of serum proteins (CDG-II) and cause an impairment of Golgi trafficking in fibroblasts from affected individuals. These results indicate that the a2 subunit of the proton pump has an important role in Golgi function.	[Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany; [Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Max Planck Inst Mol Genet, Berlin, Germany; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [van Reeuwijk, Jeroen; Brunner, Han G.; van Bokhoven, Hans] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-3525 GA Nijmegen, Netherlands; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Foulquier, Francois; Matthijs, Gert; Mundlos, Stefan] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Lefeber, Dirk; Wevers, Ron; Morava, Eva] Univ Med Ctr Nijmegen, Lab Peiat & Neurol, Dept Pediat, NL-6525 GA Nijmegen, Netherlands; [Urban, Zsolt] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Gruenewald, Stephanie] Great Ormond St Hosp Children Trust NHS, London WC1N 3JH, England; [Van Maldergem, Lionel] Univ Liege, CHU Sart Tilman, Ctr Genet Humaine, B-4000 Liege, Belgium	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; University of Cologne; University of Cologne; KU Leuven; Radboud University Nijmegen; Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Liege	Kornak, U (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany.	uwe.kornak@charite.de	Mundlos, Stefan/ABH-9585-2020; FOULQUIER, FRANCOIS/AAI-1182-2021; lefeber, dirk/G-5063-2012; van Bokhoven, Hans/D-8764-2012; Lefeber, Dirk DJ/A-2146-2014; Wevers, Ron A./H-8116-2014; Urban, Zsolt/A-2018-2013; Van Maldergem, Lionel/O-3242-2019; Van Maldergem, Lionel/G-9849-2017; Urban, Zsolt/B-1977-2008; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; Morava, E./L-4529-2015; Fischer-Zirnsak, Björn/D-7487-2013; foulquier, francois/ABE-5886-2020; van Reeuwijk, Jeroen/P-8665-2015; Nanda, Arti/H-8565-2019; Salih, Mustafa/C-1222-2014	Wevers, Ron A./0000-0003-2278-9746; Urban, Zsolt/0000-0003-3890-1843; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Fischer-Zirnsak, Björn/0000-0002-1075-7571; foulquier, francois/0000-0002-6551-3240; van Reeuwijk, Jeroen/0000-0002-0658-4399; Mundlos, Stefan/0000-0002-9788-3166; Leao Teles, Elisa/0000-0002-3011-0249; Budde, Birgit/0000-0001-9385-4168; Quelhas, Dulce/0000-0001-9989-9236; Salih, Mustafa/0000-0002-4379-2111; Nanda, Arti/0000-0002-1223-3181; Foulquier, Francois/0000-0001-5084-4015; Dobyns, William/0000-0002-7681-2844; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Matthijs, Gert/0000-0001-6710-1912				Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; MORAVA E, IN PRESS EUR J HUM G; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; RAJAB A, IN PRESS AM J MED GE; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	259	268	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					32	34		10.1038/ng.2007.45	http://dx.doi.org/10.1038/ng.2007.45			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157129				2022-12-25	WOS:000252118600015
J	Kaeser, SA; Herzig, MC; Coomaraswamy, J; Kilger, E; Selenica, ML; Winkler, DT; Staufenbiel, M; Levy, E; Grubb, A; Jucker, M				Kaeser, Stephan A.; Herzig, Martin C.; Coomaraswamy, Janaky; Kilger, Ellen; Selenica, Maj-Linda; Winkler, David T.; Staufenbiel, Matthias; Levy, Efrat; Grubb, Anders; Jucker, Mathias			Cystatin C modulates cerebral beta-amyloidosis	NATURE GENETICS			English	Article							ONSET ALZHEIMER-DISEASE; GENETIC ASSOCIATION; VARIANT; HEMORRHAGE	The CST3 Thr25 allele of CST3, which encodes cystatin C, leads to reduced cystatin C secretion and conveys susceptibility to Alzheimer's disease. Here we show that overexpression of human cystatin C in brains of APP-transgenic mice reduces cerebral amyloid-beta deposition and that cystatin C binds amyloid-beta and inhibits its fibril formation. Our results suggest that cystatin C concentrations modulate cerebral amyloidosis risk and provide an opportunity for genetic risk assessment and therapeutic interventions.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland; NYU, Sch Med, Dept Pharmacol & Psychiat, New York, NY 10016 USA; Nathan S Kline Inst, New York, NY 10962 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University; Skane University Hospital; University of Basel; Novartis; New York University; Nathan Kline Institute for Psychiatric Research	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	; Herzig, Martin/R-4601-2016	Grubb, Anders/0000-0002-0125-3662; Herzig, Martin/0000-0002-0500-353X				BALBIN M, 1992, BIOL CHEM H-S, V373, P471, DOI 10.1515/bchm3.1992.373.2.471; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Cathcart HM, 2005, NEUROLOGY, V64, P755, DOI 10.1212/01.WNL.0000151980.42337.44; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738	15	135	139	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1437	1439		10.1038/ng.2007.23	http://dx.doi.org/10.1038/ng.2007.23			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026102				2022-12-25	WOS:000251267400009
J	Khetchoumian, K; Teletin, M; Tisserand, J; Mark, M; Herquel, B; Ignat, M; Zucman-Rossi, J; Cammas, F; Lerouge, T; Thibault, C; Metzger, D; Chambon, P; Losson, R				Khetchoumian, Konstantin; Teletin, Marius; Tisserand, Johan; Mark, Manuel; Herquel, Benjamin; Ignat, Mihaela; Zucman-Rossi, Jessica; Cammas, Florence; Lerouge, Thierry; Thibault, Christelle; Metzger, Daniel; Chambon, Pierre; Losson, Regine			Loss of Trim24 (Tif1 alpha) gene function confers oncogenic activity to retinoic acid receptor alpha	NATURE GENETICS			English	Article							NUCLEAR RECEPTORS; HEPATOCELLULAR-CARCINOMA; RAR-ALPHA; LIVER; CHEMOPREVENTION; EXPRESSION; PROTEIN; FAMILY; MEMBER; TIF1	Hepatocellular carcinoma ( HCC) is a major cause of death worldwide. Here, we provide evidence that the ligand-dependent nuclear receptor co-regulator Trim24 ( also known as Tif1 alpha) functions in mice as a liver-specific tumor suppressor. In Trim24-null mice, hepatocytes fail to execute proper cell cycle withdrawal during the neonatal-to-adult transition and continue to cycle in adult livers, becoming prone to a continuum of cellular alterations that progress toward metastatic HCC. Using pharmacological approaches, we show that inhibition of retinoic acid signaling markedly reduces hepatocyte proliferation in Trim24(-/-) mice. We further show that deletion of a single retinoic acid receptor alpha ( Rara) allele in a Trim24-null background suppresses HCC development and restores wild-type expression of retinoic acid-responsive genes in the liver, thus demonstrating that in this genetic background Rara expresses an oncogenic activity correlating with a dysregulation of the retinoic acid signaling pathway. Our results not only provide genetic evidence that Trim24 and Rara co-regulate hepatocarcinogenesis in an antagonistic manner but also suggest that aberrant activation of Rara is deleterious to liver homeostasis.	Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, F-67070 Illkirch Graffenstaden, France; Inst Univ Hematol, INSERM, U674, Ctr Polymorphisme Human, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Losson, R (corresponding author), Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, BP 10142, F-67070 Illkirch Graffenstaden, France.	losson@igbmc.u-strasbg.fr	zucman-rossi, Jessica/B-5098-2009; Cammas, florence m/D-1823-2017; j, zucman-rossi/AAV-3594-2021; TELETIN, Marius/P-6460-2016; TELETIN, Marius/AAS-2241-2020	zucman-rossi, Jessica/0000-0002-5687-0334; Cammas, florence m/0000-0003-4117-8182; j, zucman-rossi/0000-0002-5687-0334; TELETIN, Marius/0000-0002-3286-8125; TELETIN, Marius/0000-0002-3286-8125; Metzger, Daniel/0000-0002-5555-046X; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Ignat, Mihaela/0000-0002-0250-3280				Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Chapellier B, 2002, GENESIS, V32, P87, DOI 10.1002/gene.10071; Di Bisceglie AM, 2005, J LAB CLIN MED, V145, P134, DOI 10.1016/j.lab.2005.01.003; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; FRITH CH, 1994, PATHOLOGY TUMORS LAB, V2, P223; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; LE DB, 1996, EMBO J, V15, P6701; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sano K, 2003, CLIN CANCER RES, V9, P3679; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	22	122	124	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1500	1506		10.1038/ng.2007.15	http://dx.doi.org/10.1038/ng.2007.15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026104				2022-12-25	WOS:000251267400019
J	Egan, CM; Sridhar, S; Wigler, M; Hall, IM				Egan, Chris M.; Sridhar, Srinath; Wigler, Michael; Hall, Ira M.			Recurrent DNA copy number variation in the laboratory mouse	NATURE GENETICS			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; PRIMATE SEGMENTAL DUPLICATIONS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; ARRAY CGH; POLYMORPHISM; DELETION; RATES; MECHANISMS; FREQUENCY	Different species, populations and individuals vary considerably in the copy number of discrete segments of their genomes. The manner and frequency with which these genetic differences arise over generational time is not well understood. Taking advantage of divergence among lineages sharing a recent common ancestry, we have conducted a genome-wide analysis of spontaneous copy number variation (CNV) in the laboratory mouse. We used high-resolution microarrays to identify 38 CNVs among 14 colonies of the C57BL/6 strain spanning similar to 967 generations of inbreeding, and we examined these loci in 12 additional strains. It is clear from our results that many CNVs arise through a highly nonrandom process: 18 of 38 were the product of recurrent mutation, and rates of change varied roughly four orders of magnitude across different loci. Recurrent CNVs are found throughout the genome, affect 43 genes and fluctuate in copy number over mere hundreds of generations, observations that raise questions about their contribution to natural variation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Cold Spring Harbor Laboratory; Carnegie Mellon University	Hall, IM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hall@cshl.edu		Wigler, Michael/0000-0003-4396-1971				Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Drake JW, 1998, GENETICS, V148, P1667; Haldane JBS, 1936, J GENET, V32, P375, DOI 10.1007/BF02982522; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollies CR, 2001, EUR J HUM GENET, V9, P143, DOI 10.1038/sj.ejhg.5200590; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kipling D, 1996, NAT GENET, V13, P78, DOI 10.1038/ng0596-78; Lakshmi B, 2006, P NATL ACAD SCI USA, V103, P11234, DOI 10.1073/pnas.0602984103; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333	30	114	119	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1384	1389		10.1038/ng.2007.19	http://dx.doi.org/10.1038/ng.2007.19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17965714				2022-12-25	WOS:000250575900023
J	Hiraoka, S; Furuichi, T; Nishimura, G; Shibata, S; Yanagishita, M; Rimoin, DL; Superti-Furga, A; Nikkels, PG; Ogawa, M; Katsuyama, K; Toyoda, H; Kinoshita-Toyoda, A; Ishida, N; Isono, K; Sanai, Y; Cohn, DH; Koseki, H; Ikegawa, S				Hiraoka, Shuichi; Furuichi, Tatsuya; Nishimura, Gen; Shibata, Shunichi; Yanagishita, Masaki; Rimoin, David L.; Superti-Furga, Andrea; Nikkels, Peter G.; Ogawa, Minako; Katsuyama, Kayoko; Toyoda, Hidenao; Kinoshita-Toyoda, Akiko; Ishida, Nobuhiro; Isono, Kyoichi; Sanai, Yutaka; Cohn, Daniel H.; Koseki, Haruhiko; Ikegawa, Shiro			Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human	NATURE MEDICINE			English	Article							SCHNECKENBECKEN DYSPLASIA; GENE; MUTATIONS; GLYCOSAMINOGLYCANS; CHONDRODYSPLASIAS; BIOSYNTHESIS; PROTEOGLYCAN; AGGRECAN; PROTEIN	Proteoglycans are a family of extracellular macromolecules comprised of glycosaminoglycan chains of a repeated disaccharide linked to a central core protein(1,2). Proteoglycans have critical roles in chondrogenesis and skeletal development. The glycosaminoglycan chains found in cartilage proteoglycans are primarily composed of chondroitin sulfate(3). The integrity of chondroitin sulfate chains is important to cartilage proteoglycan function; however, chondroitin sulfate metabolism in mammals remains poorly understood. The solute carrier-35 D1 (SLC35D1) gene (SLC35D1) encodes an endoplasmic reticulum nucleotide-sugar transporter (NST) that might transport substrates needed for chondroitin sulfate biosynthesis(4,5). Here we created Slc35d1-deficient mice that develop a lethal form of skeletal dysplasia with severe shortening of limbs and facial structures. Epiphyseal cartilage in homozygous mutant mice showed a decreased proliferating zone with round chondrocytes, scarce matrices and reduced proteoglycan aggregates. These mice had short, sparse chondroitin sulfate chains caused by a defect in chondroitin sulfate biosynthesis. We also identified that loss-of-function mutations in human SLC35D1 cause Schneckenbecken dysplasia, a severe skeletal dysplasia. Our findings highlight the crucial role of NSTs in proteoglycan function and cartilage metabolism, thus revealing a new paradigm for skeletal disease and glycobiology.	RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Tsurumi Ku, Kanagawa 2300045, Japan; RIKEN, Single Nucleotide Polymorphism Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Kiyose 2048567, Japan; Tokyo Med & Dent Univ, Dept Maxillofacial Biol, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Grad Sch, Div Biomatrix,Bunkyo Ku, Tokyo 1138549, Japan; Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90048 USA; Freiburg Univ Hosp, Ctr Paediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Med Ctr Utrecht, Dept Pathol, NL-3508 GA Utrecht, Netherlands; Chiba Univ, Fac Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Inst Med Sci, Dept Biochem Cell Res, Bunkyo Ku, Tokyo 1138613, Japan	RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Freiburg; Utrecht University; Utrecht University Medical Center; Chiba University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Koseki, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Tsurumi Ku, 1-7-22 Suehirocho, Kanagawa 2300045, Japan.	koseki@rcai.riken.jp; sikegawa@ims.u-tokyo.ac.jp	Shibata, Shunichi/AAQ-7252-2021; Ikegawa, Shiro/N-6895-2015; superti-furga, andrea/E-9162-2015; Koseki, Haruhiko/I-3825-2014	Ikegawa, Shiro/0000-0003-0316-2147; superti-furga, andrea/0000-0002-3543-7531; Koseki, Haruhiko/0000-0001-8424-5854; Isono, Kyoichi/0000-0002-4609-8985	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00425] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOROCHOWITZ Z, 1986, AM J MED GENET, V25, P47, DOI 10.1002/ajmg.1320250107; GIEDION A, 1991, SKELETAL RADIOL, V20, P534; Hastbacka J, 1996, AM J HUM GENET, V58, P255; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; JOYNER AL, 1992, GENE TARGETING; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; Kesselman MA, 2004, BOOK LIB IN, V67, P89; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Muraoka M, 2007, J BIOL CHEM, V282, P24615, DOI 10.1074/jbc.M611358200; Nikkels PG, 2001, PEDIATR RADIOL, V31, P27, DOI 10.1007/s002470000357; Ogihara Y, 2001, J BONE MINER METAB, V19, P4, DOI 10.1007/s007740170054; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; WALLIN J, 1994, DEVELOPMENT, V120, P1109	24	82	85	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1363	1367		10.1038/nm1655	http://dx.doi.org/10.1038/nm1655			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17952091				2022-12-25	WOS:000250736900030
J	Johnen, H; Lin, S; Kuffner, T; Brown, DA; Tsai, VWW; Bauskin, AR; Wu, L; Pankhurst, G; Jiang, LL; Junankar, S; Hunter, M; Fairlie, WD; Lee, NJ; Enriquez, RF; Baldock, PA; Corey, E; Apple, FS; Murakami, MM; Lin, EJ; Wang, C; During, MJ; Sainsbury, A; Herzog, H; Breit, SN				Johnen, Heiko; Lin, Shu; Kuffner, Tamara; Brown, David A.; Tsai, Vicky Wang-Wei; Bauskin, Asne R.; Wu, Liyun; Pankhurst, Greg; Jiang, Lele; Junankar, Simon; Hunter, Mark; Fairlie, W. Douglas; Lee, Nicola J.; Enriquez, Ronaldo F.; Baldock, Paul A.; Corey, Eva; Apple, Fred S.; Murakami, MaryAnn M.; Lin, En-Ju; Wang, Chuansong; During, Matthew J.; Sainsbury, Amanda; Herzog, Herbert; Breit, Samuel N.			Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1	NATURE MEDICINE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; CACHEXIA; CANCER; SERUM; PATHWAYS; BEHAVIOR; MEMBER; MEN	Anorexia and weight loss are part of the wasting syndrome of late-stage cancer, are a major cause of morbidity and mortality in cancer, and are thought to be cytokine mediated. Macrophage inhibitory cytokine-1 (MIC-1) is produced by many cancers. Examination of sera from individuals with advanced prostate cancer showed a direct relationship between MIC-1 abundance and cancer-associated weight loss. In mice with xenografted prostate tumors, elevated MIC-1 levels were also associated with marked weight, fat and lean tissue loss that was mediated by decreased food intake and was reversed by administration of antibody to MIC-1. Additionally, normal mice given systemic MIC-1 and transgenic mice overexpressing MIC-1 showed hypophagia and reduced body weight. MIC-1 mediates its effects by central mechanisms that implicate the hypothalamic transforming growth factor-beta receptor II, extracellular signal-regulated kinases 1 and 2, signal transducer and activator of transcription-3, neuropeptide Y and pro-opiomelanocortin. Thus, MIC-1 is a newly defined central regulator of appetite and a potential target for the treatment of both cancer anorexia and weight loss, as well as of obesity.	St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia; Univ New S Wales, Sydney, NSW 2010, Australia; Garvan Inst Med Res, Program Neurosci, Sydney, NSW 2010, Australia; Univ Washington, Dept Urol, Seattle, WA 98195 USA; Hennepin Cty Med Ctr, Clin Labs, Minneapolis, MN 55415 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55415 USA; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; University of Washington; University of Washington Seattle; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University	Breit, SN (corresponding author), St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia.	s.breit@cfi.unsw.edu.au	/A-4361-2010; During, Matthew/AAC-1388-2020; Fairlie, Walter/M-8401-2015; Salis, Amanda/A-3187-2011; Herzog, Herbert/B-8294-2008; /B-2038-2013; Junankar, Simon/O-2009-2019; Baldock, Paul/B-3840-2012; /E-2900-2010; Junankar, Simon/B-7677-2019	Fairlie, Walter/0000-0002-2498-1160; Salis, Amanda/0000-0001-9176-1574; /0000-0001-7766-6095; Junankar, Simon/0000-0002-3965-8278; Brown, David/0000-0003-1382-9419; lin, shu/0000-0002-4239-2028; Jiang, Lele/0000-0002-1326-5871				Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Buckhaults P, 2001, CANCER RES, V61, P6996; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Huhmann MB, 2005, LANCET ONCOL, V6, P334, DOI 10.1016/S1470-2045(05)70170-4; Kamel HK, 2002, DRUG AGING, V19, P865, DOI 10.2165/00002512-200219110-00004; Karl T, 2004, P NATL ACAD SCI USA, V101, P12742, DOI 10.1073/pnas.0404085101; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Kovesdy CP, 2007, J AM SOC NEPHROL, V18, P304, DOI 10.1681/ASN.2006060674; Lin EJD, 2006, ENDOCRINOLOGY, V147, P5094, DOI 10.1210/en.2006-0097; Marks DL, 2001, CANCER RES, V61, P1432; NAYLOR JL, 1995, HUM EXP TOXICOL, V14, P587, DOI 10.1177/096032719501400706; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pfitzenmaier J, 2003, CANCER, V97, P1211, DOI 10.1002/cncr.11178; Rall LC, 2004, RHEUMATOLOGY, V43, P1219, DOI 10.1093/rheumatology/keh321; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; Rubin H, 2003, P NATL ACAD SCI USA, V100, P5384, DOI 10.1073/pnas.0931260100; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100	25	374	422	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1333	1340		10.1038/nm1677	http://dx.doi.org/10.1038/nm1677			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17982462				2022-12-25	WOS:000250736900026
J	Li, XG; Magenheimer, BS; Xia, S; Johnson, T; Wallace, DP; Calvet, JP; Li, R				Li, Xiaogang; Magenheimer, Brenda S.; Xia, Sheng; Johnson, Teri; Wallace, Darren P.; Calvet, James P.; Li, Rong			A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease	NATURE MEDICINE			English	Article							MTOR PATHWAY; RECEPTORS; EXPRESSION; STABILIZATION; INHIBITOR; CYTOKINES; PROTEIN; TNF	Autosomal dominant polycystic kidney disease (ADPKD) is caused by heterozygous mutations in either PKD1 or PKD2, genes that encode polycystin-1 and polycystin-2, respectively(1). We show here that tumor necrosis factor-alpha (TNF-alpha), an inflammatory cytokine present in the cystic fluid of humans with ADPKD, disrupts the localization of polycystin-2 to the plasma membrane and primary cilia through a scaffold protein, FIP2, which is induced by TNF-alpha. Treatment of mouse embryonic kidney organ cultures with TNF-alpha resulted in formation of cysts, and this effect was exacerbated in the Pkd2(+/-) kidneys. TNF-alpha also stimulated cyst formation in vivo in Pkd2(+/)- mice. In contrast, treatment of Pkd2(+/-) mice with the TNF-alpha inhibitor etanercept prevented cyst formation. These data reveal a pathway connecting TNF-alpha signaling, polycystins and cystogenesis, the activation of which may reduce functional polycystin-2 below a critical threshold, precipitating the ADPKD cellular phenotype.	[Li, Xiaogang; Xia, Sheng; Johnson, Teri; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Magenheimer, Brenda S.; Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Wallace, Darren P.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org		Wallace, Darren/0000-0003-4616-7669	NIDDK NIH HHS [P50 DK057301, P50 DK05301-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; DEGROOTE D, 1993, EUR CYTOKINE NETW, V4, P359; Dell KM, 2001, KIDNEY INT, V60, P1240, DOI 10.1046/j.1523-1755.2001.00963.x; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; FISHER RA, 1922, P J ROY STAT SOC, V85, P87; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; MARTINEZ JR, 1995, DM-DIS MON, V41, P698, DOI 10.1016/S0011-5029(05)80007-0; NAKAMURA T, 1993, J AM SOC NEPHROL, V4, P1064; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Peters DJM, 2001, LANCET, V358, P1439, DOI 10.1016/S0140-6736(01)06531-X; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Todorov V, 2002, AM J PHYSIOL-REG I, V283, pR1046, DOI 10.1152/ajpregu.00142.2002; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	29	114	124	2	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2008	14	8					863	868		10.1038/nm1783	http://dx.doi.org/10.1038/nm1783			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18552856	Green Accepted			2022-12-25	WOS:000258237500034
J	Baker, DJ; Perez-Terzic, C; Jin, F; Pitel, K; Niederlander, NJ; Jeganathan, K; Yamada, S; Reyes, S; Rowe, L; Hiddinga, HJ; Eberhardt, NL; Terzic, A; van Deursen, JM				Baker, Darren J.; Perez-Terzic, Carmen; Jin, Fang; Pitel, Kevin; Niederlaender, Nicolas J.; Jeganathan, Karthik; Yamada, Satsuki; Reyes, Santiago; Rowe, Lois; Hiddinga, H. Jay; Eberhardt, Norman L.; Terzic, Andre; van Deursen, Jan M.			Opposing roles for p16(Ink4a) and p19(Arf) in senescence and ageing caused by BubR1 insufficiency	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; GENE-EXPRESSION; MICE DEFICIENT; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; ARF/P53 PATHWAY; MUTANT MICE; CANCER; CELLS; TUMORIGENESIS	Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.	[Baker, Darren J.; Jin, Fang; Pitel, Kevin; Jeganathan, Karthik; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediatr & Adolescent Med, Rochester, MN 55905 USA; [Perez-Terzic, Carmen] Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Niederlaender, Nicolas J.; Yamada, Satsuki; Reyes, Santiago; Rowe, Lois; Terzic, Andre] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; [Hiddinga, H. Jay; Eberhardt, Norman L.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Pediatr & Adolescent Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Baker, Darren/0000-0001-9006-1939; Jeganathan, KARTHIK/0000-0001-5587-1266; Niederlander, Nicolas/0000-0003-1323-8387	NATIONAL CANCER INSTITUTE [R01CA096985] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096985, R01 CA096985-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asahi M, 2005, J CEREBR BLOOD F MET, V25, P722, DOI 10.1038/sj.jcbfm.9600070; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Hengstschlager M, 1996, DNA CELL BIOL, V15, P41, DOI 10.1089/dna.1996.15.41; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Ohlson N, 2006, PROSTATE, V66, P1687, DOI 10.1002/pros.20368; Price S R, 1998, Curr Opin Clin Nutr Metab Care, V1, P79, DOI 10.1097/00075197-199801000-00013; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 1996, MECH AGEING DEV, V92, P121, DOI 10.1016/S0047-6374(96)01814-3; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	49	264	277	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					825	836		10.1038/ncb1744	http://dx.doi.org/10.1038/ncb1744			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18516091	Green Accepted			2022-12-25	WOS:000257268400012
J	Zhang, Y; Goss, AM; Cohen, ED; Kadzik, R; Lepore, JJ; Muthukumaraswamy, K; Yang, J; DeMayo, FJ; AWhitsett, J; Parmacek, MS; Morrisey, EE				Zhang, Yuzhen; Goss, Ashley M.; Cohen, Ethan David; Kadzik, Rachel; Lepore, John J.; Muthukumaraswamy, Karthika; Yang, Jifu; DeMayo, Francesco J.; AWhitsett, Jeffrey; Parmacek, Michael S.; Morrisey, Edward E.			A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration	NATURE GENETICS			English	Article							LUNG MORPHOGENESIS; REGULATES DIFFERENTIATION; RESPIRATORY-TRACT; GENE-EXPRESSION; GATA-6; WNT; PROLIFERATION; KINASE; TRANSCRIPTION; INACTIVATION	Epithelial organs, including the lung, are known to possess regenerative abilities through activation of endogenous stem cell populations, but the molecular pathways regulating stem cell expansion and regeneration are not well understood. Here we show that Gata6 regulates the temporal appearance and number of bronchioalveolar stem cells (BASCs) in the lung, its absence in Gata6-null lung epithelium leading to the precocious appearance of BASCs and concurrent loss in epithelial differentiation. This expansion of BASCs was the result of a pronounced increase in canonical Wnt signaling in lung epithelium upon loss of Gata6. Expression of the noncanonical Wnt receptor Fzd2 was downregulated in Gata6 mutants and increased Fzd2 or decreased beta-catenin expression rescued, in part, the lung epithelial defects in Gata6 mutants. During lung epithelial regeneration, canonical Wnt signaling was activated in the niche containing BASCs and forced activation of Wnt signaling led to a large increase in BASC numbers. Moreover, Gata6 was required for proper lung epithelial regeneration, and postnatal loss of Gata6 led to increased BASC expansion and decreased differentiation. Together, these data demonstrate that Gata6-regulated Wnt signaling controls the balance between progenitor expansion and epithelial differentiation required for both lung development and regeneration.	[Zhang, Yuzhen; Cohen, Ethan David; Lepore, John J.; Muthukumaraswamy, Karthika; Yang, Jifu; Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Goss, Ashley M.; Kadzik, Rachel; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [AWhitsett, Jeffrey] Cincinnatis Childrens Hosp, Div Pulm Biol, Cincinnati, OH 45229 USA; [AWhitsett, Jeffrey] Med Ctr, Cincinnati, OH 45229 USA; [Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, 956 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Parmacek, Michael/0000-0003-1449-4665	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075215, R01HL064632, R01HL087825] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064632, P01 HL075215, P01 HL075215-01A10002, HL075215, HL064632, HL087825, R01 HL087825] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; Brault V, 2001, DEVELOPMENT, V128, P1253; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; COHEN RE, 1994, SUPRAMOL SCI, V1, P117; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Li H, 2004, MOL PHARMACOL, V65, P45, DOI 10.1124/mol.65.1.45; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yang HH, 2002, DEVELOPMENT, V129, P2233; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	48	201	211	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					862	870		10.1038/ng.157	http://dx.doi.org/10.1038/ng.157			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536717	Green Accepted			2022-12-25	WOS:000257166500021
J	Richon, VM				Richon, Victoria M.			A new path to the cancer epigenome	NATURE BIOTECHNOLOGY			English	Editorial Material							GENE-EXPRESSION; TRANSCRIPTION	A regulator of the spatial organization of chromatin may be a promising target to curb the invasiveness of breast cancer.	Merck & Co Inc, Merck Res Labs, Dept Canc Biol & Therapeut, Boston, MA 02115 USA	Merck & Company	Richon, VM (corresponding author), Merck & Co Inc, Merck Res Labs, Dept Canc Biol & Therapeut, 33 Ave Louis Pasteur, Boston, MA 02115 USA.	victoria_richon@merck.com						Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/cb700110z; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	8	16	19	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					655	656		10.1038/nbt0608-655	http://dx.doi.org/10.1038/nbt0608-655			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18536689				2022-12-25	WOS:000256611900024
J	Li, JY; Englund, E; Holton, JL; Soulet, D; Hagell, P; Lees, AJ; Lashley, T; Quinn, NP; Rehncrona, S; Bjorklund, A; Widner, H; Revesz, T; Lindvall, O; Brundin, P				Li, Jia-Yi; Englund, Elisabet; Holton, Janice L.; Soulet, Denis; Hagell, Peter; Lees, Andrew J.; Lashley, Tammaryn; Quinn, Niall P.; Rehncrona, Stig; Bjorklund, Anders; Widner, Hakan; Revesz, Tamas; Lindvall, Olle; Brundin, Patrik			Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation	NATURE MEDICINE			English	Article							SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; TRANSPLANTATION	Two subjects with Parkinson's disease who had long-term survival of transplanted fetal mesencephalic dopaminergic neurons (11-16 years) developed alpha-synuclein-positive Lewy bodies in grafted neurons. Our observation has key implications for understanding Parkinson's pathogenesis by providing the first evidence, to our knowledge, that the disease can propagate from host to graft cells. However, available data suggest that the majority of grafted cells are functionally unimpaired after a decade, and recipients can still experience long-term symptomatic relief.	[Li, Jia-Yi; Soulet, Denis; Brundin, Patrik] Wallenberg Neurosci Ctr, Neuronal Survival Unit, Dept Expt Med Sci, S-22184 Lund, Sweden; [Englund, Elisabet] Univ Lund Hosp, Div Neuropathol, S-22185 Lund, Sweden; [Holton, Janice L.; Lees, Andrew J.; Lashley, Tammaryn; Revesz, Tamas] UCL, Inst Neurol, Queen Square Brain Bank Neurol Disorders, Dept Mol Neurosci, London WC1N 3BG, England; [Hagell, Peter; Widner, Hakan; Lindvall, Olle] Univ Lund Hosp, Div Neurol, S-22185 Lund, Sweden; [Quinn, Niall P.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Rehncrona, Stig] Univ Lund Hosp, Div Neurosurg, S-22185 Lund, Sweden; [Bjorklund, Anders] Wallenberg Neurosci Ctr, Neurobiol Unit, S-22184 Lund, Sweden; [Lindvall, Olle] Wallenberg Neurosci Ctr, Sect Restorat Neurol, S-22184 Lund, Sweden	Lund University; Skane University Hospital; University of London; University College London; Lund University; Skane University Hospital; University of London; University College London; Lund University; Skane University Hospital	Brundin, P (corresponding author), Wallenberg Neurosci Ctr, Neuronal Survival Unit, Dept Expt Med Sci, S-22184 Lund, Sweden.	patrik.brundin@med.lu.se	Soulet, Denis/P-4940-2019; Björklund, Anders/ABA-1326-2020; Bjørklund, Geir/B-7319-2014; Shahmoradian, Sarah H/C-7465-2015; Holton, Janice L/F-6831-2011; Lees, Andrew J/A-6605-2009; Soulet, Denis/E-8677-2011; Hagell, Peter/F-5915-2010; Hagell, Peter/G-9559-2014; Lashley, Tammaryn/D-2583-2009; Revesz, Tamas/A-8732-2010	Bjørklund, Geir/0000-0003-2632-3935; Shahmoradian, Sarah H/0000-0001-9752-7287; Holton, Janice L/0000-0002-3882-5249; Lees, Andrew J/0000-0002-2476-4385; Hagell, Peter/0000-0003-2174-372X; Hagell, Peter/0000-0003-2174-372X; Revesz, Tamas/0000-0003-2501-0259; Soulet, Denis/0000-0002-0937-7061; Bjorklund, Anders/0000-0002-5676-6203; Li, Jia-Yi/0000-0002-7770-7376; Lashley, Tammaryn/0000-0001-7389-0348; Englund, Elisabet/0000-0002-2708-2443	Parkinson&apos;s UK [G-4062] Funding Source: Medline	Parkinson&apos;s UK(Parkinson&apos;s UK)		Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; DOUCET G, 1989, EXP NEUROL, V106, P1, DOI 10.1016/0014-4886(89)90139-8; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Kordower J H, 2000, Prog Brain Res, V127, P333; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Sigurdsson EM, 2002, TRENDS MOL MED, V8, P411, DOI 10.1016/S1471-4914(02)02403-6; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x	16	1221	1248	0	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2008	14	5					501	503		10.1038/nm1746	http://dx.doi.org/10.1038/nm1746			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	298IQ	18391963				2022-12-25	WOS:000255681800028
J	Scaffidi, P; Misteli, T				Scaffidi, Paola; Misteli, Tom			Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing	NATURE CELL BIOLOGY			English	Article							HUTCHINSON-GILFORD-PROGERIA; NOTCH; PROTEIN; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; PHENOTYPE; HES; INHIBITION; EXPRESSION	The premature-ageing disease Hutchinson-Gilford Progeria Syndrome ( HGPS) is caused by constitutive production of progerin, a mutant form of the nuclear architectural protein lamin A(1,2). Progerin is also expressed sporadically in wildtype cells and has been linked to physiological ageing(3). Cells from HGPS patients exhibit extensive nuclear defects, including abnormal chromatin structure(4,5) and increased DNA damage(6). At the organismal level, HGPS affects several tissues, particularly those of mesenchymal origin(7). How the cellular defects of HGPS cells lead to the organismal defects has been unclear. Here, we provide evidence that progerin interferes with the function of human mesenchymal stem cells ( hMSCs). We find that expression of progerin activates major downstream effectors of the Notch signalling pathway. Induction of progerin in hMSCs changes their molecular identity and differentiation potential. Our results support a model in which accelerated ageing in HGPS patients, and possibly also physiological ageing, is the result of adult stem cell dysfunction and progressive deterioration of tissue functions.	[Scaffidi, Paola; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scaffidi, P (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	scaffidp@mail.nih.gov	Scaffidi, Paola/GRS-9019-2022	Scaffidi, Paola/0000-0002-3642-4193	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cau E, 2000, DEVELOPMENT, V127, P2323; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hansson EM, 2006, DEV NEUROSCI-BASEL, V28, P118, DOI 10.1159/000090758; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; PARADA LA, 2002, ESSENTIAL CELL BIOL, pCH2; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Vujovic S, 2007, CELL PROLIFERAT, V40, P185, DOI 10.1111/j.1365-2184.2007.00426.x; Wallis CV, 2004, EXP GERONTOL, V39, P461, DOI 10.1016/j.exger.2003.12.015; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	35	381	393	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					452	U167		10.1038/ncb1708	http://dx.doi.org/10.1038/ncb1708			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18311132	Green Accepted			2022-12-25	WOS:000254561700016
J	Arastu-Kapur, S; Ponder, EL; Fonovic, UP; Yeoh, S; Yuan, F; Fonovic, M; Grainger, M; Phillips, CI; Powers, JC; Bogyo, M				Arastu-Kapur, Shirin; Ponder, Elizabeth L.; Fonovic, Ursa Pecar; Yeoh, Sharon; Yuan, Fang; Fonovic, Marko; Grainger, Munira; Phillips, Carolyn I.; Powers, James C.; Bogyo, Matthew			Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum	NATURE CHEMICAL BIOLOGY			English	Article							SUBTILISIN-LIKE PROTEASE-1; I CATHEPSIN-C; CYSTEINE PROTEASE; PARASITOPHOROUS VACUOLE; SERINE-PROTEASE; STREPTOLYSIN-O; VINYL SULFONES; CELL INVASION; MEROZOITES; ANTIGEN	Newly replicated Plasmodium falciparum parasites escape from host erythrocytes through a tightly regulated process that is mediated by multiple classes of proteolytic enzymes. However, the identification of specific proteases has been challenging. We describe here a forward chemical genetic screen using a highly focused library of more than 1,200 covalent serine and cysteine protease inhibitors to identify compounds that block host cell rupture by P. falciparum. Using hits from the library screen, we identified the subtilisin-family serine protease PfSUB1 and the cysteine protease dipeptidyl peptidase 3 (DPAP3) as primary regulators of this process. inhibition of both DPAP3 and PfSUB1 caused a block in proteolytic processing of the serine repeat antigen (SERA) protein SERA5 that correlated with the observed block in rupture. Furthermore, DPAP3 inhibition reduced the levels of mature PfSUB1. These results suggest that two mechanistically distinct proteases function to regulate processing of downstream substrates required for efficient release of parasites from host red blood cells.	[Arastu-Kapur, Shirin; Fonovic, Ursa Pecar; Yuan, Fang; Fonovic, Marko; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Ponder, Elizabeth L.; Phillips, Carolyn I.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Yeoh, Sharon; Grainger, Munira] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Fonovic, Marko] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Powers, James C.] Georgia Inst Technol, Dept Chem, Atlanta, GA 30332 USA	Stanford University; Stanford University; MRC National Institute for Medical Research; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University System of Georgia; Georgia Institute of Technology	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	mbogyo@stanford.edu	Ponder, Elizabeth/E-5147-2011; Fonović, Marko/X-9957-2019	Fonovic, Marko/0000-0002-8375-6713; Yeoh, Sharon/0000-0002-8530-1405; Bogyo, Matthew/0000-0003-3753-4412	MRC [MC_U117532072, MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067, MC_U117532072] Funding Source: Medline; NCRR NIH HHS [U54 RR020843] Funding Source: Medline; NIAID NIH HHS [T32 AI007328, F32 AI069728-01A1] Funding Source: Medline; NIBIB NIH HHS [R01 EB005011] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, F32AI069728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Contreras CE, 2004, MEM I OSWALDO CRUZ, V99, P179, DOI 10.1590/S0074-02762004000200011; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Green JL, 2006, MOL BIOCHEM PARASIT, V150, P114, DOI 10.1016/j.molbiopara.2006.06.010; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Hackett F, 1999, MOL BIOCHEM PARASIT, V103, P183, DOI 10.1016/S0166-6851(99)00122-X; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jean L, 2005, MOL BIOCHEM PARASIT, V144, P187, DOI 10.1016/j.molbiopara.2005.07.008; Kam CM, 2004, ARCH BIOCHEM BIOPHYS, V427, P123, DOI 10.1016/j.abb.2004.04.011; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Nyalwidhe J, 2002, J BIOL CHEM, V277, P40005, DOI 10.1074/jbc.M207077200; O'Donnell RA, 2005, CURR OPIN MICROBIOL, V8, P422, DOI 10.1016/j.mib.2005.06.018; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pang XL, 1999, INFECT IMMUN, V67, P1821; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Saliba KJ, 2001, INT J PARASITOL, V31, P1321, DOI 10.1016/S0020-7519(01)00258-2; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Wang G, 2003, ORG LETT, V5, P737, DOI 10.1021/ol0275567; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Yuan F, 2006, J AM CHEM SOC, V128, P5616, DOI 10.1021/ja060835v	41	191	194	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					203	213		10.1038/nchembio.70	http://dx.doi.org/10.1038/nchembio.70			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18246061				2022-12-25	WOS:000253417400017
J	Loncarek, J; Hergert, P; Magidson, V; Khodjakov, A				Loncarek, Jadranka; Hergert, Polla; Magidson, Valentin; Khodjakov, Alexey			Control of daughter centriole formation by the pericentriolar material	NATURE CELL BIOLOGY			English	Article							DE-NOVO FORMATION; CELL-CYCLE PROGRESSION; HAMSTER OVARY CELLS; CENTROSOME DUPLICATION; VERTEBRATE CELLS; GAMMA-TUBULIN; ANIMAL-CELLS; HELA-CELLS; IN-VIVO; REPLICATION	Controlling the number of its centrioles is vital for the cell, as supernumerary centrioles cause multipolar mitosis and genomic instability(1,2). Normally, one daughter centriole forms on each mature (mother) centriole(3,4); however, a mother centriole can produce multiple daughters within a single cell cycle(5,6). The mechanisms that prevent centriole 'overduplication' are poorly understood. Here we use laser microsurgery to test the hypothesis that attachment of the daughter centriole to the wall of the mother inhibits formation of additional daughters(7,8). We show that physical removal of the daughter induces reduplication of the mother in S-phase-arrested cells. Under conditions when multiple daughters form simultaneously on a single mother, all of these daughters must be removed to induce reduplication. The number of daughter centrioles that form during reduplication does not always match the number of ablated daughter centrioles. We also find that exaggeration of the pericentriolar material (PCM) by overexpression of the PCM protein pericentrin(9) in S-phase-arrested CHO cells induces formation of numerous daughter centrioles. We propose that that the size of the PCM cloud associated with the mother centriole restricts the number of daughters that can form simultaneously.	[Loncarek, Jadranka; Hergert, Polla; Magidson, Valentin; Khodjakov, Alexey] New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA; [Khodjakov, Alexey] Woods Hole, Marine Biol Lab, Woods Hole, MA 02543 USA	State University of New York (SUNY) System; Wadsworth Center; Marine Biological Laboratory - Woods Hole; Woods Hole Oceanographic Institution	Khodjakov, A (corresponding author), New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org		Magidson, Valentin/0000-0002-0780-9123; Loncarek, Jadranka/0000-0003-1879-5473	NIGMS NIH HHS [GM GM59363, R01 GM059363-10, R01 GM059363] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balczon R, 2001, CHROMOSOMA, V110, P381, DOI 10.1007/s004120100157; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Duensing A, 2007, ONCOGENE, V26, P6280, DOI 10.1038/sj.onc.1210456; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kim HK, 2005, J CELL BIOL, V169, P719, DOI 10.1083/jcb.200410052; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Paoletti A, 1996, J CELL SCI, V109, P3089; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Sluder G, 1996, CELL MOTIL CYTOSKEL, V33, P1, DOI 10.1002/(SICI)1097-0169(1996)33:1<1::AID-CM1>3.0.CO;2-H; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; STRNAD P, 2007, CELL, V13, P203; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Vidwans SJ, 2003, J CELL SCI, V116, P137, DOI 10.1242/jcs.00204; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047	37	159	163	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					322	U55		10.1038/ncb1694	http://dx.doi.org/10.1038/ncb1694			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297061	Green Accepted, Green Submitted			2022-12-25	WOS:000253778300014
J	Wei, C; Moeller, CC; Altintas, MM; Li, J; Schwarz, K; Zacchigna, S; Xie, L; Henger, A; Schmid, H; Rastaldi, MP; Cowan, P; Kretzler, M; Parrilla, R; Bendayan, S; Gupta, V; Nikolic, B; Kalluri, R; Carmeliet, P; Mundel, P; Reiser, J				Wei, Changli; Moeller, Clemens C.; Altintas, Mehmet M.; Li, Jing; Schwarz, Karin; Zacchigna, Serena; Xie, Liang; Henger, Anna; Schmid, Holger; Rastaldi, Maria P.; Cowan, Peter; Kretzler, Matthias; Parrilla, Roberto; Bendayan, Se; Gupta, Vineet; Nikolic, Boris; Kalluri, Raghu; Carmeliet, Peter; Mundel, Peter; Reiser, Jochen			Modification of kidney barrier function by the urokinase receptor	NATURE MEDICINE			English	Article							GLOMERULAR SLIT DIAPHRAGM; INTEGRIN ALPHA(V)BETA(3); GENE-EXPRESSION; CATHEPSIN-L; MIGRATION; PROTEINURIA; PODOCYTES; ACTIN; BETA-1-INTEGRIN; SYNAPTOPODIN	Podocyte dysfunction, represented by foot process effacement and proteinuria, is often the starting point for progressive kidney disease. Therapies aimed at the cellular level of the disease are currently not available. Here we show that induction of urokinase receptor ( uPAR) signaling in podocytes leads to foot process effacement and urinary protein loss via a mechanism that includes lipid-dependent activation of alpha v beta 3 integrin. Mice lacking uPAR (Plaur(-/-)) are protected from lipopolysaccharide (LPS)-mediated proteinuria but develop disease after expression of a constitutively active beta 3 integrin. Gene transfer studies reveal a prerequisite for uPAR expression in podocytes, but not in endothelial cells, for the development of LPS-mediated proteinuria. Mechanistically, uPAR is required to activate alpha v beta 3 integrin in podocytes, promoting cell motility and activation of the small GTPases Cdc42 and Rac1. Blockade of alpha v beta 3 integrin reduces podocyte motility in vitro and lowers proteinuria in mice. Our findings show a physiological role for uPAR signaling in the regulation of kidney permeability.	[Wei, Changli; Moeller, Clemens C.; Altintas, Mehmet M.; Li, Jing; Gupta, Vineet; Nikolic, Boris; Reiser, Jochen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Nephrol Div, Boston, MA 02129 USA; [Wei, Changli; Moeller, Clemens C.; Altintas, Mehmet M.; Li, Jing; Gupta, Vineet; Nikolic, Boris; Reiser, Jochen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Program Glamerular Dis, Boston, MA 02129 USA; Univ Homburg, Inst Anat & Cell Biol, D-66421 Homburg, Germany; [Zacchigna, Serena; Carmeliet, Peter] Katholieke Univ Leuven, Flanders Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Zacchigna, Serena; Carmeliet, Peter] Vlaans Interuniv Inst Biotechnol, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Xie, Liang; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Henger, Anna; Kretzler, Matthias] Univ Michigan Hosp, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Schmid, Holger] Univ Munich, Med Poliklin, D-80336 Munich, Germany; [Rastaldi, Maria P.] San Carlo Borromeo Hosp, Assoc Nuova Nefrol & Fdn Damico Ricerca Malattie, Renal Immunopathol Lab, I-20153 Milan, Italy; [Cowan, Peter] St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic 3065, Australia; [Parrilla, Roberto] CSIC, Ctr Invest Biol, Dept Pathophysiol & Human Mol Genet, Madrid 28040, Spain; [Bendayan, Se] Univ Montreal, Dept Pathol, Montreal, PQ H3T 1J4, Canada; [Mundel, Peter] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; KU Leuven; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University of Munich; San Carlo Borromeo Hospital; St Vincent's Hospital Melbourne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universite de Montreal; Icahn School of Medicine at Mount Sinai	Reiser, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Nephrol Div, Boston, MA 02129 USA.	jreiser@partners.org	Parrilla, Roberto/B-6307-2008; Cowan, Peter/AAH-7218-2020; Altintas, Mehmet Mete/ABI-5904-2020; Cowan, Peter J/B-8730-2013; Altintas, Mehmet Mete/T-5333-2018; Schwarz, Karin/AAO-2819-2020; Carmeliet, Peter/AAQ-5140-2020; Kalluri, Raghu/E-2677-2015; ZACCHIGNA, SERENA/E-9496-2017	Cowan, Peter J/0000-0001-9016-4954; Altintas, Mehmet Mete/0000-0002-1871-6985; Carmeliet, Peter/0000-0001-7961-1821; Kalluri, Raghu/0000-0002-2190-547X; Schwarz, Karin/0000-0002-7328-1427; Gupta, Vineet/0000-0001-6987-2550; ZACCHIGNA, SERENA/0000-0001-6705-3076	NIDDK NIH HHS [K01 DK068253-05, DK38452, DK073495, DK057683, DK064236, DK062472, T32DK007540, K01 DK068253] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064236, R01DK062472, P01DK038452, T32DK007540, R01DK073495, R01DK057683, K01DK068253] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alfano M, 2002, P NATL ACAD SCI USA, V99, P8862, DOI 10.1073/pnas.142078099; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Butta N, 2003, BLOOD, V102, P2491, DOI 10.1182/blood-2003-01-0213; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; CARMELIET P, 1995, ANN NY ACAD SCI, V748, P367; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; de Jong PE, 2004, KIDNEY INT, V66, P2109, DOI 10.1111/j.1523-1755.2004.66001.x; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; GUGLIUCCI A, 1995, J HISTOCHEM CYTOCHEM, V43, P591, DOI 10.1177/43.6.7769229; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KELLEY VE, 1976, LAB INVEST, V35, P213; KERJASCHKI D, 1989, AM J PATHOL, V134, P481; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MAUER SM, 1974, CANCER RES, V34, P1643; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; NAKAMURA T, 1991, LAB INVEST, V64, P640; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Silberman S, 1997, J BIOL CHEM, V272, P5927, DOI 10.1074/jbc.272.9.5927; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Velasco B, 2001, GENE THER, V8, P897, DOI 10.1038/sj.gt.3301468; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	51	415	447	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					55	63		10.1038/nm1696	http://dx.doi.org/10.1038/nm1696			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18084301	Green Submitted			2022-12-25	WOS:000252222400022
J	Wirth, A; Benyo, Z; Lukasova, M; Leutgeb, B; Wettschureck, N; Gorbey, S; Orsy, P; Horvath, B; Maser-Gluth, C; Greiner, E; Lemmer, B; Schuetz, N; Gutkind, S; Offermanns, S				Wirth, Angela; Benyo, Zoltan; Lukasova, Martina; Leutgeb, Barbara; Wettschureck, Nina; Gorbey, Stefan; Orsy, Petra; Horvath, Bela; Maser-Gluth, Christiane; Greiner, Erich; Lemmer, Bjoern; Schuetz, Nther; Gutkind, Silvio; Offermanns, Stefan			G(12)-G(13)-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension	NATURE MEDICINE			English	Article							BLOOD-PRESSURE; DIETARY SALT; G-PROTEINS; ACTIVATION; REORGANIZATION; KINASE; RHOA	The tone of vascular smooth muscle cells is a primary determinant of the total peripheral vascular resistance and hence the arterial blood pressure. Most forms of hypertension ultimately result from an increased vascular tone that leads to an elevated total peripheral resistance(1-3). Regulation of vascular resistance under normotensive and hypertensive conditions involves multiple mediators, many of which act through G protein-coupled receptors on vascular smooth muscle cells(4). Receptors that mediate vasoconstriction couple with the G-proteins G(q)-G(11) and G(12)-G(13) to stimulate phosphorylation of myosin light chain (MLC) via the Ca2+/MLC kinase- and Rho/Rho kinase-mediated signaling pathways, respectively(4-6). Using genetically altered mouse models that allow for the acute abrogation of both signaling pathways by inducible Cre/loxP-mediated mutagenesis in smooth muscle cells, we show that G(q)-G(11)-mediated signaling in smooth muscle cells is required for maintenance of basal blood pressure and for the development of salt-induced hypertension. In contrast, lack of G(12)-G(13), as well as of their major effector, the leukemiaassociated Rho guanine nucleotide exchange factor (LARG), did not alter normal blood pressure regulation but did block the development of salt-induced hypertension. This identifies the G(12)-G(13)-LARG-mediated signaling pathway as a new target for antihypertensive therapies that would be expected to leave normal blood pressure regulation unaffected.	[Wirth, Angela; Benyo, Zoltan; Lukasova, Martina; Leutgeb, Barbara; Wettschureck, Nina; Orsy, Petra; Horvath, Bela; Maser-Gluth, Christiane; Offermanns, Stefan] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1082 Budapest, Hungary; [Gorbey, Stefan; Lemmer, Bjoern] Heidelberg Univ, Med Fac Mannheim, Inst Pharmacol, D-68169 Mannheim, Germany; [Greiner, Erich; Schuetz, Nther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Gutkind, Silvio] Natl Inst Dent & Craniofacial Res, Natl Inst Hlth, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Leutgeb, Barbara; Greiner, Erich] EvotecOAI AG, D-22525 Hamburg, Germany	Ruprecht Karls University Heidelberg; Semmelweis University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	Stefan.Offermanns@pharma.uni-heidelberg.de	Gorbey, Stefan/P-3874-2015; Wettschureck, Nina/L-3651-2017; Horvath, Bela/A-7368-2009; Benyo, Zoltan/C-9184-2009; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009; Offermanns, Stefan/L-3313-2017	Gorbey, Stefan/0000-0002-6852-1756; Wettschureck, Nina/0000-0001-6858-1460; Gutkind, J. Silvio/0000-0002-5150-4482; Benyo, Zoltan/0000-0001-6015-0359; Offermanns, Stefan/0000-0001-8676-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Becknell B, 2003, CELL TISSUE RES, V314, P361, DOI 10.1007/s00441-003-0802-5; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; BROWN R, 2004, MOL BASIS CARDIOVASC, P566; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Khalil RA, 2006, AM J PHYSIOL-REG I, V290, pR509, DOI 10.1152/ajpregu.00600.2005; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Maguire JJ, 2005, TRENDS PHARMACOL SCI, V26, P448, DOI 10.1016/j.tips.2005.07.007; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; O'Shaughnessy KM, 2004, J CLIN INVEST, V113, P1075, DOI 10.1172/JCI200421560; Seasholtz TM, 2004, MOL INTERV, V4, P348, DOI 10.1124/mi.4.6.8; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236	30	443	449	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2008	14	1					64	68		10.1038/nm1666	http://dx.doi.org/10.1038/nm1666			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18084302				2022-12-25	WOS:000252222400023
J	Liu, L; Bailey, SM; Okuka, M; Munoz, P; Li, C; Zhou, LJ; Wu, C; Czerwiec, E; Sandler, L; Seyfang, A; Blasco, MA; Keefe, DL				Liu, Lin; Bailey, Susan M.; Okuka, Maja; Munoz, Purificacion; Li, Chao; Zhou, Lingjun; Wu, Chao; Czerwiec, Eva; Sandler, Laurel; Seyfang, Andreas; Blasco, Maria A.; Keefe, David L.			Telomere lengthening early in development	NATURE CELL BIOLOGY			English	Article							RECOMBINATION; CELLS; MOUSE; DNA; MICE; ALT; ASSOCIATION; INSTABILITY; DEFICIENT; PATHWAY	Stem cells and cancer cells maintain telomere length mostly through telomerase(1-3). Telomerase activity is high in male germ line and stem cells, but is low or absent in mature oocytes and cleavage stage embryos, and then high again in blastocysts(3). How early embryos reset telomere length remains poorly understood. Here, we show that oocytes actually have shorter telomeres than somatic cells, but their telomeres lengthen remarkably during early cleavage development. Moreover, parthenogenetically activated oocytes also lengthen their telomeres, thus the capacity to elongate telomeres must reside within oocytes themselves. Notably, telomeres also elongate in the early cleavage embryos of telomerase-null mice, demonstrating that telomerase is unlikely to be responsible for the abrupt lengthening of telomeres in these cells. Coincident with telomere lengthening, extensive telomere sister-chromatid exchange ( T-SCE) and colocalization of the DNA recombination proteins Rad50 and TRF1 were observed in early cleavage embryos. Both T-SCE and DNA recombination proteins decrease in blastocyst stage embryos, whereas telomerase activity increases and telomeres elongate only slowly. We suggest that telomeres lengthen during the early cleavage cycles following fertilization through a recombination-based mechanism, and that from the blastocyst stage onwards, telomerase only maintains the telomere length established by this alternative mechanism.	Univ S Florida, Coll Med, Dept Obstet & Gynecol, Lab Reprod Med, Tampa, FL 33612 USA; Colorado State Univ, Ft Collins, CO 80523 USA; Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510275, Peoples R China; Women & Infants Hosp Rhode Isl, Brown Med Sch, Providence, RI 02905 USA; Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Colorado State University; Centro Nacional de Investigaciones Oncologicas (CNIO); Sun Yat Sen University; Brown University; Women & Infants Hospital Rhode Island; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liu, L (corresponding author), Univ S Florida, Coll Med, Dept Obstet & Gynecol, Lab Reprod Med, Tampa, FL 33612 USA.	liutelom@yahoo.com; dkeefe@health.usf.edu	Seyfang, Andreas/H-2445-2012; Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Seyfang, Andreas/0000-0001-6231-9955				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Baird DM, 2006, HUM MOL GENET, V15, P45, DOI 10.1093/hmg/ddi424; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Keefe DL, 2007, CELL MOL LIFE SCI, V64, P139, DOI 10.1007/s00018-006-6466-z; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; McIlrath J, 2001, CANCER RES, V61, P912; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tanemura K, 2005, DEV BIOL, V281, P196, DOI 10.1016/j.ydbio.2005.02.025; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; WANG SS, 1990, NATURE, V345, P456, DOI 10.1038/345456a0; Wright WE, 1996, DEV GENET, V18, P173; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	36	276	284	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1436	U185		10.1038/ncb1664	http://dx.doi.org/10.1038/ncb1664			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17982445				2022-12-25	WOS:000251317300017
J	Zeitlinger, J; Stark, A; Kellis, M; Hong, JW; Nechaev, S; Adelman, K; Levine, M; Young, RA				Zeitlinger, Julia; Stark, Alexander; Kellis, Manolis; Hong, Joung-Woo; Nechaev, Sergei; Adelman, Karen; Levine, Michael; Young, Richard A.			RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; MESODERM DEVELOPMENT; PROXIMAL REGION; TARGET GENES; DORSAL; PROMOTER; EXPRESSION; PROTEIN; SNAIL; RECRUITMENT	It is widely assumed that the key rate-limiting step in gene activation is the recruitment of RNA polymerase II ( Pol II) to the core promoter(1). Although there are well-documented examples in which Pol II is recruited to a gene but stalls(2-12), a general role for Pol II stalling in development has not been established. We have carried out comprehensive Pol II chromatin immunoprecipitation microarray ( ChIP-chip) assays in Drosophila embryos and identified three distinct Pol II binding behaviors: active ( uniform binding across the entire transcription unit), no binding, and stalled ( binding at the transcription start site). The notable feature of the similar to 10% genes that are stalled is that they are highly enriched for developmental control genes, which are either repressed or poised for activation during later stages of embryogenesis. We propose that Pol II stalling facilitates rapid temporal and spatial changes in gene activity during development.	Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol Cell Biol, Berkeley, CA 94720 USA; Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Broad Inst Massachustts Inst Technol & Harvard, Cambridge, MA 02141 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; NIH, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT)	Levine, M (corresponding author), Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol Cell Biol, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Nechaev, Sergei/AAQ-3450-2021; Young, Richard A/F-6495-2012; Hong, Joung-Woo/AAG-1173-2021; Kellis, Manolis/ABE-7385-2020; Stark, Alexander/D-1473-2012	Young, Richard A/0000-0001-8855-8647; Hong, Joung-Woo/0000-0001-6511-7881; Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; Levine, Michael/0000-0001-7629-0081; Adelman, Karen/0000-0001-5364-334X	Intramural NIH HHS [Z01 ES101987-02] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037, R01 HG004037-01A1, HG002668, R01 HG002668] Funding Source: Medline; NIGMS NIH HHS [GM34431, R01 GM069676, R37 GM046638, GM069676, R01 GM046638] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431, R37GM046638, R01GM046638, R01GM069676] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LASPIA MF, 1993, J MOL BIOL, V232, P732, DOI 10.1006/jmbi.1993.1427; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TOMANCAK P, 2002, GENOME BIOL, V3; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	30	572	583	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1512	1516		10.1038/ng.2007.26	http://dx.doi.org/10.1038/ng.2007.26			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994019	Green Accepted			2022-12-25	WOS:000251267400021
J	Isermann, B; Vinnikov, IA; Madhusudhan, T; Herzog, S; Kashif, M; Blautzik, J; Corat, MAF; Zeier, M; Blessing, E; Oh, J; Gerlitz, B; Berg, DT; Grinnell, BW; Chavakis, T; Esmon, CT; Weiler, H; Bierhaus, A; Nawroth, PP				Isermann, Berend; Vinnikov, Ilya A.; Madhusudhan, Thati; Herzog, Stefanie; Kashif, Muhammed; Blautzik, Janusch; Corat, Marcus A. F.; Zeier, Martin; Blessing, Erwin; Oh, Jun; Gerlitz, Bruce; Berg, David T.; Grinnell, Brian W.; Chavakis, Triantafyllos; Esmon, Charles T.; Weiler, Hartmut; Bierhaus, Angelika; Nawroth, Peter P.			Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis	NATURE MEDICINE			English	Article							POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; SEVERE SEPSIS; ANTICOAGULANT PATHWAY; CELL; THROMBOMODULIN; ALPHA; RECEPTOR-1; MOUSE; INFLAMMATION; DYSFUNCTION	Data providing direct evidence for a causative link between endothelial dysfunction, microvascular disease and diabetic end-organ damage are scarce. Here we show that activated protein C (APC) formation, which is regulated by endothelial thrombomodulin, is reduced in diabetic mice and causally linked to nephropathy. Thrombomodulin-dependent APC formation mediates cytoprotection in diabetic nephropathy by inhibiting glomerular apoptosis. APC prevents glucose-induced apoptosis in endothelial cells and podocytes, the cellular components of the glomerular filtration barrier. APC modulates the mitochondrial apoptosis pathway via the protease-activated receptor PAR-1 and the endothelial protein C receptor EPCR in glucose-stressed cells. These experiments establish a new pathway, in which hyperglycemia impairs endothelial thrombomodulin-dependent APC formation. Loss of thrombomodulin-dependent APC formation interrupts cross-talk between the vascular compartment and podocytes, causing glomerular apoptosis and diabetic nephropathy. Conversely, maintaining high APC levels during long-term diabetes protects against diabetic nephropathy.	Univ Heidelberg, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany; Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA; Univ Heidelberg, Dept Med 1, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Med 3, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Pediat Nephrol, D-69120 Heidelberg, Germany; Lilly Res Labs, BioTechnol Discovery Res, Indianapolis, IN 46285 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Howard Hughes Med Inst, Oklahoma City, OK 73104 USA	Ruprecht Karls University Heidelberg; Versiti Blood Center of Wisconsin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Isermann, B (corresponding author), Univ Heidelberg, Dept Med & Clin Chem 1, INF 410, D-69120 Heidelberg, Germany.	berend.isermann@med.uni-heidelberg.de	Corat, Marcus Alexandre Finzi/AAH-2882-2020; Corat, Marcus/M-2301-2013; Chavakis, Triantafyllos/ABE-8845-2020	Corat, Marcus/0000-0002-8801-2318; Vinnikov, Ilya/0000-0003-0488-8484				Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Baba K, 2004, NEPHROLOGY, V9, P94, DOI 10.1111/j.1440-1797.2004.00238.x; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Borcea V, 1999, VASA-J VASCULAR DIS, V28, P172, DOI 10.1024/0301-1526.28.3.172; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calkin AC, 2006, NEPHROL DIAL TRANSPL, V21, P2399, DOI 10.1093/ndt/gfl212; Chae SS, 2004, PROSTAG OTH LIPID M, V73, P141, DOI 10.1016/j.prostaglandins.2004.01.006; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Festa A, 2000, KIDNEY INT, V58, P1703, DOI 10.1046/j.1523-1755.2000.00331.x; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fujiwara Y, 1998, J Atheroscler Thromb, V5, P21; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; Haraldsson B, 2004, NEWS PHYSIOL SCI, V19, P7, DOI 10.1152/nips.01461.2003; Isermann B, 2001, J CLIN INVEST, V108, P537, DOI 10.1172/JCI13077; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Kelly KJ, 2004, AM J PHYSIOL-RENAL, V287, pF760, DOI 10.1152/ajprenal.00050.2004; Kerlin BA, 2003, BLOOD, V102, P3085, DOI 10.1182/blood-2003-06-1789; Kiss L, 2005, MEM I OSWALDO CRUZ, V100, P29, DOI 10.1590/S0074-02762005000900007; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Liaw PCY, 2004, BLOOD, V104, P3958, DOI 10.1182/blood-2004-03-1203; Macias WL, 2005, CRIT CARE, V9, pS38, DOI 10.1186/cc3747; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Murata I, 2002, AM J NEPHROL, V22, P587, DOI 10.1159/000065284; RICHARDSON MA, 1992, NATURE, V360, P261, DOI 10.1038/360261a0; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Taylor FB, 2004, J THROMB HAEMOST, V2, P708, DOI 10.1111/j.1538-7836.2004.00751.x; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; *USRDS, 1998, NIH PUBL; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Yamaji K, 2005, THROMB RES, V115, P319, DOI 10.1016/j.thromres.2004.09.011; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198	49	312	327	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1349	1358		10.1038/nm1667	http://dx.doi.org/10.1038/nm1667			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17982464				2022-12-25	WOS:000250736900028
J	Ehninger, D; Han, S; Shilyansky, C; Zhou, Y; Li, WD; Kwiatkowski, DJ; Ramesh, V; Silva, AJ				Ehninger, Dan; Han, Sangyeul; Shilyansky, Carrie; Zhou, Yu; Li, Weidong; Kwiatkowski, David J.; Ramesh, Vijaya; Silva, Alcino J.			Reversal of learning deficits in a Tsc2(+/-) mouse model of tuberous sclerosis	NATURE MEDICINE			English	Article							SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; RAT MODEL; FRAGILE-X; COMPLEX; MEMORY; HIPPOCAMPUS; TSC1; TRANSLATION; IDENTIFICATION	Tuberous sclerosis is a single-gene disorder caused by heterozygous mutations in the TSC1 (9q34) or TSC2 (16p13.3) gene(1,2) and is frequently associated with mental retardation, autism and epilepsy. Even individuals with tuberous sclerosis and a normal intelligence quotient (approximately 50%)(3-5) are commonly affected with specific neuropsychological problems, including long-term and working memory deficits(6,7). Here we report that mice with a heterozygous, inactivating mutation in the Tsc2 gene (Tsc2(+/-) mice)(8) show deficits in learning and memory. Cognitive deficits in Tsc2(+/-) mice emerged in the absence of neuropathology and seizures, demonstrating that other disease mechanisms are involved(5,9-11). We show that hyperactive hippocampal mammalian target of rapamycin (mTOR) signaling led to abnormal long-term potentiation in the CA1 region of the hippocampus and consequently to deficits in hippocampal-dependent learning. These deficits included impairments in two spatial learning tasks and in contextual discrimination. Notably, we show that a brief treatment with the mTOR inhibitor rapamycin in adult mice rescues not only the synaptic plasticity, but also the behavioral deficits in this animal model of tuberous sclerosis. The results presented here reveal a biological basis for some of the cognitive deficits associated with tuberous sclerosis, and they show that treatment with mTOR antagonists ameliorates cognitive dysfunction in a mouse model of this disorder.	[Ehninger, Dan; Shilyansky, Carrie; Zhou, Yu; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ehninger, Dan; Shilyansky, Carrie; Zhou, Yu; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Ehninger, Dan; Shilyansky, Carrie; Zhou, Yu; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Ehninger, Dan; Shilyansky, Carrie; Zhou, Yu; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Han, Sangyeul; Ramesh, Vijaya] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res,Richard B Simches Res Ctr, Boston, MA 02114 USA; [Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Genet Lab,Div Translat Med, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Li, Weidong/0000-0001-5384-4838; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279, R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038480-06, P01 NS024279, R01 NS038480, P01 NS024279-160011, NS24279, R01-NS38480, R01 NS038480-08] Funding Source: Medline; Autism Speaks [AS1862] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks		Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; de Vries PJ, 2007, NEW ENGL J MED, V356, P92; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Floresco SB, 1997, J NEUROSCI, V17, P1880; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Harrison JE, 1999, AM J MED GENET, V88, P642, DOI 10.1002/(SICI)1096-8628(19991215)88:6<642::AID-AJMG12>3.0.CO;2-O; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lewis JC, 2004, J MED GENET, V41, P203, DOI 10.1136/jmg.2003.012757; Murthy V, 2001, ACTA NEUROPATHOL, V101, P202; NELLIST M, 1993, CELL, V75, P1305; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Raznahan A, 2007, PSYCHOL MED, V37, P1293, DOI 10.1017/S0033291707000177; Ridler K, 2007, CEREB CORTEX, V17, P261, DOI 10.1093/cercor/bhj144; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Waltereit R, 2006, J NEUROCHEM, V96, P407, DOI 10.1111/j.1471-4159.2005.03538.x	30	602	624	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2008	14	8					843	848		10.1038/nm1788	http://dx.doi.org/10.1038/nm1788			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18568033	Green Accepted			2022-12-25	WOS:000258237500031
J	Neubert, K; Meister, S; Moser, K; Weisel, F; Maseda, D; Amann, K; Wiethe, C; Winkler, TH; Kalden, JR; Manz, RA; Voll, RE				Neubert, Kirsten; Meister, Silke; Moser, Katrin; Weisel, Florian; Maseda, Damian; Amann, Kerstin; Wiethe, Carsten; Winkler, Thomas H.; Kalden, Joachim R.; Manz, Rudolf A.; Voll, Reinhard E.			The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BONE-MARROW-TRANSPLANTATION; TRANSCRIPTION FACTOR XBP-1; PANCREATIC-CANCER CELLS; MYELOMA CELLS; B-CELLS; ERYTHEMATOSUS; ANTIBODY; DIFFERENTIATION; ACTIVATION	Autoantibody-mediated diseases like myasthenia gravis, autoimmune hemolytic anemia and systemic lupus erythematosus represent a therapeutic challenge. In particular, long-lived plasma cells producing autoantibodies resist current therapeutic and experimental approaches. Recently, we showed that the sensitivity of myeloma cells toward proteasome inhibitors directly correlates with their immunoglobulin synthesis rates. Therefore, we hypothesized that normal plasma cells are also hypersensitive to proteasome inhibition owing to their extremely high amount of protein biosynthesis. Here we show that the proteasome inhibitor bortezomib, which is approved for the treatment of multiple myeloma, eliminates both short- and long-lived plasma cells by activation of the terminal unfolded protein response. Treatment with bortezomib depleted plasma cells producing antibodies to double-stranded DNA, eliminated autoantibody production, ameliorated glomerulonephritis and prolonged survival of two mouse strains with lupus-like disease, NZB/W F1 and MRL/lpr mice. Hence, the elimination of autoreactive plasma cells by proteasome inhibitors might represent a new treatment strategy for antibody-mediated diseases.	[Neubert, Kirsten; Meister, Silke; Maseda, Damian; Voll, Reinhard E.] Univ Hosp, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr Mol Med, Res Grp N2, D-91054 Erlangen, Germany; [Moser, Katrin; Manz, Rudolf A.] German Arthrit Res Ctr, D-10117 Berlin, Germany; [Weisel, Florian; Winkler, Thomas H.] Univ Erlangen Nurnberg, Dept Biol, Hematopoiesis Unit, D-91054 Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany; [Wiethe, Carsten] Univ Hosp, Dept Dermatol, D-91054 Erlangen, Germany; [Kalden, Joachim R.; Voll, Reinhard E.] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Kalden, Joachim R.; Voll, Reinhard E.] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Voll, RE (corresponding author), Univ Hosp, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr Mol Med, Res Grp N2, Gluckstr 6, D-91054 Erlangen, Germany.	rvoll@molmed.uni-erlangen.de	Manz, Rudolf A/C-8340-2011	Maseda, Damian/0000-0003-0722-6881; Frey, Silke/0000-0001-9411-8357				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Ang HA, 1997, BLOOD, V89, P4646, DOI 10.1182/blood.V89.12.4646; Benner R., 1981, IMMUNOLOGICAL METHOD, VII, P247; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; Hideshima Teru, 2003, Rev Clin Exp Hematol, V7, P191; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; KLINMAN DM, 1995, IMMUNOL REV, V144, P157; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Lefkowith JB, 1996, ARTHRITIS RHEUM, V39, P894, DOI 10.1002/art.1780390605; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; Maseda D, 2008, CELL DEATH DIFFER, V15, P600, DOI 10.1038/sj.cdd.4402297; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; MILLER JJ, 1967, J EXP MED, V126, P109, DOI 10.1084/jem.126.1.109; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nencioni A, 2006, BLOOD, V108, P551, DOI 10.1182/blood-2005-08-3494; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schaumann DHS, 2007, MOL IMMUNOL, V44, P1606, DOI 10.1016/j.molimm.2006.08.021; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sfikakis PP, 2005, ARTHRITIS RHEUM-US, V52, P501, DOI 10.1002/art.20858; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Straube C, 2007, LEUKEMIA, V21, P1464, DOI 10.1038/sj.leu.2404734; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; vanTol MJD, 1996, BLOOD, V87, P818, DOI 10.1182/blood.V87.2.818.bloodjournal872818; Wellmann U, 2001, INT IMMUNOL, V13, P1461, DOI 10.1093/intimm/13.12.1461; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626	49	451	476	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					748	755		10.1038/nm1763	http://dx.doi.org/10.1038/nm1763			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18542049				2022-12-25	WOS:000257452700022
J	Park, TJ; Mitchell, BJ; Abitua, PB; Kintner, C; Wallingford, JB				Park, Tae Joo; Mitchell, Brian J.; Abitua, Philip B.; Kintner, Chris; Wallingford, John B.			Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; SUBCELLULAR-LOCALIZATION; INTRAFLAGELLAR TRANSPORT; CENTRIOLE FORMATION; SIGNALING PATHWAYS; QUAIL OVIDUCT; POLARITY; CILIOGENESIS; WNT; EMBRYOS	The planar cell polarity (PCP) signaling system governs many aspects of polarized cell behavior. Here, we use an in vivo model of vertebrate mucociliary epithelial development to show that Dishevelled (Dvl) is essential for the apical positioning of basal bodies. We find that Dvl and Inturned mediate the activation of the Rho GTPase specifically at basal bodies, and that these three proteins together mediate the docking of basal bodies to the apical plasma membrane. Moreover, we find that this docking involves a Dvl-dependent association of basal bodies with membrane-bound vesicles and the vesicle-trafficking protein, Sec8. Once docked, basal bodies again require Dvl and Rho for the planar polarization that underlies directional beating of cilia. These results demonstrate previously undescribed functions for PCP signaling components and suggest that a common signaling apparatus governs both apical docking and planar polarization of basal bodies.	[Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; [Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitchell, Brian J.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92186 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Salk Institute	Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Park, Tae Joo/G-1460-2011	Park, Tae Joo/0000-0003-3176-177X; Abitua, Philip/0000-0002-8264-0807; Mitchell, Brian/0000-0001-6281-1536	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076507, R01GM074104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076507, R01 GM074104-04, R01 GM074104-04S1, R01 GM076507-04, R01 GM074104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nokhbatolfoghahai M, 2005, J NAT HIST, V39, P887, DOI 10.1080/00222930400002937; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Raji AR, 2007, ANAT HISTOL EMBRYOL, V36, P10, DOI 10.1111/j.1439-0264.2006.00709.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SIVE HL, 2000, EARLY DEV XENOPUS IA; SOROKIN SP, 1968, J CELL SCI, V3, P207; STEINMAN RM, 1968, AM J ANAT, V122, P19, DOI 10.1002/aja.1001220103; Toskala E, 2005, AM J PHYSIOL-LUNG C, V289, pL454, DOI 10.1152/ajplung.00036.2005; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	50	334	341	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					871	879		10.1038/ng.104	http://dx.doi.org/10.1038/ng.104			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552847	Green Accepted			2022-12-25	WOS:000257166500022
J	Perez, EE; Wang, JB; Miller, JC; Jouvenot, Y; Kim, KA; Liu, O; Wang, N; Lee, G; Bartsevich, VV; Lee, YL; Guschin, DY; Rupniewski, I; Waite, AJ; Carpenito, C; Carroll, RG; Orange, JS; Urnov, FD; Rebar, EJ; Ando, D; Gregory, PD; Riley, JL; Holmes, MC; June, CH				Perez, Elena E.; Wang, Jianbin; Miller, Jeffrey C.; Jouvenot, Yann; Kim, Kenneth A.; Liu, Olga; Wang, Nathaniel; Lee, Gary; Bartsevich, Victor V.; Lee, Ya-Li; Guschin, Dmitry Y.; Rupniewski, Igor; Waite, Adam J.; Carpenito, Carmine; Carroll, Richard G.; Orange, Jordan S.; Urnov, Fyodor D.; Rebar, Edward J.; Ando, Dale; Gregory, Philip D.; Riley, James L.; Holmes, Michael C.; June, Carl H.			Establishment of HIV-1 resistance in CD4(+) T cells by genome editing using zinc-finger nucleases	NATURE BIOTECHNOLOGY			English	Article							GENE-TRANSFER; CHEMOKINE RECEPTOR; CHIMERIC NUCLEASES; LENTIVIRAL VECTOR; IMMUNE-RESPONSES; SMALL-MOLECULE; TROPIC HIV-1; STEM-CELLS; IN-VIVO; CCR5	Homozygosity for the naturally occurring Delta 32 deletion in the HIV co-receptor CCR5 confers resistance to HIV-1 infection. We generated an HIV-resistant genotype de novo using engineered zinc-finger nucleases (ZFNs) to disrupt endogenous CCR5. Transient expression of CCR5 ZFNs permanently and specifically disrupted similar to 50% of CCR5 alleles in a pool of primary human CD4(+) T cells. Genetic disruption of CCR5 provided robust, stable and heritable protection against HIV-1 infection in vitro and in vivo in a NOG model of HIV infection. HIV-1-infected mice engrafted with ZFN-modified CD4(+) T cells had lower viral loads and higher CD4(+) T-cell counts than mice engrafted with wild-type CD4(+) T cells, consistent with the potential to reconstitute immune function in individuals with HIV/AIDS by maintenance of an HIV-resistant CD4(+) T-cell population. Thus adoptive transfer of ex vivo expanded CCR5 ZFN-modified autologous CD4(+) T cells in HIV patients is an attractive approach for the treatment of HIV-1 infection.	[Perez, Elena E.; Liu, Olga; Carpenito, Carmine; Carroll, Richard G.; Riley, James L.; June, Carl H.] Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Perez, Elena E.; Orange, Jordan S.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Wang, Jianbin; Miller, Jeffrey C.; Jouvenot, Yann; Kim, Kenneth A.; Wang, Nathaniel; Lee, Gary; Bartsevich, Victor V.; Lee, Ya-Li; Guschin, Dmitry Y.; Rupniewski, Igor; Waite, Adam J.; Urnov, Fyodor D.; Rebar, Edward J.; Ando, Dale; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci Inc, Point Richmond Tech Ctr, Richmond, CA 94804 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sangamo Therapeutics, Inc.	June, CH (corresponding author), Abramson Family Canc Res Inst, Dept Pathol & Lab Med, 421 Curie Blvd,Room 554,BRB 2-3, Philadelphia, PA 19104 USA.	cjune@mail.med.upenn.edu	Wilson, Matthew H/K-3193-2013; Guschin, Dmitry/O-7594-2018; Guschin, Dmitry/U-3731-2019; Orange, Jordan S/D-5239-2009	Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; orange, jordan/0000-0001-7117-7725; Waite, Adam/0000-0002-3537-7313; Gregory, Philip/0000-0001-9249-2468; Riley, James/0000-0002-1057-576X; June, Carl/0000-0003-0241-3557	NHLBI NIH HHS [T32 HL007775] Funding Source: Medline; NIAID NIH HHS [K08AI062468, K08 AI062468, U19 AI082628-01, U19 AI082628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082628, K08AI062468] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abad JL, 2003, MOL THER, V8, P475, DOI 10.1016/S01525-0016(03)00202-8; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Bai JR, 2000, MOL THER, V1, P244, DOI 10.1006/mthe.2000.0038; Barassi C, 2005, J VIROL, V79, P6848, DOI 10.1128/JVI.79.11.6848-6858.2005; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moore M, 2001, P NATL ACAD SCI USA, V98, P1432, DOI 10.1073/pnas.98.4.1432; Morner A, 1999, J VIROL, V73, P2343; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schroers R, 2004, EXP HEMATOL, V32, P536, DOI 10.1016/j.exphem.2004.03.010; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c; Steinberger P, 2000, P NATL ACAD SCI USA, V97, P805, DOI 10.1073/pnas.97.2.805; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	50	766	951	3	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					808	816		10.1038/nbt1410	http://dx.doi.org/10.1038/nbt1410			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18587387	Green Accepted			2022-12-25	WOS:000257491600026
J	Campbell, PJ; Stephens, PJ; Pleasance, ED; O'Meara, S; Li, H; Santarius, T; Stebbings, LA; Leroy, C; Edkins, S; Hardy, C; Teague, JW; Menzies, A; Goodhead, I; Turner, DJ; Clee, CM; Quail, MA; Cox, A; Brown, C; Durbin, R; Hurles, ME; Edwards, PAW; Bignell, GR; Stratton, MR; Futreal, PA				Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Edwards, Paul A. W.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew			Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing	NATURE GENETICS			English	Article							PARTIAL TANDEM DUPLICATION; PROSTATE-CANCER; LUNG-CANCER; FUSION; GENES; TRANSLOCATIONS; TRANSCRIPTS; INVOLVE; LOCUS	Human cancers often carry many somatically acquired genomic rearrangements, some of which may be implicated in cancer development. However, conventional strategies for characterizing rearrangements are laborious and low-throughput and have low sensitivity or poor resolution. We used massively parallel sequencing to generate sequence reads from both ends of short DNA fragments derived from the genomes of two individuals with lung cancer. By investigating read pairs that did not align correctly with respect to each other on the reference human genome, we characterized 306 germline structural variants and 103 somatic rearrangements to the base-pair level of resolution. The patterns of germline and somatic rearrangement were markedly different. Many somatic rearrangements were from amplicons, although rearrangements outside these regions, notably including tandem duplications, were also observed. Some somatic rearrangements led to abnormal transcripts, including two from internal tandem duplications and two fusion transcripts created by interchromosomal rearrangements. Germline variants were predominantly mediated by retrotransposition, often involving AluY and LINE elements. The results demonstrate the feasibility of systematic, genome-wide characterization of rearrangements in complex human cancer genomes, raising the prospect of a new harvest of genes associated with cancer using this strategy.	[Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Edwards, Paul A. W.] Univ Cambridge, Hutchison Med Res Council, Res Ctr, Cambridge CB2 0XZ, England; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge CB2 0XZ, England; [Santarius, Thomas] Univ Cambridge, Dept Neurosurg, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk; paf@sanger.ac.uk	Quail, michael/ABE-6131-2020; Goodhead, Ian/ABC-9200-2020; Edwards, Paul A/M-8291-2014; Durbin, Richard/AAE-7178-2019; Li, Heng/D-9344-2011	Edwards, Paul A/0000-0002-4789-3374; Durbin, Richard/0000-0002-9130-1006; Li, Heng/0000-0003-4874-2874; Santarius, Thomas/0000-0002-1416-9566; Goodhead, Ian/0000-0002-3110-9442	Wellcome Trust [088340, 077012] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gazdar AF, 1996, J CELL BIOCHEM, P1; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grigorova M, 2005, CANCER GENET CYTOGEN, V162, P1, DOI 10.1016/j.cancergencyto.2005.03.007; HOWARTH KD, 2007, ONCOGENE ADV, DOI DOI 10.1038/SJ.ONC.1210993; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Robinson KO, 2005, MAMM GENOME, V16, P32, DOI 10.1007/s00335-004-2423-z; Rozier L, 2004, ONCOGENE, V23, P6872, DOI 10.1038/sj.onc.1207809; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wu GJ, 2000, CANCER RES, V60, P5371	24	603	682	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					722	729		10.1038/ng.128	http://dx.doi.org/10.1038/ng.128			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438408	Green Accepted			2022-12-25	WOS:000256212000014
J	Gudbjartsson, DF; Walters, GB; Thorleifsson, G; Stefansson, H; Halldorsson, BV; Zusmanovich, P; Sulem, P; Thorlacius, S; Gylfason, A; Steinberg, S; Helgadottir, A; Ingason, A; Steinthorsdottir, V; Olafsdottir, EJ; Olafsdottir, GH; Jonsson, T; Borch-Johnsen, K; Hansen, T; Andersen, G; Jorgensen, T; Pedersen, O; Aben, KK; Witjes, JA; Swinkels, DW; den Heijer, M; Franke, B; Verbeek, ALM; Becker, DM; Yanek, LR; Becker, LC; Tryggvadottir, L; Rafnar, T; Gulcher, J; Kiemeney, LA; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Walters, G. Bragi; Thorleifsson, Gudmar; Stefansson, Hreinn; Halldorsson, Bjarni V.; Zusmanovich, Pasha; Sulem, Patrick; Thorlacius, Steinunn; Gylfason, Arnaldur; Steinberg, Stacy; Helgadottir, Anna; Ingason, Andres; Steinthorsdottir, Valgerdur; Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Jonsson, Thorvaldur; Borch-Johnsen, Knut; Hansen, Torben; Andersen, Gitte; Jorgensen, Torben; Pedersen, Oluf; Aben, Katja K.; Witjes, J. Alfred; Swinkels, Dorine W.; den Heijer, Martin; Franke, Barbara; Verbeek, Andre L. M.; Becker, Diane M.; Yanek, Lisa R.; Becker, Lewis C.; Tryggvadottir, Laufey; Rafnar, Thorunn; Gulcher, Jeffrey; Kiemeney, Lambertus A.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Many sequence variants affecting diversity of adult human height	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; DATABASE; STATURE; MODEL; DNA	Adult human height is one of the classical complex human traits(1). We searched for sequence variants that affect height by scanning the genomes of 25,174 Icelanders, 2,876 Dutch, 1,770 European Americans and 1,148 African Americans. We then combined these results with previously published results from the Diabetes Genetics Initiative on 3,024 Scandinavians(2) and tested a selected subset of SNPs in 5,517 Danes. We identified 27 regions of the genome with one or more sequence variants showing significant association with height. The estimated effects per allele of these variants ranged between 0.3 and 0.6 cm and, taken together, they explain around 3.7% of the population variation in height. The genes neighboring the identified loci cluster in biological processes related to skeletal development and mitosis. Association to three previously reported loci are replicated in our analyses(3-5), and the strongest association was with SNPs in the ZBTB38 gene.	[Gudbjartsson, Daniel F.; Walters, G. Bragi; Thorleifsson, Gudmar; Stefansson, Hreinn; Halldorsson, Bjarni V.; Zusmanovich, Pasha; Sulem, Patrick; Thorlacius, Steinunn; Gylfason, Arnaldur; Steinberg, Stacy; Helgadottir, Anna; Ingason, Andres; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE, IS-101 Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Tryggvadottir, Laufey] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Jonsson, Thorvaldur] Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Hansen, Torben; Andersen, Gitte; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6500 HB Nijmegen, Netherlands; [Witjes, J. Alfred; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Dept Genet, NL-6500 HB Nijmegen, Netherlands; [Verbeek, Andre L. M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Becker, Diane M.; Yanek, Lisa R.; Becker, Lewis C.] Johns Hopkins Sch Med, Johns Hopkins Sibling & Family Heart Study, Baltimore, MD 21205 USA	Reykjavik University; Landspitali National University Hospital; Steno Diabetes Center; Aarhus University; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine	Stefansson, K (corresponding author), deCODE, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Walters, G. Bragi/L-4215-2013; Jørgensen, Torben/Z-1335-2018; Ingason, Andres/G-6817-2012; Franke, Barbara/D-4836-2009; Stefansson, Kari/AAE-7187-2019; Pedersen, Oluf/Z-1731-2019; Swinkels, Dorine W./H-8098-2014; Witjes, Fred/N-9665-2013; Verbeek, A.L.M./H-8103-2014; Aben, Katja KH/G-9686-2016; Pedersen, Oluf/AAG-8015-2020; Kiemeney, Lambertus A./D-3357-2009; den Heijer, Martin/J-8036-2015	Walters, G. Bragi/0000-0002-5415-6487; Franke, Barbara/0000-0003-4375-6572; Pedersen, Oluf/0000-0002-3321-3972; Swinkels, Dorine W./0000-0002-1040-9446; Verbeek, A.L.M./0000-0002-2319-5002; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Halldorsson, Bjarni/0000-0003-0756-0767; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; den Heijer, Martin/0000-0003-3620-5617; Hansen, Torben/0000-0001-8748-3831; Stefansson, Hreinn/0000-0002-9331-6666; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Jorgensen, Torben/0000-0001-9453-2830; Kong, Augustine/0000-0001-8193-5438				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Kiefer H, 2005, MOL CELL BIOL, V25, P1713, DOI 10.1128/MCB.25.5.1713-1729.2005; Kim KS, 2004, OBES RES, V12, P1981, DOI 10.1038/oby.2004.249; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Malecot G., 1948, MATH HEREDITE; Mamada M, 2007, HUM GENET, V120, P733, DOI 10.1007/s00439-006-0263-5; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Ogden CL, 2004, ADV DATA VITAL HLTH, V347; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121	30	495	503	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					609	615		10.1038/ng.122	http://dx.doi.org/10.1038/ng.122			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391951				2022-12-25	WOS:000255366700029
J	Petretto, E; Sarwar, R; Grieve, I; Lu, H; Kumaran, MK; Muckett, PJ; Mangion, J; Schroen, B; Benson, M; Punjabi, PP; Prasad, SK; Pennell, DJ; Kiesewetter, C; Tasheva, ES; Corpuz, LM; Webb, MD; Conrad, GW; Kurtz, TW; Kren, V; Fischer, J; Hubner, N; Pinto, YM; Pravenec, M; Aitman, TJ; Cook, SA				Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.; Kurtz, Theodore W.; Kren, Vladimir; Fischer, Judith; Hubner, Norbert; Pinto, Yigal M.; Pravenec, Michal; Aitman, Timothy J.; Cook, Stuart A.			Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; CARDIAC-HYPERTROPHY; HEART-FAILURE; PRESSURE; DISEASE; ECHOCARDIOGRAPHY; IDENTIFICATION; HERITABILITY; TRANSCRIPTS; STRESS	Left ventricular mass ( LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus(1) and quantitative trait transcript(2) ( QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin ( Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of similar to 22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.	[Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Aitman, Timothy J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W2 1PG, England; [Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Gen Teaching Hosp, Prague 12800 2, Czech Republic; [Fischer, Judith; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Pinto, Yigal M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Mol Genet & Rheumatol, London W12 0NN, England; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London; Kansas State University; University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; General University Hospital Prague; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk; stuart.cook@imperial.ac.uk	Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Punjabi, Prakash P/AAG-8724-2019	Pravenec, Michal/0000-0001-9197-5871; Punjabi, Prakash P/0000-0002-6587-1603; Cook, Stuart/0000-0001-6628-194X; Pennell, Dudley/0000-0001-5523-1314; Fischer-Sternjak, Judith/0000-0003-0398-7720; Benson, Matthew/0000-0003-4459-0439; Aitman, Timothy/0000-0002-7875-4502	NATIONAL EYE INSTITUTE [R01EY000952, R01EY013395] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120061454, MC_U120097112, MC_U120085815] Funding Source: Medline; NEI NIH HHS [R01 EY013395, EY13395, EY000952, R01 EY000952] Funding Source: Medline; Wellcome Trust [066780] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [MC_U120085815, MC_U120061454] Funding Source: UKRI	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); British Heart Foundation(British Heart Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1; Cerutti C, 2006, PHYSIOL GENOMICS, V27, P295, DOI 10.1152/physiolgenomics.00318.2005; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Cook SA, 1999, CIRC RES, V85, P940; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Devereux RB, 1997, CIRCULATION, V96, P1416, DOI 10.1161/01.CIR.96.5.1416; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hashimoto J, 2007, AM J HYPERTENS, V20, P378, DOI 10.1016/j.amjhyper.2006.09.019; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Lorell BH, 2000, CIRCULATION, V102, P470; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Tasheva ES, 2002, MOL VIS, V8, P407; Tasheva ES, 1997, J BIOL CHEM, V272, P32551, DOI 10.1074/jbc.272.51.32551; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	30	130	137	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					546	552		10.1038/ng.134	http://dx.doi.org/10.1038/ng.134			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443592	Green Accepted			2022-12-25	WOS:000255366700020
J	Saar, K; Beck, A; Bihoreau, MT; Birney, E; Brocklebank, D; Chen, Y; Cuppen, E; Demonchy, S; Dopazo, J; Flicek, P; Foglio, M; Fujiyama, A; Gut, IG; Gauguier, D; Guigo, R; Guryev, V; Heinig, M; Hummel, O; Jahn, N; Klages, S; Kren, V; Kube, M; Kuhl, H; Kuramoto, T; Kuroki, Y; Lechner, D; Lee, YA; Lopez-Bigas, N; Lathrop, GM; Mashimo, T; Medina, I; Mott, R; Patone, G; Perrier-Cornet, JA; Platzer, M; Pravenec, M; Reinhardt, R; Sakaki, Y; Schilhabel, M; Schulz, H; Serikawa, T; Shikhagaie, M; Tatsumoto, S; Taudien, S; Toyoda, A; Voigt, B; Zelenika, D; Zimdahl, H; Hubner, N				Saar, Kathrin; Beck, Alfred; Bihoreau, Marie-Therese; Birney, Ewan; Brocklebank, Denise; Chen, Yuan; Cuppen, Edwin; Demonchy, Stephanie; Dopazo, Joaquin; Flicek, Paul; Foglio, Mario; Fujiyama, Asao; Gut, Ivo G.; Gauguier, Dominique; Guigo, Roderic; Guryev, Victor; Heinig, Matthias; Hummel, Oliver; Jahn, Niels; Klages, Sven; Kren, Vladimir; Kube, Michael; Kuhl, Heiner; Kuramoto, Takashi; Kuroki, Yoko; Lechner, Doris; Lee, Young-Ae; Lopez-Bigas, Nuria; Lathrop, G. Mark; Mashimo, Tomoji; Medina, Ignacio; Mott, Richard; Patone, Giannino; Perrier-Cornet, Jeanne-Antide; Platzer, Matthias; Pravenec, Michal; Reinhardt, Richard; Sakaki, Yoshiyuki; Schilhabel, Markus; Schulz, Herbert; Serikawa, Tadao; Shikhagaie, Medya; Tatsumoto, Shouji; Taudien, Stefan; Toyoda, Atsushi; Voigt, Birger; Zelenika, Diana; Zimdahl, Heike; Hubner, Norbert		STAR Consortium	SNP and haplotype mapping for genetic analysis in the rat	NATURE GENETICS			English	Article							WISTAR-KYOTO RATS; SEQUENCE; MOUSE; MAP; STRAINS; SET	The laboratory rat is one of the most extensively studied model organisms. Inbred laboratory rat strains originated from limited Rattus norvegicus founder populations, and the inherited genetic variation provides an excellent resource for the correlation of genotype to phenotype. Here, we report a survey of genetic variation based on almost 3 million newly identified SNPs. We obtained accurate and complete genotypes for a subset of 20,238 SNPs across 167 distinct inbred rat strains, two rat recombinant inbred panels and an F-2 intercross. Using 81% of these SNPs, we constructed high-density genetic maps, creating a large dataset of fully characterized SNPs for disease gene mapping. Our data characterize the population structure and illustrate the degree of linkage disequilibrium. We provide a detailed SNP map and demonstrate its utility for mapping of quantitative trait loci. This community resource is openly available and augments the genetic tools for this workhorse of physiological studies.	[Saar, Kathrin; Heinig, Matthias; Hummel, Oliver; Lee, Young-Ae; Patone, Giannino; Schulz, Herbert; Zimdahl, Heike; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-14195 Berlin, Germany; [Beck, Alfred; Klages, Sven; Kube, Michael; Kuhl, Heiner; Mott, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Bihoreau, Marie-Therese; Brocklebank, Denise; Gauguier, Dominique; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Birney, Ewan; Chen, Yuan; Flicek, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Cuppen, Edwin; Guryev, Victor] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Demonchy, Stephanie; Foglio, Mario; Gut, Ivo G.; Lechner, Doris; Lathrop, G. Mark; Perrier-Cornet, Jeanne-Antide; Zelenika, Diana] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, F-91057 Evry, France; [Dopazo, Joaquin; Medina, Ignacio] Ctr Invest Principe Felipe, Dept Bioinformat & Funct Genom Node, Valencia 46012, Spain; [Fujiyama, Asao; Kuroki, Yoko; Sakaki, Yoshiyuki; Tatsumoto, Shouji; Toyoda, Atsushi] RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Guigo, Roderic; Lopez-Bigas, Nuria] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Guigo, Roderic; Lopez-Bigas, Nuria; Shikhagaie, Medya] Univ Pompeu Fabra, Expt & Hlth Sci Dept, Barcelona 08003, Catalonia, Spain; [Jahn, Niels; Platzer, Matthias; Schilhabel, Markus; Taudien, Stefan] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kuramoto, Takashi; Mashimo, Tomoji; Serikawa, Tadao; Voigt, Birger] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; [Lee, Young-Ae] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Prince Felipe Research Center; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Kyoto University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-14195 Berlin, Germany.	nhuebner@mdc-berlin.de	Lopez-Bigas, Nuria/F-6193-2011; Kuhl, Heiner/L-2737-2019; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Gauguier, Dominique/G-2190-2016; Dopazo, Joaquin/A-9270-2014; Medina, Ignacio/B-3045-2011; Guigo, Roderic/D-1303-2010; Pravenec, Michal/B-1666-2012; Foglio, mary A./B-9149-2012; Gut, Ivo/ABF-3188-2020; Gasull, Martina/J-4076-2019	Lopez-Bigas, Nuria/0000-0003-4925-8988; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Gauguier, Dominique/0000-0001-6156-9530; Dopazo, Joaquin/0000-0003-3318-120X; Guigo, Roderic/0000-0002-5738-4477; Pravenec, Michal/0000-0001-9197-5871; Foglio, mary A./0000-0001-7715-4452; Gut, Ivo/0000-0001-7219-632X; Shikhagaie, Medya Mara/0000-0003-1978-8048; Reinhardt, Richard/0000-0001-9376-2132; Heinig, Matthias/0000-0002-5612-1720; Mott, Richard/0000-0002-1022-9330; Saar, Kathrin/0000-0002-4483-1557; Flicek, Paul/0000-0002-3897-7955; Guryev, Victor/0000-0002-5810-6022; Birney, Ewan/0000-0001-8314-8497; Medina, Ignacio/0000-0003-0095-670X				Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Broman KW, 2005, GENETICS, V169, P1133, DOI 10.1534/genetics.104.035212; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, V3, P1154; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Guryev V, 2004, GENOME RES, V14, P1438, DOI 10.1101/gr.2154304; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; HEDRICH HJ, 1990, GENETIC MONITORING I; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-19; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Oliphant A, 2002, BIOTECHNIQUES, P56; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Shisa H, 1997, MAMM GENOME, V8, P324, DOI 10.1007/s003359900432; Smits BMG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-170; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas MA, 2003, MAMM GENOME, V14, P61, DOI 10.1007/s00335-002-2204-5; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	41	141	142	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					560	566		10.1038/ng.124	http://dx.doi.org/10.1038/ng.124			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443594	Green Accepted			2022-12-25	WOS:000255366700022
J	Cirl, C; Wieser, A; Yadav, M; Duerr, S; Schubert, S; Fischer, H; Stappert, D; Wantia, N; Rodriguez, N; Wagner, H; Svanborg, C; Miethke, T				Cirl, Christine; Wieser, Andreas; Yadav, Manisha; Duerr, Susanne; Schubert, Soeren; Fischer, Hans; Stappert, Dominik; Wantia, Nina; Rodriguez, Nuria; Wagner, Hermann; Svanborg, Catharina; Miethke, Thomas			Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins	NATURE MEDICINE			English	Article							ANTIMICROBIAL DRUG SUSCEPTIBILITY; UROPATHOGENIC ESCHERICHIA-COLI; EFFLUX PUMP INHIBITOR; BRUCELLA-ABORTUS; VIRULENCE FACTOR; VACCINIA VIRUS; URINARY-TRACT; INFECTION; 1-(1-NAPHTHYLMETHYL)-PIPERAZINE; INVASION	Pathogenic microbes have evolved sophisticated molecular strategies to subvert host defenses. Here we show that virulent bacteria interfere directly with Toll- like receptor ( TLR) function by secreting inhibitory homologs of the Toll/ interleukin- 1 receptor ( TIR) domain. Genes encoding TIR domain containing - proteins ( Tcps) were identified in Escherichia coli CFT073 ( TcpC) and Brucella melitensis ( TcpB). We found that TcpC is common in the most virulent uropathogenic E. coli strains and promotes bacterial survival and kidney pathology in vivo. In silico analysis predicted significant tertiary structure homology to the TIR domain of human TLR1, and we show that the Tcps impede TLR signaling through the myeloid differentiation factor 88 ( MyD88) adaptor protein, owing to direct binding of Tcps to MyD88. Tcps represent a new class of virulence factors that act by inhibiting TLR- and MyD88- specific signaling, thus suppressing innate immunity and increasing virulence.	[Cirl, Christine; Duerr, Susanne; Wantia, Nina; Rodriguez, Nuria; Wagner, Hermann; Miethke, Thomas] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany; [Wieser, Andreas; Schubert, Soeren] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Yadav, Manisha; Fischer, Hans; Stappert, Dominik; Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, S-22362 Lund, Sweden	Technical University of Munich; University of Munich; Lund University	Miethke, T (corresponding author), Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Trogerstr 30, D-81675 Munich, Germany.	Thomas.Miethke@lrz.tum.de						Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEAN MA, 1974, INT J CANCER, V14, P186, DOI 10.1002/ijc.2910140207; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Frendeus B, 2001, MOL MICROBIOL, V40, P37, DOI 10.1046/j.1365-2958.2001.02361.x; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; HAGBERG L, 1983, INFECT IMMUN, V40, P265, DOI 10.1128/IAI.40.1.265-272.1983; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kern WV, 2006, J ANTIMICROB CHEMOTH, V57, P339, DOI 10.1093/jac/dki445; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Pannek S, 2006, J ANTIMICROB CHEMOTH, V57, P970, DOI 10.1093/jac/dkl081; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radons JR, 2003, J BIOL CHEM, V278, P49145, DOI 10.1074/jbc.M306077200; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	32	293	315	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					399	406		10.1038/nm1734	http://dx.doi.org/10.1038/nm1734			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18327267				2022-12-25	WOS:000254674100026
J	Friedlander, MR; Chen, W; Adamidi, C; Maaskola, J; Einspanier, R; Knespel, S; Rajewsky, N				Friedlaender, Marc R.; Chen, Wei; Adamidi, Catherine; Maaskola, Jonas; Einspanier, Ralf; Knespel, Signe; Rajewsky, Nikolaus			Discovering microRNAs from deep sequencing data using miRDeep	NATURE BIOTECHNOLOGY			English	Article							C-ELEGANS; SMALL RNAS; POSTTRANSCRIPTIONAL REGULATION; NONCODING RNAS; IDENTIFICATION; EXPRESSION; GENES; CONSERVATION; MECHANISMS; GERMLINE	The capacity of highly parallel sequencing technologies to detect small RNAs at unprecedented depth suggests their value in systematically identifying microRNAs ( miRNAs). However, the identification of miRNAs from the large pool of sequenced transcripts from a single deep sequencing run remains a major challenge. Here, we present an algorithm, miRDeep, which uses a probabilistic model of miRNA biogenesis to score compatibility of the position and frequency of sequenced RNA with the secondary structure of the miRNA precursor. We demonstrate its accuracy and robustness using published Caenorhabditis elegans data and data we generated by deep sequencing human and dog RNAs. miRDeep reports altogether similar to 230 previously unannotated miRNAs, of which four novel C. elegans miRNAs are validated by northern blot analysis.	[Friedlaender, Marc R.; Adamidi, Catherine; Maaskola, Jonas; Knespel, Signe; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Chen, Wei] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Einspanier, Ralf] Free Univ Berlin, Inst Vet Biochem, D-14163 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Free University of Berlin	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	rajewsky@mdc-berlin.de	Chen, Wei/C-1273-2011	Friedlander, Marc/0000-0001-6577-4363; Chen, Wei/0000-0003-3263-1627; Rajewsky, Nikolaus/0000-0002-4785-4332				Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen Q, 2006, J REPROD IMMUNOL, V71, P149, DOI 10.1016/j.jri.2006.08.024; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Palakodeti D, 2006, RNA, V12, P1640, DOI 10.1261/rna.117206; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rettig MP, 1999, BLOOD, V93, P376, DOI 10.1182/blood.V93.1.376.401k41_376_384; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	39	905	1170	3	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					407	415		10.1038/nbt1394	http://dx.doi.org/10.1038/nbt1394			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18392026				2022-12-25	WOS:000254782500023
J	Kosaka, H; Yoshimoto, T; Yoshimoto, T; Fujimoto, J; Nakanishi, K				Kosaka, Hisashi; Yoshimoto, Tomohiro; Yoshimoto, Takayuki; Fujimoto, Jiro; Nakanishi, Kenji			Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation	NATURE MEDICINE			English	Article							HEPATOCYTE GROWTH-FACTOR; V-ALPHA-14 NKT CELLS; NEUROKININ-1 RECEPTOR; MICE; FIBRINOLYSIS; PERITONEUM; DISEASE; SURGERY; CLONING; GENE	Intestinal adhesions are bands of fibrous tissue that connect the loops of the intestine to each other, to other abdominal organs or to the abdominal wall(1-3). Fibrous tissue formation is regulated by the balance between plasminogen activator inhibitor type 1 ( PAI- 1) and tissue- type plasminogen activator ( tPA), which reciprocally regulate fibrin deposition. Several components of the inflammatory system, including cytokines(4), chemokines, cell adhesion molecules and neuropeptide substance P, have been reported to participate in adhesion formation(4-7). We have used cecal cauterization to develop a unique experimental mouse model of intestinal adhesion. Mice developed severe intestinal adhesion after this treatment. Adhesion development depended upon the interferon-gamma ( IFN-gamma) and signal transducer and activator of transcription- 1 ( STAT1) system. Natural killer T ( NKT) cell - deficient mice developed adhesion poorly, whereas they developed severe adhesion after reconstitution with NKT cells from wild- type mice, suggesting that NKT cell IFN-gamma production is indispensable for adhesion formation. This response does not depend on STAT4, STAT6, interleukin- 12 ( IL- 12), IL- 18, tumor necrosis factor-alpha, Toll- like receptor 4 or myeloid differentiation factor- 88 - mediated signals. Wild- type mice increased the ratio of PAI- 1 to tPA after cecal cauterization, whereas Ifng(-/-) or Stat1(-/-) mice did not, suggesting that IFN-gamma has a crucial role in the differential regulation of PAI- 1 and tPA. Additionally, hepatocyte growth factor, a potent mitogenic factor for hepatocytes(8,9), strongly inhibited intestinal adhesion by diminishing IFN-gamma production, providing a potential new way to prevent postoperative adhesions.	[Yoshimoto, Tomohiro; Nakanishi, Kenji] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan; [Kosaka, Hisashi; Fujimoto, Jiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Yoshimoto, Tomohiro; Nakanishi, Kenji] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Yoshimoto, Takayuki] Tokyo Med Univ, Intractable Immune Syst Dis Res Ctr, Tokyo 1608402, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Japan Science & Technology Agency (JST); Tokyo Medical University	Nakanishi, K (corresponding author), Hyogo Coll Med, Dept Immunol & Med Zool, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	nakaken@hyo-med.ac.jp	Yoshimoto, Tomohiro/E-2224-2014; Yoshimoto, Takayuki/AAN-7995-2020	Yoshimoto, Takayuki/0000-0002-2847-0341				Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Chung DR, 2002, J EXP MED, V195, P1471, DOI 10.1084/jem.20020028; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Ellis H, 1997, EUR J SURG, V163, P5; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; FANCIULLACCI M, 1993, EXPERIENTIA, V49, P242, DOI 10.1007/BF01923533; Ghellai AM, 2000, J GASTROINTEST SURG, V4, P316, DOI 10.1016/S1091-255X(00)80082-7; Holmdahl L, 1996, SURGERY, V119, P701, DOI 10.1016/S0039-6060(96)80196-6; Holmdahl L, 1997, EUR J SURG, V163, P24; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Katayama I, 1997, J DERMATOL SCI, V15, P201, DOI 10.1016/S0923-1811(97)00608-7; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kennedy R, 1996, SURGERY, V120, P866, DOI 10.1016/S0039-6060(96)80096-1; Kocak I, 1999, FERTIL STERIL, V72, P873, DOI 10.1016/S0015-0282(99)00368-4; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Parker M C, 2004, Colorectal Dis, V6, P506, DOI 10.1111/j.1463-1318.2004.00709.x; RAFTERY AT, 1979, J ANAT, V129, P659; Reed KL, 2004, P NATL ACAD SCI USA, V101, P9115, DOI 10.1073/pnas.0403210101; Reed KL, 2002, J SURG RES, V108, P165, DOI 10.1006/jsre.2002.6533; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tjarnstrom J, 1999, EUR J SURG, V165, P834; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	30	80	86	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2008	14	4					437	441		10.1038/nm1733	http://dx.doi.org/10.1038/nm1733			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18345012				2022-12-25	WOS:000254674100031
J	Zakrzewski, JL; Suh, D; Markley, JC; Smith, OM; King, C; Goldberg, GL; Jenq, R; Holland, AM; Grubin, J; Cabrera-Perez, J; Brentjens, RJ; Lu, SX; Rizzuto, G; Sant'Angelo, DB; Riviere, I; Sadelain, M; Heller, G; Zuniga-Pflucker, JC; Lu, C; van den Brink, MRM				Zakrzewski, Johannes L.; Suh, David; Markley, John C.; Smith, Odette M.; King, Christopher; Goldberg, Gabrielle L.; Jenq, Robert; Holland, Amanda M.; Grubin, Jeremy; Cabrera-Perez, Javier; Brentjens, Renier J.; Lu, Sydney X.; Rizzuto, Gabrielle; Sant'Angelo, Derek B.; Riviere, Isabelle; Sadelain, Michel; Heller, Glenn; Zuniga-Pflucker, Juan Carlos; Lu, Chen; van den Brink, Marcel R. M.			Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors	NATURE BIOTECHNOLOGY			English	Article							EARLY LYMPHOCYTE RECOVERY; PREDICTS SUPERIOR SURVIVAL; DELTA-LIKE-1 IN-VITRO; NON-HODGKIN-LYMPHOMA; VERSUS-HOST-DISEASE; STEM-CELLS; MYELOGENOUS LEUKEMIA; POSITIVE SELECTION; PROLONGED SURVIVAL; PROGENITOR CELLS	We present a strategy for adoptive immunotherapy using T-lineage committed lymphoid precursor cells generated by Notch1-based culture. We found that allogeneic T-cell precursors can be transferred to irradiated individuals irrespective of major histocompatibility complex (MHC) disparities and give rise to host-MHC restricted and host-tolerant functional allogeneic T cells, improving survival in irradiated recipients as well as enhancing anti-tumor responses. T-cell precursors transduced to express a chimeric receptor targeting hCD19 resulted in significant additional anti-tumor activity, demonstrating the feasibility of genetic engineering of these cells. We conclude that ex vivo generated MHC-disparate T-cell precursors from any donor can be used universally for 'off-the-shelf' immunotherapy, and can be further enhanced by genetic engineering for targeted immunotherapy.	[Zakrzewski, Johannes L.; Suh, David; Smith, Odette M.; King, Christopher; Goldberg, Gabrielle L.; Jenq, Robert; Holland, Amanda M.; Grubin, Jeremy; Cabrera-Perez, Javier; Lu, Sydney X.; Rizzuto, Gabrielle; Sant'Angelo, Derek B.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Markley, John C.; Riviere, Isabelle; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol, New York, NY 10021 USA; [Jenq, Robert; Brentjens, Renier J.; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Heller, Glenn] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Zuniga-Pflucker, Juan Carlos] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Lu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; State University System of Florida; University of Florida	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, 1275 York Ave, New York, NY 10021 USA.	m-van-den-brink@ski.mskcc.org	markley, john/AAJ-6686-2021; van den Brink, Marcel R. M./HGB-9434-2022; Rizzuto, Gabrielle/GWR-2224-2022; Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Rizzuto, Gabrielle/0000-0003-3052-0253; Lu, Sydney/0000-0002-2217-1674	NCI NIH HHS [R24 CA083084, P01 CA033049-260016, CA33049, R24 CA83084, P01 CA059350, R01 CA107096-03, P30 CA008748, R01 CA107096-01A1, R01 CA107096-05, P30 CA08748, CA107096, P01 CA033049, R01 CA107096-04, CA59350, R01 CA107096-02, R01 CA107096, P01 CA033049-250016, CA40350] Funding Source: Medline; NHLBI NIH HHS [R01 HL069929-01, R01 HL069929-06, R01 HL069929-04, R01 HL069929-08, R01 HL069929-03, R01 HL069929-07, R01 HL069929-05A1, R01 HL069929-02, R01 HL069929, HL69929] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA033049, R24CA083084, R01CA107096, P01CA059350, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE R, 1991, J IMMUNOL, V147, P739; ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Chinen J, 2006, J ALLERGY CLIN IMMUN, V118, P489, DOI 10.1016/j.jaci.2006.05.021; Cohen JI, 2003, SEMIN HEMATOL, V40, P116, DOI 10.1016/S0037-1963(03)70003-1; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Dallas MH, 2007, BLOOD, V109, P3579, DOI 10.1182/blood-2006-08-039842; De Smedt M, 2004, BLOOD CELL MOL DIS, V33, P227, DOI 10.1016/j.bcmd.2004.08.007; Ernst BB, 1996, J EXP MED, V183, P1235, DOI 10.1084/jem.183.3.1235; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Gordan LN, 2003, BONE MARROW TRANSPL, V31, P1009, DOI 10.1038/sj.bmt.1704050; Gottschalk S, 2005, LEUKEMIA LYMPHOMA, V46, P1, DOI 10.1080/10428190400002202; Gottschalk S, 2002, ADV CANCER RES, V84, P175, DOI 10.1016/S0065-230X(02)84006-4; Greiner J, 2006, BLOOD, V108, P4109, DOI 10.1182/blood-2006-01-023127; Grunebaum E, 2006, IMMUNOL RES, V35, P117, DOI 10.1385/IR:35:1:117; HESLOP HE, 1994, NEW ENGL J MED, V331, P679; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Joao C, 2006, BONE MARROW TRANSPL, V37, P865, DOI 10.1038/sj.bmt.1705342; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; KOLB HJ, 1995, BLOOD, V86, P2050; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Leemhuis T, 2005, BIOL BLOOD MARROW TR, V11, P181, DOI 10.1016/j.bbmt.2004.11.019; Lehrnbecher T, 1997, J PEDIAT HEMATOL ONC, V19, P399, DOI 10.1097/00043426-199709000-00001; Liggins AP, 2005, METH MOLEC MED, V115, P109; Luznik L, 2003, BLOOD, V101, P1645, DOI 10.1182/blood-2002-07-2233; Mackall CL, 1997, IMMUNOL REV, V160, P91, DOI 10.1111/j.1600-065X.1997.tb01030.x; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Ohishi K, 2002, J CLIN INVEST, V110, P1165, DOI 10.1172/JCI200216167; Porrata LF, 2001, BLOOD, V98, P579, DOI 10.1182/blood.V98.3.579; Porrata LF, 2002, BRIT J HAEMATOL, V117, P629, DOI 10.1046/j.1365-2141.2002.03478.x; Porrata LF, 2002, LEUKEMIA, V16, P1311, DOI 10.1038/sj.leu.2402503; Porrata LF, 2001, BONE MARROW TRANSPL, V28, P865, DOI 10.1038/sj.bmt.1703236; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; VACCHIO MS, 1989, J EXP MED, V170, P1335, DOI 10.1084/jem.170.4.1335; Vardi Y, 2001, BIOMETRIKA, V88, P949, DOI 10.1093/biomet/88.4.949; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Yang L, 2002, P NATL ACAD SCI USA, V99, P6204, DOI 10.1073/pnas.092154599; YARILIN AA, 1993, INT J RADIAT BIOL, V63, P519, DOI 10.1080/09553009314550681; Yotnda P, 1998, J CLIN INVEST, V101, P2290, DOI 10.1172/JCI488; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	55	90	95	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					453	461		10.1038/nbt1395	http://dx.doi.org/10.1038/nbt1395			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18376399	Green Accepted			2022-12-25	WOS:000254782500028
J	Zheng, Y; Valdez, PA; Danilenko, DM; Hu, Y; Sa, SM; Gong, Q; Abbas, AR; Modrusan, Z; Ghilardi, N; de Sauvage, FJ; Ouyang, W				Zheng, Yan; Valdez, Patricia A.; Danilenko, Dimitry M.; Hu, Yan; Sa, Susan M.; Gong, Qian; Abbas, Alexander R.; Modrusan, Zora; Ghilardi, Nico; de Sauvage, Frederic J.; Ouyang, Wenjun			Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CITROBACTER-RODENTIUM; CUTTING EDGE; EXPRESSION; IL-22; CELLS; GENE; LYMPHOCYTES; RESPONSES; CYTOKINE	Infections by attaching and effacing (A/E) bacterial pathogens, such as Escherichia coli O157:H7, pose a serious threat to public health. Using a mouse A/E pathogen, Citrobacter rodentium, we show that interleukin-22 (IL-22) has a crucial role in the early phase of host defense against C. rodentium. Infection of IL-22 knockout mice results in increased intestinal epithelial damage, systemic bacterial burden and mortality. We also find that IL-23 is required for the early induction of IL-22 during C. rodentium infection, and adaptive immunity is not essential for the protective role of IL-22 in this model. Instead, IL-22 is required for the direct induction of the Reg family of antimicrobial proteins, including RegIII beta and RegIII gamma, in colonic epithelial cells. Exogenous mouse or human RegIII gamma substantially improves survival of IL-22 knockout mice after C. rodentium infection. Together, our data identify a new innate immune function for IL-22 in regulating early defense mechanisms against A/E bacterial pathogens.	[Zheng, Yan; Valdez, Patricia A.; Hu, Yan; Gong, Qian; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Danilenko, Dimitry M.; Sa, Susan M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Abbas, Alexander R.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Modrusan, Zora; Ghilardi, Nico; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, W (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com	Zheng, Yan/A-6993-2008; de Sauvage, Frederic/ABE-8400-2020; Ouyang, Wenjun/ABA-8763-2020	Zheng, Yan/0000-0002-7002-277X; de Sauvage, Frederic/0000-0002-5275-2584; Ouyang, Wenjun/0000-0002-1811-5864; Hu, Yan Helen/0000-0003-3269-4505; Danilenko, Dimitry/0000-0002-8326-1921; Ghilardi, Nico/0000-0003-4945-3097				Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; CAMERINI V, 1993, J IMMUNOL, V151, P1765; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1045; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Goncalves NS, 2001, INFECT IMMUN, V69, P6651, DOI 10.1128/IAI.69.11.6651-6659.2001; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keilbaugh SA, 2005, GUT, V54, P623, DOI 10.1136/gut.2004.056028; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Moucadel V, 2001, EUR J CELL BIOL, V80, P156, DOI 10.1078/0171-9335-00148; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; SCHAUER DB, 1993, INFECT IMMUN, V61, P2486, DOI 10.1128/IAI.61.6.2486-2492.1993; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Weber GF, 2007, INFECT IMMUN, V75, P1690, DOI 10.1128/IAI.01564-06; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; World Health Organization, 2004, WORLD HLTH REP 2004; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	44	1391	1460	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2008	14	3					282	289		10.1038/nm1720	http://dx.doi.org/10.1038/nm1720			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18264109				2022-12-25	WOS:000253815700034
J	Cree, LM; Samuels, DC; Lopes, SCDS; Rajasimha, HK; Wonnapinij, P; Mann, JR; Dahl, HHM; Chinnery, PF				Cree, Lynsey M.; Samuels, David C.; Lopes, Susana Chuva de Sousa; Rajasimha, Harsha Karur; Wonnapinij, Passorn; Mann, Jeffrey R.; Dahl, Hans-Henrik M.; Chinnery, Patrick F.			A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PRIMORDIAL GERM-CELLS; RANDOM GENETIC DRIFT; MOUSE EMBRYOS; D-LOOP; MTDNA; OOCYTES; MICE; PROLIFERATION; HETEROPLASMY	Mammalian mitochondrial DNA (mtDNA) is inherited principally down the maternal line, but the mechanisms involved are not fully understood. Females harboring a mixture of mutant and wild-type mtDNA (heteroplasmy) transmit a varying proportion of mutant mtDNA to their offspring. In humans with mtDNA disorders, the proportion of mutated mtDNA inherited from the mother correlates with disease severity(1-4). Rapid changes in allele frequency can occur in a single generation(5,6). This could be due to a marked reduction in the number of mtDNA molecules being transmitted from mother to offspring (the mitochondrial genetic bottleneck), to the partitioning of mtDNA into homoplasmic segregating units, or to the selection of a group of mtDNA molecules to re-populate the next generation. Here we show that the partitioning of mtDNA molecules into different cells before and after implantation, followed by the segregation of replicating mtDNA between proliferating primordial germ cells, is responsible for the different levels of heteroplasmy seen in the offspring of heteroplasmic female mice.	[Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Samuels, David C.; Rajasimha, Harsha Karur; Wonnapinij, Passorn] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lopes, Susana Chuva de Sousa] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mann, Jeffrey R.] City Hope Natl Med Ctr, Div Biol, Duarte, CA 91010 USA; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Virginia Polytechnic Institute & State University; University of Cambridge; City of Hope; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Samuels, David/C-1365-2012	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Cree, Lynsey/0000-0003-2090-1589; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hogan B, 1994, MANIPULATING MOUSE E; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VILKKI J, 1990, AM J HUM GENET, V47, P95; Wright S., 1969, EVOLUTION GENETICS P	30	347	354	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					249	254		10.1038/ng.2007.63	http://dx.doi.org/10.1038/ng.2007.63			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18223651				2022-12-25	WOS:000252732900026
J	Sackstein, R; Merzaban, JS; Cain, DW; Dagia, NM; Spencer, JA; Lin, CP; Wohlgemuth, R				Sackstein, Robert; Merzaban, Jasmeen S.; Cain, Derek W.; Dagia, Nilesh M.; Spencer, Joel A.; Lin, Charles P.; Wohlgemuth, Roland			Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone	NATURE MEDICINE			English	Article							L-SELECTIN LIGAND; STEM-CELLS; ADHESION MOLECULE-1; P-SELECTIN; EXPRESSION; BINDING; FUCOSYLATION; DISTINCT; MN2+	The capacity to direct migration ('homing') of blood-borne cells to a predetermined anatomic compartment is vital to stem cell based tissue engineering and other adoptive cellular therapies. Although multipotent mesenchymal stromal cells (MSCs, also termed 'mesenchymal stem cells') hold the potential for curing generalized skeletal diseases, their clinical effectiveness is constrained by the poor osteotropism of infused MSCs (refs. 1-3). Cellular recruitment to bone occurs within specialized marrow vessels that constitutively express vascular E-selectin(4,5), a lectin that recognizes sialofucosylated determinants on its various ligands. We show here that human MSCs do not express E-selectin ligands, but express a CD44 glycoform bearing alpha-2,3-sialyl modifications. Using an alpha-1,3-fucosyltransferase preparation and enzymatic conditions specifically designed for treating live cells, we converted the native CD44 glycoform on MSCs into hematopoietic cell E-selectin/L-selectin ligand (HCELL)(6), which conferred potent E-selectin binding without effects on cell viability or multipotency. Real-time intravital microscopy in immunocompromised (NOD/SCID) mice showed that intravenously infused HCELL+ MSCs infiltrated marrow within hours of infusion, with ensuing rare foci of endosteally localized cells and human osteoid generation. These findings establish that the HCELL glycoform of CD44 confers tropism to bone and unveil a readily translatable roadmap for programming cellular trafficking by chemical engineering of glycans on a distinct membrane glycoprotein.	[Sackstein, Robert; Merzaban, Jasmeen S.; Cain, Derek W.; Dagia, Nilesh M.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Sackstein, Robert; Merzaban, Jasmeen S.; Cain, Derek W.; Dagia, Nilesh M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sackstein, Robert; Merzaban, Jasmeen S.; Cain, Derek W.; Dagia, Nilesh M.] Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Sackstein, Robert] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Spencer, Joel A.; Lin, Charles P.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wohlgemuth, Roland] Sigma Aldrich, CH-9470 Buchs, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Sackstein, R (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	rsackstein@rics.bwh.harvard.edu	Wohlgemuth, Roland/A-6340-2016; Spencer, Joel/GLT-9687-2022; Spencer, Joel/A-4590-2013; Merzaban, Jasmeen/V-3147-2018	Wohlgemuth, Roland/0000-0001-6166-3228; Spencer, Joel/0000-0002-4013-8763; Merzaban, Jasmeen/0000-0002-7276-2907	NHLBI NIH HHS [R01 HL60528, R01 HL73714] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060528, R01HL073714] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; Hidalgo A, 2005, BLOOD, V105, P567, DOI 10.1182/blood-2004-03-1026; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JIN XF, 2004, EXP HEMATOL, V32, P1204; Kobzdej MMA, 2002, BLOOD, V100, P4485, DOI 10.1182/blood-2002-06-1799; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; Mocco J, 2002, CIRC RES, V91, P907, DOI 10.1161/01.RES.0000042063.15901.20; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Schrantz N, 1999, CELL DEATH DIFFER, V6, P445, DOI 10.1038/sj.cdd.4400508; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Takamatsu Y, 1998, CELL ADHES COMMUN, V5, P349, DOI 10.3109/15419069809010781; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650; Yao LB, 1999, BLOOD, V94, P3820, DOI 10.1182/blood.V94.11.3820	30	438	470	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					181	187		10.1038/nm1703	http://dx.doi.org/10.1038/nm1703			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18193058				2022-12-25	WOS:000252946700027
J	Wu, B; Droge, P; Davey, CA				Wu, Bin; Droge, Peter; Davey, Curt A.			Site selectivity of platinum anticancer therapeutics	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOSOME CORE PARTICLE; DNA-DAMAGE; SPECIFICITY; CHROMATIN; SEQUENCE; BINDING; ANALOGS; DUPLEX	X-ray crystallographic and biochemical investigation of the reaction of cisplatin and oxaliplatin with nucleosome core particle and naked DNA reveals that histone octamer association can modulate DNA platination. Adduct formation also occurs at specific histone methionine residues, which could serve as a nuclear platinum reservoir influencing adduct transfer to DNA. Our findings suggest that the nucleosome center may provide a favorable target for the design of improved platinum anticancer drugs.	[Davey, Curt A.] Nanyang Technol Univ, Div Struct & Computat Biol, Singapore 637551, Singapore; [Wu, Bin; Droge, Peter] Nanyang Technol Univ, Sch Biol Sci, Div Genom & Genet, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Davey, CA (corresponding author), Nanyang Technol Univ, Div Struct & Computat Biol, 60 Nanyang Dr, Singapore 637551, Singapore.	davey@ntu.edu.sg	Wu, Bin/C-4715-2015; Davey, Curt A/A-2182-2011; Droge, Peter/A-2203-2011	Wu, Bin/0000-0002-0883-8006; Droge, Peter/0000-0001-5447-738X				BARNHAM KJ, 1995, J CHEM SOC DA, V22, P3721; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Galea AM, 2002, BBA-GENE STRUCT EXPR, V1579, P142, DOI 10.1016/S0167-4781(02)00535-3; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; MURRAY V, 1992, J BIOL CHEM, V267, P18805; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; ROYERPOKORA B, 1981, NUCLEIC ACIDS RES, V9, P4595, DOI 10.1093/nar/9.18.4595; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Subramanian V, 2007, CHEM BIOL, V14, P553, DOI 10.1016/j.chembiol.2007.04.004; Trzupek JD, 2006, NAT CHEM BIOL, V2, P79, DOI 10.1038/nchembio761; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; Woynarowski JM, 1998, MOL PHARMACOL, V54, P770, DOI 10.1124/mol.54.5.770	17	72	73	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2008	4	2					110	112		10.1038/nchembio.2007.58	http://dx.doi.org/10.1038/nchembio.2007.58			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254KL	18157123				2022-12-25	WOS:000252585400009
J	Gurdon, J				Gurdon, John			Primate therapeutic cloning in practive	NATURE BIOTECHNOLOGY			English	Editorial Material							CELL NUCLEAR TRANSFER; EMBRYONIC STEM-CELLS; OOCYTES; MICE	The derivation of primate embryonic stem cells by nuclear transfer marks an advance toward human therapeutic cloning.	Wellcome Trust CR UK Inst, Cambridge CB2 1QN, England		Gurdon, J (corresponding author), Wellcome Trust CR UK Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	j.gurdon@gurdon.cam.ac.uk		GURDON, JOHN/0000-0002-5621-3799	Medical Research Council [G0300723B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WILMUT I, 1997, NATURE, V385, P813	13	2	2	5	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					64	65		10.1038/nbt0108-64	http://dx.doi.org/10.1038/nbt0108-64			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18183020				2022-12-25	WOS:000252222500023
J	Huang, G; Zhang, P; Hirai, H; Elf, S; Yan, X; Chen, Z; Koschmieder, S; Okuno, Y; Dayaram, T; Growney, JD; Shivdasani, RA; Gilliland, DG; Speck, NA; Nimer, SD; Tenen, DG				Huang, Gang; Zhang, Pu; Hirai, Hideyo; Elf, Shannon; Yan, Xiaomei; Chen, Zhao; Koschmieder, Steffen; Okuno, Yutaka; Dayaram, Tajhal; Growney, Joseph D.; Shivdasani, Ramesh A.; Gilliland, D. Gary; Speck, Nancy A.; Nimer, Stephen D.; Tenen, Daniel G.			PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR PU.1; STEM-CELLS; LINEAGE COMMITMENT; POINT MUTATIONS; GENE; EXPRESSION; MICE; DIFFERENTIATION; DOMAIN	Both PU.1 (also called SFPI1), an Ets-family transcription factor, and AML1 (also called RUNX1), a DNA-binding subunit of the CBF transcription factor family, are crucial for the generation of all hematopoietic lineages, and both act as tumor suppressors in leukemia. An upstream regulatory element (URE) of PU.1 has both enhancer and repressor activity and tightly regulates PU.1 expression. Here we show that AML1 binds to functionally important sites within the PU.1 upstream regulatory element and regulates PU.1 expression at both embryonic and adult stages of development. Analysis of mice carrying conditional AML1 knockout alleles and knock-in mice carrying mutations in all three AML1 sites of the URE proximal region demonstrated that AML1 regulates PU.1 both positively and negatively in a lineage dependent manner. Dysregulation of PU.1 expression contributed to each of the phenotypes observed in these mice, and restoration of proper PU.1 expression rescued or partially rescued each phenotype. Thus, our data demonstrate that PU.1 is a major downstream target gene of AML1.	[Huang, Gang; Zhang, Pu; Hirai, Hideyo; Koschmieder, Steffen; Okuno, Yutaka; Dayaram, Tajhal; Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Inst Med, Div Hematol Oncol, Boston, MA 02115 USA; [Huang, Gang; Yan, Xiaomei] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, New York, NY 10021 USA; [Hirai, Hideyo; Nimer, Stephen D.] Kyoto Prefectural Univ Med, Dept Microbiol, Kyoto 6028566, Japan; [Chen, Zhao; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Growney, Joseph D.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Speck, Nancy A.] Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Kyoto Prefectural University of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dartmouth College	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Div Hematol Oncol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu		Koschmieder, Steffen/0000-0002-1011-8171; Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA66996, CA41456] Funding Source: Medline; NIDDK NIH HHS [DK52208] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA041456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052208, R56DK052208] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Canon J, 2003, GENE DEV, V17, P838, DOI 10.1101/gad.1064803; CHEN HM, 1995, ONCOGENE, V11, P1549; Chen Z, 2007, BLOOD, V109, P1451, DOI 10.1182/blood-2006-08-038901; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Flores GV, 1998, DEVELOPMENT, V125, P3681; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Huang G, 2004, BLOOD, V103, P3200, DOI 10.1182/blood-2003-07-2188; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Suraweera N, 2005, ONCOGENE, V24, P3678, DOI 10.1038/sj.onc.1208422; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Villeval JL, 1997, BLOOD, V90, P4369; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	49	173	181	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					51	60		10.1038/ng.2007.7	http://dx.doi.org/10.1038/ng.2007.7			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	17994017				2022-12-25	WOS:000252118600018
J	Metzger, E; Yin, N; Wissmann, M; Kunowska, N; Fischer, K; Friedrichs, N; Patnaik, D; Higgins, JMG; Potier, N; Scheidtmann, KH; Buettner, R; Schule, R				Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Friedrichs, Nicolaus; Patnaik, Debasis; Higgins, Jonathan M. G.; Potier, Noelle; Scheidtmann, Karl-Heinz; Buettner, Reinhard; Schuele, Roland			Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulationx	NATURE CELL BIOLOGY			English	Article							ANDROGEN-RECEPTOR; PROSTATE-CANCER; RNA-POLYMERASE; COMPLEX; KINASE; H3; ACTIVATION; PROTEIN; DOMAIN; GENES	Posttranslational modifications of histones such as methylation, acetylation and phosphorylation regulate chromatin structure and gene expression. Here we show that protein-kinase-C-related kinase 1 (PRK1) phosphorylates histone H3 at threonine 11 (H3T11) upon ligand-dependent recruitment to androgen receptor target genes. PRK1 is pivotal to androgen receptor function because PRK1 knockdown or inhibition impedes androgen receptor-dependent transcription. Blocking PRK1 function abrogates androgen-induced H3T11 phosphorylation and inhibits androgen-induced demethylation of histone H3. Moreover, serine-5-phosphorylated RNA polymerase II is no longer observed at androgen receptor target promoters. Phosphorylation of H3T11 by PRK1 accelerates demethylation by the Jumonji C (JmjC)-domain-containing protein JMJD2C. Thus, phosphorylation of H3T11 by PRK1 establishes a novel chromatin mark for gene activation, identifying PRK1 as a gatekeeper of androgen receptor-dependent transcription. Importantly, levels of PRK1 and phosphorylated H3T11 correlate with Gleason scores of prostate carcinomas. Finally, inhibition of PRK1 blocks proliferation of androgen receptor-induced tumour cell proliferation, making PRK1 a promising therapeutic target.	[Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Schuele, Roland] Univ Freiburg Klinikum, Univ Frauenklin, D-79106 Freiburg, Germany; [Friedrichs, Nicolaus; Buettner, Reinhard] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany; [Patnaik, Debasis; Higgins, Jonathan M. G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Potier, Noelle] ISIS, CNRS UMR 7177, Inst Chim LC3, F-67083 Strasbourg, France; [Scheidtmann, Karl-Heinz] Univ Bonn, Inst Genet, D-53117 Bonn, Germany; [Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, D-79106 Freiburg, Germany	University of Freiburg; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Bonn; University of Freiburg	Schule, R (corresponding author), Univ Freiburg Klinikum, Univ Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de	Patnaik, Debasis/K-8779-2019; Patnaik, Debasis/A-9752-2016; Noelle, POTIER/AAX-7633-2021	Patnaik, Debasis/0000-0002-9829-3352; Patnaik, Debasis/0000-0002-9829-3352; Higgins, Jonathan/0000-0001-6622-8268	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074210] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074210, R01 GM074210-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; SCHRODER FH, 1992, PROSTATE, P129; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	22	165	175	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					53	U35		10.1038/ncb1668	http://dx.doi.org/10.1038/ncb1668			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066052	Green Accepted			2022-12-25	WOS:000252116100012
J	Nakagawa, M; Koyanagi, M; Tanabe, K; Takahashi, K; Ichisaka, T; Aoi, T; Okita, K; Mochiduki, Y; Takizawa, N; Yamanaka, S				Nakagawa, Masato; Koyanagi, Michiyo; Tanabe, Koji; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Okita, Keisuke; Mochiduki, Yuji; Takizawa, Nanako; Yamanaka, Shinya			Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts	NATURE BIOTECHNOLOGY			English	Article							ES CELLS; EXPRESSION; FAMILY; NANOG; GENE	Direct reprogramming of somatic cells provides an opportunity to generate patient- or disease-specific pluripotent stem cells. Such induced pluripotent stem (iPS) cells were generated from mouse fibroblasts by retroviral transduction of four transcription factors: Oct3/4, Sox2, Klf4 and c-Myc(1). Mouse iPS cells are indistinguishable from embryonic stem (ES) cells in many respects and produce germline- competent chimeras(2-4). Reactivation of the c-Myc retrovirus, however, increases tumorigenicity in the chimeras and progeny mice, hindering clinical applications(3). Here we describe a modified protocol for the generation of iPS cells that does not require the Myc retrovirus. With this protocol, we obtained significantly fewer non-iPS background cells, and the iPS cells generated were consistently of high quality. Mice derived from Myc-iPS cells did not develop tumors during the study period. The protocol also enabled efficient isolation of iPS cells without drug selection. Furthermore, we generated human iPS cells from adult dermal fibroblasts without MYC.	[Nakagawa, Masato; Koyanagi, Michiyo; Tanabe, Koji; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Okita, Keisuke; Mochiduki, Yuji; Takizawa, Nanako; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; TAKAHASHI K, 2007, CELL            1120; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; YU J, 2007, SCIENCE         1120	18	2012	2423	5	766	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					101	106		10.1038/nbt1374	http://dx.doi.org/10.1038/nbt1374			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18059259				2022-12-25	WOS:000252222500029
J	Chuck, G; Meeley, R; Irish, E; Sakai, H; Hake, S				Chuck, George; Meeley, Robert; Irish, Erin; Sakai, Hajime; Hake, Sarah			The maize tasselseed4 microRNA controls sex determination and meristem cell fate by targeting Tasselseed6/indeterminate spikelet1	NATURE GENETICS			English	Article							FLORAL ORGAN IDENTITY; GENES; EXPRESSION; MUTANTS; PROTEIN; BOUNDARY; APETALA2; ENCODES; DOMAIN	In maize ( Zea mays), sex determination occurs through abortion of female carpels in the tassel and arrest of male stamens in the ear. The Tasselseed6 ( Ts6) and tasselseed4 ( ts4) mutations permit carpel development in the tassel while increasing meristem branching, showing that sex determination and acquisition of meristem fate share a common pathway. We show that ts4 encodes a mir172 microRNA that targets APETALA2 floral homeotic transcription factors. Three lines of evidence suggest that indeterminate spikelet1 ( ids1), an APETALA2 gene required for spikelet meristem determinacy, is a key target of ts4. First, loss of ids1 suppresses the ts4 sex determination and branching defects. Second, Ts6 mutants phenocopy ts4 and possess mutations in the microRNA binding site of ids1. Finally, IDS1 protein is expressed more broadly in ts4 mutants compared to wild type. Our results demonstrate that sexual identity in maize is acquired by limiting floral growth through negative regulation of the floral homeotic pathway.	Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer A DuPont Co, Johnston, IA 50131 USA; Univ Iowa, Dept Sci Biol, Iowa City, IA 52242 USA; Dupont Crop Genet, Wilmington, DE 19880 USA	United States Department of Agriculture (USDA); DuPont; University of Iowa; DuPont	Chuck, G (corresponding author), Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu	Irish, Erin/C-7331-2016	Irish, Erin/0000-0003-4244-7938				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson DP, 1991, MOL PLANT PATHOL, P163; Kaplinsky NJ, 2003, DEVELOPMENT, V130, P1149, DOI 10.1242/dev.00336; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Okamuro JK, 1997, PLANT CELL, V9, P37, DOI 10.1105/tpc.9.1.37; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x	26	276	306	5	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1517	1521		10.1038/ng.2007.20	http://dx.doi.org/10.1038/ng.2007.20			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026103				2022-12-25	WOS:000251267400022
J	Friese, MA; Craner, MJ; Etzensperger, R; Vergo, S; AWemmie, J; Welsh, MJ; Vincent, A; Fugger, L				Friese, Manuel A.; Craner, Matthew J.; Etzensperger, Ruth; Vergo, Sandra; AWemmie, John; Welsh, Michael J.; Vincent, Angela; Fugger, Lars			Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system	NATURE MEDICINE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; MOLECULAR-CHANGES; WHITE-MATTER; SPINAL-CORD; INJURY; MECHANISMS; CALCIUM; NEURONS; LESIONS	Multiple sclerosis is a neuroinflammatory disease associated with axonal degeneration(1,2). The neuronally expressed, protongated acid-sensing ion channel-1 (ASIC1)(3,4) is permeable to Na+ and Ca2+, and excessive accumulation of these ions is associated with axonal degeneration(5). We tested the hypothesis that ASIC1 contributes to axonal degeneration in inflammatory lesions of the central nervous system (CNS). After induction of experimental autoimmune encephalomyelitis (EAE), Asic1(-/-) mice showed both a markedly reduced clinical deficit and reduced axonal degeneration compared to wild-type mice. Consistently with acidosis-mediated injury, pH measurements in the spinal cord of EAE mice showed tissue acidosis sufficient to open ASIC1. The acidosis-related protective effect of Asic1 disruption was also observed in nerve explants in vitro. Amiloride, a licensed and clinically safe blocker of ASICs, was equally neuroprotective in nerve explants and in EAE. Although ASICs are also expressed by immune cells, this expression is unlikely to explain the neuroprotective effect of Asic1 inactivation, as CNS inflammation was similar in wild-type and Asic1(-/-) mice. In addition, adoptive transfer of T cells from wild-type mice did not affect the protection mediated by Asic1 disruption. These results suggest that ASIC1 blockers could provide neuroprotection in multiple sclerosis.	Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England; Univ Iowa, Vet Affairs Hosp, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus, Denmark	University of Oxford; University of Oxford; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Howard Hughes Medical Institute; University of Iowa; Aarhus University	Fugger, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England.	lars.fugger@imm.ox.ac.uk	Vincent, Angela/AAE-7310-2019	Friese, Manuel A./0000-0001-6380-2420; Welsh, Michael/0000-0002-1646-6206; Wemmie, John/0000-0001-7531-9065	MRC [MC_U137881016] Funding Source: UKRI; Medical Research Council [MC_U137881016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Craner MJ, 2003, J NEUROPATH EXP NEUR, V62, P968, DOI 10.1093/jnen/62.9.968; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Mamet J, 2002, J NEUROSCI, V22, P10662; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Stys PK, 1998, NEUROSCIENCE, V82, P21; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waxman SG, 2006, TRENDS MOL MED, V12, P192, DOI 10.1016/j.molmed.2006.03.001; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	30	304	318	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1483	1489		10.1038/nm1668	http://dx.doi.org/10.1038/nm1668			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	17994101				2022-12-25	WOS:000251445400023
J	Muraski, JA; Rota, M; Misao, Y; Fransioli, J; Cottage, C; Gude, N; Esposito, G; Delucchi, F; Arcarese, M; Alvarez, R; Siddiqi, S; Emmanuel, GN; Wu, W; Fischer, K; Martindale, JJ; Glembotski, CC; Leri, A; Kajstura, J; Magnuson, N; Berns, A; Beretta, RM; Houser, SR; Schaefer, EM; Anversa, P; Sussman, MA				Muraski, John A.; Rota, Marcello; Misao, Yu; Fransioli, Jenna; Cottage, Christopher; Gude, Natalie; Esposito, Grazia; Delucchi, Francesca; Arcarese, Michael; Alvarez, Roberto; Siddiqi, Sailay; Emmanuel, Gregory N.; Wu, Weitao; Fischer, Kimberlee; Martindale, Joshua J.; Glembotski, Christopher C.; Leri, Annarosa; Kajstura, Jan; Magnuson, Nancy; Berns, Anton; Beretta, Remus M.; Houser, Steven R.; Schaefer, Erik M.; Anversa, Piero; Sussman, Mark A.			Pim-1 regulates cardiomyocyte survival downstream of Akt	NATURE MEDICINE			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; HEART-FAILURE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CELL; NUCLEAR; MICE; OVEREXPRESSION; TRANSCRIPTION	The serine-threonine kinases Pim-1 and Akt regulate cellular proliferation and survival. Although Akt is known to be a crucial signaling protein in the myocardium, the role of Pim-1 has been overlooked. Pim-1 expression in the myocardium of mice decreased during postnatal development, re-emerged after acute pathological injury in mice and was increased in failing hearts of both mice and humans. Cardioprotective stimuli associated with Akt activation induced Pim-1 expression, but compensatory increases in Akt abundance and phosphorylation after pathological injury by infarction or pressure overload did not protect the myocardium in Pim-1-deficient mice. Transgenic expression of Pim-1 in the myocardium protected mice from infarction injury, and Pim-1 expression inhibited cardiomyocyte apoptosis with concomitant increases in Bcl-2 and Bcl-X-L protein levels, as well as in Bad phosphorylation levels. Relative to nontransgenic controls, calcium dynamics were significantly enhanced in Pim-1-overexpressing transgenic hearts, associated with increased expression of SERCA2a, and were depressed in Pim-1-deficient hearts. Collectively, these data suggest that Pim-1 is a crucial facet of cardioprotection downstream of Akt.	San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; New York Med Coll, Cardiovasc Res Inst, Valhalla, NY 10595 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Temple Univ, Sch Med, Cardiovasc Res Inst, Philadelphia, PA 19140 USA; Invitrogen Corp, Hopkinton, MA 01748 USA	California State University System; San Diego State University; New York Medical College; Washington State University; Netherlands Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Thermo Fisher Scientific	Sussman, MA (corresponding author), San Diego State Univ, Inst Heart, 5500 Campanile Dr, San Diego, CA 92182 USA.	sussman@heart.sdsu.edu	Sussman, Mark/H-2284-2014	Sussman, Mark/0000-0002-0104-4799	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067245, P01HL085577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG023071] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01HL067245, 1R01HL091102, 1P01HL085577] Funding Source: Medline; NIA NIH HHS [1P01AG023071] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; DOMEN J, 1993, LEUKEMIA, V7, pS108; DOMEN J, 1993, J EXP MED, V178, P1665, DOI 10.1084/jem.178.5.1665; Dupays L, 2005, J MOL CELL CARDIOL, V38, P787, DOI 10.1016/j.yjmcc.2005.02.021; Eiken HG, 2001, EUR J CLIN INVEST, V31, P389, DOI 10.1046/j.1365-2362.2001.00795.x; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Fujiwara Y, 2006, BIOCHEM BIOPH RES CO, V340, P560, DOI 10.1016/j.bbrc.2005.12.039; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Ionov Y, 2003, ANTICANCER RES, V23, P167; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Katakami N, 2004, J BIOL CHEM, V279, P54742, DOI 10.1074/jbc.M409140200; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Krishnan N, 2003, ENDOCRINE, V20, P123, DOI 10.1385/ENDO:20:1-2:123; Krumenacker JS, 1998, ENDOCRINE, V9, P163, DOI 10.1385/ENDO:9:2:163; Krumenacker JS, 2001, J NEUROIMMUNOL, V113, P249, DOI 10.1016/S0165-5728(00)00430-6; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Palaty CK, 1997, J BIOL CHEM, V272, P10514; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Phoon CKL, 2004, CIRC RES, V95, P92, DOI 10.1161/01.RES.0000133681.99617.28; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Prasad AM, 2007, AM J PHYSIOL-CELL PH, V292, pC2269, DOI 10.1152/ajpcell.00441.2006; Rahman Z, 2001, IMMUNOL LETT, V75, P199, DOI 10.1016/S0165-2478(00)00322-9; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Suarez J, 2004, AM J PHYSIOL-HEART C, V287, pH2164, DOI 10.1152/ajpheart.00428.2004; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; Takizawa T, 1999, J MOL CELL CARDIOL, V31, P2167, DOI 10.1006/jmcc.1999.1045; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Wang Z, 2001, J Vet Sci, V2, P167; Wingett D, 1996, J IMMUNOL, V156, P549; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	50	192	203	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2007	13	12					1467	1475		10.1038/nm1671	http://dx.doi.org/10.1038/nm1671			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18037896				2022-12-25	WOS:000251445400021
J	Thomson, W; Barton, A; Ke, X; Eyre, S; Hinks, A; Bowes, J; Donn, R; Symmons, D; Hider, S; Bruce, IN; Wilson, AG; Marinou, I; Morgan, A; Emery, P; Carter, A; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Strachan, D; Worthington, J				Thomson, Wendy; Barton, Anne; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Donn, Rachelle; Symmons, Deborah; Hider, Samantha; Bruce, Ian N.; Wilson, Anthony G.; Marinou, Ioanna; Morgan, Ann; Emery, Paul; Carter, Angela; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Strachan, David; Worthington, Jane		Consortium, WTCC; Consortium, Y	Rheumatoid arthritis association at 6q23	NATURE GENETICS			English	Article							NF-KAPPA-B; POPULATION; RESPONSES; PTPN22; RISK; GENE; A20	The Wellcome Trust Case Control Consortium (WTCCC) identified nine single SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-5)-5 x 10(-7) in a genome-wide association screen. One, rs6920220, was unequivocally replicated ( trend P = 1.1 x 10(-8)) in a validation study, as described here. This SNP maps to 6q23, between the genes oligodendrocyte lineage transcription factor 3 (OLIG3) and tumor necrosis factor-alpha-induced protein 3 ( TNFAIP3).	Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; Univ Leeds, Inst Genet, Acad Unit Mol Vasc Med, Hlth & Therapeut Labs, Leeds LS2 9JT, W Yorkshire, England; Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England	University of Manchester; University of Sheffield; Chapel Allerton Hospital; University of Leeds; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Aberdeen; University of Oxford; St Georges University London	Worthington, J (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England.	jane.worthington@manchester.ac.uk	Bowes, John/B-3472-2015; eyre, stephen/K-3776-2017; Brown, Matthew A/E-5749-2010; Timpson, Nicholas John/O-7548-2015; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Worthington, Jane/M-9770-2014; Dominiczak, Anna F/P-9390-2017; Hinks, Anne/E-1853-2015; emery, paul/B-3560-2013; Barton, Anne/N-2053-2014; Attrill, Lauren/V-1688-2018; Ke, Xiayi/C-7674-2009; O'Donovan, Michael C/P-7005-2018; McCarthy, Mark/M-3763-2015; Evans, David/H-6325-2013; Prescott, Natalie/F-6490-2011; dobson, richard/C-9269-2011; Robinson, James/D-9096-2016	Bowes, John/0000-0003-4659-031X; eyre, stephen/0000-0002-1251-6974; Brown, Matthew A/0000-0003-0538-8211; Timpson, Nicholas John/0000-0002-7141-9189; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Worthington, Jane/0000-0003-0544-042X; Dominiczak, Anna F/0000-0003-4913-3608; Hinks, Anne/0000-0001-8843-3967; Barton, Anne/0000-0003-3316-2527; O'Donovan, Michael C/0000-0001-7073-2379; Caulfield, Mark/0000-0001-9295-3594; Symmons, Deborah/0000-0002-8625-1200; Harrison, Pille/0000-0003-4117-6910; Jones, Lisa/0000-0002-5122-8334; Dunger, Professor David/0000-0002-2566-9304; Wilson, Anthony Gerard/0000-0003-4855-3926; Bishop, Tim/0000-0002-8752-8785; Tobin, Martin/0000-0002-3596-7874; Donn, Rachelle/0000-0001-6976-9828; Grozeva, Detelina/0000-0003-3239-8415; Munroe, Patricia/0000-0002-4176-2947; McCarthy, Mark/0000-0002-4393-0510; Evans, David/0000-0003-0663-4621; Bruce, Ian/0000-0003-3047-500X; Prescott, Natalie/0000-0002-5901-7371; Newport, Melanie/0000-0002-8946-7525; Lango Allen, Hana/0000-0002-7803-8688; Parkes, Miles/0000-0002-6467-0631; dobson, richard/0000-0003-4224-9245; Walker, Neil/0000-0001-9796-7688; Robinson, James/0000-0001-5425-7520; Lees, Charlie/0000-0002-0732-8215; Lindgren, Cecilia/0000-0002-4903-9374; Conaghan, Philip/0000-0002-3478-5665; Hensor, Elizabeth/0000-0002-5245-4755; Hocking, Lynne J/0000-0002-2414-2826; Zeggini, Eleftheria/0000-0003-4238-659X; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X; Thomson, Wendy/0000-0002-9022-5179; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X	MRC [G0000934] Funding Source: UKRI; Arthritis Research UK [17552] Funding Source: Medline; Medical Research Council [G0000934, G0000934(68341)] Funding Source: Medline; Wellcome Trust [076113, 068545, 090532, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Filippi A, 2005, P NATL ACAD SCI USA, V102, P4377, DOI 10.1073/pnas.0407284102; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harrison P, 2006, RHEUMATOLOGY, V45, P1009, DOI 10.1093/rheumatology/kei250; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	13	317	323	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1431	1433		10.1038/ng.2007.32	http://dx.doi.org/10.1038/ng.2007.32			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982455	Green Accepted			2022-12-25	WOS:000251267400007
J	Radu, CG; Shu, CJ; Nair-Gill, E; Shelly, SM; Barrio, JR; Satyamurthy, N; Phelps, ME; Witte, ON				Radu, Caius G.; Shu, Chengyi J.; Nair-Gill, Evan; Shelly, Stephanie M.; Barrio, Jorge R.; Satyamurthy, Nagichettiar; Phelps, Michael E.; Witte, Owen N.			Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [F-18]-labeled 2 '-deoxycytidine analog	NATURE MEDICINE			English	Article							NUCLEOSIDE TRANSPORTER FAMILY; IN-VIVO; DEOXYRIBONUCLEOSIDE KINASES; ANTITUMOR RESPONSE; T-CELLS; MICE; GEMCITABINE; REGRESSION; GENE; PROLIFERATION	Monitoring immune function with molecular imaging could have a considerable impact on the diagnosis and treatment evaluation of immunological disorders and therapeutic immune responses. Positron emission tomography ( PET) is a molecular imaging modality with applications in cancer and other diseases. PET studies of immune function have been limited by a lack of specialized probes. We identified [F-18]FAC (1-(2'-deoxy-2'[F-18] fluoroarabinofuranosyl) cytosine) by differential screening as a new PET probe for the deoxyribonucleotide salvage pathway. [F-18]FAC enabled visualization of lymphoid organs and was sensitive to localized immune activation in a mouse model of antitumor immunity. [F-18] FAC microPET also detected early changes in lymphoid mass in systemic autoimmunity and allowed evaluation of immunosuppressive therapy. These data support the use of [F-18]FAC PET for immune monitoring and suggest a wide range of clinical applications in immune disorders and in certain types of cancer.	[Radu, Caius G.; Nair-Gill, Evan; Shelly, Stephanie M.; Barrio, Jorge R.; Satyamurthy, Nagichettiar; Phelps, Michael E.; Witte, Owen N.] 23 120 Ctr Hlth Sci, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Shu, Chengyi J.; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Radu, Caius G.; Phelps, Michael E.] Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Radu, CG (corresponding author), 23 120 Ctr Hlth Sci, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	cradu@mednet.ucla.edu	Radu, Caius/D-3936-2013	Radu, Caius/0000-0002-9338-5397; Nair-Gill, Evan/0000-0002-9876-7853	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P50 CA86306, P50 CA086306, 5U54 CA119347, R24 CA092865, P50 CA086306-10, R24 CA92865, U54 CA119347, U54 CA119347-03] Funding Source: Medline; NIGMS NIH HHS [T32 GM008042, T32 GM008042-23, T32 GM08042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA086306, R24CA092865, U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Chow PL, 2006, PHYS MED BIOL, V51, P379, DOI 10.1088/0031-9155/51/2/013; Dubey P, 2003, P NATL ACAD SCI USA, V100, P1232, DOI 10.1073/pnas.0337418100; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; FEFER A, 1968, CANCER RES, V28, P1577; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; HAMACHER K, 1986, J NUCL MED, V27, P235; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Mangner TJ, 2003, NUCL MED BIOL, V30, P215, DOI 10.1016/S0969-8051(02)00445-6; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; MORSE HC, 1982, J IMMUNOL, V129, P2612; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pankiewicz KW, 2000, CARBOHYD RES, V327, P87, DOI 10.1016/S0008-6215(00)00089-6; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Radu CG, 2007, P NATL ACAD SCI USA, V104, P1937, DOI 10.1073/pnas.0610544104; Schepers K, 2002, J IMMUNOL, V169, P3191, DOI 10.4049/jimmunol.169.6.3191; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; SHIPLEY LA, 1992, DRUG METAB DISPOS, V20, P849; Shu CYJ, 2005, P NATL ACAD SCI USA, V102, P17412, DOI 10.1073/pnas.0508698102; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Su H, 2006, J IMMUNOL, V176, P4459, DOI 10.4049/jimmunol.176.7.4459; Sun HH, 2005, J NUCL MED, V46, P292; Van der Wilt CL, 2000, ADV EXP MED BIOL, V486, P287; Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001	30	158	168	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2008	14	7					783	788		10.1038/nm1724	http://dx.doi.org/10.1038/nm1724			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18542051	Green Accepted, Green Submitted			2022-12-25	WOS:000257452700028
J	Williams, A; Sarkar, S; Cuddon, P; Ttofi, EK; Saiki, S; Siddiqi, FH; Jahreiss, L; Fleming, A; Pask, D; Goldsmith, P; O'Kane, CJ; Floto, A; Rubinsztein, DC				Williams, Andrea; Sarkar, Sovan; Cuddon, Paul; Ttofi, Evangelia K.; Saiki, Shinji; Siddiqi, Farah H.; Jahreiss, Luca; Fleming, Angeleen; Pask, Dean; Goldsmith, Paul; O'Kane, Cahir J.; Floto, Andres; Rubinsztein, David C.			Novel targets for Huntington's disease in an mTOR-independent autophagy pathway	NATURE CHEMICAL BIOLOGY			English	Article							AGGREGATE-PRONE PROTEINS; HISTONE DEACETYLASE INHIBITORS; PHOSPHOLIPASE-C-EPSILON; ALPHA-SYNUCLEIN; HEPATOCYTIC AUTOPHAGY; REDUCES TOXICITY; CAMP; POLYGLUTAMINE; CALPAIN; CALCIUM	Autophagy is a major clearance route for intracellular aggregate-prone proteins causing diseases such as Huntington's disease. Autophagy induction with the mTOR inhibitor rapamycin accelerates clearance of these toxic substrates. As rapamycin has nontrivial side effects, we screened FDA-approved drugs to identify new autophagy-inducing pathways. We found that L-type Ca2+ channel antagonists, the K-ATP(+) channel opener minoxidil, and the G(i) signaling activator clonidine induce autophagy. These drugs revealed a cyclical mTOR-independent pathway regulating autophagy, in which cAMP regulates IP3 levels, influencing calpain activity, which completes the cycle by cleaving and activating G(s alpha), which regulates cAMP levels. This pathway has numerous potential points where autophagy can be induced, and we provide proof of principle for therapeutic relevance in Huntington's disease using mammalian cell, fly and zebrafish models. Our data also suggest that insults that elevate intracytosolic Ca2+ (like excitotoxicity) inhibit autophagy, thus retarding clearance of aggregate-prone proteins.	[Cuddon, Paul; Fleming, Angeleen; Pask, Dean] Summit Plc, Cambridge CB25 9TN, England; [Ttofi, Evangelia K.; O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Goldsmith, Paul] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England; [Floto, Andres] Univ Cambridge, Addenbrookes Hosp, Inst Med Res, Dept Med, Cambridge CB20XY, England; [Williams, Andrea; Sarkar, Sovan; Cuddon, Paul; Ttofi, Evangelia K.; Saiki, Shinji; Siddiqi, Farah H.; Jahreiss, Luca; Rubinsztein, David C.] Univ Cambridge, Addenbrookes Hosp, Inst Med Res, Dept Med Genet, Cambridge CB20XY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB20XY, England.	dcr1000@hermes.cam.ac.uk	O'Kane, Cahir/Q-6681-2019; Sarkar, Sovan/F-8486-2017; Saiki, Shinji/ABC-8214-2021; O'Kane, Cahir J/C-4413-2011; Rubinsztein, David C/C-3472-2011	O'Kane, Cahir/0000-0002-3488-2078; Sarkar, Sovan/0000-0002-9456-4362; Saiki, Shinji/0000-0002-9732-8488; Fleming, Angeleen/0000-0003-3721-7126	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0600194(77639), G0600194, G108/485, G0400066] Funding Source: Medline; Wellcome Trust [064354] Funding Source: Medline; MRC [G108/485, G0400066, G0600194] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FELSEN D, 1994, J PHARMACOL EXP THER, V268, P1063; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GORDON PB, 1993, J BIOL CHEM, V268, P26107; GREENBERG DA, 1984, BRAIN RES, V305, P365, DOI 10.1016/0006-8993(84)90444-X; Greney H, 2000, MOL PHARMACOL, V57, P1142; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HAYASHI S, 1993, J PHARMACOL EXP THER, V265, P1527; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; OSBORNE NN, 1991, BRAIN RES, V553, P84, DOI 10.1016/0006-8993(91)90233-L; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sato-Kusubata K, 2000, BIOCHEM J, V347, P733, DOI 10.1042/0264-6021:3470733; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; vom Dorp F, 2004, CELL SIGNAL, V16, P921, DOI 10.1016/j.cellsig.2004.01.009; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	50	611	648	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2008	4	5					295	305		10.1038/nchembio.79	http://dx.doi.org/10.1038/nchembio.79			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291CM	18391949	Green Accepted			2022-12-25	WOS:000255170400010
J	Ahuja, SK; Kulkarni, H; Catano, G; Agan, BK; Camargo, JF; He, W; O'Connell, RJ; Marconi, VC; Delmar, J; Eron, J; Clark, RA; Frost, S; Martin, J; Ahuja, SS; Deeks, SG; Little, S; Richman, D; Hecht, FM; Dolan, MJ				Ahuja, Sunil K.; Kulkarni, Hemant; Catano, Gabriel; Agan, Brian K.; Camargo, Jose F.; He, Weijing; O'Connell, Robert J.; Marconi, Vincent C.; Delmar, Judith; Eron, Joseph; Clark, Robert A.; Frost, Simon; Martin, Jeffrey; Ahuja, Seema S.; Deeks, Steven G.; Little, Susan; Richman, Douglas; Hecht, Frederick M.; Dolan, Matthew J.			CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED ADULTS; CD4(+) CELL COUNT; PLASMA VIRAL LOAD; DISEASE PROGRESSION; VIROLOGICAL SUPPRESSION; GENETIC PROFILES; RNA LEVEL; AIDS; MORTALITY	The basis for the extensive variability seen in the reconstitution of CD4(+) T cell counts in HIV- infected individuals receiving highly active antiretroviral therapy ( HAART) is not fully known. Here, we show that variations in CCL3L1 gene dose and CCR5 genotype, but not major histocompatibility complex HLA alleles, influence immune reconstitution, especially when HAART is initiated at <350 CD4(+) T cells/ mm(3). The CCL3L1- CCR5 genotypes favoring CD4(+) T cell recovery are similar to those that blunted CD4(+) T cell depletion during the time before HAART became available ( pre- HAART era), suggesting that a common CCL3L1- CCR5 genetic pathway regulates the balance between pathogenic and reparative processes from early in the disease course. Hence, CCL3L1-CCR5 variations influence HIV pathogenesis even in the presence of HAART and, therefore, may prospectively identify subjects in whom earlier initiation of therapy is more likely to mitigate immunologic failure despite viral suppression by HAART. Furthermore, as reconstitution of CD4(+) cells during HAART is more sensitive to CCL3L1 dose than to CCR5 genotypes, CCL3L1 analogs might be efficacious in supporting immunological reconstitution.	[Ahuja, Sunil K.; Kulkarni, Hemant; Catano, Gabriel; Camargo, Jose F.; He, Weijing; Clark, Robert A.; Ahuja, Seema S.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV1 Infect, San Antonio, TX 78229 USA; [Ahuja, Sunil K.; Kulkarni, Hemant; Catano, Gabriel; Camargo, Jose F.; He, Weijing; Clark, Robert A.; Ahuja, Seema S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Agan, Brian K.; O'Connell, Robert J.; Marconi, Vincent C.; Delmar, Judith; Dolan, Matthew J.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Agan, Brian K.; O'Connell, Robert J.; Marconi, Vincent C.; Delmar, Judith; Dolan, Matthew J.] Wilford Hall USAF Med Ctr, Infect Dis Serv, Lackland AFB, TX 78236 USA; [Agan, Brian K.; Dolan, Matthew J.] Wilford Hall USAF Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX 78236 USA; [Agan, Brian K.; Marconi, Vincent C.; Delmar, Judith; Dolan, Matthew J.] San Antonio Mil Med Ctr, Ft Sam Houston, TX 78234 USA; [Eron, Joseph] Univ N Carolina, Chapel Hill, NC 27599 USA; [Frost, Simon; Little, Susan; Richman, Douglas] Univ Calif San Diego, Antiviral Res Ctr, Dept Med, San Diego, CA 92103 USA; [Frost, Simon; Richman, Douglas] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Martin, Jeffrey] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; San Antonio Military Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Ahuja, SK (corresponding author), S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV1 Infect, 7400 Merton Minister, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu; mdolan@hjf.org	Clark, Robert/Q-6764-2019; Marconi, Vincent/N-3210-2014; Frost, Simon/F-3648-2010; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Little, Susan/AAA-6116-2019; Kulkarni, Hemant/AEM-5750-2022; Catano, Gabriel/AAQ-5387-2020	Clark, Robert/0000-0002-4892-3619; Marconi, Vincent/0000-0001-8409-4689; Frost, Simon/0000-0002-5207-9879; Marconi, Vincent/0000-0001-8409-4689; Hecht, Frederick/0000-0002-5782-1171; Agan, Brian/0000-0002-5114-1669	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326, R24AI106039, P30AI050410, P01AI074621] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI074621-01A10002, R37 AI046326, P01 AI074621, P30 AI050410, R24 AI106039] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anastos K, 2004, ANN INTERN MED, V140, P256, DOI 10.7326/0003-4819-140-4-200402170-00007; Brumme ZL, 2007, J INFECT DIS, V195, P1694, DOI 10.1086/516789; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 2001, IMMUNOL LETT, V79, P131, DOI 10.1016/S0165-2478(01)00275-9; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Deeks SG, 2001, JAMA-J AM MED ASSOC, V286, P224, DOI 10.1001/jama.286.2.224; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kasten S, 2000, Eur J Med Res, V5, P323; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; MEHANDRU S, 2006, PLOS MED, V484, P1; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nguyen L, 2004, JAIDS-J ACQ IMM DEF, V37, P1318, DOI 10.1097/01.qai.0000127059.98621.55; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Pahwa S, 2007, IMMUNOL RES, V38, P373, DOI 10.1007/s12026-007-0036-9; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1, P1; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; RAUCH A, 2004, IN PRESS CLIN INFECT; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; Tang JM, 2002, AIDS, V16, P2275, DOI 10.1097/00002030-200211220-00007; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Tenorio AR, 2003, JAIDS-J ACQ IMM DEF, V34, P491, DOI 10.1097/00126334-200312150-00007; Valdez H, 1999, JAMA-J AM MED ASSOC, V282, P734, DOI 10.1001/jama.282.8.734; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017	50	101	103	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					413	420		10.1038/nm1741	http://dx.doi.org/10.1038/nm1741			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376407	Green Submitted, Green Accepted			2022-12-25	WOS:000254674100028
J	Du, ZQ; Park, KW; Yu, HJ; Fan, Q; Li, LM				Du, Zhiqiang; Park, Kyung-Won; Yu, Haijing; Fan, Qing; Li, Liming			Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae	NATURE GENETICS			English	Article							DE-NOVO APPEARANCE; PSI+ PRION; YEAST; PROTEIN; EXPRESSION; RICH; AGGREGATION; DOMAINS; COMPLEX; GENES	SWI/SNF, an evolutionarily conserved ATP-dependent chromatin-remodeling complex, has an important role in transcriptional regulation(1). In Saccharomyces cerevisiae, SWI/SNF regulates the expression of similar to 6% of total genes through activation or repression(2). Swi1, a subunit of SWI/SNF, contains an N-terminal region rich in glutamine and asparagine, a notable feature shared by all characterized yeast prions-a group of unique proteins capable of self-perpetuating changes in conformation and function(3). Here we provide evidence that Swi1 can become a prion, [SWI+]. Swi1 aggregates in [SWI+] cells but not in nonprion cells. Cells bearing [SWI+] show a partial loss-of-function phenotype of SWI/SNF. [SWI+] can be eliminated by guanidine hydrochloride treatment, HSP104 deletion or loss of Swi1. Moreover, we show [SWI+] is dominantly and cytoplasmically transmitted. Our findings reveal a novel mechanism of 'protein-only' inheritance that results in modification of chromatin-remodeling and, ultimately, global gene regulation.	[Du, Zhiqiang; Park, Kyung-Won; Yu, Haijing; Fan, Qing; Li, Liming] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Li, LM (corresponding author), Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Searle 5-474,320 E Super St, Chicago, IL 60611 USA.	limingli@northwestern.edu	FAN, QING/G-6356-2012; Du, Zhiqiang/G-2649-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056086] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS056086, R01 NS056086, R01 NS056086-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LAURENT BC, 1990, MOL CELL BIOL, V10, P5616, DOI 10.1128/MCB.10.11.5616; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, GENETICS, V115, P247; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	30	234	240	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					460	465		10.1038/ng.112	http://dx.doi.org/10.1038/ng.112			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362884	Green Accepted			2022-12-25	WOS:000254388100018
J	Lee, KS; Kwon, OY; Lee, JH; Kwon, K; Min, KJ; Jung, SA; Kim, AK; You, KH; Tatar, M; Yu, K				Lee, Kyu-Sun; Kwon, O-Yu; Lee, Joon H.; Kwon, Kisang; Min, Kyung-Jin; Jung, Sun-Ah; Kim, Ae-Kyeong; You, Kwan-Hee; Tatar, Marc; Yu, Kweon			Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN; CELL-LINES; RECEPTOR; DOWNSTREAM; EXPRESSION; PHENOTYPES; PEPTIDES; ABLATION; PATHWAY; BODY	Insulin and insulin growth factor have central roles in growth(1,2), metabolism(3) and ageing(4,5) of animals, including Drosophila melanogaster. In Drosophila, insulin-like peptides ( Dilps) are produced by specialized neurons in the brain(3,6). Here we show that Drosophila short neuropeptide F ( sNPF), an orthologue of mammalian neuropeptide Y ( NPY), and sNPF receptor sNPFR1 regulate expression of Dilps. Body size was increased by overexpression of sNPF or sNPFR1. The fat body of sNPF mutant Drosophila had downregulated Akt, nuclear localized FOXO, upregulated translational inhibitor 4E-BP and reduced cell size. Circulating levels of glucose were elevated and lifespan was also extended in sNPF mutants. We show that these effects are mediated through activation of extracellular signal-related kinases ( ERK) in insulin-producing cells of larvae and adults. Insulin expression was also increased in an ERK-dependent manner in cultured Drosophila central nervous system ( CNS) cells and in rat pancreatic cells treated with sNPF or NPY peptide, respectively. Drosophila sNPF and the evolutionarily conserved mammalian NPY seem to regulate ERK- mediated insulin expression and thus to systemically modulate growth, metabolism and lifespan.	[Lee, Kyu-Sun; Kim, Ae-Kyeong; Yu, Kweon] Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305333, South Korea; [You, Kwan-Hee] Chungnam Natl Univ, Sch Biosci & Biotechnol, Taejon, South Korea; [Lee, Joon H.; Jung, Sun-Ah] Konyang Univ, Coll Med, Kims Eye Hosp, Myung Gok Eye Res Inst, Chungnam, South Korea; [Min, Kyung-Jin; Tatar, Marc] Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Konyang University; Konyang University Hospital; Brown University	Yu, K (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305333, South Korea.	kweonyu@kribb.re.kr	Min, Kyung-Jin/AAG-5774-2020	Min, Kyung-Jin/0000-0001-5829-6842; Tatar, Marc/0000-0003-3232-6884; Yu, Kweon/0000-0002-4942-2576				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; EMESON RB, 2005, SCI STKE, pPE12; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kim M, 2004, MOL CELL BIOL, V24, P573, DOI 10.1128/MCB.24.2.573-583.2004; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; WAHLESTEDT C, 1993, SCIENCE, V259, P528, DOI 10.1126/science.8380941; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang S, 2007, P NATL ACAD SCI USA, V104, P19873, DOI 10.1073/pnas.0707465104; Yu K, 2000, DEVELOPMENT, V127, P2143; Zimanyi IA, 1998, CURR PHARM DESIGN, V4, P349	27	165	168	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					468	U230		10.1038/ncb1710	http://dx.doi.org/10.1038/ncb1710			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344986				2022-12-25	WOS:000254561700018
J	David, R; Brenner, C; Stieber, J; Schwarz, F; Brunner, S; Vollmer, M; Mentele, E; Muller-Hocker, J; Kitajima, S; Lickert, H; Rupp, R; Franz, WM				David, R.; Brenner, C.; Stieber, J.; Schwarz, F.; Brunner, S.; Vollmer, M.; Mentele, E.; Mueller-Hoecker, J.; Kitajima, S.; Lickert, H.; Rupp, R.; Franz, W. -M.			MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; HEART PRECURSOR CELLS; IN-VITRO; CARDIAC MESODERM; XENOPUS-LAEVIS; CARDIOMYOCYTES; SPECIFICATION; GENE; CARDIOMYOGENESIS; CARDIOGENESIS	ES-cell-based cardiovascular repair requires an in-depth understanding of the molecular mechanisms underlying the differentiation of cardiovascular ES cells. A candidate cardiovascular-fate inducer is the bHLH transcription factor MesP1(1,2). As one of the earliest markers, it is expressed specifically in almost all cardiovascular precursors and is required for cardiac morphogenesis(2,3). Here we show that MesP1 is a key factor sufficient to induce the formation of ectopic heart tissue in vertebrates and increase cardiovasculogenesis by ES cells. Electrophysiological analysis showed all subtypes of cardiac ES-cell differentiation(4). MesP1 overexpression and knockdown experiments revealed a prominent function of MesP1 in a gene regulatory cascade, causing Dkk-1-mediated blockade of canonical Wnt-signalling. Independent evidence from ChIP and in vitro DNA-binding studies, expression analysis in wild-type and MesP knockout mice, and reporter assays confirm that Dkk-1 is a direct target of MesP1. Further analysis of the regulatory networks involving MesP1 will be required to preprogramme ES cells towards a cardiovascular fate for cell therapy and cardiovascular tissue engineering. This may also provide a tool to elicit cardiac transdifferentiation in native human adult stem cells.	[David, R.; Brenner, C.; Schwarz, F.; Brunner, S.; Franz, W. -M.] Klinikum Grosshadern LMU, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Stieber, J.] Univ Erlangen Nurnberg, Lehrstuhl Pharmakol & Toxikol, D-91054 Erlangen, Germany; [Vollmer, M.] GSF, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; [Mentele, E.; Rupp, R.] Adolph Butenandt Inst LMU, D-80336 Munich, Germany; [Mueller-Hoecker, J.] Pathol Inst LMU, D-80337 Munich, Germany; [Kitajima, S.] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan	University of Munich; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; National Institute of Health Sciences - Japan	David, R (corresponding author), Klinikum Grosshadern LMU, Med Klin & Poliklin 1, D-81377 Munich, Germany.	robert.david@med.uni-muenchen.de; wolfgang.franz@med.uni-muenchen.de	Schwarz, Florian/AAE-5840-2022; Lickert, Heiko/K-9045-2013	Schwarz, Florian/0000-0001-9889-5153; rupp, ralph/0000-0002-8068-9957				David R, 1998, MECH DEVELOP, V79, P137, DOI 10.1016/S0925-4773(98)00181-6; David R, 2005, STEM CELLS, V23, P477, DOI 10.1634/stemcells.2004-0177; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kitajima S, 2006, DEV DYNAM, V235, P395, DOI 10.1002/dvdy.20640; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Nir SG, 2003, CARDIOVASC RES, V58, P313, DOI 10.1016/S0008-6363(03)00264-5; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tillet E, 2005, EXP CELL RES, V310, P392, DOI 10.1016/j.yexcr.2005.08.021; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433	30	176	190	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					338	U75		10.1038/ncb1696	http://dx.doi.org/10.1038/ncb1696			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297060				2022-12-25	WOS:000253778300016
J	Eberhart, JK; He, XJ; Swartz, ME; Yan, YL; Song, H; Boling, TC; Kunerth, AK; Walker, MB; Kimmel, CB; Postlethwait, JH				Eberhart, Johann K.; He, Xinjun; Swartz, Mary E.; Yan, Yin-Lin; Song, Hao; Boling, Taylor C.; Kunerth, Allison K.; Walker, Macie B.; Kimmel, Charles B.; Postlethwait, John H.			MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis	NATURE GENETICS			English	Article							CREST CELL-MIGRATION; GROWTH-FACTOR; SONIC HEDGEHOG; ALPHA; EXPRESSION; RECEPTOR; SPECIFICATION; REQUIREMENT; CARTILAGE; ORIGINS	Disruption of signaling pathways such as those mediated by sonic hedgehog (Shh) or platelet-derived growth factor (Pdgf) causes craniofacial abnormalities, including cleft palate. The role that microRNAs play in modulating palatogenesis, however, is completely unknown. We show that, in zebrafish, the microRNA Mirn140 negatively regulates Pdgf signaling during palatal development, and we provide a mechanism for how disruption of Pdgf signaling causes palatal clefting. The pdgf receptor alpha (pdgfra) 3' UTR contained a Mirn140 binding site functioning in the negative regulation of Pdgfra protein levels in vivo. pdgfra mutants and Mirn140-injected embryos shared a range of facial defects, including clefting of the crest-derived cartilages that develop in the roof of the larval mouth. Concomitantly, the oral ectoderm beneath where these cartilages develop lost pitx2 and shha expression. Mirn140 modulated Pdgf-mediated attraction of cranial neural crest cells to the oral ectoderm, where crest-derived signals were necessary for oral ectodermal gene expression. Mirn140 loss of function elevated Pdgfra protein levels, altered palatal shape and caused neural crest cells to accumulate around the optic stalk, a source of the ligand Pdgfaa. These results suggest that the conserved regulatory interactions of mirn140 and pdgfra define an ancient mechanism of palatogenesis, and they provide candidate genes for cleft palate.	[Eberhart, Johann K.; He, Xinjun; Swartz, Mary E.; Yan, Yin-Lin; Song, Hao; Boling, Taylor C.; Kunerth, Allison K.; Kimmel, Charles B.; Postlethwait, John H.] 1254 Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Eberhart, JK (corresponding author), 1254 Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eberhart@uoneuro.uoregon.edu	He, Xinjun/F-9797-2011; Eberhart, Johann/AAO-4241-2020; Swartz, Mary/AAO-4293-2020	Kunerth, Allison/0000-0002-9035-507X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE018088, R00DE018088] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR020833-03, R01 RR020833-04, R01 RR020833, 5R01RR020833] Funding Source: Medline; NICHD NIH HHS [P01 HD22486, P01 HD022486-22, P01 HD022486, P01 HD022486-220001, P01 HD022486-159007, P01 HD022486-169007] Funding Source: Medline; NIDCR NIH HHS [R00 DE018088, K99 DE018088-01, R00 DE018088-03, 5 K99 DE018088, K99 DE018088-02, K99 DE018088] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; DARNELL DK, 2006, DEV DYNAM, V235, P3516; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; HO L, 1994, MECH DEVELOP, V48, P165, DOI 10.1016/0925-4773(94)90057-4; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu D, 1999, DEVELOPMENT, V126, P4873; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Liu LH, 2002, MECH DEVELOP, V116, P227, DOI 10.1016/S0925-4773(02)00142-9; Liu LH, 2002, DEV GENES EVOL, V212, P298, DOI 10.1007/s00427-002-0234-3; McLennan R, 2007, DEV BIOL, V301, P227, DOI 10.1016/j.ydbio.2006.08.019; Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Soriano P, 1997, DEVELOPMENT, V124, P2691; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Trainor PA, 2003, INT J DEV BIOL, V47, P541; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827	43	249	267	4	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					290	298		10.1038/ng.82	http://dx.doi.org/10.1038/ng.82			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264099	Green Accepted			2022-12-25	WOS:000253548400019
J	Bovee, D; Zhou, Y; Haugen, E; Wu, ZN; Hayden, HS; Gillett, W; Tuzun, E; Cooper, GM; Sampas, N; Phelps, K; Levy, R; Morrison, VA; Sprague, J; Jewett, D; Buckley, D; Subramaniam, S; Chang, J; Smith, DR; Olson, MV; Eichler, EE; Kaul, R				Bovee, Donald; Zhou, Yang; Haugen, Eric; Wu, Zaining; Hayden, Hillary S.; Gillett, Will; Tuzun, Eray; Cooper, Gregory M.; Sampas, Nick; Phelps, Karen; Levy, Ruth; Morrison, V. Anne; Sprague, James; Jewett, Donald; Buckley, Danielle; Subramaniam, Sandhya; Chang, Jean; Smith, Douglas R.; Olson, Maynard V.; Eichler, Evan E.; Kaul, Rajinder			Closing gaps in the human genome with fosmid resources generated from multiple individuals	NATURE GENETICS			English	Article							COPY NUMBER POLYMORPHISM; HUMAN GENETIC-VARIATION; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; SEQUENCE; PREDISPOSES	The human genome sequence has been finished to very high standards; however, more than 340 gaps remained when the finished genome was published by the International Human Genome Sequencing Consortium in 2004. Using fosmid resources generated from multiple individuals, we targeted gaps in the euchromatic part of the human genome. Here we report 2,488,842 bp of previously unknown euchromatic sequence, 363,114 bp of which close 26 of 250 euchromatic gaps, or 10%, including two remaining euchromatic gaps on chromosome 19. Eight (30.7%) of the closed gaps were found to be polymorphic. These sequences allow complete annotation of several human genes as well as the assignment of mRNAs. The gap sequences are 2.3-fold enriched in segmentally duplicated sequences compared to the whole genome. Our analysis confirms that not all gaps within 'finished' genomes are recalcitrant to subcloning and suggests that the paired-end-sequenced fosmid libraries could prove to be a rich resource for completion of the human euchromatic genome.	[Bovee, Donald; Zhou, Yang; Haugen, Eric; Hayden, Hillary S.; Gillett, Will; Phelps, Karen; Levy, Ruth; Jewett, Donald; Buckley, Danielle; Subramaniam, Sandhya; Chang, Jean; Olson, Maynard V.; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Tuzun, Eray; Cooper, Gregory M.; Morrison, V. Anne; Sprague, James; Olson, Maynard V.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sampas, Nick] Agilent Technol, Mol Technol Lab, Santa Clara, CA 95051 USA; [Smith, Douglas R.] Agencourt Biosci Corp, Agencourt Sequencing Ctr, Cummings Ctr 500, Beverly, MA 01519 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Agilent Technologies; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Kaul, R (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	rkkaul@u.washington.edu	Tuzun, Eray/AAD-7282-2021; Tuzun, Eray/B-5949-2018; Cooper, Gregory/D-6914-2011	Tuzun, Eray/0000-0002-5550-7816; Tuzun, Eray/0000-0002-5550-7816; Cooper, Gregory/0000-0001-5509-9923; Haugen, Eric/0000-0001-7444-8981; Kaul, Rajinder/0000-0002-7895-9284	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002043, P01HG004120] Funding Source: NIH RePORTER; NHGRI NIH HHS [3 U54 HG002043, HG004120] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225	27	40	43	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					96	101		10.1038/ng.2007.34	http://dx.doi.org/10.1038/ng.2007.34			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157130				2022-12-25	WOS:000252118600024
J	Jaeger, E; Webb, E; Howarth, K; Carvajal-Carmona, L; Rowan, A; Broderick, P; Walther, A; Spain, S; Pittman, A; Kemp, Z; Sullivan, K; Heinimann, K; Lubbe, S; Domingo, E; Barclay, E; Martin, L; Gorman, M; Chandler, I; Vijayakrishnan, J; Wood, W; Papaemmanuil, E; Penegar, S; Qureshi, M; Farrington, S; Tenesa, A; Cazier, JB; Kerr, D; Gray, R; Peto, J; Dunlop, M; Campbell, H; Thomas, H; Houlston, R; Tomlinson, I				Jaeger, Emma; Webb, Emily; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Broderick, Peter; Walther, Axel; Spain, Sarah; Pittman, Alan; Kemp, Zoe; Sullivan, Kate; Heinimann, Karl; Lubbe, Steven; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra; Farrington, Susan; Tenesa, Albert; Cazier, Jean-Baptiste; Kerr, David; Gray, Richard; Peto, Julian; Dunlop, Malcolm; Campbell, Harry; Thomas, Huw; Houlston, Richard; Tomlinson, Ian		CORGI Consortium	Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED POLYPOSIS SYNDROME; PROSTATE-CANCER; SUSCEPTIBILITY; SCAN; 8Q24	We mapped a high-penetrance gene (CRAC1; also known as HMPS) associated with colorectal cancer (CRC) in the Ashkenazi population to a 0.6-Mb region on chromosome 15 containing SCG5 (also known as SGNE1), GREM1 and FMN1. We hypothesized that the CRAC1 locus harbored low-penetrance variants that increased CRC risk in the general population. In a large series of colorectal cancer cases and controls, SNPs near GREM1 and SCG5 were strongly associated with increased CRC risk (for rs4779584, P=4.44x10(-14)).	[Jaeger, Emma; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Walther, Axel; Spain, Sarah; Kemp, Zoe; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Tomlinson, Ian] Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan; Lubbe, Steven; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Carvajal-Carmona, Luis; Tomlinson, Ian] Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London EC1M 6BQ, England; [Heinimann, Karl] KBW Ctr Biomed, Dept Clin & Biol Sci, Res Grp Human Genet, CH-4058 Basel, Switzerland; [Martin, Lynn] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn] Birmingham Womens Hosp, Dept Med Genet, Birmingham B15 2TG, W Midlands, England; [Farrington, Susan; Dunlop, Malcolm] Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan; Dunlop, Malcolm] Western Gen Hosp, UK Med Res Council, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Cazier, Jean-Baptiste] Canc Res UK, London WC2A 3PX, England; [Kerr, David] Univ Oxford, Dept Clin Pharmacol, Radcliffe Infirm, Oxford OX2 6HA, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Peto, Julian] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin & Imperial Coll, Harrow HA1 3UJ, Middx, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; University of London; Queen Mary University London; University of Manchester; Birmingham Women's Hospital; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cancer Research UK; Radcliffe Infirmary; University of Oxford; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; Imperial College London	Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	richard.houlston@icr.ac.uk; ian.tomlinson@cancer.org.uk	Farrington, Susan M/C-7319-2013; Cazier, Jean-Baptiste/GLR-2949-2022; Domingo, Enric/A-9099-2018; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Dunlop, Malcolm G/F-1973-2011; Carvajal-Carmona, Luis G/B-3882-2010; Campbell, Harry/E-2959-2010; Pittman, Alan/AAP-2534-2020; Evans, D Gareth/AAB-4308-2022; Pittman, Alan M/D-6231-2012; Farrington, Susan M/Q-2710-2019; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Cazier, Jean-Baptiste/0000-0001-7581-9051; Domingo, Enric/0000-0003-4390-8767; Lubbe, Steven/0000-0002-7103-6671; Cazier, Jean-Baptiste/0000-0001-7581-9051; Dunlop, Malcolm G/0000-0002-3033-5851; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Campbell, Harry/0000-0002-6169-6262; Pittman, Alan/0000-0002-8112-2987; Evans, D Gareth/0000-0002-8482-5784; Pittman, Alan M/0000-0002-8112-2987; Farrington, Susan M/0000-0001-5955-7389; Houlston, Richard/0000-0002-5268-0242; Spain, Sarah/0000-0002-7591-8364; Gray, Richard/0000-0003-4440-574X; Penegar, Steven/0000-0002-3768-0236; Tenesa, Albert/0000-0003-4884-4475; Lucassen, Anneke/0000-0003-3324-4338; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Wood, Wendy/0000-0001-9062-4455; Broderick, Peter/0000-0002-8348-5829; Green, Andrew/0000-0002-1077-7417; Webb, Emily/0000-0002-4019-7456	MRC [MC_U127527198, G0301096] Funding Source: UKRI; Medical Research Council [G0301096, MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	15	250	257	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					26	28		10.1038/ng.2007.41	http://dx.doi.org/10.1038/ng.2007.41			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084292				2022-12-25	WOS:000252118600013
J	Lee, J; Kitajima, TS; Tanno, Y; Yoshida, K; Morita, T; Miyano, T; Miyake, M; Watanabe, Y				Lee, Jibak; Kitajima, Tomoya S.; Tanno, Yuji; Yoshida, Kayo; Morita, Takashi; Miyano, Takashi; Miyake, Masashi; Watanabe, Yoshinori			Unified mode of centromeric protection by shugoshin in mammalian oocytes and somatic cells	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; PROTEIN PHOSPHATASE 2A; MEIOSIS-I; CHROMOSOME SEGREGATION; AURORA-B; INNER CENTROMERE; COHESIN; REC8; LOCALIZATION	Reductional chromosome segregation in germ cells, where sister chromatids are pulled to the same pole, accompanies the protection of cohesin at centromeres from separase cleavage. Here, we show that mammalian shugoshin Sgo2 is expressed in germ cells and is solely responsible for the centromeric localization of PP2A and the protection of cohesin Rec8 in oocytes, proving conservation of the mechanism from yeast to mammals. However, this role of Sgo2 contrasts with its mitotic role in protecting centromeric cohesin only from prophase dissociation, but never from anaphase cleavage. We demonstrate that, in somatic cells, shugoshin colocalizes with cohesin in prophase or prometaphase, but their localizations become separate when centromeres are pulled oppositely at metaphase. Remarkably, if tension is artificially removed from the centromeres at the metaphase-anaphase transition, cohesin at the centromeres can be protected from separase cleavage even in somatic cells, as in germ cells. These results argue for a unified view of centromeric protection by shugoshin in mitosis and meiosis.	[Kitajima, Tomoya S.; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Lee, Jibak; Miyano, Takashi; Miyake, Masashi] Kobe Univ, Lab Reprod Biol & Biotechnol, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Yoshida, Kayo; Morita, Takashi] Osaka City Univ, Dept Mol Genet, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	University of Tokyo; Kobe University; Osaka Metropolitan University	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016	Kitajima, Tomoya/0000-0002-6486-7143; Watanabe, Yoshinori/0000-0002-5488-4812				Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Gomez R, 2007, EMBO REP, V8, P173, DOI 10.1038/sj.embor.7400877; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; NAKAJIMA M, 2007, J CELL SCI; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pouwels J, 2007, CELL CYCLE, V6, P1579, DOI 10.4161/cc.6.13.4442; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yalon M, 2004, J CELL SCI, V117, P1961, DOI 10.1242/jcs.01032; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	48	194	203	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					42	U29		10.1038/ncb1667	http://dx.doi.org/10.1038/ncb1667			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084284				2022-12-25	WOS:000252116100011
J	Houlden, H; Johnson, J; Gardner-Thorpe, C; Lashley, T; Hernandez, D; Worth, P; Singleton, AB; Hilton, DA; Holton, J; Revesz, T; Davis, MB; Giunti, P; Wood, NW				Houlden, Henry; Johnson, Janel; Gardner-Thorpe, Christopher; Lashley, Tammaryn; Hernandez, Dena; Worth, Paul; Singleton, Andrew B.; Hilton, David A.; Holton, Janice; Revesz, Tamas; Davis, Mary B.; Giunti, Paolo; Wood, Nicholas W.			Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR ATAXIAS; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; DISORDERS; PROTEIN; FAMILY	The microtubule-associated protein tau ( encoded by MAPT) and several tau kinases have been implicated in neurodegeneration, but only MAPT has a proven role in disease. We identified mutations in the gene encoding tau tubulin kinase 2 ( TTBK2) as the cause of spinocerebellar ataxia type 11. Affected brain tissue showed substantial cerebellar degeneration and tau deposition. These data suggest that TTBK2 is important in the tau cascade and in spinocerebellar degeneration.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; NIA, NIH, Neurogenet Lab, Mol Genet Unit, Bethesda, MD 20892 USA; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; Norwich Univ Hosp, Dept Neurol, Natl Hlth Serv, Norwich NR4 7UY, Norfolk, England; Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; NHS Blood & Transplant (NHSBT); Derriford Hospital	Houlden, H (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, Queen Square, London WC1N 3BG, England.	h.houlden@ion.ucl.ac.uk; n.wood@ion.ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Wood, Nicholas W/C-2505-2009; Johnson, Janel/A-7136-2010; Giunti, Paola/E-5526-2012; Revesz, Tamas/A-8732-2010; Holton, Janice L/F-6831-2011; Houlden, Henry J/C-1532-2008; Lashley, Tammaryn/D-2583-2009	Wood, Nicholas W/0000-0002-9500-3348; Giunti, Paola/0000-0003-3508-4788; Revesz, Tamas/0000-0003-2501-0259; Holton, Janice L/0000-0002-3882-5249; Houlden, Henry J/0000-0002-2866-7777; 	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G108/638] Funding Source: Medline; MRC [G108/638] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [Z01AG000958, ZIAAG000958] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Kitano-Takahashi M, 2007, ACTA CRYSTALLOGR F, V63, P602, DOI 10.1107/S1744309107028783; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; MANN DMA, 1990, NEUROPATH APPL NEURO, V16, P17, DOI 10.1111/j.1365-2990.1990.tb00928.x; MUKAETOVALADINSKA EB, 1993, AM J PATHOL, V143, P565; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Riudavets MA, 2006, J NEUROPATH EXP NEUR, V65, P1143, DOI 10.1097/01.jnen.0000248548.20799.a3; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Worth PF, 1999, AM J HUM GENET, V65, P420, DOI 10.1086/302495	15	122	129	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1434	1436		10.1038/ng.2007.43	http://dx.doi.org/10.1038/ng.2007.43			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18037885				2022-12-25	WOS:000251267400008
J	Luedtke, NW; Dexter, RJ; Fried, DB; Schepartz, A				Luedtke, Nathan W.; Dexter, Rachel J.; Fried, Daniel B.; Schepartz, Alanna			Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH	NATURE CHEMICAL BIOLOGY			English	Article							GREEN-FLUORESCENT PROTEIN; IN-VIVO; LIVING CELLS; LEUCINE-ZIPPER; AGGREGATION; FRET; RESOLUTION; AEQUOREA; HORMONE; VITRO	Recombinant polypeptides and protein domains containing two cysteine pairs located distal in primary sequence but proximal in the native folded or assembled state are labeled selectively in vitro and in mammalian cells using the profluorescent biarsenical reagents FlAsH-EDT2 and ReAsH-EDT2. This strategy, termed bipartite tetracysteine display, enables the detection of protein-protein interactions and alternative protein conformations in live cells. As proof of principle, we show that the equilibrium stability and fluorescence intensity of polypeptide - biarsenical complexes correlates with the thermodynamic stability of the protein fold or assembly. Destabilized protein variants form less stable and less bright biarsenical complexes, which allows discrimination of live cells expressing folded polypeptide and protein domains from those containing disruptive point mutations. Bipartite tetracysteine display may provide a means to detect early protein misfolding events associated with Alzheimer's disease, Parkinson's disease and cystic fibrosis; it may also enable high-throughput screening of compounds that stabilize discrete protein folds.	Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Chem & Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	Schepartz, A (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	alanna.schepartz@yale.edu	Luedtke, Nathan/F-5276-2010		NIGMS NIH HHS [R01 GM083257-01, R01 GM083257] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083257] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Andresen M, 2004, MOL BIOL CELL, V15, P5616, DOI 10.1091/mbc.E04-06-0454; BLUNDELL TL, 1981, P NATL ACAD SCI-BIOL, V78, P4175, DOI 10.1073/pnas.78.7.4175; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WATT RM, 1977, IMMUNOCHEMISTRY, V14, P533, DOI 10.1016/0019-2791(77)90308-1; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170	27	109	112	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					779	784		10.1038/nchembio.2007.49	http://dx.doi.org/10.1038/nchembio.2007.49			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17982447	Green Accepted			2022-12-25	WOS:000251028600012
J	Traer, CJ; Rutherford, AC; Palmer, KJ; Wassmer, T; Oakley, J; Attar, N; Carlton, JG; Kremerskothen, J; Stephens, DJ; Cullen, PJ				Traer, Colin J.; Rutherford, Anna C.; Palmer, Krysten J.; Wassmer, Thomas; Oakley, Jacqueline; Attar, Naomi; Carlton, Jez G.; Kremerskothen, Joachim; Stephens, David J.; Cullen, Peter J.			SNX4 coordinates endosomal sorting of TfnR with dynein-mediated transport into the endocytic recycling compartment	NATURE CELL BIOLOGY			English	Article							RETROGRADE TRANSPORT; MAMMALIAN-CELLS; YEAST ENDOSOMES; GOLGI NETWORK; MEMBRANE; RECEPTOR; PROTEIN; RETROMER; TRAFFICKING; KIBRA	SNX-BAR proteins are a sub-family of sorting nexins implicated in endosomal sorting. Here, we establish that through its phox homology (PX) and Bin-Amphiphysin-Rvs ( BAR) domains, sorting nexin-4 (SNX4) is associated with tubular and vesicular elements of a compartment that overlaps with peripheral early endosomes and the juxtanuclear endocytic recycling compartment ( ERC). Suppression of SNX4 perturbs transport between these compartments and causes lysosomal degradation of the transferrin receptor (TfnR). Through an interaction with KIBRA, a protein previously shown to bind dynein light chain 1, we establish that SNX4 associates with the minus end-directed microtubule motor dynein. Although suppression of KIBRA and dynein perturbs early endosome-to-ERC transport, TfnR sorting is maintained. We propose that by driving membrane tubulation, SNX4 coordinates iterative, geometric-based sorting of the TfnR with the long-range transport of carriers from early endosomes to the ERC. Finally, these data suggest that by associating with molecular motors, SNX-BAR proteins may coordinate sorting with carrier transport between donor and recipient membranes.	Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrat Signalling Labs, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Munster, Dept Expt Tumorbiol, D-4400 Munster, Germany; Guys Hosp, Univ London Kings Coll, London SE1 9RT, England	University of Bristol; University of Bristol; University of Munster; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Cullen, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrat Signalling Labs, Bristol BS8 1TD, Avon, England.	Pete.Cullen@bristol.ac.uk	Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014	Carlton, Jeremy/0000-0002-7255-1894; attar, naomi/0000-0002-6370-7885; Stephens, David/0000-0001-5297-3240; Cullen, Peter/0000-0002-9070-8349	MRC [G117/554] Funding Source: UKRI; Medical Research Council [G117/554, G117/554(71630)] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; DIA J, 2004, DEV CELL, V7, P771; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; EKENA K, 1995, MOL CELL BIOL, V15, P1671; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Krsmanovic T, 2005, MOL BIOL CELL, V16, P2809, DOI 10.1091/mbc.E04-10-0941; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Pelham HRB, 2002, CURR OPIN CELL BIOL, V14, P454, DOI 10.1016/S0955-0674(02)00352-6; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; VANDERGOOT G, 1956, TRENDS CELL BIOL, V16, P514; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999	41	195	203	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1370	U55		10.1038/ncb1656	http://dx.doi.org/10.1038/ncb1656			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17994011				2022-12-25	WOS:000251317300010
J	Tsai, YC; Mendoza, A; Mariano, JM; Zhou, M; Kostova, Z; Chen, B; Veenstra, T; Hewitt, SM; Helman, LJ; Khanna, C; Weissman, AM				Tsai, Yien Che; Mendoza, Arnulfo; Mariano, Jennifer M.; Zhou, Ming; Kostova, Zlatka; Chen, Bo; Veenstra, Timothy; Hewitt, Stephen M.; Helman, Lee J.; Khanna, Chand; Weissman, Allan M.			The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation	NATURE MEDICINE			English	Article							AUTOCRINE MOTILITY FACTOR; RETICULUM-ASSOCIATED DEGRADATION; FACTOR-RECEPTOR; ENDOPLASMIC-RETICULUM; SUPPRESSOR GENES; TETRASPANIN CD82; PROTEIN LIGASE; EXPRESSION; CELLS; IDENTIFICATION	Metastasis is the primary cause of mortality from cancer, but the mechanisms leading to metastasis are poorly understood. In particular, relatively little is known about metastasis in cancers of mesenchymal origins, which are known as sarcomas. Approximately ten proteins have been characterized as 'metastasis suppressors', but how these proteins function and are regulated is, in general, not well understood. Gp78 (also known as AMFR or RNF45) is a RING finger E3 ubiquitin ligase that is integral to the endoplasmic reticulum (ER) and involved in ER-associated degradation (ERAD) of diverse substrates(1-6). Here we report that expression of gp78 has a causal role in the metastasis of an aggressive human sarcoma and that this prometastatic activity requires the E3 activity of gp78. Further, gp78 associates with and targets the transmembrane metastasis suppressor, KAI1 (also known as CD82), for degradation. Suppression of gp78 increases KAI1 abundance and reduces the metastatic potential of tumor cells, an effect that is largely blocked by concomitant suppression of KAI1. An inverse relationship between these proteins was confirmed in a human sarcoma tissue microarray. Whereas most previous efforts have focused on genetic mechanisms for the loss of metastasis suppressor genes, our results provide new evidence for post-translational downregulation of a metastasis suppressor by its ubiquitin ligase, resulting in abrogation of its metastasis suppressing effects.	NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Lab Protein Dynam & Signaling, Ctr Canc Res, NIH, Frederick, MD 21702 USA; NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; NCI, Biomed Proteom Program, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khanna, C (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	khannac@mail.nih.gov; amw@nih.gov		Tsai, Yien Che/0000-0001-9624-1092; Hewitt, Stephen/0000-0001-8283-1788	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Duriez C, 2000, ONCOGENE, V19, P2461, DOI 10.1038/sj.onc.1203580; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Hammond C, 1998, J IMMUNOL, V161, P3282; Houle CD, 2002, GYNECOL ONCOL, V86, P69, DOI 10.1006/gyno.2002.6729; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; NABI IR, 1990, CANCER RES, V50, P409; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Ono M, 1999, CANCER RES, V59, P2335; Schoenfeld N, 2004, FASEB J, V18, P158, DOI 10.1096/fj.03-0420fje; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; WATANABE H, 1991, J BIOL CHEM, V266, P13442; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	27	139	148	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1504	1509		10.1038/nm1686	http://dx.doi.org/10.1038/nm1686			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18037895				2022-12-25	WOS:000251445400026
J	Fagerholm, R; Hofstetter, B; Tommiska, J; Aaltonen, K; Vrtel, R; Syrjakoski, K; Kallioniemi, A; Kilpivaara, O; Mannermaa, A; Kosma, VM; Uusitupa, M; Eskelinen, M; Kataja, V; Aittomakii, K; von Smitten, K; Heikkila, P; Lukas, J; Holli, K; Bartkova, J; Blomqvist, C; Bartek, J; Nevanlinna, H				Fagerholm, Rainer; Hofstetter, Barbara; Tommiska, Johanna; Aaltonen, Kirsimari; Vrtel, Radek; Syrjakoski, Kirsi; Kallioniemi, Anne; Kilpivaara, Outi; Mannermaa, Arto; Kosma, Veli-Matti; Uusitupa, Matti; Eskelinen, Matti; Kataja, Vesa; Aittomakii, Kristiina; von Smitten, Karl; Heikkilae, Paeivi; Lukas, Jiri; Holli, Kaija; Bartkova, Jirina; Blomqvist, Carl; Bartek, Jiri; Nevanlinna, Heli			NAD(P)H : quinone oxidoreductase 1 NQO1(star)2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer	NATURE GENETICS			English	Article							NAD(P)H QUINONE OXIDOREDUCTASE; P53 PROTEASOMAL DEGRADATION; KAPPA-B; POLYMORPHISM; NQO1; ALPHA; SUSCEPTIBILITY; CELLS; ASSOCIATION; APOPTOSIS	NQO1 guards against oxidative stress and carcinogenesis and stabilizes p53. We find that a homozygous common missense variant (NQO1*2, rs1800566(T), NM_000903.2:c.558C>T) that disables NQO1 strongly predicts poor survival among two independent series of women with breast cancer (P = 0.002, N = 1,005; P = 0.005, N = 1,162), an effect particularly evident after anthracycline-based adjuvant chemotherapy with epirubicin (P = 7.52 x 10(-6)) and in p53-aberrant tumors (P = 6.15 x 10(-5)). Survival after metastasis was reduced among NQO1*2 homozygotes, further implicating NQO1 deficiency in cancer progression and treatment resistance. Consistently, response to epirubicin was impaired in NQO1*2-homozygous breast carcinoma cells in vitro, reflecting both p53-linked and p53-independent roles of NQO1. We propose a model of defective anthracycline response in NQO1-deficient breast tumors, along with increased genomic instability promoted by elevated reactive oxygen species (ROS), and suggest that the NQO1 genotype is a prognostic and predictive marker for breast cancer.	[Hofstetter, Barbara; Vrtel, Radek; Lukas, Jiri; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Hofstetter, Barbara; Vrtel, Radek; Lukas, Jiri; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Fagerholm, Rainer; Tommiska, Johanna; Aaltonen, Kirsimari; Kilpivaara, Outi; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Ginecol, FI-00029 Helsinki, Finland; [Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Dept Oncol, FI-00029 Helsinki, Finland; [Syrjakoski, Kirsi; Kallioniemi, Anne] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Syrjakoski, Kirsi; Kallioniemi, Anne] Univ Tampere, Tampere Univ Hosp, Canc Genet Lab, FI-33014 Tampere, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Kuopio, Inst Clin Med Pathol & Forens Med, FI-70211 Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol, FI-70211 Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Dept Publ Hlth & Clin Nutr, FI-70211 Kuopio, Finland; [Eskelinen, Matti] Kuopio Univ Hosp, Dept Surg, FI-70211 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, FI-70211 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, FI-651000 Vaasa, Finland; [Aittomakii, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, FI-00029 Helsinki, Finland; [von Smitten, Karl] Univ Helsinki, Cent Hosp, Dept Surg, FI-00029 Helsinki, Finland; [Heikkilae, Paeivi] Univ Helsinki, Cent Hosp, Dept Pathol, FI-00029 Helsinki, Finland; [Holli, Kaija] Tampere Univ Hosp, Palliat Unit, FI-33014 Tampere, Finland; [Holli, Kaija] Tampere Univ Hosp, Sch Med, FI-33014 Tampere, Finland; [Blomqvist, Carl] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden; [Vrtel, Radek; Bartek, Jiri] Palacky Univ, Lab Genome Integr, CZ-77515 Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Uppsala University; Uppsala University Hospital; Palacky University Olomouc	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; heli.nevanlinna@hus.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Bartek, Jiri/G-5870-2014	Kallioniemi, Anne/0000-0003-3552-8158; Kataja, Vesa/0000-0003-4846-4843; Blomqvist, Carl/0000-0003-3041-1938; Nevanlinna, Heli/0000-0002-0916-2976; Lukas, Jiri/0000-0001-9087-506X; Tommiska, Johanna/0000-0001-7958-8262				Abe O, 2005, LANCET, V366, P2087; AHERN RP, 1993, BRIT J CANCER, V67, P801, DOI 10.1038/bjc.1993.146; Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200; Anwar A, 2003, J BIOL CHEM, V278, P10368, DOI 10.1074/jbc.M211981200; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Berberoglu U, 2004, INT J BIOL MARKER, V19, P130, DOI 10.1177/172460080401900207; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Estevam FR, 2005, CANCER IMMUNOL IMMUN, V54, P671, DOI 10.1007/s00262-004-0639-0; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Fossati R, 1998, J CLIN ONCOL, V16, P3439, DOI 10.1200/JCO.1998.16.10.3439; Fowke JH, 2004, CANCER EPIDEM BIOMAR, V13, P1308; Garte S, 2005, CHEM-BIOL INTERACT, V153, P247, DOI 10.1016/j.cbi.2005.03.030; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Goode EL, 2002, CANCER RES, V62, P3052; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Kelsey KT, 1997, BRIT J CANCER, V76, P852, DOI 10.1038/bjc.1997.474; Kovalenko A, 2006, MOL CELL, V22, P433, DOI 10.1016/j.molcel.2006.05.002; Krajinovic M, 2002, INT J CANCER, V97, P230, DOI 10.1002/ijc.1589; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Larson RA, 1999, BLOOD, V94, P803, DOI 10.1182/blood.V94.2.803.414k44_803_807; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Long DJ, 2000, CANCER RES, V60, P5913; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Naoe T, 2000, CLIN CANCER RES, V6, P4091; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perik PJ, 2006, ACTA ONCOL, V45, P175, DOI 10.1080/02841860500482225; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Rothman N, 1997, CANCER RES, V57, P2839; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarmanova J, 2004, EUR J HUM GENET, V12, P848, DOI 10.1038/sj.ejhg.5201249; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Siemankowski LM, 2000, CANCER RES, V60, P3638; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Wiemels JL, 1999, CANCER RES, V59, P4095; Winski SL, 2001, BIOCHEM PHARMACOL, V61, P1509, DOI 10.1016/S0006-2952(01)00631-1; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513	49	171	180	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					844	853		10.1038/ng.155	http://dx.doi.org/10.1038/ng.155			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511948				2022-12-25	WOS:000257166500019
J	Shen, L; Peterson, S; Sedaghat, AR; McMahon, MA; Callender, M; Zhang, HL; Zhou, Y; Pitt, E; Anderson, KS; Acosta, EP; Siliciano, RF				Shen, Lin; Peterson, Susan; Sedaghat, Ahmad R.; McMahon, Moira A.; Callender, Marc; Zhang, Haili; Zhou, Yan; Pitt, Eleanor; Anderson, Karen S.; Acosta, Edward P.; Siliciano, Robert F.			Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; DARUNAVIR-RITONAVIR; VIRAL DYNAMICS; INFECTION; THERAPY; PHARMACODYNAMICS; SUSCEPTIBILITY; REPLICATION; ZIDOVUDINE	Highly active antiretroviral therapy (HAART) can control HIV-1 replication(1,2), but suboptimal treatment allows for the evolution of resistance and rebound viremia(3-8). A comparative measure of antiviral activity under clinically relevant conditions would guide drug development and the selection of regimens that maximally suppress replication. Here we show that current measures of antiviral activity, including IC(50) and inhibitory quotient, neglect a key dimension, the dose-response curve slope. Using infectivity assays with wide dynamic range, we show that this slope has noteworthy effects on antiviral activity. Slope values are class specific for antiviral drugs and define intrinsic limitations on antiviral activity for some classes. Nucleoside reverse transcriptase inhibitors and integrase inhibitors have slopes of similar to 1, characteristic of noncooperative reactions, whereas non-nucleoside reverse transcriptase inhibitors, protease inhibitors and fusion inhibitors unexpectedly show slopes >1. Instantaneous inhibitory potential (IIP), the log reduction in single-round infectivity at clinical drug concentrations, is strongly influenced by slope and varies by >8 logs for anti-HIV drugs. IIP provides a more accurate measure of antiviral activity and in general correlates with clinical outcomes. Only agents with slopes >1 achieve high-level inhibition of single-round infectivity, a finding with profound implications for drug and vaccine development.	[Shen, Lin; Peterson, Susan; Sedaghat, Ahmad R.; McMahon, Moira A.; Callender, Marc; Zhang, Haili; Zhou, Yan; Pitt, Eleanor; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shen, Lin; McMahon, Moira A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Acosta, Edward P.] Univ Alabama, Med Sch Birmingham, Div Clin Pharmacol, Birmingham, AL 35294 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Yale University; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 733 N Broadway, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu		Shen, Lin/0000-0003-2392-3353; McMahon, Moira/0000-0001-9810-8623; Wilson, Eleanor/0000-0002-4855-514X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI051178, R37 AI051178-07, AI43222, R01 AI051178-05, R01 AI043222-08, R37 AI051178-06A1, R37 AI051178, AI51178, R01 AI043222-09, R01 AI043222, R01 AI043222-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, R01AI051178, R37AI051178] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACOSTA EP, 2007, ANTIRETROVIRAL PHARM, P115; Ambrose Z, 2006, J VIROL, V80, P2578, DOI 10.1128/JVI.80.5.2578-2581.2006; BARTLETT JG, 2007, 2007 MED MANAGEMENT, V510; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Ferguson NM, 2001, TRENDS PHARMACOL SCI, V22, P97, DOI 10.1016/S0165-6147(00)01615-1; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoefnagel JGM, 2005, ANTIVIR THER, V10, P879; HOFFMAN A, 1994, J PHARMACOKINET BIOP, V2, P449; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Morse GD, 2006, LANCET INFECT DIS, V6, P215, DOI 10.1016/S1473-3099(06)70436-4; ORTIZ R, 1948, AIDS IN PRESS; Pandey KK, 2007, J VIROL, V81, P12189, DOI 10.1128/JVI.02863-06; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Talal AH, 2006, HEPATOLOGY, V43, P943, DOI 10.1002/hep.21136; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; 2008, PANEL ANTIRETROVIRAL	29	237	241	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					762	766		10.1038/nm1777	http://dx.doi.org/10.1038/nm1777			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18552857	Green Accepted, Bronze			2022-12-25	WOS:000257452700024
J	Laurencin, CT; Nair, L				Laurencin, Cato T.; Nair, Lakshmi			The FDA and safety - beyond the heparin crisis	NATURE BIOTECHNOLOGY			English	Editorial Material								The discovery of a contaminant in batches of heparin throws into stark relief the difficulties, not only for the US Food and Drug Administration, but also for international regulatory agencies, to ensure the safety and quality of active pharmaceutical ingredients.	[Laurencin, Cato T.] Univ Connecticut, Coll Med, Storrs, CT 06269 USA; [Laurencin, Cato T.; Nair, Lakshmi] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA	University of Connecticut; University of Virginia	Laurencin, CT (corresponding author), Univ Virginia, Dept Orthopaed Surg, 400 Ray C Hunt Dr, Charlottesville, VA 22903 USA.	Laurencin@virginia.edu						*FDA SCI BOARD SUB, 2007, FDA SCI MISS RISK RE; GUERRINI M, 2008, NAT BIOTECHNOL  0423; KISHIMOTO TK, 2008, N ENGL J MED    0423	3	27	30	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					621	623		10.1038/nbt0608-621	http://dx.doi.org/10.1038/nbt0608-621			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18536680	Bronze			2022-12-25	WOS:000256611900016
J	Kraft, C; Deplazes, A; Sohrmann, M; Peter, M				Kraft, Claudine; Deplazes, Anna; Sohrmann, Marc; Peter, Matthias			Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; DEUBIQUITINATING ENZYMES; FUNCTIONAL-ANALYSIS; MESSENGER-RNA; YEAST; PROTEINS; KINASE; SUBUNITS; COMPLEX	Eukaryotic cells use autophagy and the ubiquitin-proteasome system ( UPS) as their major protein degradation pathways. Whereas the UPS is required for the rapid degradation of proteins when fast adaptation is needed, autophagy pathways selectively remove protein aggregates and damaged or excess organelles(1). However, little is known about the targets and mechanisms that provide specificity to this process. Here we show that mature ribosomes are rapidly degraded by autophagy upon nutrient starvation in Saccharomyces cerevisiae. Surprisingly, this degradation not only occurs by a nonselective mechanism, but also involves a novel type of selective autophagy, which we term 'ribophagy'. A genetic screen revealed that selective degradation of ribosomes requires catalytic activity of the Ubp3p/Bre5p ubiquitin protease. Although ubp3 Delta and bre5 Delta cells strongly accumulate 60S ribosomal particles upon starvation, they are proficient in starvation sensing and in general trafficking and autophagy pathways. Moreover, ubiquitination of several ribosomal subunits and/or ribosome-associated proteins was specifically enriched in ubp3 Delta cells, suggesting that the regulation of ribophagy by ubiquitination may be direct. Interestingly, ubp3 Delta cells are sensitive to rapamycin and nutrient starvation, implying that selective degradation of ribosomes is functionally important in vivo. Taken together, our results suggest a link between ubiquitination and the regulated degradation of mature ribosomes by autophagy.	[Kraft, Claudine; Deplazes, Anna; Sohrmann, Marc; Peter, Matthias] ETH Honggerberg, Inst Biochem, HPM, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kraft, C (corresponding author), ETH Honggerberg, Inst Biochem, HPM, CH-8093 Zurich, Switzerland.	claudine.kraft@bc.biol.ethz.ch; matthias.peter@bc.biol.ethz.ch		Deplazes Zemp, Anna/0000-0002-1992-1622; Peter, Matthias/0000-0002-2160-6824				BAKER RT, 1992, J BIOL CHEM, V267, P23364; Baxter BK, 2005, J BIOL CHEM, V280, P39067, DOI 10.1074/jbc.M508064200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brew CT, 2002, GENETICS, V162, P1079; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Espert L, 2007, J MOL MED, V85, P811, DOI 10.1007/s00109-007-0173-6; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Mizushima N, 2007, AUTOPHAGY, V3, P179, DOI 10.4161/auto.4051; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; PICKART CM, 1985, J BIOL CHEM, V260, P7903; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Valtz N, 1997, METHOD ENZYMOL, V283, P350; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018	40	519	534	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					602	610		10.1038/ncb1723	http://dx.doi.org/10.1038/ncb1723			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18391941				2022-12-25	WOS:000255502400017
J	Novembre, J; Stephens, M				Novembre, John; Stephens, Matthew			Interpreting principal component analyses of spatial population genetic variation	NATURE GENETICS			English	Article							SYNTHETIC MAPS; DEMIC EXPANSIONS; ASSOCIATION; STRATIFICATION; EUROPE; ORIGIN	Nearly 30 years ago, Cavalli-Sforza et al. pioneered the use of principal component analysis (PCA) in population genetics and used PCA to produce maps summarizing human genetic variation across continental regions(1). They interpreted gradient and wave patterns in these maps as signatures of specific migration events(1-3). These interpretations have been controversial(4-7), but influential(8), and the use of PCA has become widespread in analysis of population genetics data(9-13). However, the behavior of PCA for genetic data showing continuous spatial variation, such as might exist within human continental groups, has been less well characterized. Here, we find that gradients and waves observed in Cavalli-Sforza et al.'s maps resemble sinusoidal mathematical artifacts that arise generally when PCA is applied to spatial data, implying that the patterns do not necessarily reflect specific migration events. Our findings aid interpretation of PCA results and suggest how PCA can help correct for continuous population structure in association studies.	[Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Stephens, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 5th Floor, Chicago, IL 60637 USA.	stephens@galton.uchicago.edu	Novembre, John/G-1339-2011		NHGRI NIH HHS [R01 HG02585-01, R01 HG002585] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Brillinger D. R., 1975, TIME SERIES DATA ANA; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DIACONIS P, IN PRESS ANN APPL ST; FREIBERGER WF, 1960, INT DICT APPL MATH; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Heidemann G, 2006, IEEE T PATTERN ANAL, V28, P822, DOI 10.1109/TPAMI.2006.107; INWIN DE, 2005, SCIENCE, V307, P414; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Podani J, 2002, ECOLOGY, V83, P3331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rendine S, 1999, HUM BIOL, V71, P15; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sokal RR, 1999, HUM BIOL, V71, P1; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	30	355	357	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					646	649		10.1038/ng.139	http://dx.doi.org/10.1038/ng.139			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425127	Green Accepted			2022-12-25	WOS:000255366700034
J	Twigger, SN; Pruitt, KD; Fernandez-Suarez, XM; Karolchik, D; Worley, KC; Maglott, DR; Brown, G; Weinstock, G; Gibbs, RA; Kent, J; Birney, E; Jacob, HJ				Twigger, Simon N.; Pruitt, Kim D.; Fernandez-Suarez, Xose M.; Karolchik, Donna; Worley, Kim C.; Maglott, Donna R.; Brown, Garth; Weinstock, George; Gibbs, Richards A.; Kent, Jim; Birney, Ewan; Jacob, Howard J.			What everybody should know about the rat genome and its online resources	NATURE GENETICS			English	Editorial Material							DATABASE; GENE; MOUSE; SEQUENCE; BROWSER	It has been four years since the original publication of the draft sequence of the rat genome. Five groups are now working together to assemble, annotate and release an updated version of the rat genome. As the prevailing model for physiology, complex disease and pharmacological studies, there is an acute need for the rat's genomic resources to keep pace with the rat's prominence in the laboratory. In this commentary, we describe the current status of the rat genome sequence and the plans for its impending 'upgrade'. We then cover the key online resources providing access to the rat genome, including the new SNP views at Ensembl, the RefSeq and Genes databases at the US National Center for Biotechnology Information, Genome Browser at the University of California Santa Cruz and the disease portals for cardiovascular disease and obesity at the Rat Genome Database.	[Twigger, Simon N.; Jacob, Howard J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pruitt, Kim D.; Karolchik, Donna] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Fernandez-Suarez, Xose M.; Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SD, England; [Maglott, Donna R.; Kent, Jim] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Worley, Kim C.; Weinstock, George; Gibbs, Richards A.] Baylor Coll Med, Houston, TX 77030 USA	Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); European Molecular Biology Laboratory (EMBL); University of California System; University of California Santa Cruz; Baylor College of Medicine	Twigger, SN (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	simont@hmgc.mcw.edu	Weinstock, George M/C-6314-2013; Fernandez, Xose/ABA-7117-2020	Weinstock, George M/0000-0002-2997-4592; Fernandez, Xose/0000-0001-7139-6215; Birney, Ewan/0000-0001-8314-8497; Pruitt, Kim/0000-0001-7950-1374; Twigger, Simon/0000-0001-5659-3632; Worley, Kim/0000-0002-0282-1000	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline; NHGRI NIH HHS [HG-002273, U54 HG003273, U41 HG002273, R01 HG002273, P41 HG002273, HG-003273] Funding Source: Medline; NHLBI NIH HHS [R01 HL064541, HL-64541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cunningham F, 2006, NAT GENET, V38, P853, DOI 10.1038/ng0806-853a; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; FERNANDEZSUAREZ XM, 2006, SILICO GENOMICS PROT, P109; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mueller M, 2006, BIOINFORMATICS, V22, P509, DOI 10.1093/bioinformatics/btk007; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Worley KC, 2008, PHYSIOL GENOMICS, V32, P273, DOI 10.1152/physiolgenomics.00208.2007; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	24	35	37	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					523	527		10.1038/ng0508-523	http://dx.doi.org/10.1038/ng0508-523			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443589	Green Accepted			2022-12-25	WOS:000255366700017
J	Ubeda-Tomas, S; Swarup, R; Coates, J; Swarup, K; Laplaze, L; Beemster, GTS; Hedden, P; Bhalerao, R; Bennett, MJ				Ubeda-Tomas, Susana; Swarup, Ranjan; Coates, Juliet; Swarup, Kamal; Laplaze, Laurent; Beemster, Gerrit T. S.; Hedden, Peter; Bhalerao, Rishikesh; Bennett, Malcolm J.			Root growth in Arabidopsis requires gibberellin/DELLA signalling in the endodermis	NATURE CELL BIOLOGY			English	Article							PROTEIN; RECEPTOR; AUXIN; GAI; RGA; DEGRADATION; REPRESSOR; THALIANA; GID1	Gibberellins ( Gas) are key regulators of plant growth and development. they promote growth by targeting the degradation of DELLA repressor proteins; however, their site of action at the cellular, tissue or organ levels remains unknown. to map the site of GA action in regulating root growth, we expressed gai, a non-degradable, mutant DELLA protein, in selected root tissues. root growth was retarded specifically when gai was expressed in endodermal cells. our results demonstrate that the endodermis represents the primary GA-responsive tissue regulating organ growth and that endodermal cell expansion is rate-limiting for elongation of other tissues and therefore of the root as a whole.	[Bhalerao, Rishikesh] SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Ubeda-Tomas, Susana; Swarup, Ranjan; Swarup, Kamal; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Coates, Juliet] Univ Birmingham, Sch Biosci, Edgbaston B15 2TT, England; [Laplaze, Laurent] Inst Rech Dev, UMR 1097, F-34394 Montpellier 5, France; [Beemster, Gerrit T. S.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beemster, Gerrit T. S.] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Hedden, Peter] Rothamsted Res, Harpenden AL5 2JQ, Herts, England	Swedish University of Agricultural Sciences; Umea University; University of Nottingham; University of Birmingham; Institut de Recherche pour le Developpement (IRD); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Bhalerao, R (corresponding author), SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden.	Rishi.Bhalerao@genfys.slu.se; malcolm.bennett@nottingham.ac.uk	Beemster, Gerrit/E-6668-2016; Coates, Juliet C/A-3608-2013; Laplaze, Laurent/I-5435-2016; Bennett, Malcolm/G-4004-2010	Beemster, Gerrit/0000-0001-6014-053X; Coates, Juliet C/0000-0002-2381-0298; Laplaze, Laurent/0000-0002-6568-6504; Bennett, Malcolm/0000-0003-0475-390X; Ubeda Tomas, Susanna/0000-0001-9012-2412; swarup, Ranjan/0000-0002-6438-9188; Bhalerao, Rishikesh/0000-0003-4384-7036	BBSRC [BBS/E/C/00004954, BB/D007550/1, BB/D019613/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004162, BB/D019613/1, REI20541, BBS/E/C/00004954, BBS/E/C/00004161, BB/D007550/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; King KE, 2001, GENETICS, V159, P767; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	18	216	229	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					625	628		10.1038/ncb1726	http://dx.doi.org/10.1038/ncb1726			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425113				2022-12-25	WOS:000255502400020
J	Varadarajan, N; Rodriguez, S; Hwang, BY; Georgiou, G; Iverson, BL				Varadarajan, Navin; Rodriguez, Sarah; Hwang, Bum-Yeol; Georgiou, George; Iverson, Brent L.			Highly active and selective endopeptidases with programmed substrate specificities	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE PROTEASE OMPT; ESCHERICHIA-COLI; PLASMINOGEN-ACTIVATOR; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; IDENTIFICATION; PROTEINS; EVOLUTION; THROMBIN; REVERSAL	A family of engineered endopeptidases has been created that is capable of cleaving a diverse array of peptide sequences with high selectivity and catalytic efficiency (K-cat/K-M > 10(4) M-1 s(-1)). By screening libraries with a selection-counterselection substrate method, protease variants were programmed to recognize amino acids having altered charge, size and hydrophobicity properties adjacent to the scissile bond of the substrate, including Glu down arrow Arg, a specificity that to our knowledge has not been observed among natural proteases. Members of this artificial protease family resulted from a relatively small number of amino acid substitutions that (at least in one case) proved to be epistatic.	[Varadarajan, Navin; Georgiou, George; Iverson, Brent L.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Varadarajan, Navin; Hwang, Bum-Yeol; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Rodriguez, Sarah; Iverson, Brent L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.	gg@che.utexas.edu; biverson@mail.utexas		Varadarajan, Navin/0000-0001-7524-8228	NIGMS NIH HHS [R01 GM065551-04S1, R01 GM065551, R01 GM073089, R01 GM073089-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065551, R01GM073089] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballinger MD, 1996, BIOCHEMISTRY-US, V35, P13579, DOI 10.1021/bi961543h; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Caputo A, 1999, PROTEINS, V35, P415, DOI 10.1002/(SICI)1097-0134(19990601)35:4<415::AID-PROT5>3.0.CO;2-7; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; DAWSON KM, 1994, J BIOL CHEM, V269, P15989; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; GARDELL SJ, 1989, J BIOL CHEM, V264, P17947; GRAF L, 1987, BIOCHEMISTRY-US, V26, P2616, DOI 10.1021/bi00383a031; GRODBERG J, 1988, NUCLEIC ACIDS RES, V16, P1209, DOI 10.1093/nar/16.3.1209; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hopfner KP, 1998, P NATL ACAD SCI USA, V95, P9813, DOI 10.1073/pnas.95.17.9813; Hwang BY, 2007, J BACTERIOL, V189, P522, DOI 10.1128/JB.01493-06; HWANG JK, 1988, NATURE, V334, P270, DOI 10.1038/334270a0; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kukkonen M, 2004, INT J MED MICROBIOL, V294, P7, DOI 10.1016/j.ijmm.2004.01.003; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Marnett AB, 2005, TRENDS BIOTECHNOL, V23, P59, DOI 10.1016/j.tibtech.2004.12.010; McCarter JD, 2004, J BACTERIOL, V186, P5919, DOI 10.1128/JB.186.17.5919-5925.2004; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; Turkina Maria V., 2007, V355, P305; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Yamada T, 1996, BIOCHEM BIOPH RES CO, V228, P306, DOI 10.1006/bbrc.1996.1657	32	65	74	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2008	4	5					290	294		10.1038/nchembio.80	http://dx.doi.org/10.1038/nchembio.80			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291CM	18391948	Green Accepted			2022-12-25	WOS:000255170400009
J	Puschendorf, M; Terranova, R; Boutsma, E; Mao, XH; Isono, KI; Brykczynska, U; Kolb, C; Otte, AP; Koseki, H; Orkin, SH; van Lohuizen, M; Peters, AHFM				Puschendorf, Mareike; Terranova, Remi; Boutsma, Erwin; Mao, Xiaohong; Isono, Kyo-ichi; Brykczynska, Urszula; Kolb, Carolin; Otte, Arie P.; Koseki, Haruhiko; Orkin, Stuart H.; van Lohuizen, Maarten; Peters, Antoine H. F. M.			PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos	NATURE GENETICS			English	Article							REPRESSIVE HISTONE METHYLATION; H3 LYSINE-9 METHYLATION; PERICENTRIC HETEROCHROMATIN; X-INACTIVATION; SATELLITE REPEATS; DNA METHYLATION; CLONED EMBRYOS; GROUP PROTEINS; POLYCOMB; CHROMATIN	In eukaryotes, Suv39h H3K9 trimethyltransferases are required for pericentric heterochromatin formation and function. In early mouse preimplantation embryos, however, paternal pericentric heterochromatin lacks Suv39h-mediated H3K9me3 and downstream marks. Here we demonstrate Ezh2-independent targeting of maternally provided polycomb repressive complex 1 (PRC1) components to paternal heterochromatin. In Suv39h2 maternally deficient zygotes, PRC1 also associates with maternal heterochromatin lacking H3K9me3, thereby revealing hierarchy between repressive pathways. In Rnf2 maternally deficient zygotes, the PRC1 complex is disrupted, and levels of pericentric major satellite transcripts are increased at the paternal but not the maternal genome. We conclude that in early embryos, Suv39h-mediated H3K9me3 constitutes the dominant maternal transgenerational signal for pericentric heterochromatin formation. In absence of this signal, PRC1 functions as the default repressive back-up mechanism. Parental epigenetic asymmetry, also observed along cleavage chromosomes, is resolved by the end of the 8-cell stage-concurrent with blastomere polarization-marking the end of the maternal-to-embryonic transition.	[Puschendorf, Mareike; Terranova, Remi; Brykczynska, Urszula; Kolb, Carolin; Peters, Antoine H. F. M.] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Boutsma, Erwin; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Boutsma, Erwin; van Lohuizen, Maarten] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Mao, Xiaohong; Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mao, Xiaohong; Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Isono, Kyo-ichi; Koseki, Haruhiko] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Otte, Arie P.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Friedrich Miescher Institute for Biomedical Research; Netherlands Cancer Institute; Netherlands Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; RIKEN; University of Amsterdam	Peters, AHFM (corresponding author), Friedrich Miescher Inst, Maulbeerst 66, CH-4058 Basel, Switzerland.	antoine.peters@fmi.ch	Peters, Antoine/ABA-6283-2020; Koseki, Haruhiko/I-3825-2014; Albert, Mareike/AAJ-5980-2020	Koseki, Haruhiko/0000-0001-8424-5854; Albert, Mareike/0000-0001-9855-9344; Isono, Kyoichi/0000-0002-4609-8985; Peters, Antoine/0000-0002-0311-1887				Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Arney KL, 2002, INT J DEV BIOL, V46, P317; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Ekwall K, 1996, J CELL SCI, V109, P2637; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Johnson M H, 1986, Dev Biol (N Y 1985), V4, P279; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Merico V, 2007, CHROMOSOME RES, V15, P341, DOI 10.1007/s10577-007-1130-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; Yoshida N, 2007, DEV BIOL, V301, P464, DOI 10.1016/j.ydbio.2006.08.006	49	248	251	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					411	420		10.1038/ng.99	http://dx.doi.org/10.1038/ng.99			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311137				2022-12-25	WOS:000254388100011
J	Vitre, B; Coquelle, FM; Heichette, C; Garnier, C; Chretien, D; Arnal, I				Vitre, Benjamin; Coquelle, Frederic M.; Heichette, Claire; Garnier, Cyrille; Chretien, Denis; Arnal, Isabelle			EB1 regulates microtubule dynamics and tubulin sheet closure in vitro	NATURE CELL BIOLOGY			English	Article							PLUS-END-TRACKING; PROTOFILAMENT NUMBERS; STRUCTURAL BASIS; PROTEINS; INSTABILITY; MECHANISM; APC; STABILIZATION; MODULATION; CLIP-170	End binding 1 ( EB1) is a plus-end-tracking protein (+TIP) that localizes to microtubule plus ends where it modulates their dynamics and interactions with intracellular organelles(1,2). Although the regulating activity of EB1 on microtubule dynamics has been studied in cells(3-6) and purified systems(7-13), the molecular mechanisms involved in its specific activity are still unclear. Here, we describe how EB1 regulates the dynamics and structure of microtubules assembled from pure tubulin. We found that EB1 stimulates spontaneous nucleation and growth of microtubules, and promotes both catastrophes ( transitions from growth to shrinkage) and rescues ( reverse events). Electron cryomicroscopy showed that EB1 induces the initial formation of tubulin sheets, which rapidly close into the common 13-protofilament-microtubule architecture. Our results suggest that EB1 favours the lateral association of free tubulin at microtubule-sheet edges, thereby stimulating nucleation, sheet growth and closure. The reduction of sheet length at microtubule growing-ends together with the elimination of stressed microtubule lattices may account for catastrophes. Conversely, occasional binding of EB1 to the microtubule lattice may induce rescues.	[Vitre, Benjamin; Coquelle, Frederic M.; Heichette, Claire; Garnier, Cyrille; Chretien, Denis; Arnal, Isabelle] Univ Rennes 1, CNRS, Unite Mixte Rech 6026, Inst Federatif Rech 140, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Chretien, D (corresponding author), Univ Rennes 1, CNRS, Unite Mixte Rech 6026, Inst Federatif Rech 140, Campus Beaulieu,263 Ave Gen Leclerc, F-35042 Rennes, France.	denis.chretien@univ-rennes1.fr; isabelle.arnal@univ-rennes1.fr	Arnal, Isabelle/X-6559-2019; Vitre, Benjamin/R-2169-2019	Chretien, Denis/0000-0001-8261-4396; GARNIER, Cyrille/0000-0002-5715-8218; Arnal, Isabelle/0000-0001-6149-8189; Vitre, Benjamin/0000-0001-5954-4270; COQUELLE, Frederic/0000-0002-5483-8787				Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Chretien D, 1999, CELL STRUCT FUNCT, V24, P299, DOI 10.1247/csf.24.299; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Chretien D, 2000, J MOL BIOL, V298, P663, DOI 10.1006/jmbi.2000.3696; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DETRICH HW, 1985, J BIOL CHEM, V260, P9479; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hunyadi V, 2005, J MOL BIOL, V348, P927, DOI 10.1016/j.jmb.2005.03.019; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Mahadevan L, 2005, NATURE, V435, P895, DOI 10.1038/435895a; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; TILNEY LG, 1973, J CELL BIOL, V59, P267, DOI 10.1083/jcb.59.2.267; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	35	183	186	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					415	U81		10.1038/ncb1703	http://dx.doi.org/10.1038/ncb1703			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364701	Green Submitted			2022-12-25	WOS:000254561700011
J	Ma, QH; Futagawa, T; Yang, WL; Jiang, XD; Zeng, L; Takeda, Y; Xu, RX; Bagnard, D; Schachner, M; Furley, AJ; Karagogeos, D; Watanabe, K; Dawe, GS; Xiao, ZC				Ma, Quan-Hong; Futagawa, Toshitaka; Yang, Wu-Lin; Jiang, Xiao-Dan; Zeng, Li; Takeda, Yasuo; Xu, Ru-Xiang; Bagnard, Dominique; Schachner, Melitta; Furley, Andrew J.; Karagogeos, Domna; Watanabe, Kazutada; Dawe, Gavin S.; Xiao, Zhi-Cheng			A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis	NATURE CELL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; DEPENDENT TRANSCRIPTIONAL CONTROL; DEGRADING ENZYME NEPRILYSIN; REGULATED INTRAMEMBRANE PROTEOLYSIS; CARBOXYL-TERMINAL DOMAIN; PIQUARD ET-AL.; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; A-BETA; ADHESION MOLECULES	The release of amyloid precursor protein (APP) intracellular domain (AICD) may be triggered by extracellular cues through gamma-secretase-dependent cleavage. AICD binds to Fe65, which may have a role in AICD-dependent signalling; however, the functional ligand has not been characterized. In this study, we have identified TAG1 as a functional ligand of APP. We found that, through an extracellular interaction with APP, TAG1 increased AICD release and triggered Fe65-dependent activity in gamma-secretase-dependent manner. TAG1, APP and Fe65 colocalized in the neural stem cell niche of the fetal ventricular zone. Neural precursor cells from TAG1(-/-), APP(-/-) and TAG1(-/-); APP(-/-) mice had aberrantly enhanced neurogenesis, which was significantly reversed in TAG1(-/-) mice by TAG1 or AICD but not by AICD mutated at the Fe65 binding site. Notably, TAG1 reduced normal neurogenesis in Fe65(+/+) mice. Abnormally enhanced neurogenesis also occurred in Fe65(-/-) mice but could not be reversed by TAG1. These results describe a TAG1-APP signalling pathway that negatively modulates neurogenesis through Fe65.	[Ma, Quan-Hong; Zeng, Li; Xiao, Zhi-Cheng] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Ma, Quan-Hong; Futagawa, Toshitaka; Yang, Wu-Lin; Xiao, Zhi-Cheng] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Ma, Quan-Hong; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; [Ma, Quan-Hong; Bagnard, Dominique] Ctr Neurochim, INSERM, U Physiopathol Syst Nerveux 575, F-67084 Strasbourg, France; [Futagawa, Toshitaka; Takeda, Yasuo] Kagoshima Univ, Dept Clin Pharm & Parmacol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Jiang, Xiao-Dan; Xu, Ru-Xiang] So Med Univ, Zhujiang Hosp, Neuromed Inst, Guangzhou 510282, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Furley, Andrew J.] Univ Sheffield, Ctr Dev Genet, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Karagogeos, Domna] Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Karagogeos, Domna] Univ Crete, Sch Med, Iraklion 71110, Crete, Greece; [Watanabe, Kazutada] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Dawe, Gavin S.] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore; [Xiao, Zhi-Cheng] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Singapore General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kagoshima University; Southern Medical University - China; Rutgers State University New Brunswick; University of Sheffield; University of Crete; Nagaoka University of Technology; National University of Singapore; National University of Singapore	Dawe, GS (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	gavindawe@nus.edu.sg; xiao.zhi.cheng@sgh.com.sg	xiao, zhicheng/A-1529-2011; Bagnard, Dominique/I-6535-2013; Furley, Andrew JW/B-7316-2012; Furley, Andrew J. W./D-4798-2013	Furley, Andrew JW/0000-0001-5549-8668; Bagnard, Dominique/0000-0002-5261-902X; Dawe, Gavin/0000-0001-6119-701X; xiao, zhicheng/0000-0001-5172-762X; Ma, Quanhong/0000-0001-9392-8956; Karagogeos, Domna/0000-0002-8129-9731				Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; FISHER S, 1991, P NATL ACAD SCI USA, V88, P1779, DOI 10.1073/pnas.88.5.1779; Fukamauchi F, 2001, BIOCHEM BIOPH RES CO, V281, P220, DOI 10.1006/bbrc.2001.4334; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; HEMANN C, 1994, DNA CELL BIOL, V13, P437, DOI 10.1089/dna.1994.13.437; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Karagogeos D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1304, DOI 10.2741/1214; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; KUHN HG, 2007, EUR ARCH PSYCHIAT CL; Lopez-Sanchez N, 2005, NEUROSCIENCE, V130, P51, DOI 10.1016/j.neuroscience.2004.09.020; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Ozaki T, 2006, BIOCHEM BIOPH RES CO, V351, P57, DOI 10.1016/j.bbrc.2006.09.162; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2007, NEURON, V53, P483, DOI 10.1016/j.neuron.2007.01.024; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; RODIER PM, 1977, TERATOLOGY, V16, P235, DOI 10.1002/tera.1420160220; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tanahashi H, 2002, BIOCHEM J, V367, P687, DOI 10.1042/BJ20020562; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	47	157	163	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					283	U29		10.1038/ncb1690	http://dx.doi.org/10.1038/ncb1690			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18278038	Green Submitted			2022-12-25	WOS:000253778300010
J	Padovani, D; Labunska, T; Palfey, BA; Ballou, DP; Banerjee, R				Padovani, Dominique; Labunska, Tetyana; Palfey, Bruce A.; Ballou, David P.; Banerjee, Ruma			Adenosyltransferase tailors and delivers coenzyme B-12	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN ATP; PROTEIN; CHAPERONE; BINDING; ENZYME; ESCORT; MEAB	The reactivity and relative rarity of most cofactors pose challenges for their delivery to target enzymes. Using kinetic analyses, we demonstrate that adenosyltransferase, which catalyzes the final step in the assimilation of coenzyme B-12, directly transfers the cofactor to methylmalonyl coenzyme A mutase. The strategy of using the final enzyme in an assimilation pathway for tailoring a cofactor and delivering it to a dependent enzyme may be general for cofactor trafficking.	[Padovani, Dominique; Palfey, Bruce A.; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Padovani, Dominique; Labunska, Tetyana; Banerjee, Ruma] Univ Nebraska, Redox Biol Ctr, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801; Palfey, Bruce/0000-0001-5098-259X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK45776] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; BROWN KL, 1984, J AM CHEM SOC, V106, P7894, DOI 10.1021/ja00337a043; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fasching M, 2005, CHEM BIODIVERS, V2, P178, DOI 10.1002/cbdv.200590001; HSU JM, 1966, NATURE, V210, P1264, DOI 10.1038/2101264a0; Ivanova EG, 2006, MICROBIOLOGY+, V75, P494, DOI 10.1134/S0026261706040217; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Stich TA, 2005, J AM CHEM SOC, V127, P7660, DOI 10.1021/ja050546r; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008	15	58	60	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2008	4	3					194	196		10.1038/nchembio.67	http://dx.doi.org/10.1038/nchembio.67			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266EN	18264093				2022-12-25	WOS:000253417400014
J	Danial, NN; Walensky, LD; Zhang, CY; Choi, CS; Fisher, JK; Molina, AJA; Datta, SR; Pitter, KL; Bird, GH; Wikstrom, JD; Deeney, JT; Robertson, K; Morash, J; Kulkarni, A; Neschen, S; Kim, S; Greenberg, ME; Corkey, BE; Shirihai, OS; Shulman, GI; Lowell, BB; Korsmeyer, SJ				Danial, Nika N.; Walensky, Loren D.; Zhang, Chen-Yu; Choi, Cheol Soo; Fisher, Jill K.; Molina, Anthony J. A.; Datta, Sandeep Robert; Pitter, Kenneth L.; Bird, Gregory H.; Wikstrom, Jakob D.; Deeney, Jude T.; Robertson, Kirsten; Morash, Joel; Kulkarni, Ameya; Neschen, Susanne; Kim, Sheene; Greenberg, Michael E.; Corkey, Barbara E.; Shirihai, Orian S.; Shulman, Gerald I.; Lowell, Bradford B.; Korsmeyer, Stanley J.			Dual role of proapoptotic BAD in insulin secretion and beta cell survival	NATURE MEDICINE			English	Article							GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; PANCREATIC-ISLETS; GLUCOKINASE GENE; BH3 DOMAIN; KINASE; PHOSPHORYLATION; PROTEIN; GROWTH; MODEL	The proapoptotic BCL-2 family member BAD resides in a glucokinase-containing complex that regulates glucose-driven mitochondrial respiration. Here, we present genetic evidence of a physiologic role for BAD in glucose- stimulated insulin secretion by beta cells. This novel function of BAD is specifically dependent upon the phosphorylation of its BH3 sequence, previously defined as an essential death domain. We highlight the pharmacologic relevance of phosphorylated BAD BH3 by using cell-permeable, hydrocarbon-stapled BAD BH3 helices that target glucokinase, restore glucose- driven mitochondrial respiration and correct the insulin secretory response in Bad-deficient islets. Our studies uncover an alternative target and function for the BAD BH3 domain and emphasize the therapeutic potential of phosphorylated BAD BH3 mimetics in selectively restoring beta cell function. Furthermore, we show that BAD regulates the physiologic adaptation of beta cell mass during high-fat feeding. Our findings provide genetic proof of the bifunctional activities of BAD in both beta cell survival and insulin secretion.	[Danial, Nika N.; Fisher, Jill K.; Robertson, Kirsten; Lowell, Bradford B.; Korsmeyer, Stanley J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walensky, Loren D.; Pitter, Kenneth L.; Bird, Gregory H.; Morash, Joel] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Danial, Nika N.; Walensky, Loren D.; Fisher, Jill K.; Pitter, Kenneth L.; Bird, Gregory H.; Robertson, Kirsten; Morash, Joel] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Danial, Nika N.; Walensky, Loren D.; Fisher, Jill K.; Pitter, Kenneth L.; Bird, Gregory H.; Robertson, Kirsten; Morash, Joel] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Walensky, Loren D.; Pitter, Kenneth L.; Bird, Gregory H.; Morash, Joel] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Choi, Cheol Soo; Kulkarni, Ameya; Neschen, Susanne; Kim, Sheene; Shulman, Gerald I.; Korsmeyer, Stanley J.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Choi, Cheol Soo; Kulkarni, Ameya; Neschen, Susanne; Kim, Sheene; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Molina, Anthony J. A.; Wikstrom, Jakob D.; Shirihai, Orian S.] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Datta, Sandeep Robert; Greenberg, Michael E.] Childrens Hosp, Dept Neurol, Neurobiol Program, Boston, MA 02115 USA; [Deeney, Jude T.; Corkey, Barbara E.] Boston Univ, Med Ctr, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Lowell, Bradford B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrionol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Nanjing University; Howard Hughes Medical Institute; Yale University; Yale University; Tufts University; Harvard University; Boston Children's Hospital; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Danial, NN (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.	nika_danial@dfci.harvard.edu	Shulman, Gerald I./P-7176-2019; Corkey, Barbara/E-7712-2015	Shulman, Gerald I./0000-0003-1529-5668; Molina, Anthony/0000-0002-5786-4622; Corkey, Barbara/0000-0002-5467-1630; Shirihai, Orian/0000-0002-9502-2661; Pitter, Kenneth/0000-0002-9450-313X; Datta, Sandeep/0000-0002-8068-3862; Deeney, Jude/0000-0003-0988-9419; Wikstrom, Jakob/0000-0002-4287-1774	NCI NIH HHS [K01 CA106596-03, K01 CA106596-04, K01 CA106596-02, K01CA10659, K01 CA106596-01, R01 CA050239, K01 CA106596, 5R01CA50239] Funding Source: Medline; NHLBI NIH HHS [K08 HL074049, 5K08HL074049] Funding Source: Medline; NICHD NIH HHS [P30 HD018655] Funding Source: Medline; NIDDK NIH HHS [R01 DK040936, 5R01DK68781, U24 DK059635, R01 DK068781] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024926] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050239, K01CA106596] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068781, R01DK040936, U24DK059635] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili Domenico, 2001, Current Molecular Medicine (Hilversum), V1, P9, DOI 10.2174/1566524013364040; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Arden C, 2006, FEBS LETT, V580, P2065, DOI 10.1016/j.febslet.2006.03.009; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BURCH PT, 1981, DIABETES, V30, P923, DOI 10.2337/diabetes.30.11.923; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Liang Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE846, DOI 10.1152/ajpendo.1996.270.5.E846; MAGNUSON MA, 2004, GLUCOKINASE GLYCEMIC; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; TRUS MD, 1981, DIABETES, V30, P911, DOI 10.2337/diabetes.30.11.911; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	50	239	260	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					144	153		10.1038/nm1717	http://dx.doi.org/10.1038/nm1717			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18223655	Green Accepted			2022-12-25	WOS:000252946700022
J	Franch-Marro, X; Wendler, F; Guidato, S; Griffith, J; Baena-Lopez, A; Itasaki, N; Maurice, MM; Vincent, JP				Franch-Marro, Xavier; Wendler, Franz; Guidato, Sonia; Griffith, Janice; Baena-Lopez, Alberto; Itasaki, Nobue; Maurice, Madelon M.; Vincent, Jean-Paul			Wingless secretion requires endosome-to-Golgi retrieval of Wntless/Evi/Sprinter by the retromer complex	NATURE CELL BIOLOGY			English	Article							WNT PROTEINS; TRANSMEMBRANE PROTEIN; GRADIENT FORMATION; DROSOPHILA; HEDGEHOG; SIGNALS; RECEPTION; POLARITY; LIGANDS; CELLS	The glycolipoproteins of the Wnt family raise interesting trafficking issues, especially with respect to spreading within tissues. Recently, the retromer complex has been suggested to participate in packaging Wnts into long-range transport vehicles(1,2). Our analysis of a Drosophila mutant in Vps35 show that, instead, the retromer complex is required for efficient progression of Wingless ( a Drosophila Wnt) through the secretory pathway. Indeed expression of senseless, a short-range target gene(3), is lost in Vps35-deficient imaginal discs. In contrast, Vps35 is not required for Hedgehog secretion, suggesting specificity. Overexpression of Wntless, a transmembrane protein known to be specifically required for Wingless secretion(4-6) overcomes the secretion block of Vps35-mutant cells. Furthermore, biochemical evidence confirms that Wntless engages with the retromer complex. We propose that Wntless accompanies Wingless to the plasma membrane where the two proteins dissociate. Following dissociation from Wingless, Wntless is internalized and returns to the Golgi apparatus in a retromer-dependent manner. Without the retromer-dependent recycling route, Wingless secretion is impaired and, as electron microscopy suggests, Wntless is diverted to a degradative compartment.	[Franch-Marro, Xavier; Wendler, Franz; Guidato, Sonia; Baena-Lopez, Alberto; Itasaki, Nobue; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England; [Griffith, Janice; Maurice, Madelon M.] UMCU, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	MRC National Institute for Medical Research; Unilever; Utrecht University; Utrecht University Medical Center	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk	Baena, Luis Alberto/GLR-1590-2022; Franch-Marro, Xavier/E-4457-2017	Baena, Luis Alberto/0000-0002-8663-3794; Franch-Marro, Xavier/0000-0002-7465-6729; Maurice, Madelon/0000-0001-6885-5361; Itasaki, Nobue/0000-0003-0587-9141	European Research Council [294523] Funding Source: Medline; Medical Research Council [MC_U117560543, MC_U117584268] Funding Source: Medline; MRC [MC_U117560543, MC_U117584268] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandre C, 1999, DEVELOPMENT, V126, P5689; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; LIOU W, 1996, CELL BIOL, V106, P41; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	24	197	205	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					170	U40		10.1038/ncb1678	http://dx.doi.org/10.1038/ncb1678			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193037	Green Accepted			2022-12-25	WOS:000252897800012
J	Kai, M; Motoki, K; Yoshida, H; Emuta, C; Chisaka, Y; Tsuruhata, K; Endo, C; Muto, M; Shimabe, M; Nishiyama, U; Hagiwara, T; Matsumoto, A; Miyazaki, H; Kataoka, S				Kai, Masayuki; Motoki, Kazuhiro; Yoshida, Hideaki; Emuta, Chie; Chisaka, Yukiko; Tsuruhata, Kumi; Endo, Chisato; Muto, Mari; Shimabe, Munetake; Nishiyama, Uichi; Hagiwara, Tetsuya; Matsumoto, Atsushi; Miyazaki, Hiroshi; Kataoka, Shiro			Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor	NATURE BIOTECHNOLOGY			English	Article							MONOCLONAL-ANTIBODY; THROMBOCYTOPENIA; FLEXIBILITY; FRAGMENT; BIOLOGY	We enhanced the activities of two agonist antibodies specific for the thrombopoietin receptor (c-MPL) by switching domains within their constant regions to those of different antibody isotypes. Our results suggest the importance of the hinge region in modulating agonist activity. The antibodies' thrombopoietin-like activity in vitro and in vivo, as well as the desirable pharmacokinetic profile conferred by retaining the whole-IgG structure, suggests that they provide a valuable option for treating thrombocytopenia.	[Kai, Masayuki; Motoki, Kazuhiro; Yoshida, Hideaki; Emuta, Chie; Chisaka, Yukiko; Tsuruhata, Kumi; Endo, Chisato; Muto, Mari; Miyazaki, Hiroshi; Kataoka, Shiro] Discovery Res Labs, Gunma 3701295, Japan; [Shimabe, Munetake; Nishiyama, Uichi] Res & Dev Labs, Div Res, Gunma 3701295, Japan; [Hagiwara, Tetsuya] Kirin Pharma Co Ltd, Frontier Lab, Gunma 3701295, Japan; [Matsumoto, Atsushi] Kirin Pharma Co Ltd, Prod Div, CMC R&D Labs, Gunma 3700013, Japan		Kataoka, S (corresponding author), Discovery Res Labs, 3 Miyahara, Gunma 3701295, Japan.	s-kataoka@kirin.co.jp		Kai, Masayuki/0000-0001-7572-9005				ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Deng BJ, 1998, BLOOD, V92, P1981, DOI 10.1182/blood.V92.6.1981.418k15_1981_1988; Drachman J G, 1995, Curr Opin Hematol, V2, P22; Frederickson S, 2006, P NATL ACAD SCI USA, V103, P14307, DOI 10.1073/pnas.0602658103; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; Komatsu N, 1996, BLOOD, V87, P4552, DOI 10.1182/blood.V87.11.4552.bloodjournal87114552; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Miyazaki H, 1999, INT J HEMATOL, V70, P216; Orita T, 2005, BLOOD, V105, P562, DOI 10.1182/blood-2004-04-1482; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; Roux KH, 1997, J IMMUNOL, V159, P3372; TAN LK, 1990, P NATL ACAD SCI USA, V87, P162, DOI 10.1073/pnas.87.1.162; Ziegler S, 2002, BLOOD, V100, P1072, DOI 10.1182/blood-2002-01-0281	15	21	44	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2008	26	2					209	211		10.1038/nbt1376	http://dx.doi.org/10.1038/nbt1376			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	263BQ	18157117				2022-12-25	WOS:000253193000023
J	Fernandez-Suarez, M; Baruah, H; Martinez-Hernandez, L; Xie, KT; Baskin, JM; Bertozzi, CR; Ting, AY				Fernandez-Suarez, Marta; Baruah, Hemanta; Martinez-Hernandez, Laura; Xie, Kathleen T.; Baskin, Jeremy M.; Bertozzi, Carolyn R.; Ting, Alice Y.			Redirecting lipoic acid ligase for cell surface protein labeling with small-molecule probes	NATURE BIOTECHNOLOGY			English	Article							LOW-DENSITY-LIPOPROTEIN; ESCHERICHIA-COLI; BIOTIN LIGASE; LIVING CELLS; BINDING-SITE; IN-VITRO; RECEPTOR; LIGANDS; COMPLEX; AZIDES	Live cell imaging is a powerful method to study protein dynamics at the cell surface, but conventional imaging probes are bulky, or interfere with protein function, or dissociate from proteins after internalization. Here, we report technology for covalent, specific tagging of cellular proteins with chemical probes. Through rational design, we redirected a microbial lipoic acid ligase (LplA) to specifically attach an alkyl azide onto an engineered LplA acceptor peptide (LAP). The alkyl azide was then selectively derivatized with cyclooctyne conjugates to various probes. We labeled LAP fusion proteins expressed in living mammalian cells with Cy3, Alexa Fluor 568 and biotin. We also combined LplA labeling with our previous biotin ligase labeling, to simultaneously image the dynamics of two different receptors, coexpressed in the same cell. Our methodology should provide general access to biochemical and imaging studies of cell surface proteins, using small fluorophores introduced via a short peptide tag.	MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Div Mat Sci, Mol Foundry, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Ting, AY (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ating@mit.edu	Baskin, Jeremy/X-7077-2019	Baskin, Jeremy/0000-0003-2939-3138; Ting, Alice/0000-0002-8277-5226; Xie, Kathleen/0000-0002-3178-8959	NIGMS NIH HHS [GM58867, R01 GM072670, R01 GM072670-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R01GM072670, R37GM058867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; DEBANT A, 1989, BIOCHEMISTRY-US, V28, P14, DOI 10.1021/bi00427a003; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GREEN JDF, 1995, J MOL BIOL, V248, P328, DOI 10.1006/jmbi.1995.0225; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Griffin R J, 1994, Prog Med Chem, V31, P121, DOI 10.1016/S0079-6468(08)70020-1; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Marks KM, 2006, NAT METHODS, V3, P591, DOI 10.1038/NMETH906; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Tuli SS, 2006, CURR EYE RES, V31, P709, DOI 10.1080/02713680600837390; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	30	267	285	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1483	1487		10.1038/nbt1355	http://dx.doi.org/10.1038/nbt1355			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	18059260	Green Accepted			2022-12-25	WOS:000251457800039
J	Ray, S; Britschgi, M; Herbert, C; Takeda-Uchimura, Y; Boxer, A; Blennow, K; Friedman, LF; Galasko, DR; Jutel, M; Karydas, A; Kaye, JA; Leszek, J; Miller, BL; Minthon, L; Quinn, JF; Rabinovici, GD; Robinson, WH; Sabbagh, MN; So, YT; Sparks, DL; Tabaton, M; Tinklenberg, J; Yesavage, JA; Tibshirani, R; Wyss-Coray, T				Ray, Sandip; Britschgi, Markus; Herbert, Charles; Takeda-Uchimura, Yoshiko; Boxer, Adam; Blennow, Kaj; Friedman, Leah F.; Galasko, Douglas R.; Jutel, Marek; Karydas, Anna; Kaye, Jeffrey A.; Leszek, Jerzy; Miller, Bruce L.; Minthon, Lennart; Quinn, Joseph F.; Rabinovici, Gil D.; Robinson, William H.; Sabbagh, Marwan N.; So, Yuen T.; Sparks, D. Larry; Tabaton, Massimo; Tinklenberg, Jared; Yesavage, Jerome A.; Tibshirani, Robert; Wyss-Coray, Tony			Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins	NATURE MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; GENE-EXPRESSION; DISEASE; RESPONSES; IMMUNE	A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 signaling proteins in blood plasma that can be used to classify blinded samples from Alzheimer's and control subjects with close to 90% accuracy and to identify patients who had mild cognitive impairment that progressed to Alzheimer's disease 2-6 years later. Biological analysis of the 18 proteins points to systemic dysregulation of hematopoiesis, immune responses, apoptosis and neuronal support in presymptomatic Alzheimer's disease.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Satoris Inc, Redwood City, CA 94063 USA; Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94117 USA; Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Expt Neurosci, Inst Clin Neurosci, S-43180 Molndal, Sweden; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Wroclaw Med Univ, Dept Internal Med & Allergol, PL-50417 Wroclaw, Poland; Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; Wroclaw Med Univ, Dept Psychiat, PL-51622 Wroclaw, Poland; Lund Univ, Dept Clin Sci Malmo, Clin Mem Res Unit, Univ Sjukhuset MAS, SE-20502 Malmo, Sweden; Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Sun Hlth Res Inst, Sun City, AZ 85351 USA; Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Sahlgrenska University Hospital; University of Gothenburg; Stanford University; University of California System; University of California San Diego; Wroclaw Medical University; Oregon Health & Science University; Wroclaw Medical University; Lund University; Stanford University; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Genoa; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 300 Pasteur Dr, Stanford, CA 94305 USA.	twc@stanford.edu	Abrams, William R/A-5782-2008; Wyss-Coray, Tony/AAF-3380-2019; Rabinovici, Gil/AAA-2495-2020	Wyss-Coray, Tony/0000-0001-5893-0831; Britschgi, Markus/0000-0001-6151-4257; Quinn, Joseph/0000-0001-7305-2256; Kaye, Jeffrey/0000-0002-9971-3478	NATIONAL INSTITUTE ON AGING [R01AG020603, P30AG008017, P50AG005131] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Assini A, 2004, NEUROLOGY, V63, P828, DOI 10.1212/01.WNL.0000137040.64252.ED; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Huang Ruo-Pan, 2004, Methods Mol Biol, V264, P215; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; MAES OC, 2006, NEUROBIOL AGING 0918; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Storandt M, 2002, NEUROLOGY, V59, P1034, DOI 10.1212/WNL.59.7.1034; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	15	780	841	3	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2007	13	11					1359	1362		10.1038/nm1653	http://dx.doi.org/10.1038/nm1653			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17934472				2022-12-25	WOS:000250736900029
J	Beli, P; Mascheroni, D; Xu, DL; Innocenti, M				Beli, Petra; Mascheroni, Debora; Xu, Dalu; Innocenti, Metello			WAVE and Arp2/3 jointly inhibit filopodium formation by entering into a complex with mDia2	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; N-WASP; FORMIN; NUCLEATION; MECHANISM; PROTEINS; REVEALS; ABI1; IDENTIFICATION; ACTIVATION	Lamellipodia/ruffles and filopodia are protruding organelles containing short and highly branched or long and unbranched actin filaments, respectively(1-3). the microscopic morphology, dynamic development and protein signature of both lamellipodia/ruffles and filopodia have been investigated(2,3); however, little is known about the mechanisms by which cells coordinate the formation of these actin-based extensions. Here, we show that WAVE holds mDia2 and the Arp2/3 complex in a multimolecular complex. WAVE- and Arp2/3-dependent ruffling induced by EGF does not require mDia2. Conversely, the emission of mDia2-dependent filopodia correlates with its disengagement from WAVe. Consistently, the ability of eGF, Cdc42 and serum to induce mDia2-dependent formation of filopodia is increased in the absence of either the WAVe/Abi1/Nap1/PIR121 (WANP) or the Arp2/3 complex. reintroduction of WAVE2 into WANP-complex knockdown cells markedly reduces filopodia formation independently of actin polymerization. thus, WAVe and the Arp2/3 complex jointly orchestrate different types of actin-based plasma membrane protrusions by promoting ruffling and inhibiting mDia2-induced filopodia.	[Beli, Petra; Mascheroni, Debora; Xu, Dalu; Innocenti, Metello] Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Innocenti, M (corresponding author), Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	innocenti@biochem2.de	Innocenti, Metello/X-2182-2019	Innocenti, Metello/0000-0002-7455-2559; Beli, Petra/0000-0001-9507-9820				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Harris ES, 2004, CURR BIOL, V14, pR520, DOI 10.1016/j.cub.2004.06.043; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	29	80	80	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					849	857		10.1038/ncb1745	http://dx.doi.org/10.1038/ncb1745			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18516090				2022-12-25	WOS:000257268400014
J	Garcia-Higuera, I; Manchado, E; Dubus, P; Canamero, M; Mendez, J; Moreno, S; Malumbres, M				Garcia-Higuera, Irene; Manchado, Eusebio; Dubus, Pierre; Canamero, Marta; Mendez, Juan; Moreno, Sergio; Malumbres, Marcos			Genomic stability and tumour suppression by the APC/C cofactor Cdh1	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANSGENIC MOUSE STRAIN; CELL-CYCLE; UBIQUITIN LIGASE; S-PHASE; CHROMOSOMAL INSTABILITY; POSTMITOTIC NEURONS; SUBVENTRICULAR ZONE; MITOSIS; PROTEIN	The anaphase promoting complex or cyclosome (APC/C) is a ubiquitin protein ligase that, together with Cdc20 or Cdh1, targets cell-cycle proteins for degradation. APC/C-Cdh1 specifically promotes protein degradation in late mitosis and G1. Mutant embryos lacking Cdh1 die at E9.5-E10.5 due to defects in the endoreduplication of trophoblast cells and placental malfunction. This lethality is prevented when Cdh1 is expressed in the placenta. Cdh1-deficient cells proliferate inefficiently and accumulate numeric and structural chromosomal aberrations, indicating that Cdh1 contributes to the maintenance of genomic stability. Cdh1 heterozygous animals show increased susceptibility to spontaneous tumours, suggesting that Cdh1 functions as a haploinsufficient tumour suppressor. These heterozygous mice also show several defects in behaviour associated with increased proliferation of stem cells in the nervous system. These results indicate that Cdh1 is required for preventing unscheduled proliferation of specific progenitor cells and protecting mammalian cells from genomic instability.	[Garcia-Higuera, Irene; Moreno, Sergio] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Garcia-Higuera, Irene; Manchado, Eusebio; Malumbres, Marcos] CNIO, Cell Div, Madrid, Spain; [Garcia-Higuera, Irene; Manchado, Eusebio; Malumbres, Marcos] CNIO, Canc Grp, Madrid, Spain; [Dubus, Pierre] Univ Bordeaux 2, F-33076 Bordeaux, France; [Canamero, Marta] CNIO, Comparat Pathol Unit, Madrid, Spain; [Mendez, Juan] CNIO, DNA Replicat Grp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Moreno, S (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, Salamanca 37007, Spain.	malumbres@cnio.es; smo@usal.es	/AAI-3238-2021; Holt, Janet E/B-2415-2013; Malumbres, Marcos/E-8834-2011; 2008, Ibsal/A-1268-2012; Garcia-Higuera, Irene/L-5004-2014; Moreno, Sergio/K-3671-2014; Mendez, Juan/K-8001-2014	Malumbres, Marcos/0000-0002-0829-6315; Garcia-Higuera, Irene/0000-0001-6331-075X; Moreno, Sergio/0000-0002-8039-1413; Mendez, Juan/0000-0002-3235-2559; Dubus, Pierre/0000-0003-1803-4711				Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ANG XL, 2004, SCI STKE, pPE31; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MIQUEL J, 1978, EXP GERONTOL, V13, P389, DOI 10.1016/0531-5565(78)90049-9; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Quereda V, 2007, ONCOGENE, V26, P7665, DOI 10.1038/sj.onc.1210578; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yamaguchi S, 1997, MOL BIOL CELL, V8, P2475, DOI 10.1091/mbc.8.12.2475	46	279	283	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					802	811		10.1038/ncb1742	http://dx.doi.org/10.1038/ncb1742			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552834				2022-12-25	WOS:000257268400010
J	Nakaya, Y; Sukowati, EW; Wu, Y; Sheng, GJ				Nakaya, Yukiko; Sukowati, Erike W.; Wu, Yuping; Sheng, Guojun			RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NUCLEOTIDE EXCHANGE FACTOR; MOUSE GASTRULATION; EPITHELIOMESENCHYMAL TRANSFORMATION; FAMILY GTPASES; ACTIVE RHOA; E-CADHERIN; TGF-BETA; MORPHOGENESIS; ACTIVATION	Molecular and cellular mechanisms of epithelial-mesenchymal transition (EMT), crucial in development and pathogenesis, are still poorly understood. Here we provide evidence that distinct cellular steps of EMT occur sequentially during gastrulation. Basement membrane ( BM) breakdown is the first recognizable step and is controlled by loss of basally localized RhoA activity and its activator neuroepithelial-transforming- protein-1 (Net1). Failure of RhoA downregulation during EMT leads to BM retention and reduction of its activity in normal epithelium leads to BM breakdown. We also show that this is in part mediated by RhoA-regulated basal microtubule stability. Microtubule disruption causes BM breakdown and its stabilization results in BM retention. We propose that loss of Net1 before EMT reduces basal RhoA activity and destabilizes basal microtubules, causing disruption of epithelial cell-BM interaction and subsequently, breakdown of the BM.	[Nakaya, Yukiko; Sukowati, Erike W.; Wu, Yuping; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan	RIKEN	Sheng, GJ (corresponding author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/G-4116-2014; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-8746-2013					AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan AML, 1996, ONCOGENE, V12, P1259; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; GUSTAFSON T, 1961, EXP CELL RES, V22, P437, DOI 10.1016/0014-4827(61)90120-3; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Halfter W, 2002, J NEUROSCI, V22, P6029; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hay ED, 1995, ACTA ANAT, V154, P8; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu JP, 1998, DEVELOPMENT, V125, P5055; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Sasai N, 2004, NAT CELL BIOL, V6, P741, DOI 10.1038/ncb1158; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Simoes S, 2006, DEVELOPMENT, V133, P4257, DOI 10.1242/dev.02588; Stern C.D., 2004, GASTRULATION CELLS E; STERN CD, 1985, J EMBRYOL EXP MORPH, V88, P365; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	50	212	220	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					765	775		10.1038/ncb1739	http://dx.doi.org/10.1038/ncb1739			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552836				2022-12-25	WOS:000257268400007
J	Doyon, Y; McCammon, JM; Miller, JC; Faraji, F; Ngo, C; Katibah, GE; Amora, R; Hocking, TD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Amacher, SL				Doyon, Yannick; McCammon, Jasmine M.; Miller, Jeffrey C.; Faraji, Farhoud; Ngo, Catherine; Katibah, George E.; Amora, Rainier; Hocking, Toby D.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Amacher, Sharon L.			Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; CELLS; SITE; EXPRESSION; INDUCTION; CLEAVAGE; GENOME; REPAIR	We describe the use of zinc-finger nucleases (ZFNs) for somatic and germline disruption of genes in zebrafish (Danio rerio), in which targeted mutagenesis was previously intractable. ZFNs induce a targeted double-strand break in the genome that is repaired to generate small insertions and deletions. We designed ZFNs targeting the zebrafish golden and no tail/Brachyury (ntl) genes and developed a budding yeast-based assay to identify the most active ZFNs for use in vivo. Injection of ZFN-encoding mRNA into one-cell embryos yielded a high percentage of animals carrying distinct mutations at the ZFN-specified position and exhibiting expected loss-of-function phenotypes. Over half the ZFN mRNA-injected founder animals transmitted disrupted ntl alleles at frequencies averaging 20%. The frequency and precision of gene-disruption events observed suggest that this approach should be applicable to any loci in zebrafish or in other organisms that allow mRNA delivery into the fertilized egg.	[McCammon, Jasmine M.; Urnov, Fyodor D.; Amacher, Sharon L.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McCammon, Jasmine M.; Urnov, Fyodor D.; Amacher, Sharon L.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Doyon, Yannick; Miller, Jeffrey C.; Faraji, Farhoud; Ngo, Catherine; Katibah, George E.; Amora, Rainier; Hocking, Toby D.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Pt Richmond Tech Ctr, Richmond, CA 94804 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.	Amacher, SL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	amacher@berkeley.edu	Faraji, Farhoud/AAG-2417-2019; Wilson, Matthew H/K-3193-2013	Faraji, Farhoud/0000-0001-5078-813X; Doyon, Yannick/0000-0002-3889-9563; Gregory, Philip/0000-0001-9249-2468	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061952, R01GM088041] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22486, P01 HD022486] Funding Source: Medline; NIGMS NIH HHS [R01 GM061952-03, R01 GM061952-06A2S1, R01 GM061952-06A2, R01 GM061952-01A2, R01 GM061952-04, R01 GM061952-05, 1-R01-GM061952, R01 GM088041, R01 GM061952, R01 GM061952-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2002, GENETICS, V161, P1169; Chen Q, 2004, ANAL BIOCHEM, V335, P253, DOI 10.1016/j.ab.2004.09.004; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SEDIVY JM, 1992, GENE TARGETING; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; STREISINGER G, 1989, DEV BIOL, V131, P60, DOI 10.1016/S0012-1606(89)80038-7; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	29	656	820	4	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					702	708		10.1038/nbt1409	http://dx.doi.org/10.1038/nbt1409			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18500334	Green Accepted			2022-12-25	WOS:000256611900030
J	Tang, XL; Jang, SW; Okada, M; Chan, CB; Feng, Y; Liu, Y; Luo, SW; Hong, Y; Rama, N; Xiong, WC; Mehlen, P; Ye, KQ				Tang, Xiaoling; Jang, Sung-Wuk; Okada, Masashi; Chan, Chi-Bun; Feng, Yue; Liu, Yu; Luo, Shi-Wen; Hong, Yan; Rama, Nicolas; Xiong, Wen-Cheng; Mehlen, Patrick; Ye, Keqiang			Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; CELL-DEATH; APOPTOTIC CLEAVAGE; NUCLEAR GTPASE; AXON GUIDANCE; DCC; PROTEIN; SRC; PHOSPHORYLATION	Netrins, a family of secreted molecules, have critical functions in axon guidance and cell migration during neuronal development(1,2). In addition to its role as a chemotropic molecule, netrin-1 also acts as a survival factor(3-7). Both UNC5 (that is, UNC5A, UNC5B, UNC5C or UNC5D) and DCC are transmembrane receptors for netrin-1 (refs 8, 9). In the absence of netrin-1, DCC and UNC5 act as dependence receptors and trigger apoptosis(3,6,10). However, how netrin-1 suppresses the apoptotic activity of the receptors remains elusive. Here we show that netrin-1 induces interaction of UNC5B with the brain-specific GtPase PIKe-L. this interaction triggers the activation of PtdIns-3-OH kinase signalling, prevents UNC5B's pro-apoptotic activity and enhances neuronal survival. Moreover, this process relies strongly on Fyn because PIKe-L is tyrosine phosphorylated in response to netrin-1, and the netrin-1-mediated interaction of UNC5B with PIKe-l is inhibited in Fyn-null mice. thus, PIKe-L acts as a downstream survival effector for netrin-1 through UNC5B in the nervous system.	[Tang, Xiaoling; Jang, Sung-Wuk; Okada, Masashi; Chan, Chi-Bun; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Liu, Yu; Luo, Shi-Wen; Hong, Yan; Xiong, Wen-Cheng] Med Coll Georgia, Dept Neurol, Augusta, GA 30809 USA; [Liu, Yu; Luo, Shi-Wen; Hong, Yan; Xiong, Wen-Cheng] Med Coll Georgia, Inst Mol Med & Genom, Augusta, GA 30809 USA; [Rama, Nicolas; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Euipe La Ligue, CNRS,UMR5328, F-69008 Lyon, France	Emory University; Emory University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Okada, Masashi/AAC-2171-2021	Xiong, Wen-Cheng/0000-0001-9071-7598; Rama, Nicolas/0000-0003-1614-7755; Feng, Yue/0000-0002-7905-2182	NINDS NIH HHS [R01 NS045627, R01 NS045627-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Tang X, 2007, CELL DEATH DIFFER, V14, P368, DOI 10.1038/sj.cdd.4402011; Tang XL, 2006, ADV ENZYME REGUL, V46, P289, DOI 10.1016/j.advenzreg.2006.01.017; Tang XL, 2004, J MOL MED, V82, P383, DOI 10.1007/s00109-004-0535-2; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Williams ME, 2003, J NEUROSCI, V23, P11279; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a	30	77	81	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					698	706		10.1038/ncb1732	http://dx.doi.org/10.1038/ncb1732			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469807	Green Accepted			2022-12-25	WOS:000256350100016
J	Lallemand-Breitenbach, V; Jeanne, M; Benhenda, S; Nasr, R; Lei, M; Peres, L; Zhou, J; Zhu, J; Raught, B; de The, H				Lallemand-Breitenbach, Valerie; Jeanne, Marion; Benhenda, Shirine; Nasr, Rihab; Lei, Ming; Peres, Laurent; Zhou, Jun; Zhu, Jun; Raught, Brian; de The, Hugues			Arsenic degrades PML or PML - RAR alpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway	NATURE CELL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR-BODY FORMATION; MASS-SPECTROMETRY; SNURF RNF4; PROTEIN; IDENTIFICATION; DEGRADATION; TRIOXIDE; LOCALIZATION; SUMOYLATION	In acute promyelocytic leukaemia (APL), arsenic trioxide induces degradation of the fusion protein encoded by the PML-RARA oncogene, differentiation of leukaemic cells and produces clinical remissions. SUMOylation of its PML moiety was previously implicated, but the nature of the degradation pathway involved and the role of PML-RAR alpha catabolism in the response to therapy have both remained elusive. Here, we demonstrate that arsenic-induced PML SUMOylation triggers its Lys 48-linked polyubiquitination and proteasome-dependent degradation. When exposed to arsenic, SUMOylated PML recruits RNF4, the human orthologue of the yeast SUMO-dependent E3 ubiquitin-ligase, as well as ubiquitin and proteasomes onto PML nuclear bodies. Arsenic-induced differentiation is impaired in cells transformed by a non-degradable PML-RAR alpha SUMOylation mutant or in APL cells transduced with a dominant-negative RNF4, directly implicating PML w-RAR alpha catabolism in the therapeutic response. We thus identify PML as the first protein degraded by SUMO-dependent polyubiquitination. As PML SUMOylation recruits not only RNF4, ubiquitin and proteasomes, but also many SUMOylated proteins onto PML nuclear bodies, these domains could physically integrate the SUMOylation, ubiquitination and degradation pathways.	[Lallemand-Breitenbach, Valerie; Jeanne, Marion; Benhenda, Shirine; Nasr, Rihab; Lei, Ming; Peres, Laurent; Zhou, Jun; Zhu, Jun; de The, Hugues] Univ Paris 07, CNRS, UMR 7151, Hop St Louis,Equipe Labellisee Ligue Natl Canc 11, F-75475 Paris 10, France; [Zhou, Jun; Zhu, Jun; de The, Hugues] Rui Jin Hosp, CNRS, Lab Associe MPC, Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Raught, Brian] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Raught, Brian] McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [de The, Hugues] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Institut Universitaire de France	de The, H (corresponding author), Univ Paris 07, CNRS, UMR 7151, Hop St Louis,Equipe Labellisee Ligue Natl Canc 11, 1 Av C Vellefaux, F-75475 Paris 10, France.	dethe@univ-paris-diderot.fr	Nasr, Rihab/AAF-1606-2020	Lallemand, Valerie/0000-0001-9852-204X; Nasr, Rihab/0000-0003-1166-4999; Jeanne, Marion/0000-0001-7334-3061	NCI NIH HHS [R37 CA49152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Boddy MN, 1996, ONCOGENE, V13, P971; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Chen GQ, 1997, BLOOD, V89, P3345; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Duprez E, 1999, J CELL SCI, V112, P381; Fabunmi RP, 2001, J CELL SCI, V114, P29; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Miller WH, 2002, CANCER RES, V62, P3893; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; TATHAM MH, 2008, NATURE CELL BIOL; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	34	540	556	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					547	555		10.1038/ncb1717	http://dx.doi.org/10.1038/ncb1717			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18408733				2022-12-25	WOS:000255502400011
J	Jermy, A				Jermy, Andrew			STIM1 tracks growing microtubule ends	NATURE CELL BIOLOGY			English	Editorial Material														Jermy, Andrew/0000-0002-7454-0670					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					384	384		10.1038/ncb0408-384	http://dx.doi.org/10.1038/ncb0408-384			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379599	Bronze			2022-12-25	WOS:000254561700007
J	Kozyrev, SV; Abelson, AK; Wojcik, J; Zaghlool, A; Reddy, MVPL; Sanchez, E; Gunnarsson, I; Svenungsson, E; Sturfelt, G; Jonsen, A; Truedsson, L; Pons-Estel, BA; Witte, T; D'Alfonso, S; Barrizzone, N; Danieli, MG; Gutierrez, C; Suarez, A; Junker, P; Laustrup, H; Gonzalez-Escribano, MF; Martin, J; Abderrahim, H; Alarcon-Riquelme, ME				Kozyrev, Sergey V.; Abelson, Anna-Karin; Wojcik, Jerome; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Sanchez, Elena; Gunnarsson, Iva; Svenungsson, Elisabet; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Pons-Estel, Bernardo A.; Witte, Torsten; D'Alfonso, Sandra; Barrizzone, Nadia; Danieli, Maria Giovanna; Gutierrez, Carmen; Suarez, Ana; Junker, Peter; Laustrup, Helle; Gonzalez-Escribano, Maria Francisca; Martin, Javier; Abderrahim, Hadi; Alarcon-Riquelme, Marta E.			Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus (vol 40, pg 211, 2008)	NATURE GENETICS			English	Correction													D'Alfonso, Sandra/K-7295-2014; Martín, María/HDL-9512-2022; Witte, Torsten/B-5783-2016; Martin, Javier/B-8141-2008; Alarcón-Riquelme, Marta E./ABF-8163-2020; Martín, Javier/AAV-5209-2021; Suarez, Ana/F-4492-2015	D'Alfonso, Sandra/0000-0002-3983-9925; Martin, Javier/0000-0002-2202-0622; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Suarez, Ana/0000-0002-4452-7539; Kozyrev, Sergey/0000-0001-6209-4100; Laustrup, Helle/0000-0002-4421-9907; Danieli, Maria Giovanna/0000-0002-9608-2252; Svenungsson, Elisabet/0000-0003-3396-3244; Abelson, Anna-Karin/0000-0002-4205-3456; Pons-Estel, Bernardo/0000-0003-2518-0266; Rapa, Anna/0000-0002-5523-5224				Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79	1	7	8	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					484	484		10.1038/ng0408-484	http://dx.doi.org/10.1038/ng0408-484			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18368128	Bronze			2022-12-25	WOS:000254388100022
J	Kroon, E; Martinson, LA; Kadoya, K; Bang, AG; Kelly, OG; Eliazer, S; Young, H; Richardson, M; Smart, NG; Cunningham, J; Agulnick, AD; D'Amour, KA; Carpenter, MK; Baetge, EE				Kroon, Evert; Martinson, Laura A.; Kadoya, Kuniko; Bang, Anne G.; Kelly, Olivia G.; Eliazer, Susan; Young, Holly; Richardson, Mike; Smart, Nora G.; Cunningham, Justine; Agulnick, Alan D.; D'Amour, Kevin A.; Carpenter, Melissa K.; Baetge, Emmanuel E.			Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo	NATURE BIOTECHNOLOGY			English	Article							GENE-TRANSCRIPTION FACTOR; HUMAN-FETAL PANCREAS; BETA-CELLS; ENDOCRINE-CELLS; ISLET TRANSPLANTATION; BLOOD-GLUCOSE; EXPRESSION; MAFA; DIFFERENTIATION; MOUSE	Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human beta-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with similar to 3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional beta-cells, including expression of critical beta-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell-derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells.	[Kroon, Evert; Martinson, Laura A.; Kadoya, Kuniko; Bang, Anne G.; Kelly, Olivia G.; Eliazer, Susan; Young, Holly; Richardson, Mike; Smart, Nora G.; Cunningham, Justine; Agulnick, Alan D.; D'Amour, Kevin A.; Carpenter, Melissa K.; Baetge, Emmanuel E.] Novocell Inc, San Diego, CA 92121 USA		Kroon, E (corresponding author), Novocell Inc, 3550 Gen At Ct, San Diego, CA 92121 USA.			KROON, EVERT/0000-0002-4069-3644				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; BEATTIE GM, 1994, CELL TRANSPLANT, V3, P421, DOI 10.1177/096368979400300509; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; FOMONI A, 2008, DIABETOLOGIA, V51, P298; Gaber AO, 2004, TRANSPL P, V36, P1108, DOI 10.1016/j.transproceed.2004.04.055; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hayek A, 1997, J CLIN ENDOCR METAB, V82, P2471, DOI 10.1210/jc.82.8.2471; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Joannides A, 2006, STEM CELLS, V24, P230, DOI 10.1634/stemcells.2005-0243; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Klimstra DS, 1997, HISTOLOGY PATHOLOGIS, V2, P613; Kobayashi H, 2002, GASTROENTEROLOGY, V123, P1331, DOI 10.1053/gast.2002.35949; Lakey JRT, 2006, METH MOL B, V333, P47; Marzban L, 2006, DIABETES, V55, P2192, DOI 10.2337/db05-1566; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; OKAMOTO H, 1985, BIOMED BIOCHIM ACTA, V44, P15; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Schrot RJ., 2007, CLIN DIABETES, V25, P43; TUCH BE, 1991, TRANSPLANTATION, V51, P557, DOI 10.1097/00007890-199103000-00002; TUCH BE, 1985, DIABETOLOGIA, V28, P28, DOI 10.1007/BF00276996; TUCH BE, 1989, TRANSPLANT P, V21, P2665; TUCH BE, 1991, TRANSPLANTATION, V51, P1156, DOI 10.1097/00007890-199106000-00003; Tulachan SS, 2003, DIABETES, V52, P76, DOI 10.2337/diabetes.52.1.76; Weitgasser R, 1999, DIABETOLOGIA, V42, P256; Wilson ME, 2002, MECH DEVELOP, V115, P171, DOI 10.1016/S0925-4773(02)00118-1; Yang H, 2002, ENDOCRINOLOGY, V143, P2491, DOI 10.1210/en.143.7.2491; ZERTALZIDANI S, 2007, DIABETES, V56, P1248; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZOM AM, 2007, INT REV CYTOL, V259, P49	44	1302	1493	2	216	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2008	26	4					443	452		10.1038/nbt1393	http://dx.doi.org/10.1038/nbt1393			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	285NC	18288110				2022-12-25	WOS:000254782500027
J	Koestler, SA; Auinger, S; Vinzenz, M; Rottner, K; Small, JV				Koestler, Stefan A.; Auinger, Sonja; Vinzenz, Marlene; Rottner, Klemens; Small, J. Victor			Differentially oriented populations of actin filaments generated in lamellipodia collaborate in pushing and pausing at the cell front	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; MONOMERIC RED; LEADING-EDGE; ORGANIZATION; DYNAMICS; MECHANISMS; NETWORKS; MOVEMENT; DRIVEN; FLOW	eukaryotic cells advance in phases of protrusion, pause and withdrawal(1). Protrusion occurs in lamellipodia, which are composed of diagonal networks of actin filaments, and withdrawal terminates with the formation of actin bundles parallel to the cell edge. Using correlated live-cell imaging and electron microscopy, we have shown that actin filaments in protruding lamellipodia subtend angles from 15-90 degrees to the front, and that transitions from protrusion to pause are associated with a proportional increase in filaments oriented more parallel to the cell edge. Microspike bundles of actin filaments also showed a wide angular distribution and correspondingly variable bilateral polymerization rates along the cell front. We propose that the angular shift of filaments in lamellipodia serves in adapting to slower protrusion rates while maintaining the filament densities required for structural support; further, we suggest that single filaments and microspike bundles contribute to the construction of the lamella behind and to the formation of the cell edge when protrusion ceases. Our findings provide an explanation for the variable turnover dynamics of actin filaments in lamellipodia observed by fluorescence speckle microscopy(2) and are inconsistent with a current model of lamellipodia structure that features actin filaments branching at 70 degrees in a dendritic array(3).	[Koestler, Stefan A.; Auinger, Sonja; Vinzenz, Marlene; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Rottner, Klemens] Helmholtz Ctr Infect Res HZI, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Helmholtz Association; Helmholtz-Center for Infection Research	Small, JV (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	vic.small@imba.oeaw.ac.at		Koestler, Stefan/0000-0002-7223-8291; Rottner, Klemens/0000-0003-4244-4198				ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; AUINGER S, 2007, IN PRESS METHODS CEL; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HEATH JP, 1993, SYM SOC EXP BIOL, V47, P35; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Muller-Taubenberger A, 2006, EUR J CELL BIOL, V85, P1119, DOI 10.1016/j.ejcb.2006.05.006; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2001, J CELL SCI, V114, P3; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Resch GP, 2002, J STRUCT BIOL, V137, P305, DOI 10.1016/S1047-8477(02)00005-9; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Small J V, 1988, Electron Microsc Rev, V1, P155; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615	34	148	148	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					306	U33		10.1038/ncb1692	http://dx.doi.org/10.1038/ncb1692			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18278037	Green Submitted			2022-12-25	WOS:000253778300012
J	Wagner, BK; Kitami, T; Gilbert, TJ; Peck, D; Ramanathan, A; Schreiber, SL; Golub, TR; Mootha, VK				Wagner, Bridget K.; Kitami, Toshimori; Gilbert, Tamara J.; Peck, David; Ramanathan, Arvind; Schreiber, Stuart L.; Golub, Todd R.; Mootha, Vamsi K.			Large-scale chemical dissection of mitochondrial function	NATURE BIOTECHNOLOGY			English	Article							HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; SMALL MOLECULES; OXIDATIVE-PHOSPHORYLATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; BIOGENESIS; DISEASE; RHABDOMYOLYSIS; TOXICITY	Mitochondrial oxidative phosphorylation ( OXPHOS) is under the control of both mitochondrial ( mtDNA) and nuclear genomes and is central to energy homeostasis. To investigate how its function and regulation are integrated within cells, we systematically combined four cell-based assays of OXPHOS physiology with multiplexed measurements of nuclear and mtDNA gene expression across 2,490 small-molecule perturbations in cultured muscle. Mining the resulting compendium revealed, first, that protein synthesis inhibitors can decouple coordination of nuclear and mtDNA transcription; second, that a subset of HMG-CoA reductase inhibitors, combined with propranolol, can cause mitochondrial toxicity, yielding potential clues about the etiology of statin myopathy; and, third, that structurally diverse microtubule inhibitors stimulate OXPHOS transcription while suppressing reactive oxygen species, via a transcriptional mechanism involving PGC-1 alpha and ERR alpha, and thus may be useful in treating age-associated degenerative disorders. Our screening compendium can be used as a discovery tool both for understanding mitochondrial biology and toxicity and for identifying novel therapeutics.	[Wagner, Bridget K.; Kitami, Toshimori; Gilbert, Tamara J.; Peck, David; Ramanathan, Arvind; Schreiber, Stuart L.; Golub, Todd R.; Mootha, Vamsi K.] MIT, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), MIT, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Kitami, Toshimori/N-7460-2019	Kitami, Toshimori/0000-0001-8418-5230	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R24 DK080261-01, R24 DK080261] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790; Aronson J.K., 2006, MEYLERS SIDE EFFECTS, V15th ed.; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; BLESSING W, 1977, LANCET, V1, P73; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CAPRIO S, 1984, DIABETOLOGIA, V27, P52, DOI 10.1007/BF00253502; CHANCE B, 1955, J BIOL CHEM, V217, P409; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DAVIDSON BK, 1995, AM FAM PHYSICIAN, V52, P1277; Delobel P, 2003, J ANTIMICROB CHEMOTH, V51, P1319, DOI 10.1093/jac/dkg195; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Franz AK, 2007, J AM CHEM SOC, V129, P1020, DOI 10.1021/ja067552n; FRENDIN TJ, 1985, NEW ZEAL MED J, V98, P690; Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Karbowski M, 2001, J CELL SCI, V114, P281; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Lee SJ, 2002, CRIT REV EUKAR GENE, V12, P297, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.40; Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; ROWINSKY EK, 1993, J CLIN ONCOL, V11, P2010, DOI 10.1200/JCO.1993.11.10.2010; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; vanVliet AK, 1996, BIOCHEM PHARMACOL, V52, P1387, DOI 10.1016/S0006-2952(96)00467-4; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777	49	164	173	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2008	26	3					343	351		10.1038/nbt1387	http://dx.doi.org/10.1038/nbt1387			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	276EF	18297058	Green Accepted			2022-12-25	WOS:000254123400028
J	Cox, LJ; Hengst, U; Gurskaya, NG; Lukyanov, KA; Jaffrey, SR				Cox, Llewellyn J.; Hengst, Ulrich; Gurskaya, Nadya G.; Lukyanov, Konstantin A.; Jaffrey, Samie R.			Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival	NATURE CELL BIOLOGY			English	Article							NERVE GROWTH-FACTOR; ACTIN MESSENGER-RNA; SYMPATHETIC NEURONS; PROTEIN-SYNTHESIS; SENSORY NEURONS; TRANSPORT; RECEPTOR; EXPRESSION; LOCALIZATION; APOPTOSIS	During development of the nervous system, axons and growth cones contain mRNAs such as beta-actin, cofilin and RhoA, which are locally translated in response to guidance cues. Intra-axonal translation of these mRNAs results in local morphological responses; however, other functions of intra-axonal mRNA translation remain unknown. Here, we show that axons of developing mammalian neurons contain mRNA encoding the cAMP-responsive element (CRE)-binding protein ( CREB). CREB is translated within axons in response to nerve growth factor (NGF) and is retrogradely trafficked to the cell body. In neurons that are selectively deficient in axonal CREB transcripts, increases in nuclear pCREB, CRE-mediated transcription and neuronal survival elicited by axonal application of NGF are abolished, indicating a signalling function for axonally synthesized CREB. These studies identify a signalling role for axonally derived CREB, and indicate that signal-dependent synthesis and retrograde trafficking of transcription factors enables specific transcriptional responses to signalling events at distal axons.	[Cox, Llewellyn J.; Hengst, Ulrich; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Gurskaya, Nadya G.; Lukyanov, Konstantin A.] Russian Acad Sci, Inst Bioorgan Chem, Moscow 117997, Russia	Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	srj2003@med.cornell.edu	Lukyanov, Konstantin A/D-4030-2013; Gurskaya, Nadya G/Q-1750-2016; Hengst, Ulrich/L-1413-2014	Lukyanov, Konstantin A/0000-0001-9845-2088; Gurskaya, Nadya G/0000-0002-8028-8176; Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958	NIMH NIH HHS [R01 MH080420-01, R01 MH080420] Funding Source: Medline; NINDS NIH HHS [R01 NS056306, R01 NS056306-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BRIMIJOIN S, 1976, BRAIN RES, V102, P217, DOI 10.1016/0006-8993(76)90878-7; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Crino P, 1998, P NATL ACAD SCI USA, V95, P2313, DOI 10.1073/pnas.95.5.2313; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jeromin A, 2003, J NEUROPHYSIOL, V90, P2741, DOI 10.1152/jn.00464.2003; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; MARTENSON CH, 1995, TOXICOL APPL PHARM, V133, P73, DOI 10.1006/taap.1995.1128; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tong JX, 1997, J NEUROCYTOL, V26, P771, DOI 10.1023/A:1018566431912; Ure DR, 1997, J NEUROSCI, V17, P1282; WAEBER G, 1991, MOL ENDOCRINOL, V5, P1418, DOI 10.1210/mend-5-10-1418; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	49	214	218	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					149	U30		10.1038/ncb1677	http://dx.doi.org/10.1038/ncb1677			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193038	Green Accepted			2022-12-25	WOS:000252897800010
J	Griffith, E; Walker, S; Martin, CA; Vagnarelli, P; Stiff, T; Vernay, B; Al Sanna, N; Saggar, A; Hamel, B; Earnshaw, WC; Jeggo, PA; Jackson, AP; O'Driscoll, M				Griffith, Elen; Walker, Sarah; Martin, Carol-Anne; Vagnarelli, Paola; Stiff, Tom; Vernay, Bertrand; Al Sanna, Nouriya; Saggar, Anand; Hamel, Ben; Earnshaw, William C.; Jeggo, Penny A.; Jackson, Andrew P.; O'Driscoll, Mark			Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling	NATURE GENETICS			English	Article							MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; MITOTIC ENTRY; PROTEIN; CENTROSOME; CONTRIBUTES; PATHWAY; MITOSIS; FLORES; PHASE	Large brain size is one of the defining characteristics of modern humans. Seckel syndrome (MIM 210600), a disorder of markedly reduced brain and body size(1,2), is associated with defective ATR-dependent DNA damage signaling(3). Only a single hypomorphic mutation of ATR has been identified in this genetically heterogeneous condition(4). We now report that mutations in the gene encoding pericentrin (PCNT)-resulting in the loss of pericentrin from the centrosome, where it has key functions anchoring both structural and regulatory proteins-also cause Seckel syndrome(5,6). Furthermore, we find that cells of individuals with Seckel syndrome due to mutations in PCNT (PCNT-Seckel) have defects in ATR-dependent checkpoint signaling, providing the first evidence linking a structural centrosomal protein with DNA damage signaling. These findings also suggest that other known microcephaly genes implicated in either DNA repair responses(7) or centrosomal function(8,9), may act in common developmental pathways determining human brain and body size.	[Griffith, Elen; Martin, Carol-Anne; Vernay, Bertrand; Jackson, Andrew P.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Walker, Sarah; Stiff, Tom; Jeggo, Penny A.; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Vagnarelli, Paola; Earnshaw, William C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Al Sanna, Nouriya] Dhahran Hlth Ctr, Pediat Serv Div, Dhahran, Saudi Arabia; [Saggar, Anand] St George Hosp, Sch Med, SW Thames Reg Genet Serv, London SW17 0RE, England; [Hamel, Ben] Radboud Univ Nijmegen Med Ctr, Dept Human Genet 417, NL-6525 GA Nijmegen, Netherlands	University of Edinburgh; University of Sussex; University of Edinburgh; St Georges University London; Radboud University Nijmegen	Jackson, AP (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@hgu.mrc.ac.uk	Vagnarelli, Paola/AAI-1996-2020; Jackson, Andrew P/D-3442-2009; Earnshaw, William/AAY-7438-2020	Vagnarelli, Paola/0000-0002-0000-2271; Jackson, Andrew P/0000-0002-8739-2646; Martin, Carol-Anne/0000-0001-5914-2757; Vernay, Bertrand/0000-0002-7843-3872; O'Driscoll, Mark/0000-0003-2765-316X; Earnshaw, William/0000-0002-7191-0621; Mason, Sarah/0000-0002-0065-1503	Medical Research Council [MC_PC_U127580972, U.1275.03.008(80972), MC_U127580972] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline; MRC [MC_U127580972] Funding Source: UKRI; Medical Research Council [G0300662B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Liu QQ, 2001, J CELL SCI, V114, P797; Loffler H, 2007, CELL CYCLE, V6, P2541; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; SECKEL HPG, 1960, BIRD HEADED DRAFTS S; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	30	234	239	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					232	236		10.1038/ng.2007.80	http://dx.doi.org/10.1038/ng.2007.80			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18157127	Green Accepted			2022-12-25	WOS:000252732900023
J	Kagami, M; Sekita, Y; Nishimura, G; Irie, M; Kato, F; Okada, M; Yamamori, S; Kishimoto, H; Nakayama, M; Tanaka, Y; Matsuoka, K; Takahashi, T; Noguchi, M; Tanaka, Y; Masumoto, K; Utsunomiya, T; Kouzan, H; Komatsu, Y; Ohashi, H; Kurosawa, K; Kosaki, K; Ferguson-Smith, AC; Ishino, F; Ogata, T				Kagami, Masayo; Sekita, Yoichi; Nishimura, Gen; Irie, Masahito; Kato, Fumiko; Okada, Michiyo; Yamamori, Shunji; Kishimoto, Hiroshi; Nakayama, Masahiro; Tanaka, Yukichi; Matsuoka, Kentarou; Takahashi, Tsutomu; Noguchi, Mika; Tanaka, Yoko; Masumoto, Kouji; Utsunomiya, Takeshi; Kouzan, Hiroko; Komatsu, Yumiko; Ohashi, Hirofumi; Kurosawa, Kenji; Kosaki, Kenjirou; Ferguson-Smith, Anne C.; Ishino, Fumitoshi; Ogata, Tsutomu			Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes	NATURE GENETICS			English	Article							REPRESSIVE HISTONE METHYLATION; UNIPARENTAL DISOMY; GENE-EXPRESSION; DOMAIN; PLACENTA; LOCUS; IDENTIFICATION; MICE	Human chromosome 14q32.2 carries a cluster of imprinted genes including paternally expressed genes (PEGs) such as DLK1 and RTL1 and maternally expressed genes (MEGs) such as MEG3 (also known as GTL2), RTL1as (RTL1 antisense) and MEG8 (refs. 1,2), together with the intergenic differentially methylated region (IG-DMR) and the MEG3-DMR3-5. Consistent with this, paternal and maternal uniparental disomy for chromosome 14 (upd(14) pat and upd(14) mat) cause distinct phenotypes(6,7). We studied eight individuals (cases 1-8) with a upd(14) pat-like phenotype and three individuals (cases 9-11) with a upd(14) mat-like phenotype in the absence of upd(14) and identified various deletions and epimutations affecting the imprinted region. The results, together with recent mouse data(4,8-10), imply that the IG-DMR has an important cis-acting regulatory function on the maternally inherited chromosome and that excessive RTL1 expression and decreased DLK1 and RTL1 expression are relevant to upd(14) pat-like and upd(14) mat-like phenotypes, respectively.	[Sekita, Yoichi; Irie, Masahito; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo 1010062, Japan; [Kagami, Masayo; Kato, Fumiko; Okada, Michiyo; Ogata, Tsutomu] Nat Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan; [Nishimura, Gen] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Tokyo 2048567, Japan; [Yamamori, Shunji] Mitsubishi Chem Medience Corp, Tokyo 1748555, Japan; [Kishimoto, Hiroshi] Saitama Childrens Med Ctr, Div Pathol, Kawagoe, Saitama 3398551, Japan; [Nakayama, Masahiro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Div Pathol, Osaka 5941101, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Div Pathol, Yokohama, Kanagawa 2328555, Japan; [Matsuoka, Kentarou] Natl Ctr Child Hlth & Dev, Div Pathol, Tokyo 1578535, Japan; [Takahashi, Tsutomu] Akita Univ, Sch Med, Dept Pediat, Akita 0108543, Japan; [Noguchi, Mika] Chiba Kaihin Municipal Hosp, Dept Neonatol, Chiba 2610012, Japan; [Tanaka, Yoko] Tokyo Dent Coll Ichikawa Gen Hosp, Dept Pediat, Ichikawa 2728513, Japan; [Utsunomiya, Takeshi] Kyushu Univ, Sch Med, Dept Pediat Surg, Fukuoka 8128582, Japan; [Kouzan, Hiroko] Takamatsu Red Cross Hosp, Dept Pediat, Takamatsu, Kagawa 7600017, Japan; [Komatsu, Yumiko] Numazu City Hosp, Dept Pediat, Numazu 4100302, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Kawagoe, Saitama 3398551, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Kosaki, Kenjirou] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Utsunomiya, Takeshi] Kagoshima City Hosp, Dept Neonatol, Kagoshima 8928580, Japan	Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Saitama Children's Medical Center; National Center for Child Health & Development - Japan; Akita University; Tokyo Dental College; Kyushu University; Saitama Children's Medical Center; Keio University; University of Cambridge; Kagoshima City Hospital	Ishino, F (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo 1010062, Japan.	fishino.epgn@mri.tmd.ac.jp; tomogata@nch.go.jp	Utsunomiya, Takeshi/AGK-3535-2022; Kurosawa, Kenji/B-6561-2016; Ferguson-Smith, Anne C/G-7534-2011; Kosaki, Kenjiro/K-5350-2013	Utsunomiya, Takeshi/0000-0003-2332-4377; Kurosawa, Kenji/0000-0002-6817-7748; SEKITA, YOICHI/0000-0002-6230-8719; Kagami, Masayo/0000-0003-3020-455X; Ogata, Tsutomu/0000-0001-7178-9991; Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0400156] Funding Source: UKRI; Medical Research Council [G0400156] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Kagami M, 2005, AM J MED GENET A, V138A, P127, DOI 10.1002/ajmg.a.30941; Kaneko-Ishino T, 2006, CYTOGENET GENOME RES, V113, P24, DOI 10.1159/000090811; Kaneko-Ishino T, 2003, J BIOCHEM, V133, P699, DOI 10.1093/jb/mvg090; Kosaki K, 2000, J Med Genet, V37, pE19, DOI 10.1136/jmg.37.9.e19; Kotzot D, 2004, ANN GENET-PARIS, V47, P251, DOI 10.1016/j.anngen.2004.03.006; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Murphy SK, 2003, HUM MUTAT, V22, P92, DOI 10.1002/humu.10237; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takahashi I, 2005, TOHOKU J EXP MED, V207, P333, DOI 10.1620/tjem.207.333; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	28	229	236	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					237	242		10.1038/ng.2007.56	http://dx.doi.org/10.1038/ng.2007.56			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176563				2022-12-25	WOS:000252732900024
J	Chandrasekaran, A; Srinivasan, A; Raman, R; Viswanathan, K; Raguram, S; Tumpey, TM; Sasisekharan, V; Sasisekharan, R				Chandrasekaran, Aarthi; Srinivasan, Aravind; Raman, Rahul; Viswanathan, Karthik; Raguram, S.; Tumpey, Terrence M.; Sasisekharan, V.; Sasisekharan, Ram			Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin	NATURE BIOTECHNOLOGY			English	Article							LOWER RESPIRATORY-TRACT; RECEPTOR-BINDING SPECIFICITY; 1918 INFLUENZA-VIRUS; A VIRUSES; TRANSMISSION; MODEL; ACID	A switch in specificity of avian influenza A viruses' hemagglutinin (HA) from avian-like (alpha 2-3 sialylated glycans) to human- like (alpha 2-6 sialylated glycans) receptors is believed to be associated with their adaptation to infect humans(1-4). We show that a characteristic structural topology - and not the alpha 2-6 linkage itself - enables specific binding of HA to alpha 2-6 sialylated glycans and that recognition of this topology may be critical for adaptation of HA to bind glycans in the upper respiratory tract of humans. An integrated biochemical, analytical and data mining approach demonstrates that HAs from the human- adapted H1N1 and H3N2 viruses, but not H5N1 (bird flu) viruses, specifically bind to long alpha 2-6 sialylated glycans with this topology. This could explain why H5N1 viruses have not yet gained a foothold in the human population(5,6). Our findings will enable the development of additional strategies for effective surveillance and potential therapeutic interventions for H5N1 and possibly other influenza A viruses.	[Chandrasekaran, Aarthi; Srinivasan, Aravind; Raman, Rahul; Viswanathan, Karthik; Raguram, S.; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Coordinating Ctr Infect Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Sasisekharan, V.; Sasisekharan, Ram] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sasisekharan, Ram] MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, U54GM062116, R01GM057073] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57073, U54 GM62116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Grun CH, 2006, ANAL BIOCHEM, V354, P54, DOI 10.1016/j.ab.2006.03.055; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	27	318	349	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					107	113		10.1038/nbt1375	http://dx.doi.org/10.1038/nbt1375			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18176555	Bronze			2022-12-25	WOS:000252222500030
J	Guillaud, L; Wong, R; Hirokawa, N				Guillaud, Laurent; Wong, Richard; Hirokawa, Nobutaka			Disruption of KIF17-Mint1 interaction by CaMKII-dependent phosphorylation: a molecular model of kinesin-cargo release	NATURE CELL BIOLOGY			English	Article							MOTOR PROTEIN KIF17; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; AXONAL-TRANSPORT; LIGHT-CHAINS; MYOSIN-V; TRAFFICKING; SUPERFAMILY; SPECIFICITY; MECHANISMS	Establishment and maintenance of cell structures and functions are highly dependent on the efficient regulation of intracellular transport in which proteins of the kinesin superfamily ( KIFs) are very important. In this regard, how KIFs regulate the release of their cargo is a critical process that remains to be elucidated. To address this specific question, we have investigated the mechanism behind the regulation of the KIF17-Mint1 interaction. Here we report that the tail region of the molecular motor KIF17 is regulated by phosphorylation. Using direct visualization of protein-protein interaction by FRET and various in vitro and in vivo approaches we have demonstrated that CaMKII-dependent phosphorylation of KIF17 on Ser 1029 disrupts the KIF17-Mint1 association and results in the release of the transported cargo from its microtubule-based transport.	[Guillaud, Laurent; Wong, Richard; Hirokawa, Nobutaka] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Wong, Richard W./E-9155-2011; Guillaud, Laurent/Q-4214-2016	Guillaud, Laurent/0000-0002-9688-0991				ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frank R, 1996, Methods Mol Biol, V66, P149; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Guillaud L, 2003, J NEUROSCI, V23, P131; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mok H, 2002, J NEUROSCI, V22, P5253; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sparks AB, 1998, METH MOL B, V84, P87; SPIEGEL RM, 2000, SCI STKE, V38, pI1; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WASHBOURNE P, 2004, J NEUROSCI, V90, P3950; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099	39	141	144	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					19	U8		10.1038/ncb1665	http://dx.doi.org/10.1038/ncb1665			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066053				2022-12-25	WOS:000252116100009
J	Kumari, S; Mayor, S				Kumari, Sudha; Mayor, Satyajit			ARF1 is directly involved in dynamin-independent endocytosis	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR-1; GPI-ANCHORED PROTEINS; BREFELDIN-A; GUANINE-NUCLEOTIDE; RECYCLING ENDOSOMES; EXCHANGE FACTOR; GOLGI; CLATHRIN; TRANSPORT; COMPLEX	Endocytosis of glycosylphosphatidyl inositol (GPI)-anchored proteins (GPI-APs) and the fluid phase takes place primarily through a dynamin- and clathrin-independent, Cdc42-regulated pinocytic mechanism. This mechanism is mediated by primary carriers called clathrin-independent carriers (CLICs), which fuse to form tubular early endocytic compartments called GPI-AP enriched endosomal compartments (GEECs). Here, we show that reduction in activity or levels of ARF1 specifically inhibits GPI-AP and fluid-phase endocytosis without affecting other clathrin-dependent or independent endocytic pathways. ARF1 is activated at distinct sites on the plasma membrane, and by the recruitment of RhoGAP domain-containing protein, ARHGAP10, to the plasma membrane, modulates cell-surface Cdc42 dynamics. This results in the coupling of ARF1 and Cdc42 activity to regulate endocytosis at the plasma membrane. These findings provide a molecular basis for a crosstalk of endocytosis with secretion by the sharing of a key regulator of secretory traffic, ARF1.	[Kumari, Sudha; Mayor, Satyajit] Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in		Kumari, Sudha/0000-0001-7082-2825				Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Deretic D, 2004, MOL BIOL CELL, V15, P359, DOI 10.1091/mbc.E03-04-0203; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Ellis MA, 2004, J BIOL CHEM, V279, P52735, DOI 10.1074/jbc.M410533200; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Vasudevan C, 1998, J CELL SCI, V111, P1277; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	49	158	159	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					30	U22		10.1038/ncb1666	http://dx.doi.org/10.1038/ncb1666			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084285				2022-12-25	WOS:000252116100010
J	Piontek, K; Menezes, LF; Garcia-Gonzalez, MA; Huso, DL; Germino, GG				Piontek, Klaus; Menezes, Luis F.; Garcia-Gonzalez, Miguel A.; Huso, David L.; Germino, Gregory G.			A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1	NATURE MEDICINE			English	Article							PLANAR CELL POLARITY; DISEASE; PROLIFERATION; POLYCYSTIN-1; MORPHOGENESIS; INHIBITION; APOPTOSIS; TISSUES; MICE	Autosomal dominant polycystic kidney disease is an important cause of end-stage renal disease, for which there is no proven therapy(1). Mutations in PKD1 (the gene encoding polycystin-1) are the principal cause of this disease. The disease begins in utero(2) and is slowly progressive, but it is not known whether cystogenesis is an ongoing process during adult life. We now show that inactivation of Pkd1 in mice before postnatal day 13 results in severely cystic kidneys within 3 weeks, whereas inactivation at day 14 and later results in cysts only after 5 months. We found that cellular proliferation was not appreciably higher in cystic specimens than in age-matched controls, but the abrupt change in response to Pkd1 inactivation corresponded to a previously unrecognized brake point during renal growth and significant changes in gene expression. These findings suggest that the effects of Pkd1 inactivation are defined by a developmental switch that signals the end of the terminal renal maturation process. Our studies show that Pkd1 regulates tubular morphology in both developing and adult kidney, but the pathologic consequences of inactivation are defined by the organ's developmental status. These results have important implications for clinical understanding of the disease and therapeutic approaches.	Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Ross 958,720 Rutland Ave, Baltimore, MD 21205 USA.	ggermino@jhmi.edu	Gonzalez, Miguel Garcia/ABF-9880-2020; Menezes, Luis Fernando/C-7286-2015; Garcia-Gonzalez, Miguel A/G-6920-2011	Gonzalez, Miguel Garcia/0000-0002-4330-7200; Germino, Gregory/0000-0002-3609-5588; Menezes, Luis Fernando/0000-0003-2225-168X	NIDDK NIH HHS [R01 DK051259, R37 DK048006-13, R01 DK048006, R01 DK051259-11, DK51259, R37 DK048006-14, R37 DK048006, DK48006, R01 DK051259-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048006, R01DK048006, R01DK051259] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75; Boucher C, 2004, EUR J HUM GENET, V12, P347, DOI 10.1038/sj.ejhg.5201162; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Calvet J P, 1994, Curr Opin Nephrol Hypertens, V3, P340, DOI 10.1097/00041552-199405000-00017; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; HEGG O, 1966, J PATHOL BACTERIOL, V91, P311, DOI 10.1002/path.1700910204; Lanoix J, 1996, ONCOGENE, V13, P1153; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; OSATHANONDH V, 1964, ARCH PATHOL, V77, P459; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; PRETORIUS DH, 1987, J ULTRAS MED, V6, P249; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Sweeney WE, 2003, KIDNEY INT, V64, P1310, DOI 10.1046/j.1523-1755.2003.00232.x; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	30	294	297	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1490	1495		10.1038/nm1675	http://dx.doi.org/10.1038/nm1675			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	17965720	Green Accepted			2022-12-25	WOS:000251445400024
J	Liu, CY; Noorchashm, H; Sutter, JA; Naji, M; Prak, EL; Boyer, J; Green, T; Rickels, MR; Tomaszewski, JE; Koeberlein, B; Wang, ZL; Paessler, ME; Velidedeoglu, E; Rostami, SY; Yu, M; Barker, CF; Naji, A				Liu, Chengyang; Noorchashm, Hooman; Sutter, Jennifer A.; Naji, Mina; Prak, Eline Luning; Boyer, Jean; Green, Taryn; Rickels, Michael R.; Tomaszewski, John E.; Koeberlein, Brigitte; Wang, Zhonglin; Paessler, Michelle E.; Velidedeoglu, Ergun; Rostami, Susan Y.; Yu, Ming; Barker, Clyde F.; Naji, Ali			B lymphocyte - directed immunotherapy promotes long-term islet allograft survival in nonhuman primates	NATURE MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; ANTIGEN PRESENTATION; CELL SUBSETS; TRANSPLANTATION; REJECTION; BLOOD	We found that an induction immunotherapy regimen consisting of rabbit anti-thymocyte globulin (Thymoglobulin) and the monoclonal antibody to CD20 rituximab (Rituxan) promoted long-term islet allograft survival in cynomolgus macaques maintained on rapamycin monotherapy. B lymphocyte reconstitution after rituximab-mediated depletion was characterized by a preponderance of immature and transitional cells, whose persistence was associated with long-term islet allograft survival. Development of donor-specific alloantibodies was abrogated only in the setting of continued rapamycin monotherapy.	Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Naji, A (corresponding author), Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA.	Ali.Naji@uphs.upenn.edu	Rickels, Michael/D-1380-2009	Rickels, Michael/0000-0002-9253-838X	NIAID NIH HHS [AI065356] Funding Source: Medline; NIDDK NIH HHS [DK64603] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI065356] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P723, DOI 10.1002/art.21650; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; MCCULLOCH DK, 1991, DIABETES, V40, P673, DOI 10.2337/diabetes.40.6.673; Miller JP, 2006, J IMMUNOL, V176, P6405, DOI 10.4049/jimmunol.176.11.6405; Noorchashm H, 2006, J IMMUNOL, V177, P7715, DOI 10.4049/jimmunol.177.11.7715; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schroder C, 2003, TRANSPL IMMUNOL, V12, P19, DOI 10.1016/S0966-3274(03)00059-5; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039	15	125	130	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2007	13	11					1295	1298		10.1038/nm1673	http://dx.doi.org/10.1038/nm1673			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17965721				2022-12-25	WOS:000250736900021
J	German, MA; Pillay, M; Jeong, DH; Hetawal, A; Luo, SJ; Janardhanan, P; Kannan, V; Rymarquis, LA; Nobuta, K; German, R; De Paoli, E; Lu, C; Schroth, G; Meyers, BC; Green, PJ				German, Marcelo A.; Pillay, Manoj; Jeong, Dong-Hoon; Hetawal, Amit; Luo, Shujun; Janardhanan, Prakash; Kannan, Vimal; Rymarquis, Linda A.; Nobuta, Kan; German, Rana; De Paoli, Emanuele; Lu, Cheng; Schroth, Gary; Meyers, Blake C.; Green, Pamela J.			Global identification of microRNA-target RNA pairs by parallel analysis of RNA ends	NATURE BIOTECHNOLOGY			English	Article							MESSENGER-RNA; ARABIDOPSIS-THALIANA; MIRNA TARGETS; TRANSCRIPTOME; METHYLATION; PREDICTION; CLEAVAGE; GENES	MicroRNAs (miRNAs) are important regulatory molecules in most eukaryotes and identification of their target mRNAs is essential for their functional analysis. Whereas conventional methods rely on computational prediction and subsequent experimental validation of target RNAs, we directly sequenced > 28,000,000 signatures from the 5' ends of polyadenylated products of miRNA-mediated mRNA decay, isolated from inflorescence tissue of Arabidopsis thaliana, to discover novel miRNA-target RNA pairs. Within the set of similar to 27,000 transcripts included in the 8,000,000 nonredundant signatures, several previously predicted but nonvalidated targets of miRNAs were found. Like validated targets, most showed a single abundant signature at the miRNA cleavage site, particularly in libraries from a mutant deficient in the 5'-to-3' exonuclease AtXRN4. Although miRNAs in Arabidopsis have been extensively investigated, working in reverse from the cleaved targets resulted in the identification and validation of novel miRNAs. This versatile approach will affect the study of other aspects of RNA processing beyond miRNA-target RNA pairs.	[German, Marcelo A.; Pillay, Manoj; Jeong, Dong-Hoon; Hetawal, Amit; Janardhanan, Prakash; Kannan, Vimal; Rymarquis, Linda A.; Nobuta, Kan; German, Rana; De Paoli, Emanuele; Lu, Cheng; Meyers, Blake C.; Green, Pamela J.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Luo, Shujun; Schroth, Gary] Illumina Inc, Hayward, CA 94545 USA	University of Delaware; Illumina	Meyers, BC (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA.	green@dbi.udel.edu; meyers@dbi.udel.edu	Meyers, Blake/B-6535-2012; Pillay, Nischalan/F-9536-2012	Meyers, Blake/0000-0003-3436-6097; Rymarquis, Linda/0000-0003-0297-8371; De Paoli, Emanuele/0000-0003-3646-7692	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR16472-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; GREGORY BD, 2008, DEV CELL        0515; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Maroney PA, 2007, RNA, V13, P930, DOI 10.1261/rna.518107; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	22	624	670	9	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					941	946		10.1038/nbt1417	http://dx.doi.org/10.1038/nbt1417			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18542052				2022-12-25	WOS:000258325500029
J	Lang, PA; Contaldo, C; Georgiev, P; El-Badry, AM; Recher, M; Kurrer, M; Cervantes-Barragan, L; Ludewig, B; Calzascia, T; Bolinger, B; Merkler, D; Odermatt, B; Bader, M; Graf, R; Clavien, PA; Hegazy, AN; Loehning, M; Harris, NL; Ohashi, PS; Hengartner, H; Zinkernagel, RM; Lang, KS				Lang, Philipp A.; Contaldo, Claudio; Georgiev, Panco; El-Badry, Ashraf Mohammad; Recher, Mike; Kurrer, Michael; Cervantes-Barragan, Luisa; Ludewig, Burkhard; Calzascia, Thomas; Bolinger, Beatrice; Merkler, Doron; Odermatt, Bernhard; Bader, Michael; Graf, Rolf; Clavien, Pierre-Alain; Hegazy, Ahmed N.; Loehning, Max; Harris, Nicola L.; Ohashi, Pamela S.; Hengartner, Hans; Zinkernagel, Rolf M.; Lang, Karl S.			Aggravation of viral hepatitis by platelet-derived serotonin	NATURE MEDICINE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROVASCULAR REGULATORY MECHANISMS; B-VIRUS; T-CELLS; BLOOD-PLATELETS; LIVER-DAMAGE; P-SELECTIN; INFECTION; CLEARANCE; ACTIVATION	More than 500 million people worldwide are persistently infected with hepatitis B virus or hepatitis C virus(1). Although both viruses are poorly cytopathic, persistence of either virus carries a risk of chronic liver inflammation, potentially resulting in liver steatosis, liver cirrhosis, end-stage liver failure or hepatocellular carcinoma. Virus-specific T cells are a major determinant of the outcome of hepatitis, as they contribute to the early control of chronic hepatitis viruses, but they also mediate immunopathology during persistent virus infection(1-4). We have analyzed the role of platelet-derived vasoactive serotonin during virus-induced CD8(+) T cell-dependent immunopathological hepatitis in mice infected with the noncytopathic lymphocytic choriomeningitis virus. After virus infection, platelets were recruited to the liver, and their activation correlated with severely reduced sinusoidal microcirculation, delayed virus elimination and increased immunopathological liver cell damage. Lack of platelet-derived serotonin in serotonin-deficient mice normalized hepatic microcirculatory dysfunction, accelerated virus clearance in the liver and reduced CD8(+) T cell-dependent liver cell damage. In keeping with these observations, serotonin treatment of infected mice delayed entry of activated CD8(+) T cells into the liver, delayed virus control and aggravated immunopathological hepatitis. Thus, vasoactive serotonin supports virus persistence in the liver and aggravates virus-induced immunopathology.	[Lang, Philipp A.; Recher, Mike; Merkler, Doron; Hegazy, Ahmed N.; Loehning, Max; Harris, Nicola L.; Hengartner, Hans; Zinkernagel, Rolf M.; Lang, Karl S.] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Lang, Philipp A.; Calzascia, Thomas; Ohashi, Pamela S.; Lang, Karl S.] UHN, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Contaldo, Claudio] Univ Zurich Hosp, Div Plast & Reconstruct Surg, CH-8091 Zurich, Switzerland; [Georgiev, Panco; El-Badry, Ashraf Mohammad; Graf, Rolf; Clavien, Pierre-Alain] Univ Zurich Hosp, Swiss Hepato Pancreato Biliary Ctr, Dept Surg, CH-8091 Zurich, Switzerland; [Kurrer, Michael; Odermatt, Bernhard] Univ Zurich Hosp, Dept Surg Pathol, CH-8091 Zurich, Switzerland; [Cervantes-Barragan, Luisa; Ludewig, Burkhard; Bolinger, Beatrice] Kantonal Hosp St Gallen, Res Dept, CH-9007 St Gallen, Switzerland; [Merkler, Doron] Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany; [Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hegazy, Ahmed N.; Loehning, Max] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Hegazy, Ahmed N.; Loehning, Max] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany	University of Zurich; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Gottingen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Zinkernagel, RM (corresponding author), Univ Zurich, Inst Expt Immunol, Schmelzberstr 12, CH-8091 Zurich, Switzerland.	rolf.zinkernagel@usz.ch; karlslang@gmail.com	Bader, Michael/K-2124-2013; harris, nicola/E-5342-2019; Merkler, Doron/N-9157-2016; Lang, Karl S/R-2505-2016; El-Badry, Ashraf Mohammad/X-7818-2019; Löhning, Max/AAL-2967-2021	harris, nicola/0000-0003-2922-0210; Merkler, Doron/0000-0002-0247-2007; El-Badry, Ashraf Mohammad/0000-0003-4125-3373; Löhning, Max/0000-0001-6382-7281; Calzascia, Thomas/0000-0001-8225-6744; Hegazy, Ahmed N./0000-0002-2946-8251; Graf, Rolf/0000-0001-7449-7302; Lang, Karl/0000-0001-9783-7605; Bader, Michael/0000-0003-4780-4164; Recher, Mike/0000-0002-9121-6936; Ohashi, Pamela S./0000-0003-2915-9317				Bergthaler A, 2007, J GEN VIROL, V88, P592, DOI 10.1099/vir.0.82428-0; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; BLANKENSHIP LL, 1991, MICROCIRC ENDOTH LYM, V7, P57; Blann AD, 1997, ATHEROSCLEROSIS, V128, P135, DOI 10.1016/S0021-9150(96)05980-1; BORN GVR, 1972, BRIT J PHARMACOL, V44, P117, DOI 10.1111/j.1476-5381.1972.tb07244.x; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Contaldo C, 2005, ANESTH ANALG, V100, P817, DOI 10.1213/01.ANE.0000144427.90174.B6; CUMMINGS JL, 1993, INT J MICROCIRC, V13, P99; GREGORY PB, 1976, NEW ENGL J MED, V294, P681, DOI 10.1056/NEJM197603252941301; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Nakamura I, 2001, HEPATOLOGY, V33, P439, DOI 10.1053/jhep.2001.21748; Panasiuk A, 2001, HEPATO-GASTROENTEROL, V48, P818; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sobao Y, 2002, J HEPATOL, V36, P105, DOI 10.1016/S0168-8278(01)00264-1; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Uhlmann S, 1999, J INVEST SURG, V12, P179; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; VANNUETEN JM, 1985, PHARMACOL RES COMMUN, V17, P585, DOI 10.1016/0031-6989(85)90067-0; VANNUETEN JM, 1985, J CARDIOVASC PHARM, V7, pS49; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	29	183	187	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					756	761		10.1038/nm1780	http://dx.doi.org/10.1038/nm1780			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18516052	Green Submitted, Green Published			2022-12-25	WOS:000257452700023
J	Guerrini, M; Beccati, D; Shriver, Z; Naggi, A; Viswanathan, K; Bisio, A; Capila, I; Lansing, JC; Guglieri, S; Fraser, B; Al-Hakim, A; Gunay, NS; Zhang, ZQ; Robinson, L; Buhse, L; Nasr, M; Woodcock, J; Langer, R; Venkataraman, G; Linhardt, RJ; Casu, B; Torri, G; Sasisekharan, R				Guerrini, Marco; Beccati, Daniela; Shriver, Zachary; Naggi, Annamaria; Viswanathan, Karthik; Bisio, Antonella; Capila, Ishan; Lansing, Jonathan C.; Guglieri, Sara; Fraser, Blair; Al-Hakim, Ali; Gunay, Nur Sibel; Zhang, Zhenqing; Robinson, Luke; Buhse, Lucinda; Nasr, Moheb; Woodcock, Janet; Langer, Robert; Venkataraman, Ganesh; Linhardt, Robert J.; Casu, Benito; Torri, Giangiacomo; Sasisekharan, Ram			Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events	NATURE BIOTECHNOLOGY			English	Article							DEXTRAN SULFATE; FLAVOBACTERIUM-HEPARINUM; RECOMBINANT EXPRESSION; MOLECULAR-CLONING; THROMBOCYTOPENIA; ACTIVATION; SYSTEM; C-13; H-1	Recently, certain lots of heparin have been associated with an acute, rapid onset of serious side effects indicative of an allergic-type reaction. To identify potential causes for this sudden rise in side effects, we examined lots of heparin that correlated with adverse events using orthogonal high-resolution analytical techniques. Through detailed structural analysis, the contaminant was found to contain a disaccharide repeat unit of glucuronic acid linked beta 1 -> 3 to a beta-N-acetylgalactosamine. The disaccharide unit has an unusual sulfation pattern and is sulfated at the 2-O and 3-O positions of the glucuronic acid as well as at the 4-O and 6-O positions of the galactosamine. Given the nature of this contaminant, traditional screening tests cannot differentiate between affected and unaffected lots. Our analysis suggests effective screening methods that can be used to determine whether or not heparin lots contain the contaminant reported here.	[Shriver, Zachary; Viswanathan, Karthik; Robinson, Luke; Langer, Robert; Venkataraman, Ganesh; Sasisekharan, Ram] Harvard MIT Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Guerrini, Marco; Naggi, Annamaria; Bisio, Antonella; Guglieri, Sara; Casu, Benito; Torri, Giangiacomo] Ist Ric Chim & Biochim G Ronzoni, I-20133 Milan, Italy; [Beccati, Daniela; Shriver, Zachary; Capila, Ishan; Lansing, Jonathan C.; Gunay, Nur Sibel; Venkataraman, Ganesh] Momenta Pharmaceut Inc, Cambridge, MA 02142 USA; [Fraser, Blair; Al-Hakim, Ali; Buhse, Lucinda; Nasr, Moheb; Woodcock, Janet] Ctr Drug Evaluat & Res, US FDA, Silver Spring, MD 20993 USA; [Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Harvard University; US Food & Drug Administration (FDA); Rensselaer Polytechnic Institute; Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), Harvard MIT Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu		Torri, Giangiacomo/0000-0002-2077-1203; Guerrini, Marco/0000-0001-7246-9113; Lansing, Jonathan/0000-0003-2041-190X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060, R01GM057073, T32GM008334, R37GM057073] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL052622, R01 HL052622-09] Funding Source: Medline; NIGMS NIH HHS [R01 GM038060-19, GM57073, R01 GM038060, GM38060, R01 GM057073, T32 GM008334, R37 GM057073] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*BAXT INV UPD, 2008, 2008 HEP REC INF; *BAXT INV UPD, 2008, BAXT PROV UPD INV; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cicero DO, 2001, J MAGN RESON, V148, P209, DOI 10.1006/jmre.2000.2234; CIFONELL.JA, 1968, CARBOHYD RES, V8, P233, DOI 10.1016/S0008-6215(00)80159-7; Fischer Karl-Georg, 2007, Hemodial Int, V11, P178, DOI 10.1111/j.1542-4758.2007.00166.x; *GERM REG AUTH, 2008, NOT REC ROT BFARM; GREINACHER A, 1992, BRIT J HAEMATOL, V81, P252, DOI 10.1111/j.1365-2141.1992.tb08216.x; Guerrini M, 2001, SEMIN THROMB HEMOST, V27, P473, DOI 10.1055/s-2001-17958; HADDING U, 1973, EUR J IMMUNOL, V3, P527, DOI 10.1002/eji.1830030817; HOJIMA Y, 1984, BLOOD, V63, P1453; HOLME KR, 1989, CARBOHYD RES, V186, P301, DOI 10.1016/0008-6215(89)84044-3; Kang OH, 2006, INT J MOL MED, V18, P893; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Lepor NE, 2007, REV CARDIOVASC MED, V8, pS9; LINHARDT R, 1994, CURRENT PROTOCOLS MO; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; NAGGI A, 1989, BIOMEDICAL AND BIOTECHNOLOGICAL ADVANCES IN INDUSTRIAL POLYSACCHARIDES, P101; SIEBECK M, 1994, J APPL PHYSIOL, V77, P2675, DOI 10.1152/jappl.1994.77.6.2675; SIEGMETH W, 1983, Z RHEUMATOL, V42, P223; *US FDA, COMM INF HEP SOD INJ; Weimann G, 2001, EUR J HAEMATOL, V66, P195, DOI 10.1034/j.1600-0609.2001.00353.x; *WHO, 2008, 118 WHO; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; 2008, MORBID MORTAL WKLY R, V57	29	480	505	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					669	675		10.1038/nbt1407	http://dx.doi.org/10.1038/nbt1407			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18437154	Green Accepted			2022-12-25	WOS:000256611900026
J	Nomura, DK; Blankman, JL; Simon, GM; Fujioka, K; Issa, RS; Ward, AM; Cravatt, BF; Casida, JE				Nomura, Daniel K.; Blankman, Jacqueline L.; Simon, Gabriel M.; Fujioka, Kazutoshi; Issa, Roger S.; Ward, Anna M.; Cravatt, Benjamin F.; Casida, John E.			Activation of the endocannabinoid system by organophosphorus nerve agents	NATURE CHEMICAL BIOLOGY			English	Article							NEUROPATHY TARGET ESTERASE; ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; CANNABINOID RECEPTOR; LIPID-METABOLISM; BRAIN; MICE; INHIBITORS; ENZYME; CB1	Delta(9)-Tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, has useful medicinal properties but also undesirable side effects. The brain receptor for THC, CB1, is also activated by the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). Augmentation of endocannabinoid signaling by blockade of their metabolism may offer a more selective pharmacological approach compared with CB1 agonists. Consistent with this premise, inhibitors of the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH) produce analgesic and anxiolytic effects without cognitive defects. In contrast, we show that dual blockade of the endocannabinoid-degrading enzymes monoacylglycerol lipase (MAGL) and FAAH by selected organophosphorus agents leads to greater than ten-fold elevations in brain levels of both 2-AG and anandamide and to robust CB1-dependent behavioral effects that mirror those observed with CB1 agonists. Arachidonic acid levels are decreased by the organophosphorus agents in amounts equivalent to elevations in 2-AG, which indicates that endocannabinoid and eicosanoid signaling pathways may be coordinately regulated in the brain.	[Nomura, Daniel K.; Fujioka, Kazutoshi; Issa, Roger S.; Ward, Anna M.; Casida, John E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Environm Chem & Toxicol Lab, Berkeley, CA 94720 USA; [Blankman, Jacqueline L.; Simon, Gabriel M.; Cravatt, Benjamin F.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute	Casida, JE (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Environm Chem & Toxicol Lab, 114 Wellman Hall, Berkeley, CA 94720 USA.	ectl@nature.berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008762] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; GROSS NJ, 1995, ANNU REV PHYSIOL, V57, P135; Gupta R.C., 2006, TOXICOLOGY ORGANOPHO; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Martin BR, 2000, J PHARMACOL EXP THER, V294, P1209; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nomura DK, 2008, TOXICOL APPL PHARM, V228, P42, DOI 10.1016/j.taap.2007.11.021; Nomura DK, 2005, P NATL ACAD SCI USA, V102, P6195, DOI 10.1073/pnas.0501915102; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Quistad CB, 2001, TOXICOL APPL PHARM, V173, P48, DOI 10.1006/taap.2001.9175; Quistad GB, 2006, TOXICOL APPL PHARM, V211, P78, DOI 10.1016/j.taap.2005.10.007; Quistad GB, 2003, P NATL ACAD SCI USA, V100, P7983, DOI 10.1073/pnas.1232473100; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Saario SM, 2007, BASIC CLIN PHARMACOL, V101, P287, DOI 10.1111/j.1742-7843.2007.00130.x; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Segall Y, 2003, SYNTHETIC COMMUN, V33, P2151, DOI 10.1081/SCC-120021043; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; WU SY, 1995, CHEM RES TOXICOL, V8, P1070, DOI 10.1021/tx00050a011; Wu SY, 1996, TOXICOL APPL PHARM, V139, P195, DOI 10.1006/taap.1996.0158; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; [No title captured]	44	98	105	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2008	4	6					373	378		10.1038/nchembio.86	http://dx.doi.org/10.1038/nchembio.86			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	303VI	18438404	Green Accepted			2022-12-25	WOS:000256068600014
J	Chang, S; Bray, SM; Li, ZG; Zarnescu, DC; He, C; Jin, P; Warren, ST				Chang, Shuang; Bray, Steven M.; Li, Zigang; Zarnescu, Daniela C.; He, Chuan; Jin, Peng; Warren, Stephen T.			Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila	NATURE CHEMICAL BIOLOGY			English	Article							MENTAL-RETARDATION PROTEIN; MUSHROOM BODIES; GABA(A) RECEPTOR; MUSCARINIC RECEPTORS; COURTSHIP BEHAVIOR; MESSENGER-RNAS; MOUSE MODEL; BRAIN; GENE; TRANSLATION	Fragile X syndrome is caused by the functional loss of the fragile X mental retardation 1 (FMR1) gene. Deletion of the FMR1 ortholog in Drosophila melanogaster (Fmr1) recapitulates many phenotypes associated with fragile X syndrome. We have discovered that Fmr1 mutant Drosophila die during development when reared on food containing increased levels of glutamate, which is consistent with the theory that FMR1 loss results in excess glutamate signaling. Using this lethal phenotype, we screened a chemical library of 2,000 compounds and identified nine molecules that rescued the lethality, including three that implicate the GABAergic inhibitory pathway. Indeed, GABA treatment rescued several known Fmr1 mutant phenotypes in flies, including mushroom bodies defects, excess Futsch translation and abnormal male courtship behavior. These data are consistent with GABAergic inhibition of the enhanced excitatory pathway in fragile X syndrome. In addition, our screen reveals that the muscarinic cholinergic receptors may have a role in fragile X syndrome in parallel to the GABAergic pathway. These results point to potential therapeutic approaches for treating fragile X syndrome.	[Chang, Shuang; Bray, Steven M.; Jin, Peng; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Li, Zigang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zarnescu, Daniela C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat & Biochem, Atlanta, GA 30322 USA	Emory University; University of Chicago; University of Arizona; Emory University	Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St Suite 300, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012	Bray, Steven/0000-0002-0854-8121	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020521, R37HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD024064, HD24064, HD020521] Funding Source: Medline; NIMH NIH HHS [R01 MH076090] Funding Source: Medline; NINDS NIH HHS [R01 NS051630] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bell KFS, 2006, EUR J PHARMACOL, V545, P11, DOI 10.1016/j.ejphar.2006.06.045; Brotz TM, 1997, J COMP NEUROL, V383, P42, DOI 10.1002/(SICI)1096-9861(19970623)383:1<42::AID-CNE3>3.0.CO;2-L; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Degroot A, 2005, BEHAV BRAIN RES, V162, P161, DOI 10.1016/j.bbr.2005.02.018; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gantois I, 2006, NEUROBIOL DIS, V21, P346, DOI 10.1016/j.nbd.2005.07.017; Gao FB, 2002, NEURON, V34, P859, DOI 10.1016/S0896-6273(02)00740-7; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hefco V, 2004, Rom J Physiol, V41, P21; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Reith MEA, 2006, HANDB EXP PHARM, V175, P75; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Schurmann FW, 2000, J COMP NEUROL, V418, P227; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Strambi C, 1998, LEARN MEMORY, V5, P78; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tzavaral ET, 2003, MOL PSYCHIATR, V8, P673, DOI 10.1038/sj.mp.4001270; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Villella A, 1996, GENETICS, V143, P331; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weinberger Norman M, 2006, Sci STKE, V2006, ppe23, DOI 10.1126/stke.3362006pe23; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yamazaki Y, 1998, BRAIN RES, V788, P80, DOI 10.1016/S0006-8993(97)01515-1; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zhang YQ, 2004, DEV BIOL, V270, P290, DOI 10.1016/j.ydbio.2004.02.010; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	50	210	215	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2008	4	4					256	263		10.1038/nchembio.78	http://dx.doi.org/10.1038/nchembio.78			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278EY	18327252				2022-12-25	WOS:000254268300013
J	Markstein, M; Pitsouli, C; Villalta, C; Celniker, SE; Perrimon, N				Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Celniker, Susan E.; Perrimon, Norbert			Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; WHITE GENE; CHROMOSOMAL POSITION; TRANSPOSABLE ELEMENT; REGULATORY ELEMENTS; PHI-C31 INTEGRASE; RNA INTERFERENCE; TRANSFORMATION; PROTEIN	A major obstacle to creating precisely expressed transgenes lies in the epigenetic effects of the host chromatin that surrounds them. Here we present a strategy to overcome this problem, employing a Gal4-inducible luciferase assay to systematically quantify position effects of host chromatin and the ability of insulators to counteract these effects at phiC31 integration loci randomly distributed throughout the Drosophila genome. We identify loci that can be exploited to deliver precise doses of transgene expression to specific tissues. Moreover, we uncover a previously unrecognized property of the gypsy retrovirus insulator to boost gene expression to levels severalfold greater than at most or possibly all un-insulated loci, in every tissue tested. These findings provide the first opportunity to create a battery of transgenes that can be reliably expressed at high levels in virtually any tissue by integration at a single locus, and conversely, to engineer a controlled phenotypic allelic series by exploiting several loci. The generality of our approach makes it adaptable to other model systems to identify and modify loci for optimal transgene expression.	[Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Celniker, Susan E.] Lawrence Berkeley Natl Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Markstein, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mmarkstein@genetics.med.harvard.edu		Markstein, Michele/0000-0003-2635-8118; Perrimon, Norbert/0000-0001-7542-472X; Pitsouli, Chrysoula/0000-0003-4074-9684	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Anderson KV, 2003, NAT GENET, V33, P285, DOI 10.1038/ng1105; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FIETZ MJ, 1995, CURR BIOL, V5, P643, DOI 10.1016/S0960-9822(95)00129-1; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Giraldo P, 2003, TRANSGENIC RES, V12, P751, DOI 10.1023/B:TRAG.0000005089.30408.25; GLOOR GB, 1993, GENETICS, V135, P81; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HOGAN BL, 1995, MANIPULATING MOUSE E; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kuhn EJ, 2003, EMBO J, V22, P2463, DOI 10.1093/emboj/cdg241; Ledford H, 2007, NATURE, V448, P115, DOI 10.1038/448115a; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; QIANQIAN Z, 2007, FLY, V1, P55; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; SMITH PA, 1995, GENETICS, V139, P215; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Thummel CS, 1992, DROS INF SERV, V71, P150; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	49	361	364	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					476	483		10.1038/ng.101	http://dx.doi.org/10.1038/ng.101			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311141	Green Accepted, Green Published			2022-12-25	WOS:000254388100021
J	Kashiwagi, S; Tsukada, K; Xu, L; Miyazaki, J; Kozin, SV; Tyrrell, JA; Sessa, WC; Gerweck, LE; Jain, RK; Fukumura, D				Kashiwagi, Satoshi; Tsukada, Kosuke; Xu, Lei; Miyazaki, Junichi; Kozin, Sergey V.; Tyrrell, James A.; Sessa, William C.; Gerweck, Leo E.; Jain, Rakesh K.; Fukumura, Dai			Perivascular nitric oxide gradients normalize tumor vasculature	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MURAL CELL RECRUITMENT; SYNTHASE; ANGIOGENESIS	Normalization of tumor vasculature is an emerging strategy to improve cytotoxic therapies. Here we show that eliminating nitric oxide (NO) production from tumor cells via neuronal NO synthase silencing or inhibition establishes perivascular gradients of NO in human glioma xenografts in mice and normalizes the tumor vasculature, resulting in improved tumor oxygenation and response to radiation treatment. Creation of perivascular NO gradients may be an effective strategy for normalizing abnormal vasculature.	[Kashiwagi, Satoshi; Tsukada, Kosuke; Xu, Lei; Miyazaki, Junichi; Kozin, Sergey V.; Tyrrell, James A.; Gerweck, Leo E.; Jain, Rakesh K.; Fukumura, Dai] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, Boyer Ctr Mol Med, New Haven, CT 06536 USA; [Kashiwagi, Satoshi; Tsukada, Kosuke; Xu, Lei; Miyazaki, Junichi; Kozin, Sergey V.; Tyrrell, James A.; Gerweck, Leo E.; Jain, Rakesh K.; Fukumura, Dai] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Yale University; Harvard University; Harvard Medical School	Fukumura, D (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, 100 Blossom St, Boston, MA 02114 USA.	dai@steele.mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019; Jain, Rakesh K/I-1384-2017; Sessa, William C/B-6844-2011; Tsukada, Kosuke/C-9986-2014; Tyrrell, James/A-6359-2010; Xu, Lei/GRR-9174-2022	Jain, Rakesh K/0000-0001-7571-3548; Sessa, William C/0000-0001-5759-1938; Tsukada, Kosuke/0000-0003-1463-2204; 	NCI NIH HHS [P01 CA080124, R01-CA96915, R01 CA096915, P01-CA80124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA096915] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Dulak J, 2000, ARTERIOSCL THROM VAS, V20, P659, DOI 10.1161/01.ATV.20.3.659; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; HALL EJ, 1985, RADIOBIOLOGY RADIOBI; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI24015; MITCHELL JB, 1993, CANCER RES, V53, P5845; POU S, 1992, J BIOL CHEM, V267, P24173; vanderZee R, 1997, CIRCULATION, V95, P1030; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Ziche M, 1997, CIRC RES, V80, P845, DOI 10.1161/01.res.80.6.845	15	115	122	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					255	257		10.1038/nm1730	http://dx.doi.org/10.1038/nm1730			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18278052				2022-12-25	WOS:000253815700030
J	Moser, M; Nieswandt, B; Ussar, S; Pozgajova, M; Fassler, R				Moser, Markus; Nieswandt, Bernhard; Ussar, Siegfried; Pozgajova, Miroslava; Faessler, Reinhard			Kindlin-3 is essential for integrin activation and platelet aggregation	NATURE MEDICINE			English	Article							GLYCOPROTEIN-IIB-IIIA; GLANZMANN THROMBASTHENIA; CYTOSKELETAL PROTEINS; MEDIATED ADHESION; TALIN; DOMAIN; BETA; COLLAGEN; MODULATION; RECEPTOR	Integrin-mediated platelet adhesion and aggregation are essential for sealing injured blood vessels and preventing blood loss, and excessive platelet aggregation can initiate arterial thrombosis, causing heart attacks and stroke(1). To ensure that platelets aggregate only at injury sites, integrins on circulating platelets exist in a low-affinity state and shift to a high-affinity state (in a process known as integrin activation or priming) after contacting a wounded vessel(2). The shift is mediated through binding of the cytoskeletal protein Talin to the beta subunit cytoplasmic tail(3-5). Here we show that platelets lacking the adhesion plaque protein Kindlin-3 cannot activate integrins despite normal Talin expression. As a direct consequence, Kindlin-3 deficiency results in severe bleeding and resistance to arterial thrombosis. Mechanistically, Kindlin-3 can directly bind to regions of beta-integrin tails distinct from those of Talin and trigger integrin activation. We have therefore identified Kindlin-3 as a novel and essential element for platelet integrin activation in hemostasis and thrombosis.	[Moser, Markus; Ussar, Siegfried; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Nieswandt, Bernhard; Pozgajova, Miroslava] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Sgemeinschaft Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard] Inst Clin Biochem & Pathobiochem, D-97078 Wurzburg, Germany	Max Planck Society; University of Wurzburg	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Pozgajova, Miroslava/AAG-1841-2019; Ussar, Siegfried/AAL-4331-2021; Pozgajova, Miroslava/AAG-2513-2019	Ussar, Siegfried/0000-0001-7575-0920; Pozgajova, Miroslava/0000-0003-3713-0717				Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; NIESWANDT B, IN PRESS J EXP MED; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8	23	498	513	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2008	14	3					325	330		10.1038/nm1722	http://dx.doi.org/10.1038/nm1722			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18278053				2022-12-25	WOS:000253815700039
J	Henke, E; Perk, J; Vider, J; de Candia, P; Chin, Y; Solit, DB; Ponomarev, V; Cartegni, L; Manova, K; Rosen, N; Benezra, R				Henke, Erik; Perk, Jonathan; Vider, Jelena; de Candia, Paola; Chin, Yvette; Solit, David B.; Ponomarev, Vladimir; Cartegni, Luca; Manova, Katia; Rosen, Neal; Benezra, Robert			Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo	NATURE BIOTECHNOLOGY			English	Article							EPIDERMAL-GROWTH-FACTOR; ID1 PROTEIN EXPRESSION; LOOP-HELIX PROTEINS; ENDOTHELIAL-CELLS; BONE-MARROW; TUMOR ANGIOGENESIS; SIGNAL TRANSDUCER; FACTOR RECEPTOR; BREAST-TUMORS; CANCER	Transcription factors are important targets for the treatment of a variety of malignancies but are extremely difficult to inhibit, as they are located in the cell's nucleus and act mainly by protein-DNA and protein-protein interactions. The transcriptional regulators Id1 and Id3 are attractive targets for cancer therapy as they are required for tumor invasiveness, metastasis and angiogenesis. We report here the development of an antitumor agent that downregulates Id1 effectively in tumor endothelial cells in vivo. Efficient delivery and substantial reduction of Id1 protein levels in the tumor endothelium were effected by fusing an antisense molecule to a peptide known to home specifically to tumor neovessels. In two different tumor models, systemic delivery of this drug led to enhanced hemorrhage, hypoxia and inhibition of primary tumor growth and metastasis, similar to what is observed in Id1 knockout mice. Combination with the Hsp90 inhibitor 17-( allylamino)-17-demethoxygeldanamycin yielded virtually complete growth suppression of aggressive breast tumors.	[Henke, Erik; Perk, Jonathan; de Candia, Paola; Chin, Yvette; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Vider, Jelena; Ponomarev, Vladimir] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Solit, David B.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Solit, David B.; Cartegni, Luca; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; [Manova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Benezra, R (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1270 York Ave, New York, NY 10021 USA.	r-benezra@ski.mskcc.org	de Candia, Paola/HGC-8826-2022; Rosen, Neal/ABF-2677-2020; Vider, Jelena/B-9663-2011; Vider, Jelena/AAW-8577-2020; Henke, Erik/AAG-7053-2020; de Candia, Paola/Z-1498-2019; Solit, David B./AAC-5309-2019	de Candia, Paola/0000-0003-4767-446X; Vider, Jelena/0000-0003-1696-9812; Henke, Erik/0000-0003-2380-2682; de Candia, Paola/0000-0003-4767-446X; Ponomarev, Vladimir/0000-0002-9119-9128				Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Ardelt PU, 2003, J UROLOGY, V169, P1535, DOI 10.1097/01.ju.0000055477.37115.66; Belletti B, 2002, EXP CELL RES, V277, P107, DOI 10.1006/excr.2002.5542; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; COREY DR, 1995, J AM CHEM SOC, V117, P9373, DOI 10.1021/ja00141a038; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; de Candia P, 2003, P NATL ACAD SCI USA, V100, P12337, DOI 10.1073/pnas.2031337100; Doubrovin M, 2004, BIOCONJUGATE CHEM, V15, P1376, DOI 10.1021/bc0498572; EMANUEL BS, 1984, P NATL ACAD SCI-BIOL, V81, P2444, DOI 10.1073/pnas.81.8.2444; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GUPTA GP, IN PRESS P NATL ACAD; Harrison JG, 1998, NUCLEIC ACIDS RES, V26, P3136, DOI 10.1093/nar/26.13.3136; Henry SP, 1997, TOXICOLOGY, V116, P77, DOI 10.1016/S0300-483X(96)03532-9; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lee KT, 2004, BRIT J CANCER, V90, P1198, DOI 10.1038/sj.bjc.6601684; Lee L, 2002, ARTHRITIS RHEUM, V46, P2109, DOI 10.1002/art.10464; Li HQ, 2004, CANCER RES, V64, P6137, DOI 10.1158/0008-5472.CAN-04-1287; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mateo-Lozano S, 2006, CLIN CANCER RES, V12, P6781, DOI 10.1158/1078-0432.CCR-06-0609; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Petit AMV, 1997, AM J PATHOL, V151, P1523; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Solit DB, 2002, CLIN CANCER RES, V8, P986; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; Trepel M, 2001, CANCER RES, V61, P8110; Turkson J, 2004, MOL CANCER THER, V3, P261; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhao QY, 1998, ANTISENSE NUCLEIC A, V8, P451, DOI 10.1089/oli.1.1998.8.451	51	95	103	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2008	26	1					91	100		10.1038/nbt1366	http://dx.doi.org/10.1038/nbt1366			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	249IW	18176556				2022-12-25	WOS:000252222500028
J	Law, M; Maruyama, T; Lewis, J; Giang, E; Tarr, AW; Stamataki, Z; Gastaminza, P; Chisari, FV; Jones, IM; Fox, RI; Ball, JK; McKeating, JA; Kneteman, NM; Burton, DR				Law, Mansun; Maruyama, Toshiaki; Lewis, Jamie; Giang, Erick; Tarr, Alexander W.; Stamataki, Zania; Gastaminza, Pablo; Chisari, Francis V.; Jones, Ian M.; Fox, Robert I.; Ball, Jonathan K.; McKeating, Jane A.; Kneteman, Norman M.; Burton, Dennis R.			Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge	NATURE MEDICINE			English	Article							E2 ENVELOPE GLYCOPROTEIN; BINDING; CHIMPANZEES; PARTICLES; CULTURE; CD81	A major problem in hepatitis C virus (HCV) immunotherapy or vaccine design is the extreme variability of the virus. We identified human monoclonal antibodies (mAbs) that neutralize genetically diverse HCV isolates and protect against heterologous HCV quasispecies challenge in a human liver-chimeric mouse model. The results provide evidence that broadly neutralizing antibodies to HCV protect against heterologous viral infection and suggest that a prophylactic vaccine against HCV may be achievable.	[Law, Mansun; Maruyama, Toshiaki; Giang, Erick; Burton, Dennis R.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Gastaminza, Pablo; Chisari, Francis V.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Lewis, Jamie; Kneteman, Norman M.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada; [Tarr, Alexander W.; Ball, Jonathan K.] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England; [Stamataki, Zania; McKeating, Jane A.] Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading RG6 6AH, Berks, England; [Fox, Robert I.] Scripps Mem Hosp, Rheumatol Clin, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Alberta; University of Nottingham; University of Birmingham; University of Reading	Law, M (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	norm.kneteman@capitalhealth.ca; burton@scripps.edu	Cheng, Yushao/E-6256-2011; Stamataki, Zania/H-6541-2011; Ball, Jonathan/HGU-3130-2022; Chisari, Francis V/A-3086-2008; Tarr, Alexander W/B-7953-2008; Stamataki, Zania/P-4681-2019; Law, Mansun/A-3899-2008; Gastaminza, Pablo/K-5444-2014	Tarr, Alexander W/0000-0003-1009-0823; Stamataki, Zania/0000-0003-3823-4497; Chisari, Francis/0000-0002-4832-1044; McKeating, Jane/0000-0002-7229-5886; Law, Mansun/0000-0002-8934-9756; ball, jonathan/0000-0001-5773-8733; Gastaminza Landart, Pablo/0000-0002-7873-5491	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071084] Funding Source: NIH RePORTER; MRC [G0200000, G0400802] Funding Source: UKRI; Medical Research Council [G0801976, G0400802, G0200000] Funding Source: Medline; NIAID NIH HHS [R01 AI071084] Funding Source: Medline; Medical Research Council [G9818340B] Funding Source: researchfish	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kneteman NM, 2006, HEPATOLOGY, V43, P1346, DOI 10.1002/hep.21209; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	15	467	489	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					25	27		10.1038/nm1698	http://dx.doi.org/10.1038/nm1698			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18064037				2022-12-25	WOS:000252222400018
J	Galvis, MLE; Jia, J; Zhang, X; Jastrebova, N; Spillmann, D; Gottfridsson, E; van Kuppevelt, TH; Zcharia, E; Vlodavsky, I; Lindahl, U; Li, JP				Galvis, Martha L. Escobar; Jia, Juan; Zhang, Xiao; Jastrebova, Nadja; Spillmann, Dorothe; Gottfridsson, Eva; van Kuppevelt, Toin H.; Zcharia, Eyal; Vlodavsky, Israel; Lindahl, Ulf; Li, Jin-Ping			Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate	NATURE CHEMICAL BIOLOGY			English	Article							MACROMOLECULAR HEPARIN; MAMMALIAN HEPARANASE; PROTEOGLYCANS; BIOSYNTHESIS; PROGRESSION; ENZYME; MICE	Heparan sulfate proteoglycans (HSPGs) interact with numerous proteins of importance in animal development and homeostasis(1-3). Heparanase, which is expressed in normal tissues and upregulated in angiogenesis, cancer and inflammation, selectively cleaves beta-glucuronidic linkages in HS chains. In a previous study, we transgenically overexpressed heparanase in mice to assess the overall effects of heparanase on HS metabolism. Metabolic labeling confirmed extensive fragmentation of HS in vivo(4,5). In the current study we found that in liver showing excessive heparanase overexpression, HSPG turnover is accelerated along with upregulation of HS N- and O- sulfation, thus yielding heparin-like chains without the domain structure typical of HS. Heparanase overexpression in other mouse organs and in human tumors correlated with increased 6-O-sulfation of HS, whereas the domain structure was conserved. The heavily sulfated HS fragments strongly promoted formation of ternary complexes with fibroblast growth factor 1 (FGF1) or FGF2 and FGF receptor 1. Heparanase thus contributes to regulation of HS biosynthesis in a way that may promote growth factor action in tumor angiogenesis and metastasis.	Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Dept Publ Hlth & Caring Sci, SE-75185 Uppsala, Sweden; Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci 280, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Uppsala University; Uppsala University; Radboud University Nijmegen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582,Husargatan 3, SE-75123 Uppsala, Sweden.	jin-ping.li@imbim.uu.se	Galvis, Martha L Escobar/AAD-1998-2019; van Kuppevelt, A.H.M.S.M./L-4463-2015	Escobar Galvis, Martha L/0000-0001-8400-9392				Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GINGISVELITSKI S, IN PRESS FASEB J; Gong F, 2003, J BIOL CHEM, V278, P35152, DOI 10.1074/jbc.M300925200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; OGREN S, 1975, J BIOL CHEM, V250, P2690; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	30	84	85	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					773	778		10.1038/nchembio.2007.41	http://dx.doi.org/10.1038/nchembio.2007.41			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17952066				2022-12-25	WOS:000251028600011
J	Gandotra, S; Schnappinger, D; Monteleone, M; Hillen, W; Ehrt, S				Gandotra, Sheetal; Schnappinger, Dirk; Monteleone, Mercedes; Hillen, Wolfgang; Ehrt, Sabine			In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice	NATURE MEDICINE			English	Article							20S PROTEASOME; ATPASE HOMOLOG; RESISTANCE; SMEGMATIS; PROTEINS; INACTIVATION; EXPRESSION; INFECTION	The success of Mycobacterium tuberculosis (Mtb) as a human pathogen relies on its ability to resist eradication by the immune system. The identification of mechanisms that enable Mtb to persist is key for finding ways to limit latent tuberculosis, which affects one-third of the world's population. Here we show that conditional gene silencing can be used to determine whether an Mtb gene required for optimal growth in vitro is also important for virulence and, if so, during which phase of an infection it is required. Application of this approach to the prcBA genes, which encode the core of the mycobacterial proteasome, revealed an unpredicted requirement of the core proteasome for the persistence of Mtb during the chronic phase of infection in mice. Proteasome depletion also attenuated Mtb in interferon gamma-deficient mice, pointing to a function of the proteasome beyond defense against the adaptive immune response. Genes that are essential for growth in vitro, in vivo or both account for approximately 20% of Mtb's genome. Conditional gene silencing could therefore facilitate the validation of up to 800 potential Mtb drug targets and improve our understanding of host-pathogen dynamics.	Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10065 USA; Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, D-91058 Erlangen, Germany	Cornell University; Cornell University; Cornell University; University of Erlangen Nuremberg	Ehrt, S (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	sae2004@med.cornell.edu	Monteleone, Maria/J-1813-2014; Ehrt, Sabine/AAU-6449-2020	Monteleone, Maria/0000-0003-0777-3965; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063446] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI063446-02, AI63446, R01 AI063446] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; De Mot R, 2007, ARCH MICROBIOL, V188, P257, DOI 10.1007/s00203-007-0243-8; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hong B, 2005, MICROBIOL-SGM, V151, P3137, DOI 10.1099/mic.0.28034-0; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lamichhane G, 2006, J INFECT DIS, V194, P1233, DOI 10.1086/508288; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nagy I, 2003, J BACTERIOL, V185, P496, DOI 10.1128/JB.185.2.496-503.2003; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x	30	191	208	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1515	1520		10.1038/nm1683	http://dx.doi.org/10.1038/nm1683			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18059281	Green Accepted			2022-12-25	WOS:000251445400028
J	Hunsberger, JG; Newton, SS; Bennett, AH; Duman, CH; Russell, DS; Salton, SR; Duman, RS				Hunsberger, Joshua G.; Newton, Samuel S.; Bennett, Alicia H.; Duman, Catharine H.; Russell, David S.; Salton, Stephen R.; Duman, Ronald S.			Antidepressant actions of the exercise-regulated gene VGF	NATURE MEDICINE			English	Article							GROWTH-FACTOR; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; MESSENGER-RNA; BRAIN; DEPRESSION; EXPRESSION; STRESS; EPIDEMIOLOGY; PROFILE	Exercise has many health benefits, including antidepressant actions in depressed human subjects, but the mechanisms underlying these effects have not been elucidated. We used a custom microarray to identify a previously undescribed profile of exercise-regulated genes in the mouse hippocampus, a brain region implicated in mood and antidepressant response. Pathway analysis of the regulated genes shows that exercise upregulates a neurotrophic factor signaling cascade that has been implicated in the actions of antidepressants. One of the most highly regulated target genes of exercise and of the growth factor pathway is the gene encoding the VGF nerve growth factor, a peptide precursor previously shown to influence synaptic plasticity and metabolism. We show that administration of a synthetic VGF-derived peptide produces a robust antidepressant response in mice and, conversely, that mutation of VGF in mice produces the opposite effects. The results suggest a new role for VGF and identify VGF signaling as a potential therapeutic target for antidepressant drug development.	Yale Univ, Dept Psychiat, New Haven, CT 06508 USA; Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Yale University; Icahn School of Medicine at Mount Sinai	Duman, RS (corresponding author), Yale Univ, Dept Psychiat, 34 Pk St, New Haven, CT 06508 USA.	ronald.duman@yale.edu	Yan, Shuo/B-8381-2009	Salton, Stephen/0000-0003-4087-8427	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071308, R01DK057702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642, R01MH045481, R29MH045481, R37MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045305] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-071308, DK57702] Funding Source: Medline; NIMH NIH HHS [MH45481, MH25642] Funding Source: Medline; NINDS NIH HHS [U24 NS05186, NS45305] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alder J, 2003, J NEUROSCI, V23, P10800; Alfonso J, 2005, REV NEUROSCIENCE, V16, P43; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Anderson BJ, 2000, PHYSIOL BEHAV, V70, P425, DOI 10.1016/S0031-9384(00)00282-1; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cui XS, 2005, MOL REPROD DEV, V70, P471, DOI 10.1002/mrd.20228; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Eagleson KL, 2001, J NEUROSCI, V21, P9315, DOI 10.1523/JNEUROSCI.21-23-09315.2001; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Karssen AM, 2006, METHODS, V38, P227, DOI 10.1016/j.ymeth.2005.09.017; Kavanagh T, 1983, Ann Acad Med Singap, V12, P331; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Koo JW, 2003, FASEB J, V17, P1556, DOI 10.1096/fj.02-1032fje; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lai SM, 2006, J AM GERIATR SOC, V54, P240, DOI 10.1111/j.1532-5415.2006.00573.x; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; McEwen BS, 2004, EUR NEUROPSYCHOPHARM, V14, pS497, DOI 10.1016/j.euroneuro.2004.09.008; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Newton SS, 2004, MOL BRAIN RES, V129, P185, DOI 10.1016/j.molbrainres.2004.06.032; Newton SS, 2003, J NEUROSCI, V23, P10841; Newton SS, 2002, BRAIN RES PROTOC, V9, P214, DOI 10.1016/S1385-299X(02)00148-4; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Salton SRJ, 2003, MT SINAI J MED, V70, P93; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015	42	201	205	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2007	13	12					1476	1482		10.1038/nm1669	http://dx.doi.org/10.1038/nm1669			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	238KB	18059283				2022-12-25	WOS:000251445400022
J	Kim, HK; Rasnik, I; Liu, JW; Ha, TJ; Lu, Y				Kim, Hee-Kyung; Rasnik, Ivan; Liu, Juewen; Ha, Taekjip; Lu, Yi			Dissecting metal ion-dependent folding and catalysis of a single DNAzyme	NATURE CHEMICAL BIOLOGY			English	Article							RESONANCE ENERGY-TRANSFER; RNA; RIBOZYME; MOLECULE; LEAD; DEOXYRIBOZYMES; BIOSENSOR; SELECTION; DYNAMICS; CLEAVAGE	Protein metalloenzymes use various modes for functions for which metal-dependent global conformational change is required in some cases but not in others. In contrast, most ribozymes require a global folding that almost always precedes enzyme reactions. Herein we studied metal-dependent folding and cleavage activity of the 8-17 DNAzyme using single-molecule fluorescence resonance energy transfer. Addition of Zn2+ and Mg2+ induced folding of the DNAzyme into a more compact structure followed by a cleavage reaction, which suggests that the DNAzyme may require metal-dependent global folding for activation. In the presence of Pb2+, however, the cleavage reaction occurred without a precedent folding step, which suggests that the DNAzyme may be prearranged to accept Pb2+ for the activity. Neither ligation reaction of the cleaved substrates nor dynamic changes between folded and unfolded states was observed. These features may contribute to the unusually fast Pb2+-dependent reaction of the DNAzyme. These results suggest that DNAzymes can use all modes of activation that metalloproteins use.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, TJ (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu; yi-lu@uiuc.edu	Liu, Juewen/A-2701-2014; Ha, Taekjip/B-9506-2009; Lu, Yi/GQQ-1069-2022; liu, yi/GXE-9662-2022; Lu, Yi/B-5461-2010	Liu, Juewen/0000-0001-5918-9336; Ha, Taekjip/0000-0003-2195-6258; Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709	NIEHS NIH HHS [R01 ES016865] Funding Source: Medline; NIGMS NIH HHS [GM065367, R01 GM065367] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassi GS, 1997, EMBO J, V16, P7481, DOI 10.1093/emboj/16.24.7481; Bokinsky G, 2003, P NATL ACAD SCI USA, V100, P9302, DOI 10.1073/pnas.1133280100; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Bren KL, 2004, INORG CHEM, V43, P7894, DOI 10.1021/ic040121q; Brown AK, 2003, BIOCHEMISTRY-US, V42, P7152, DOI 10.1021/bi027332w; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Cruz RPG, 2004, CHEM BIOL, V11, P57, DOI 10.1016/j.chembiol.2003.12.012; Fang XW, 1999, NAT STRUCT BIOL, V6, P1091; Faulhammer D, 1996, ANGEW CHEM INT EDIT, V35, P2837, DOI 10.1002/anie.199628371; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hampel KJ, 2006, BIOCHEMISTRY-US, V45, P7861, DOI 10.1021/bi060337z; Hohng S, 2004, J MOL BIOL, V336, P69, DOI 10.1016/j.jmb.2003.12.014; Kim HK, 2007, J AM CHEM SOC, V129, P6896, DOI 10.1021/ja0712625; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Li J, 2000, J AM CHEM SOC, V122, P10466, DOI 10.1021/ja0021316; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li YF, 1999, CURR OPIN STRUC BIOL, V9, P315, DOI 10.1016/S0959-440X(99)80042-6; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Liu JW, 2003, J AM CHEM SOC, V125, P6642, DOI 10.1021/ja034775u; Liu JW, 2003, ANAL CHEM, V75, P6666, DOI 10.1021/AC034924r; Lu Y, 2002, CHEM-EUR J, V8, P4589; Lu Y, 2006, CURR OPIN BIOTECH, V17, P580, DOI 10.1016/j.copbio.2006.10.004; Lu Y, 2007, ACCOUNTS CHEM RES, V40, P315, DOI 10.1021/ar600053g; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Nahas MK, 2004, NAT STRUCT MOL BIOL, V11, P1107, DOI 10.1038/nsmb842; Peracchi A, 2000, J BIOL CHEM, V275, P11693, DOI 10.1074/jbc.275.16.11693; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Roychowdhury-Saha M, 2007, RNA, V13, P841, DOI 10.1261/rna.339207; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2004, BIOCHEMISTRY-US, V43, P9695, DOI 10.1021/bi049757j; Sen D, 1998, CURR OPIN CHEM BIOL, V2, P680, DOI 10.1016/S1367-5931(98)80103-8; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Wilson TJ, 2002, RNA, V8, P587, DOI 10.1017/S1355838202020514; Xiao Y, 2007, J AM CHEM SOC, V129, P262, DOI 10.1021/ja067278x; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	39	115	119	6	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					763	768		10.1038/nchembio.2007.45	http://dx.doi.org/10.1038/nchembio.2007.45			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17965708	Green Accepted			2022-12-25	WOS:000251028600009
J	Wang, CS; St Leger, RJ				Wang, Chengshu; St Leger, Raymond J.			A scorpion neurotoxin increases the potency of a fungal insecticide	NATURE BIOTECHNOLOGY			English	Article							IMPROVED BACULOVIRUS INSECTICIDE; METARHIZIUM-ANISOPLIAE; CONSTRUCTION; RESPONSES; FIELD	The low virulence of the insecticidal fungus Metarhizium anisopliae has stymied its widespread use in controlling insect pests. We show that high-level expression of an insect-specific neurotoxin from the scorpion Androctonus australis in hemolymph by M. anisopliae increases fungal toxicity 22-fold against tobacco hornworm ( Manduca sexta) caterpillars and ninefold against adult yellow fever mosquitoes ( Aedes aegypti) without compromising host specificity. Prelethal effects include reduced mobility and feeding of the insects targeted.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cswang@sibs.ac.cn; stleger@umd.edu	Wang, Chengshu/A-1656-2011; St. Leger, Raymond/N-3219-2013	Wang, Chengshu/0000-0003-1477-1466; 				Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; CORY JS, 1994, NATURE, V370, P138, DOI 10.1038/370138a0; Freimoser FM, 2003, MICROBIOL-SGM, V149, P239, DOI 10.1099/mic.0.25761-0; Hajek AE, 1997, ADV MICROB ECOL, V15, P193; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; LAWRENCE L, 2005, PEST MANAG, V16, P253; Ritter SK, 2006, CHEM ENG NEWS, V84, P82, DOI 10.1021/cen-v084n049.p082; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; SAMUELS RI, 1988, MYCOPATHOLOGIA, V104, P51, DOI 10.1007/BF00437924; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Zlotkin E, 2000, BIOCHIMIE, V82, P869, DOI 10.1016/S0300-9084(00)01177-9	15	155	179	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2007	25	12					1455	1456		10.1038/nbt1357	http://dx.doi.org/10.1038/nbt1357			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	238OT	17994009				2022-12-25	WOS:000251457800035
J	Weiss, WA; Taylor, SS; Shokat, KM				Weiss, William A.; Taylor, Stephen S.; Shokat, Kevan M.			Recognizing and exploiting differences between RNAi and small-molecule inhibitors	NATURE CHEMICAL BIOLOGY			English	Editorial Material							AURORA-A; PHOSPHOINOSITIDE 3-KINASE; REVEALS; APOPTOSIS; SUBUNITS; KINASES; GROWTH	The biology of RNA interference has greatly facilitated analysis of loss-of-function phenotypes, but correlating these phenotypes with small-molecule inhibition profiles is not always straightforward. We examine the rationale of comparing RNA interference to pharmacological intervention in chemical biology.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Manchester, Manchester M13 9PT, Lancs, England	University of California System; University of California San Francisco; University of Manchester	Weiss, WA (corresponding author), Univ Calif San Francisco, 533 Parnassus Ave, San Francisco, CA 94143 USA.	weiss@cgl.ucsf.edu	Taylor, Stephen/GZL-6499-2022	Weiss, William/0000-0003-2230-9132; Taylor, Stephen/0000-0003-4621-9326	NATIONAL CANCER INSTITUTE [R01CA102321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055750] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102321, R01 CA102321-05, R01 CA102321-04A1, R01 CA102321-03, R01 CA102321-06, R01 CA102321-08, R01 CA102321-01, R01 CA102321-02, R01 CA102321-07] Funding Source: Medline; NINDS NIH HHS [R01 NS055750-01A2S1, R01 NS055750, R01 NS055750-01A2, R01 NS055750-04, R01 NS055750-02, R01 NS055750-02S1, R01 NS055750-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		An HJ, 2007, J PATHOL, V212, P161, DOI 10.1002/path.2158; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matthews N, 2006, EXPERT REV ANTICANC, V6, P109, DOI 10.1586/14737140.6.1.109; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Pu PY, 2006, TECHNOL CANCER RES T, V5, P271, DOI 10.1177/153303460600500308; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191	25	197	202	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					739	744		10.1038/nchembio1207-739	http://dx.doi.org/10.1038/nchembio1207-739			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	18007642	Green Accepted			2022-12-25	WOS:000251028600002
J	Yang, T; Suhail, Y; Dalton, S; Kernan, T; Colecraft, HM				Yang, Tingting; Suhail, Yasir; Dalton, Stanislava; Kernan, Timothy; Colecraft, Henry M.			Genetically encoded molecules for inducibly inactivating Ca-V channels	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-C; N-TYPE; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; NEURONAL-ACTIVITY; CALCIUM-CHANNELS; SMALL GTPASE; RAS FAMILY; CELLS; GEM	Voltage-gated Ca2+ (Ca-V) channels are central to the biology of excitable cells, and therefore regulating their activity has widespread applications. We describe genetically encoded molecules for inducibly inhibiting CaV channels GEMIICCs). GEMIICCs are derivatives of Rem, a Ras-like GTPase that constitutively inhibits Ca2+ currents (I-Ca). C terminus - truncated Rem(1-265) lost the ability to inhibit I-Ca owing to loss of membrane targeting. Fusing the C1 domain of protein kinase C gamma to yellow fluorescent protein (YFP)-Rem(1-265) generated a molecule that rapidly translocated from cytosol to plasma membrane with phorbol-12,13-dibutyrate in human embryonic kidney cells. Recombinant Ca(V)2.2 and Ca(V)1.2 channels were inhibited concomitantly with C1(PKC gamma)-YFP-Rem(1-265) membrane translocation. The generality of the approach was confirmed by creating a GEMIICC using rapamycin-dependent heterodimerization of YFP-FKBP-Rem(1-265) and a constitutively membrane-targeted rapamycin-binding domain. GEMIICCs reduced ICa without diminishing gating charge, thereby ruling out decreased number of surface channels and voltage-sensor immobilization as mechanisms for inhibition. We introduce small-molecule-regulated GEMIICCs as potent tools for rapidly manipulating Ca2+ signals in excitable cells.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University	Colecraft, HM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th,P&S 7-422, New York, NY 10032 USA.	hcolecr1@jhmi.edu	Suhail, Yasir/M-7280-2018	Suhail, Yasir/0000-0002-1296-9738	NHLBI NIH HHS [R01 HL069911] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069911] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; COLLICELLI J, 2004, SCI STKE; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; George MS, 2006, P NATL ACAD SCI USA, V103, P7535, DOI 10.1073/pnas.0602389103; Hawke TJ, 2006, AM J PHYSIOL-CELL PH, V290, pC379, DOI 10.1152/ajpcell.00270.2005; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Johns DC, 1999, J NEUROSCI, V19, P1691; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; Leone M, 2000, NEUROLOGY, V54, P1382, DOI 10.1212/WNL.54.6.1382; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Marek KW, 2003, CURR OPIN NEUROBIOL, V13, P607, DOI 10.1016/j.conb.2003.09.001; Muller A, 2007, J NEUROSCI, V27, P483, DOI 10.1523/JNEUROSCI.3816-06.2007; Murata M, 2004, CIRC RES, V95, P398, DOI 10.1161/01.RES.0000138449.85324.c5; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Slimko EM, 2002, J NEUROSCI, V22, P7373; Triggle DJ, 2003, ASSAY DRUG DEV TECHN, V1, P719, DOI 10.1089/154065803770381075; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; WU LG, 1994, J NEUROSCI, V14, P645; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	50	45	45	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					795	804		10.1038/nchembio.2007.42	http://dx.doi.org/10.1038/nchembio.2007.42			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17952065				2022-12-25	WOS:000251028600014
J	Rybak, A; Fuchs, H; Smirnova, L; Brandt, C; Pohl, EE; Nitsch, R; Wulczyn, FG				Rybak, Agnieszka; Fuchs, Heiko; Smirnova, Lena; Brandt, Christine; Pohl, Elena E.; Nitsch, Robert; Wulczyn, F. Gregory			A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment	NATURE CELL BIOLOGY			English	Article							POSTTRANSCRIPTIONAL REGULATION; HETEROCHRONIC GENE; NEURONAL DIFFERENTIATION; SMALL RNAS; MICRORNA; PROLIFERATION; EXPRESSION; REVEALS; NICHE	miRNA populations, including mammalian homologues of lin-4 (mir-125) and let-7, undergo a marked transition during stem-cell differentiation(1). Originally identified on the basis of their mutational phenotypes in stem-cell maturation, mir-125 and let-7 are strongly induced during neural differentiation of embryonic stem (ES) cells and embryocarcinoma (EC) cells. We report that embryonic neural stem (NS) cells express let-7 and mir-125, and investigate post-transcriptional mechanisms contributing to the induction of let-7. We demonstrate that the pluripotency factor Lin-28 binds the pre-let-7 RNA and inhibits processing by the Dicer ribonuclease in ES and EC cells. In NS cells, Lin-28 is downregulated by mir-125 and let-7, allowing processing of pre-let-7 to proceed. Suppression of let-7 or mir-125 activity in NS cells led to upregulation of Lin-28 and loss of pre-let-7 processing activity, suggesting that let-7, mir-125 and lin-28 participate in an autoregulatory circuit that controls miRNA processing during NS-cell commitment.	[Rybak, Agnieszka; Fuchs, Heiko; Smirnova, Lena; Brandt, Christine; Pohl, Elena E.; Nitsch, Robert; Wulczyn, F. Gregory] Charite, Ctr Anat, Inst Cell & Neurobiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wulczyn, FG (corresponding author), Charite, Ctr Anat, Inst Cell & Neurobiol, D-13353 Berlin, Germany.	gregory.wulczyn@charite.de	Pohl, Elena E./A-4025-2009; Nitsch, Robert/AAI-9129-2021	Pohl, Elena E./0000-0002-0604-5950; Fuchs, Heiko/0000-0001-9142-4084; Rybak-Wolf, Agnieszka/0000-0002-1192-5290				Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; CHENDRIMADA TP, 2005, NATURE; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanamoto T, 2006, DEV DYNAM, V235, P1142, DOI 10.1002/dvdy.20712; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	33	630	667	3	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					987	993		10.1038/ncb1759	http://dx.doi.org/10.1038/ncb1759			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604195				2022-12-25	WOS:000258147100017
J	Kondo, Y; Shen, L; Cheng, AS; Ahmed, S; Boumber, Y; Charo, C; Yamochi, T; Urano, T; Furukawa, K; Kwabi-Addo, B; Gold, DL; Sekido, Y; Huang, THM; Issa, JPJ				Kondo, Yutaka; Shen, Lanlan; Cheng, Alfred S.; Ahmed, Saira; Boumber, Yanis; Charo, Chantale; Yamochi, Tadanori; Urano, Takeshi; Furukawa, Koichi; Kwabi-Addo, Bernard; Gold, David L.; Sekido, Yoshitaka; Huang, Tim Hui-Ming; Issa, Jean-Pierre J.			Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation	NATURE GENETICS			English	Article							HISTONE LYSINE METHYLATION; CPG ISLAND MICROARRAY; EMBRYONIC STEM-CELLS; GROUP PROTEIN EZH2; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL-CANCER; PROSTATE-CANCER; SUPPRESSOR GENE; H3; HYPERMETHYLATION	Epigenetic silencing in cancer cells is mediated by at least two distinct histone modifications, polycomb-based histone H3 lysine 27 trimethylation (H3K27triM) and H3K9 dimethylation. The relationship between DNA hypermethylation and these histone modifications is not completely understood. Using chromatin immunoprecipitation microarrays (ChIP-chip) in prostate cancer cells compared to normal prostate, we found that up to 5% of promoters (16% CpG islands and 84% non-CpG islands) were enriched with H3K27triM. These genes were silenced specifically in prostate cancer, and those CpG islands affected showed low levels of DNA methylation. Downregulation of the EZH2 histone methyltransferase restored expression of the H3K27triM target genes alone or in synergy with histone deacetylase inhibition, without affecting promoter DNA methylation, and with no effect on the expression of genes silenced by DNA hypermethylation. These data establish EZH2-mediated H3K27triM as a mechanism of tumor-suppressor gene silencing in cancer that is potentially independent of promoter DNA methylation.	[Kondo, Yutaka; Shen, Lanlan; Ahmed, Saira; Boumber, Yanis; Charo, Chantale; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Kondo, Yutaka; Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Cheng, Alfred S.; Huang, Tim Hui-Ming] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yamochi, Tadanori] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Urano, Takeshi; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kwabi-Addo, Bernard] Baylor Coll Med & Michael E DeBakey, Dept Pathol, Dept Vet Affairs Med Ctr, Houston, TX 77030 USA; [Gold, David L.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Aichi Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; Nagoya University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; University of Texas System; UTMD Anderson Cancer Center	Issa, JPJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jpissa@mdanderson.org	Sekido, Yoshitaka/P-9756-2015; Cheng, Alfred SL/C-3327-2014; Boumber, Yanis/AAP-8901-2021; Kwabi-Addo, Bernard/A-6993-2016	Cheng, Alfred SL/0000-0003-2345-6951; Urano, Takeshi/0000-0003-3383-3554; Boumber, Yanis/0000-0001-5003-248X; Issa, Jean-Pierre/0000-0003-2258-5030; Sekido, Yoshitaka/0000-0002-2428-3848; Kwabi-Addo, Bernard/0000-0003-3692-6350	NCI NIH HHS [R33CA89837, R01CA098006, P50CA100632, P50CA058204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098006, P50CA100632, P50CA058204, R33CA089837] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Campisi Judith, 2003, Methods Mol Biol, V223, P155; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DEY A, 1994, MOL CELL BIOL, V14, P8191, DOI 10.1128/MCB.14.12.8191; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941	37	483	506	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					741	750		10.1038/ng.159	http://dx.doi.org/10.1038/ng.159			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18488029				2022-12-25	WOS:000256212000016
J	Meng, XD; Noyes, MB; Zhu, LHJ; Lawson, ND; Wolfe, SA				Meng, Xiangdong; Noyes, Marcus B.; Zhu, Lihua J.; Lawson, Nathan D.; Wolfe, Scot A.			Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; CHIMERIC NUCLEASES; CLEAVAGE; MUTAGENESIS; DROSOPHILA; SEQUENCES; TOXICITY; DOMAIN	Direct genomic manipulation at a specific locus is still not feasible in most vertebrate model organisms. In vertebrate cell lines, genomic lesions at a specific site have been introduced using zinc-finger nucleases (ZFNs)(1-3). Here we adapt this technology to create targeted mutations in the zebrafish germ line. ZFNs were engineered that recognize sequences in the zebrafish ortholog of the vascular endothelial growth factor-2 receptor, kdr (also known as kdra). Co-injection of mRNAs encoding these ZFNs into one-cell-stage zebrafish embryos led to mutagenic lesions at the target site that were transmitted through the germ line with high frequency. The use of engineered ZFNs to introduce heritable mutations into a genome obviates the need for embryonic stem cell lines and should be applicable to most animal species for which early-stage embryos are easily accessible.	[Meng, Xiangdong; Noyes, Marcus B.; Zhu, Lihua J.; Lawson, Nathan D.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Lazare Res Bldg,6th Floor,364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu; scot.wolfe@umassmed.edu	Ha, Dat Thinh/D-4995-2015	Ha, Dat Thinh/0000-0003-4260-4876; Lawson, Nathan/0000-0001-7788-9619; Zhu, Lihua/0000-0001-7416-0590	NHLBI NIH HHS [R01 HL079266-05, R01 HL079266, R01HL079266] Funding Source: Medline; NIGMS NIH HHS [R01 GM068110, 1R01GM068110, R01 GM068110-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068110] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; NOYES MB, 2008, NUCL ACIDS RES  0310; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Westerfield M, 1993, ZEBRAFISH BOOK; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xu QL, 1999, METH MOL B, V127, P125, DOI 10.1385/1-59259-678-9:125; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	32	564	653	5	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2008	26	6					695	701		10.1038/nbt1398	http://dx.doi.org/10.1038/nbt1398			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	311PK	18500337	Green Accepted			2022-12-25	WOS:000256611900029
J	Kordower, JH; Chu, YP; Hauser, RA; Freeman, TB; Olanow, CW				Kordower, Jeffrey H.; Chu, Yaping; Hauser, Robert A.; Freeman, Thomas B.; Olanow, C. Warren			Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease	NATURE MEDICINE			English	Article							DOPAMINE NEURONS; PATIENT; IMPLANTS	Fourteen years after transplantation into the striatum of an individual with Parkinson's disease, grafted nigral neurons were found to have Lewy body-like inclusions that stained positively for alpha-synuclein and ubiquitin and to have reduced immunostaining for dopamine transporter. These pathological changes suggest that Parkinson's disease is an ongoing process that can affect grafted cells in the striatum in a manner similar to host dopamine neurons in the substantia nigra. These findings have implications for cell-based therapies and for understanding the cause of Parkinson's disease.	[Kordower, Jeffrey H.; Chu, Yaping] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Kordower, Jeffrey H.; Chu, Yaping] Rush Univ, Med Ctr, Ctr Brain Repair, Chicago, IL 60612 USA; [Hauser, Robert A.] Univ S Florida, Dept Neurol, Tampa, FL 33606 USA; [Freeman, Thomas B.] Univ S Florida, Dept Neurosurg, Tampa, FL 33606 USA; [Olanow, C. Warren] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Rush University; Rush University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Icahn School of Medicine at Mount Sinai	Kordower, JH (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St, Chicago, IL 60612 USA.	jkordowe@rush.edu	Shahmoradian, Sarah H/C-7465-2015; Hauser, Robert/I-5372-2012	Shahmoradian, Sarah H/0000-0001-9752-7287; 				Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Kordower JH, 1997, CELL TRANSPLANT, V6, P213, DOI 10.1016/S0963-6897(97)00019-5; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kordower JH, 1996, J COMP NEUROL, V370, P203; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207	11	1148	1172	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2008	14	5					504	506		10.1038/nm1747	http://dx.doi.org/10.1038/nm1747			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	298IQ	18391962				2022-12-25	WOS:000255681800029
J	Saharinen, P; Eklund, L; Miettinen, J; Wirkkala, R; Anisimov, A; Winderlich, M; Nottebaum, A; Vestweber, D; Deutsch, U; Koh, GY; Olsen, BR; Alitalo, K				Saharinen, Pipsa; Eklund, Lauri; Miettinen, Juho; Wirkkala, Riikka; Anisimov, Andrey; Winderlich, Mark; Nottebaum, Astrid; Vestweber, Dietmar; Deutsch, Urban; Koh, Gou Young; Olsen, Bjorn R.; Alitalo, Kari			Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; GROWTH-FACTORS; VE-CADHERIN; IN-VITRO; ANGIOGENESIS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; MIGRATION	The receptor tyrosine kinase Tie2, and its activating ligand Angiopoietin-1 (Ang1), are required for vascular remodelling and vessel integrity, whereas Ang2 may counteract these functions. However, it is not known how Tie2 transduces these different signals. Here, we show that Ang1 induces unique Tie2 complexes in mobile and confluent endothelial cells. Matrix-bound Ang1 induced cell adhesion, motility and Tie2 activation in cell-matrix contacts that became translocated to the trailing edge in migrating endothelial cells. In contrast, in contacting cells Ang1 induced Tie2 translocation to cell-cell contacts and the formation of homotypic Tie2-Tie2 trans-associated complexes that included the vascular endothelial phosphotyrosine phosphatase, leading to inhibition of paracellular permeability. Distinct signalling proteins were preferentially activated by Tie2 in the cell-matrix and cell -cell contacts, where Ang2 inhibited Ang1-induced Tie2 activation. This novel type of cellular microenvironment-dependent receptor tyrosine kinase activation may explain some of the effects of angiopoietins in angiogenesis and vessel stabilization.	[Saharinen, Pipsa; Miettinen, Juho; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FIN-00014 Helsinki, Finland; [Saharinen, Pipsa; Miettinen, Juho; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; [Eklund, Lauri; Wirkkala, Riikka] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu 90014, Finland; [Eklund, Lauri; Wirkkala, Riikka] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu 90014, Finland; [Winderlich, Mark; Nottebaum, Astrid; Vestweber, Dietmar] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Deutsch, Urban] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Eklund, Lauri; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Oulu; University of Oulu; Max Planck Society; University of Bern; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard School of Dental Medicine	Alitalo, K (corresponding author), Univ Helsinki, Lab Mol Canc Biol, Haartmaninkatu 8,POB 63, FIN-00014 Helsinki, Finland.	Kari.Alitalo@Helsinki.fi	Alitalo, Kari K/J-5013-2014; Miettinen, Juho/J-7356-2016; Koh, Gou Young/C-1615-2011; Saharinen, Pipsa I/C-9601-2016	Alitalo, Kari K/0000-0002-7331-0902; Miettinen, Juho/0000-0002-3987-1693; Saharinen, Pipsa I/0000-0003-2652-0584; Nottebaum, Astrid Fee/0000-0003-2246-7851; Vestweber, Dietmar/0000-0002-3517-732X; Deutsch, Urban/0000-0003-4265-6262	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036820, R01AR036820] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL075183-02] Funding Source: Medline; NIAMS NIH HHS [P01 AR048564, R01 AR036820, AR36820, AR48564] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jones N, 2003, MOL CELL BIOL, V23, P2658, DOI 10.1128/MCB.23.8.2658-2668.2003; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Pfaff D, 2006, J LEUKOCYTE BIOL, V80, P719, DOI 10.1189/jlb.1105652; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Salven P, 1996, BRIT J CANCER, V74, P69, DOI 10.1038/bjc.1996.317; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	42	323	336	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					527	537		10.1038/ncb1715	http://dx.doi.org/10.1038/ncb1715			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425119				2022-12-25	WOS:000255502400009
J	Piliponsky, AM; Chen, CC; Nishimura, T; Metz, M; Rios, EJ; Dobner, PR; Wada, E; Wada, K; Zacharias, S; Mohanasundaram, UM; Faix, JD; Abrink, M; Pejler, G; Pearl, RG; Tsai, M; Galli, SJ				Piliponsky, Adrian M.; Chen, Ching-Cheng; Nishimura, Toshihiko; Metz, Martin; Rios, Eon J.; Dobner, Paul R.; Wada, Etsuko; Wada, Keiji; Zacharias, Sherma; Mohanasundaram, Uma M.; Faix, James D.; Abrink, Magnus; Pejler, Gunnar; Pearl, Ronald G.; Tsai, Mindy; Galli, Stephen J.			Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis	NATURE MEDICINE			English	Article							ENDOTHELIAL-CELLS; RECEPTOR ANTAGONIST; CARBOXYPEPTIDASE-A; INNATE IMMUNITY; HIGH-AFFINITY; PEPTIDE; RAT; INHIBITION; MICE; ENDOPEPTIDASE	Sepsis is a complex, incompletely understood and often fatal disorder, typically accompanied by hypotension, that is considered to represent a dysregulated host response to infection. Neurotensin (NT) is a 13-amino-acid peptide that, among its multiple effects, induces hypotension. We find that intraperitoneal and plasma concentrations of NT are increased in mice after severe cecal ligation and puncture (CLP), a model of sepsis, and that mice treated with a pharmacological antagonist of NT, or NT-deficient mice, show reduced mortality during severe CLP. In mice, mast cells can degrade NT and reduce NT-induced hypotension and CLP-associated mortality, and optimal expression of these effects requires mast cell expression of neurotensin receptor 1 and neurolysin. These findings show that NT contributes to sepsis-related mortality in mice during severe CLP and that mast cells can lower NT concentrations, and suggest that mast cell-dependent reduction in NT levels contributes to the ability of mast cells to enhance survival after CLP.	[Piliponsky, Adrian M.; Chen, Ching-Cheng; Rios, Eon J.; Faix, James D.; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Chen, Ching-Cheng; Nishimura, Toshihiko] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Metz, Martin] Charite Univ Med Berlin, Allergie Ctr Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Metz, Martin] Univ Hosp, Dept Dermatol, D-55131 Mainz, Germany; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Wada, Etsuko; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan; [Wada, Keiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3220012, Japan; [Zacharias, Sherma; Mohanasundaram, Uma M.; Pearl, Ronald G.] Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA; [Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75105 Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University Hospital Mainz; University of Massachusetts System; University of Massachusetts Worcester; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Stanford University; Uppsala University; Swedish University of Agricultural Sciences; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	sgalli@stanford.edu	Chen, Ching-Cheng/C-1259-2009; Maurer, Marcus/ABG-2174-2020; Metz, Martin/B-8799-2009; Åbrink, Magnus/AAK-8346-2020; Metz, Martin/M-5237-2013; Wada, Keiji/AAV-1500-2021	Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Abrink, Magnus/0000-0002-1335-3927; Chen, Ching-Cheng/0000-0003-4499-0889; Tsai, Mindy/0000-0002-8421-4721	NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL087936, R00HL087936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R01AI070813] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA072074, R01 CA072074-15] Funding Source: Medline; NHLBI NIH HHS [K99 HL087936, R00 HL087936-03, R00 HL087936-05, K99 HL087936-02, R00 HL087936, R00 HL087936-04, K99 HL087936-01] Funding Source: Medline; NIAID NIH HHS [R01 AI070813-01, R01 AI070813, R01 AI023990-20, R01 AI023990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; BAKER CC, 1983, SURGERY, V94, P331; BARELLI H, 1992, BIOCHEM J, V287, P621, DOI 10.1042/bj2870621; BIENENSTOCK J, 1984, ANN ALLERGY, V53, P535; COCHRANE DE, 1991, PEPTIDES, V12, P1187, DOI 10.1016/0196-9781(91)90193-S; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Feldberg RS, 1998, INFLAMM RES, V47, P245, DOI 10.1007/s000110050325; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; FOX CC, 1984, J IMMUNOL, V132, P2177; GOLDSTEIN SM, 1991, PEPTIDES, V12, P995, DOI 10.1016/0196-9781(91)90049-U; Grocott-Mason RM, 1998, INTENS CARE MED, V24, P286, DOI 10.1007/s001340050570; Gully D, 1997, J PHARMACOL EXP THER, V280, P802; KUROSE M, 1981, EUR J PHARMACOL, V76, P129, DOI 10.1016/0014-2999(81)90494-5; Maeno H, 2004, BRAIN RES, V998, P122, DOI 10.1016/j.brainres.2003.11.039; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; METCALFE DD, 1984, ANN ALLERGY, V53, P563; Miller LA, 1998, INT ARCH ALLERGY IMM, V116, P147, DOI 10.1159/000023938; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1978, DOI 10.1152/ajpheart.01116.2002; Patel Gourang P, 2003, Curr Opin Crit Care, V9, P390, DOI 10.1097/00075198-200310000-00009; POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; QUIRION R, 1980, LIFE SCI, V27, P1889, DOI 10.1016/0024-3205(80)90435-X; Reinhart K, 2006, CRIT CARE CLIN, V22, P503, DOI 10.1016/j.ccc.2006.03.003; Remaury A, 2002, BRAIN RES, V953, P63, DOI 10.1016/S0006-8993(02)03271-7; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; RIOUX F, 1982, ANN NY ACAD SCI, V400, P56, DOI 10.1111/j.1749-6632.1982.tb31560.x; Schaeffer P, 1997, EUR J PHARMACOL, V323, P215, DOI 10.1016/S0014-2999(97)00041-1; SCHAEFFER P, 1995, J BIOL CHEM, V270, P3409, DOI 10.1074/jbc.270.7.3409; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tyler-McMahon BM, 2000, REGUL PEPTIDES, V93, P125, DOI 10.1016/S0167-0115(00)00183-X; Vincent JL, 2002, ANN MED, V34, P606, DOI 10.1080/078538902321117832; WILK S, 1983, J NEUROCHEM, V41, P69, DOI 10.1111/j.1471-4159.1983.tb11815.x; WOODBURY RG, 1981, METHOD ENZYMOL, V80, P588	47	95	97	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2008	14	4					392	398		10.1038/nm1738	http://dx.doi.org/10.1038/nm1738			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	283ZD	18376408	Green Accepted			2022-12-25	WOS:000254674100025
J	Geiss, GK; Bumgarner, RE; Birditt, B; Dahl, T; Dowidar, N; Dunaway, DL; Fell, HP; Ferree, S; George, RD; Grogan, T; James, JJ; Maysuria, M; Mitton, JD; Oliveri, P; Osborn, JL; Peng, T; Ratcliffe, AL; Webster, PJ; Davidson, EH; Hood, L				Geiss, Gary K.; Bumgarner, Roger E.; Birditt, Brian; Dahl, Timothy; Dowidar, Naeem; Dunaway, Dwayne L.; Fell, H. Perry; Ferree, Sean; George, Renee D.; Grogan, Tammy; James, Jeffrey J.; Maysuria, Malini; Mitton, Jeffrey D.; Oliveri, Paola; Osborn, Jennifer L.; Peng, Tao; Ratcliffe, Amber L.; Webster, Philippa J.; Davidson, Eric H.; Hood, Leroy			Direct multiplexed measurement of gene expression with color-coded probe pairs	NATURE BIOTECHNOLOGY			English	Article							CONTROL MAQC PROJECT; BREAST-CANCER; MICROARRAYS; PLATFORMS; ALIGNMENT	We describe a technology, the NanoString nCounter gene expression system, which captures and counts individual mRNA transcripts. Advantages over existing platforms include direct measurement of mRNA expression levels without enzymatic reactions or bias, sensitivity coupled with high multiplex capability, and digital readout. Experiments performed on 509 human genes yielded a replicate correlation coefficient of 0.999, a detection limit between 0.1 fM and 0.5 fM, and a linear dynamic range of over 500-fold. Comparison of the NanoString nCounter gene expression system with microarrays and TaqMan PCR demonstrated that the nCounter system is more sensitive than microarrays and similar in sensitivity to real-time PCR. Finally, a comparison of transcript levels for 21 genes across seven samples measured by the nCounter system and SYBR Green real-time PCR demonstrated similar patterns of gene expression at all transcript levels.	[Geiss, Gary K.; Birditt, Brian; Dahl, Timothy; Dowidar, Naeem; Dunaway, Dwayne L.; Fell, H. Perry; Ferree, Sean; George, Renee D.; Grogan, Tammy; James, Jeffrey J.; Maysuria, Malini; Mitton, Jeffrey D.; Osborn, Jennifer L.; Ratcliffe, Amber L.; Webster, Philippa J.] NanoString Technol Inc, Seattle, WA 98119 USA; [Bumgarner, Roger E.; Peng, Tao] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Oliveri, Paola; Davidson, Eric H.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Hood, Leroy] Inst Syst Biol, Seattle, WA 98103 USA	University of Washington; University of Washington Seattle; California Institute of Technology; Institute for Systems Biology (ISB)	Geiss, GK (corresponding author), NanoString Technol Inc, 201 Elliott Ave W,Suite 300, Seattle, WA 98119 USA.	ggeiss@nanostring.com	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015	Bumgarner, Roger E/0000-0002-8168-6985; Oliveri, Paola/0000-0002-3477-8529				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rast JP, 2000, DEV BIOL, V228, P270, DOI 10.1006/dbio.2000.9941; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487	18	1477	1666	7	253	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2008	26	3					317	325		10.1038/nbt1385	http://dx.doi.org/10.1038/nbt1385			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	276EF	18278033				2022-12-25	WOS:000254123400025
J	Hilton, MJ; Tu, XL; Wu, XM; Bai, ST; Zhao, HB; Kobayashi, T; Kronenberg, HM; Teitelbaum, SL; Ross, FP; Kopan, R; Long, FX				Hilton, Matthew J.; Tu, Xiaolin; Wu, Ximei; Bai, Shuting; Zhao, Haibo; Kobayashi, Tatsuya; Kronenberg, Henry M.; Teitelbaum, Steven L.; Ross, F. Patrick; Kopan, Raphael; Long, Fanxin			Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation	NATURE MEDICINE			English	Article							EMBRYONIC LETHALITY; MICE LACKING; DEFECTS; EXPRESSION; SKELETAL; PRESENILIN-1; ACTIVATION; REQUIRES; LIMB; WNT	Postnatal bone marrow houses mesenchymal progenitor cells that are osteoblast precursors. These cells have established therapeutic potential, but they are difficult to maintain and expand in vitro, presumably because little is known about the mechanisms controlling their fate decisions. To investigate the potential role of Notch signaling in osteoblastogenesis, we used conditional alleles to genetically remove components of the Notch signaling system during skeletal development. We found that disruption of Notch signaling in the limb skeletogenic mesenchyme markedly increased trabecular bone mass in adolescent mice. Notably, mesenchymal progenitors were undetectable in the bone marrow of mice with high bone mass. As a result, these mice developed severe osteopenia as they aged. Moreover, Notch signaling seemed to inhibit osteoblast differentiation through Hes or Hey proteins, which diminished Runx2 transcriptional activity via physical interaction. These results support a model wherein Notch signaling in bone marrow normally acts to maintain a pool of mesenchymal progenitors by suppressing osteoblast differentiation. Thus, mesenchymal progenitors may be expanded in vitro by activating the Notch pathway, whereas bone formation in vivo may be enhanced by transiently suppressing this pathway.	[Hilton, Matthew J.; Tu, Xiaolin; Wu, Ximei; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bai, Shuting; Zhao, Haibo; Teitelbaum, Steven L.; Ross, F. Patrick] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kobayashi, Tatsuya; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Kopan, Raphael; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	flong@wustl.edu	Kopan, Raphael/AAF-1357-2022; Zhao, Haibo/ABG-9729-2021; Kopan, Raphael/AFG-3275-2022	Teitelbaum, Steven/0000-0002-4054-6679; Kobayashi, Tatsuya/0000-0003-4264-5117; Kopan, Raphael/0000-0002-0350-2730; ZHAO, HAIBO/0000-0003-0836-7555; Hilton, Matthew/0000-0003-3165-267X; Wu, Ximei/0000-0002-3316-893X	NIAMS NIH HHS [R37 AR046523, AR046523, 5T32AR07033, T32 AR007033, R01 AR046523, R01 AR046852, AR046852] Funding Source: Medline; NICHD NIH HHS [R01 HD044056, HD044056, R01 HD044056-05] Funding Source: Medline; NIDDK NIH HHS [DK065789, DK11794, R01 DK065789-05, R01 DK065789] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046852, R37AR046523, T32AR007033, R01AR046523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, R01DK065789] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Krebs LT, 2000, GENE DEV, V14, P1343; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; OWEN M, 1988, CIBA F SYMP, V136, P42; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shindo K, 2003, EXP CELL RES, V290, P370, DOI 10.1016/S0014-4827(03)00349-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200	46	434	478	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2008	14	3					306	314		10.1038/nm1716	http://dx.doi.org/10.1038/nm1716			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	271VB	18297083	Green Accepted			2022-12-25	WOS:000253815700037
J	Jiang, JM; Chan, YS; Loh, YH; Cai, J; Tong, GQ; Lim, CA; Robson, P; Zhong, S; Ng, HH				Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Cai, Jun; Tong, Guo-Qing; Lim, Ching-Aeng; Robson, Paul; Zhong, Sheng; Ng, Huck-Hui			A core Klf circuitry regulates self-renewal of embryonic stem cells	NATURE CELL BIOLOGY			English	Article							FINGER TRANSCRIPTION FACTOR; KRUPPEL-LIKE FACTOR; MOUSE EPIBLAST; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; EXPRESSION; NANOG; SOX2; FIBROBLASTS	Embryonic stem (ES) cells are unique in their ability to self-renew indefinitely and maintain pluripotency. These properties require transcription factors that specify the gene expression programme of ES cells. It has been possible to reverse the highly differentiated state of somatic cells back to a pluripotent state with a combination of four transcription factors: Klf4 is one of the reprogramming factors required, in conjunction with Oct4, Sox2 and c-Myc. Maintenance of self-renewal and pluripotency of ES cells requires Oct4, Sox2 and c-Myc, but Klf4 is dispensable. Here, we show that Kruppel- like factors are required for the self-renewal of ES cells. Simultaneous depletion of Klf2, Klf4 and Klf5 lead to ES cell differentiation. Chromatin immunoprecipitation coupled to microarray assay reveals that these Klf proteins share many common targets of Nanog, suggesting a close functional relationship between these factors. Expression analysis after triple RNA interference (RNAi) of the Klfs shows that they regulate key pluripotency genes, such as Nanog. Taken together, our study provides new insight into how the core Klf circuitry integrates into the Nanog transcriptional network to specify gene expression that is unique to ES cells.	[Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Lim, Ching-Aeng; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Lim, Ching-Aeng; Robson, Paul; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Cai, Jun; Zhong, Sheng] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Tong, Guo-Qing] Nanjing Med Univ, Dept Obstet & Gynecol, Nanjing Maternal & Child Hlth Care Hosp, Nanjing 210004, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing Medical University	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Loh, Yuin-Han/E-1096-2014; Chan, Yun-Shen/GWC-4616-2022; Ng, Huck Hui/A-1135-2009; Robson, Paul/A-3464-2009; jiang, jianming/B-3421-2012	Loh, Yuin-Han/0000-0002-4715-6454; Robson, Paul/0000-0002-0191-3958; jiang, jianming/0000-0003-3251-2716				Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2007, NAT CELL BIOL, V9, P871, DOI 10.1038/ncb0807-871; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	31	572	597	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					353	U103		10.1038/ncb1698	http://dx.doi.org/10.1038/ncb1698			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264089				2022-12-25	WOS:000253778300018
J	Jones, NC; Lynn, ML; Gaudenz, K; Sakai, D; Aoto, K; Rey, JP; Glynn, EF; Ellington, L; Du, C; Dixon, J; Dixon, MJ; Trainor, PA				Jones, Natalie C.; Lynn, Megan L.; Gaudenz, Karin; Sakai, Daisuke; Aoto, Kazushi; Rey, Jean-Phillipe; Glynn, Earl F.; Ellington, Lacey; Du, Chunying; Dixon, Jill; Dixon, Michael J.; Trainor, Paul A.			Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function	NATURE MEDICINE			English	Article							TREACHER-COLLINS-SYNDROME; TERMINATION CODON; CELL-CYCLE; GENE; PROTEIN; MICE; APOPTOSIS; EXPRESSION; DYSOSTOSIS; TRANSCRIPTION	Treacher Collins syndrome (TCS) is a congenital disorder of craniofacial development arising from mutations in TCOF1, which encodes the nucleolar phosphoprotein Treacle. Haploinsufficiency of Tcof1 perturbs mature ribosome biogenesis, resulting in stabilization of p53 and the cyclin G1-mediated cell-cycle arrest that underpins the specificity of neuroepithelial apoptosis and neural crest cell hypoplasia characteristic of TCS. Here we show that inhibition of p53 prevents cyclin G1-driven apoptotic elimination of neural crest cells while rescuing the craniofacial abnormalities associated with mutations in Tcof1 and extending life span. These improvements, however, occur independently of the effects on ribosome biogenesis; thus suggesting that it is p53-dependent neuroepithelial apoptosis that is the primary mechanism underlying the pathogenesis of TCS. Our work further implies that neuroepithelial and neural crest cells are particularly sensitive to cellular stress during embryogenesis and that suppression of p53 function provides an attractive avenue for possible clinical prevention of TCS craniofacial birth defects and possibly those of other neurocristopathies.	[Jones, Natalie C.; Lynn, Megan L.; Gaudenz, Karin; Sakai, Daisuke; Aoto, Kazushi; Rey, Jean-Phillipe; Glynn, Earl F.; Ellington, Lacey; Du, Chunying; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Dixon, Michael J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Dixon, Jill; Dixon, Michael J.] Univ Manchester, Sch Dent, Manchester M13 9PT, Lancs, England	Stowers Institute for Medical Research; University of Manchester; University of Manchester	Trainor, PA (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	pat@stowers-institute.org		Trainor, Paul/0000-0003-2774-3624; Jones, Natalie/0000-0002-3300-0571	MRC [G0400264] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; Medical Research Council [G0400264] Funding Source: Medline; NIDCR NIH HHS [R01 DE016082-01, R01 DE016082-05, R01 DE016082-06, P50 DE016215, R01 DE016082-03, R01 DE016082-04, R01 DE016082-02, R01 DE016082, P50 DE 016215, R01 DE 016082-01] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 1996, NAT GENET, V12, P130; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Edwards SJ, 1997, AM J HUM GENET, V60, P515; FAZEN LE, 1967, AM J DIS CHILD, V113, P405, DOI 10.1001/archpedi.1967.02090190051001; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gladwin AJ, 1996, HUM MOL GENET, V5, P1533, DOI 10.1093/hmg/5.10.1533; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jensen MR, 2003, HEPATOLOGY, V37, P862, DOI 10.1053/jhep.2003.50137; KAUFMAN MH, 1992, ATLAS MOUSE DEV, V507; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krull CE, 2004, DEV DYNAM, V229, P433, DOI 10.1002/dvdy.10473; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEIER UT, 1992, CELL, V70, P127; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Nagy A, 2003, MANIPULATING MOUSE E; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; PHELPS PD, 1981, CLIN OTOLARYNGOL, V6, P15, DOI 10.1111/j.1365-2273.1981.tb01782.x; R Development Core Team, 2006, LANG ENV STAT COMP; Reczek EE, 2003, MOL CANCER RES, V1, P1048; ROVIN S, 1964, J PEDIATR-US, V65, P215, DOI 10.1016/S0022-3476(64)80522-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wise CA, 1997, P NATL ACAD SCI USA, V94, P3110, DOI 10.1073/pnas.94.7.3110; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhao L, 2003, MOL CANCER RES, V1, P195	37	292	299	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2008	14	2					125	133		10.1038/nm1725	http://dx.doi.org/10.1038/nm1725			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	259NT	18246078	Green Accepted			2022-12-25	WOS:000252946700020
J	Port, F; Kuster, M; Herr, P; Furger, E; Banziger, C; Hausmann, G; Basler, K				Port, Fillip; Kuster, Marco; Herr, Patrick; Furger, Edy; Baenziger, Carla; Hausmann, George; Basler, Konrad			Wingless secretion promotes and requires retromer-dependent cycling of Wntless	NATURE CELL BIOLOGY			English	Article							SEGMENT POLARITY GENE; GRADIENT FORMATION; WNT PROTEINS; DROSOPHILA; PATHWAY; COMPLEX	Wnt ligands are lipid-modified, secreted glycoproteins that control multiple steps during embryogenesis and adult-tissue homeostasis. Little is known about the mechanisms underlying Wnt secretion. Recently, Wntless (Wls/Evi/Srt) was identified as a conserved multi-pass transmembrane protein whose function seems to be dedicated to promoting the release of Wnts(1-3). Here, we describe Wls accumulation in the Golgi apparatus of Wnt/Wingless (Wg)-producing cells in Drosophila, and show that this localization is essential for Wg secretion. Moreover, Wls localization and levels critically depend on retromer, a conserved protein complex that mediates endosome-to-Golgi protein trafficking in yeast(4). In the absence of the retromer components Dvps35 or Dvps26, but in presence of Wg, Wls is degraded and Wg secretion impaired. Our results indicate that Wg, clathrin-mediated endocytosis and retromer sustain a Wls traffic loop from the Golgi to the plasma membrane and back to the Golgi, thereby enabling Wls to direct Wnt secretion.	[Port, Fillip; Kuster, Marco; Herr, Patrick; Furger, Edy; Baenziger, Carla; Hausmann, George; Basler, Konrad] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.uzh.ch	Herr, Patrick/ABA-6092-2021	Herr, Patrick/0000-0003-2945-966X; Basler, Konrad/0000-0003-3534-1529; Port, Fillip/0000-0002-5157-4835				BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Llimargas M, 2001, P NATL ACAD SCI USA, V98, P14487, DOI 10.1073/pnas.251304398; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; THEISEN H, 1994, DEVELOPMENT, V120, P347; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	36	195	200	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					178	U48		10.1038/ncb1687	http://dx.doi.org/10.1038/ncb1687			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193032				2022-12-25	WOS:000252897800013
J	Hu, WG; Ferris, SP; Tweten, RK; Wu, GX; Radaeva, S; Gao, B; Bronson, RT; Halperin, JA; Qin, XB				Hu, Weiguo; Ferris, Sean P.; Tweten, Rodney K.; Wu, Gongxiong; Radaeva, Svetlana; Gao, Bin; Bronson, Roderick T.; Halperin, Jose A.; Qin, Xuebin			Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin	NATURE MEDICINE			English	Article							STREPTOCOCCUS-INTERMEDIUS; PLATELET ACTIVATION; NITRIC-OXIDE; IN-VIVO; RECEPTOR; DISEASE; ENDOTHELIUM; HEMOGLOBIN; THROMBOSIS; HEMOLYSIS	Conditional targeted cell ablation is a powerful approach for investigating the pathogenesis of human diseases and in vivo cellular functions. Intermedilysin (ILY) is a cytolytic poreforming toxin secreted by Streptococcus intermedius that lyses human cells exclusively, owing to its receptor specificity for human CD59. We generated two transgenic mouse strains that express human CD59 either on erythrocytes (strain ThCD59(RBC)) or on endothelia (strain ThCD59(END)). Intravenous injection of ILY in ThCD59(RBC) mice induced acute intravascular hemolysis, leading to reduced nitric oxide bioavailability, increased platelet activation and rapid death. In ThCD59(END) mice, ILY induced rapid endothelial damage, leading to acute death and disseminated intravascular coagulation. Additionally, we show that human serum contains ILY-specific neutralizing antibodies not found in any other animal species. Together, these results suggest that this new rapid conditional targeted ILY-mediated cell ablation technique can be used in combination with any available transgenic expression system to study the physiologic role of specific cell populations.	[Hu, Weiguo; Halperin, Jose A.; Qin, Xuebin] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Hu, Weiguo; Ferris, Sean P.; Wu, Gongxiong; Halperin, Jose A.; Qin, Xuebin] Harvard Univ, Sch Med, Lab Translat Res, Cambridge, MA 02139 USA; [Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Radaeva, Svetlana] NIAAA, Natl Inst Hlth, Lab Physiol Studies, Div Metab & Hlth Effects, Bethesda, MD 20892 USA; [Gao, Bin] NIAAA, Natl Inst Hlth, Sect Liver Biol, Lab Physiol Studies, Bethesda, MD 20892 USA; [Bronson, Roderick T.] Harvard Univ, Ctr Canc, Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Harvard University; Dana-Farber Cancer Institute	Qin, XB (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	xuebin_qin@hms.harvard.edu	Hu, Weiguo/AAP-2239-2021	Hu, Weiguo/0000-0002-7397-6800	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061174, R01AI063444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060979] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI063444, R01 AI061174] Funding Source: Medline; NIDDK NIH HHS [R01 DK060979] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brouchet L, 2001, CIRCULATION, V103, P423; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; COLLIER RJ, 1990, ADP RIBOSYLATING TOX, P3, DOI DOI 10.1126/SCIENCE.250.4982.841-A; Danishpajooh IO, 2001, J BIOL CHEM, V276, P27296, DOI 10.1074/jbc.M104043200; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Foteinos G, 2005, CIRCULATION, V112, P1206, DOI 10.1161/CIRCULATIONAHA.105.547414; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; HOMER KA, 1994, J MED MICROBIOL, V41, P414, DOI 10.1099/00222615-41-6-414; Isermann B, 2001, J CLIN INVEST, V108, P537, DOI 10.1172/JCI13077; Jancar S, 2005, TRENDS IMMUNOL, V26, P48, DOI 10.1016/j.it.2004.11.007; Kadl A, 2005, ANTIOXID REDOX SIGN, V7, P1744, DOI 10.1089/ars.2005.7.1744; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Nagamune H, 1996, INFECT IMMUN, V64, P3093, DOI 10.1128/IAI.64.8.3093-3100.1996; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Qin XB, 2003, IMMUNITY, V18, P217, DOI 10.1016/S1074-7613(03)00022-0; RAVANAT C, 1995, BLOOD COAGUL FIBRIN, V6, P446, DOI 10.1097/00001721-199507000-00012; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Sukeno A, 2005, MICROBIOL IMMUNOL, V49, P681, DOI 10.1111/j.1348-0421.2005.tb03647.x; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; WHILEY RA, 1992, J CLIN MICROBIOL, V30, P243, DOI 10.1128/JCM.30.1.243-244.1992	29	30	32	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2008	14	1					98	103		10.1038/nm1674	http://dx.doi.org/10.1038/nm1674			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	249IV	18157141				2022-12-25	WOS:000252222400029
J	Livingston, AL; O'Shea, VL; Kim, T; Koo, ET; David, SS				Livingston, Alison L.; O'Shea, Valerie L.; Kim, Taewoo; Koo, Eric T.; David, Sheila S.			Unnatural substrates reveal the importance of 8-oxoguanine for in vivo mismatch repair by MutY	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI MUTY; ADENINE GLYCOSYLASE MUTY; BASE-EXCISION-REPAIR; STEADY-STATE KINETICS; COLORECTAL-CANCER; DNA-DAMAGE; G-A; FUNCTIONAL CONSEQUENCES; INHERITED VARIANTS; HMYH VARIANTS	Escherichia coli MutY has an important role in preventing mutations associated with the oxidative lesion 7,8-dihydro-8-oxo-2'-deoxyguanosine (OG) in DNA by excising adenines from OG center dot A mismatches as the first step of base excision repair. To determine the importance of specific steps in the base pair recognition and base removal process of MutY, we have evaluated the effects of modifications of the OG center dot A substrate on the kinetics of base removal, mismatch affinity and repair to G-C in an E coli-based assay. Notably, adenine modification was tolerated in the cellular assay, whereas modification of OG resulted in minimal cellular repair. High affinity for the mismatch and efficient base removal required the presence of OG. Taken together, these results suggest that the presence of OG is a critical feature that is necessary for MutY to locate OG center dot A mismatches and select the appropriate adenines for excision to initiate repair in vivo before replication.	[David, Sheila S.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Livingston, Alison L.; O'Shea, Valerie L.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Kim, Taewoo; Koo, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California Davis; Utah System of Higher Education; University of Utah; Stanford University	David, SS (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	david@chem.ucdavis.edu		Kool, Eric/0000-0002-7310-2935	NATIONAL CANCER INSTITUTE [T32CA093247, R29CA067985, R01CA067985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008537, R01GM072705] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA067985-14, R01 CA067985-12, CA093247, R01 CA067985, T32 CA093247, R01 CA067985-13, 5P30CA43014, R29 CA067985, CA67985] Funding Source: Medline; NIGMS NIH HHS [GM08537, GM072705, R01 GM072705, T32 GM008537] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; Bai HB, 2007, J BACTERIOL, V189, P902, DOI 10.1128/JB.01513-06; Bai HB, 2005, NUCLEIC ACIDS RES, V33, P597, DOI 10.1093/nar/gki209; Bernards AS, 2002, J BIOL CHEM, V277, P20960, DOI 10.1074/jbc.C200181200; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Chepanoske CL, 1999, NUCLEIC ACIDS RES, V27, P3197, DOI 10.1093/nar/27.15.3197; Chmiel NH, 2003, J MOL BIOL, V327, P431, DOI 10.1016/S0022-2836(03)00124-4; Chmiel NH, 2001, NUCLEIC ACIDS RES, V29, P553, DOI 10.1093/nar/29.2.553; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h; Francis AW, 2003, J AM CHEM SOC, V125, P16235, DOI 10.1021/ja0374426; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Golinelli MP, 1999, BIOCHEMISTRY-US, V38, P6997, DOI 10.1021/bi982300n; Hang B, 2003, CHEM RES TOXICOL, V16, P1181, DOI 10.1021/tx030020p; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Livingston AL, 2005, BIOCHEMISTRY-US, V44, P14179, DOI 10.1021/bi050976u; LU AL, 1988, GENETICS, V118, P593; LU AL, 1988, CELL, V54, P805, DOI 10.1016/S0092-8674(88)91109-9; Maki AS, 2004, BIOCHEMISTRY-US, V43, P1102, DOI 10.1021/bi035340m; McCann JAB, 2003, J BIOL CHEM, V278, P29587, DOI 10.1074/jbc.M212474200; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Pearson CG, 2004, NUCLEIC ACIDS RES, V32, P263, DOI 10.1093/nar/gkh150; Pope MA, 2005, DNA REPAIR, V4, P315, DOI 10.1016/j.dnarep.2004.10.003; Pope MA, 2005, DNA REPAIR, V4, P91, DOI 10.1016/j.dnarep.2004.08.004; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; RADICELLA JP, 1988, P NATL ACAD SCI USA, V85, P9674, DOI 10.1073/pnas.85.24.9674; RECORD MT, 1991, METHOD ENZYMOL, V208, P291; Sambrook J., 1989, MOL CLONING LABORATO, P33; Sampson JR, 2005, BIOCHEM SOC T, V33, P679, DOI 10.1042/BST0330679; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; SU SS, 1988, J BIOL CHEM, V263, P6829; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; WEHRLI W, 1968, P NATL ACAD SCI USA, V61, P667, DOI 10.1073/pnas.61.2.667; Zhao JY, 2000, J BACTERIOL, V182, P5025, DOI 10.1128/JB.182.17.5025-5028.2000	42	29	31	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2008	4	1					51	58		10.1038/nchembio.2007.40	http://dx.doi.org/10.1038/nchembio.2007.40			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	246EJ	18026095	Green Accepted			2022-12-25	WOS:000251990000013
J	Basu, S; Grubina, R; Huang, J; Conradie, J; Huang, Z; Jeffers, A; Jiang, A; He, X; Azarov, I; Seibert, R; Mehta, A; Patel, R; King, SB; Hogg, N; Ghosh, A; Gladwin, MT; Kim-Shapiro, DB				Basu, Swati; Grubina, Rozalina; Huang, Jinming; Conradie, Jeanet; Huang, Zhi; Jeffers, Anne; Jiang, Alice; He, Xiaojun; Azarov, Ivan; Seibert, Ryan; Mehta, Atul; Patel, Rakesh; King, Stephen Bruce; Hogg, Neil; Ghosh, Abhik; Gladwin, Mark T.; Kim-Shapiro, Daniel B.			Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin	NATURE CHEMICAL BIOLOGY			English	Article							RED-BLOOD-CELLS; S-NITROSOHEMOGLOBIN; CORRELATION-ENERGY; NITROGEN-OXIDES; FLOW REGULATION; NO; OXIDATION; DEOXYHEMOGLOBIN; MECHANISM; HEME	Nitrite reacts with deoxyhemoglobin to form nitric oxide (NO) and methemoglobin. Though this reaction is experimentally associated with NO generation and vasodilation, kinetic analysis suggests that NO should not be able to escape inactivation in the erythrocyte. We have discovered that products of the nitrite-hemoglobin reaction generate dinitrogen trioxide (N2O3) via a novel reaction of NO and nitrite-bound methemoglobin. The oxygen-bound form of nitrite-methemoglobin shows a degree of ferrous nitrogen dioxide (Fe(II)-NO2) character, so it may rapidly react with NO to form N2O3. N2O3 partitions in lipid, homolyzes to NO and readily nitrosates thiols, all of which are common pathways for NO escape from the erythrocyte. These results reveal a fundamental heme globin- and nitrite-catalyzed chemical reaction pathway to N2O3, NO and S-nitrosothiol that could form the basis of in vivo nitrite-dependent signaling. Because the reaction redox-cycles ( that is, regenerates ferrous heme) and the nitrite-methemoglobin intermediate is not observable by electron paramagnetic resonance spectroscopy, this reaction has been 'invisible' to experimentalists over the last 100 years.	Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; NHLBI, Vasc Med Branch, NIH, Bethesda, MD 20892 USA; Natl Inst Hlth Res Scholars Program, Howard Hughes Med Inst, Bethesda, MD 20814 USA; Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; Univ Tromso, Dept Chem, N-9037 Tromso, Norway; Univ Tromso, Ctr Theoret & Computat Chem, N-9037 Tromso, Norway; Univ Orange Free State, Dept Chem, ZA-9301 Bloemfontein, South Africa; Wake Forest Univ, Sch Med, Wake Forest Univ Sch Biomed Engn & Sci, Virginia Tech, Winston Salem, NC 27157 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA	Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; Wake Forest University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of the Free State; Virginia Polytechnic Institute & State University; Wake Forest University; University of Alabama System; University of Alabama Birmingham; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, 1834 Wake Forest Rd, Winston Salem, NC 27109 USA.	mgladwin@nih.gov; shapiro@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022; Mehta, Atul/GPC-7364-2022; Conradie, Jeanet/O-1838-2019; Ghosh, Abhik/AAH-1277-2020; Conradie, Jeanet/C-4719-2018	Conradie, Jeanet/0000-0002-8120-6830; Ghosh, Abhik/0000-0003-1161-6364; Conradie, Jeanet/0000-0002-8120-6830; Azarov, Ivan/0000-0002-9886-3298; Seibert, Ryan/0000-0002-9704-5330; Patel, Rakesh/0000-0002-1526-4303	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL58091, R37 HL058091, K02 HL078706, HL62198] Funding Source: Medline; NIGMS NIH HHS [GM55792] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL078706, R37HL058091, R01HL062198, R01HL058091, R29HL058091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055792, R29GM055792] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL008050] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER		Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; CASTRO CE, 1995, J ORG CHEM, V60, P1922, DOI 10.1021/jo00112a006; CHALLIS BC, 1978, J CHEM SOC P2, V2, P1296; Conradie J, 2006, INORG CHEM, V45, P4902, DOI 10.1021/ic060362t; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Copeland DM, 2006, J INORG BIOCHEM, V100, P1413, DOI 10.1016/j.jinorgbio.2006.04.011; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; DABORA R, 1984, IARC SCI PUBL, V57, P311; DAY EP, 1988, BIOCHEMISTRY-US, V27, P2126, DOI 10.1021/bi00406a046; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; Handy NC, 2001, MOL PHYS, V99, P403, DOI 10.1080/00268970010018451; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang KT, 2006, BLOOD, V107, P2602, DOI 10.1182/blood-2005-10-4104; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Jeffers A, 2005, COMP BIOCHEM PHYS A, V142, P130, DOI 10.1016/j.cbpb.2005.04.016; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lim MD, 2002, J AM CHEM SOC, V124, P9737, DOI 10.1021/ja020653a; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nasri H, 2004, INORG CHEM, V43, P2932, DOI 10.1021/ic035119y; OShea SK, 1996, J ORG CHEM, V61, P6388, DOI 10.1021/jo960546x; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Robinson JM, 2005, AM J RESP CELL MOL, V32, P257, DOI 10.1165/rcmb.F292; RODKEY FL, 1976, CLIN CHEM, V22, P1986; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Stepuro II, 1997, BIOCHEMISTRY-MOSCOW+, V62, P960; Wanat A, 2002, J BIOL INORG CHEM, V7, P165, DOI 10.1007/s007750100284; Williams D. L. H., 2004, NITROSATION REACTION; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; Yang BK, 2003, FREE RADICAL RES, V37, P1, DOI 10.1080/1071576021000033112; YOUNG LJ, 1988, BIOCHEMISTRY-US, V27, P2790, DOI 10.1021/bi00408a020	51	191	199	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2007	3	12					785	794		10.1038/nchembio.2007.46	http://dx.doi.org/10.1038/nchembio.2007.46			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	232OI	17982448				2022-12-25	WOS:000251028600013
J	Burnette, DT; Schaefer, AW; Ji, L; Danuser, G; Forscher, P				Burnette, Dylan T.; Schaefer, Andrew W.; Ji, Lin; Danuser, Gaudenz; Forscher, Paul			Filopodial actin bundles are not necessary for microtubule advance into the peripheral domain of Aplysia neuronal growth cones	NATURE CELL BIOLOGY			English	Article							FLUORESCENT SPECKLE MICROSCOPY; DYNAMIC INSTABILITY; ENA/VASP PROTEINS; 2 POPULATIONS; FILAMENTS; ORGANIZATION; CYTOSKELETON; TRANSPORT; GUIDANCE; FLOW	Filopodial actin bundles guide microtubule assembly in the growth cone peripheral ( P) domain and retrograde actin-network flow simultaneously transports microtubules rearward. Therefore, microtubule-end position is determined by the sum of microtubule assembly and retrograde transport rates. However, how filopodia actually affect microtubule assembly dynamics is unknown. To address this issue we quantitatively assessed microtubule and actin dynamics before and after selective removal of filopodia. Filopodium removal had surprisingly little effect on retrograde actin-flow rates or underlying network structures, but resulted in an approximate doubling of peripheral microtubule density and deeper penetration of microtubules into the P domain. The latter stemmed from less efficient coupling of microtubules to remaining actin networks and not from a change in microtubule polymer dynamics. Loss of filopodia also resulted in increased lateral microtubule movements and a more randomized microtubule distribution in the P domain. In summary, filopodia do not seem to be formally required for microtubule advance; however, their presence ensures radial distribution of microtubules in the P domain and facilitates microtubule transport by retrograde flow. The resulting dynamic steady state has interesting implications for rapid microtubule-positioning responses in the P domain.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Yale University; Scripps Research Institute	Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	paul.forscher@yale.edu		Danuser, Gaudenz/0000-0001-8583-2014	NIGMS NIH HHS [U54-GM64346, R01-GM67230] Funding Source: Medline; NINDS NIH HHS [R01 NS051786, R01-NS28695, R01-NS051786] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM067230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Buck KB, 2002, J NEUROSCI, V22, P9358; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Koleske Anthony J, 2003, Sci STKE, V2003, ppe20; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Torreano PJ, 2005, CELL MOTIL CYTOSKEL, V60, P166, DOI 10.1002/cm.20051; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	30	69	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1360	U39		10.1038/ncb1655	http://dx.doi.org/10.1038/ncb1655			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026092				2022-12-25	WOS:000251317300009
J	Stock, JK; Giadrossi, S; Casanova, M; Brookes, E; Vidal, M; Koseki, H; Brockdorff, N; Fisher, AG; Pombo, A				Stock, Julie K.; Giadrossi, Sara; Casanova, Miguel; Brookes, Emily; Vidal, Miguel; Koseki, Haruhiko; Brockdorff, Neil; Fisher, Amanda G.; Pombo, Ana			Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells	NATURE CELL BIOLOGY			English	Article							DEVELOPMENTAL REGULATORS; TRANSCRIPTION FACTOR; HISTONE H2A; POLYCOMB; EXPRESSION; UBIQUITYLATION; ASSOCIATION; RECRUITMENT; SIGNATURES; BLOCKS	Changes in phosphorylation of the carboxy-terminal domain ( CTD) of RNA polymerase II ( RNAP) are associated with transcription initiation, elongation and termination(1-3). Sites of active transcription are generally characterized by hyperphosphorylated RNAP, particularly at Ser 2 residues, whereas inactive or poised genes may lack RNAP or may bind Ser 5-phosphorylated RNAP at promoter proximal regions. Recent studies have demonstrated that silent developmental regulator genes have an unusual histone modification profile in ES cells, being simultaneously marked with Polycomb repressor-mediated histone H3K27 methylation, and marks normally associated with gene activity(4,5). Contrary to the prevailing view, we show here that this important subset of developmental regulator genes, termed bivalent genes, assemble RNAP complexes phosphorylated on Ser 5 and are transcribed at low levels. We provide evidence that this poised RNAP configuration is enforced by Polycomb Repressor Complex ( PRC)-mediated ubiquitination of H2A, as conditional deletion of Ring1A and Ring1B leads to the sequential loss of ubiquitination of H2A, release of poised RNAP, and subsequent gene de-repression. These observations provide an insight into the molecular mechanisms that allow ES cells to self-renew and yet retain the ability to generate multiple lineage outcomes.	Hammersmith Hosp, Nucl Org, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr,Dev Epigenet Grp, London W12 0NN, England; CSIC, Ctr Invest Biol, Dept Dev & Cell Biol, Madrid, Spain; Yokohama Inst, RIKEN, Res Ctr Allergy & Immunol, Dept Dev Genet, Yokohama, Kanagawa, Japan	Imperial College London; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); RIKEN	Pombo, A (corresponding author), Hammersmith Hosp, Nucl Org, Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk; ana.pombo@csc.mrc.ac.uk	Pombo, Ana/A-1045-2010; Koseki, Haruhiko/I-3825-2014; Vidal, Miguel/M-8861-2016	Pombo, Ana/0000-0002-7493-6288; Koseki, Haruhiko/0000-0001-8424-5854; Brookes, Emily/0000-0003-2175-4349; Vidal, Miguel/0000-0003-4374-6761; Casanova, Miguel/0000-0001-8622-6550; Brockdorff, Neil/0000-0003-4838-2653	MRC [MC_U120027516, MC_U120061476, MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120027516, MC_U120031757, MC_U120061476] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lam LT, 2001, GENOME BIOL, V2; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726	39	474	493	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1428	U174		10.1038/ncb1663	http://dx.doi.org/10.1038/ncb1663			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037880	Green Submitted			2022-12-25	WOS:000251317300016
J	Day, SE; Kettunen, MI; Gallagher, FA; Hu, DE; Lerche, M; Wolber, J; Golman, K; Ardenkjaer-Larsen, JH; Brindle, KM				Day, Sam E.; Kettunen, Mikko I.; Gallagher, Ferdia A.; Hu, De-En; Lerche, Mathilde; Wolber, Jan; Golman, Klaes; Ardenkjaer-Larsen, Jan Henrik; Brindle, Kevin M.			Detecting tumor response to treatment using hyperpolarized C-13 magnetic resonance imaging and spectroscopy	NATURE MEDICINE			English	Article							EMISSION-TOMOGRAPHY; APOPTOSIS; THERAPY; INHIBITION; INDUCTION; CELLS; P-31	Measurements of early tumor responses to therapy have been shown, in some cases, to predict treatment outcome. We show in lymphoma-bearing mice injected intravenously with hyperpolarized [1-C-13] pyruvate that the lactate dehydrogenase-catalyzed flux of C-13 label between the carboxyl groups of pyruvate and lactate in the tumor can be measured using 13C magnetic resonance spectroscopy and spectroscopic imaging, and that this flux is inhibited within 24 h of chemotherapy. The reduction in the measured flux after drug treatment and the induction of tumor cell death can be explained by loss of the coenzyme NAD(H) and decreases in concentrations of lactate and enzyme in the tumors. The technique could provide a new way to assess tumor responses to treatment in the clinic.	Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; Imagnia AB, S-20041 Malmo, Sweden; GE Healthcare, Grove Ctr, Amersham HP7 9LL, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; General Electric	Brindle, KM (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	kmb@mole.bio.cam.ac.uk	Kettunen, Mikko I/K-2299-2012; Ardenkjær-Larsen, Jan Henrik/B-5765-2017; Lerche, Mathilde Hauge/J-5487-2017	Kettunen, Mikko I/0000-0002-2004-660X; Ardenkjær-Larsen, Jan Henrik/0000-0001-6167-6926; Gallagher, Ferdia Aidan/0000-0003-4784-5230; Lerche, Mathilde Hauge/0000-0002-5899-2781				Aboagye EO, 1998, CANCER RES, V58, P1063; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; BRINDLE KM, 1986, EUR J BIOCHEM, V158, P299, DOI 10.1111/j.1432-1033.1986.tb09751.x; BRINDLE KM, 1988, PROG NUCL MAG RES SP, V20, P257, DOI 10.1016/0079-6565(88)80003-7; Czernin J, 2006, ANNU REV MED, V57, P99, DOI 10.1146/annurev.med.57.080904.190431; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, ACAD RADIOL, V13, P932, DOI 10.1016/j.acra.2006.06.001; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Kettunen MI, 2005, PROG NUCL MAG RES SP, V47, P175, DOI 10.1016/j.pnmrs.2005.08.005; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Neves AA, 2006, BBA-REV CANCER, V1766, P242, DOI 10.1016/j.bbcan.2006.10.002; Poot M, 1999, CYTOMETRY, V35, P311, DOI 10.1002/(SICI)1097-0320(19990401)35:4<311::AID-CYTO3>3.3.CO;2-5; Poptani H, 2003, NMR BIOMED, V16, P102, DOI 10.1002/nbm.816; Ross BD, 2003, MOL CANCER THER, V2, P581; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; SHULMAN RG, 1979, SCIENCE, V205, P160, DOI 10.1126/science.36664; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; Stroobants S, 2003, EUR J CANCER, V39, P2012, DOI 10.1016/S0959-8049(03)00073-X; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118; Weber WA, 2006, J CLIN ONCOL, V24, P3282, DOI 10.1200/JCO.2006.06.6068; Williams SNO, 1998, MAGNET RESON MED, V40, P411, DOI 10.1002/mrm.1910400311; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	26	690	705	1	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2007	13	11					1382	1387		10.1038/nm1650	http://dx.doi.org/10.1038/nm1650			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	228NP	17965722				2022-12-25	WOS:000250736900033
